Psyllid ID: psy7505
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | 2.2.26 [Sep-21-2011] | |||||||
| Q6ZMQ8 | 1374 | Serine/threonine-protein | yes | N/A | 0.609 | 0.174 | 0.414 | 3e-49 | |
| Q80YE4 | 1365 | Serine/threonine-protein | yes | N/A | 0.606 | 0.175 | 0.421 | 8e-48 | |
| Q3TYD6 | 1471 | Serine/threonine-protein | no | N/A | 0.634 | 0.169 | 0.386 | 1e-47 | |
| Q8IWU2 | 1503 | Serine/threonine-protein | no | N/A | 0.634 | 0.166 | 0.386 | 1e-47 | |
| Q5XJV6 | 1424 | Serine/threonine-protein | no | N/A | 0.644 | 0.178 | 0.381 | 2e-46 | |
| Q96Q04 | 1460 | Serine/threonine-protein | no | N/A | 0.626 | 0.169 | 0.383 | 3e-46 | |
| Q91048 | 1051 | Inactive tyrosine-protein | no | N/A | 0.672 | 0.252 | 0.343 | 3e-42 | |
| Q13308 | 1070 | Inactive tyrosine-protein | no | N/A | 0.692 | 0.255 | 0.335 | 3e-42 | |
| P14616 | 1297 | Insulin receptor-related | no | N/A | 0.609 | 0.185 | 0.392 | 4e-42 | |
| P14617 | 1300 | Insulin receptor-related | no | N/A | 0.609 | 0.184 | 0.384 | 8e-42 |
| >sp|Q6ZMQ8|LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 196 bits (497), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 102/246 (41%), Positives = 151/246 (61%), Gaps = 6/246 (2%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y+KEIGRGWFGKV GE ++G ++++V V+ L+ AS E++ FL E P
Sbjct: 122 RHSLLYLKEIGRGWFGKVFLGEV-----NSGISSAQVVVKELQASASVQEQMQFLEEVQP 176
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + + +MA +
Sbjct: 177 YRALKHSNLLQCLAQCAEVTPYLLVMEFCPLGDLKGYLRSCRVAESMAPDPRTLQRMACE 236
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG-EVALPVRW 262
VA G+ ++ + F+H+D+A RNCL+T++L VKIGD G + KY DY+V ++ +P+RW
Sbjct: 237 VACGVLHLHRNNFVHSDLALRNCLLTADLTVKIGDYGLAHCKYREDYFVTADQLWVPLRW 296
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE + +++ T+ NVWS GV +WE+FE G PY + SD QV+ + L
Sbjct: 297 IAPELVDEVHSNLLVVDQTKSGNVWSLGVTIWELFELGTQPYPQHSDQQVLAYTVREQQL 356
Query: 323 RLPAPR 328
+LP P+
Sbjct: 357 KLPKPQ 362
|
May be involved in neuronal differentiation. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q80YE4|LMTK1_MOUSE Serine/threonine-protein kinase LMTK1 OS=Mus musculus GN=Aatk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 104/247 (42%), Positives = 151/247 (61%), Gaps = 8/247 (3%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y+KEIG GWFGKV GE +G + ++V V+ LK AS E++ FL EA P
Sbjct: 123 RHSLLYLKEIGHGWFGKVFLGEVH-----SGVSGTQVVVKELKVSASVQEQMQFLEEAQP 177
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ +T+ +MA
Sbjct: 178 YRALQHSNLLQCLAQCAEVTPYLLVMEFCPLGDLKGYLRSCRVT-ESMAPDPLTLQRMAC 236
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG-EVALPVR 261
+VA G+ ++ ++H+D+A RNCL+T++L VK+GD G S KY DY V ++ +P+R
Sbjct: 237 EVACGVLHLHRHNYVHSDLALRNCLLTADLTVKVGDYGLSHCKYREDYLVTADQLWVPLR 296
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + ++ T+ NVWS GV +WE+FE G PY + SD QV+ +
Sbjct: 297 WIAPELVDEVHGNLLVVDQTKSSNVWSLGVTIWELFELGAQPYPQHSDRQVLAYAVREQQ 356
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 357 LKLPKPQ 363
|
May be involved in neuronal differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3TYD6|LMTK2_MOUSE Serine/threonine-protein kinase LMTK2 OS=Mus musculus GN=Lmtk2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 145/256 (56%), Gaps = 6/256 (2%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
Q R L+Y++EIG GWFGKV+ GE TG + ++V V+ LK AS E+ FL
Sbjct: 130 QVARHSLNYIQEIGSGWFGKVLLGETY-----TGTSVARVIVKELKVSASPKEQDTFLKS 184
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
PY L+H N+L+ + C+E+ P+LLVFE C GDLK +L + + + + +M
Sbjct: 185 GEPYYILQHPNVLQCVGQCVEAIPYLLVFEFCDLGDLKAYLHNEQEHVRGDSQTMLLQRM 244
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALP 259
A ++A GL+ M + F+H+D+A RNC +TS+L VK+GD G +Y DY + P
Sbjct: 245 ACEIAAGLAAMHKLHFLHSDLALRNCYLTSDLNVKVGDYGIGFSRYKEDYIETDDKKVFP 304
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
+RW APE + + T T+ N+WS GV LWE+F PYA LSD V+ +V
Sbjct: 305 LRWTAPELVTSFQDRLLTADQTKYSNIWSLGVTLWELFNNAAQPYANLSDLDVLNQVIRE 364
Query: 320 EALRLPAPRAVNSHVD 335
++LP P+ + D
Sbjct: 365 RDMKLPKPQLEQPYSD 380
|
Phosphorylates PPP1C, phosphorylase b and CFTR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8IWU2|LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 145/256 (56%), Gaps = 6/256 (2%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
Q R L+Y++EIG GWFGKV+ GE TG + ++V V+ LK A+ E+ FL
Sbjct: 131 QVARHSLNYIQEIGNGWFGKVLLGEIY-----TGTSVARVIVKELKASANPKEQDTFLKN 185
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
PY L+H NIL+ + C+E+ P+LLVFE C GDLK +L S + + + +M
Sbjct: 186 GEPYYILQHPNILQCVGQCVEAIPYLLVFEFCDLGDLKAYLRSEQEHMRGDSQTMLLQRM 245
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALP 259
A +VA GL+ M + F+H+D+A RNC +TS+L VK+GD G +Y DY + P
Sbjct: 246 ACEVAAGLAAMHKLHFLHSDLALRNCFLTSDLNVKVGDYGIGFSRYKEDYIETDDKKVFP 305
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
+RW APE + + T T+ N+WS GV LWE+F+ PY+ LS+ V+ +V
Sbjct: 306 LRWTAPELVTSFQDRLLTADQTKYSNIWSLGVTLWELFDNAAQPYSNLSNLDVLNQVIRE 365
Query: 320 EALRLPAPRAVNSHVD 335
+LP P+ + D
Sbjct: 366 RDTKLPKPQLEQPYSD 381
|
Phosphorylates PPP1C, phosphorylase b and CFTR. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5XJV6|LMTK3_MOUSE Serine/threonine-protein kinase LMTK3 OS=Mus musculus GN=Lmtk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 101/265 (38%), Positives = 154/265 (58%), Gaps = 11/265 (4%)
Query: 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF 136
S+ RQ L Y++EIG GWFGKV+ GE + + ++V V+ L+ A E+
Sbjct: 123 STPLGLSRQHLSYLQEIGSGWFGKVILGEV-----FSDYSPAQVVVKELRASAGPLEQRK 177
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN---EASREALLE 193
F+ EA PYR L+H N+L+ + C+E+ P+LL+ E C GDLK +L + E L
Sbjct: 178 FISEAQPYRSLQHPNVLQCLGVCVETLPFLLIMEFCQLGDLKRYLRAQRPPEGMSPELPP 237
Query: 194 QGITI--KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
+ + +M +++A GL+++ ++H+D+A RNCL+TS+L V+IGD G + Y DYY
Sbjct: 238 RDLRTLQRMGLEIARGLAHLHSHNYVHSDLALRNCLLTSDLTVRIGDYGLAHSNYKEDYY 297
Query: 252 VHGE-VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310
+ E + +P+RW APE L S + + NVWS GV LWE+FEFG PY LSD+
Sbjct: 298 LTPERLWVPLRWAAPELLGELHGSFVLVDQSRESNVWSLGVTLWELFEFGAQPYRHLSDE 357
Query: 311 QVITRVFGTEALRLPAPRAVNSHVD 335
+V+ V + ++L PR + D
Sbjct: 358 EVLAFVVRQQHVKLARPRLKLPYAD 382
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96Q04|LMTK3_HUMAN Serine/threonine-protein kinase LMTK3 OS=Homo sapiens GN=LMTK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 99/258 (38%), Positives = 152/258 (58%), Gaps = 11/258 (4%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
RQ L Y++EIG GWFGKV+ GE + T ++V V+ L+ A E+ F+ EA P
Sbjct: 130 RQHLSYLQEIGSGWFGKVILGEI-----FSDYTPAQVVVKELRASAGPLEQRKFISEAQP 184
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN---EASREALLEQGITI-- 198
YR L+H N+L+ + C+E+ P+LL+ E C GDLK +L + E L + +
Sbjct: 185 YRSLQHPNVLQCLGLCVETLPFLLIMEFCQLGDLKRYLRAQRPPEGLSPELPPRDLRTLQ 244
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VA 257
+M +++A GL+++ ++H+D+A RNCL+TS+L V+IGD G + Y DYY+ E +
Sbjct: 245 RMGLEIARGLAHLHSHNYVHSDLALRNCLLTSDLTVRIGDYGLAHSNYKEDYYLTPERLW 304
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
+P+RW APE L + + + N+WS GV LWE+FEFG PY LSD++V+ V
Sbjct: 305 IPLRWAAPELLGELHGTFMVVDQSRESNIWSLGVTLWELFEFGAQPYRHLSDEEVLAFVV 364
Query: 318 GTEALRLPAPRAVNSHVD 335
+ ++L PR + D
Sbjct: 365 RQQHVKLARPRLKLPYAD 382
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91048|PTK7_CHICK Inactive tyrosine-protein kinase 7 OS=Gallus gallus GN=PTK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 99/288 (34%), Positives = 158/288 (54%), Gaps = 23/288 (7%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+ FPR L + +GRG FG+V +A+G E++ G V V+ L+ Q + L F
Sbjct: 769 KMHFPRSNLQTITTLGRGEFGEVFLAKAKGAEDAEGEAL--VLVKSLQTRDEQLQ-LDFR 825
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA + +L HVN++RL+ C E++P +V E GDLK+FL +++ E+L Q ++
Sbjct: 826 REAEMFGKLNHVNVVRLLGLCREAEPHYMVLEYVDLGDLKQFLRISKSKDESLKPQPLST 885
Query: 199 KMAI----DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG 254
K + VA G+ ++ F+H D+AARNCLV+++ +VK+ S D Y +YY
Sbjct: 886 KHKVSLCTQVALGMEHLSNGRFVHRDLAARNCLVSAQRQVKVSALSLSKDVYNSEYYHFR 945
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
+ +P+RW PE++L + S K +VWSFGVL+WE+F G++PYA L+DD+V+
Sbjct: 946 QAWIPLRWMPPEAVLEDEFST-------KSDVWSFGVLMWEVFTQGEMPYAPLADDEVLA 998
Query: 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVT--------SELRVKIGDT 354
+ + +LP P S + + C SEL +GD+
Sbjct: 999 GLKSGKT-KLPQPEGCPSRLTKLMQRCWAPSPKDRPSFSELAAALGDS 1045
|
Inactive tyrosine kinase involved in Wnt signaling. pathway. Gallus gallus (taxid: 9031) |
| >sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 100/298 (33%), Positives = 162/298 (54%), Gaps = 25/298 (8%)
Query: 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF 136
S + FPR L + +G+ FG+V +A+GLEE T V V+ L+ Q ++L
Sbjct: 786 SDKMHFPRSSLQPITTLGKSEFGEVFLAKAQGLEEGVAETL--VLVKSLQSKDEQ-QQLD 842
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
F E + +L H N++RL+ C E++P +V E GDLK+FL +++ E L Q +
Sbjct: 843 FRRELEMFGKLNHANVVRLLGLCREAEPHYMVLEYVDLGDLKQFLRISKSKDEKLKSQPL 902
Query: 197 TIKMAI----DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV 252
+ K + VA G+ ++ + F+H D+AARNCLV+++ +VK+ G S D Y +YY
Sbjct: 903 STKQKVALCTQVALGMEHLSNNRFVHKDLAARNCLVSAQRQVKVSALGLSKDVYNSEYYH 962
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
+ +P+RW +PE++L D S K +VW+FGVL+WE+F G++P+ +DD+V
Sbjct: 963 FRQAWVPLRWMSPEAILEGDFST-------KSDVWAFGVLMWEVFTHGEMPHGGQADDEV 1015
Query: 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVT--------SELRVKIGDTGSSIDKYP 362
+ + +A RLP P S + + C SE+ +GD S++D P
Sbjct: 1016 LADLQAGKA-RLPQPEGCPSKLYRLMQRCWALSPKDRPSFSEIASALGD--STVDSKP 1070
|
Inactive tyrosine kinase involved in Wnt signaling pathway. Component of both the non-canonical (also known as the Wnt/planar cell polarity signaling) and the canonical Wnt signaling pathway. Functions in cell adhesion, cell migration, cell polarity, proliferation, actin cytoskeleton reorganization and apoptosis. Has a role in embryogenesis, epithelial tissue organization and angiogenesis. Homo sapiens (taxid: 9606) |
| >sp|P14616|INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 100/255 (39%), Positives = 147/255 (57%), Gaps = 15/255 (5%)
Query: 69 LSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED 128
S + + E++ PR+Q+ ++E+G+G FG V EG ARGLE G ++ V ++ + E
Sbjct: 961 FSASDMYVPDEWEVPREQISIIRELGQGSFGMVYEGLARGLE--AGEESTPVALKTVNEL 1018
Query: 129 ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL--LSNEA 186
AS E + FL EA+ + + +++RL+ + P L++ E +RGDLK L L EA
Sbjct: 1019 ASPRECIEFLKEASVMKAFKCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSHLRSLRPEA 1078
Query: 187 SREALLEQ---GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243
L Q G I+MA ++A G++Y+ + F+H D+AARNC+V+ + VKIGD G +
Sbjct: 1079 ENNPGLPQPALGEMIQMAGEIADGMAYLAANKFVHRDLAARNCMVSQDFTVKIGDFGMTR 1138
Query: 244 DKYPGDYYVHGEVA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
D Y DYY G LPVRW APESL + T +VWSFGV+LWEI +
Sbjct: 1139 DVYETDYYRKGGKGLLPVRWMAPESL-------KDGIFTTHSDVWSFGVVLWEIVTLAEQ 1191
Query: 303 PYAELSDDQVITRVF 317
PY LS++QV+ V
Sbjct: 1192 PYQGLSNEQVLKFVM 1206
|
Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P14617|INSRR_CAVPO Insulin receptor-related protein OS=Cavia porcellus GN=INSRR PE=3 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 150/255 (58%), Gaps = 15/255 (5%)
Query: 69 LSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED 128
LS + + E++ PR+Q+ ++E+G+G FG V EG A+GLE G ++ V ++ + E
Sbjct: 961 LSASDMYIPDEWEVPREQISIIRELGQGSFGMVYEGVAKGLE--AGEESTPVALKTVNEL 1018
Query: 129 ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL--LSNEA 186
AS E++ FL EA+ + + +++RL+ + P L++ E +RGDLK L L EA
Sbjct: 1019 ASPRERIEFLKEASVMKAFQCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSHLRSLRPEA 1078
Query: 187 SREALLEQ---GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243
+ + G I+MA ++A G++Y+ + F+H D+AARNC+V+ + VKIGD G +
Sbjct: 1079 ENNPGIPRPALGDMIQMAGEIADGMAYLAANKFVHRDLAARNCMVSQDFTVKIGDFGMTR 1138
Query: 244 DKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
D Y DYY G+ LPVRW APESL + T +VWSFGV+LWEI +
Sbjct: 1139 DVYETDYYRKGGKGLLPVRWMAPESL-------KDGIFTTHSDVWSFGVVLWEIVTLAEQ 1191
Query: 303 PYAELSDDQVITRVF 317
PY LS++QV+ V
Sbjct: 1192 PYQGLSNEQVLKFVM 1206
|
Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. Cavia porcellus (taxid: 10141) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| 242005799 | 2395 | hypothetical protein Phum_PHUM083230 [Pe | 0.802 | 0.131 | 0.497 | 4e-86 | |
| 307205571 | 1645 | Serine/threonine-protein kinase LMTK1 [H | 0.743 | 0.178 | 0.496 | 2e-78 | |
| 322780431 | 1594 | hypothetical protein SINV_09261 [Solenop | 0.723 | 0.178 | 0.490 | 4e-76 | |
| 307173989 | 1625 | Serine/threonine-protein kinase LMTK1 [C | 0.771 | 0.187 | 0.464 | 4e-76 | |
| 332020386 | 1623 | Serine/threonine-protein kinase LMTK1 [A | 0.723 | 0.175 | 0.483 | 5e-76 | |
| 340716399 | 1631 | PREDICTED: hypothetical protein LOC10064 | 0.697 | 0.168 | 0.496 | 3e-74 | |
| 350406316 | 1632 | PREDICTED: hypothetical protein LOC10074 | 0.697 | 0.168 | 0.496 | 4e-74 | |
| 328789087 | 1612 | PREDICTED: hypothetical protein LOC55206 | 0.687 | 0.168 | 0.489 | 5e-73 | |
| 345490008 | 1734 | PREDICTED: hypothetical protein LOC10067 | 0.639 | 0.145 | 0.505 | 8e-72 | |
| 270003173 | 1817 | hypothetical protein TcasGA2_TC002138 [T | 0.847 | 0.183 | 0.388 | 5e-62 |
| >gi|242005799|ref|XP_002423748.1| hypothetical protein Phum_PHUM083230 [Pediculus humanus corporis] gi|212506950|gb|EEB11010.1| hypothetical protein Phum_PHUM083230 [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 324 bits (831), Expect = 4e-86, Method: Composition-based stats.
Identities = 166/334 (49%), Positives = 220/334 (65%), Gaps = 18/334 (5%)
Query: 13 GFVNPLASSPEVSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQ 72
GFVNP S+ E++IFPPPG + I FEPLP + P N+ RP A+S R +S Q
Sbjct: 29 GFVNP-TSNAELTIFPPPGVNSG--QICRFEPLPDIKPQIPNL-RPAAFSYS-ERDISSQ 83
Query: 73 NWFD----SSEF-------QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVF 121
+WF S +F FPR QL YV+E GRGWFGKVV+GEA+ + +KV
Sbjct: 84 DWFCKLIFSKKFLLPEPCSNFPRNQLKYVEEYGRGWFGKVVKGEAQNIIPK--EKVTKVM 141
Query: 122 VRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL 181
V++L EDA+ ++++FLHE Y+ L H NILRL+ CLE++P+L++ E GDLK FL
Sbjct: 142 VKMLHEDATPTDQMYFLHEVKFYKDLNHPNILRLLGRCLETEPFLVILECYPNGDLKTFL 201
Query: 182 LSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241
N AS AL EQG+T++M ++A+GL YM ++ FIHTD+AARNCLV +L +KIGD G+
Sbjct: 202 SQNLASARALSEQGVTLQMCSNIASGLQYMHKNKFIHTDLAARNCLVGPDLTIKIGDYGN 261
Query: 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301
SI+ + DYY G VALP+RWCAPE+L C+D +I+T VT N+WS ++ WEI EF K
Sbjct: 262 SIENFKSDYYCAGSVALPIRWCAPETLKCTDVTIETREVTPPANIWSLAIVFWEICEFCK 321
Query: 302 LPYAELSDDQVITRVFGTEALRLPAPRAVNSHVD 335
LPY+EL+DDQVITRV G + L P H D
Sbjct: 322 LPYSELNDDQVITRVLGDKNYFLEKPNMFCLHKD 355
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307205571|gb|EFN83866.1| Serine/threonine-protein kinase LMTK1 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 298 bits (764), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 153/308 (49%), Positives = 208/308 (67%), Gaps = 15/308 (4%)
Query: 46 PTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGE 105
P +P HN ++ +E + Q WF S+E PR++L Y++EIG GWFGKVVEG
Sbjct: 143 PKSIPLLHNEEQD---TERSILQEPCSEWFQSNELNVPREKLKYLREIGHGWFGKVVEGR 199
Query: 106 ARGLEESTGRTTSK-VFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164
A LE+STG + S V VRIL E+A+ EK +FL EATPY +LRH N+L L+ CLE+DP
Sbjct: 200 A-DLEQSTGVSKSGGVVVRILTEEATTKEKAWFLGEATPYLKLRHQNVLALLGFCLETDP 258
Query: 165 WLLVFESCSRGDLKEFLLSNE--ASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVA 222
+LL+FESC GDLK FLLSN SREAL ++ I I++AI++A GL +M GF HTD++
Sbjct: 259 YLLLFESCPAGDLKGFLLSNRDTKSREALTKENIPIRIAIEIAAGLKHMHNHGFAHTDLS 318
Query: 223 ARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTE 282
ARNCLV +L K+GD G+ ++KYP DYY+ G+ ALP+RW APESL C+DT+I+T +T
Sbjct: 319 ARNCLVAPDLSAKLGDYGTGVEKYPNDYYIVGDRALPIRWSAPESLNCTDTTIETQEITL 378
Query: 283 KCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV------FGTEALRLPAPRAVN--SHV 334
+ N+WS+ VLLWEI +G+ PY +++D+QVI + F RL VN S++
Sbjct: 379 QANMWSYAVLLWEIISWGERPYNDMNDEQVIQMILSLKNEFPPNGTRLLQSYLVNCSSNI 438
Query: 335 DVAARNCL 342
A R+CL
Sbjct: 439 YQATRSCL 446
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322780431|gb|EFZ09919.1| hypothetical protein SINV_09261 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 291 bits (745), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 148/302 (49%), Positives = 203/302 (67%), Gaps = 17/302 (5%)
Query: 40 ISFEPLP--TLVPPQHNVKRPPAY-----------SEELVRQLSMQNWFDSSEFQFPRQQ 86
I FEPLP ++V N + A ++ + Q WF+S+E PR++
Sbjct: 93 IQFEPLPVDSIVSGARNTPKHIAIPLSAPRIEDQDTDRSILQEPCSEWFNSNELYVPREK 152
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK-VFVRILKEDASQAEKLFFLHEATPYR 145
L Y++EIG GWFGKVVEG A LE+S G + S V VRIL E+A+ EK +FL EATPY
Sbjct: 153 LKYLREIGHGWFGKVVEGRA-DLEQSKGISKSGGVVVRILTEEATTREKAWFLGEATPYL 211
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLEQGITIKMAID 203
+LRH N+L L+ CLE+DP+LL+FESC GDLK FLLSN SREAL ++ I I++AI+
Sbjct: 212 KLRHQNVLALLGFCLETDPYLLLFESCPAGDLKGFLLSNCDNKSREALTKENIPIRIAIE 271
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+A+GL +M GF HTD++ARNCLV +L K+GD G+ ++KYP DYY+ G+ ALP+RW
Sbjct: 272 IASGLKHMHNHGFAHTDLSARNCLVAPDLSAKLGDYGTGVEKYPEDYYIVGDRALPIRWS 331
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
APESL C+DT+I+T +T N+WS+ VLLWEI +G+ PY +++D+QVI + +
Sbjct: 332 APESLNCTDTTIETQEITLSANMWSYAVLLWEIASWGERPYNDMNDEQVIQMILSLKKQF 391
Query: 324 LP 325
LP
Sbjct: 392 LP 393
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307173989|gb|EFN64707.1| Serine/threonine-protein kinase LMTK1 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 291 bits (745), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 150/323 (46%), Positives = 212/323 (65%), Gaps = 19/323 (5%)
Query: 40 ISFEPLP-------TLVPPQHNV------KRPPAYSEELVRQLSMQNWFDSSEFQFPRQQ 86
+ FEPLP T PP+ + ++ + Q WF+S+E PR++
Sbjct: 117 VQFEPLPVDSIVSGTRSPPKAKAIPLSTPRNEDQDTDRSILQEPCSEWFNSNELYVPREK 176
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK-VFVRILKEDASQAEKLFFLHEATPYR 145
L Y++EIG GWFGKVVEG A LE+S G + S V VRIL E+A+ EK +FL EATPY
Sbjct: 177 LKYLREIGHGWFGKVVEGRA-DLEQSKGISKSGGVVVRILTEEATTREKAWFLGEATPYL 235
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLEQGITIKMAID 203
+LRH N+L L+ CLE+DP+LL+FESC GDLK FLLSN SR+AL ++ + I++AI+
Sbjct: 236 KLRHQNVLALLGFCLETDPYLLLFESCPAGDLKGFLLSNCDTTSRDALTKENVPIRIAIE 295
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+A GL +M GF HTD++ARNCL+ +L K+GD G+ ++KYP DYY+ G+ ALP+RW
Sbjct: 296 IAAGLKHMHSHGFAHTDLSARNCLIAPDLSAKLGDYGTGVEKYPEDYYIIGDRALPIRWS 355
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
APESL C+DT+I+T +T K N+WS+ VLLWEI +G+ PY +++D+QVI + +
Sbjct: 356 APESLNCTDTTIETQEITLKANMWSYAVLLWEIISWGERPYNDMNDEQVIQMILSLKKQV 415
Query: 324 LP-APRAVNSH-VDVAARNCLVT 344
P R + S+ V+ ++ C VT
Sbjct: 416 SPNGTRLLQSYLVNCSSNICQVT 438
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332020386|gb|EGI60806.1| Serine/threonine-protein kinase LMTK1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 291 bits (744), Expect = 5e-76, Method: Compositional matrix adjust.
Identities = 146/302 (48%), Positives = 204/302 (67%), Gaps = 17/302 (5%)
Query: 40 ISFEPLP-------TLVPPQHN---VKRPPAYSEEL---VRQLSMQNWFDSSEFQFPRQQ 86
+ FEPLP T P+H + P ++ + Q WF+S+E PR++
Sbjct: 122 VQFEPLPVDSIVSGTRSVPKHKAIPLSAPRIEDQDTDYSILQEPCSEWFNSNELYVPREK 181
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK-VFVRILKEDASQAEKLFFLHEATPYR 145
L Y++EIG GWFGKVVEG A LE+S G + S V VRIL E+A+ EK +FL EATPY
Sbjct: 182 LKYLREIGHGWFGKVVEGRA-DLEQSKGMSKSGGVVVRILTEEATTREKAWFLGEATPYL 240
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNE--ASREALLEQGITIKMAID 203
+LRH N+L L+ CLE+DP+LL+FESC GDLK FLLSN SREAL ++ I I++AID
Sbjct: 241 KLRHQNVLALLGFCLETDPYLLLFESCPAGDLKGFLLSNRDSKSREALAKENIPIRIAID 300
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+A+GL +M GF HTD++ARNCL+ +L K+GD G+ ++KYP DYY+ G+ ALP+RW
Sbjct: 301 IASGLKHMHSHGFAHTDLSARNCLIAPDLSAKLGDYGTGVEKYPEDYYIVGDRALPIRWS 360
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
APESL C+DT+I+T +T + N+WS+ +LLWEI +G+ PY +++D+QVI + +
Sbjct: 361 APESLNCTDTTIETQEITLQANMWSYAILLWEITSWGERPYNDMNDEQVIQIILSLKNQF 420
Query: 324 LP 325
+P
Sbjct: 421 VP 422
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340716399|ref|XP_003396686.1| PREDICTED: hypothetical protein LOC100649624 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 285 bits (728), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 147/296 (49%), Positives = 199/296 (67%), Gaps = 21/296 (7%)
Query: 40 ISFEPLPT---LVPPQHNVKRPP-----AYSEELVRQLSM-----QNWFDSSEFQFPRQQ 86
+ FEPLP + P++ K P ++ EE + WFD+ + PR++
Sbjct: 122 VQFEPLPVEHIISGPRNTTKPKPLPLSTSFFEEHDSDSNTLPEHCHEWFDAQDLCVPREK 181
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK---VFVRILKEDASQAEKLFFLHEATP 143
L Y++EIG GWFGKVVEG A LE R TSK V VRIL E+A+ EK +FL EATP
Sbjct: 182 LKYLREIGHGWFGKVVEGRA-DLE--GHRRTSKNGGVIVRILTEEATMKEKAWFLGEATP 238
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLEQGITIKMA 201
Y +L H NIL L+ CLE+DP+LL+FESCS GDLK FLLSN + S+EAL ++ I I+MA
Sbjct: 239 YLKLHHQNILTLLGFCLETDPYLLLFESCSVGDLKGFLLSNHDKKSQEALSKENIPIRMA 298
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+D+A GL +M GF+HTD++ARNCLV S+L K+GD G+ ++KYP DYYV G+ ALP+R
Sbjct: 299 LDIAAGLKHMHSHGFVHTDLSARNCLVASDLSAKLGDYGTGVEKYPEDYYVVGDRALPIR 358
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
W APES+ C+DT+I+T +T + N+WS+ + LWEI +G PY + SD+QVI +
Sbjct: 359 WSAPESVECTDTTIETREITSQANMWSYAIFLWEIITWGNRPYHDKSDEQVIQMLL 414
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350406316|ref|XP_003487728.1| PREDICTED: hypothetical protein LOC100749516 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 284 bits (727), Expect = 4e-74, Method: Compositional matrix adjust.
Identities = 147/296 (49%), Positives = 199/296 (67%), Gaps = 21/296 (7%)
Query: 40 ISFEPLPT---LVPPQHNVKRPP-----AYSEELVRQLSM-----QNWFDSSEFQFPRQQ 86
+ FEPLP + P++ K P ++ EE + WFD+ + PR++
Sbjct: 122 VQFEPLPVEHIISGPRNTTKPKPLPLSTSFFEEHDSDSNTLPEHCHEWFDAQDLCVPREK 181
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK---VFVRILKEDASQAEKLFFLHEATP 143
L Y++EIG GWFGKVVEG A LE R TSK V VRIL E+A+ EK +FL EATP
Sbjct: 182 LKYLREIGHGWFGKVVEGRA-DLE--GHRRTSKNGGVIVRILTEEATMKEKAWFLGEATP 238
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLEQGITIKMA 201
Y +L H NIL L+ CLE+DP+LL+FESCS GDLK FLLSN + S+EAL ++ I I+MA
Sbjct: 239 YLKLHHQNILTLLGFCLETDPYLLLFESCSVGDLKGFLLSNHDKKSQEALNKENIPIRMA 298
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+D+A GL +M GF+HTD++ARNCLV S+L K+GD G+ ++KYP DYYV G+ ALP+R
Sbjct: 299 LDIAAGLKHMHSHGFVHTDLSARNCLVASDLSAKLGDYGTGVEKYPEDYYVVGDRALPIR 358
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
W APES+ C+DT+I+T +T + N+WS+ + LWEI +G PY + SD+QVI +
Sbjct: 359 WSAPESVECTDTTIETREITSQANMWSYAIFLWEIITWGNRPYHDKSDEQVIQMLL 414
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328789087|ref|XP_624443.3| PREDICTED: hypothetical protein LOC552061 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 281 bits (718), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 142/290 (48%), Positives = 197/290 (67%), Gaps = 19/290 (6%)
Query: 36 PHSIISFEPLP--TLVPPQHNVKRP--PAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVK 91
P +I+ +PLP +L +H+ P Y E WFD+ + R++L Y++
Sbjct: 136 PKNILKPKPLPLSSLFFEKHDSDSNTLPEYCRE---------WFDAKDLCVSREKLKYLR 186
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSK--VFVRILKEDASQAEKLFFLHEATPYRRLRH 149
EIG GWFGKVVEG R E RT+ V VRIL E+A+ EK +FL EATPY +L H
Sbjct: 187 EIGHGWFGKVVEG--RADLEGHKRTSKNGGVVVRILTEEATMKEKAWFLGEATPYLKLHH 244
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLEQGITIKMAIDVATG 207
NIL L+ CLE+DP+LL+FESCS GDLK FLLSN + S+EAL ++ I I++A+D+A G
Sbjct: 245 QNILTLIGFCLETDPYLLLFESCSVGDLKSFLLSNRDKKSQEALNKENILIRIALDIAAG 304
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
L +M +GF+HTD++ARNCLV S+L K+GD G+ ++KYP DYYV G+ ALP+RW APES
Sbjct: 305 LKHMHCNGFVHTDLSARNCLVASDLSAKLGDYGTGVEKYPEDYYVVGDRALPIRWSAPES 364
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
+ C+DT+I+T +T + N+WS+ + LWEI +G +PY + SD+QVI +
Sbjct: 365 VECTDTTIETREITSEANMWSYAIFLWEIITWGNIPYHDKSDEQVIQMLL 414
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345490008|ref|XP_003426281.1| PREDICTED: hypothetical protein LOC100679044 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 277 bits (708), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 130/257 (50%), Positives = 183/257 (71%), Gaps = 5/257 (1%)
Query: 70 SMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK---VFVRILK 126
S WF ++ PR++L Y++E+G GWFGKVVEG A + G+T K V VRIL
Sbjct: 165 SCHEWFQKTDLHVPREKLKYLREMGHGWFGKVVEGCAELQGTNLGKTNVKNGNVVVRILT 224
Query: 127 EDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNE- 185
E+A+ EK +FL EATPY +LRH NIL L +CLE+DP+LL+FESC GDLK FL SN
Sbjct: 225 EEATAKEKAWFLGEATPYFKLRHRNILSLFGSCLETDPYLLLFESCPLGDLKGFLRSNRD 284
Query: 186 -ASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
SR+AL ++ + ++AI+V GL +M E G HTD++ARNCLV S+L +K+GD G+ ++
Sbjct: 285 AESRQALDKENMPTRIAIEVGAGLRHMHEHGLAHTDLSARNCLVASDLSIKLGDYGTGVE 344
Query: 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
KYPGDYYV G+ ALP+RW APES+ C++T+I+T +T + N+WS+ VLLWEI +G+ PY
Sbjct: 345 KYPGDYYVLGDRALPIRWSAPESVECTETTIETREITPRANLWSYAVLLWEIAMWGERPY 404
Query: 305 AELSDDQVITRVFGTEA 321
+L D++VI + +++
Sbjct: 405 NDLEDEKVIEMLLSSKS 421
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270003173|gb|EEZ99620.1| hypothetical protein TcasGA2_TC002138 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 244 bits (623), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 138/355 (38%), Positives = 211/355 (59%), Gaps = 21/355 (5%)
Query: 13 GFVNPLASSPEVSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQ 72
G VNP+A+ E +IF P Q +++ + Q + R + + + +
Sbjct: 42 GHVNPVANG-EFTIFTPLSPPHQNNNV--------FLANQQIITR--TQEDYIFGDVDVS 90
Query: 73 NWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA 132
+WF+ +E FPR +L Y+KEIG+GWFG+VVEG A+ ++ T V VRIL+ AS+
Sbjct: 91 SWFNGTETDFPRIKLKYIKEIGKGWFGRVVEGAAQDIDSEQKWTP--VVVRILEATASKR 148
Query: 133 EKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALL 192
E++ FLH+A+ YR H NIL+L+ CL++ P LL+ E C +GDLK +L N+ + + LL
Sbjct: 149 ERVVFLHDASIYRCGSHPNILKLIGRCLDTIPLLLLQEYCPQGDLKNYLRQNKPTADKLL 208
Query: 193 EQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV 252
+ +++ L ++ E+ H D+AARNC +TS L +K+GD G ++ +YP DYY+
Sbjct: 209 STEYPLVWCCQLSSALKFLHENRLSHPDLAARNCQLTSNLTLKLGDYGLAVLQYPEDYYL 268
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
G + VRWCAPESL + T+I+ TVT + N+WSF V +WEI E G+ PY+ L+DD+V
Sbjct: 269 -GAAGVSVRWCAPESLSYTSTTIEPKTVTLEANIWSFAVTMWEICECGEQPYSSLTDDEV 327
Query: 313 ITRVFGTEALRLPAPR---AVNSHVDVAARNCLVTSELRVKIGDTGSSIDKYPGD 364
I++V G++ +RL PR N ++ + C TSE R + S ID GD
Sbjct: 328 ISQVLGSQKVRLSRPRFQMLYNDYIFRLMQLCWTTSESRPAM----SQIDLMLGD 378
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| ZFIN|ZDB-GENE-100812-4 | 1608 | aatka "apoptosis-associated ty | 0.606 | 0.148 | 0.432 | 1.3e-46 | |
| MGI|MGI:3039582 | 1424 | Lmtk3 "lemur tyrosine kinase 3 | 0.644 | 0.178 | 0.384 | 1.4e-46 | |
| UNIPROTKB|F1MIB7 | 1365 | AATK "Uncharacterized protein" | 0.606 | 0.175 | 0.429 | 2.6e-46 | |
| ZFIN|ZDB-GENE-100922-162 | 2769 | si:dkey-40m6.8 "si:dkey-40m6.8 | 0.659 | 0.093 | 0.411 | 7.5e-46 | |
| UNIPROTKB|F1PRD2 | 813 | AATK "Uncharacterized protein" | 0.606 | 0.293 | 0.412 | 1.1e-45 | |
| UNIPROTKB|H7C175 | 1271 | AATK "Serine/threonine-protein | 0.606 | 0.188 | 0.421 | 1.2e-45 | |
| UNIPROTKB|Q6ZMQ8 | 1374 | AATK "Serine/threonine-protein | 0.606 | 0.173 | 0.421 | 1.5e-45 | |
| UNIPROTKB|F1RZY5 | 1369 | AATK "Uncharacterized protein" | 0.606 | 0.174 | 0.421 | 2.4e-45 | |
| UNIPROTKB|I3L8C7 | 1382 | AATK "Uncharacterized protein" | 0.606 | 0.172 | 0.421 | 2.4e-45 | |
| MGI|MGI:1197518 | 1365 | Aatk "apoptosis-associated tyr | 0.606 | 0.175 | 0.421 | 1e-44 |
| ZFIN|ZDB-GENE-100812-4 aatka "apoptosis-associated tyrosine kinase a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 1.3e-46, P = 1.3e-46
Identities = 106/245 (43%), Positives = 149/245 (60%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y+KE+G GWFGKV+ GE + G +T++V V+ LK AS E++ FL E P
Sbjct: 133 RHSLLYIKEMGHGWFGKVLLGEV-----NAGLSTTQVVVKELKASASVQEQMQFLEEVQP 187
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
YR L+H +L+ ++ E P+LLV E C GD+K +L S A+ + I +MA +
Sbjct: 188 YRVLQHPALLQCLSQSTEVTPYLLVMEHCPLGDVKGYLRSCRAADSVTPDPLILQRMACE 247
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRW 262
+A+GL Y+ + +IH+D+A RNCL+TSEL VKIGD G S KY DYYV + + +P+RW
Sbjct: 248 IASGLLYLHKHNYIHSDLALRNCLLTSELAVKIGDYGLSHSKYKDDYYVTADQIWVPLRW 307
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE + ++ T+ NVWS GV +WE+FE G PY SD QV+T + L
Sbjct: 308 IAPELIDEVHGNLLVVDQTKASNVWSLGVTIWELFELGNQPYRHYSDRQVLTYAVKEQQL 367
Query: 323 RLPAP 327
+LP P
Sbjct: 368 KLPKP 372
|
|
| MGI|MGI:3039582 Lmtk3 "lemur tyrosine kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 1.4e-46, Sum P(2) = 1.4e-46
Identities = 102/265 (38%), Positives = 156/265 (58%)
Query: 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF 136
S+ RQ L Y++EIG GWFGKV+ GE + + ++V V+ L+ A E+
Sbjct: 123 STPLGLSRQHLSYLQEIGSGWFGKVILGEV-----FSDYSPAQVVVKELRASAGPLEQRK 177
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN---EASREALLE 193
F+ EA PYR L+H N+L+ + C+E+ P+LL+ E C GDLK +L + E L
Sbjct: 178 FISEAQPYRSLQHPNVLQCLGVCVETLPFLLIMEFCQLGDLKRYLRAQRPPEGMSPELPP 237
Query: 194 QGI-TI-KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
+ + T+ +M +++A GL+++ ++H+D+A RNCL+TS+L V+IGD G + Y DYY
Sbjct: 238 RDLRTLQRMGLEIARGLAHLHSHNYVHSDLALRNCLLTSDLTVRIGDYGLAHSNYKEDYY 297
Query: 252 VHGE-VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310
+ E + +P+RW APE L S + + NVWS GV LWE+FEFG PY LSD+
Sbjct: 298 LTPERLWVPLRWAAPELLGELHGSFVLVDQSRESNVWSLGVTLWELFEFGAQPYRHLSDE 357
Query: 311 QVITRVFGTEALRLPAPRAVNSHVD 335
+V+ V + ++L PR + D
Sbjct: 358 EVLAFVVRQQHVKLARPRLKLPYAD 382
|
|
| UNIPROTKB|F1MIB7 AATK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 2.6e-46, P = 2.6e-46
Identities = 106/247 (42%), Positives = 154/247 (62%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y++EIG GWFGKV GE ++G ++++V V+ LK AS E++ FL EA P
Sbjct: 105 RHSLLYLEEIGHGWFGKVFLGEV-----NSGISSTQVVVKELKASASVQEQMQFLEEAQP 159
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + EA+ +T+ +MA
Sbjct: 160 YRALQHSNLLQCLAQCAEVTPYLLVMEFCPMGDLKGYLRSCRVA-EAMAPDPLTLQRMAC 218
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ + F+H+D+A RNCL+T++L VKIGD G S KY DY+V + + +P+R
Sbjct: 219 EVACGVLHLHRNNFVHSDLALRNCLLTADLTVKIGDYGLSHGKYREDYFVTADQLWVPLR 278
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + ++ T+ NVWS GV +WE+FE G PY SD QV+ +
Sbjct: 279 WIAPELVDEVHCNLLVVDQTKASNVWSLGVTIWELFELGAQPYPHHSDRQVLAYAVREQQ 338
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 339 LKLPKPQ 345
|
|
| ZFIN|ZDB-GENE-100922-162 si:dkey-40m6.8 "si:dkey-40m6.8" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 7.5e-46, Sum P(2) = 7.5e-46
Identities = 112/272 (41%), Positives = 167/272 (61%)
Query: 70 SMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA 129
S+ N DSS+ F R L+Y++EIG GWFGKV+ E L + + + + V+ L+ A
Sbjct: 117 SIPNGTDSSQC-FRRHTLNYLQEIGNGWFGKVILAEV--LCDCS---SYQAVVKELRVSA 170
Query: 130 SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEAS-- 187
S E+ FL E+ PYR L+H NIL+ + C ES P+LLV E C GDLK +L + S
Sbjct: 171 SPLEQRKFLAESEPYRSLQHPNILQCLGQCSESVPFLLVMEFCQLGDLKRYLRAQRKSDG 230
Query: 188 -REALLEQGI-TI-KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
LL + + T+ +MA ++ +GL ++ E+ +IH+D+A RNCL+TS+L V+IGD G S +
Sbjct: 231 MTPDLLNRDLLTLQRMAYEITSGLLHLHENNYIHSDLALRNCLLTSDLTVRIGDYGLSHN 290
Query: 245 KYPGDYYVHGE-VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
+Y DYY+ + + +P+RW APE L ++ T+ NVWS GV++WE+FEFG P
Sbjct: 291 QYKEDYYLTPDKLWIPLRWIAPELLEEFRGNLIVTDQTKTSNVWSLGVVIWELFEFGAQP 350
Query: 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVD 335
+ LSD++V+T V + L PR +H D
Sbjct: 351 HRHLSDEEVLTFVIRERQITLAQPRLKLAHAD 382
|
|
| UNIPROTKB|F1PRD2 AATK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 1.1e-45, P = 1.1e-45
Identities = 102/247 (41%), Positives = 153/247 (61%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y++E+G GWFGKV GE ++G ++++V V+ LK AS E++ FL EA P
Sbjct: 112 RHSLLYLEEVGHGWFGKVFLGEV-----NSGISSTQVVVKELKASASVQEQMQFLEEAQP 166
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ +T+ +MA
Sbjct: 167 YRALQHSNLLQCLAQCAEVTPYLLVMEFCPMGDLKGYLRSCRVA-ESMAPDPLTLQRMAC 225
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ + ++H+D+A RNCL+ ++L VKIGD G S KY DY+V + + +P+R
Sbjct: 226 EVACGVLHLHRNNYVHSDLALRNCLLAADLTVKIGDYGLSHGKYREDYFVTADQLWVPLR 285
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + ++ T+ NVWS GV +WE+FE G PY SD QV+ +
Sbjct: 286 WIAPELVDEVHCNLLVVDQTKASNVWSLGVTIWELFELGAQPYPHHSDRQVLAYAVREQQ 345
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 346 LKLPKPQ 352
|
|
| UNIPROTKB|H7C175 AATK "Serine/threonine-protein kinase LMTK1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 491 (177.9 bits), Expect = 1.2e-45, P = 1.2e-45
Identities = 104/247 (42%), Positives = 155/247 (62%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y+KEIGRGWFGKV GE ++G ++++V V+ L+ AS E++ FL E P
Sbjct: 19 RHSLLYLKEIGRGWFGKVFLGEV-----NSGISSAQVVVKELQASASVQEQMQFLEEVQP 73
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ T+ +MA
Sbjct: 74 YRALKHSNLLQCLAQCAEVTPYLLVMEFCPLGDLKGYLRSCRVA-ESMAPDPRTLQRMAC 132
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ + F+H+D+A RNCL+T++L VKIGD G + KY DY+V + + +P+R
Sbjct: 133 EVACGVLHLHRNNFVHSDLALRNCLLTADLTVKIGDYGLAHCKYREDYFVTADQLWVPLR 192
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + +++ T+ NVWS GV +WE+FE G PY + SD QV+ +
Sbjct: 193 WIAPELVDEVHSNLLVVDQTKSGNVWSLGVTIWELFELGTQPYPQHSDQQVLAYTVREQQ 252
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 253 LKLPKPQ 259
|
|
| UNIPROTKB|Q6ZMQ8 AATK "Serine/threonine-protein kinase LMTK1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 491 (177.9 bits), Expect = 1.5e-45, P = 1.5e-45
Identities = 104/247 (42%), Positives = 155/247 (62%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y+KEIGRGWFGKV GE ++G ++++V V+ L+ AS E++ FL E P
Sbjct: 122 RHSLLYLKEIGRGWFGKVFLGEV-----NSGISSAQVVVKELQASASVQEQMQFLEEVQP 176
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ T+ +MA
Sbjct: 177 YRALKHSNLLQCLAQCAEVTPYLLVMEFCPLGDLKGYLRSCRVA-ESMAPDPRTLQRMAC 235
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ + F+H+D+A RNCL+T++L VKIGD G + KY DY+V + + +P+R
Sbjct: 236 EVACGVLHLHRNNFVHSDLALRNCLLTADLTVKIGDYGLAHCKYREDYFVTADQLWVPLR 295
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + +++ T+ NVWS GV +WE+FE G PY + SD QV+ +
Sbjct: 296 WIAPELVDEVHSNLLVVDQTKSGNVWSLGVTIWELFELGTQPYPQHSDQQVLAYTVREQQ 355
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 356 LKLPKPQ 362
|
|
| UNIPROTKB|F1RZY5 AATK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 2.4e-45, P = 2.4e-45
Identities = 104/247 (42%), Positives = 153/247 (61%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y++EIG GWFGKV GE ++G ++++V V+ LK AS E++ FL EA P
Sbjct: 123 RHSLLYLEEIGHGWFGKVFLGEV-----NSGISSTQVVVKELKASASVQEQVQFLEEAQP 177
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ +T+ +MA
Sbjct: 178 YRALQHSNLLQCLAQCAEVTPYLLVMEFCPMGDLKGYLRSCRVA-ESMAPDPLTLQRMAC 236
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ ++H+D+A RNCL+T++L VKIGD G S KY DY+V + + +P+R
Sbjct: 237 EVACGVLHLHRHNYVHSDLALRNCLLTADLTVKIGDYGLSHGKYREDYFVTADQLWVPLR 296
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + ++ T+ NVWS GV +WE+FE G PY SD QV+ +
Sbjct: 297 WIAPELVDEVHCNLLVVDQTKASNVWSLGVTIWELFELGAQPYPHHSDRQVLAYAVREQQ 356
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 357 LKLPKPQ 363
|
|
| UNIPROTKB|I3L8C7 AATK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 2.4e-45, P = 2.4e-45
Identities = 104/247 (42%), Positives = 153/247 (61%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y++EIG GWFGKV GE ++G ++++V V+ LK AS E++ FL EA P
Sbjct: 123 RHSLLYLEEIGHGWFGKVFLGEV-----NSGISSTQVVVKELKASASVQEQVQFLEEAQP 177
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ +T+ +MA
Sbjct: 178 YRALQHSNLLQCLAQCAEVTPYLLVMEFCPMGDLKGYLRSCRVA-ESMAPDPLTLQRMAC 236
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ ++H+D+A RNCL+T++L VKIGD G S KY DY+V + + +P+R
Sbjct: 237 EVACGVLHLHRHNYVHSDLALRNCLLTADLTVKIGDYGLSHGKYREDYFVTADQLWVPLR 296
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + ++ T+ NVWS GV +WE+FE G PY SD QV+ +
Sbjct: 297 WIAPELVDEVHCNLLVVDQTKASNVWSLGVTIWELFELGAQPYPHHSDRQVLAYAVREQQ 356
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 357 LKLPKPQ 363
|
|
| MGI|MGI:1197518 Aatk "apoptosis-associated tyrosine kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 1.0e-44, P = 1.0e-44
Identities = 104/247 (42%), Positives = 151/247 (61%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R L Y+KEIG GWFGKV GE +G + ++V V+ LK AS E++ FL EA P
Sbjct: 123 RHSLLYLKEIGHGWFGKVFLGEVH-----SGVSGTQVVVKELKVSASVQEQMQFLEEAQP 177
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI-KMAI 202
YR L+H N+L+ +A C E P+LLV E C GDLK +L S + E++ +T+ +MA
Sbjct: 178 YRALQHSNLLQCLAQCAEVTPYLLVMEFCPLGDLKGYLRSCRVT-ESMAPDPLTLQRMAC 236
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVR 261
+VA G+ ++ ++H+D+A RNCL+T++L VK+GD G S KY DY V + + +P+R
Sbjct: 237 EVACGVLHLHRHNYVHSDLALRNCLLTADLTVKVGDYGLSHCKYREDYLVTADQLWVPLR 296
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + ++ T+ NVWS GV +WE+FE G PY + SD QV+ +
Sbjct: 297 WIAPELVDEVHGNLLVVDQTKSSNVWSLGVTIWELFELGAQPYPQHSDRQVLAYAVREQQ 356
Query: 322 LRLPAPR 328
L+LP P+
Sbjct: 357 LKLPKPQ 363
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 394 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-79 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-76 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-74 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-73 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-72 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-66 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-60 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-58 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-57 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-57 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-54 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-54 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-53 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-52 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-51 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-50 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-49 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-48 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-47 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-47 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-45 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-45 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-45 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-44 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-44 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-43 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-42 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-42 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-41 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-40 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-40 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-38 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-37 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-37 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-37 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-37 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-37 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-37 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-37 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-36 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-36 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-36 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-36 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-35 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-35 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-35 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-35 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-35 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-34 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-33 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-32 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-32 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-32 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-32 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-31 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-30 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-29 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-29 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-27 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-27 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-27 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-23 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-22 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-19 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-16 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-16 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-14 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-14 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-06 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-06 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.001 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.001 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.001 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.001 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.002 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.003 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.003 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.003 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.003 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.003 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.003 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 243 bits (624), Expect = 4e-79
Identities = 99/243 (40%), Positives = 138/243 (56%), Gaps = 17/243 (6%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
L K++G G FG+V +G +G E T KV V+ LKE AS+ E+ FL EA+ ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTET---KVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L H NI+RL+ C + +P +V E GDL +FL + L ++MA+ +A
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK----LTLKDLLQMALQIAK 113
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAP 265
G+ Y+ F+H D+AARNCLVT L VKI D G S D Y DYY G LP++W AP
Sbjct: 114 GMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
E S++ T K +VWSFGVLLWEIF G+ PY +S+++V+ + + RLP
Sbjct: 174 E-------SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL--EDGYRLP 224
Query: 326 APR 328
P
Sbjct: 225 RPE 227
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 2e-76
Identities = 98/242 (40%), Positives = 138/242 (57%), Gaps = 18/242 (7%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K++G G FG+V +G+ +G + T++V V+ LKEDAS+ E+ FL EA ++L H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDG----KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT----IKMAIDVAT 206
N++RL+ C E +P LV E GDL ++L + + + ++ + AI +A
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAP 265
G+ Y+ F+H D+AARNCLV +L VKI D G S D Y DYY LP+RW AP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
ESL I T K +VWSFGVLLWEIF G PY LS+++V+ + + RLP
Sbjct: 177 ESL---KDGIF----TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL--RKGYRLP 227
Query: 326 AP 327
P
Sbjct: 228 KP 229
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 2e-74
Identities = 97/241 (40%), Positives = 133/241 (55%), Gaps = 15/241 (6%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
L K++G G FG+V +G +G + +V V+ LKEDAS+ + FL EA R+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEV---EVAVKTLKEDASEQQIEEFLREARIMRK 57
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L H NI++L+ C E +P ++V E GDL ++L N R L + A+ +A
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN---RPKELSLSDLLSFALQIAR 114
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266
G+ Y+ FIH D+AARNCLV L VKI D G S D Y DYY LP+RW APE
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
S++ T K +VWSFGVLLWEIF G+ PY +S+ +V+ + + RLP
Sbjct: 175 -------SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL--KKGYRLPK 225
Query: 327 P 327
P
Sbjct: 226 P 226
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 9e-73
Identities = 94/237 (39%), Positives = 129/237 (54%), Gaps = 16/237 (6%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K++G G FG+V +G+ +G +V V+ LKEDAS+ + FL EA R+L H
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKV---EVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
N+++L+ C E +P +V E GDL +L N L + A+ +A G+ Y
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEY 117
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
+ FIH D+AARNCLV L VKI D G S D Y DYY LP+RW APE
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE---- 173
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
S++ T K +VWSFGVLLWEIF G+ PY +S+++V+ + RLP P
Sbjct: 174 ---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL--KNGYRLPQP 225
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 7e-72
Identities = 100/239 (41%), Positives = 151/239 (63%), Gaps = 6/239 (2%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
EIG GWFGKV+ GEA G + ++V V+ L+ A+ E+L FL E PYR L H
Sbjct: 1 DEIGNGWFGKVLLGEA-----HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
N+L+ + C+ES P+LLV E C GDLK +L SN + ++ + +MA +VA+GL +
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPESLL 269
+ + FIH+D+A RNC +T++L VKIGD G ++++YP DYY+ + A+P+RW APE +
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+ T+K N+WS GV +WE+F PY +LSD+QV+ +V + ++LP P+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 1e-66
Identities = 106/246 (43%), Positives = 151/246 (61%), Gaps = 6/246 (2%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
KEIG GWFGKV+ GE ++G T ++V V+ L+ AS E++ FL EA PYR L+H
Sbjct: 1 KEIGNGWFGKVILGEV-----NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
N+L+ + C E P+LLV E C GDLK +L S + + +MA ++A GL +
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPESLL 269
+ ++ FIH+D+A RNCL+T++L VKIGD G S +KY DYYV + + +P+RW APE +
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRA 329
++ T++ NVWS GV +WE+FE G PY LSD+QV+T + L+LP PR
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 330 VNSHVD 335
D
Sbjct: 236 KLPLSD 241
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 2e-60
Identities = 91/250 (36%), Positives = 141/250 (56%), Gaps = 14/250 (5%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
FPR L + +GRG FG+V +A+G+EE G T V V+ L++ + + F E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETL--VLVKALQKTKDENLQSEFRREL 59
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK-- 199
+R+L H N++RL+ C E++P ++ E GDLK+FL + ++ E L ++ K
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 200 --MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
+ +A G+ ++ F+H D+AARNCLV+S+ VK+ S D Y +YY
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
+P+RW APE++ D S K +VWSFGVL+WE+F G+LP+ LSD++V+ R+
Sbjct: 180 IPLRWLAPEAVQEDDFS-------TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL- 231
Query: 318 GTEALRLPAP 327
L LP P
Sbjct: 232 QAGKLELPVP 241
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 101/269 (37%), Positives = 137/269 (50%), Gaps = 21/269 (7%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
R + +E+G G FGKV GE LE V V+ LKE AS + F EA
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEP--ENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN---------EASREALLE 193
+H NI++ C E DP ++VFE GDL +FL S+ S L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-V 252
+++A+ +A+G+ Y+ F+H D+A RNCLV +L VKIGD G S D Y DYY V
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
G LP+RW PES++ T + +VWSFGV+LWEIF +GK P+ LS+++V
Sbjct: 181 GGHTMLPIRWMPPESIMYR-------KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 313 ITRVFGTEALRLPAPRAVNSHVDVAARNC 341
I + T+ L PR S V C
Sbjct: 234 IECI--TQGRLLQRPRTCPSEVYDIMLGC 260
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 2e-57
Identities = 95/251 (37%), Positives = 144/251 (57%), Gaps = 15/251 (5%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ PR+++ ++E+G+G FG V EG A+G+ G ++V ++ + E+AS E++ FL+E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVV--KGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT--- 197
A+ + +++RL+ P L+V E ++GDLK +L S E G
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 198 --IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHG 254
I+MA ++A G++Y+ F+H D+AARNC+V +L VKIGD G + D Y DYY G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
+ LPVRW APESL D T K +VWSFGV+LWE+ + PY LS+++V+
Sbjct: 180 KGLLPVRWMAPESL--KDGVFTT-----KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232
Query: 315 RVFGTEALRLP 325
V L LP
Sbjct: 233 FVIDGGHLDLP 243
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 96/242 (39%), Positives = 142/242 (58%), Gaps = 13/242 (5%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+EIG GWFGKV+ E T ++V V+ LK +AS E+ FL + PYR L+H
Sbjct: 1 QEIGNGWFGKVLLSEI-----YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHP 55
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR---EALLEQGITIKMAIDVATG 207
NIL+ + C+E+ P+LLVFE C GDLK +L + R + LL Q +MA ++A G
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ----RMACEIAAG 111
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPE 266
+++M + F+H+D+A RNC +TS+L VK+GD G +Y DY + +P+RW APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
+ + T T+ NVW+ GV LWE+FE PY+ LSD +V+ V + ++L
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231
Query: 327 PR 328
P+
Sbjct: 232 PQ 233
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 91/250 (36%), Positives = 126/250 (50%), Gaps = 24/250 (9%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEEST---------GRTTSKVFVRILKEDASQ 131
+FPRQ L++V+++G G FG+V EA GL++ + V V++L+ DAS
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 132 AEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL 191
+ FL E RL NI RL+ C P ++ E GDL +FL + A L
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 192 LEQGITIK------MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245
++ MA +A+G+ Y+ F+H D+A RNCLV +KI D G S +
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 246 YPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL-P 303
Y DYY V G LP+RW A ES+L T K +VW+FGV LWEI + P
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLG-------KFTTKSDVWAFGVTLWEILTLCREQP 233
Query: 304 YAELSDDQVI 313
Y L+D QVI
Sbjct: 234 YEHLTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-54
Identities = 97/254 (38%), Positives = 133/254 (52%), Gaps = 17/254 (6%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ PR + ++ +G G FG+V EG RG + +V V+ L E S+ ++ FL E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDA--VELQVAVKTLPESCSEQDESDFLME 59
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNE--ASREALLEQGITI 198
A + H NI+RL+ E P ++ E + GDLK FL N R + L +
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE--LRV-KIGDTGSSIDKYPGDYYVHGE 255
A DVA G Y+ E+ FIH D+AARNCL+T + RV KI D G + D Y YY G
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 256 VA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
A LP++W PE+ L I T K +VWSFGVLLWEIF G +PY ++ +V+
Sbjct: 180 RAMLPIKWMPPEAFL---DGIFTS----KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
Query: 315 RVFGTEALRLPAPR 328
V T RL P+
Sbjct: 233 FV--TGGGRLDPPK 244
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 3e-53
Identities = 87/254 (34%), Positives = 131/254 (51%), Gaps = 27/254 (10%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
++PR + YV++IG+G FG+V + A GL + V V++LKE+AS + F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGL--LPYEPFTMVAVKMLKEEASADMQADFQRE 58
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG----- 195
A H NI++L+ C P L+FE + GDL EFL + L
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 196 ------------ITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243
+ +A VA G++Y+ E F+H D+A RNCLV + VKI D G S
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 244 DKYPGDYYVHGEV-ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
+ Y DYY E A+P+RW PES+ + + ++ +VW++GV+LWEIF +G
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-------DVWAYGVVLWEIFSYGMQ 231
Query: 303 PYAELSDDQVITRV 316
PY ++ ++VI V
Sbjct: 232 PYYGMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-52
Identities = 92/259 (35%), Positives = 136/259 (52%), Gaps = 23/259 (8%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ P + +++E+G G FGKV +GE G + + + V ++ LKE+A + F E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGP--NERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN------EASRE----- 189
A L+H NI+ L+ C + P ++FE + GDL EFL+ N A
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 190 ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249
+ L+ + +AI +A G+ Y+ F+H D+AARNCLV L VKI D G S D Y D
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 250 YY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
YY V + LPVRW PE++L + ++ ++WSFGV+LWEIF +G PY S
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTES-------DIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 309 DDQVITRVFGTEALRLPAP 327
+ +VI + LP P
Sbjct: 232 NQEVIEMI--RSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 4e-51
Identities = 95/244 (38%), Positives = 128/244 (52%), Gaps = 18/244 (7%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+G G FG+V EG A G +V V+ L++ A+ EK FL EA H NI
Sbjct: 3 LGSGAFGEVYEGTATD-ILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR--EALLEQGITIKMAIDVATGLSY 210
++L+ CL ++P ++ E GDL +L R LL + + +DVA G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 211 MIEDGFIHTDVAARNCLVTSELR-----VKIGDTGSSIDKYPGDYY-VHGEVALPVRWCA 264
+ + FIH D+AARNCLV+ + VKIGD G + D Y DYY GE LPVRW A
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 265 PESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324
PESLL + Q+ +VWSFGVL+WEI G+ PY L++ +V+ V T RL
Sbjct: 182 PESLLDGKFTTQS-------DVWSFGVLMWEILTLGQQPYPALNNQEVLQHV--TAGGRL 232
Query: 325 PAPR 328
P
Sbjct: 233 QKPE 236
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-50
Identities = 95/250 (38%), Positives = 138/250 (55%), Gaps = 24/250 (9%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLE---------ESTGRTTSKVFVRILKEDASQ 131
+FPR++L + +++G G FG+V EA G+E + +G V V++L+EDA++
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 132 AEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL 191
+ FL E RL+ NI+RL+A C+ SDP ++ E GDL +FL +E A
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 192 LEQGITIK------MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245
+TI MA +A+G+ Y+ F+H D+A RNCLV +KI D G S +
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 246 YPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK-LP 303
Y GDYY + G LP+RW + ES+L T +VW+FGV LWEI K P
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLG-------KFTTASDVWAFGVTLWEILTLCKEQP 233
Query: 304 YAELSDDQVI 313
Y++LSD+QVI
Sbjct: 234 YSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 7e-49
Identities = 93/249 (37%), Positives = 133/249 (53%), Gaps = 23/249 (9%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK-------VFVRILKEDASQAE 133
+FPRQQL +++G G FG+V EA GL E G + V V++L+ D ++
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 134 KLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLE 193
+ FL E RL++ NI+RL+ C+ DP ++ E GDL +FL E
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 194 QGIT-------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246
I + MA+ +A+G+ Y+ F+H D+A RNCLV + +KI D G S + Y
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 247 PGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK-LPY 304
GDYY + G LP+RW A ES+L T + +VW+FGV LWE+F K PY
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLG--KFTTAS-----DVWAFGVTLWEMFTLCKEQPY 233
Query: 305 AELSDDQVI 313
+ LSD+QVI
Sbjct: 234 SLLSDEQVI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 86/239 (35%), Positives = 127/239 (53%), Gaps = 22/239 (9%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
E++ PR +L K +G G FG+VV+ EA GL+ +T V V++LK+DA++ + +
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETST--VAVKMLKDDATEKDLSDLV 63
Query: 139 HEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL------ 191
E + + +H NI+ L+ C + P +V E + G+L++FL + E
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 192 -LEQGITIK----MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246
E+ +T K A VA G+ ++ IH D+AARN LVT + +KI D G + D +
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 247 PGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
DYY LPV+W APE+L D T + +VWSFGVLLWEIF G PY
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEAL--FDR-----VYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 88/229 (38%), Positives = 120/229 (52%), Gaps = 14/229 (6%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+++FPR L + K +G G FGKVVE A GL +S KV V++LK A +E+
Sbjct: 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKS--DAVMKVAVKMLKPTAHSSEREAL 85
Query: 138 LHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
+ E L H NI+ L+ AC P L++ E C GDL FL RE+ L
Sbjct: 86 MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK---RESFLTLED 142
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGE 255
+ + VA G++++ IH D+AARN L+T VKI D G + D +Y V G
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
LPV+W APES+ C T + +VWS+G+LLWEIF G PY
Sbjct: 203 ARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 6e-47
Identities = 97/261 (37%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
E+G G FGKV E L + V V+ LKE AS++ + F EA L+H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKML--VAVKALKE-ASESARQDFQREAELLTVLQHQH 68
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSN-------EASREALLEQ---GITIKMA 201
I+R C E P L+VFE GDL FL S+ + Q G + +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPV 260
+A+G+ Y+ F+H D+A RNCLV L VKIGD G S D Y DYY V G LP+
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
RW PES+L T + ++WSFGV+LWEIF +GK P+ +LS+ + I + T+
Sbjct: 189 RWMPPESILYR-------KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI--TQ 239
Query: 321 ALRLPAPRAVNSHVDVAARNC 341
L PR V + C
Sbjct: 240 GRELERPRTCPPEVYAIMQGC 260
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-45
Identities = 90/252 (35%), Positives = 141/252 (55%), Gaps = 15/252 (5%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ R+++ +E+G+G FG V EG A+G+ + T +V ++ + E AS E++ FL+
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPET--RVAIKTVNEAASMRERIEFLN 58
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI--- 196
EA+ + +++RL+ + P L++ E +RGDLK +L S E Q
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 197 --TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH- 253
I+MA ++A G++Y+ + F+H D+AARNC+V + VKIGD G + D Y DYY
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
G+ LPVRW +PESL + T +VWSFGV+LWEI + PY +S++QV+
Sbjct: 179 GKGLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
Query: 314 TRVFGTEALRLP 325
V L P
Sbjct: 232 RFVMEGGLLDKP 243
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 93/253 (36%), Positives = 142/253 (56%), Gaps = 17/253 (6%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ R+++ ++E+G+G FG V EG AR + + G ++V V+ + E AS E++ FL+
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIK--GEAETRVAVKTVNESASLRERIEFLN 58
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLS------NEASREALLE 193
EA+ + +++RL+ + P L+V E + GDLK +L S N R
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH 253
Q + I+MA ++A G++Y+ F+H D+AARNC+V + VKIGD G + D Y DYY
Sbjct: 119 QEM-IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 254 -GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
G+ LPVRW APESL + T ++WSFGV+LWEI + PY LS++QV
Sbjct: 178 GGKGLLPVRWMAPESL-------KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
Query: 313 ITRVFGTEALRLP 325
+ V L P
Sbjct: 231 LKFVMDGGYLDQP 243
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 7e-45
Identities = 82/251 (32%), Positives = 123/251 (49%), Gaps = 27/251 (10%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
+L ++KE+G G FG V G+ RG V +++++E A + F+ EA
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRG--------KIDVAIKMIREGAMSEDD--FIEEAKVMM 54
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
+L H N+++L C + P +V E + G L +L R+ L + M DV
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVC 110
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD--YYVHGEVALPVRWC 263
+ Y+ +GFIH D+AARNCLV + VK+ D G + +Y D Y PV+W
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA--RYVLDDQYTSSQGTKFPVKWA 168
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
PE S S K +VWSFGVL+WE+F GK+PY S+ +V+ V + R
Sbjct: 169 PPEVFDYSRFS-------SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV--SAGYR 219
Query: 324 LPAPRAVNSHV 334
L P+ + V
Sbjct: 220 LYRPKLAPTEV 230
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 9e-45
Identities = 78/238 (32%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
++IG+G FG V +G + ++V V+ + K FL EA ++ H
Sbjct: 1 EKIGKGNFGDVYKG--------VLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
NI++L+ C++ P +V E G L FL + L ++M++D A G+ Y
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEY 108
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLL 269
+ IH D+AARNCLV +KI D G S ++ G Y V G +P++W APE+L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL- 167
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
T + +VWS+G+LLWE F G PY +S+ Q TR R+PAP
Sbjct: 168 ------NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGYRMPAP 217
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 99/260 (38%), Positives = 135/260 (51%), Gaps = 21/260 (8%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R + +E+G G FGKV E L + V V+ LK DAS + F EA
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKIL--VAVKTLK-DASDNARKDFHREAEL 60
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL--------LSNEASREALLEQG 195
L+H +I++ C+E DP ++VFE GDL +FL L E +R A L Q
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 196 ITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHG 254
+ +A +A G+ Y+ F+H D+A RNCLV L VKIGD G S D Y DYY V G
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
LP+RW PES++ T + +VWS GV+LWEIF +GK P+ +LS+++VI
Sbjct: 181 HTMLPIRWMPPESIMYR-------KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
Query: 315 RVFGTEALRLPAPRAVNSHV 334
+ T+ L PR V
Sbjct: 234 CI--TQGRVLQRPRTCPKEV 251
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-44
Identities = 95/257 (36%), Positives = 140/257 (54%), Gaps = 24/257 (9%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
R+ + +E+G G FGKV E L + + V V+ LK D + A + F EA
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKML--VAVKALK-DPTLAARKDFQREAEL 60
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL---------LSNEASREALLEQ 194
L+H +I++ C + DP ++VFE GDL +FL L + R+A E
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 195 GIT--IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY- 251
G++ + +A +A+G+ Y+ F+H D+A RNCLV + L VKIGD G S D Y DYY
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
V G LP+RW PES++ + ++ +VWSFGV+LWEIF +GK P+ +LS+ +
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTES-------DVWSFGVILWEIFTYGKQPWFQLSNTE 233
Query: 312 VITRVFGTEALRLPAPR 328
VI + T+ L PR
Sbjct: 234 VIECI--TQGRVLERPR 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-44
Identities = 85/259 (32%), Positives = 135/259 (52%), Gaps = 27/259 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
++L IG+G FG V+ G+ RG KV V+ LK+D++ A+ FL EA+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYRG---------QKVAVKCLKDDSTAAQA--FLAEAS 52
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
LRH N+++L+ L+ +P +V E ++G L ++L S A++ + A+
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFAL 109
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
DV G+ Y+ E F+H D+AARN LV+ +L K+ D G + + G LPV+W
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKW 165
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE+L + + K +VWSFG+LLWEI+ FG++PY + V+ V +
Sbjct: 166 TAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV--EKGY 216
Query: 323 RLPAPRAVNSHVDVAARNC 341
R+ AP V ++C
Sbjct: 217 RMEAPEGCPPEVYKVMKDC 235
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 4e-43
Identities = 80/248 (32%), Positives = 124/248 (50%), Gaps = 22/248 (8%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ R + ++++G G FG+V EG T+ V V+ LK + FL
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN--------TTPVAVKTLKPGTMDPKD--FLA 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA ++LRH +++L A C +P +V E G L E+L A R L Q I
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQ--LID 107
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
MA VA+G++Y+ +IH D+AARN LV K+ D G + Y P
Sbjct: 108 MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE+ L + SI K +VWSFG+LL EI +G++PY +++ +V+ +V
Sbjct: 168 IKWTAPEAALYNRFSI-------KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV--D 218
Query: 320 EALRLPAP 327
+ R+P P
Sbjct: 219 QGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 83/247 (33%), Positives = 126/247 (51%), Gaps = 22/247 (8%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR+ L +++G G FG+V G G T+KV V+ LK E FL EA
Sbjct: 4 PRESLKLERKLGAGQFGEVWMGTWNG--------TTKVAVKTLKPGTMSPEA--FLQEAQ 53
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
++LRH +++L A C E +P +V E S+G L +FL S E + L + + MA
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL---VDMAA 110
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+A G++Y+ +IH D+AARN LV L KI D G + +Y P++W
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE+ +I K +VWSFG+LL EI +G++PY +++ +V+ +V
Sbjct: 171 TAPEAANYGRFTI-------KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV--ERGY 221
Query: 323 RLPAPRA 329
R+P P
Sbjct: 222 RMPRPPN 228
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 81/239 (33%), Positives = 115/239 (48%), Gaps = 21/239 (8%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
KE+G G FG VV+G +V V+ LK++ A K FL EA+ +L H
Sbjct: 1 KELGHGNFGSVVKGVYL----MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
I+RL+ C +P +LV E G L ++L + L ++A VA G++Y
Sbjct: 57 CIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAY 110
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA--LPVRWCAPESL 268
+ F+H D+AARN L+ + + KI D G S G Y A P++W APE
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC- 169
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
I + K +VWS+GV LWE F +G PY E+ +VI + E RLP P
Sbjct: 170 ------INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--RLPRP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 90/259 (34%), Positives = 128/259 (49%), Gaps = 34/259 (13%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEE----------STGRTTSKVFVRILKEDAS 130
+FPR L + +++G G FG+V E ++ GR V V+IL+ DA+
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL-VAVKILRPDAN 59
Query: 131 QAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLS------- 183
+ + FL E RL+ NI+RL+ C++ DP ++ E GDL +FL S
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 184 -NEASREALLEQGITIK------MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236
N I +A+ +A+G+ Y+ F+H D+A RNCLV L +KI
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179
Query: 237 GDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWE 295
D G S + Y GDYY + G LP+RW A E +L T +VW+FGV LWE
Sbjct: 180 ADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-------KFTTASDVWAFGVTLWE 232
Query: 296 IFEFGK-LPYAELSDDQVI 313
I K PY EL+D+QVI
Sbjct: 233 ILMLCKEQPYGELTDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 80/241 (33%), Positives = 122/241 (50%), Gaps = 20/241 (8%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
K IG G FG+V RG + G+ V ++ LK +S ++L FL EA+ + H
Sbjct: 9 EKVIGGGEFGEV----CRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH 64
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NI+RL +S P +++ E G L +FL N+ G + M +A+G+
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMK 120
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPES 267
Y+ E ++H D+AARN LV S L K+ D G S ++ Y G +P+RW APE
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG-KIPIRWTAPE- 178
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+I T +VWSFG+++WE+ +G+ PY ++S+ VI V + RLP P
Sbjct: 179 ------AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--EDGYRLPPP 230
Query: 328 R 328
Sbjct: 231 M 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 80/246 (32%), Positives = 130/246 (52%), Gaps = 24/246 (9%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR++ +++G G+FG+V EG + +V ++ILK D ++ F E
Sbjct: 4 PREEFTLERKLGSGYFGEVWEG--------LWKNRVRVAIKILKSDDLLKQQDFQK-EVQ 54
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+RLRH +++ L A C +P ++ E +G L FL S E +L I MA
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE---GQVLPVASLIDMAC 111
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVR 261
VA G++Y+ E IH D+AARN LV +L K+ D G + + K D Y+ + +P +
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYK 169
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + T + K +VWSFG+LL+E+F +G++PY +++ +V ++ T
Sbjct: 170 WTAPE-------AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI--TAG 220
Query: 322 LRLPAP 327
R+P P
Sbjct: 221 YRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 5e-38
Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 27/260 (10%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEAR--GLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+ P + +++E+G FGK+ +G G++ + V ++ LK+ + + F
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHA-----QLVAIKTLKDINNPQQWGEFQ 55
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLL------------SNEA 186
EA+ L H NI+ L+ + P ++FE ++GDL EFL+ +
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 187 SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246
+ ++ L+ G + +AI +A G+ Y+ F+H D+AARN L+ +L VKI D G S + Y
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 247 PGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305
DYY V + LP+RW PE+++ S + ++WSFGV+LWEIF FG PY
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS-------DIWSFGVVLWEIFSFGLQPYY 228
Query: 306 ELSDDQVITRVFGTEALRLP 325
S+ +VI V + L
Sbjct: 229 GFSNQEVIEMVRKRQLLPCS 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 80/218 (36%), Positives = 121/218 (55%), Gaps = 17/218 (7%)
Query: 96 GWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRL 155
G FG++ G L + +VFV+ +K+ AS+ + L E+ L H NIL +
Sbjct: 17 GTFGRIFYGI---LIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 156 MAACLE-SDPWLLVFESCSRGDLKEFL----LSNEASREALLEQGITIKMAIDVATGLSY 210
+ C+E +P +++ + G+LK FL L + +AL Q + MAI +A G+SY
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ-LVHMAIQIACGMSY 132
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 269
+ + G IH D+AARNC++ EL+VKI D S D +P DY+ G+ PV+W A ESL+
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
+ S + +VWSFGVLLWE+ G+ PY E+
Sbjct: 193 NKEYSSAS-------DVWSFGVLLWELMTLGQTPYVEI 223
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 82/249 (32%), Positives = 122/249 (48%), Gaps = 35/249 (14%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
+L ++KE+G G FG V G+ R KV ++ + E A E F+ EA
Sbjct: 5 ELTFMKELGSGQFGVVHLGK--------WRAQIKVAIKAINEGAMSEED--FIEEAKVMM 54
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEA--SREALLEQGITIKMAID 203
+L H +++L C + P +V E G L +L + S++ LL M D
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQD 108
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS---IDKYPGDYYVHGEVA-LP 259
V G+ Y+ + FIH D+AARNCLV+S VK+ D G + +D D Y A P
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFP 164
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
V+W PE S S K +VWSFGVL+WE+F GK+P+ + S+ +V+ + +
Sbjct: 165 VKWSPPEVFNFSKYS-------SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--S 215
Query: 320 EALRLPAPR 328
RL P+
Sbjct: 216 RGFRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 87/241 (36%), Positives = 121/241 (50%), Gaps = 18/241 (7%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K++G G FG V GE S G+ V V+ LK D FL EA L H
Sbjct: 1 KKLGDGSFGVVRRGEW---STSGGKVIP-VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
N++RL L + P ++V E G L + L +A L+ A+ +A G+ Y
Sbjct: 57 NLIRLYGVVL-THPLMMVTELAPLGSLLD-RLRKDALGHFLI--STLCDYAVQIANGMRY 112
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE-VALPVRWCAPESL 268
+ FIH D+AARN L+ S+ +VKIGD G D+YV E + +P WCAPESL
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+T T + +VW FGV LWE+F +G+ P+A LS Q++ ++ E RL P
Sbjct: 173 -------RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGERLERPE 224
Query: 329 A 329
A
Sbjct: 225 A 225
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-37
Identities = 79/251 (31%), Positives = 128/251 (50%), Gaps = 21/251 (8%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
+ +++E+G FGKV +G G + G T V ++ LK+ A + F HEA R
Sbjct: 7 VRFMEELGEDRFGKVYKGHLFG--TAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLL-----------SNEASREALLEQG 195
L+H NI+ L+ + P ++F CS DL EFL+ ++ + ++ LE
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 196 ITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHG 254
+ + +A G+ ++ +H D+A RN LV +L VKI D G + Y DYY + G
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
LP+RW +PE+++ SI + ++WS+GV+LWE+F +G PY S+ VI
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDS-------DIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237
Query: 315 RVFGTEALRLP 325
+ + L P
Sbjct: 238 MIRNRQVLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 2e-37
Identities = 92/280 (32%), Positives = 144/280 (51%), Gaps = 32/280 (11%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR +L K +G G FG+VV EA GL++ +KV V++LK DA++ + +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS 72
Query: 140 EATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLE----- 193
E + + +H NI+ L+ AC + P ++ E S+G+L+E+L A R +E
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNP 129
Query: 194 -----QGITIK----MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
+ ++ K A VA G+ Y+ IH D+AARN LVT + +KI D G + D
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 245 KYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301
+ DYY +G LPV+W APE+L T + +VWSFGVLLWEIF G
Sbjct: 190 IHHIDYYKKTTNGR--LPVKWMAPEALFDR-------IYTHQSDVWSFGVLLWEIFTLGG 240
Query: 302 LPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNC 341
PY + +++ + E R+ P + + + R+C
Sbjct: 241 SPYPGVPVEELFKLL--KEGHRMDKPSNCTNELYMMMRDC 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 88/238 (36%), Positives = 121/238 (50%), Gaps = 21/238 (8%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+ IGRG FG+V G R + V V+ +E K FL EA ++ H
Sbjct: 1 ERIGRGNFGEVFSGRLRA-------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
NI+RL+ C + P +V E GD FL E R L+ I+M + A G+ Y
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPR---LKVKELIQMVENAAAGMEY 109
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEV-ALPVRWCAPESLL 269
+ IH D+AARNCLVT + +KI D G S ++ G Y G + +PV+W APE+L
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
S ++ +VWSFG+LLWE F G +PYA LS+ Q TR + +RLP P
Sbjct: 170 YGRYSSES-------DVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRLPCP 218
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 80/248 (32%), Positives = 120/248 (48%), Gaps = 18/248 (7%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ R+ + + IG G FG V +G E V V+ K S + + FL
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEK----IAVAVKTCKNCTSPSVREKFLQ 56
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA R+ H +I++L+ E+ W+ V E G+L+ +L N+ S L+ I
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYLQVNKYS----LDLASLIL 111
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
+ ++T L+Y+ F+H D+AARN LV+S VK+GD G S YY + LP
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE SI T +VW FGV +WEI G P+ + ++ VI R+
Sbjct: 172 IKWMAPE-------SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG 224
Query: 320 EALRLPAP 327
E RLP P
Sbjct: 225 E--RLPMP 230
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 3e-37
Identities = 84/251 (33%), Positives = 116/251 (46%), Gaps = 27/251 (10%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
+L V+EIG G FG V G KV ++ ++E A E F+ EA
Sbjct: 5 ELTLVQEIGSGQFGLVWLG--------YWLEKRKVAIKTIREGAMSEED--FIEEAQVMM 54
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEA--SREALLEQGITIKMAID 203
+L H +++L C E P LVFE G L ++L + S+E LL M +D
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLG------MCLD 108
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
V G++Y+ IH D+AARNCLV VK+ D G + Y PV+W
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
+PE S S K +VWSFGVL+WE+F GK PY S+ +V+ + R
Sbjct: 169 SPEVFSFSKYS-------SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI--NAGFR 219
Query: 324 LPAPRAVNSHV 334
L PR + V
Sbjct: 220 LYKPRLASQSV 230
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-37
Identities = 85/277 (30%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+++FPR +L K +G G FG+VV EA G+++S T V V++LK++A+ +
Sbjct: 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64
Query: 138 LHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEA---------- 186
+ E + + +H NI+ L+ C + P ++ E ++G+L+EFL +
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 187 -SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245
E L + A VA G+ Y+ IH D+AARN LVT + +KI D G +
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 246 YPGDYYVHGEVA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ DYY LPV+W APE+L T + +VWSFG+L+WEIF G PY
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDR-------VYTHQSDVWSFGILMWEIFTLGGSPY 237
Query: 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNC 341
+ +++ + E R+ P + + R C
Sbjct: 238 PGIPVEELFKLL--REGHRMDKPSNCTHELYMLMREC 272
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 82/273 (30%), Positives = 132/273 (48%), Gaps = 20/273 (7%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K IG G FG+V RG+ + GR V ++ LK ++ ++ FL EA+ + H
Sbjct: 11 KVIGAGEFGEVF----RGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
NI+RL + P +++ E G L ++L ++ + G M +A G+ Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG----MLRGIAAGMKY 122
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESL 268
+ + ++H D+AARN LV S L K+ D G S ++ P Y +P+RW APE+
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA- 181
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
I T +VWSFG+++WE+ FG+ PY ++S+ +V+ + + RLPAP
Sbjct: 182 ------IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI--NDGFRLPAPM 233
Query: 329 AVNSHVDVAARNC-LVTSELRVKIGDTGSSIDK 360
S V C R + D + +DK
Sbjct: 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 80/248 (32%), Positives = 125/248 (50%), Gaps = 26/248 (10%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED-ASQAEKLFFLHEATPYRRLRH 149
K +G G FG V+EG+ + S KV V+ +K D + +E FL EA + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQL----KVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 150 VNILRLMAACLESDPW------LLVFESCSRGDLKEFLLSNEASREALLEQGITIKM--- 200
N+++L+ C E+ +++ GDL FLL SR L + + ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTLLK 117
Query: 201 -AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-L 258
+D+A G+ Y+ FIH D+AARNC++ ++ V + D G S Y GDYY G +A +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
PV+W A ESL +D T K +VW+FGV +WEI G+ PY + + ++ +
Sbjct: 178 PVKWIAIESL--ADR-----VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230
Query: 319 TEALRLPA 326
L+ P
Sbjct: 231 GNRLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 88/278 (31%), Positives = 137/278 (49%), Gaps = 28/278 (10%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++F R +L K +G G FG+VV EA G+++ + V V++LK+DA++ + +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69
Query: 140 EATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
E + + +H NI+ L+ AC + P ++ E S+G+L+E+L A R +E I
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYSYDI 126
Query: 199 KMAID--------------VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
D VA G+ Y+ IH D+AARN LVT +KI D G + D
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 245 KYPGDYYVHGEVA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
DYY LPV+W APE+L T + +VWSFGVL+WEIF G P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDR-------VYTHQSDVWSFGVLMWEIFTLGGSP 239
Query: 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNC 341
Y + +++ + E R+ P + + + R+C
Sbjct: 240 YPGIPVEELFKLL--KEGHRMDKPANCTNELYMMMRDC 275
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-36
Identities = 83/234 (35%), Positives = 116/234 (49%), Gaps = 29/234 (12%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K +G G FGKVV+ A L+ G TT V V++LKE+AS +E L E +++ H
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTT--VAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFL---------------LSNEASREALLEQG 195
++++L AC + P LL+ E G L+ FL N + + E+
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 196 ITIKMAIDVA----TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
+T+ I A G+ Y+ E +H D+AARN LV ++KI D G S D Y D Y
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 252 V-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
V + +PV+W A ESL T + +VWSFGVLLWEI G PY
Sbjct: 184 VKRSKGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 72/220 (32%), Positives = 114/220 (51%), Gaps = 21/220 (9%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
++G G +G+V EG + + + V V+ LKED + E+ FL EA + ++H N
Sbjct: 13 KLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 63
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM 211
+++L+ C P+ ++ E + G+L ++L + + + MA +++ + Y+
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYL 120
Query: 212 IEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCS 271
+ FIH D+AARNCLV VK+ D G S Y H P++W APESL +
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 272 DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY--AELSD 309
SI K +VW+FGVLLWEI +G PY +LS
Sbjct: 181 KFSI-------KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 82/260 (31%), Positives = 126/260 (48%), Gaps = 27/260 (10%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
+ L ++KE+G G FG V G+ RG + V ++++KE S +E F EA
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWRGQYD--------VAIKMIKE-GSMSEDEFI-EEAKV 52
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL--LEQGITIKMA 201
+L H +++L C + P +V E S G L +L RE + ++M
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLEMC 106
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
DV G++Y+ FIH D+AARNCLV + VK+ D G S +Y PVR
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W PE LL + K +VW+FGVL+WE++ GK+PY ++ + + +V ++
Sbjct: 167 WSPPEVLL-------YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV--SQG 217
Query: 322 LRLPAPRAVNSHVDVAARNC 341
LRL P + V +C
Sbjct: 218 LRLYRPHLASEKVYAIMYSC 237
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 80/244 (32%), Positives = 124/244 (50%), Gaps = 24/244 (9%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED---ASQAEKLFFLHEATPYRRLRH 149
+G+G FG V E + + E+ + + KV V++LK D +S E+ FL EA + H
Sbjct: 7 LGKGEFGSVREAQLK-SEDGSFQ---KVAVKMLKADIFSSSDIEE--FLREAACMKEFDH 60
Query: 150 VNILRLMAACLESDPW------LLVFESCSRGDLKEFLLSNEASREAL-LEQGITIKMAI 202
N+++L+ L S +++ GDL FLL + E L ++ I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVR 261
D+A+G+ Y+ FIH D+AARNC++ + V + D G S Y GDYY G + LPV+
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W A ESL +D T +VW+FGV +WEI G+ PYA + + ++ +
Sbjct: 181 WLALESL--ADN-----VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 322 LRLP 325
L+ P
Sbjct: 234 LKQP 237
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-35
Identities = 90/278 (32%), Positives = 142/278 (51%), Gaps = 26/278 (9%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++ R +L K +G G FG+VV EA G+++ V V++LK+DA+ + +
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 139 HEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN-----EASREA-- 190
E + + +H NI+ L+ AC + P ++ E S+G+L+E+L + + S +
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 191 LLEQGITIK----MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246
L E+ +T K A VA G+ Y+ IH D+AARN LVT + +KI D G + D +
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 247 PGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
DYY +G LPV+W APE+L T + +VWSFGVLLWEIF G P
Sbjct: 186 NIDYYKKTTNGR--LPVKWMAPEALFDR-------VYTHQSDVWSFGVLLWEIFTLGGSP 236
Query: 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNC 341
Y + +++ + E R+ P + + R C
Sbjct: 237 YPGIPVEELFKLL--KEGHRMDKPANCTHELYMIMREC 272
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 80/249 (32%), Positives = 122/249 (48%), Gaps = 21/249 (8%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+G+G FG+V +G T + + V V+ KED Q K+ FL EA ++ H NI
Sbjct: 3 LGKGNFGEVFKG--------TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
++L+ C + P +V E GD FL + E +Q +K A+D A G++Y+
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQ--LVKFALDAAAGMAYLE 110
Query: 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD 272
IH D+AARNCLV +KI D G S + G Y G +P++W APE+L
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL---- 166
Query: 273 TSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNS 332
+ + +VWS+G+LLWE F G PY +++ Q +V + R+ P+
Sbjct: 167 ---NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV--EKGYRMSCPQKCPD 221
Query: 333 HVDVAARNC 341
V + C
Sbjct: 222 DVYKVMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 8e-34
Identities = 79/235 (33%), Positives = 127/235 (54%), Gaps = 29/235 (12%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEAT 142
++L ++ IG+G FG V+ G+ RG +KV V+ +K DA+ QA FL EA+
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYRG---------NKVAVKCIKNDATAQA----FLAEAS 51
Query: 143 PYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+LRH N+++L+ +E L +V E ++G L ++L S S +L +K +
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFS 108
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+DV + Y+ + F+H D+AARN LV+ + K+ D G + + LPV+
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVK 164
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
W APE+L + + K +VWSFG+LLWEI+ FG++PY + V+ RV
Sbjct: 165 WTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 82/245 (33%), Positives = 125/245 (51%), Gaps = 21/245 (8%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-EDASQAEKLFFLHEATPYRRLRH 149
K +G G FG V+EG+ + + KV V+ +K +++E FL EA + H
Sbjct: 5 KTLGEGEFGSVMEGQL-----NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 150 VNILRLMAACL---ESDPW---LLVFESCSRGDLKEFLL-SNEASREALLEQGITIKMAI 202
N++RL+ CL ES+ + +++ GDL FLL S L + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVR 261
D+A+G+ Y+ FIH D+AARNC++ + V + D G S Y GDYY G +A +PV+
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W A ESL +D T K +VWSFGV +WEI G+ PY + + ++ +
Sbjct: 180 WIAIESL--ADR-----VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232
Query: 322 LRLPA 326
L+ P
Sbjct: 233 LKQPP 237
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 83/259 (32%), Positives = 130/259 (50%), Gaps = 33/259 (12%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATP 143
Q+L + IG G FG V++GE G KV V+ +K D + QA FL E
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTG---------QKVAVKNIKCDVTAQA----FLEETAV 52
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
+L H N++RL+ L + ++ V E S+G+L FL + AL+ ++ ++D
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRG---RALVSVIQLLQFSLD 108
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRW 262
VA G+ Y+ +H D+AARN LV+ + K+ D G + + D LPV+W
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKW 163
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE+L + + K +VWS+GVLLWE+F +G+ PY ++S +V V +
Sbjct: 164 TAPEAL-------KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV--EKGY 214
Query: 323 RLPAPRAVNSHVDVAARNC 341
R+ P + V V +C
Sbjct: 215 RMEPPEGCPADVYVLMTSC 233
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 75/248 (30%), Positives = 125/248 (50%), Gaps = 22/248 (8%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR+ + VK++G G FG+V G ++KV V+ LK + FL
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN--------NSTKVAVKTLKPGTMSVQA--FLE 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA + L+H ++RL A + +P ++ E ++G L +FL S+E + L + I
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK---LID 107
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
+ +A G++Y+ +IH D+ A N LV+ L KI D G + +Y P
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE+ I + T K +VWSFG+LL+EI +GK+PY +S+ V++ +
Sbjct: 168 IKWTAPEA-------INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL--Q 218
Query: 320 EALRLPAP 327
R+P
Sbjct: 219 RGYRMPRM 226
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 77/239 (32%), Positives = 120/239 (50%), Gaps = 19/239 (7%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K IG G FG+V G + G+ V ++ LK ++ ++ FL EA+ + H
Sbjct: 10 KVIGAGEFGEVCSGRLK----LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
NI+ L +S P ++V E G L FL ++ + G M +A+G+ Y
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG----MLRGIASGMKY 121
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESL 268
+ + G++H D+AARN LV S L K+ D G S ++ P Y +P+RW APE
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-- 179
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+I T +VWS+G+++WE+ +G+ PY E+S+ VI + E RLPAP
Sbjct: 180 -----AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--EEGYRLPAP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 92/308 (29%), Positives = 141/308 (45%), Gaps = 69/308 (22%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR +L K +GRG FGKV++ A G+E+S T V V++LKE A+ +E +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRT--VAVKMLKEGATASEYKALM 58
Query: 139 HEATPYRRL-RHVNILRLMAACLESD-PWLLVFESCSRGDLKEFLLS---------NEAS 187
E + H+N++ L+ AC + P +++ E C G+L +L S N+++
Sbjct: 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKST 118
Query: 188 REALLEQGITIKMAID-------------------------------------------- 203
R+ ++Q K +D
Sbjct: 119 RKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISY 178
Query: 204 ---VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYYVHGEVALP 259
VA G+ ++ IH D+AARN L++ VKI D G + D Y DY G+ LP
Sbjct: 179 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APES+ + Q+ +VWSFGVLLWEIF G PY + D+ R
Sbjct: 239 LKWMAPESIFDKVYTTQS-------DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-K 290
Query: 320 EALRLPAP 327
E R+ AP
Sbjct: 291 EGTRMRAP 298
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+G G FG V + + KV ++I+K++ S + L E ++L H NI
Sbjct: 1 LGEGGFGTVYLARDKKTGK-------KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI 53
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
++L + + LV E C G LK+ L NE L + +++ + + GL Y+
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLH 109
Query: 213 EDGFIHTDVAARNCLVTS-ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCS 271
+G IH D+ N L+ S +VK+ D G S + V P + APE LL
Sbjct: 110 SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPEVLL-- 166
Query: 272 DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
+EK ++WS GV+L+E+ E L
Sbjct: 167 ----GKGYYSEKSDIWSLGVILYELPELKDL 193
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 78/278 (28%), Positives = 120/278 (43%), Gaps = 34/278 (12%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
F ++ L ++K++G G FGKV E + T +V V+ L + + F E
Sbjct: 1 FEKRHLKFIKQLGEGHFGKV---ELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREI 57
Query: 142 TPYRRLRHVNILRLMAACLESDPW--LLVFESCSRGDLKEFL--LSNEASREALLEQGIT 197
R L H NI++ C + L+ E G L+++L ++ + + LL
Sbjct: 58 EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL----- 112
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGE 255
+ + G+ Y+ +IH D+AARN LV SE VKI D G + + + YYV
Sbjct: 113 -LFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP 171
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG---KLPYAELSDDQV 312
P+ W APE L +T + +VWSFGV L+E+F +G + P AE
Sbjct: 172 GESPIFWYAPECL-------RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG 224
Query: 313 ITRVFGT---------EALRLPAPRAVNSHVDVAARNC 341
I + E RLP P + V + C
Sbjct: 225 IAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLC 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 78/248 (31%), Positives = 125/248 (50%), Gaps = 23/248 (9%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR+ L VK++G G FG+V G G +KV ++ LK+ + E FL
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNG--------HTKVAIKSLKQGSMSPEA--FLA 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA ++L+H ++RL A + +P ++ E G L +FL + E + L I
Sbjct: 51 EANLMKQLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIK---LTINKLID 106
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
MA +A G++++ +IH D+ A N LV+ L KI D G + +Y P
Sbjct: 107 MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE+ I T T K +VWSFG+LL EI +G++PY +++ +VI +
Sbjct: 167 IKWTAPEA-------INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL--E 217
Query: 320 EALRLPAP 327
R+P P
Sbjct: 218 RGYRMPRP 225
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 88/247 (35%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTS---KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
IG+G FG V G L +S G+ K RI D + E+ FL E + H
Sbjct: 3 IGKGHFGCVYHGT---LIDSDGQKIHCAVKSLNRI--TDLEEVEQ--FLKEGIIMKDFSH 55
Query: 150 VNILRLMAACLESD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK----MAID 203
N+L L+ CL S+ P L+V GDL+ F+ S T+K +
Sbjct: 56 PNVLSLLGICLPSEGSP-LVVLPYMKHGDLRNFIRSET--------HNPTVKDLIGFGLQ 106
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV---HGEVALPV 260
VA G+ Y+ F+H D+AARNC++ VK+ D G + D Y +YY H LPV
Sbjct: 107 VAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W A ESL QT T K +VWSFGVLLWE+ G PY ++ D IT V+ +
Sbjct: 167 KWMALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDIT-VYLLQ 217
Query: 321 ALRLPAP 327
RL P
Sbjct: 218 GRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 22/273 (8%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
IG G FG+V G + G+ V ++ LK ++ ++ FL EA+ + H NI
Sbjct: 12 IGAGEFGEVCRGRLK----LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
+ L +S P +++ E G L FL N+ + G M +A G+ Y+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG----MLRGIAAGMKYLS 123
Query: 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVA--LPVRWCAPESL 268
E ++H D+AARN LV S L K+ D G S ++ D + +P+RW APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE-- 181
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+I T +VWS+G+++WE+ +G+ PY ++S+ VI + + RLP P
Sbjct: 182 -----AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI--EQDYRLPPPM 234
Query: 329 AVNSHVDVAARNCLVTSE-LRVKIGDTGSSIDK 360
+ + +C R K G S++DK
Sbjct: 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 80/241 (33%), Positives = 124/241 (51%), Gaps = 25/241 (10%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRH 149
E+G G FG V +G + ++ V V+ILK D + A K L EA ++L +
Sbjct: 1 GELGSGNFGTVKKGMYK-----MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
I+R++ C E++ W+LV E G L +FL N+ + E+ IT ++ V+ G+
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKH----VTEKNIT-ELVHQVSMGMK 109
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYY---VHGEVALPVRWCAP 265
Y+ E F+H D+AARN L+ ++ KI D G S +YY HG+ PV+W AP
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK--WPVKWYAP 167
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
E C + + K +VWSFGVL+WE F +G+ PY + ++V + E + P
Sbjct: 168 E---C----MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP 220
Query: 326 A 326
Sbjct: 221 Q 221
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 80/249 (32%), Positives = 124/249 (49%), Gaps = 23/249 (9%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR+ L +K++G G FG+V G G +KV V+ LK E FL
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNG--------NTKVAVKTLKPGTMSPES--FLE 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA ++LRH +++L A E +P +V E S+G L +FL E R L +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEG-RALKLPN--LVD 106
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
MA VA G++Y+ +IH D+ + N LV L KI D G + +Y P
Sbjct: 107 MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE+ L +I K +VWSFG+LL E+ G++PY +++ +V+ +V
Sbjct: 167 IKWTAPEAALYGRFTI-------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV--E 217
Query: 320 EALRLPAPR 328
R+P P+
Sbjct: 218 RGYRMPCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-29
Identities = 90/328 (27%), Positives = 141/328 (42%), Gaps = 75/328 (22%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR +L K +GRG FG+V+E +A G++++ T V V++LKE A+ +E +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTA--TCRTVAVKMLKEGATHSEHRALM 58
Query: 139 HEATPYRRL-RHVNILRLMAACLE-SDPWLLVFESCSRGDLKEFLLSNEA------SREA 190
E + H+N++ L+ AC + P +++ E C G+L +L S +++A
Sbjct: 59 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDA 118
Query: 191 LLEQG--------ITIKMAIDVATGLSYMIEDGFI------------------------- 217
QG +K +D T GF+
Sbjct: 119 RFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTL 178
Query: 218 -----------------------HTDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYYVH 253
H D+AARN L++ VKI D G + D Y DY
Sbjct: 179 EDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
G+ LP++W APE++ +IQ+ +VWSFGVLLWEIF G PY + D+
Sbjct: 239 GDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
Query: 314 TRVFGTEALRLPAPRAVNSHVDVAARNC 341
R E R+ AP + +C
Sbjct: 292 CRRL-KEGTRMRAPDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 75/250 (30%), Positives = 115/250 (46%), Gaps = 19/250 (7%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+G G FG++ RG + + V + L+ S ++ FL EA + H NI
Sbjct: 13 LGTGRFGEL----CRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
+RL + ++V E S G L FL +E L G + M +A+G+ Y+
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLS 124
Query: 213 EDGFIHTDVAARNCLVTSELRVKIGDTGS-SIDKYPGDYYVHGEVALPVRWCAPESLLCS 271
E G++H +AA LV S+L KI DK Y + PV W APE+
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS-PVLWAAPEA---- 179
Query: 272 DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVN 331
IQ + +VWSFG+++WE+ +G+ PY ++S VI V + RLPAPR
Sbjct: 180 ---IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV--EDGFRLPAPRNCP 234
Query: 332 SHVDVAARNC 341
+ + +C
Sbjct: 235 NLLHQLMLDC 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 87/262 (33%), Positives = 123/262 (46%), Gaps = 30/262 (11%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVN 151
IG G FG+V+ R + + G + +++LKE AS+ + F E +L H N
Sbjct: 10 IGEGNFGQVI----RAMIKKDGLKMNAA-IKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFL-----------LSNEASREALLEQGITIKM 200
I+ L+ AC + E G+L +FL + E + L ++
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LP 259
A DVATG+ Y+ E FIH D+AARN LV L KI D G S + + YV + LP
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGE---EVYVKKTMGRLP 181
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
VRW A ESL S T K +VWSFGVLLWEI G PY ++ ++ ++
Sbjct: 182 VRWMAIESLNYS-------VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL--P 232
Query: 320 EALRLPAPRAVNSHVDVAARNC 341
+ R+ PR + V R C
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 22/238 (9%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
++++G G FGKV ++ TG+ V ++++K+ + ++ L E ++L+H
Sbjct: 4 LEKLGEGSFGKVY----LARDKKTGK---LVAIKVIKKKKIKKDRERILREIKILKKLKH 56
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NI+RL + D LV E C GDL + L L + + + L
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-----LSEDEARFYLRQILSALE 111
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
Y+ G +H D+ N L+ + VK+ D G + PG+ V P + APE LL
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPE-YMAPEVLL 169
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ ++WS GV+L+E+ GK P+ + + G P P
Sbjct: 170 GKG-------YGKAVDIWSLGVILYELL-TGKPPFPGDDQLLELFKKIGKPKPPFPPP 219
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 18/247 (7%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
+L +K +G G FG V +G E + V +++L+E+ S L EA
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGE---KVKIPVAIKVLREETSPKANKEILDEA 60
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+ H +++RL+ CL S L+ + G L +++ ++ ++ + Q + +
Sbjct: 61 YVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNH---KDNIGSQYL-LNWC 115
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPV 260
+ +A G+SY+ E +H D+AARN LV + VKI D G + + H E +P+
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W A ES I T K +VWS+GV +WE+ FG PY + ++ + +
Sbjct: 176 KWMALES-------ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL--EK 226
Query: 321 ALRLPAP 327
RLP P
Sbjct: 227 GERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 95/335 (28%), Positives = 140/335 (41%), Gaps = 82/335 (24%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR +L + K +G G FGKVVE A GL +S T V V++LK A E+ +
Sbjct: 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMT--VAVKMLKPSAHLTEREALM 86
Query: 139 HEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFL--------------LS 183
E L H+NI+ L+ AC P L++ E C GDL FL +
Sbjct: 87 SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHA 146
Query: 184 NEASREALLEQ----GITIKMAIDVATGLSYMIE-----------DGFIHTDV------- 221
A + LL Q ++ +D+ G+SY++ +I DV
Sbjct: 147 EAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEE 206
Query: 222 ------------------------AARNC----------LVTSELRVKIGDTGSSID-KY 246
A++NC L+T KI D G + D +
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306
+Y V G LPV+W APE SI C T + +VWS+G+LLWEIF G PY
Sbjct: 267 DSNYVVKGNARLPVKWMAPE-------SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 307 LSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNC 341
+ D ++ E R+ +P S + ++C
Sbjct: 320 MPVDSKFYKMI-KEGYRMLSPECAPSEMYDIMKSC 353
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 72/234 (30%), Positives = 124/234 (52%), Gaps = 21/234 (8%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR+ L K++G G FG+V +T +KV V+ +K + E FL
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWM--------ATYNKHTKVAVKTMKPGSMSVEA--FLA 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA + L+H +++L A + +P ++ E ++G L +FL S+E S++ L + I
Sbjct: 51 EANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LID 106
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
+ +A G++++ + +IH D+ A N LV++ L KI D G + +Y P
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
++W APE +I + T K +VWSFG+LL EI +G++PY +S+ +VI
Sbjct: 167 IKWTAPE-------AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 69/243 (28%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL-KEDASQAEKLFFLHEATPYR 145
++++G G FG V + + TG+ V V+IL K + E R
Sbjct: 1 YELLRKLGSGSFGTVY----KAKHKGTGK---IVAVKILKKRSEKSKKDQTARREIRILR 53
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
RL H NI+RL+ A + D LV E C GDL ++L SR L + K+A+ +
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQIL 108
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAP 265
GL Y+ +G IH D+ N L+ VKI D G + + V P + AP
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP-WYMAP 167
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
E LL + K +VWS GV+L+E+ GK P++ + + + L
Sbjct: 168 EVLLGGN------GYGPKVDVWSLGVILYELL-TGKPPFSGENILDQLQLIRRILGPPLE 220
Query: 326 APR 328
Sbjct: 221 FDE 223
|
Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 81/262 (30%), Positives = 115/262 (43%), Gaps = 30/262 (11%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVN 151
IG G FG+V+ + + G ++ +KE AS+ + F E +L H N
Sbjct: 3 IGEGNFGQVL----KARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFL-----------LSNEASREALLEQGITIKM 200
I+ L+ AC L E G+L +FL + S + L +
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LP 259
A DVA G+ Y+ + FIH D+AARN LV KI D G S + + YV + LP
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLP 174
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
VRW A ESL S T +VWS+GVLLWEI G PY ++ ++ ++
Sbjct: 175 VRWMAIESLNYS-------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--P 225
Query: 320 EALRLPAPRAVNSHVDVAARNC 341
+ RL P + V R C
Sbjct: 226 QGYRLEKPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR+ L ++G+G FG+V G G T+KV ++ LK E FL
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNG--------TTKVAIKTLKPGTMMPEA--FLQ 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA ++LRH ++ L A E +P +V E +G L +FL + L + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ---LVD 106
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
MA +A G++Y+ +IH D+ A N LV L KI D G + +Y P
Sbjct: 107 MAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE+ L +I K +VWSFG+LL E+ G++PY + + +V+ +V
Sbjct: 167 IKWTAPEAALYGRFTI-------KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV--E 217
Query: 320 EALRLPAPRAVNSHVDVAARNC 341
R+P P+ + + C
Sbjct: 218 RGYRMPCPQGCPESLHELMKLC 239
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-27
Identities = 76/248 (30%), Positives = 124/248 (50%), Gaps = 23/248 (9%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
++ PR+ L ++G+G FG+V G G T++V ++ LK E FL
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMSPEA--FLQ 50
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA ++LRH +++L A E +P +V E S+G L +FL E + L Q +
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQ--LVD 106
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
MA +A+G++Y+ ++H D+ A N LV L K+ D G + +Y P
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE+ L +I K +VWSFG+LL E+ G++PY + + +V+ +V
Sbjct: 167 IKWTAPEAALYGRFTI-------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--E 217
Query: 320 EALRLPAP 327
R+P P
Sbjct: 218 RGYRMPCP 225
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 65/237 (27%), Positives = 116/237 (48%), Gaps = 19/237 (8%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
E+G G FG V +G + ++ V +++LK + ++ + + EA +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQI-----DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM 211
I+R++ C E++ +LV E S G L +FL ++ + + M V+ G+ Y+
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMH-QVSMGMKYL 111
Query: 212 IEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA--LPVRWCAPESLL 269
F+H D+AARN L+ ++ KI D G S D Y A P++W APE +
Sbjct: 112 EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
S + +VWS+G+ +WE F +G+ PY ++ +V++ + + L PA
Sbjct: 172 FRKFS-------SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA 221
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 82/276 (29%), Positives = 124/276 (44%), Gaps = 30/276 (10%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
F ++ L ++++G G FGKV E + T +V V+ LK ++ E
Sbjct: 1 FEKRFLKRIRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 57
Query: 142 TPYRRLRHVNILRLMAACLES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
R L H NI++ C E + L+ E G LKE+L N+ L+Q +K
Sbjct: 58 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN--LKQ--QLK 113
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG--SSIDKYPGDYYVHGEVA 257
A+ + G+ Y+ ++H D+AARN LV SE +VKIGD G +I+ Y V ++
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-------- 309
PV W APE L+ S I + +VWSFGV L+E+ + + ++
Sbjct: 174 SPVFWYAPECLIQSKFYIAS-------DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226
Query: 310 --DQVITRVFGT--EALRLPAPRAVNSHVDVAARNC 341
+TR+ E RLP P V R C
Sbjct: 227 HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKC 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 82/264 (31%), Positives = 116/264 (43%), Gaps = 34/264 (12%)
Query: 93 IGRGWFGKVVEGEAR--GLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RH 149
IG G FG+V++ + GL ++ +KE AS+ + F E +L H
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAA-------IKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEA-----------SREALLEQGITI 198
NI+ L+ AC L E G+L +FL + S + L +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA- 257
A DVA G+ Y+ + FIH D+AARN LV KI D G S + + YV +
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGR 184
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
LPVRW A ESL S T +VWS+GVLLWEI G PY ++ ++ ++
Sbjct: 185 LPVRWMAIESLNYS-------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL- 236
Query: 318 GTEALRLPAPRAVNSHVDVAARNC 341
+ RL P + V R C
Sbjct: 237 -PQGYRLEKPLNCDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 83/312 (26%), Positives = 133/312 (42%), Gaps = 76/312 (24%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR +L K +G G FGKVVE A G+++ + T V V++LKE A+ +E +
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNT--VAVKMLKEGATASEHKALM 58
Query: 139 HEATPYRRL-RHVNILRLMAACLESD-PWLLVFESCSRGDLKEFLLSNEASREALL---- 192
E + H+N++ L+ AC + + P +++ E C G+L FL A RE
Sbjct: 59 SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL---RAKREFFSPYRE 115
Query: 193 ---EQGITIKMAIDVA-------TGLSYMIEDGFIHTD---------------------- 220
+Q + ++ + G + ++ F +
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 221 --------------VAARNC---------LVTSELRV-KIGDTGSSIDKYPG-DYYVHGE 255
+A+R C ++ SE V KI D G + D Y DY G
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
LP++W APES+ T + +VWSFGVLLWEIF G PY + ++ +
Sbjct: 236 ARLPLKWMAPESIFDK-------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288
Query: 316 VFGTEALRLPAP 327
+ R+ AP
Sbjct: 289 RL-KDGTRMRAP 299
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 45/102 (44%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRW 262
VA G+ ++ IH DVAARN L+T KI D G + D +Y V G LPV+W
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW 280
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
APES+ C T + +VWS+G+LLWEIF GK PY
Sbjct: 281 MAPESIF-------DCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 73/226 (32%), Positives = 111/226 (49%), Gaps = 27/226 (11%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF-FLHE 140
F + L +++++G+G FG V L+++TG V + K S AE L F E
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGE-----VVAVKKLQHSTAEHLRDFERE 55
Query: 141 ATPYRRLRHVNILRLMAACLESD-PWL-LVFESCSRGDLKEFLLSNEASREALLEQGITI 198
+ L+H NI++ C + L LV E G L+++L + L+ +
Sbjct: 56 IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLL 111
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS----IDKYPGDYYVHG 254
A + G+ Y+ ++H D+A RN LV SE RVKIGD G + DK +YY
Sbjct: 112 LYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK---EYYKVR 168
Query: 255 EVA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299
E P+ W APESL S S+ + +VWSFGV+L+E+F +
Sbjct: 169 EPGESPIFWYAPESLTESKFSVAS-------DVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-20
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHE 140
+L +K +G G FG V +G+ G + V ++ +++ + + E
Sbjct: 4 LKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQT----FQE 55
Query: 141 ATPYR----RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
T + L H I+RL+ C + LV + G L + + + S L+
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDS----LDPQR 110
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGE 255
+ + +A G+ Y+ E +H ++AARN L+ S+ V+I D G + YP D Y + E
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
P++W A ES+L T + +VWS+GV +WE+ +G PYA + +V
Sbjct: 171 HKTPIKWMALESILFG-------RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
Query: 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSE 346
+ E RL P+ V + C + E
Sbjct: 224 LEKGE--RLAQPQICTIDVYMVMVKCWMIDE 252
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 23/283 (8%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPY 144
+L VK +G G FG V +G+ G T V ++IL E + F+ EA
Sbjct: 8 ELKRVKVLGSGAFGTVY----KGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ H +++RL+ CL S LV + G L +++ ++ + + + + + +
Sbjct: 64 ASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDN----IGSQLLLNWCVQI 118
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRW 262
A G+ Y+ E +H D+AARN LV S VKI D G + ++ +Y G +P++W
Sbjct: 119 AKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKW 177
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
A E I T + +VWS+GV +WE+ FG PY + ++ + E
Sbjct: 178 MALE-------CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-- 228
Query: 323 RLPAPRAVNSHVDVAARNC-LVTSELRVKIGDTGSSIDKYPGD 364
RLP P V + C ++ ++ R K + + + D
Sbjct: 229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 30/249 (12%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPY 144
+ + +GRG FG V L++ TG K V + + + E L E
Sbjct: 1 EWTRGELLGRGSFGSVYLA----LDKDTGELMAVKS-VELSGDSEEELEAL--EREIRIL 53
Query: 145 RRLRHVNILRLMAACLESDP--WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
L+H NI+R + + + + E S G L L E ++ K
Sbjct: 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKYTR 108
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV-- 260
+ GL+Y+ +G +H D+ N LV S+ VK+ D G + K GD
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCA--KRLGDIETGEGTGSVRGT 166
Query: 261 -RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQVITRV-F 317
W APE + + ++WS G + E+ GK P++EL + + ++
Sbjct: 167 PYWMAPEVIRGEEY-------GRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGS 218
Query: 318 GTEALRLPA 326
E +P
Sbjct: 219 SGEPPEIPE 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 89/331 (26%), Positives = 135/331 (40%), Gaps = 57/331 (17%)
Query: 71 MQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS 130
MQ +DS+ ++ PR L + +G G FG+VVE A GL S ++T KV V++LK A
Sbjct: 24 MQLPYDSA-WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHS--QSTMKVAVKMLKSTAR 80
Query: 131 QAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN----- 184
+EK + E L H+NI+ L+ AC + P ++ E C GDL ++L N
Sbjct: 81 SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFL 140
Query: 185 -----EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR-----V 234
+ + L G + ++ + +S E + D++ ++ V
Sbjct: 141 QYYLDKNRDDGSLISGGSTPLS-QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199
Query: 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294
K D SS + P D Y+ APE DT I ++ F +
Sbjct: 200 KYADIESSNYESPYDQYLPS---------APER-TRRDTLINESPALSYMDLVGFSYQVA 249
Query: 295 EIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRVKIGDT 354
EF L + V H D+AARN L+ VKI D
Sbjct: 250 NGMEF------------------------LASKNCV--HRDLAARNVLICEGKLVKICDF 283
Query: 355 GSSID-KYPGDYYVHGEVALPVRWCAPESLL 384
G + D +Y G LP++W APES+
Sbjct: 284 GLARDIMRDSNYISKGSTFLPLKWMAPESIF 314
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-18
Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 32/279 (11%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
F ++ L ++ +G G FGKV + TG V V+ LK + Q + E
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEM---VAVKTLKRECGQQNTSGWKKEI 57
Query: 142 TPYRRLRHVNILRLMAACLES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
+ L H NI++ C E L+ E G L+++L ++ + LL
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------L 111
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY--VHGEVA 257
A + G++Y+ +IH D+AARN L+ ++ VKIGD G + G Y V +
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF---EFGKLPYAELSD----- 309
PV W A E L + + +VWSFGV L+E+ + + P + +
Sbjct: 172 SPVFWYAVECL-------KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK 224
Query: 310 DQVITRVFGTEAL----RLPAPRAVNSHVDVAARNCLVT 344
+T V E L RLP P+ V + +NC T
Sbjct: 225 QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWET 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 23/272 (8%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPY 144
+L VK +G G FG V +G+ G V +++L+E+ S L EA
Sbjct: 8 ELKKVKVLGSGAFGTVY----KGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ + RL+ CL S L V + G L +++ N ++ + Q + + + +
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVREN---KDRIGSQDL-LNWCVQI 118
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRW 262
A G+SY+ E +H D+AARN LV S VKI D G + +D +Y+ G +P++W
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG-KVPIKW 177
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
A ES+L T + +VWS+GV +WE+ FG PY + ++ + E
Sbjct: 178 MALESILHR-------RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-- 228
Query: 323 RLPAPRAVNSHVDVAARNC-LVTSELRVKIGD 353
RLP P V + C ++ SE R + +
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRE 260
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 22/241 (9%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLR 148
+K +G G FG V +GL G V ++ L+E S L EA +
Sbjct: 12 IKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
+ ++ RL+ CL S L+ + G L +++ + ++ + Q + + + +A G+
Sbjct: 68 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREH---KDNIGSQYL-LNWCVQIAKGM 122
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPE 266
+Y+ E +H D+AARN LV + VKI D G + + +Y+ G +P++W A E
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKWMALE 181
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
S I T + +VWS+GV +WE+ FG PY + ++ + + E RLP
Sbjct: 182 S-------ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQ 232
Query: 327 P 327
P
Sbjct: 233 P 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 31/52 (59%), Positives = 34/52 (65%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESL 383
H D+AARNCLVT L VKI D G S D Y DYY G LP++W APESL
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
|
Length = 258 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 42/105 (40%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRW 262
VA G+ ++ +H D+AARN L+ VKI D G + D +Y G LP++W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
APES+ + T +VWSFG+LLWEIF G PY EL
Sbjct: 308 MAPESIFNN-------LYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 5e-16
Identities = 30/51 (58%), Positives = 32/51 (62%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARNCLV L VKI D G S D Y DYY LP+RW APESL
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 6e-16
Identities = 30/51 (58%), Positives = 32/51 (62%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARNCLV L VKI D G S D Y DYY LP+RW APESL
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 11/137 (8%)
Query: 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228
++ + ++K L + + L+ + VA G+ ++ +H D+AARN L+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLD---LLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270
Query: 229 TSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVW 287
VKI D G + D + +Y G LPV+W APES+ D T + +VW
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLS-----DVW 323
Query: 288 SFGVLLWEIFEFGKLPY 304
S+G+LLWEIF G PY
Sbjct: 324 SYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR 148
+++IG+G FG+V + + RT +V ++++K + S+ +K ++E ++ +
Sbjct: 4 ILEKIGKGGFGEVYKARHK-------RTGKEVAIKVIKLE-SKEKKEKIINEIQILKKCK 55
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI++ + L+ D +V E CS G LK+ L S L + + ++ GL
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGL 111
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ +G IH D+ A N L+TS+ VK+ D G S V P W APE +
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT-MVGTPY-WMAPEVI 169
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
K ++WS G+ E+ E GK PY+EL
Sbjct: 170 NGKPYD-------YKADIWSLGITAIELAE-GKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 56/249 (22%), Positives = 94/249 (37%), Gaps = 37/249 (14%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKV-FVRILKEDASQAEKLF--FLHEATPYRRLRH 149
+G+G F + +G R +S V ++ + + F A+ +L H
Sbjct: 3 LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL- 208
++++L C+ D ++V E G L FL + +++ +DVA L
Sbjct: 61 KHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLA 111
Query: 209 ---SYMIEDGFIHTDVAARNCLVTSE-------LRVKIGDTGSSIDKYPGDYYVHGEVAL 258
Y+ + +H +V +N LV +K+ D G I + V
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV-----E 166
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
+ W APE + +K WSFG L EI G+ P + LS + F
Sbjct: 167 RIPWIAPE--CIRNGQASLTIAADK---WSFGTTLLEICSNGEEPLSTLSSSE--KERFY 219
Query: 319 TEALRLPAP 327
+ RLP P
Sbjct: 220 QDQHRLPMP 228
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 30/52 (57%), Positives = 33/52 (63%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESL 383
H D+AARNCLV +L VKI D G S D Y DYY LP+RW APESL
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 73.6 bits (179), Expect = 2e-14
Identities = 61/294 (20%), Positives = 103/294 (35%), Gaps = 29/294 (9%)
Query: 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL 147
++++G G FG+V KV + L+ + + E+ FL E L
Sbjct: 3 RILRKLGEGSFGEVYLAR------DRKLVALKVLAKKLESKSKEVER--FLREIQILASL 54
Query: 148 RH-VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
H NI++L + LV E G L++ L R+ L + + + + +
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI--GRKGPLSESEALFILAQILS 112
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYYVHGEVALPV----- 260
L Y+ G IH D+ N L+ + VK+ D G +
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV------IT 314
+ APE LL + + ++WS G+ L+E G P+ + I
Sbjct: 173 GYMAPEVLL----GLSLAYASSSSDIWSLGITLYE-LLTGLPPFEGEKNSSATSQTLKII 227
Query: 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH 368
T +L P + + AA + L+ L + SS D H
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASD-LLKKLLAKDPKNRLSSSSDLSHDLLAH 280
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 31/52 (59%), Positives = 36/52 (69%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESL 383
H D+AARNC+V +L VKIGD G + D Y DYY G+ LPVRW APESL
Sbjct: 142 HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 46/118 (38%), Positives = 64/118 (54%), Gaps = 4/118 (3%)
Query: 71 MQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS 130
MQ +DS ++FPR L + +G G FGKVVEG A GL S + KV V++LK A
Sbjct: 24 MQLPYDS-RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRS--QPVMKVAVKMLKPTAR 80
Query: 131 QAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEAS 187
+EK + E L H+NI+ L+ AC +S P ++ E C GDL +L N +
Sbjct: 81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDN 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR L + K +G G FGKVVE A GL + +V V++LK A E+ +
Sbjct: 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKED--NVLRVAVKMLKASAHTDEREALM 89
Query: 139 HEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFL 181
E L +H NI+ L+ AC P L++ E C GDL FL
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 30/240 (12%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFV---RILKEDASQAEKLFFLHEATPYRRLR 148
IGRG FG V +GL TG FV +I E + + E + L+
Sbjct: 7 LIGRGAFGVVY----KGLNLETGD-----FVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI++ + + SD ++ E G L++ + E+L + + + V GL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVY-QVLQGL 112
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPE 266
+Y+ E G IH D+ A N L T + VK+ D G + ++ D V W APE
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA---SVVGTPYWMAPE 169
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
I+ + ++WS G + E+ G PY +L+ + R+ + LP
Sbjct: 170 -------VIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDDHPPLPE 221
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 28/245 (11%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL-KEDASQAEKLFFLHEATPYRRLRHVN 151
+G+G F K+ +G R + + ++V +++L K + +E F A+ +L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSES--FFEAASMMSQLSHKH 60
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM 211
++ C+ D ++V E G L +L N+ + +++A +A L ++
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK----LEVAKQLAWALHFL 116
Query: 212 IEDGFIHTDVAARNCLVTSELR--------VKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+ G H +V A+N L+ E +K+ D G SI P + + + W
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----RIPWV 171
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
PE C + +K WSFG LWEIF G P + L D F + +
Sbjct: 172 PPE---CIENPQNLSLAADK---WSFGTTLWEIFSGGDKPLSAL--DSQKKLQFYEDRHQ 223
Query: 324 LPAPR 328
LPAP+
Sbjct: 224 LPAPK 228
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 25/60 (41%), Positives = 36/60 (60%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARNCLV+S+ VK+ S D Y +YY +P+RW APE++ D S ++
Sbjct: 140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKS 199
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 30/53 (56%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV +L VKIGD G S D Y DYY V G LP+RW PES++
Sbjct: 145 HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 26/50 (52%), Positives = 38/50 (76%), Gaps = 1/50 (2%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPE 381
H D+A RNC +T++L VKIGD G ++++YP DYY+ + A+P+RW APE
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 33/58 (56%), Positives = 37/58 (63%), Gaps = 6/58 (10%)
Query: 333 HVDVAARNCLVTSELR-----VKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNCLV+ + VKIGD G + D Y DYY GE LPVRW APESLL
Sbjct: 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 27/53 (50%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV +KI D G S + Y DYY V G LP+RW A ES+L
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 31/53 (58%), Positives = 34/53 (64%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV L VKIGD G S D Y DYY V G LP+RW PES+L
Sbjct: 145 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 197
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR- 148
V+ IG G +GKV + + TG+ V ++I+ + E++ E Y LR
Sbjct: 11 VEVIGEGTYGKVY----KARHKKTGQ---LVAIKIMDIIEDEEEEI--KEE---YNILRK 58
Query: 149 ---HVNILRLMAACLESDP-------WLLVFESCSRG---DL-KEFLLSNEASREALLEQ 194
H NI A ++ +P WL V E C G DL K + +E +
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWL-VMELCGGGSVTDLVKGLRKKGKRLKEEWI-- 115
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG 254
++ + GL+Y+ E+ IH D+ +N L+T VK+ D G S +
Sbjct: 116 AYILR---ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
+ P W APE + C + + + +VWS G+ E+ + GK P ++
Sbjct: 173 FIGTPY-WMAPEVIACDEQP--DASYDARSDVWSLGITAIELAD-GKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 40/272 (14%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + + E+G G FGKV + + + E+ +KV + S+ E ++ E
Sbjct: 3 PEEFWEIIGELGDGAFGKVYKAQNK---ETGVLAAAKVI-----DTKSEEELEDYMVEID 54
Query: 143 PYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI--K 199
H NI++L+ A E++ W+L+ E C+ G + +L E L E I + K
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELE---RPLTEPQIRVVCK 110
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI---------DKYPGDY 250
++ L+Y+ E+ IH D+ A N L T + +K+ D G S D + G
Sbjct: 111 QTLE---ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310
Y W APE ++C + + K +VWS G+ L E+ + + P+ EL+
Sbjct: 168 Y----------WMAPEVVMCETSKDRPYDY--KADVWSLGITLIEMAQI-EPPHHELNPM 214
Query: 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
+V+ ++ +E L P +S + CL
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCL 246
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 47/223 (21%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE----DASQAEKLFFLHEATPY 144
+K+IG+G FGKV L + K++V LKE + S+ E+ L+E
Sbjct: 4 IIKQIGKGSFGKVY------LVRRK--SDGKLYV--LKEIDLSNMSEKEREDALNEVKIL 53
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
++L H NI++ + E +V E GDL + + + + E+ I + + +
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWFVQL 112
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG------SSIDK------YPGDYYV 252
L Y+ +H D+ +N +TS VK+GD G S++D P YY+
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP--YYL 170
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWE 295
+PE LC + K ++WS G +L+E
Sbjct: 171 -----------SPE--LCQNKP-----YNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 30/53 (56%), Positives = 34/53 (64%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNCLV L VKI D G S D Y DYY V + LPVRW PE++L
Sbjct: 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-EDASQAEKLFFLHEATPYRRLRH 149
K+IG+G F V + GR + V+I + DA + L E ++L H
Sbjct: 8 KKIGKGQFSVVYKAICL----LDGRVVALKKVQIFEMMDAKARQDC--LKEIDLLKQLDH 61
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
N+++ +A+ +E++ +V E GDL ++ + ++ L+ + K + + + L
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY------VHGEVALPVRWC 263
+M +H D+ N +T+ VK+GD G G ++ H V P +
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGTPY-YM 173
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299
+PE I K ++WS G LL+E+
Sbjct: 174 SPE-------RIHENGYNFKSDIWSLGCLLYEMAAL 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 30/53 (56%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV + L VKIGD G S D Y DYY V G LP+RW PES++
Sbjct: 146 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 66/262 (25%), Positives = 108/262 (41%), Gaps = 18/262 (6%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + E+G G FGKV ++ + T + + S+ E F+ E
Sbjct: 3 PNDIWEIIGELGDGAFGKV--------YKAQHKETGLFAAAKIIQIESEEELEDFMVEID 54
Query: 143 PYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+H NI+ L A E+ W+L+ E C G L +L E L E I
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELER---GLTEPQIRYVCR 110
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+ L+++ IH D+ A N L+T + VK+ D G S + P
Sbjct: 111 -QMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP-Y 168
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE + C K ++WS G+ L E+ + + P+ EL+ +V+ ++ +E
Sbjct: 169 WMAPEVVACETFKDN--PYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLLKILKSEP 225
Query: 322 LRLPAPRAVNSHVDVAARNCLV 343
L P +S + ++CLV
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLV 247
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 55/236 (23%), Positives = 102/236 (43%), Gaps = 18/236 (7%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K++G+G +G V + + L ++ +V + + SQ E+ ++E + H
Sbjct: 6 KKLGKGSYGSVYK--VKRLSDNQFYALKEVDLGSM----SQKEREDAVNEIRILASVNHP 59
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
NI+ A L+ + +V E GDL + +S + L+ + ++ I + GL
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSK-AISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
+ E +H D+ + N L+ + VKIGD G I K ++ P + APE +
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLG--ISKVLKKNMAKTQIGTPH-YMAPE--VW 173
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
+ K ++WS G LL+E+ F P+ S + +V + +P
Sbjct: 174 KGRP-----YSYKSDIWSLGCLLYEMATF-APPFEARSMQDLRYKVQRGKYPPIPP 223
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 30/53 (56%), Positives = 34/53 (64%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV L VKIGD G S D Y DYY V G LP+RW PES++
Sbjct: 143 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
IG+G FG V + + ++ R + + + K ++ E+ + EA +L I
Sbjct: 8 IGKGSFGVVF----KVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLDSSYI 61
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
+R + L+ +V E GDL + L L E + + I + GL+++
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP--LPEDQVW-RFFIQILLGLAHLH 118
Query: 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD 272
+H D+ + N + + VKIGD G + + + V P + +PE LC D
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY-YLSPE--LCED 175
Query: 273 TSIQTCTVTEKCNVWSFGVLLWE 295
EK +VW+ GV+L+E
Sbjct: 176 KPYN-----EKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 30/52 (57%), Positives = 35/52 (67%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESL 383
H D+AARNC+V + VKIGD G + D Y DYY G+ LPVRW APESL
Sbjct: 142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 65/229 (28%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEES--------TGRTTSKVFVRILKEDASQAEK 134
P + ++EIG G FG V E +G+ +++ + I+KE
Sbjct: 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE------- 65
Query: 135 LFFLHEATPYRRLRHVNILRLMAACL-ESDPWLLVFESC--SRGDLKEFLLSNEASREAL 191
+ FL +LRH N + L E WL V E C S D+ E ++ L
Sbjct: 66 VRFLQ------QLRHPNTIEYKGCYLREHTAWL-VMEYCLGSASDILEVH------KKPL 112
Query: 192 LEQGITIKMAI--DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249
E I AI GL+Y+ IH D+ A N L+T VK+ D GS+ P +
Sbjct: 113 QEVEIA---AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169
Query: 250 YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
+ V P W APE +L D K +VWS G+ E+ E
Sbjct: 170 SF----VGTPY-WMAPEVILAMDEG----QYDGKVDVWSLGITCIELAE 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 31/290 (10%)
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK 134
FDS F P ++ IG+G +GKV + L + G SK V+IL E+
Sbjct: 10 FDS--FPDPSDTWEIIETIGKGTYGKVF----KVLNKKNG---SKAAVKILDPIHDIDEE 60
Query: 135 LFFLHEATPYRRLR----HVNILRLMAACLESDP------WLLVFESCSRGDLKEFLLSN 184
+ EA Y L+ H N+++ + D WL V E C+ G + + L+
Sbjct: 61 I----EAE-YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL-VLELCNGGSVTD-LVKG 113
Query: 185 EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
R +E+ I + + GL ++ + IH DV N L+T+E VK+ D G S
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173
Query: 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ V P W APE + C + + + T +C+VWS G+ E+ + G P
Sbjct: 174 LTSTRLRRNTSVGTPF-WMAPEVIAC-EQQLDS-TYDARCDVWSLGITAIELGD-GDPPL 229
Query: 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTS-ELRVKIGD 353
A+L + + ++ L P ++ + R CL E R + D
Sbjct: 230 ADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 28/50 (56%), Positives = 37/50 (74%), Gaps = 1/50 (2%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPE 381
H D+A RNCL+T++L VKIGD G S +KY DYYV + + +P+RW APE
Sbjct: 123 HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 26/53 (49%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEV-ALPVRWCAPESLL 384
H D+A RNCLV + VKI D G S + Y DYY E A+P+RW PES+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 27/53 (50%), Positives = 33/53 (62%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV L +KI D G S + Y GDYY + G LP+RW A E +L
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHE 140
P + ++EIG G FG V AR + R + V ++ + Q+ + + + E
Sbjct: 13 PEKLFSDLREIGHGSFGAVYF--ARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
++LRH N ++ L LV E C G + L E ++ L E I +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIA-AV 120
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
GL+Y+ IH DV A N L++ VK+GD GS+ P + + V P
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPY 176
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
W APE +L D K +VWS G+ E+ E
Sbjct: 177 -WMAPEVILAMDEG----QYDGKVDVWSLGITCIELAE 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA-----TPYRRL 147
IG G FG V G+ S+G + V + AS ++ + +A + L
Sbjct: 8 IGSGSFGSVY----LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
+H NI++ + + L++D + E G + L + A E L+ + + G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-----QILKG 118
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP-----VRW 262
L+Y+ G IH D+ N LV ++ +KI D G S A P V W
Sbjct: 119 LNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE ++ + T K ++WS G L+ E+ GK P+ + + Q I ++
Sbjct: 179 MAPE-------VVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGE---N 227
Query: 323 RLPAPRAVNSHVDVAARNCLV-TSELRVKIGDTGSSIDKYP 362
P S++ A + L T E+ T + + K+P
Sbjct: 228 ASPEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 29/62 (46%), Positives = 36/62 (58%), Gaps = 7/62 (11%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL------C 385
H D+A RNCLV + +KI D G S + Y GDYY + G LP+RW A ES+L
Sbjct: 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211
Query: 386 SD 387
SD
Sbjct: 212 SD 213
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 29/52 (55%), Positives = 35/52 (67%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESL 383
H D+AARNC+V + VKIGD G + D Y DYY G+ LPVRW +PESL
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 47/255 (18%), Positives = 91/255 (35%), Gaps = 48/255 (18%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVF--VRILKEDASQA---EK--LFFLHEAT 142
K IG G F VV E+ T + + K+ +++KE + EK L L+
Sbjct: 7 KIIGEGSFSTVV----LAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--- 59
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL-----LSNEASREALLEQGIT 197
H I++L + + V E G+L +++ L + +R E
Sbjct: 60 -----GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE---- 110
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
+ L Y+ G IH D+ N L+ ++ +KI D G++ P +
Sbjct: 111 ------ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 258 LPVRWCAPESLLCSDTS------------IQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305
E S + + ++W+ G +++++ GK P+
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML-TGKPPFR 223
Query: 306 ELSDDQVITRVFGTE 320
++ ++ E
Sbjct: 224 GSNEYLTFQKILKLE 238
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 88 HY--VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
HY ++ +G+G FG+ L T + V+ + S+ E+ L+E
Sbjct: 1 HYIPIRVLGKGAFGEAT------LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILS 54
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
L+H NI+ ++ + L+ E + G L + ++ + L E+ + + +
Sbjct: 55 LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIV 111
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE--VALPVRWC 263
+ +SY+ + G +H D+ N +T +K+GD G I K G Y E V P +
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFG--ISKILGSEYSMAETVVGTPY-YM 168
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+PE LC K ++W+ G +L+E+
Sbjct: 169 SPE--LCQGVK-----YNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 26/237 (10%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV-- 150
IGRG +G V RG TGR V ++I+ D + E +LR
Sbjct: 9 IGRGAYGAVY----RGKHVPTGRV---VALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 151 -NILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
NI + P L ++ E G ++ + +A A + I+ +V L
Sbjct: 62 PNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIR---EVLVAL 114
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ + G IH D+ A N LVT+ VK+ D G + V P W APE +
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-WMAPEVI 173
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
+ K ++WS G+ ++E+ G PY+++ + + + ++ RL
Sbjct: 174 T------EGKYYDTKADIWSLGITIYEM-ATGNPPYSDVDAFRAMMLIPKSKPPRLE 223
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 26/53 (49%), Positives = 33/53 (62%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV +KI D G S + Y GDYY + G LP+RW + ES+L
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 31/241 (12%)
Query: 119 KVFVRILKEDASQAEKLF--FLHEATPYRRLRHVNILRLMAACLE-SDPW---LLVFESC 172
+V +R K+ + L +E RR+ NIL++ ++ D L+ E C
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 173 SRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSE 231
+RG L+E L +E L + MAID GL + + + ++ + + LVT
Sbjct: 105 TRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN 159
Query: 232 LRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFG 290
++KI G I P V+ V + +L S T K +++S G
Sbjct: 160 YKLKIICHGLEKILSSPPFKNVNFMVYFSYK------MLNDIFS----EYTIKDDIYSLG 209
Query: 291 VLLWEIFEFGKLPYAELSDDQV---ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL 347
V+LWEIF GK+P+ L+ ++ I + L L P + V+ C +
Sbjct: 210 VVLWEIFT-GKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE----ACTSHDSI 264
Query: 348 R 348
+
Sbjct: 265 K 265
|
Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+ IG+G FG+V + +++ T + V ++++ + ++ E E + R
Sbjct: 7 ECIGKGSFGEVY----KAIDKRTNQV---VAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
I + + L+ ++ E C G + L + L++ + +V GL Y
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEY 113
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-----------VALP 259
+ E+G IH D+ A N L++ E VK+ D G V G+ V P
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFG-----------VSGQLTSTMSKRNTFVGTP 162
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
W APE + S EK ++WS G+ E+ + G+ P ++L
Sbjct: 163 F-WMAPEVIKQSGYD-------EKADIWSLGITAIELAK-GEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 26/53 (49%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARNC++ EL+VKI D S D +P DY+ G+ PV+W A ESL+
Sbjct: 140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 3e-09
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 38/243 (15%)
Query: 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKED---ASQAEKLFFLHEATP 143
++++G G +G V + ++ TG + K +R+ E+ S A L E +
Sbjct: 2 EKLEKLGEGTYGVVY----KARDKKTGEIVALKK-IRLDNEEEGIPSTA-----LREISL 51
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK-MAI 202
+ L+H NI++L+ LVFE C DLK++L + IK +
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMY 105
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVR 261
+ GL+Y +H D+ +N L+ + +K+ D G + P Y H V L R
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR 165
Query: 262 WCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRV 316
APE LL S T++ ++WS G + E+ L + DQ+ I ++
Sbjct: 166 --APEILLGSKHYSTAV---------DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214
Query: 317 FGT 319
GT
Sbjct: 215 LGT 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 32/253 (12%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR L +IG G G V E+ +GR +V V+++ Q +L F +E
Sbjct: 19 PRSLLENYIKIGEGSTGIVCIAR----EKHSGR---QVAVKMMDLRKQQRRELLF-NEVV 70
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R +H N++ + + L + ++ E G L++ S+ L E+ I +
Sbjct: 71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG-----ALTDIVSQTRLNEEQIA-TVCE 124
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG--SSIDKYPGDYYVHGEVALPV 260
V L Y+ G IH D+ + + L+T + RVK+ D G + I K D +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKSLVGTP 181
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
W APE I + ++WS G+++ E+ + G+ PY S Q + R+ +
Sbjct: 182 YWMAPE-------VISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDS- 232
Query: 321 ALRLPAPRAVNSH 333
P P+ N+H
Sbjct: 233 ----PPPKLKNAH 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 7e-09
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHE 140
P + ++EIG G FG V RT V ++ + Q+ + + + E
Sbjct: 23 PEKLFTDLREIGHGSFGAVYFAR-------DVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
+R++H N + L LV E C G + L E ++ L E I +
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIA-AI 130
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
GL+Y+ IH D+ A N L+T +VK+ D GS+ P + + V P
Sbjct: 131 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF----VGTPY 186
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
W APE +L D K +VWS G+ E+ E
Sbjct: 187 -WMAPEVILAMDEG----QYDGKVDVWSLGITCIELAE 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 27/56 (48%), Positives = 34/56 (60%), Gaps = 4/56 (7%)
Query: 333 HVDVAARNCLVTSE--LRV-KIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARNCL+T + RV KI D G + D Y YY G A LP++W PE+ L
Sbjct: 139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL 194
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 64/251 (25%), Positives = 104/251 (41%), Gaps = 28/251 (11%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR+ L +IG G G V E+ TG+ +V V+ + Q +L F +E
Sbjct: 20 PREYLDSFIKIGEGSTGIV----CIATEKHTGK---QVAVKKMDLRKQQRRELLF-NEVV 71
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R H N++ + + L D +V E G L + + + E + + +
Sbjct: 72 IMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCL 125
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
V LSY+ G IH D+ + + L+TS+ R+K+ D G V P W
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY-W 184
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE I + ++WS G+++ E+ + G+ PY Q + R+
Sbjct: 185 MAPE-------VISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIRDN--- 233
Query: 323 RLPAPRAVNSH 333
LP PR +SH
Sbjct: 234 -LP-PRVKDSH 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 35/218 (16%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE-DASQAEKLFFLHEATPYRRL 147
+ +G G +G V++ R TG V ++ KE + + K L E R+L
Sbjct: 5 VLGVVGEGAYGVVLK--CRNKA--TGEI---VAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI-DVAT 206
RH NI+ L A LVFE R L+ EAS L ++ I +
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPD--AVRSYIWQLLQ 111
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG------SSIDKYPGDYYVHGEVALPV 260
++Y IH D+ N LV+ +K+ D G + DY VA
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY-----VA--T 164
Query: 261 RWC-APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
RW APE LL DT+ + +VW+ G ++ E+
Sbjct: 165 RWYRAPE-LLVGDTN-----YGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 25/52 (48%), Positives = 34/52 (65%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESL 383
H D+AARNC++ ++ V + D G S Y GDYY G +A +PV+W A ESL
Sbjct: 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 25/52 (48%), Positives = 33/52 (63%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESL 383
H D+AARNC++ + V + D G S Y GDYY G +A +PV+W A ESL
Sbjct: 135 HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 88 HYVKEIGRGWFGKVVEGEARG-LEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
+K+IG G FGK+ +A+ E + + + +++AS+ E + +
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILL-------AK 55
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
++H NI+ A+ E+ +V E C GDL + + R L + + + ++
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI---NRQRGVLFSEDQILSWFVQISL 112
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRV-KIGDTGSSIDKYPGDYYVHGEVALPVRWCAP 265
GL ++ + +H D+ ++N ++ V K+GD G I + D E+A C
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFG--IARQLNDSM---ELA---YTCVG 164
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
S Q K ++WS G +L+E+
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 32/237 (13%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P ++ IG+G +GKV + + + S V+IL + E++ EA
Sbjct: 20 PTDTWEIIETIGKGTYGKV-------YKVTNKKDGSLAAVKILDPISDVDEEI----EAE 68
Query: 143 PYRRLR----HVNILRLMAACLESDPWL-----LVFESCSRGDLKEFLLSNEASREALLE 193
Y L+ H N+++ ++D + LV E C+ G + E L+ L+
Sbjct: 69 -YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE-LVKGLLICGQRLD 126
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH 253
+ + + GL ++ + IH DV N L+T+E VK+ D G S +
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 254 GEVALPVRWCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
V P W APE + C D S +C+VWS G+ E+ + G P ++
Sbjct: 187 TSVGTPF-WMAPEVIACEQQYDYSYDA-----RCDVWSLGITAIELGD-GDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEATPYRRLRH 149
EIG G FG V + T V V+ + Q + + + E ++L+H
Sbjct: 28 EIGHGSFGAVYFA-------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
N + L+ LV E C G + L E ++ L E I + GL+
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIA-AITHGALQGLA 135
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
Y+ IH D+ A N L+T +VK+ D GS+ P + + V P W APE +L
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF----VGTPY-WMAPEVIL 190
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
D K +VWS G+ E+ E
Sbjct: 191 AMDEG----QYDGKVDVWSLGITCIELAE 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 30/241 (12%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY 144
+QL +++G G + V +G R T V ++ + DA + + E +
Sbjct: 3 KQL---EKLGEGTYATVYKGRNR-------TTGEIVALKEIHLDAEEGTPSTAIREISLM 52
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L+H NI+RL + +LVFE DLK+++ ++ L+ +
Sbjct: 53 KELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGA--LDPNTVKSFTYQL 109
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWC 263
G+++ E+ +H D+ +N L+ +K+ D G + P + + + V L R
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR-- 167
Query: 264 APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFG 318
AP+ LL S TSI ++WS G ++ E+ L ++DQ+ I R+ G
Sbjct: 168 APDVLLGSRTYSTSI---------DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
Query: 319 T 319
T
Sbjct: 219 T 219
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 25/53 (47%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+T VKI D G + D +Y V G LPV+W APES+
Sbjct: 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 25/52 (48%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESL 383
H D+AARNC++ + V + D G S Y GDYY G + LPV+W A ESL
Sbjct: 136 HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL 187
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 26/211 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED-ASQAEKLFFLHEATPYRRLR 148
+ +IG G +G V + + T V ++ +K S+ L E + L
Sbjct: 4 LGKIGEGTYGVVYKARDK-------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI++L+ LVFE DL + + + + L E I + + GL
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLI---KDRQRGLPESLIKSYL-YQLLQGL 111
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY-PGDYYVHGEVALPVRWC-APE 266
++ G +H D+ N L+ +E +K+ D G + P Y H V RW APE
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-YVV--TRWYRAPE 168
Query: 267 SLLCSDTSIQTCTV-TEKCNVWSFGVLLWEI 296
LL + ++WS G + E+
Sbjct: 169 LLL-------GDKGYSTPVDIWSVGCIFAEL 192
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 34/254 (13%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + + E+G G FGKV + + + E+ +KV E S+ E ++ E
Sbjct: 10 PNEVWEIIGELGDGAFGKVYKAKNK---ETGALAAAKVI-----ETKSEEELEDYMVEIE 61
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
H I++L+ A ++ E C G + +L E R L E I + +
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML--ELDR-GLTEPQIQV-ICR 117
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI---------DKYPGDYYVH 253
+ L Y+ IH D+ A N L+T + +K+ D G S D + G Y
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY-- 175
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
W APE ++C +++ K ++WS G+ L E+ + + P+ EL+ +V+
Sbjct: 176 --------WMAPEVVMCE--TMKDTPYDYKADIWSLGITLIEMAQI-EPPHHELNPMRVL 224
Query: 314 TRVFGTEALRLPAP 327
++ +E L P
Sbjct: 225 LKIAKSEPPTLSQP 238
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE---VALPV 260
V GL+Y+ G +H D+ A N LV ++ KI D G I K D Y + + + V
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFG--ISKKSDDIYDNDQNMSMQGSV 174
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF--G 318
W APE + + + K ++WS G ++ E+F G+ P+ SD++ I +F G
Sbjct: 175 FWMAPEVI-----HSYSQGYSAKVDIWSLGCVVLEMFA-GRRPW---SDEEAIAAMFKLG 225
Query: 319 TEALRLPAPRAVNSHVDVAARN-----CLVTSELR 348
+ P P V+ ++ A + + + R
Sbjct: 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 25/53 (47%), Positives = 34/53 (64%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARN L+ +L VKI D G S + Y DYY V + LP+RW PE+++
Sbjct: 147 HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 25/177 (14%)
Query: 76 DSSEFQFPRQQLHYVK--EIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQ 131
D EF F + Y K +IG+G FG+V + AR + T ++ ++L E+ +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFK--ARH------KKTKQIVALKKVLMENEKE 52
Query: 132 AEKLFFLHEATPYRRLRHVNILRLMAAC-LESDPW-------LLVFESCSRGDLKEFLLS 183
+ L E + L+H N++ L+ C ++ P+ LVFE C DL LLS
Sbjct: 53 GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAG-LLS 110
Query: 184 NEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240
N+ + L E +KM + GL Y+ + +H D+ A N L+T + +K+ D G
Sbjct: 111 NKNVKFTLSEIKKVMKMLL---NGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K+IGRG F +V A L + KV + L + ++A+ + E ++L H
Sbjct: 8 KKIGRGQFSEVYR--ATCLLDGVPVALKKVQIFDLMDAKARAD---CIKEIDLLKQLNHP 62
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
N+++ A+ +E + +V E GDL + + + + E+ + K + + + L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALEH 121
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
M +H D+ N +T+ VK+GD G H V P + +PE
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPE---- 176
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEI 296
I K ++WS G LL+E+
Sbjct: 177 ---RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 29/237 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+++IG G +G V + + R T + VR+ +D + L E + L+H
Sbjct: 5 LEKIGEGTYGTVFKAKNR----ETHEIVALKRVRL--DDDDEGVPSSALREICLLKELKH 58
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NI+RL LVFE C + DLK++ S + + + ++ GL+
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL----KGLA 113
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESL 268
+ +H D+ +N L+ +K+ D G + P Y V L R P+ L
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYR--PPDVL 171
Query: 269 LCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGK--LPYAELSDD-QVITRVFGT 319
+ TSI ++WS G + E+ G+ P ++ D + I R+ GT
Sbjct: 172 FGAKLYSTSI---------DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 110 EESTGRTTSKVFVRILKE-DASQAE-KLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167
+E G + K ILK D S + L F A+ R++ H +I+ L C+ ++
Sbjct: 22 DEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81
Query: 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227
V E G L F+ + +L K+A +A+ LSY+ + +H +V +N L
Sbjct: 82 VEEFVEFGPLDLFM----HRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNIL 137
Query: 228 VTSE-------LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTV 280
+ E +K+ D G P E + W APE C + S
Sbjct: 138 LAREGIDGECGPFIKLSDPG-----IPITVLSRQECVERIPWIAPE---CVEDSKNLSIA 189
Query: 281 TEKCNVWSFGVLLWEIFEFGKLP 303
+K WSFG LWEI G++P
Sbjct: 190 ADK---WSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 25/52 (48%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESL 383
H D+AARN LVT + +KI D G + D + DYY LPV+W APE+L
Sbjct: 155 HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 24/52 (46%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESL 383
H D+AARNCLV +KI D G S ++ G Y V G +P++W APE+L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 25/53 (47%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRWCAPESLL 384
H DVAARN L+T KI D G + D +Y V G LPV+W APES+
Sbjct: 235 HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 23/50 (46%), Positives = 31/50 (62%), Gaps = 1/50 (2%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPE 381
H D+A RNC +TS+L VK+GD G +Y DY + +P+RW APE
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 26/53 (49%), Positives = 33/53 (62%), Gaps = 2/53 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE-VALPVRWCAPESL 383
H D+AARN L+ S+ +VKIGD G D+YV E + +P WCAPESL
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQ 391
H D+A RN LV +L VKI D G + Y DYY + G LP+RW +PE+++ SI
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID 206
Query: 392 T 392
+
Sbjct: 207 S 207
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
RL H +I+R++ A E + L E + G + L S+ ++ + I +
Sbjct: 59 RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLL 113
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGDTGSSID---KYPGDYYVHGEVALPVR 261
GLSY+ E+ IH DV N L+ S R++I D G++ K G G++ +
Sbjct: 114 RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ APE L C+VWS G ++ E+ K P+
Sbjct: 174 FMAPEVLRGEQYG-------RSCDVWSVGCVIIEMAT-AKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY 144
QQ V EIG G +GKV + AR L+ GR + VR+ + + L + E
Sbjct: 1 QQYECVAEIGEGAYGKVFK--ARDLKNG-GRFVALKRVRVQTGE--EGMPLSTIREVAVL 55
Query: 145 RRLR---HVNILRLMAACLES-----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
R L H N++RL C S LVFE + DL +L + + E G+
Sbjct: 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-------DKVPEPGV 107
Query: 197 ---TIK-MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV 252
TIK M + GL ++ +H D+ +N LVTS ++K+ D G + +
Sbjct: 108 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG--LARIYSFQMA 165
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
V + + + APE LL S + ++WS G + E+F
Sbjct: 166 LTSVVVTLWYRAPEVLLQS-------SYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + ++++G G +G V + + + TG+ + V + +ED + K E +
Sbjct: 1 PEEVFDILEKLGEGSYGSVY----KAIHKETGQVVAIKVVPV-EEDLQEIIK-----EIS 50
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
++ I++ + ++ +V E C G + + + + + + L E+ I +
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILY- 106
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
GL Y+ + IH D+ A N L+ E + K+ D G S + V W
Sbjct: 107 QTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFW 165
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
APE + + K ++WS G+ E+ E GK PY+++
Sbjct: 166 MAPEVIQEIGYN-------NKADIWSLGITAIEMAE-GKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 69/271 (25%), Positives = 113/271 (41%), Gaps = 43/271 (15%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR L +IG G G V ++STGR +V V+ + Q +L F +E
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIAT----DKSTGR---QVAVKKMDLRKQQRRELLF-NEVV 68
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R +H NI+ + ++ L D +V E G L + + + E Q T+ +A+
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAV 124
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR- 261
A LS++ G IH D+ + + L+TS+ RVK+ D G + +P R
Sbjct: 125 LKA--LSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFG---------FCAQVSKEVPRRK 173
Query: 262 -------WCAPE--SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
W APE S L T + ++WS G+++ E+ + G+ PY Q
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEV---------DIWSLGIMVIEMVD-GEPPYFNEPPLQA 223
Query: 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLV 343
+ R+ +L V+ + LV
Sbjct: 224 MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTS--KVFVRILKED-ASQAEKLFFLHEATPYRRLRH 149
IG G G V + A+ E TG T + KV +R L+ +QA L E + +H
Sbjct: 8 IGEGAHGIVFK--AKDRE--TGETVALKKVALRRLEGGIPNQA-----LREIKALQACQH 58
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
+++L+ ++LV E DL E L E L + + G++
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVL----RDEERPLPEAQVKSYMRMLLKGVA 113
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWC-APE 266
YM +G +H D+ N L++++ +KI D G + + Y H +VA RW APE
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-QVA--TRWYRAPE 170
Query: 267 SLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFGT 319
L + D + ++W+ G + E+ L E +Q+ + R GT
Sbjct: 171 LLYGARKYDPGV---------DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 36/234 (15%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P++ ++ IG G +G V + AR + KV +D ++ E +
Sbjct: 1 PQEDYELIQRIGSGTYGDVYK--ARDIATGE-LVAIKVIKLEPGDDFEIIQQ-----EIS 52
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ RH NI+ + L D +V E C G L++ + +R L E I +
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY---QVTRGPLSELQIAY-VCR 108
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG------SSIDK---YPGDYYVH 253
+ GL+Y+ E G IH D+ N L+T + VK+ D G ++I K + G Y
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-- 166
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
W APE KC++W+ G+ E+ E + P +L
Sbjct: 167 --------WMAPEVAAVERKG----GYDGKCDIWALGITAIELAE-LQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 38/234 (16%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR+ +++IG G G+V + + +TG+ +V ++ ++ E + +E
Sbjct: 17 PRELYKNLEKIGEGASGEVY----KATDRATGK---EVAIKKMRLRKQNKELII--NEIL 67
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ +H NI+ + L D +V E G L + + N + E I
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCR- 123
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR- 261
+V GL Y+ IH D+ + N L++ + VK+ D G + R
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFG---------FAAQLTKEKSKRN 174
Query: 262 -------WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
W APE + D K ++WS G++ E+ E G+ PY
Sbjct: 175 SVVGTPYWMAPEVIKRKDYG-------PKVDIWSLGIMCIEMAE-GEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-07
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 34/256 (13%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEA 141
P V+ +G G +G+V +G TG+ + KV E+ +++ L +
Sbjct: 4 PAGIFELVELVGNGTYGQVYKGR----HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY 59
Query: 142 TPYRRLRHVNILRLMAACLESDP-------WLLVFESCSRGDLKEFLLSNEASREALLEQ 194
+ +R NI A ++ +P WL V E C G + + + + + + L E+
Sbjct: 60 SHHR-----NIATYYGAFIKKNPPGMDDQLWL-VMEFCGAGSVTDLIKNTKGN--TLKEE 111
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYV 252
I + ++ GLS++ + IH D+ +N L+T VK+ D G S +D+ G
Sbjct: 112 WIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 170
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
+ P W APE + C + T K ++WS G+ E+ E G P ++ +
Sbjct: 171 F--IGTPY-WMAPEVIACDENP--DATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRA 224
Query: 313 ITRVFGTEALRLPAPR 328
+ + R PAPR
Sbjct: 225 LFLI-----PRNPAPR 235
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 24/53 (45%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV SE VKI D G + + + YYV P+ W APE L
Sbjct: 132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 24/54 (44%), Positives = 31/54 (57%), Gaps = 3/54 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV---HGEVALPVRWCAPESL 383
H D+AARNC++ VK+ D G + D Y +YY H LPV+W A ESL
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
K+IGRG F +V + ++F ++ A Q + E ++L H
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIF-EMMDAKARQD----CVKEIDLLKQLNHP 62
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
N+++ + + +E + +V E GDL + + + + + E+ + K + + + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVEH 121
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
M +H D+ N +T+ VK+GD G H V P + +PE
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPE---- 176
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEI 296
I K ++WS G LL+E+
Sbjct: 177 ---RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 26/54 (48%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG--SSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV SE +VKIGD G +I+ Y V ++ PV W APE L+
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 24/51 (47%), Positives = 31/51 (60%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV+S VK+GD G S YY + LP++W APES+
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 30/65 (46%), Positives = 36/65 (55%), Gaps = 8/65 (12%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS----IDKYPGDYYVHGEVA-LPVRWCAPESLLCSD 387
H D+A RN LV SE RVKIGD G + DK +YY E P+ W APESL S
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDK---EYYKVREPGESPIFWYAPESLTESK 187
Query: 388 TSIQT 392
S+ +
Sbjct: 188 FSVAS 192
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 22/197 (11%)
Query: 119 KVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLK 178
KV ++ + + Q E + H N+++ + + D LV S G L
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 179 EFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238
+ + S + L++ I + +V GL Y+ +G IH D+ A N L+ + VKI D
Sbjct: 88 DIMKS--SYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIAD 145
Query: 239 TGSSIDKYPGDYYVHGEVALPVR--------WCAPESLLCSDTSIQTCTVTEKCNVWSFG 290
G S G G+ VR W APE + Q K ++WSFG
Sbjct: 146 FGVSASLADG-----GDRTRKVRKTFVGTPCWMAPEVME------QVHGYDFKADIWSFG 194
Query: 291 VLLWEIFEFGKLPYAEL 307
+ E+ G PY++
Sbjct: 195 ITAIELAT-GAAPYSKY 210
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 48/223 (21%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR- 148
+K++G G FG V + TG V ++ +K+ K + E R ++
Sbjct: 4 IKQLGDGTFGSVYLARNK----ETGE---LVAIKKMKK------KFYSWEECMNLREVKS 50
Query: 149 ------HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
H NI++L E+D VFE G+L + + R+ I+ I
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKD----RKGKPFSESVIRSII 105
Query: 203 -DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG---SSIDKYPGDYYVHGEVAL 258
+ GL+++ + GF H D+ N LV+ VKI D G + P YV
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV------ 159
Query: 259 PVRWC-APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIF 297
RW APE LL S + + ++W+ G ++ E++
Sbjct: 160 STRWYRAPEILLRSTSYSSPV---------DIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 22/231 (9%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + ++ IG+G FG+V +G RT V ++I+ + ++ E E T
Sbjct: 2 PEELFTKLERIGKGSFGEVYKG-------IDNRTKEVVAIKIIDLEEAEDEIEDIQQEIT 54
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ I R + L+ ++ E G + L + LE+ +
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILR 108
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
++ GL Y+ + IH D+ A N L++ + VK+ D G + + V P W
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-W 167
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
APE I+ K ++WS G+ E+ + G+ P ++L +V+
Sbjct: 168 MAPE-------VIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVL 210
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 25/52 (48%), Positives = 34/52 (65%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEV-ALPVRWCAPESL 383
H D+AARNCLVT + +KI D G S ++ G Y G + +PV+W APE+L
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR L +IG G G V + S+G+ V V+ + Q +L F +E
Sbjct: 18 PRTYLDNFIKIGEGSTGIVCIATVK----SSGKL---VAVKKMDLRKQQRRELLF-NEVV 69
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R +H N++ + + L D +V E G L + + + E + + +
Sbjct: 70 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------AAVCL 123
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
V LS + G IH D+ + + L+T + RVK+ D G V P W
Sbjct: 124 AVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-W 182
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
APE I + ++WS G+++ E+ + G+ PY
Sbjct: 183 MAPE-------LISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 53/240 (22%), Positives = 91/240 (37%), Gaps = 37/240 (15%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH-EATPYRRLRHVN 151
+G G FG V EG G + V + + + E + L E +L+H N
Sbjct: 8 LGSGSFGSVYEGLNL----DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI-DVATGLSY 210
I++ + E D + E G L + L + E + I++ + GL Y
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV------IRLYTRQILLGLEY 117
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTG--------SSIDKYPGDYYVHGEVALPVRW 262
+ + +H D+ N LV + VK+ D G S + G Y W
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY----------W 167
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE + Q ++WS G + E+ GK P+++L + ++ ++ L
Sbjct: 168 MAPEVIA------QQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIGRSKEL 220
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEA 141
P+++ ++IG+G G V ++ +TG+ V I + + Q +K ++E
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTA----IDVATGQE-----VAIKQMNLQQQPKKELIINEI 67
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
R +H NI+ + + L D +V E + G L + + E +++G +
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVC 121
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+ L ++ + IH D+ + N L+ + VK+ D G P V P
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY- 180
Query: 262 WCAPESLLCSDTSIQTCTVTEK-----CNVWSFGVLLWEIFEFGKLPY 304
W APE VT K ++WS G++ E+ E G+ PY
Sbjct: 181 WMAPE------------VVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 43/284 (15%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKEDASQAEKLFFLHEATPYRRLR 148
+K I +G FG V + R +T F +++LK+ A+ +A R +
Sbjct: 1 LKPISKGAFGSVYLAKKR--------STGDYFAIKVLKKSDMIAKNQVTNVKAE--RAIM 50
Query: 149 HV-----NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
+ + +L + D LV E + GD + + L E + +
Sbjct: 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAK-QYIAE 105
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRW 262
V G+ + + G IH D+ N L+ +K+ D G S + V P +
Sbjct: 106 VVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF-----VGTP-DY 159
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE++L + + WS G +++E F FG P+ + D V + +
Sbjct: 160 LAPETILGVGD-------DKMSDWWSLGCVIFE-FLFGYPPFHAETPDAVFDNI---LSR 208
Query: 323 RLPAPRAVNSHVDVAAR---NCLVTSELRVKIGDTG-SSIDKYP 362
R+ P V A N L+ + ++G G I +P
Sbjct: 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+LRH NI+R LE+D +V + L E S + ++ E+ I + + +
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW-NIFVQM 122
Query: 205 ATGLSYMIEDGFI-HTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
L Y+ ++ I H D+ N ++ + +V I D G + K P V + +
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT--SVVGTILYS 180
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
PE ++ EK +VW+FG +L+++
Sbjct: 181 CPEI-------VKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 29/169 (17%)
Query: 138 LHEATPYRRLRHVNILRLMAACL-ESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQG 195
L E + + I++ A L ES + + E C G L + + R + +
Sbjct: 47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEK 105
Query: 196 ITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS---IDKYPG---- 248
+ K+A V GLSY+ IH D+ N L+T + +VK+ D G S ++ G
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG 165
Query: 249 -DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+Y+ APE IQ + +VWS G+ L E+
Sbjct: 166 TSFYM-----------APE-------RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 22/53 (41%), Positives = 30/53 (56%), Gaps = 3/53 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV S L K+ D G S ++ Y G +P+RW APE++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG-KIPIRWTAPEAI 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 23/51 (45%), Positives = 30/51 (58%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARNCLV +KI D G S + G Y G +P++W APE+L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL 166
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 25/60 (41%), Positives = 32/60 (53%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARNCLV VK+ D G S Y H P++W APESL + SI++
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 27/245 (11%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVR--ILKEDASQAEKLFFLHEATPYRRLR 148
+ IG+G FG V + R +S G K+ V I + ++ EK + E R L+
Sbjct: 6 ETIGKGSFGTVRK--VR--RKSDG----KILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 149 HVNILRLMAACL--ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
H NI+R + + +V E C GDL + + + R+ + E+ I ++ +
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLL 116
Query: 207 GLS---YMIEDG--FIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
L + G +H D+ N + + VK+GD G + + V P
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
+PE + S EK ++WS G L++E+ P+ + Q+ +++ +
Sbjct: 177 M-SPE--QLNHMS-----YDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASKIKEGKF 227
Query: 322 LRLPA 326
R+P
Sbjct: 228 RRIPY 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 22/231 (9%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + ++ IG+G FG+V +G RT V ++I+ + ++ E E T
Sbjct: 2 PEELFTKLERIGKGSFGEVFKG-------IDNRTQQVVAIKIIDLEEAEDEIEDIQQEIT 54
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ + + + L+ ++ E G + L R ++ M
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLK 108
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
++ GL Y+ + IH D+ A N L++ + VK+ D G + + V P W
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-W 167
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
APE IQ K ++WS G+ E+ + G+ P +++ +V+
Sbjct: 168 MAPE-------VIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 30/240 (12%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEK-LFFLHEATPYRRL 147
K +G+G FGKV+ E +G E K V ++ +D + EK + L P+ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
H L + V E + GDL + + R L A ++ G
Sbjct: 59 TH-----LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATF---YAAEIVCG 108
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
L ++ G I+ D+ N ++ + +KI D G + GD P + APE
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP-DYIAPEI 167
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
L Q T + WSFGVLL+E+ G+ P+ +D++ E++R+ P
Sbjct: 168 L-------QGLKYTFSVDWWSFGVLLYEML-IGQSPFHGDDEDELF------ESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 25/52 (48%), Positives = 31/52 (59%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESL 383
H D+AARN LV ++KI D G S D Y D YV + +PV+W A ESL
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 25/57 (43%), Positives = 29/57 (50%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTS 389
H D+AARNCLV + VK+ D G S +Y PVRW PE LL S S
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 50/231 (21%), Positives = 95/231 (41%), Gaps = 22/231 (9%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + +++IG+G FG+V +G RT V ++I+ + ++ E E T
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKG-------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 54
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ + + + L+ ++ E G + L L++ +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILR 108
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
++ GL Y+ + IH D+ A N L++ VK+ D G + + V P W
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-W 167
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
APE I+ K ++WS G+ E+ + G+ P++EL +V+
Sbjct: 168 MAPE-------VIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 67/258 (25%), Positives = 105/258 (40%), Gaps = 31/258 (12%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH-EATPYRRLRH 149
K +G+G FG+V + TGR + V + +++ L E + L+H
Sbjct: 8 KLLGQGAFGRVY----LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 150 VNILRLMAACLESDPWLLVF-ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
I++ CL D L +F E G +K+ L + A L + +T K + G+
Sbjct: 64 ERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILEGV 117
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR----WCA 264
Y+ + +H D+ N L S VK+GD G+S K G V W +
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS--KRLQTICSSGTGMKSVTGTPYWMS 175
Query: 265 PESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324
PE + K +VWS G + E+ K P+AE I ++ A +
Sbjct: 176 PEVISGE-------GYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKI----ATQP 223
Query: 325 PAPRAVNSHVDVAARNCL 342
P+ + SHV ARN L
Sbjct: 224 TNPQ-LPSHVSPDARNFL 240
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 24/52 (46%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYYVHGEVALPVRWCAPESL 383
H D+AARN L++ VKI D G + D Y DY G+ LP++W APES+
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 48/197 (24%), Positives = 69/197 (35%), Gaps = 54/197 (27%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L+H NI+ L+ LVFE DL E +++ + D+
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFE-FMETDL-----------EKVIKDKSIVLTPADI 104
Query: 205 A-------TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEV 256
GL Y+ + +H D+ N L+ S+ +K+ D G + P H V
Sbjct: 105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 257 ALPVRWC-APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-------- 307
RW APE L + ++WS G IF AEL
Sbjct: 165 T---RWYRAPELLFGAR------HYGVGVDMWSVGC----IF-------AELLLRVPFLP 204
Query: 308 --SD-DQ--VITRVFGT 319
SD DQ I GT
Sbjct: 205 GDSDIDQLGKIFEALGT 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P+++ ++IG+G G V ++ +TG+ +V +R + Q +K ++E
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTA----MDVATGQ---EVAIRQMNLQ-QQPKKELIINEIL 69
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R ++ NI+ + + L D +V E + G L + + E +++G +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCR 123
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+ L ++ + IH D+ + N L+ + VK+ D G P V P W
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-W 182
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
APE + K ++WS G++ E+ E G+ PY
Sbjct: 183 MAPE-------VVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 20/53 (37%), Positives = 27/53 (50%), Gaps = 2/53 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA--LPVRWCAPESL 383
H D+AARN L+ + + KI D G S G Y A P++W APE +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 9e-06
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 34/240 (14%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFV-------RILKEDASQAEKLFFLHEATPYR 145
+G+G FGKV+ R + T K++ +I+K E L E
Sbjct: 1 LGKGSFGKVLL--VRK------KDTGKLYAMKVLKKKKIIKRK----EVEHTLTERNILS 48
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
R+ H I++L A + LV E G+L LS E E+ A ++
Sbjct: 49 RINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF-SHLSKEGR---FSEERARFYAA-EIV 103
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAP 265
L Y+ G I+ D+ N L+ ++ +K+ D G + + + P + AP
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP-EYLAP 162
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
E LL + WS GVLL+E+ GK P+ D + I + LR P
Sbjct: 163 EVLLGKGYGKA-------VDWWSLGVLLYEML-TGKPPFYA-EDRKEIYEKILKDPLRFP 213
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 36/235 (15%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY 144
Q+ + IG G FGKV + TG + +RI D +++ E
Sbjct: 3 QRGNK---IGGGTFGKVY----TAVNLDTGELMAVKEIRIQDNDPKTIKEI--ADEMKVL 53
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM-AID 203
L+H N+++ + + + E CS G L+E L + I++ +
Sbjct: 54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL------EHGRILDEHVIRVYTLQ 107
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI------DKYPGDYYVHGEVA 257
+ GL+Y+ G +H D+ N + +K+GD G ++ V
Sbjct: 108 LLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE--EVQSLAG 165
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEK---CNVWSFGVLLWEIFEFGKLPYAELSD 309
P + APE I ++WS G ++ E+ GK P++EL +
Sbjct: 166 TPA-YMAPE-------VITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 58/260 (22%), Positives = 105/260 (40%), Gaps = 31/260 (11%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF-LHEATPY-RRLRHV 150
+G+G +G V G + G+ + V + + AEK + L E + L+HV
Sbjct: 8 LGKGAYGTVYCGLT-----NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
NI++ + CL+ + + E G + L +R L + + K + G++Y
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAY 117
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVR----WCAP 265
+ + +H D+ N ++ +K+ D G + + G + H + + W AP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
E I K ++WS G ++E+ GK P A + + +F A R
Sbjct: 178 E-------VINESGYGRKSDIWSIGCTVFEM-ATGKPPLASMDR---LAAMFYIGAHRGL 226
Query: 326 APRAVNSHVDVAA---RNCL 342
PR +S A +CL
Sbjct: 227 MPRLPDSFSAAAIDFVTSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 1e-05
Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P+++ ++IG+G G V G+ + + + K Q +K ++E
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVAT----GQEVAIKQINLQK----QPKKELIINEIL 68
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ L++ NI+ + + L D +V E + G L + + E +++ +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCR 122
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+ L ++ + IH D+ + N L+ + VK+ D G P V P W
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-W 181
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
APE + K ++WS G++ E+ E G+ PY
Sbjct: 182 MAPE-------VVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 91 KEIGRGWFGKV---VEGEARGLEESTGRTTSKVFVRILKE----DASQAEKLFFLHEATP 143
+ +G+G FG V + +A E +++LKE + + E + EA
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEER----------LKVLKEIPVGELNPNETVQANQEAQL 55
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
+L H I++ A+ LE D + ++ E C DL L + + + L E + + I
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV-CEWFIQ 114
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+ G+ YM + +H D+ A+N + + L +KIGD G S + G L +
Sbjct: 115 LLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVS-------RLLMGSCDLATTFT 166
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+ S +++ K ++WS G +L+E+
Sbjct: 167 GTPYYM-SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR- 148
+ EIG G +G V + + +TGR + VR+ + + L L E ++L
Sbjct: 4 LAEIGEGAYGTVY----KARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLES 57
Query: 149 --HVNILRLMAACLESDPW-----LLVFESCSRGDLKEFLLSNEASREALLEQGI---TI 198
H NI+RL+ C LVFE + DL +L + G+ TI
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-------SKCPKPGLPPETI 109
Query: 199 K-MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
K + + G+ ++ +H D+ +N LVTS+ +VKI D G + + V
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA--RIYSFEMALTSVV 167
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
+ + + APE LL S + ++WS G + E+F
Sbjct: 168 VTLWYRAPEVLLQS-------SYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 47/247 (19%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRL 147
+ +IG G +G+V + + T ++ +I E+ + + + E ++L
Sbjct: 4 IAQIGEGTYGQVYKARNK--------KTGELVALKKIRMENEKEGFPITAIREIKLLQKL 55
Query: 148 RHVNILRLMAACLESDP--WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID-- 203
RH NI+RL +VFE DL L S E +K
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE------------VKFTESQI 102
Query: 204 ------VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG--SSIDKYPGDYYVHGE 255
+ GL Y+ +G +H D+ N L+ ++ +K+ D G K Y +
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA---ELSDDQV 312
+ L R PE LL + + ++WS G +L E+F GK + EL +
Sbjct: 163 ITLWYR--PPELLLGATRY------GPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEK 213
Query: 313 ITRVFGT 319
I + G+
Sbjct: 214 IFELCGS 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 23/53 (43%), Positives = 29/53 (54%), Gaps = 8/53 (15%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS---IDKYPGDYYVHGEVA-LPVRWCAPE 381
H D+AARNCLV+S VK+ D G + +D D Y A PV+W PE
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKWSPPE 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 26/55 (47%), Positives = 34/55 (61%), Gaps = 5/55 (9%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLL 384
H D+AARN LVT + +KI D G + D + DYY +G LPV+W APE+L
Sbjct: 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--LPVKWMAPEALF 215
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LVT + +KI D G + + DYY LPV+W APE+L
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 26/55 (47%), Positives = 34/55 (61%), Gaps = 5/55 (9%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLL 384
H D+AARN LVT + +KI D G + D + DYY +G LPV+W APE+L
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR--LPVKWMAPEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 25/61 (40%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYYVHGEVALPVRWCAPESLLCSDTSIQ 391
H D+AARN L++ VKI D G + D Y DY G+ LP++W APE++ +IQ
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261
Query: 392 T 392
+
Sbjct: 262 S 262
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+T KI D G + D + +Y V G LPV+W APES+
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 48/222 (21%), Positives = 94/222 (42%), Gaps = 23/222 (10%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P+++ ++IG+G G V ++ +TG+ + + + + Q +K ++E
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTA----IDIATGQEVAIKQMNLQQ----QPKKELIINEIL 68
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R ++ NI+ + + L D +V E + G L + + E +++G +
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCR 122
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+ L ++ + IH D+ + N L+ + VK+ D G P V P W
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-W 181
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
APE + K ++WS G++ E+ E G+ PY
Sbjct: 182 MAPE-------VVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+++IG G +GKV + +++TG+ + LK+ + ++ E P LR
Sbjct: 6 LEKIGEGTYGKVYKAR----DKNTGKLVA------LKKTRLEMDE-----EGIPPTALRE 50
Query: 150 VNILRLMAAC-----------LESD---PWL-LVFESCSRGDLKEFLLSNEASREALLEQ 194
+++L++++ +E P L LVFE DLK+F+ SN L
Sbjct: 51 ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPA 109
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV-KIGDTG-SSIDKYPGDYYV 252
+ G+++ + G +H D+ +N LV + + KI D G P Y
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
H V L R APE LL S + ++WS G + E+
Sbjct: 170 HEIVTLWYR--APEVLLGST------HYSTPVDIWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 51/169 (30%), Positives = 70/169 (41%), Gaps = 28/169 (16%)
Query: 138 LHEATPYRRLRHVNILRLMAACLES--DPWLLVFESCSRGDLKEFLLSN------EASRE 189
L E T LRH NI+ L + D LV E C + DL LL N E+ +
Sbjct: 54 LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLAS-LLDNMPTPFSESQVK 111
Query: 190 ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPG 248
L+ Q + GL Y+ E+ IH D+ N L+T + +KI D G + P
Sbjct: 112 CLMLQ---------LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162
Query: 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
V L R APE LL T T ++W+ G +L E+
Sbjct: 163 KPMTPKVVTLWYR--APELLLGCTTY------TTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 140 EATPYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA +++H NI+ + E+D L +V E C GDL + + + R L + +
Sbjct: 48 EAVLLAKMKHPNIVAFKES-FEADGHLYIVMEYCDGGDLMQKI---KLQRGKLFPEDTIL 103
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS-IDKYPGDY---YVHG 254
+ + + G+ ++ E +H D+ ++N +T +VK+GD GS+ + PG Y YV
Sbjct: 104 QWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+P PE + K ++WS G +L+E+
Sbjct: 164 PYYVP-----PEIW-------ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRR 146
+V+ +G+G +G+V RT K +V ++ +AS+ E+ EA +
Sbjct: 4 FVRVVGKGSYGEV--------SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQ 55
Query: 147 LRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
L+H NI+ + D L +V C GDL L E + L E + ++ + +A
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQV-VEWFVQIA 112
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240
L Y+ E +H D+ +N +T +K+GD G
Sbjct: 113 MALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 60/258 (23%), Positives = 107/258 (41%), Gaps = 48/258 (18%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKEDASQAEKLFFLHEATP 143
L Y+ E+G G G V + R T K+ V+ ++ + ++A + L E
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRP--------TGKIMAVKTIRLEINEAIQKQILRELDI 52
Query: 144 YRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ I+ A D + + E G L + L + + + E+ I K+A+
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKIL---KEVQGRIPER-ILGKIAV 107
Query: 203 DVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSS---IDKYPGDY-----YVH 253
V GL+Y+ E IH DV N LV S ++K+ D G S ++ + Y+
Sbjct: 108 AVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYM- 166
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD--- 310
APE + +D S+++ ++WS G+ L E+ G+ PY +D
Sbjct: 167 ----------APERIQGNDYSVKS-------DIWSLGLSLIEL-ATGRFPYPPENDPPDG 208
Query: 311 --QVITRVFGTEALRLPA 326
+++ + RLP+
Sbjct: 209 IFELLQYIVNEPPPRLPS 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 18/166 (10%)
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
L EA + + H +++R M L S + DL +L + + + + I
Sbjct: 105 LIEAMLLQNVNHPSVIR-MKDTLVSGAITCMVLPHYSSDLYTYL-TKRSRPLPIDQALII 162
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY--PGDYYVHGE 255
K + GL Y+ IH DV N + +V IGD G++ P + G
Sbjct: 163 EKQ---ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301
V APE +L D K ++WS G++L+E+ +
Sbjct: 220 VETN----APE-VLARD------KYNSKADIWSAGIVLFEMLAYPS 254
|
Length = 357 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
D S + P V+ +G G +G+V +G TG+ + + V + ED + KL
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGR----HVKTGQLAA-IKVMDVTEDEEEEIKL 61
Query: 136 FFLHEATPYRRL-RHVNILRLMAACLESDP-------WLLVFESCSRGDLKEFLLSNEAS 187
E ++ H NI A ++ P WL V E C G + + + + + +
Sbjct: 62 ----EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL-VMEFCGAGSVTDLVKNTKGN 116
Query: 188 REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDK 245
AL E I + ++ GL+++ IH D+ +N L+T VK+ D G S +D+
Sbjct: 117 --ALKEDWIAY-ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173
Query: 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
G + P W APE + C + T + ++WS G+ E+ E
Sbjct: 174 TVGRRNTF--IGTPY-WMAPEVIACDENP--DATYDYRSDIWSLGITAIEMAE 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 22/53 (41%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV S L K+ D G S ++ P Y +P+RW APE++
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYYVHGEVALPVRWCAPESLL 384
H D+AARN L++ VKI D G + D Y DY G LP++W APES+
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 46/246 (18%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED---ASQAEKLFFLHEATPYRR 146
+++IG G +G V +G + TG+ + +R+ E+ S A + E + +
Sbjct: 5 IEKIGEGTYGVVYKGRNK----KTGQIVAMKKIRLESEEEGVPSTA-----IREISLLKE 55
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L+H NI+ L ++ L+FE S DLK++L S + +D
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDS------------LPKGQYMDAEL 102
Query: 207 GLSYM--IEDGF--------IHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE 255
SY+ I G +H D+ +N L+ ++ +K+ D G + P Y H
Sbjct: 103 VKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--I 313
V L R APE LL S + V ++WS G + E+ L + + DQ+ I
Sbjct: 163 VTLWYR--APEVLLGS--PRYSTPV----DIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214
Query: 314 TRVFGT 319
R+ GT
Sbjct: 215 FRILGT 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 64/265 (24%), Positives = 113/265 (42%), Gaps = 60/265 (22%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
+IG G +G+V + AR ++ TG + VR+ ++ + + + E R+L H N
Sbjct: 14 QIGEGTYGQVYK--AR--DKDTGELVALKKVRL--DNEKEGFPITAIREIKILRQLNHRN 67
Query: 152 ILRLMAACLESDPWL----------LVFESCSRGDLKEFLLS-----NEASREALLEQGI 196
I+ L + L LVFE DL L S +E ++ ++Q
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ-- 124
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-----SSIDKYPGDYY 251
+ GL+Y + F+H D+ N L+ ++ ++K+ D G +S + P Y
Sbjct: 125 -------LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP---Y 174
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY----AEL 307
+ + L W P LL + +VWS G +L E+F K P EL
Sbjct: 175 TNKVITL---WYRPPELLLGEER-----YGPAIDVWSCGCILGELFT--KKPIFQANQEL 224
Query: 308 SDDQVITRVFGT-------EALRLP 325
+ ++I+R+ G+ + ++LP
Sbjct: 225 AQLELISRLCGSPCPAVWPDVIKLP 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRL 147
++ +GRG FG V + K+ + +I E ++ E+L +E + L
Sbjct: 5 IRVVGRGAFGIV--------HLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL 56
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
H NI+ LE ++V E G L E++ + +LL++ + + +
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLA 113
Query: 208 LSYMIEDGFIHTDVAARNCLVTS-ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266
L ++ +H D+ +N L+ ++ VKIGD G I K V + +PE
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFG--ISKILSSKSKAYTVVGTPCYISPE 171
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEI------FEFGKLP 303
LC + +K ++W+ G +L+E+ FE LP
Sbjct: 172 --LC-----EGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 29/221 (13%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
Q V EIG G +G V + AR +G + VR+ + L + E +
Sbjct: 1 QYEPVAEIGVGAYGTVYK--ARDPH--SGHFVALKSVRV--QTNEDGLPLSTVREVALLK 54
Query: 146 RLR---HVNILRLMAAC--LESDPWL---LVFESCSRGDLKEFLLSNEASREALLEQGIT 197
RL H NI+RLM C +D LVFE + DL+ +L ++ L + I
Sbjct: 55 RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL--DKVPPPGLPAETIK 111
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEV 256
M GL ++ + +H D+ N LVTS +VK+ D G + I V
Sbjct: 112 DLMR-QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPV 167
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
+ + + APE LL S T ++WS G + E+F
Sbjct: 168 VVTLWYRAPEVLLQS-------TYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 51/230 (22%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
++++G G + V +G+++ G+ + +R+ +E+ + + EA+ + L+H
Sbjct: 10 LEKLGEGSYATVYKGKSK----VNGKLVALKVIRLQEEEGT---PFTAIREASLLKGLKH 62
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NI+ L + LVFE DL +++ + L + + + + + GLS
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG---GLHPENVKLFL-FQLLRGLS 117
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK-YPGDYYVHGEVALPVRWCAPESL 268
Y+ + +H D+ +N L++ +K+ D G + K P Y + V L W P +
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL---WYRPPDV 174
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ-VITRVF 317
L T TC ++W G + E+ + G + + D Q + R+F
Sbjct: 175 LLGSTEYSTCL-----DMWGVGCIFVEMIQ-GVAAFPGMKDIQDQLERIF 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 25/53 (47%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LVT +KI D G + D DYY LPV+W APE+L
Sbjct: 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 42/234 (17%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKED---------ASQAEK-LFFLH 139
K +G+G FGKV+ E +G T +++ V++LK+D + EK + L
Sbjct: 1 KVLGKGSFGKVLLAELKG--------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 140 EATPYRRLRHVNILRLMAACLES-DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
P+ L + +C ++ D V E + GDL + + E
Sbjct: 53 GKHPF--------LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RAR 99
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
A ++ GL ++ E G I+ D+ N L+ SE +KI D G + G
Sbjct: 100 FYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
P + APE L + W+ GVLL+E+ G+ P+ +D++
Sbjct: 160 P-DYIAPEILSYQPYGPAV-------DWWALGVLLYEML-AGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLL 384
H ++AARN L+ S+ V+I D G + YP D Y + E P++W A ES+L
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 34/236 (14%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
+G G +G V++ + + TG+ + K F+ ED +K+ E ++LRH N
Sbjct: 9 VGEGSYGMVMKCKHK----ETGQIVAIKKFLE--SEDDKMVKKIAM-REIRMLKQLRHEN 61
Query: 152 ILRLMAACLESDPWLLVFESCSR---GDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
++ L+ LVFE DL+++ L++ K + G+
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--------PNGLDESRVRKYLFQILRGI 113
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWC-APE 266
+ IH D+ N LV+ VK+ D G + PG+ Y VA RW APE
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD-YVA--TRWYRAPE 170
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQV--ITRVFGT 319
LL DT ++W+ G L+ E+ G+ + SD DQ+ I + G
Sbjct: 171 -LLVGDTK-----YGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQLYHIIKCLGN 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 23/59 (38%), Positives = 29/59 (49%), Gaps = 4/59 (6%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGD--YYVHGEVALPVRWCAPESLLCSDTS 389
H D+AARNCLV + VK+ D G + +Y D Y PV+W PE S S
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA--RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK----EDASQAEKLFFL 138
P++ ++ IG G +G V + AR + +TG + ++++K ED + ++
Sbjct: 7 PQEDFELIQRIGSGTYGDVYK--ARNV--NTGELAA---IKVIKLEPGEDFAVVQQ---- 55
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
E + +H NI+ + L D + E C G L++ E+ +
Sbjct: 56 -EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---- 110
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
++ + GL Y+ G +H D+ N L+T VK+ D G S +
Sbjct: 111 -VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT 169
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299
P W APE + + C++W+ G+ E+ E
Sbjct: 170 PY-WMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAEL 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 38/240 (15%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---------SQAEKLFF 137
+++ +G+G FGKV+ E +G +E ++ILK+D + EK
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYA-------IKILKKDVVIQDDDVECTMVEKRVL 54
Query: 138 LHEATPYRRLRHVNILRLMAACLES-DPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
P L + +C ++ D V E + GDL + + ++
Sbjct: 55 ALSGKP-------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMY-----QIQQVGRFKEPH 102
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEV 256
+ A ++A GL ++ G I+ D+ N ++ SE +KI D G +
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
P + APE I + + W+FGVLL+E+ G+ P+ +D++ +
Sbjct: 163 GTP-DYIAPE-------IIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 37/129 (28%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 199 KMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
KM + + L Y+ E G IH DV N L+ + VK+ D G I D A
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG--ISGRLVDSKAKTRSA 175
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRV 316
+ APE + D + +VWS G+ L E+ G+ PY + +V+T++
Sbjct: 176 GCAAYMAPERI---DPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVLTKI 231
Query: 317 FGTEALRLP 325
E LP
Sbjct: 232 LQEEPPSLP 240
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 22/53 (41%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV S L K+ D G S ++ P Y +P+RW APE++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 60/256 (23%), Positives = 113/256 (44%), Gaps = 33/256 (12%)
Query: 93 IGRGWFG--KVVEGEARGLEESTGRTTSKVFVRILKEDASQA-EKLFFLHEATPYRRLRH 149
+GRG FG +VV E++TG + ++++K+ A E + F E R +
Sbjct: 9 VGRGHFGEVQVVR------EKATGDIYA---MKVMKKSVLLAQETVSFFEEE---RDILS 56
Query: 150 VN----ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
++ I +L A + D LV E GDL LS E ++ + ++
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL----LSLLNRYEDQFDEDMAQFYLAELV 112
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV---RW 262
+ + + G++H D+ N L+ +K+ D GS+ + + V+ + LPV +
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSK--LPVGTPDY 169
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG-TEA 321
APE L + T +C+ WS GV+ +E+ +G+ P+ E + + +
Sbjct: 170 IAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMI-YGRSPFHEGTSAKTYNNIMNFQRF 227
Query: 322 LRLPA-PRAVNSHVDV 336
L+ P P+ + +D+
Sbjct: 228 LKFPEDPKVSSDFLDL 243
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 36/220 (16%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVF-------VRILKEDASQAEKLFFLHEATPYR 145
IG+G FGKV +++ R T K+F + +++ + + L+E +
Sbjct: 8 IGKGAFGKV-----CIVQK---RDTKKMFAMKYMNKQKCVEKGSVRN----VLNERRILQ 55
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI-DV 204
L H ++ L + + + LV + GDL+ L E +K I ++
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKFWICEI 109
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCA 264
L Y+ G IH D+ N L+ + V I D + K D P + A
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTSGTPG-YMA 167
Query: 265 PESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
PE L S+ + WS GV +E GK PY
Sbjct: 168 PEVLCRQGYSVAV-------DWWSLGVTAYE-CLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE----DASQAEKLFFLHEATPYR 145
VK+IG G FGK + L +S + K +V +KE S E+ E
Sbjct: 5 VKKIGEGSFGKAI------LVKS--KEDGKQYV--IKEINISKMSPKEREESRKEVAVLS 54
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
++H NI++ + E+ +V + C GDL + N A R L + + + +
Sbjct: 55 NMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKIN-AQRGVLFPEDQILDWFVQIC 111
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAP 265
L ++ + +H D+ ++N +T + +K+GD G + ++ V L R C
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA-------RVLNSTVEL-ARTCIG 163
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI------FEFGKL 302
S + K ++W+ G +L+E+ FE G +
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 26/221 (11%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK----EDASQAEKLFFL 138
P+ ++ +G G +G V + AR L TG + V+I+K +D S ++ F+
Sbjct: 7 PQHDYELIQRVGSGTYGDVYK--ARNL--HTGELAA---VKIIKLEPGDDFSLIQQEIFM 59
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
+ +H NI+ + L + + E C G L++ E +
Sbjct: 60 -----VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---- 110
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
+ + GL+Y+ G +H D+ N L+T VK+ D G + +
Sbjct: 111 -VCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299
P W APE + C++W+ G+ E+ E
Sbjct: 170 PY-WMAPEVAAVEKNG----GYNQLCDIWAVGITAIELAEL 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARN LV K+ D G + Y P++W APE+ L + SI++
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARN LV L KI D G + +Y P++W APE+ +I++
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 20/52 (38%), Positives = 30/52 (57%), Gaps = 3/52 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV +L K+ D G + + K D Y+ + +P +W APE+
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 29/237 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
V++IG G +G V + AR TG + +R+ E ++ + E + + L H
Sbjct: 5 VEKIGEGTYGVVYK--ARNKL--TGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNH 58
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA----IDVA 205
NI++L+ + LVFE + DLK+F+ ++ S GI + + +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLS-------GIPLPLIKSYLFQLL 110
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCA 264
GL++ +H D+ +N L+ +E +K+ D G + P Y H V L R A
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR--A 168
Query: 265 PESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFGT 319
PE LL + ++WS G + E+ L + DQ+ I R GT
Sbjct: 169 PEILLGCK------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 32/228 (14%)
Query: 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKEDA--SQAEKLFFLHEATPY 144
+K IGRG FG+V + +++ +V+ +++L + +++ FF E
Sbjct: 46 DVIKVIGRGAFGEV--------QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI- 96
Query: 145 RRLRHVN---ILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
+ H N I++L A + D +L +V E GDL + + + + + +
Sbjct: 97 --MAHANSEWIVQLHYA-FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL 153
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
A+D + GFIH DV N L+ +K+ D G+ + K + V + A+
Sbjct: 154 ALDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMDANGMVRCDTAVGT 206
Query: 261 -RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YAE 306
+ +PE L + +C+ WS GV L+E+ G P YA+
Sbjct: 207 PDYISPEVLK---SQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP-YRRLRHVN 151
+G+G +G V R L T ++ ++ + E S+ + LHE + L+H N
Sbjct: 16 LGKGTYGIVYAA--RDL-----STQVRIAIKEIPERDSRYVQP--LHEEIALHSYLKHRN 66
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM-AIDVATGLSY 210
I++ + + E+ + + E G L L S L + TI + GL Y
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKY 123
Query: 211 MIEDGFIHTDVAARNCLV-TSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
+ ++ +H D+ N LV T VKI D G+S + G +++ APE +
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS-KRLAGINPCTETFTGTLQYMAPEVI- 181
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
D + ++WS G + E+ GK P+ EL + Q
Sbjct: 182 --DKGPR--GYGAPADIWSLGCTIVEM-ATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 23/53 (43%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSID-KYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+ VKI D G + D + +Y G LPV+W APES+
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 135 LFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQ 194
L F A+ ++ H+++ + C+ ++V E G L + L E R +
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGR---VPV 116
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT-------SELRVKIGDTGSSIDKYP 247
I +A +A+ LSY+ + +H +V A+N L+ + +K+ D G S
Sbjct: 117 AWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
+ V + W APE C T +K WSFG L EI G++P E
Sbjct: 177 REERVE-----RIPWIAPE---CVPGGNSLSTAADK---WSFGTTLLEICFDGEVPLKER 225
Query: 308 SDDQVITRVFGTEALRLPAP 327
+ + F + RLP P
Sbjct: 226 TPSE--KERFYEKKHRLPEP 243
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 52/235 (22%), Positives = 98/235 (41%), Gaps = 40/235 (17%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---------SQAEK-LFFLHEAT 142
+G+G FGKV+ E +G +E ++ILK+D + EK + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYA-------IKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 143 PYRRLRHVNILRLMAACLES-DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
P+ L + +C ++ D V E + GDL + + ++ + A
Sbjct: 61 PF--------LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYA 107
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+++ GL ++ G I+ D+ N ++ SE +KI D G + P
Sbjct: 108 AEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP-D 166
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
+ APE I + + W++GVLL+E+ G+ P+ +D++ +
Sbjct: 167 YIAPE-------IIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 28/121 (23%)
Query: 199 KMAIDVATGLSYMI-EDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
K+A+ V GL+Y+ +H D+ N LV S ++K+ D G V GE+
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG-----------VSGELI 155
Query: 258 LPV--------RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
+ + +PE IQ T K +VWS G+ + E+ GK P+A +
Sbjct: 156 NSIADTFVGTSTYMSPE-------RIQGGKYTVKSDVWSLGISIIEL-ALGKFPFAFSNI 207
Query: 310 D 310
D
Sbjct: 208 D 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 44/241 (18%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED---------ASQAEK-LFFL 138
++ +G+G FGKV+ E +G +E ++ILK+D + EK + L
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYA-------IKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 139 HEATPYRRLRHVNILRLMAACLES-DPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
P+ L + +C ++ D V E + GDL + +E
Sbjct: 57 PGKPPF--------LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----HA 103
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
+ A ++A GL ++ G I+ D+ N ++ +E +KI D G + G
Sbjct: 104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 258 LPVRWCAPESLLCS--DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
P + APE + S+ + W+FGVLL+E+ G+ P+ +D++
Sbjct: 164 TP-DYIAPEIIAYQPYGKSV---------DWWAFGVLLYEMLA-GQPPFDGEDEDELFQS 212
Query: 316 V 316
+
Sbjct: 213 I 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILK--EDASQAEKLFFLHEATPYRR 146
VK IGRG FG+V + ++T KV+ +++L E +++ FF E
Sbjct: 48 VKVIGRGAFGEV--------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 147 LRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
+++L A + D +L +V E GDL + + + + + +A+D
Sbjct: 100 ANSPWVVQLFYA-FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD-- 156
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV-RWCA 264
+ M GFIH DV N L+ +K+ D G+ + K + V + A+ + +
Sbjct: 157 -AIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTAVGTPDYIS 211
Query: 265 PESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-ALR 323
PE L + +C+ WS GV L+E+ G P+ S +++ + +L
Sbjct: 212 PEVL---KSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSLVGTYSKIMNHKNSLT 267
Query: 324 LPAPRAVNSHVDVAARN--CLVTSELRVKIGDTG-SSIDKYP 362
P ++ + A+N C ++ V++G G I ++
Sbjct: 268 FPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 57/184 (30%), Positives = 82/184 (44%), Gaps = 19/184 (10%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
IG G +G V + R TG+ + K FV ED +K+ L E ++L+H N
Sbjct: 9 IGEGSYGVVFKCRNR----ETGQIVAIKKFVE--SEDDPVIKKIA-LREIRMLKQLKHPN 61
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM 211
++ L+ LVFE C L E E + + E I K+ +++
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNEL----EKNPRGVPEHLIK-KIIWQTLQAVNFC 116
Query: 212 IEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWC-APESLL 269
+ IH DV N L+T + ++K+ D G + I PGD Y VA RW APE LL
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD-YVA--TRWYRAPE-LL 172
Query: 270 CSDT 273
DT
Sbjct: 173 VGDT 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 18/163 (11%)
Query: 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF--LHEATPYR 145
IGRG +G+V + A+ G+ + ++ K D Q + E R
Sbjct: 3 EIEGCIGRGTYGRVYK--AKRKNGKDGK---EYAIKKFKGDKEQYTGISQSACREIALLR 57
Query: 146 RLRHVNILRLMAACLESDP---WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
L+H N++ L+ LE +L +F+ DL + + + ++ + +K +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYL-LFDYAEH-DLWQIIKFHRQAKRVSIPPS-MVKSLL 114
Query: 203 -DVATGLSYMIEDGFIHTDVAARNCLVTSEL----RVKIGDTG 240
+ G+ Y+ + +H D+ N LV E VKIGD G
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 19/49 (38%), Positives = 24/49 (48%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 381
H D+AARNCLV VK+ D G + Y PV+W +PE
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 23/138 (16%)
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGD----TGSSIDKYPGDYYVHGEVALPVRW 262
GL Y+ +H D+ N LV ++ +KI D G S + ++ VA RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA--TRW 174
Query: 263 C-APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD--DQV--ITRVF 317
APE +L S Q+ T+ +VWS G +L E+ G+ P + D DQ+ I +V
Sbjct: 175 YRAPEIML----SFQSY--TKAIDVWSVGCILAEL--LGRKPVFKGKDYVDQLNQILQVL 226
Query: 318 GT---EAL-RLPAPRAVN 331
GT E L R+ +P+A N
Sbjct: 227 GTPDEETLSRIGSPKAQN 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 24/237 (10%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLR 148
K +G+G FGKV+ E+++G+ + ++ILK++ ++ E L E+ + R
Sbjct: 1 KLLGKGTFGKVILVR----EKASGKYYA---MKILKKEVIIAKDEVAHTLTESRVLKNTR 53
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H + L + D V E + G+L L SRE + + T ++ + L
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSAL 108
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ ++ D+ N ++ + +KI D G + + P + APE L
Sbjct: 109 DYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP-EYLAPEVL 167
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
+D + W GV+++E+ G+LP+ D + + + E ++ P
Sbjct: 168 EDNDYG-------RAVDWWGLGVVMYEMM-CGRLPFYN-QDHEKLFELILMEDIKFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 42/146 (28%), Positives = 60/146 (41%), Gaps = 22/146 (15%)
Query: 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNC 226
LV E GDL LL N +L E I +A ++ L Y+ +G IH D+ N
Sbjct: 70 LVMEYLPGGDLAS-LLENV---GSLDEDVARIYIA-EIVLALEYLHSNGIIHRDLKPDNI 124
Query: 227 LVTSELRVKIGDTGSS--------IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTC 278
L+ S +K+ D G S I+ + V P + APE +L S
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP-DYIAPEVILGQGHSKT-- 181
Query: 279 TVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ WS G +L+E F G P+
Sbjct: 182 -----VDWWSLGCILYE-FLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 43/233 (18%)
Query: 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL 147
+ ++G G FG+V + + TGR + +IL + + L E ++L
Sbjct: 11 EILGKLGEGTFGEV----YKARQIKTGRVVA--LKKILMHNEKDGFPITALREIKILKKL 64
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEF-------------LLSNEASREALLEQ 194
+H N++ L+ +E S+ LL N + + L E
Sbjct: 65 KHPNVVPLIDMAVERPD-------KSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTES 115
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG--------SSIDKY 246
I M + + G++Y+ E+ +H D+ A N L+ ++ +KI D G K
Sbjct: 116 QIKCYM-LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 247 PGDYYVHGEVALPV-RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
G L V RW P LL + T ++W G + E+F
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGE-----RRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG------SSIDKYPGDYYV 252
++A+ V GL+Y+ +H DV N LV + +VK+ D G +SI K YV
Sbjct: 99 RIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK----TYV 154
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
G A + APE + I + +VWS G+ E+ G+ PY ++ +Q
Sbjct: 155 -GTNA----YMAPERISGEQYGIHS-------DVWSLGISFMEL-ALGRFPYPQIQKNQ 200
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 89 YVK--EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
YVK ++G G + V +G ++ T + V ++ ++ + + + E + +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEEGAPCTAIREVSLLKN 59
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L+H NI+ L LVFE DLK++L + + + I M +
Sbjct: 60 LKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYL---DNCGNLMSMHNVKIFM-FQLLR 114
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK-YPGDYYVHGEVALPVRWCAP 265
GLSY + +H D+ +N L+ + +K+ D G + K P Y + V L W P
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL---WYRP 171
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+L T T ++W G +L+E+
Sbjct: 172 PDVLLGSTEYST-----PIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LV + VKI D G + + H E +P++W A ES+L
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 29/251 (11%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH-EATPYRRLRH 149
K +G+G FG+V + TGR + V+ E ++++ L E + L+H
Sbjct: 8 KLLGQGAFGRV----YLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 150 VNILRLMAACLE--SDPWLLVF-ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
I++ CL ++ L +F E G +K+ L + A L + +T K +
Sbjct: 64 ERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILE 117
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG----EVALPVRW 262
G+SY+ + +H D+ N L S VK+GD G+S K + G V W
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS--KRLQTICMSGTGIRSVTGTPYW 175
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
+PE I K +VWS G + E+ K P+AE I ++ T+
Sbjct: 176 MSPE-------VISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAIFKI-ATQPT 226
Query: 323 RLPAPRAVNSH 333
P ++ H
Sbjct: 227 NPQLPSHISEH 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 44/227 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKL---------FFLH 139
K +G+G FGKV E +G + K V ++ +D + EK F H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
++ + L + L + +SC + DL R
Sbjct: 61 LYCTFQTKEN---LFFVMEYLNGGDLMFHIQSCHKFDL---------PRATF-------- 100
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
A ++ GL ++ G ++ D+ N L+ ++ +KI D G + GD P
Sbjct: 101 YAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160
Query: 260 VRWCAPESLLCS--DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ APE LL +TS+ + WSFGVLL+E+ G+ P+
Sbjct: 161 -DYIAPEILLGQKYNTSV---------DWWSFGVLLYEML-IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 22/232 (9%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+G+G FG+V + R +TG+ + + + + E + L+E ++ +
Sbjct: 8 LGKGGFGEVCACQVR----ATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQFV 62
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
+ L A D LV + GDLK F + N + E+ + A ++ GL +
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLK-FHIYNMGNPG--FEEERALFYAAEILCGLEDLH 119
Query: 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD 272
+ ++ D+ N L+ ++I D G ++ K P + G V V + APE
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAV-KIPEGESIRGRVG-TVGYMAPE------ 171
Query: 273 TSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY----AELSDDQVITRVFGTE 320
+ T + W G L++E+ E G+ P+ ++ ++V RV TE
Sbjct: 172 -VLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLETE 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 93 IGRGWFGKVVEGEARGLEESTGR--TTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+G+G FG+V + R +TG+ K+ + +K+ ++ L+E ++
Sbjct: 8 LGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGES---MALNEKQILEKVNSR 60
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
++ L A D LV + GDLK F + + EA E+G + A ++ GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLK-FHIYHMG--EAGFEEGRAVFYAAEICCGLED 117
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
+ ++ ++ D+ N L+ ++I D G ++ P + G V V + APE
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRVG-TVGYMAPE---- 171
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306
++ T + W+ G LL+E+ G+ P+ +
Sbjct: 172 ---VVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 56/259 (21%), Positives = 104/259 (40%), Gaps = 45/259 (17%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEAT 142
Q+ ++ IG+G G+V + R +V ++ ++ED S+ L FL EA
Sbjct: 2 QRYDIIRLIGKGGMGEVY----LAYDPVCSR---RVALKKIREDLSENPLLKKRFLREAK 54
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL---LEQGITIK 199
L H I+ + + C + DP LK LL + +E+L L + ++
Sbjct: 55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKS-LLKSVWQKESLSKELAEKTSVG 113
Query: 200 ----MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK---------- 245
+ + + Y+ G +H D+ N L+ V I D G++I K
Sbjct: 114 AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 246 -YPGDYYVHGEVALPVR------WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI-- 296
+ + +P + + APE LL S T ++++ GV+L+++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST-------DIYALGVILYQMLT 226
Query: 297 --FEFGKLPYAELSDDQVI 313
F + + ++S VI
Sbjct: 227 LSFPYRRKKGRKISYRDVI 245
|
Length = 932 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 4/55 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVA--LPVRWCAPESL 383
H D+AARN LV S L K+ D G S ++ D + +P+RW APE++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 25/288 (8%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH 139
Q + VK IGRG FG+V + ++ F I + D++ FF
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSA-----FFWE 92
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
E +++L A + +V E GDL L+SN E +
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAK-----F 146
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
+V L + G IH DV N L+ +K+ D G+ + K V + A+
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM-KMDETGMVRCDTAVG 205
Query: 260 V-RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
+ +PE L + +C+ WS GV L+E+ G P+ S +++
Sbjct: 206 TPDYISPEVL---KSQGGDGYYGRECDWWSVGVFLFEML-VGDTPFYADSLVGTYSKIMD 261
Query: 319 TE-ALRLPAPRAVNSHVDVAARN--CLVTSELRVKIGDTG-SSIDKYP 362
+ +L P ++ H A+N C ++ V++G G I ++P
Sbjct: 262 HKNSLNFPEDVEISKH----AKNLICAFLTDREVRLGRNGVEEIKQHP 305
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 32/246 (13%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH-EATPYRRLRHV 150
IG+ + ++ A+ + T V V+ + D+ E L L E R+L+H
Sbjct: 5 LIGKCFEDLMIVHLAK--HKPTNTL---VAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 151 NILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NIL + D L +V + G ++ L ++ E L E I + DV L
Sbjct: 60 NILPYVT-SFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILK-DVLNALD 115
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI--------DKYPGDYYVHGEVALPVR 261
Y+ GFIH V A + L++ + +V + S+ + D+ LP
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-- 173
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W +PE L ++Q EK +++S G+ E+ G +P+ ++ Q++ E
Sbjct: 174 WLSPEVL---QQNLQ--GYNEKSDIYSVGITACELAN-GHVPFKDMPATQML-----LEK 222
Query: 322 LRLPAP 327
+R P
Sbjct: 223 VRGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 36/256 (14%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR- 148
+ +IG G F +V++ ++R +T ++ +K+ E++ L E RRL
Sbjct: 4 LGKIGEGTFSEVLKAQSR-------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP 56
Query: 149 HVNILRLMAACLESDP--WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
H NILRL+ + LVFE +L E + + + L E+ + +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFE-LMDMNLYELI---KGRKRPLPEKRVK-SYMYQLLK 111
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS--SI-DKYPGDYYVHGEVALPVRWC 263
L +M +G H D+ N L+ ++ +K+ D GS I K P Y+ RW
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYI------STRWY 164
Query: 264 -APESLLCSDTSIQTCTV-TEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFGT 319
APE LL T K ++W+ G + +EI L DQ+ I V GT
Sbjct: 165 RAPECLL-------TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT 217
Query: 320 EALRLPAPRAVNSHVD 335
+ + H++
Sbjct: 218 PDAEVLKKFRKSRHMN 233
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 116 TTSKVFVRILKEDASQAEKLF--FLHEATPYRRLRHVNILRLMAACLESDPWLL--VFES 171
T +V +++L+ DA + E F E RL H NI+ L+ + E+ P LL VFE
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG-EAPPGLLFAVFEY 60
Query: 172 CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229
L+E L + + L G T ++ + V L+ G +H D+ +N +V+
Sbjct: 61 VPGRTLREVL-----AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 14/165 (8%)
Query: 192 LEQGITI------KMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSSID 244
++G+TI K+A+ + L Y+ IH DV N L+ +VK+ D G I
Sbjct: 94 YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG--IS 151
Query: 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
Y D A + APE + + + + V K +VWS G+ + E+ G+ PY
Sbjct: 152 GYLVDSVAKTIDAGCKPYMAPER-INPELNQKGYDV--KSDVWSLGITMIEL-ATGRFPY 207
Query: 305 AELSDD-QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELR 348
Q + +V + +LPA + D + + R
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKER 252
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 21/51 (41%), Positives = 29/51 (56%), Gaps = 4/51 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV+ +L K+ D G + + G LPV+W APE+L
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 20/52 (38%), Positives = 28/52 (53%), Gaps = 6/52 (11%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV+ + K+ D G + + D LPV+W APE+L
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEAL 169
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 28/98 (28%), Positives = 38/98 (38%), Gaps = 18/98 (18%)
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG---SSIDKYPGDYYVHGEVALPVRWC 263
GL Y+ IH D+ N LV S +KI D G ++ V RW
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--TRWY 172
Query: 264 -APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIF 297
APE LL S +I ++WS G + E+
Sbjct: 173 RAPELLLSSSRYTKAI---------DIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 50/221 (22%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKE---------DASQAEKLFFLHEAT 142
+GRG FGKV+ E + T +++ ++ LK+ ++ EK F
Sbjct: 7 LGRGHFGKVLLAEYKK--------TGELYAIKALKKGDIIARDEVESLMCEKRIFETAN- 57
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
RH ++ L A D V E + GDL + ++ S + A
Sbjct: 58 ---SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR------AVFYAA 108
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVR 261
V GL Y+ E+ ++ D+ N L+ +E VKI D G GD
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--------TST 160
Query: 262 WC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+C APE L +TS T + W GVL++E+
Sbjct: 161 FCGTPEFLAPEVLT--ETS-----YTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 51/238 (21%), Positives = 101/238 (42%), Gaps = 25/238 (10%)
Query: 89 YVK--EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
Y+K ++G G + V +G ++ T + V ++ ++ + + + E + +
Sbjct: 8 YIKLEKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L+H NI+ L LVFE + DLK+++ + + + I + +
Sbjct: 61 LKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYM---DDCGNIMSMHNVKIFL-YQILR 115
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK-YPGDYYVHGEVALPVRWCAP 265
GL+Y +H D+ +N L+ +K+ D G + K P Y + V L W P
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL---WYRP 172
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL-PYAELSDD-QVITRVFGTEA 321
+L + T + ++W G + +E+ L P + + D+ +I R+ GT
Sbjct: 173 PDVLLGSSEYST-----QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 35/241 (14%)
Query: 89 YVK--EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR 146
Y+K ++G G + V +G ++ T + V ++ ++ + + + E + +
Sbjct: 8 YIKLDKLGEGTYATVYKGRSK-------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL-----LSNEASREALLEQGITIKMA 201
L+H NI+ L LVFE + DLK++L N + + L Q
Sbjct: 61 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ------- 112
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK-YPGDYYVHGEVALPV 260
+ GL+Y +H D+ +N L+ +K+ D G + K P Y + V L
Sbjct: 113 --LLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL-- 168
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFG 318
W P +L T T + ++W G + +E+ L ++Q+ I R+ G
Sbjct: 169 -WYRPPDILLGSTDYST-----QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
Query: 319 T 319
T
Sbjct: 223 T 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 24/237 (10%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLR 148
K +G+G FGKV+ E++TGR + ++IL+++ ++ E + E+ + R
Sbjct: 1 KLLGKGTFGKVILVR----EKATGRYYA---MKILRKEVIIAKDEVAHTVTESRVLQNTR 53
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H + L A D V E + G+L L SRE + + ++ + L
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSAL 108
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ ++ D+ N ++ + +KI D G + + P + APE L
Sbjct: 109 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVL 167
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325
+D + W GV+++E+ G+LP+ +++ + E +R P
Sbjct: 168 EDNDYG-------RAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELIL-MEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 39/232 (16%)
Query: 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE---KLFFLHEA- 141
++ + E+G+G +G V + L TG T + +R+ +++ + +L LH+A
Sbjct: 2 EIEVLDELGKGNYGSV----YKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV 57
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+PY I+ A + E G L + L + + + ++
Sbjct: 58 SPY-------IVDFYGAFFIEGAVYMCMEYMDAGSLDK--LYAGGVATEGIPEDVLRRIT 108
Query: 202 IDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
V GL ++ E+ IH DV N LV +VK+ D G V G + +
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG-----------VSGNLVASL 157
Query: 261 --------RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ APE + S Q T T + +VWS G+ + E+ G+ PY
Sbjct: 158 AKTNIGCQSYMAPERIK-SGGPNQNPTYTVQSDVWSLGLSILEM-ALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 25/52 (48%), Positives = 29/52 (55%), Gaps = 4/52 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESL 383
H D+AARN LV L KI D G S + + YV + LPVRW A ESL
Sbjct: 142 HRDLAARNVLVGENLASKIADFGLSRGE---EVYVKKTMGRLPVRWMAIESL 190
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0665|consensus | 369 | 99.98 | ||
| KOG0670|consensus | 752 | 99.98 | ||
| KOG1345|consensus | 378 | 99.97 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290|consensus | 590 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0195|consensus | 448 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1167|consensus | 418 | 99.93 | ||
| KOG0603|consensus | 612 | 99.93 | ||
| KOG1164|consensus | 322 | 99.92 | ||
| KOG0590|consensus | 601 | 99.92 | ||
| KOG1163|consensus | 341 | 99.92 | ||
| KOG1023|consensus | 484 | 99.9 | ||
| KOG4158|consensus | 598 | 99.89 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG0606|consensus | 1205 | 99.88 | ||
| KOG1165|consensus | 449 | 99.88 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240|consensus | 1431 | 99.85 | ||
| KOG1166|consensus | 974 | 99.81 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG1033|consensus | 516 | 99.75 | ||
| KOG0590|consensus | 601 | 99.74 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0601|consensus | 524 | 99.59 | ||
| KOG0606|consensus | 1205 | 99.53 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG1266|consensus | 458 | 99.45 | ||
| KOG0601|consensus | 524 | 99.42 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| KOG1243|consensus | 690 | 99.32 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG3087|consensus | 229 | 99.18 | ||
| KOG3741|consensus | 655 | 99.05 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| KOG2137|consensus | 700 | 98.73 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| KOG0576|consensus | 829 | 98.56 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.81 | |
| KOG1826|consensus | 2724 | 97.73 | ||
| KOG1235|consensus | 538 | 97.69 | ||
| KOG1035|consensus | 1351 | 97.6 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.21 | |
| KOG0197|consensus | 468 | 97.07 | ||
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.56 | |
| KOG1026|consensus | 774 | 96.49 | ||
| KOG1093|consensus | 725 | 96.06 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 96.05 | |
| KOG4278|consensus | 1157 | 95.79 | ||
| PLN02236 | 344 | choline kinase | 95.7 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.2 | |
| KOG1095|consensus | 1025 | 95.06 | ||
| KOG2268|consensus | 465 | 94.97 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.96 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.42 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.33 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.89 | |
| KOG2270|consensus | 520 | 93.77 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.47 | |
| KOG1094|consensus | 807 | 93.17 | ||
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.84 | |
| KOG1236|consensus | 565 | 92.09 | ||
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.3 | |
| KOG0200|consensus | 609 | 90.8 |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-61 Score=450.61 Aligned_cols=265 Identities=32% Similarity=0.604 Sum_probs=236.8
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.+.|+++++.+++++.||+|.||+||.|.+++ ..+||+|.++...... ..|++|+++|++|+|+|||+++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~--------~~~vavk~ik~~~m~~--~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG--------STKVAVKTIKEGSMSP--EAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC--------CCcccceEEeccccCh--hHHHHHHHHHHhCcccCeEEEE
Confidence 57889999999999999999999999999985 3378999988764221 2356999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
|+|..++.+|||||||+.|+|.+||+..... .+.....+.++.|||+||+||+++++|||||.++||||+++..+||
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~---~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRTREGG---LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhhcCCC---ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEE
Confidence 9999988999999999999999999973221 2566778899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|+....+.+........++.|+|||.+..+. |+.|||||||||+||||+|+|+.||.++++.+++..+
T Consensus 345 sDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-------FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l 417 (468)
T KOG0197|consen 345 SDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK-------FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL 417 (468)
T ss_pred cccccccccCCCceeecCCCCCCceecCHHHHhhCC-------cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH
Confidence 999999966666666666667899999999998776 8899999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+|+ |+|.|..||++++++|+.||..+|+ |||+..+...|..+..
T Consensus 418 e~Gy--Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 418 ERGY--RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred hccC--cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 9998 9999999999999999999999998 9999988777776653
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-59 Score=459.27 Aligned_cols=277 Identities=36% Similarity=0.628 Sum_probs=252.4
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..-.++++.+..+.++||+|+||+||+|+..+..... ....||||.+++..+...+..|.+|+++|..|+|||||+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~--~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQ--DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCc--cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 4456889999999999999999999999988766443 44599999999999887777889999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhh---------hhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREA---------LLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
|+|..++++|||+|||..|||.+||+........ .++..+.+.++.|||.||.||.++.+|||||..+|||
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 9999999999999999999999999876433222 2677888999999999999999999999999999999
Q ss_pred EcCCCeEEEccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 228 VTSELRVKIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
|.++..|||+|||+++..+..+||... ....+++||+||.|..++ |+.++|||||||+|||++++|+.||.+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-------FTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-------FTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-------ccchhhhhhhhhhhhhhhccccCcccc
Confidence 999999999999999999999988776 446789999999998887 899999999999999999999999999
Q ss_pred CCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 307 LSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 307 ~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.++.|+++.|..|. -++.|++||.++++||+.||+.+|+ ||+++||..+|+.....
T Consensus 709 lSn~EVIe~i~~g~--lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 709 LSNQEVIECIRAGQ--LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cchHHHHHHHHcCC--cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99999999999887 5999999999999999999999998 99999999999987654
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=410.82 Aligned_cols=269 Identities=30% Similarity=0.499 Sum_probs=227.4
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..+.+...++.+.+.||+|+||+||+|.|++.. .||||.+.... .......|.+|+.+|.+++|||||+++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~--------~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~ 105 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD--------VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFY 105 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCce--------eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 455666777788888999999999999998522 38999887654 222255678999999999999999999
Q ss_pred eEEEeCC-ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEcCCC-e
Q psy7505 157 AACLESD-PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG-FIHTDVAARNCLVTSEL-R 233 (394)
Q Consensus 157 ~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-iiHrDlk~~NiLl~~~~-~ 233 (394)
|+|.+.. .++|||||+++|+|.++|... ....++...++.++.||++||.|||+++ |||||||++|||++.++ +
T Consensus 106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~ 182 (362)
T KOG0192|consen 106 GACTSPPGSLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT 182 (362)
T ss_pred EEEcCCCCceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE
Confidence 9999877 799999999999999999773 1223788889999999999999999999 99999999999999998 9
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
+||+|||+++...... ...+...||..|||||++.+. ...|+.|+|||||||+||||+| |+.||.+....++.
T Consensus 183 ~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~~~~~ 255 (362)
T KOG0192|consen 183 LKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAPVQVA 255 (362)
T ss_pred EEECCCccceeecccc-ccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHH-CCCCCCCCCHHHHH
Confidence 9999999997654322 222336889999999999854 1238999999999999999999 99999999987777
Q ss_pred HHHh-cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcce
Q psy7505 314 TRVF-GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYY 366 (394)
Q Consensus 314 ~~i~-~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~ 366 (394)
..+. ++. |++.|..+++.+..+|..||..+|. ||++.+++..|+.+...+.
T Consensus 256 ~~v~~~~~--Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 256 SAVVVGGL--RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHhcCC--CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 7665 443 7888888999999999999999998 9999999999998876543
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-55 Score=396.58 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=218.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..+|.+.++||+|+||+||+|+++ ..+..||||.+.... ....++.+..|+.+|+.++|||||++++++.++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~-------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK-------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEec-------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 467888899999999999999998 455699999887664 555556678999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC------CeEEE
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE------LRVKI 236 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~------~~vKl 236 (394)
+.+|||||||.||||.+||+..+. +++.....++.||+.||++||+++||||||||.||||+.. -.+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGR-----LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 999999999999999999988753 6778888999999999999999999999999999999875 46899
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|+....+. ...+.+|++.|||||++.... |+.|+|+||+|++||+|++ |+.||...+..+++..+
T Consensus 157 ADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~-------YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 157 ADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQ-------YDAKADLWSIGTILYQCLT-GKPPFDAETPKELLLYI 226 (429)
T ss_pred cccchhhhCCchh--HHHHhhCCccccCHHHHHhcc-------ccchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHH
Confidence 9999999876543 345679999999999997655 8999999999999999998 99999999999999998
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..+.......+..++..+.+++...++.++. |.++.+.+
T Consensus 227 ~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 227 KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred hccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 8887666666777888888999999999987 66666554
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=388.26 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=223.0
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
..+...+++.+..||+|..|+||+++++ .++..+|+|++....+...+..+.+|+++++..+||+||.+||+|
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk-------~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF 146 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHK-------PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF 146 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEc-------CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence 3455678888999999999999999998 456688999997777666667778999999999999999999999
Q ss_pred EeCCc-eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEc
Q psy7505 160 LESDP-WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 160 ~~~~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
..++. ++|+||||++|+|+++++..+. +++...-.++.+|++||.|||+ ++||||||||+|||+++.|.||||
T Consensus 147 ~~~~~~isI~mEYMDgGSLd~~~k~~g~-----i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 147 YSNGEEISICMEYMDGGSLDDILKRVGR-----IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred EeCCceEEeehhhcCCCCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEec
Confidence 99985 9999999999999999987543 6777788999999999999995 999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-----SDDQV 312 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-----~~~~~ 312 (394)
|||.|+..... ...+..||..|||||.+.+.. |+.++||||||++++||++ |+.||... ...++
T Consensus 222 DFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~-------Ys~~sDIWSLGLsllE~a~-GrfP~~~~~~~~~~~~~L 290 (364)
T KOG0581|consen 222 DFGVSGILVNS---IANTFVGTSAYMSPERISGES-------YSVKSDIWSLGLSLLELAI-GRFPYPPPNPPYLDIFEL 290 (364)
T ss_pred cccccHHhhhh---hcccccccccccChhhhcCCc-------CCcccceecccHHHHHHhh-CCCCCCCcCCCCCCHHHH
Confidence 99999765443 345778999999999998876 8899999999999999997 99999874 67888
Q ss_pred HHHHhcCCCcCCCCCC-CCChHHHHHHHhhhcCCcc-ccchhhhh--hhhhcCC
Q psy7505 313 ITRVFGTEALRLPAPR-AVNSHVDVAARNCLVTSEL-RVKIGDTG--SSIDKYP 362 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~-~~~~~~~~l~~~cl~~~p~-r~~~~e~~--~~l~~~~ 362 (394)
+..|..+..++ .|. .++++++.++..||+.||. |++..+++ ..|.+..
T Consensus 291 l~~Iv~~ppP~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 291 LCAIVDEPPPR--LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHhcCCCCC--CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999887444 445 4999999999999999997 99998886 3344443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-55 Score=397.82 Aligned_cols=253 Identities=20% Similarity=0.266 Sum_probs=214.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH------HHHHHHHHHHHhccCCCcceeceee
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA------EKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.+.|.+.+.||+|+||.|-+|..+ .+.+.||||++....... ......+|+++|++|+|||||++++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~-------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEK-------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEc-------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 567888899999999999999987 567799999997654211 2233469999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeE
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRV 234 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~v 234 (394)
+|...+..||||||+.||+|.+++-.++. +.+.....++.|++.|+.|||++||+||||||+|||+..+ ..+
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEE
Confidence 99999999999999999999999987754 5566667899999999999999999999999999999876 789
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ-VI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~-~~ 313 (394)
||+|||+|+... ......+.|||+.|.|||++...... .+..++||||+||+||-+++ |.+||++..... +.
T Consensus 319 KItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~----~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~~~~sl~ 391 (475)
T KOG0615|consen 319 KITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVE----YYPSKVDIWSLGCVLFVCLS-GYPPFSEEYTDPSLK 391 (475)
T ss_pred Eecccchhhccc--cceehhhhcCCccccChhheecCCee----cccchheeeeccceEEEEec-cCCCcccccCCccHH
Confidence 999999998764 33456788999999999999877643 25569999999999999998 999999876554 77
Q ss_pred HHHhcCCCcCC-CCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 314 TRVFGTEALRL-PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 314 ~~i~~~~~~~~-~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+|.+|...-. +....++++..++|.++|..||+ |+++.|.+
T Consensus 392 eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 392 EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 88888753222 33458999999999999999998 99998875
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=388.30 Aligned_cols=245 Identities=19% Similarity=0.301 Sum_probs=215.6
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
...++|++++.||+|+||+||+++.+ .+.+.+|+|++++.. ...+.+...+|..+|.+++||+||+++..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~-------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKK-------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEc-------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 44689999999999999999999987 356688999987765 333455567999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
++...+|||+||+.||+|+.+|++++. +++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecc
Confidence 999999999999999999999987654 677778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+|+....... .+.+++||+.|||||++.+.. |+.++|+||+|+++|||++ |.+||.+.+..+++.+|..+
T Consensus 170 gL~k~~~~~~~-~t~tfcGT~eYmAPEil~~~g-------y~~~vDWWsLGillYeML~-G~pPF~~~~~~~~~~~I~~~ 240 (357)
T KOG0598|consen 170 GLCKEDLKDGD-ATRTFCGTPEYMAPEILLGKG-------YDKAVDWWSLGILLYEMLT-GKPPFYAEDVKKMYDKILKG 240 (357)
T ss_pred ccchhcccCCC-ccccccCCccccChHHHhcCC-------CCcccchHhHHHHHHHHhh-CCCCCcCccHHHHHHHHhcC
Confidence 99986543322 345689999999999998876 8999999999999999998 99999999999999999888
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcccc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSELRV 349 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~ 349 (394)
. .+..|..++.+..++++.+|..+|++|
T Consensus 241 k--~~~~p~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 241 K--LPLPPGYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred c--CCCCCccCCHHHHHHHHHHhccCHHHh
Confidence 4 344456699999999999999999844
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-54 Score=436.35 Aligned_cols=272 Identities=35% Similarity=0.552 Sum_probs=245.0
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+++...++...||+|+||.||.|...+...... ...||+|.+++..+..++..|++|+.+|++++|||||+++|+|.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~--~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS--PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCcc--ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 668899999999999999999999986443211 447999999998888888888999999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchh--hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEAS--REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
....+|++|||.+|||..||++.+.. ....+....++.++.|||+|+.||+++++|||||..+|||++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999986321 1334777889999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCc-cCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 240 GSSIDKYPGDYYVHGEV-ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
|+|++....++++.... ..+++|||||.+..+. |+.|+|||||||+|||++|.|..||.+.++.+++..+.+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-------FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-------FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE 919 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcc-------cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence 99998888888877665 6678999999998765 899999999999999999999999999999999998888
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+. |++.|.+|++.++++|++||..+|+ ||++.++++.+..+..+
T Consensus 920 gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 87 9999999999999999999999998 99999999988887753
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=402.73 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=218.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..|+..+.||+|||+.||++++.. ++..||+|++.+.. +......+.+|+++.+.|+|||||+++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence 679999999999999999999862 45589999987643 333444567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||+|+|..|+|..+++..+. +++..+..+.+||+.||.|||+++|||||||..|++++++..|||+|||+|
T Consensus 91 ~nVYivLELC~~~sL~el~Krrk~-----ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRRKP-----LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred CceEEEEEecCCccHHHHHHhcCC-----CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEeccccee
Confidence 999999999999999999975433 788899999999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
...... ..+..+.|||+.|.|||++.... ++..+||||+||+||-|+. |++||...+..+.+.+|..+
T Consensus 166 t~le~~-~Erk~TlCGTPNYIAPEVl~k~g-------HsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~Ik~~--- 233 (592)
T KOG0575|consen 166 TQLEYD-GERKKTLCGTPNYIAPEVLNKSG-------HSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNKIKLN--- 233 (592)
T ss_pred eeecCc-ccccceecCCCcccChhHhccCC-------CCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHHHHhc---
Confidence 765432 22456789999999999998665 7889999999999999997 99999999999999999877
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
....|..++.++++||+++|..+|. ||++.+|+
T Consensus 234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred CcccccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 4567779999999999999999997 99998885
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-54 Score=414.63 Aligned_cols=267 Identities=29% Similarity=0.494 Sum_probs=240.1
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+|.....++.+.||.|.||+|++|+++.. ++.-..||||.+|....+..+..|+.|+.||.+++||||++|-|+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~p----gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLP----GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCC----CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 35567788999999999999999998843 24556899999999998888888899999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
....++||+|||++|+|+.||+.+... +..-.++.|.+.|+.||.||.+++.|||||..+|||++.+..+|++|||
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGq----ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQ----FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCc----eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence 999999999999999999999987532 6667788999999999999999999999999999999999999999999
Q ss_pred CCccCCCCc--eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 241 SSIDKYPGD--YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 241 ~a~~~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
+++...++. .+....-..+++|.|||.|...+ ++.++|||||||+|||.++||+.||.++++.++++.|..
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-------FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcc-------cCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 998664433 23333345589999999998766 899999999999999999999999999999999999998
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
|+ |+|.|..||..++.||..||+.+.. ||.+.+|+..|+++...
T Consensus 850 gy--RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GY--RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cc--CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 87 9999999999999999999999987 99999999999999864
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=373.34 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=220.1
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceee-E
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMA-A 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~ 158 (394)
.-+..+|+++++||+|+||+||++.+. .++..+|.|.++-+. +......+..|+.+|++|+|||||++++ .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~-------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~ 87 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCL-------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS 87 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeec-------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence 344678899999999999999999987 345578888776443 4555556779999999999999999999 4
Q ss_pred EEeCCc-eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEEcCCCe
Q psy7505 159 CLESDP-WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE--DG--FIHTDVAARNCLVTSELR 233 (394)
Q Consensus 159 ~~~~~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~--~~--iiHrDlk~~NiLl~~~~~ 233 (394)
|.+++. ++||||||.+|||.+.|+..+. ....+++..++.++.|+++||..+|. .+ |+||||||.||+|+.+|.
T Consensus 88 f~~~~evlnivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 88 FIEDNEVLNIVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred hhccchhhHHHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 555555 8999999999999999986543 33458899999999999999999999 55 999999999999999999
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
|||+|||+++...... ......+||+.||+||.+.... |+.++||||+||++|||++ -..||.+.+-.++-
T Consensus 167 vKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~-------Y~~kSDiWslGCllyEMca-L~~PF~g~n~~~L~ 237 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESG-------YNFKSDIWSLGCLLYEMCA-LQSPFYGDNLLSLC 237 (375)
T ss_pred eeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCC-------CCcchhHHHHHHHHHHHHh-cCCCcccccHHHHH
Confidence 9999999998764433 3344568999999999998877 8999999999999999998 89999999999999
Q ss_pred HHHhcCCCcCCCCC-CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 314 TRVFGTEALRLPAP-RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 314 ~~i~~~~~~~~~~p-~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
.+|.+|+ -.|.| ...+..+.+++..|+..|++ ||++..++..+++
T Consensus 238 ~KI~qgd--~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 238 KKIEQGD--YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHcCC--CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 9999986 44556 67899999999999999998 9986665555554
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-52 Score=388.15 Aligned_cols=248 Identities=18% Similarity=0.345 Sum_probs=219.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACL 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 160 (394)
..+|.+++.||+|+|++|++|+.+ .+...+|||++.+.. .+...+....|-.+|.+| +||.||+|+..|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~-------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREK-------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred hhhcchhheeccccceeEEEeeec-------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 578999999999999999999988 356689999997765 444555677899999999 9999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+...+|+|+||+++|+|.++|++.+. +++.....++.||+.||+|||++|||||||||+|||+|.+|++||+|||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecc
Confidence 99999999999999999999988754 6777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCce----------ee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 241 SSIDKYPGDY----------YV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 241 ~a~~~~~~~~----------~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
.|+....... .. ...++||..|.+||+|..+. .+..+|+|+||||||+|++ |.+||.+.+
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-------~~~~sDiWAlGCilyQmla-G~PPFra~N 291 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-------AGPSSDLWALGCILYQMLA-GQPPFRAAN 291 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-------CCcccchHHHHHHHHHHhc-CCCCCcccc
Confidence 9976532211 11 14578999999999998876 6789999999999999998 999999999
Q ss_pred HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
+.-++++|+.- ..++|+.+++.+.+|++++|..||. |.++.+|
T Consensus 292 eyliFqkI~~l---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 292 EYLIFQKIQAL---DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred HHHHHHHHHHh---cccCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence 99999999875 6789999999999999999999998 7787665
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=398.23 Aligned_cols=275 Identities=29% Similarity=0.510 Sum_probs=236.6
Q ss_pred ccCCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecc--cccHHHHHHHHHHHHHhccCCCc
Q psy7505 73 NWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE--DASQAEKLFFLHEATPYRRLRHV 150 (394)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~--~~~~~~~~~~~~E~~~l~~l~Hp 150 (394)
..+....|++..++..+.++||+|+||+||+|+++..... ....||||..+. .........+++|+++|++++||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~---~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF---KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCc---eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence 3456678999999999999999999999999999843211 122389999885 23455556677999999999999
Q ss_pred ceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 151 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
|||++||++....+++||||+|+||+|.+||++++. .++......++.+.+.||+|||++++|||||..+|||++.
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK 297 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC
Confidence 999999999999999999999999999999998754 2567778899999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
++.+||+|||+|+... .+.... ....+++|+|||.+.... |+.++|||||||++||+++.|..||.+...
T Consensus 298 ~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~-------~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGI-------FSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred CCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCc-------cccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 9999999999987653 222222 225789999999987664 899999999999999999989999999999
Q ss_pred HHHHHHH-hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 310 DQVITRV-FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 310 ~~~~~~i-~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
.++..+| .++. +.+.|...+..+..++.+||..+|+ |+++.++...|+.+....
T Consensus 369 ~~v~~kI~~~~~--r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 369 YEVKAKIVKNGY--RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHHHHHHHhcCc--cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 9999999 5555 8889999999999999999999998 999999998888887643
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=395.64 Aligned_cols=266 Identities=30% Similarity=0.530 Sum_probs=240.9
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
-+.|+..+.++...++||.|.||.||.|.|+ +....||||.++.+..+.+ .|+.|+.+|+.++|||+|+|+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWK-------kyslTvAVKtLKEDtMeve--EFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVE--EFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeee-------ccceeeehhhhhhcchhHH--HHHHHHHHHHhhcCccHHHHh
Confidence 3689999999999999999999999999998 4556899999998875433 467999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
|+|.....+|||+|||..|+|.+||++.... .+..-.++.|+.||.+||.||..+++|||||..+|||+.++..|||
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEe
Confidence 9999999999999999999999999876332 2566678899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++.+..+.+........++.|.|||.|..+. ++.|+|||+|||+|||+.|||-.||.+.+..+++..+
T Consensus 407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNt-------FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL 479 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT-------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL 479 (1157)
T ss_pred eccchhhhhcCCceecccCccCcccccCcccccccc-------cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence 999999998888887777778899999999998776 7889999999999999999999999999999999888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+|+ |+..|+.|++.+++||+.||.++|. ||+++|+-..++.+..
T Consensus 480 Ekgy--RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 480 EKGY--RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred hccc--cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 8887 9999999999999999999999997 9999999877766554
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=357.96 Aligned_cols=241 Identities=17% Similarity=0.274 Sum_probs=216.0
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
...++|++++.||.|+||.|.+++.+. .+.-+|+|+++... .....+-..+|..+|+.+.||+++++++.|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~-------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~ 113 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKH-------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF 113 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEcc-------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence 567899999999999999999999883 45588999997765 233334456899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+.+||||||.+||.|+.+|++.+. +++..+..+++||+.||+|||+++|++|||||+|||||.+|.+||+||
T Consensus 114 ~d~~~lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 114 KDNSNLYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999999987654 677788999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+|+..... +-+.|||+.|+|||++.... |+.++|+|||||++|||+. |.+||.+.++.++..+|.++
T Consensus 189 GFAK~v~~r----T~TlCGTPeYLAPEii~sk~-------ynkavDWWalGVLIYEMla-G~pPF~~~~~~~iY~KI~~~ 256 (355)
T KOG0616|consen 189 GFAKRVSGR----TWTLCGTPEYLAPEIIQSKG-------YNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQIYEKILEG 256 (355)
T ss_pred cceEEecCc----EEEecCCccccChHHhhcCC-------CCcchhHHHHHHHHHHHHc-CCCCCcCCChHHHHHHHHhC
Confidence 999876443 33579999999999998776 8899999999999999998 99999999999999999998
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcccc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSELRV 349 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~ 349 (394)
.+.+|..+++.+++|++.+|+.|-.+|
T Consensus 257 ---~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 ---KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 688999999999999999999998744
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=393.75 Aligned_cols=270 Identities=30% Similarity=0.515 Sum_probs=243.1
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...+++.++.+.+.+.||+|.||.||+|.+....+ ....-||||+.+.+......+.|+.|+.+|++++|||||+|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~k---ge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEK---GERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEeccccc---CcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 35778889999999999999999999999986532 334469999999877666666778999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
|+|.+ .+.|||||+++.|.|..||+.+... ++......++.||+.||.|||++++|||||..+|||+.+...|||
T Consensus 458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk~s----L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 458 GVCVE-QPMWIVMELAPLGELREYLQQNKDS----LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eeeec-cceeEEEecccchhHHHHHHhcccc----chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeee
Confidence 99975 6899999999999999999877543 677778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|+......+|.......++.|||||.+...+ ++.++|||-|||.+||++..|..||.+..+.+++-.+
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr-------FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i 605 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRR-------FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI 605 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhc-------ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe
Confidence 999999998888888777778899999999987665 8999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+|+ |+|.|++||+.++.+|.+||+.+|. ||.+.++.+.|..++.
T Consensus 606 EnGe--RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGE--RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCC--CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 8998 9999999999999999999999997 9999999888877664
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=395.38 Aligned_cols=255 Identities=25% Similarity=0.480 Sum_probs=222.4
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceece
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
..+.|+|+-+.+.-++-||+|+.|.||+|+.+ +..||||+++.-. ..+++.|++|+||||+.+
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~---------netVAVKKV~elk--------ETdIKHLRkLkH~NII~F 177 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH---------NETVAVKKVRELK--------ETDIKHLRKLKHPNIITF 177 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeecc---------CceehhHHHhhhh--------hhhHHHHHhccCcceeeE
Confidence 35688999888888888999999999999987 3478998775321 256788999999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
.|+|.....+|||||||+.|-|+..|+.... +.....+.+..+||.||.|||.+.|||||||.-||||..+..||
T Consensus 178 kGVCtqsPcyCIiMEfCa~GqL~~VLka~~~-----itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 178 KGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP-----ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eeeecCCceeEEeeeccccccHHHHHhccCc-----cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEE
Confidence 9999999999999999999999999987644 56667889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||.++..... .....++||+.|||||+|.... .+.|+||||||||||||+| |+.||.+.+...++.-
T Consensus 253 IsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrneP-------csEKVDIwSfGVVLWEmLT-~EiPYkdVdssAIIwG 322 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEP-------CSEKVDIWSFGVVLWEMLT-GEIPYKDVDSSAIIWG 322 (904)
T ss_pred eccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCC-------cccccceehhHHHHHHHHh-cCCCccccchheeEEe
Confidence 9999998765433 3445679999999999998776 7899999999999999999 9999999988888776
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+ +...+.+|.|..|++.+.-||++||...|. ||++.+++.-|+-.-.
T Consensus 323 V-GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 323 V-GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred c-cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 6 344579999999999999999999999998 9999999876654443
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=388.89 Aligned_cols=267 Identities=25% Similarity=0.413 Sum_probs=226.1
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceec
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
...+|+|+.+++.+...||+|.||+||+|+|.+ .||||+++.+. .....+.|.+|+..+++-+|.||+-
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG----------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL 452 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG----------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL 452 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc----------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence 348999999999999999999999999999986 79999998776 4556667889999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
++|+|...+. .||+.+|.|.+|+.+|+... ..++....+.|+.||++||.|||.++|||||||..||++.+++.|
T Consensus 453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred eehhhcCCce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcE
Confidence 9999987655 99999999999999997542 337788889999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 235 KIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+|||++.....-. ..-.....|.+.|||||++.... ..+|++.+||||||||+|||+| |..||......+++
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd----~nPfS~qSDVYaFGiV~YELlt-g~lPysi~~~dqIi 602 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQD----DNPFSFQSDVYAFGIVWYELLT-GELPYSIQNRDQII 602 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcc----cCCCCcccchhhhhHHHHHHHh-CcCCcCCCChhheE
Confidence 999999985332110 00112235678899999998554 2359999999999999999998 99999977788888
Q ss_pred HHHhcCCCcCCCC----CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 314 TRVFGTEALRLPA----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 314 ~~i~~~~~~~~~~----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.++-+|+ -.+. -..++.++++|+..||..+++ ||.+.+|++.|..++..
T Consensus 603 fmVGrG~--l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 603 FMVGRGY--LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EEecccc--cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 8886664 2232 247888999999999999998 99999999988888763
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=357.49 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=206.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
+.|+.+.++|+|+||+||+|+++ .+++.||||+..... +...++..++|+.+|++|+|+|+|.|+.+|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 35677889999999999999998 467799999987665 4566667789999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++||+|||+. ++.+-|...... ++...+..++.|++.|+.|||+++||||||||+||||+.+|.+||||||+|+
T Consensus 75 klhLVFE~~dh-TvL~eLe~~p~G----~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 75 KLHLVFEYCDH-TVLHELERYPNG----VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred eeEEEeeecch-HHHHHHHhccCC----CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhH
Confidence 99999999987 555556544222 5777888999999999999999999999999999999999999999999998
Q ss_pred cCC-CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--
Q psy7505 244 DKY-PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-- 320 (394)
Q Consensus 244 ~~~-~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-- 320 (394)
... .++.| +..+.|.||.|||.+.+.. .|+..+||||+||++.||++ |.+-|.+.++.+.+..|...-
T Consensus 150 ~L~~pgd~Y--TDYVATRWYRaPELLvGDt------qYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~ktLG~ 220 (396)
T KOG0593|consen 150 TLSAPGDNY--TDYVATRWYRAPELLVGDT------QYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRKTLGN 220 (396)
T ss_pred hhcCCcchh--hhhhhhhhccChhhhcccC------cCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHHHHcc
Confidence 765 44433 2345688999999998754 39999999999999999998 999999998776654443211
Q ss_pred ----------------CcCCCCCC----------CCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 321 ----------------ALRLPAPR----------AVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 321 ----------------~~~~~~p~----------~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+.++|.|. .++.-+.++|+.||..||. |.+.++++
T Consensus 221 L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 221 LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 13455553 5566788999999999998 88877764
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=383.83 Aligned_cols=244 Identities=23% Similarity=0.373 Sum_probs=213.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+..++|.+++.||+|+||+|+++..++ +...+|||+++++. ...+.+..+.|..|+... +||.+++++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~-------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG-------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC-------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence 5667999999999999999999999985 44589999998875 334444556788877766 6999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
.|++.+++|+||||+.|||+..+++.. .+++..+..|++.|+.||.|||++|||+||||.+|||+|.+|.+||+
T Consensus 437 ~fQT~~~l~fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 437 CFQTKEHLFFVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred ccccCCeEEEEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEec
Confidence 999999999999999999955444322 26777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++....... .+++.+||+.|||||++.+.. |+.++|+|||||+||||+. |..||.+.+++++...|+
T Consensus 511 DFGlcKe~m~~g~-~TsTfCGTpey~aPEil~e~~-------Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 511 DFGLCKEGMGQGD-RTSTFCGTPEFLAPEVLTEQS-------YTRAVDWWGLGVLLYEMLV-GESPFPGDDEEEVFDSIV 581 (694)
T ss_pred ccccccccCCCCC-ccccccCChhhcChhhhccCc-------ccchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Confidence 9999987653333 567889999999999998876 8999999999999999997 999999999999999998
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcccc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSELRV 349 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~ 349 (394)
.. ....|..++.+...+|+++|..+|++|
T Consensus 582 ~d---~~~yP~~ls~ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 582 ND---EVRYPRFLSKEAIAIMRRLLRKNPEKR 610 (694)
T ss_pred cC---CCCCCCcccHHHHHHHHHHhccCcccc
Confidence 77 456788999999999999999999843
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=377.52 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=221.8
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCC-Ccceeceee
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLR-HVNILRLMA 157 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~-HpnIv~l~~ 157 (394)
....|.+.+.||+|+||+|++|++.. ++..||+|++.... .......+.+|+.+++.++ ||||+++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~-------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e 87 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL-------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE 87 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc-------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence 36789999999999999999999873 44689999776541 1123334558999999998 999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEE
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKI 236 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl 236 (394)
++.....+|+|||||.||+|++++.+.+. +.+..+..++.|++.|+.|||++||+||||||+|||++.+ +.+||
T Consensus 88 v~~t~~~~~ivmEy~~gGdL~~~i~~~g~-----l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 88 VFATPTKIYIVMEYCSGGDLFDYIVNKGR-----LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred EEecCCeEEEEEEecCCccHHHHHHHcCC-----CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEE
Confidence 99999999999999999999999987443 5667888999999999999999999999999999999999 99999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCC-CCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD-TSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
+|||++.... .......+.+||+.|+|||++.+.. + .+.++||||+||+||.|++ |..||.+.+...+..+
T Consensus 163 ~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y------~g~~aDvWS~GViLy~ml~-G~~PF~d~~~~~l~~k 234 (370)
T KOG0583|consen 163 SDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTY------SGKAADVWSLGVILYVLLC-GRLPFDDSNVPNLYRK 234 (370)
T ss_pred eccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCc------CCchhhhhhhHHHHHHHHh-CCCCCCCccHHHHHHH
Confidence 9999997663 2223455779999999999998866 4 3689999999999999998 9999999888888888
Q ss_pred HhcCCCcCCCCCCCC-ChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 316 VFGTEALRLPAPRAV-NSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 316 i~~~~~~~~~~p~~~-~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
|..+ ++..|..+ ++++..++++||..+|. |+++.+++ .-.++..
T Consensus 235 i~~~---~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 235 IRKG---EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HhcC---CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 8877 68888888 99999999999999998 99999998 6555554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=375.52 Aligned_cols=273 Identities=31% Similarity=0.538 Sum_probs=218.2
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
|.++.++|++.+.||+|+||.||+|.+.+.... .....||+|+++..........+.+|+.+++++ +|||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKK--SSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCc--ccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 678899999999999999999999987532211 233479999987655444445577999999999 89999999999
Q ss_pred EEeC-CceEEEEeeCCCCCHHHHHhhcchhh-------------------------------------------------
Q psy7505 159 CLES-DPWLLVFESCSRGDLKEFLLSNEASR------------------------------------------------- 188 (394)
Q Consensus 159 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~------------------------------------------------- 188 (394)
|... +.+++|||||++|+|.+++.......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 46899999999999999997542100
Q ss_pred --------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCC
Q psy7505 189 --------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALP 259 (394)
Q Consensus 189 --------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t 259 (394)
...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...+...++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 01245667788999999999999999999999999999999999999999999875433222 222334556
Q ss_pred cccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCcCCCCCCCCChHHHHHH
Q psy7505 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEALRLPAPRAVNSHVDVAA 338 (394)
Q Consensus 260 ~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~p~~~~~~~~~l~ 338 (394)
..|||||++.+.. ++.++|||||||++|||++.|..||.+.... .+...+..+. ....|..+++.+.+++
T Consensus 240 ~~y~aPE~~~~~~-------~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li 310 (338)
T cd05102 240 LKWMAPESIFDKV-------YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--RMRAPENATPEIYRIM 310 (338)
T ss_pred ccccCcHHhhcCC-------CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--CCCCCCCCCHHHHHHH
Confidence 7899999987654 7889999999999999997699999886543 3344444444 4556778899999999
Q ss_pred HhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 339 RNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 339 ~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+||..+|+ ||++.|++..|+++..
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999998 9999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=377.39 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=222.0
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++..|....+||+|+.|.||.|+... ....||||.+....... +..+++|+.+|+.++|+|||++++.|..+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~-------~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKIS-------TKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhhcchhhhccccccceeeeeecc-------CCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 56778888999999999999999773 44579999886655433 34456999999999999999999999988
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+|||||+||+|.+.+.... +++..+..++++++.||.|||.+||||||||.+|||++.+|.+||+|||+|
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeee
Confidence 99999999999999999986542 677788899999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ...+..||+.|||||++.... |++++||||||++++||+. |++||-..++...+..|..+..+
T Consensus 417 aqi~~~~~-KR~TmVGTPYWMAPEVvtrk~-------YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyLIa~ng~P 487 (550)
T KOG0578|consen 417 AQISEEQS-KRSTMVGTPYWMAPEVVTRKP-------YGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTP 487 (550)
T ss_pred eccccccC-ccccccCCCCccchhhhhhcc-------cCccccchhhhhHHHHHhc-CCCCccCCChHHHHHHHhhcCCC
Confidence 76654443 455779999999999987665 8999999999999999997 99999998888888999888888
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
++..|..+++.+++++.+||+.|++ |+++.|++
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL 521 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELL 521 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHh
Confidence 9999999999999999999999998 99999886
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=371.50 Aligned_cols=246 Identities=18% Similarity=0.323 Sum_probs=209.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++++.||+|+||.||+|+.+. ++..+|+|++++.. ...+..-.+.|-.+|...++|+||+||..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~-------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKD-------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEcc-------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 4667999999999999999999999884 56689999998765 23334446689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
|++.+.+||||||++|||+..+|...+. +++..+..++.+++.|+.-+|..|+|||||||+|+|||..|++||+|
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~~~-----L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRKDT-----LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhcCc-----CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecc
Confidence 9999999999999999999999976543 78888999999999999999999999999999999999999999999
Q ss_pred CCCCccCCC----------------------Ccee-----e-------------------eCCccCCcccccccccccCC
Q psy7505 239 TGSSIDKYP----------------------GDYY-----V-------------------HGEVALPVRWCAPESLLCSD 272 (394)
Q Consensus 239 FG~a~~~~~----------------------~~~~-----~-------------------~~~~~~t~~y~aPE~l~~~~ 272 (394)
||||.-... .+.. . ....+||+.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999832110 0000 0 01247899999999999887
Q ss_pred CCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc
Q psy7505 273 TSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL 347 (394)
Q Consensus 273 ~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~ 347 (394)
|+..+|+||||||+||||. |.+||.+.++.+...+|.+.. .+..|....+++++.+||.+|+. ||+
T Consensus 365 -------Y~~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 365 -------YGKECDWWSLGCIMYEMLV-GYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred -------CCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHH
Confidence 8899999999999999997 999999999999999987643 24555556788999999999999 887
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=372.02 Aligned_cols=266 Identities=34% Similarity=0.611 Sum_probs=231.4
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
--+++++.+.++++||+|.||+|.+|...+ ..+||||+++.+........|.+|+++|.+|+|||||+|+|+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg--------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGV 603 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG--------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGV 603 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecC--------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEee
Confidence 347899999999999999999999998763 459999999998876666778899999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
|..++++++|+|||.+|||.+||..+.... +.....++++.||++||+||.+.++|||||.++|||++.++++||+|
T Consensus 604 C~~DePicmI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 604 CVQDDPLCMITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred eecCCchHHHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecC
Confidence 999999999999999999999998773321 34445677999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF-GKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~-g~~Pf~~~~~~~~~~~i 316 (394)
||+++....++++... ....+++|||+|.+..++ ++.++|+|+||+++||+++. .+.||...+++++....
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-------FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~ 753 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-------FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA 753 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhcc-------ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh
Confidence 9999988888877654 457899999999998776 89999999999999998754 56899999998887654
Q ss_pred h---c--CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 317 F---G--TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 317 ~---~--~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
- . +....++.|..|+..++++|..||..+-+ ||++.++..-|++..
T Consensus 754 ~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 754 GEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2 2 22345678999999999999999999987 999999988777653
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=384.03 Aligned_cols=263 Identities=29% Similarity=0.500 Sum_probs=229.8
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
..-|+.+++.+.++||+|+||+|++|.|.. ...+...||||.++.+........|++|+.+|.+|+|+|+|+|||+
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~----psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQ----PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccC----CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeee
Confidence 445788899999999999999999999985 2355668999999988866566778899999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
..+ ..+.||||+++.|+|.+.|++... ..+-...+..|+.||+.||.||.++++|||||..+|+|+.....|||+|
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence 987 789999999999999999987321 2245566778999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCc-eee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGD-YYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~-~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||+.+....++ +|. ......+..|+|||.|.... ++.++|||+|||++|||+|||+.||.+....+++.+|
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-------FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-------FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhcccc-------ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 99998765443 333 23347788999999998776 8899999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
-.++ +++.|..|++.++++|++||+.+|. ||++.+|.+.+
T Consensus 329 D~~e--rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGE--RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccc--cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 8777 9999999999999999999999997 99999986433
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=358.58 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=223.1
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
..|....++|++..+||.|..++||+|++. .++..||||++.-+.-....+.+.+|++.|+.++|||||+++.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~-------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~ 91 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCI-------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHC 91 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeec-------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEE
Confidence 356667899999999999999999999987 3456999999987775555677889999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
.|..+..+|+||.||.+|++.++++.... ..+++..+..+.++++.||.|||.+|.||||||+.||||+++|.|||+
T Consensus 92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 92 SFVVDSELWVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEEecceeEEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEc
Confidence 99999999999999999999999987532 227888888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCce--eee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 238 DTGSSIDKYPGDY--YVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 238 DFG~a~~~~~~~~--~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
|||.+........ ... .+..||+.|||||++.....+ |+.|+||||||++..||.+ |..||..+.+.+++.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~G-----YdfKaDIwSfGITA~ELA~-G~aPf~k~pPmkvLl 242 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHG-----YDFKADIWSFGITACELAH-GHAPFSKYPPMKVLL 242 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccC-----ccchhhhhhhhHHHHHHhc-CCCCcccCChHHHHH
Confidence 9997755433221 112 556899999999997665543 9999999999999999997 999999999999988
Q ss_pred HHhcCCCcCCC-------CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 315 RVFGTEALRLP-------APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 315 ~i~~~~~~~~~-------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+-+++..+.+. .....+..+.+++..||+.||. |||+.+++
T Consensus 243 ~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 243 LTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred HHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 77777543221 1235677899999999999998 99998876
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=368.90 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=211.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..+.|+.+++||+|.||.||+|++. .++..||+|.+..+. ...-..+..+|+.||++|+||||++|.+...+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~-------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDL-------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeec-------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 3567888999999999999999987 466689999987766 34444566799999999999999999999987
Q ss_pred C--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 162 S--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 162 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. ..+|||+|||+. ||.-++...+.. +++..+..++.|++.||.|||++||+|||||.+|||||.+|.+||+||
T Consensus 188 ~~~~siYlVFeYMdh-DL~GLl~~p~vk----ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDH-DLSGLLSSPGVK----FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred cCCceEEEEEecccc-hhhhhhcCCCcc----cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccc
Confidence 6 689999999987 999998765332 778889999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+|+..........+..+.|.+|.|||+|++... |+.++|+||.||||.||++ |++.|.+.++.+.+.+|++-
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~------Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS------YGTAVDLWSVGCILAELFL-GKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcc------cccceeehhhhHHHHHHHc-CCCCcCCccHHHHHHHHHHH
Confidence 9998765554333445677999999999998763 9999999999999999997 99999999988877776542
Q ss_pred CC---------cCCCC--------C---------CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 320 EA---------LRLPA--------P---------RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 320 ~~---------~~~~~--------p---------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
-+ ..+|. + ..+++..-+|+..+|+.||. |.|+.+.+
T Consensus 336 cGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 336 CGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred hCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 11 12221 1 25677888999999999998 88876653
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=360.13 Aligned_cols=253 Identities=19% Similarity=0.307 Sum_probs=205.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
.++...+.||+|+||.||++.++. .+...|||......... ...+.+|+.+|++|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~-------~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK-------TGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecC-------CCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 446667889999999999999873 24578888876653322 444679999999999999999999854444
Q ss_pred -ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEEccCCC
Q psy7505 164 -PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKIGDTGS 241 (394)
Q Consensus 164 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl~DFG~ 241 (394)
.++|.|||+++|+|.+++...+. . +++..+..+.+||+.||.|||++|||||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~-~---l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGG-K---LPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCC-C---CCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 69999999999999999988753 1 788889999999999999999999999999999999999 79999999999
Q ss_pred CccCCC--CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhc
Q psy7505 242 SIDKYP--GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE-LSDDQVITRVFG 318 (394)
Q Consensus 242 a~~~~~--~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~-~~~~~~~~~i~~ 318 (394)
++.... ..........||+.|||||++..+.. .+.++|||||||++.||+| |+.||.+ ....+.+..+..
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~------~~~~sDiWSlGCtVvEM~T-g~~PW~~~~~~~~~~~~ig~ 237 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV------ARRESDIWSLGCTVVEMLT-GKPPWSEFFEEAEALLLIGR 237 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCc------CCccchhhhcCCEEEeccC-CCCcchhhcchHHHHHHHhc
Confidence 876543 11122334688999999999985321 2359999999999999999 9999998 454554455543
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
.. ..++.|..+++++++++++|++.+|+ |||+.+++..
T Consensus 238 ~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 238 ED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred cC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 33 23478889999999999999999997 9999998754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=353.66 Aligned_cols=263 Identities=28% Similarity=0.480 Sum_probs=220.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|++.+.||+|+||.||+|.++.. ......|++|.++..........+.+|+.++++++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLP----SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecC----CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 4567899999999999999999987532 134558999998876555555567799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++++||||||+|||++.++.+|++|||.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence 9999999999999999999976422 256777889999999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+...............++..|+|||.+.+.. ++.++|||||||++||+++.|..||.+.+..+++..+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~- 225 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-------FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF- 225 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCC-------ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-
Confidence 7543222222222234456899999986654 78899999999999998866999999998888888776664
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+++.|..++..+.+++.+||+.+|. ||++.++...|.++
T Consensus 226 -~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 6677889999999999999999998 99999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=375.91 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=220.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
-|++++.||.|+-|.|-+|++. .+++.+|||++.... .+.....+.+|+.+|+-+.||||+++|++++++.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~-------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHA-------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ceeccccccCCCCceehhhhcc-------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 3677889999999999999876 677899999986652 3334445679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|+|.||+++|.|+++|...+. +.+..+.+++.||+.|+.|||..+|+||||||+|+|+|.++.+||+|||+|.
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee
Confidence 99999999999999999987654 6777888999999999999999999999999999999999999999999997
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....+. ...+.||+++|.|||++.+..| .+.++||||.|||||.|+| |+.||.+.+...++.+|..| .
T Consensus 161 Le~~gk--lLeTSCGSPHYA~PEIV~G~pY------dG~~sDVWSCGVILfALLt-G~LPFdDdNir~LLlKV~~G---~ 228 (786)
T KOG0588|consen 161 LEVPGK--LLETSCGSPHYAAPEIVSGRPY------DGRPSDVWSCGVILFALLT-GKLPFDDDNIRVLLLKVQRG---V 228 (786)
T ss_pred cccCCc--cccccCCCcccCCchhhcCCCC------CCCccccchhHHHHHHHHh-CCCCCCCccHHHHHHHHHcC---c
Confidence 654443 3456799999999999999886 4789999999999999998 99999999999999999998 6
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..|..++.++++|+++|+..||. |.|+.||+.
T Consensus 229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 888899999999999999999998 889999873
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=366.70 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=217.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|.+.+.||+|+||.||+|+.++ +...||+|.+.+.. .+.+...+.+|++|++.|+|||||.++++|+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~-------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY-------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc-------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 578888999999999999999883 56689999886654 5556666789999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
++|+|.|||.| +|+.+|...+. ++++.+..++.|++.||.|||+++|+|||+||.|||++..|.+|+||||+|+
T Consensus 75 ~~~vVte~a~g-~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred eEEEEehhhhh-hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhh
Confidence 99999999976 99999987654 7788889999999999999999999999999999999999999999999998
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....+. .......||+.|||||++.+.. |+..+|+||+||++|||++ |++||-..+..++...|....
T Consensus 149 ~m~~~t-~vltsikGtPlYmAPElv~e~p-------yd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I~~d~--- 216 (808)
T KOG0597|consen 149 AMSTNT-SVLTSIKGTPLYMAPELVEEQP-------YDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSILKDP--- 216 (808)
T ss_pred hcccCc-eeeeeccCcccccCHHHHcCCC-------ccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHHhcCC---
Confidence 765544 3445678999999999987665 8899999999999999998 999999888888888888763
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
...|...+..+..+++.+|..||. |.+..+++
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 445668999999999999999998 98988775
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=331.77 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=218.1
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+..++|++.+.||+|-||.||+|+.+ ...-.||+|++.+.. .......+.+|++|-+.|+||||+++|++|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarek-------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREK-------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cchhhccccccccCCccccEeEeeec-------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 44688999999999999999999987 455589999986654 222334467999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+...+||++||.+.|+|+..|++....+ +++.....++.|+|.|+.|+|.++||||||||+|+|++..|.+||+||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~---f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKR---FDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhccccc---ccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999999998543322 566677889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|.+..... ....+.|||.-|.+||...+.. ++..+|+|++|++.||++. |.+||...+..+.+.+|.+.
T Consensus 169 GwsV~~p~---~kR~tlcgt~dyl~pEmv~~~~-------hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~etYkrI~k~ 237 (281)
T KOG0580|consen 169 GWSVHAPS---NKRKTLCGTLDYLPPEMVEGRG-------HDKFVDLWSLGVLCYEFLV-GLPPFESQSHSETYKRIRKV 237 (281)
T ss_pred CceeecCC---CCceeeecccccCCHhhcCCCC-------ccchhhHHHHHHHHHHHHh-cCCchhhhhhHHHHHHHHHc
Confidence 99866532 2345779999999999987766 7889999999999999996 99999999988999988766
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++..|..++..+.++|.+|+..+|. |++..|+++
T Consensus 238 ---~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 ---DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 6777899999999999999999997 889888763
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=331.80 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=206.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.+|...+.||+|.||.||+|++. .+++.||||.++... .+......++|++.|+.++|+||+.+.++|-..+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence 35667789999999999999987 466789999987654 2222333469999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+.||+|||+. ||...|+.... .+....+..++.++++|++|||++.|+||||||.|+||+++|.+||+|||+|+
T Consensus 75 ~l~lVfEfm~t-dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 75 NLSLVFEFMPT-DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred ceEEEEEeccc-cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchh
Confidence 99999999987 99999986533 37788889999999999999999999999999999999999999999999998
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL- 322 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~- 322 (394)
.......... ..+.|.+|.|||.+.+.+. |+..+||||.|||+.||+- |.+-|.|.++.+.+..|++.-+.
T Consensus 150 ~f~~p~~~~~-~~V~TRWYRAPELLfGsr~------Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~If~~LGTP 221 (318)
T KOG0659|consen 150 FFGSPNRIQT-HQVVTRWYRAPELLFGSRQ------YGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKIFRALGTP 221 (318)
T ss_pred ccCCCCcccc-cceeeeeccChHHhccchh------cCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHHHHHcCCC
Confidence 7754432222 2267889999999988763 9999999999999999995 98889999888777666542110
Q ss_pred C------------------CCCC------CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 R------------------LPAP------RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~------------------~~~p------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
. .|.| ..+++.+-+++.++|..||. |.++.|.+
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 0 1111 24566889999999999998 88998864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=367.52 Aligned_cols=273 Identities=34% Similarity=0.559 Sum_probs=218.4
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|.++.++|++.+.||+|+||.||+|++.+... ......||+|+++..........+.+|+.+++.+ +|||||+++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~--~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFK--SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEecccc--CccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 3567888899999999999999999998753222 1234579999987655434445567999999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhh------------------------------------------------
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASR------------------------------------------------ 188 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~------------------------------------------------ 188 (394)
++|...+..++|||||++|+|.++++......
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999997532100
Q ss_pred ----------------------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 189 ----------------------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 189 ----------------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0124566778899999999999999999999999999999999999999999987553
Q ss_pred CCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCcCC
Q psy7505 247 PGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ-VITRVFGTEALRL 324 (394)
Q Consensus 247 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~ 324 (394)
..... ..+...++..|+|||++.+.. ++.++|||||||++|||++.|..||.+..... ....+..+. +.
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~ 336 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--RM 336 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCC-------CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--cC
Confidence 33221 122334567799999987654 78899999999999999977899998876443 344444443 45
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
..|...+.++.+++.+||..+|+ ||++.|+++.|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 56677889999999999999998 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=367.74 Aligned_cols=275 Identities=32% Similarity=0.545 Sum_probs=220.6
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|.++.++|++.+.||+|+||.||+|++...... .....||+|.++..........+.+|+.+++.+ +|+|||+++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKE--DNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcc--cccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 46778889999999999999999999997643321 233479999987665444455677999999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchh-------------------------------------------------
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEAS------------------------------------------------- 187 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------------------------------------- 187 (394)
++|...+.+++|||||++|+|.+++......
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999999653210
Q ss_pred ----------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce-
Q psy7505 188 ----------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY- 250 (394)
Q Consensus 188 ----------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~- 250 (394)
....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 001245667789999999999999999999999999999999999999999999875433322
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAV 330 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~ 330 (394)
...+...++..|||||++.... ++.++|||||||++|||++.|+.||........+..+.... .+...|..+
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 340 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-YQMSRPDFA 340 (374)
T ss_pred eeccCCCCccceeCHHHhcCCC-------CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-cCccCCCCC
Confidence 1222334567799999986554 78999999999999999966999998876544443333322 255666778
Q ss_pred ChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 331 NSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 331 ~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+.++.+++++||+.+|+ ||++.+++..|+++.
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999998 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-49 Score=360.90 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=210.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 162 (394)
-++|.++++||.|+||.||+|+.+ .++..||||.++......+...-++|+.-|++|+ |||||+|++++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~-------~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK-------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec-------CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 467888999999999999999987 4555799999887664333333459999999998 99999999999988
Q ss_pred C-ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 163 D-PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 163 ~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+ .+|+|||||+. +|+++++.. ...+++..+..|+.||++||+|+|.+|+.||||||+|||+.....+||+|||+
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccc
Confidence 8 89999999976 999999765 23488999999999999999999999999999999999999888999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG--- 318 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~--- 318 (394)
||.......+ +..+.|.||.|||+|....+ |+.++||||+|||++|+.+ -++-|.|.++.+.+.+|..
T Consensus 157 ARev~SkpPY--TeYVSTRWYRAPEvLLrs~~------Ys~pvD~wA~GcI~aEl~s-LrPLFPG~sE~Dqi~KIc~VLG 227 (538)
T KOG0661|consen 157 AREVRSKPPY--TEYVSTRWYRAPEVLLRSGY------YSSPVDMWAVGCIMAELYS-LRPLFPGASEIDQIYKICEVLG 227 (538)
T ss_pred ccccccCCCc--chhhhcccccchHHhhhccc------cCCchHHHHHHHHHHHHHH-hcccCCCCcHHHHHHHHHHHhC
Confidence 9987665544 34577899999999987664 9999999999999999998 7888999988777666532
Q ss_pred CC---------------CcCCCCC---------CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 319 TE---------------ALRLPAP---------RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 319 ~~---------------~~~~~~p---------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.. ..++|.- ..++.++..+|.+|+++||+ |||+.+.+
T Consensus 228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 11 0122211 25788999999999999998 99988765
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=351.99 Aligned_cols=248 Identities=18% Similarity=0.317 Sum_probs=214.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..+|++.+.||+|.||+|-+|+.+ ..+..||||.++++. ++.+...+.+|++||+.|+||||+.+|.+|+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~-------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH-------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc-------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 567888999999999999999876 456689999998776 44445567899999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+.|||||..+|+|++|+.+.+. +++..+..+++||.+|+.|||.++++|||||.+|||+|.++.+||+|||+
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccch
Confidence 9999999999999999999976643 78888999999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+-...... ...++||++-|.+||++.+..+ -+..+|-|||||+||-|+ +|..||.+.+...++.+|..|..
T Consensus 200 SNly~~~k--fLqTFCGSPLYASPEIvNG~PY------~GPEVDsWsLGvLLYtLV-yGtMPFDG~Dhk~lvrQIs~GaY 270 (668)
T KOG0611|consen 200 SNLYADKK--FLQTFCGSPLYASPEIVNGTPY------KGPEVDSWSLGVLLYTLV-YGTMPFDGRDHKRLVRQISRGAY 270 (668)
T ss_pred hhhhcccc--HHHHhcCCcccCCccccCCCCC------CCCccchhhHHHHHHHHh-hcccccCCchHHHHHHHhhcccc
Confidence 86554332 3456799999999999988775 468999999999999999 69999999999999999988864
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++ .+..+.-||+.+|-.||+ |-|+.||..
T Consensus 271 rEP~----~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 271 REPE----TPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred cCCC----CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 3333 355778899999999999 557877753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=351.39 Aligned_cols=271 Identities=33% Similarity=0.589 Sum_probs=213.9
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccc---------cCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcce
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEES---------TGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~---------~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 152 (394)
++.++|.+.++||+|+||.||+|.++..... .......||+|.+...........+.+|+.++++++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 4578899999999999999999987542210 1123347899998776544455567799999999999999
Q ss_pred eceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhh--------------hhhhhHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7505 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR--------------EALLEQGITIKMAIDVATGLSYMIEDGFIH 218 (394)
Q Consensus 153 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiH 218 (394)
+++++++.+.+..++||||+.+|+|.+++....... ...+++.....++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999996542110 012456677889999999999999999999
Q ss_pred cCCCCCCEEEcCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHH
Q psy7505 219 TDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297 (394)
Q Consensus 219 rDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~ 297 (394)
|||||+|||++.++.+||+|||+++........ ..+...++..|||||++.... ++.++|||||||++|||+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-------FTTASDVWAFGVTLWEIL 234 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-------CCchhhhHHHHHHHHHHH
Confidence 999999999999999999999998765443332 223345678899999986654 788999999999999998
Q ss_pred cC-CCCCCCCCCHHHHHHHHhc-----CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 298 EF-GKLPYAELSDDQVITRVFG-----TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 298 t~-g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+. +..||.+.+..+++..+.. ........|..++..+.+++.+||+.+|+ ||++.++...|.
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 52 6789988877766544321 11123345667899999999999999998 999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=350.27 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=207.4
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH-------------HHHHHHHHHHHhccC
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA-------------EKLFFLHEATPYRRL 147 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~-------------~~~~~~~E~~~l~~l 147 (394)
....++|++.+.||+|.||+|-+|+.. ...+.||||++.+..... ..+...+|+.+|++|
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~-------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDE-------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeec-------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 345689999999999999999999986 345689999986532110 112456899999999
Q ss_pred CCcceeceeeEEEe--CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7505 148 RHVNILRLMAACLE--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARN 225 (394)
Q Consensus 148 ~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~N 225 (394)
+|||||+|+.+.-+ .+.+|||+|||..|.+...=. ....+.+..++.++++++.||.|||.+|||||||||+|
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 99999999999875 457999999999998764211 11116778889999999999999999999999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCce----eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDY----YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
+||+++|+|||+|||.+.....+.. .......||+.|||||.+..+.. ....+.+.||||+||+||.|+ +|+
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~---~~~~g~a~DiWalGVTLYCll-fG~ 316 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS---FSYSGFALDIWALGVTLYCLL-FGQ 316 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC---ccccchhhhhhhhhhhHHHhh-hcc
Confidence 9999999999999998865422211 11112579999999999987431 112578999999999999999 699
Q ss_pred CCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 302 LPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 302 ~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.||-+....++..+|.+. .+.+|.-+.+.+.+++||.++|..||+ |.++.||.
T Consensus 317 ~PF~~~~~~~l~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred CCcccchHHHHHHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 999999999999999765 344555456899999999999999998 99988874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=363.87 Aligned_cols=276 Identities=32% Similarity=0.516 Sum_probs=222.8
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-Ccceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l 155 (394)
.+.|++++++|.+.+.||+|+||.||+|++.+.... .....||+|+++..........+.+|+.++++++ |||||++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRS--QPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCC--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 357899999999999999999999999998643321 2234799999976655555556779999999996 9999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhh-----------------------------------------------
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASR----------------------------------------------- 188 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~----------------------------------------------- 188 (394)
++++.+.+.+|||||||++|+|.++|.......
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 999999999999999999999999997642100
Q ss_pred --------------------------------------------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 189 --------------------------------------------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 189 --------------------------------------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
...+++..++.++.|++.||.|||+++|+||||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 012455667789999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++.|..|
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwSlGvil~ellt~g~~P 339 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-------YTTLSDVWSYGILLWEIFSLGGTP 339 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-------CCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999875433222 1222335667899999986654 788999999999999999768999
Q ss_pred CCCCCHHH-HHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 304 YAELSDDQ-VITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 304 f~~~~~~~-~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
|....... +...+..+. +++.+..++..+.+++.+||+.+|+ ||++.++.+.|.++..
T Consensus 340 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 340 YPGMIVDSTFYNKIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CcccchhHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 98765443 344454443 6677788999999999999999998 9999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=348.57 Aligned_cols=268 Identities=36% Similarity=0.666 Sum_probs=221.8
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.++|++.+.||+|+||.||+|...+... ......|++|.++..........+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNE--RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCC--CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 45678899999999999999999864322 1234578999887665555555677999999999999999999999998
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhh-----------hhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASRE-----------ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
+..+++|||+++|+|.+++........ ..++......++.|++.||.|||+++++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999999976432111 235667788899999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
+.+||+|||+++........ ......++..|+|||.+.... ++.++|||||||++|||++.|..||.+....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-------FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-------CchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999998754333222 222335577899999986554 7889999999999999997799999998888
Q ss_pred HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
++...+..+. ..+.|..++.++.+++.+||+.+|. ||++.|+...|.++
T Consensus 234 ~~~~~i~~~~--~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 EVIEMIRSRQ--LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHcCC--cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 8888877665 4566788999999999999999998 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=360.05 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=216.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
...|...+.||+|+||.||+|.+. .+...||+|++..+....+...+.+|+.++.+++++||.++||.+..+.
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~-------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDN-------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred ccccccchhccccccceeeeeeec-------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 456677789999999999999987 5667899999988876666666779999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|++||||.||++.+.|+.... +.+.....++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||++.
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceee
Confidence 99999999999999999976543 2455556688999999999999999999999999999999999999999987
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....... ...++.||+.|||||++.+.. |+.++||||||++.+||++ |.+||.+..+..++..|-+..+++
T Consensus 160 ql~~~~~-rr~tfvGTPfwMAPEVI~~~~-------Y~~KADIWSLGITaiEla~-GePP~s~~hPmrvlflIpk~~PP~ 230 (467)
T KOG0201|consen 160 QLTNTVK-RRKTFVGTPFWMAPEVIKQSG-------YDTKADIWSLGITAIELAK-GEPPHSKLHPMRVLFLIPKSAPPR 230 (467)
T ss_pred eeechhh-ccccccccccccchhhhcccc-------ccchhhhhhhhHHHHHHhc-CCCCCcccCcceEEEeccCCCCCc
Confidence 6544433 346789999999999998655 8999999999999999998 999999999988777776665444
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+.. .+++.+++++..||..||+ ||++.+++
T Consensus 231 L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 231 LDG--DFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccc--ccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 443 8899999999999999998 99988775
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=382.60 Aligned_cols=279 Identities=33% Similarity=0.553 Sum_probs=243.3
Q ss_pred CCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCccee
Q psy7505 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNIL 153 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 153 (394)
.++ .|+++++++++.+.||+|.||.|++|..++...........||||+++......+...+..|+.+|+.+ +|+|||
T Consensus 287 ~~~-~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 287 EDP-KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred cCC-ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchh
Confidence 344 899999999999999999999999999886554332235689999999888777777788999999999 799999
Q ss_pred ceeeEEEeCCceEEEEeeCCCCCHHHHHhhcc---------hhhhh--hhhHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7505 154 RLMAACLESDPWLLVFESCSRGDLKEFLLSNE---------ASREA--LLEQGITIKMAIDVATGLSYMIEDGFIHTDVA 222 (394)
Q Consensus 154 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk 222 (394)
.++|+|..++.+++|+|||..|+|.+||+..+ ..... .+....++.++.|||.||+||+++++|||||.
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 99999999999999999999999999999876 11111 26777889999999999999999999999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccCCCCceeeeCCcc--CCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA--LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG 300 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~--~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g 300 (394)
.+|||+..+..+||+|||+|+......++...... .++.|||||.+.... |+.++|||||||+||||+|.|
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-------ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-------FTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-------ccccchhhHHHHHHHHHhhCC
Confidence 99999999999999999999987776766643332 578899999997754 899999999999999999999
Q ss_pred CCCCCCCC-HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 301 KLPYAELS-DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 301 ~~Pf~~~~-~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..||.+.. ..+++..+..|. |+..|..|+.+++++|+.||..+|+ ||++.++.+.+..++.
T Consensus 519 ~~PYp~~~~~~~l~~~l~~G~--r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 519 GTPYPGIPPTEELLEFLKEGN--RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 99999977 777777788887 9999999999999999999999998 9999999999888654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=343.14 Aligned_cols=256 Identities=32% Similarity=0.549 Sum_probs=210.4
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
++.+.||.|.||.||+|.++. ........|+||.++..........+.+|++.+++++||||++++|++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~---~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ---KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES---TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc---ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccc
Confidence 567889999999999999983 12245568999999776655545567799999999999999999999998888999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
|||||++|+|.++|..... ..+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999987611 1267778889999999999999999999999999999999999999999999876532
Q ss_pred Cce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCC
Q psy7505 248 GDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326 (394)
Q Consensus 248 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 326 (394)
... ........+..|+|||.+.... ++.++||||||+++|||++.|+.||.+....++..++..+. +++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--~~~~ 226 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGE-------YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--RLPI 226 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSE-------ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE--ETTS
T ss_pred cccccccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccc--ccee
Confidence 222 2233345677899999987765 78999999999999999986789999999999888887775 6778
Q ss_pred CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 327 PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 327 p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
+..++..+.+++.+||..+|+ ||++.+++..|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 889999999999999999998 99999998775
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.31 Aligned_cols=241 Identities=18% Similarity=0.283 Sum_probs=206.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
..++|++.+.||+|+||.||+|+++. ....||+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKG-------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35789999999999999999999873 34579999886543 2223344678999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+++.+|+||||+.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGR-----FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999999976533 5666677889999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++....... ....|++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..+
T Consensus 164 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~- 230 (329)
T PTZ00263 164 FAKKVPDRT----FTLCGTPEYLAPEVIQSKG-------HGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKILAG- 230 (329)
T ss_pred CceEcCCCc----ceecCChhhcCHHHHcCCC-------CCCcceeechHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-
Confidence 987543322 1346788999999987655 6789999999999999998 99999998888888888766
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
+++.|..++..+.+++++||+.||. |++
T Consensus 231 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 231 --RLKFPNWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred --CcCCCCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 5667788999999999999999998 775
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=338.18 Aligned_cols=253 Identities=20% Similarity=0.289 Sum_probs=212.7
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceece
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
....+..++|++++.||.|.-|+||+++.++ +....|+|++.+..-. ....+...|.+||+.++||.+..|
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~-------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTL 142 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRG-------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTL 142 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecC-------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchh
Confidence 3445667889999999999999999999985 3358899998776532 222344568899999999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
|..|+.+...|+|||||+||||..+.+++.. ..+++..+..++.+|+.||+|||-.|||+|||||+||||.++|++.
T Consensus 143 Ya~fet~~~~cl~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 143 YASFETDKYSCLVMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred hheeeccceeEEEEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEE
Confidence 9999999999999999999999999887643 3478888999999999999999999999999999999999999999
Q ss_pred EccCCCCccCCC---------------------------------C-c---------------------eeeeCCccCCc
Q psy7505 236 IGDTGSSIDKYP---------------------------------G-D---------------------YYVHGEVALPV 260 (394)
Q Consensus 236 l~DFG~a~~~~~---------------------------------~-~---------------------~~~~~~~~~t~ 260 (394)
|+||.++..... . . ..+.+..+||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998732100 0 0 01223457899
Q ss_pred ccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHh
Q psy7505 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARN 340 (394)
Q Consensus 261 ~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~ 340 (394)
.|+|||++.+.. .+.++|||+|||++|||+ ||..||.+.+..+.+..|+.. .+++|.-..++..+++||++
T Consensus 300 EYlAPEvI~G~G-------HgsAVDWWtfGIflYEmL-yG~TPFKG~~~~~Tl~NIv~~-~l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 300 EYLAPEVIRGEG-------HGSAVDWWTFGIFLYEML-YGTTPFKGSNNKETLRNIVGQ-PLKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred ccccceeeecCC-------CCchhhHHHHHHHHHHHH-hCCCCcCCCCchhhHHHHhcC-CCcCCCCCcchhHHHHHHHH
Confidence 999999999887 788999999999999999 699999999999999888755 35667666889999999999
Q ss_pred hhcCCcccc
Q psy7505 341 CLVTSELRV 349 (394)
Q Consensus 341 cl~~~p~r~ 349 (394)
+|..||.+|
T Consensus 371 LLvKdP~kR 379 (459)
T KOG0610|consen 371 LLVKDPSKR 379 (459)
T ss_pred HhccChhhh
Confidence 999999843
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=349.76 Aligned_cols=267 Identities=25% Similarity=0.406 Sum_probs=218.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|++.+.||+|+||.||+|++..... .....||+|.++..........+.+|+.+++.++||||++++|++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCC---ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 456789999999999999999999764221 12335899998765544444456789999999999999999999976
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+..++++||+++|+|.+++..... .++....+.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence 457899999999999999976532 256667788999999999999999999999999999999999999999999
Q ss_pred CccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++......... .....++..|+|||.+.... ++.++|||||||++|||+++|..||.+....++...+..+.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-------~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRI-------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCC-------CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC
Confidence 97654332211 12234467899999986654 78899999999999999977999999888777665555544
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
+++.+..++..+.+++.+||..+|. ||++.+++..|..+..+.
T Consensus 229 --~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 6777888999999999999999998 999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=341.48 Aligned_cols=270 Identities=35% Similarity=0.594 Sum_probs=218.7
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|.+..++|++.+.||+|+||.||+|.+++.... .....|++|.+...........+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCC--CceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 456788999999999999999999998653221 234579999886544333444567999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhh-----hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASR-----EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
..+...++||||+++|+|.+++....... ...+.+..+..++.|++.||.|||+++++||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 99899999999999999999997643210 1123456677889999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+|||+++........... ...++..|||||.+.+.. ++.++|||||||++|||++.|..||.+....+.+
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~ 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-------FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-------cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999998755443332222 224567899999987654 7889999999999999998678999998888877
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
..+..+. ..+.+..++..+.+++.+||+.+|+ ||++.|++..|++
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 7776664 3456778899999999999999998 9999999887753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=348.58 Aligned_cols=239 Identities=18% Similarity=0.298 Sum_probs=203.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.++++++||||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC
Confidence 468889999999999999999873 34579999886432 222334466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++...+. +++.....++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcc
Confidence 999999999999999999976533 566677789999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... ....|++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+
T Consensus 149 ~~~~~~~----~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~i~~~--- 213 (291)
T cd05612 149 KKLRDRT----WTLCGTPEYLAPEVIQSKG-------HNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAG--- 213 (291)
T ss_pred hhccCCc----ccccCChhhcCHHHHcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC---
Confidence 7543321 2346788999999987654 7889999999999999998 99999998888888888766
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
.+..|..++..+.+++++||+.||. |++
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 214 KLEFPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CcCCCccCCHHHHHHHHHHcCCCHHHccC
Confidence 4667778899999999999999998 874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=344.01 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=204.7
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEEEe----CCc
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAACLE----SDP 164 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~ 164 (394)
..||+|++|.||+|.+. +..||+|.++.... ......+.+|+.+|++++|||||+++|++.+ ...
T Consensus 26 ~~i~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred eEEeeCCceEEEEEEEC---------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 56999999999999875 34789998875432 2223456799999999999999999999977 346
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+++|||||++|+|.+++.+... +++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCCC-----CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 8999999999999999976532 56677788999999999999984 99999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
...... ....++..|+|||++.+.. ..++.++|||||||++|||++ |+.||.+.+..++...+..+. .+
T Consensus 172 ~~~~~~----~~~~~~~~y~aPE~~~~~~-----~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~-~~ 240 (283)
T PHA02988 172 ILSSPP----FKNVNFMVYFSYKMLNDIF-----SEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLIINKN-NS 240 (283)
T ss_pred hhcccc----ccccCcccccCHHHhhhcc-----ccccchhhhhHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcC-CC
Confidence 543221 1235677899999986521 127899999999999999998 999999998888877765443 25
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
++.|..++..+.+++.+||+.+|+ ||++.|++..|+.+.
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 666778999999999999999998 999999999888764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=353.06 Aligned_cols=253 Identities=17% Similarity=0.226 Sum_probs=199.7
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
....+|+.++.||+|+||.||+|+++. .+..||+|++...........+.+|+.+++.++|+||+++++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRP-------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECC-------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 345778888999999999999999863 3458999998765555555567799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+++|||||.+|+|.+... ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 144 ~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLEGTHI---------ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred CCeEEEEEecCCCCccccccc---------CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999999875421 23445667899999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD---DQVITRVFG 318 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~---~~~~~~i~~ 318 (394)
++...... .......|+..|+|||++..... .....+.++|||||||++|||++ |+.||..... ......+..
T Consensus 215 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~ 290 (353)
T PLN00034 215 SRILAQTM-DPCNSSVGTIAYMSPERINTDLN--HGAYDGYAGDIWSLGVSILEFYL-GRFPFGVGRQGDWASLMCAICM 290 (353)
T ss_pred ceeccccc-ccccccccCccccCccccccccc--cCcCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHHHHhc
Confidence 87543221 11223467889999998754321 11124578999999999999998 9999974332 223333333
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. ....+..++.++.++|++||..+|+ ||++.|++.
T Consensus 291 ~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 291 SQ--PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred cC--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 32 4455678899999999999999998 999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.54 Aligned_cols=261 Identities=29% Similarity=0.527 Sum_probs=218.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|++...+|.+.+.||+|+||.||+|.++. ....|++|.++..... ...+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 71 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEec-------CCceEEEEEecCCchH--HHHHHHHHHHHHhCCCCChhheEEEE
Confidence 46677889999999999999999999873 3457889987654322 23456899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
...+.++++|||+++|+|.+++..... ..+++.....++.|++.||.|||+++++||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 72 TREPPFYIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCC
Confidence 999999999999999999999976432 12566677889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++...............++..|+|||.+.+.. ++.++|||||||++|||+++|..||.+....+....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred ccccccccceeeccCCCCCccccCCHHHhccCC-------CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 998765443332222334456799999886554 7789999999999999997799999988887777777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +.+.|..++.++.+++.+||..+|+ ||++.++.+.|+.+
T Consensus 222 ~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 Y--RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred C--CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 4 5677888999999999999999998 99999999988765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.20 Aligned_cols=278 Identities=32% Similarity=0.558 Sum_probs=226.3
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
...|+++.++|.+.+.||+|+||.||+|++.+...........+|+|.++..........+.+|+.+++++ +|+||+++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 45678888999999999999999999999865443333344579999987654444444566899999999 89999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
++++...+..|+||||+++|+|.+++...... ....+++.....++.|++.||.|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999999764321 1123667778899999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||++............ ...++..|+|||.+.+.. ++.++|||||||++|||++.|..|
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-------YTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-------CCcHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999998654322211111 123346799999986654 788999999999999999768899
Q ss_pred CCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 304 f~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
|.+....++...+..+. +.+.|..++.++.+++++||..+|+ ||++.++++.|.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 243 YPGVPVEELFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CCcCCHHHHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 98888777777766554 5667788999999999999999997 9999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=355.37 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=222.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|..++.+|+|+||.+++++++. ....+++|.+.... ....+....+|+.++++++|||||.+.+.|..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 4678889999999999999999874 23378888876655 334444567999999999999999999999998
Q ss_pred Cc-eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 163 DP-WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 163 ~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+. ++|||+||+||+|.+.|.+.+ ...++++.+..++.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhh
Confidence 88 999999999999999998764 23478888999999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+...... ....+..||+.||.||++.+.. |+.|+|||||||++|||++ -+.+|.+.+...++.+|..+.
T Consensus 153 aK~l~~~~-~~a~tvvGTp~YmcPEil~d~p-------Yn~KSDiWsLGC~~yEm~~-lk~aF~a~~m~~Li~ki~~~~- 222 (426)
T KOG0589|consen 153 AKILNPED-SLASTVVGTPYYMCPEILSDIP-------YNEKSDIWSLGCCLYEMCT-LKPAFKASNMSELILKINRGL- 222 (426)
T ss_pred hhhcCCch-hhhheecCCCcccCHHHhCCCC-------CCccCcchhhcchHHHHHh-cccccCccchHHHHHHHhhcc-
Confidence 98775543 2345678999999999998776 8999999999999999998 899999999999999998875
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
-.|.|...+.++..+|+.|+..+|. ||++.+++..
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 5788999999999999999999998 9999999755
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=339.20 Aligned_cols=270 Identities=36% Similarity=0.637 Sum_probs=222.3
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|++..++|++.+.||+|+||.||+|.++.... +.....|++|.+...........+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVK--GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCC--CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 56788999999999999999999999874331 2334589999987665444445567899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhh-----hhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASRE-----ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
......++||||+++|+|.+++........ ..+.+..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 999999999999999999999976432111 124566778899999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+|||+++......... .....++..|+|||.+.... ++.++|||||||++|||++.|..||.+.+..+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-------FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-------CCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence 999999987554333221 22335577899999986554 7789999999999999997799999988888887
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
..+..+. ..+.|..++..+.+++++||+.+|+ ||++.++++.|++
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 7776554 5666778899999999999999998 9999999888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.88 Aligned_cols=277 Identities=30% Similarity=0.551 Sum_probs=226.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|.+..++|++.+.||+|+||.||+|++.+...........|++|..+..........+.+|+.+++.+ +||||++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 4577889999999999999999999998764333233344578999887654444445567999999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARN 225 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~N 225 (394)
+++...+..++||||+++|+|.+++...... ....++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999764221 01125666778899999999999999999999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
||++.++.+||+|||+++......... .....++..|+|||++.+.. ++.++|||||||++|||++.|..||
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-------YTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-------CCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999987553322221 12234566799999986654 7889999999999999998788999
Q ss_pred CCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+.+..++...+..+. +...+..++..+.+++.+||..+|+ ||++.|++..|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 241 PGIPVEELFKLLKEGH--RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ccCCHHHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 9988888888876665 5666788999999999999999998 9999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=351.20 Aligned_cols=241 Identities=20% Similarity=0.304 Sum_probs=201.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 168 (394)
+.||+|+||.||+|+.+. .+..+|+|+++... .......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEE
Confidence 369999999999999863 44589999887543 222334456899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCC
Q psy7505 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~ 248 (394)
|||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 999999999999976532 567777889999999999999999999999999999999999999999998653222
Q ss_pred ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC
Q psy7505 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 249 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~ 328 (394)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+...+...+..+ ....|.
T Consensus 149 ~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~---~~~~p~ 216 (323)
T cd05571 149 GA-TMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME---EIRFPR 216 (323)
T ss_pred CC-cccceecCccccChhhhcCCC-------CCccccCcccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC---CCCCCC
Confidence 11 122346889999999987654 7889999999999999998 99999988877777777655 456678
Q ss_pred CCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.++..+.+++++||..||+ |+ ++.+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence 8999999999999999998 88 566664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=335.50 Aligned_cols=262 Identities=31% Similarity=0.523 Sum_probs=219.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+++... .....|++|.++..........+.+|+.++++++||||+++++++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPG----KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCC----CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 567899999999999999999986421 2344789998876655555555678999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999999999976432 25677788999999999999999999999999999999999999999999987
Q ss_pred cCCC-CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 244 DKYP-GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 244 ~~~~-~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
.... ..........++..|+|||.+.... ++.++||||||+++|||++.|..||.+....++...+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-------~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-- 225 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRK-------FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-- 225 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCC-------CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--
Confidence 6531 1212222234567899999986554 78899999999999999977999999888888888777665
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+.+.+..++..+.+++++||+.+|+ ||++.++++.|+++.
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 5667788999999999999999998 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=340.03 Aligned_cols=274 Identities=34% Similarity=0.585 Sum_probs=222.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|++..++|++.+.||+|+||.||+|.++.... +.....||+|.++..........+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIK--GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCC--CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 56778999999999999999999998764221 1234478999876555433444466899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhh-----hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASR-----EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
.+.+..++||||+++|+|.+++....... ...........++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999997532110 0112445667889999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+|||+++........... ...++..|+|||.+.+.. ++.++|||||||++|||++.|..||.+....++.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-------~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-------FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCC-------CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999998755433322222 223466799999987654 7889999999999999998688999998888887
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+..+. ..+.+..+++.+.+++++||..+|+ ||++.|+++.|++....
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 232 KFVMDGG--YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 7777665 4556678889999999999999998 99999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=341.77 Aligned_cols=274 Identities=33% Similarity=0.572 Sum_probs=225.4
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|.+..++|++.+.||+|+||.||+|.++.... ......+++|.+...........+.+|+.+++++ +|+||++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN--PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCC--CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 4677889999999999999999999999874332 1233478899887655444444567899999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcch-----------hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEA-----------SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARN 225 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~N 225 (394)
+++..++.++++|||+++|+|.+++..... .....+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 999999999999999999999999975321 111236777888999999999999999999999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
||++.++.+||+|||+++.......... ....++..|+|||++.+.. ++.++|||||||++|||++.|..||
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~ 235 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-------YTHQSDVWSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-------cCcccceeehhhHHHHHhcCCCCCC
Confidence 9999999999999999876543332221 2223456799999886554 7889999999999999997799999
Q ss_pred CCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.+....++...+..+. ..+.+..++..+.+++.+||..+|+ ||++.|+++.|.+++
T Consensus 236 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 236 PGIPVEELFKLLKEGY--RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCHHHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9988888877776665 5667778899999999999999998 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=351.18 Aligned_cols=249 Identities=16% Similarity=0.253 Sum_probs=208.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++.+.||+|+||.||+|.++.. ....||+|.+.... .......+.+|+.+++.++|||||+++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNE------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECC------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 45568899999999999999999987631 22478999876433 22233446689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|+||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEec
Confidence 9999999999999999999999976533 56777788999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++....... ....||+.|||||++.+.. ++.++|||||||++|||++ |..||.+.+...+...+..
T Consensus 175 FG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~ 242 (340)
T PTZ00426 175 FGFAKVVDTRT----YTLCGTPEYIAPEILLNVG-------HGKAADWWTLGIFIYEILV-GCPPFYANEPLLIYQKILE 242 (340)
T ss_pred CCCCeecCCCc----ceecCChhhcCHHHHhCCC-------CCccccccchhhHHHHHhc-CCCCCCCCCHHHHHHHHhc
Confidence 99987543221 2346888999999987654 7889999999999999998 9999999888888888876
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
+ ....|..++..+.+++++||..+|+ |+ ++.++.
T Consensus 243 ~---~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 243 G---IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred C---CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 6 3456778899999999999999998 64 555554
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=339.87 Aligned_cols=267 Identities=39% Similarity=0.660 Sum_probs=219.0
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|.+.+.||+|+||.||+|.+..... ......|++|.++..........+.+|++++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEP--ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccC--cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45678889999999999999998764311 1234579999987766554445677999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhh---------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASR---------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
...++||||+++|+|.++|...+... ...+.+.....++.|++.|+.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999998653211 122566778889999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
+||+|||++......... ..+...+++.|+|||++.+.. ++.++|||||||++|||+++|..||.+....+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~ 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-------FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCC-------cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999998754332222 122334567899999987654 788999999999999999779999998888888
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
...+..+. ....+..++..+.+++++||+.+|+ ||++.|+++.|.+
T Consensus 234 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGR--LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCC--cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 87777664 3445668899999999999999998 9999999988863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=333.74 Aligned_cols=252 Identities=31% Similarity=0.544 Sum_probs=210.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+++++. ...+++|.++..... ...+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~--------~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA--------QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc--------CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 4678889999999999999998763 236888887644322 223568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++|+|.+++..... .+++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 99999999999999999975422 25677788899999999999999999999999999999999999999999987
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
..............++..|+|||.+.... ++.++||||||+++|||++.|+.||...+..+.+..+..+. +
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~--~ 219 (256)
T cd05114 149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSK-------YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--R 219 (256)
T ss_pred ccCCCceeccCCCCCchhhCChhhcccCc-------cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--C
Confidence 65433333223334567899999986554 78899999999999999976899999988888888887765 5
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
+..|...+..+.+++++||+.+|+ ||++.+++..|
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 566777889999999999999997 99999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=335.33 Aligned_cols=260 Identities=30% Similarity=0.531 Sum_probs=216.7
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|.+..++|++.++||+|+||.||+|...+ ...|++|.+...... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNN--------STKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecC--------CceEEEEEccCCchh--HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 56778999999999999999999998652 236888887654322 23466899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
...+..+++|||+++|+|.+++...... .++......++.|++.||.|||+++++||||||+||+++.++.+||+||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGG---KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCC
Confidence 9999999999999999999999754221 2456667788999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++...............++..|+|||.+.... ++.++|||||||++|||++.|..||.+....+....+..+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05072 148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-------FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220 (261)
T ss_pred ccceecCCCceeccCCCccceecCCHHHhccCC-------CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 998765433322222334567899999986554 6789999999999999997799999988888888777766
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +.+.+..++..+.+++.+||..+|+ ||++.++...|+.+
T Consensus 221 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 Y--RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C--CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 4 5666778899999999999999998 99999999888764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.93 Aligned_cols=275 Identities=31% Similarity=0.533 Sum_probs=221.6
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-Ccceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l 155 (394)
...|+++.++|.+.+.||+|+||.||+|++++.... .....||+|+++..........+.+|+.+|.++. |||||++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHS--QSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCC--CCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 346899999999999999999999999998743211 2345799999986654444445679999999997 9999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh------------------------------------------------
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS------------------------------------------------ 187 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------------------------------------ 187 (394)
++++...+.+++|||||++|+|.++|+..+..
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 99999999999999999999999999764310
Q ss_pred ---------------------------------------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7505 188 ---------------------------------------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVA 222 (394)
Q Consensus 188 ---------------------------------------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk 222 (394)
....+++...+.++.|++.||.|||+++|+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 00123455677889999999999999999999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
|+|||++.++.+||+|||+++....... .......++..|||||.+.... ++.++|||||||++|||++.|.
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslGvil~e~l~~g~ 339 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-------YTTLSDVWSFGILLWEIFTLGG 339 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-------CCcHhHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999875432221 1122335677899999986554 7889999999999999997688
Q ss_pred CCCCCCCHHHHHHH-HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 302 LPYAELSDDQVITR-VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 302 ~Pf~~~~~~~~~~~-i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.||......+.... +..+. +++.|..++.++.+++.+||..+|. ||++.|++..|..+.
T Consensus 340 ~P~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 340 TPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCCchHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99988765554433 44443 5667788999999999999999998 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=336.03 Aligned_cols=262 Identities=38% Similarity=0.721 Sum_probs=205.5
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEee
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFES 171 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 171 (394)
+||+|+||+||+|..... .....+++|.+...........+.+|+.+++.++|+||+++++.+...+.+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecC-----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 589999999999976532 234578888876555444455567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCcee
Q psy7505 172 CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251 (394)
Q Consensus 172 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~ 251 (394)
+++|+|.+++............+.....++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999999997754322222345667789999999999999999999999999999999999999999998654333322
Q ss_pred e-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCC---C
Q psy7505 252 V-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA---P 327 (394)
Q Consensus 252 ~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---p 327 (394)
. .....++..|+|||++...........++.++|||||||++|||++.|..||....+.+.+..+.......++. +
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 2 22334567899999986533222233478899999999999999986889999888777766665554334433 3
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
..++..+.++++.||. +|+ ||++.||.+.|.
T Consensus 237 ~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYEVMQFCWL-DPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHHHHHHHhc-CcccccCHHHHHHHhc
Confidence 4678889999999995 887 999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=343.21 Aligned_cols=277 Identities=31% Similarity=0.557 Sum_probs=225.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|.++.++|++.+.||+|+||.||+|+..+...........+++|.++..........+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 4678889999999999999999999998764333222344578899887655444444567899999999 699999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcch-----------hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEA-----------SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARN 225 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~N 225 (394)
+++...+.++++|||+++|+|.+++..... .....+++.....++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 999988899999999999999999976421 011236677788899999999999999999999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
||++.++.+||+|||+++......... .....++..|||||.+.... ++.++|||||||++|||++.|..||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-------YTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-------cCccchhhHHHHHHHHHHhCCCCCC
Confidence 999999999999999997553322211 11123345799999986554 7889999999999999998789999
Q ss_pred CCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+....++...+..+. ....+..++..+.+++.+||..+|+ ||++.|+++.|.++..
T Consensus 238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 238 PGIPVEELFKLLREGH--RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 9988888887776664 4566778899999999999999998 9999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.04 Aligned_cols=235 Identities=20% Similarity=0.271 Sum_probs=198.4
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||+|+||.||+|+++. ....||+|.++... .......+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEc
Confidence 7999999999999873 34578999886532 22333445689999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++...+. +++.....++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 74 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQREGR-----FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 9999999999976532 56677788999999999999999999999999999999999999999999875332221
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAV 330 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~ 330 (394)
......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..+ .+..|..+
T Consensus 149 -~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 216 (312)
T cd05585 149 -KTNTFCGTPEYLAPELLLGHG-------YTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKILQE---PLRFPDGF 216 (312)
T ss_pred -ccccccCCcccCCHHHHcCCC-------CCCccceechhHHHHHHHh-CCCCcCCCCHHHHHHHHHcC---CCCCCCcC
Confidence 223456889999999987654 7889999999999999998 99999998888888877765 45667889
Q ss_pred ChHHHHHHHhhhcCCcc-ccch
Q psy7505 331 NSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 331 ~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
++.+.+++.+||..+|+ |+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCC
Confidence 99999999999999998 8764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=345.99 Aligned_cols=277 Identities=31% Similarity=0.541 Sum_probs=227.0
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|++...+|++.+.||+|+||.||+|++.+..+........|++|.++..........+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 5788888999999999999999999998765443333334478999887655444445567899999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcch-----------hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEA-----------SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARN 225 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~N 225 (394)
+++...+.++++|||+++|+|.++|..... .....+.+..++.++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 999999999999999999999999976421 112235667778899999999999999999999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
||++.++.+||+|||+++.......... ....++..|+|||++.... ++.++|||||||++|||++.|..||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-------YTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-------cCchhhhHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999875433222211 1223356799999986654 7889999999999999997789999
Q ss_pred CCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+.+..+....+..+. ..+.+..++.++.+++++||..+|+ ||++.|++..|.++..
T Consensus 238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 238 PGIPVEELFKLLKEGH--RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 9988888887776654 5566778899999999999999998 9999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=359.97 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=221.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
|++.+.++..||.|+||+||+|..+ .+....|.|++.... ..+...++-|+.||..++||+||+|++.|+..
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nk-------et~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNK-------ETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcc-------cchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 3566778889999999999999887 233345566664443 34444566899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+||+.|||.||.++..+.+.+. .+.+..+..+++|++.||.|||+++|||||||.-|||++.+|.++|+|||.+
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccc
Confidence 999999999999999998876543 3788888899999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
..... .......+.||+.|||||+..+.. ++..+|+.++||||||++|.||.. +.+|..+.++..++-+|.+.+++
T Consensus 178 AKn~~-t~qkRDsFIGTPYWMAPEVvmCET--~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRVllKiaKSePP 253 (1187)
T KOG0579|consen 178 AKNKS-TRQKRDSFIGTPYWMAPEVVMCET--FKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPP 253 (1187)
T ss_pred ccchh-HHhhhccccCCcccccchheeecc--ccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHHHHHHhhcCCC
Confidence 54322 223345678999999999999876 445569999999999999999997 99999999999999999999988
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+-.|..++..+.+++.+||..||. ||++++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 8999999999999999999999998 99988775
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=345.50 Aligned_cols=241 Identities=19% Similarity=0.306 Sum_probs=200.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 168 (394)
+.||+|+||.||+++.+. .+..||+|+++... .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEE
Confidence 369999999999999863 45589999887543 222334456899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCC
Q psy7505 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~ 248 (394)
|||+++|+|..++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 74 ~E~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 999999999998876532 567778889999999999999999999999999999999999999999988653222
Q ss_pred ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC
Q psy7505 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 249 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~ 328 (394)
.. ......|++.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+..+ ....|.
T Consensus 149 ~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~~~~~---~~~~p~ 216 (323)
T cd05595 149 GA-TMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME---EIRFPR 216 (323)
T ss_pred CC-ccccccCCcCcCCcccccCCC-------CCchhchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCC
Confidence 21 122346888999999987654 7889999999999999998 99999988887777776654 345677
Q ss_pred CCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.+++++.+++++||..+|+ |+ ++.+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l 249 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 249 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHH
Confidence 8999999999999999998 76 565554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.33 Aligned_cols=266 Identities=31% Similarity=0.557 Sum_probs=216.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+..+|++.+.||+|+||.||+|.+..... .....+++|.++..........+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGM---DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCC---CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45778999999999999999998642211 234578899887554444445567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchh------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEAS------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
+..|+||||+++|+|.+++...... ....+++.....++.|++.||.|||+++|+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998643210 0122566777889999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
++.+||+|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++.|..||.+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-------FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCC-------CCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999875433322 1222334567799999986554 788999999999999999779999998888
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
.++...+..+. .++.+..+++.+.+++.+||+.+|+ ||++.++...|.+
T Consensus 233 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQ--LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 77777776654 5667788999999999999999998 9999999888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=336.79 Aligned_cols=270 Identities=36% Similarity=0.631 Sum_probs=220.2
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+.+++|.+.+.||+|+||+||++....... ......+++|.+...... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~--~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCP--EQDKILVAVKTLKDASDN-ARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCC--CCcceEEEEEecCCcCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 457889999999999999999998653211 123346788887654433 33446689999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchh--------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEAS--------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
.+.+++||||+++|+|.+++...+.. ....+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 99999999999999999999765321 1122677788899999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
+||+|||++.......... .....++..|+|||++.+.. ++.++|||||||++|||++.|..||......+.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~ 231 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-------FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999987553332222 22234567899999986554 788999999999999999768999999888888
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+..+..+. ..+.+..++..+.+++.+||+.+|. ||++.++...|+++..
T Consensus 232 ~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 232 IECITQGR--VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHHcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 88887765 3455677899999999999999998 9999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=349.66 Aligned_cols=252 Identities=18% Similarity=0.283 Sum_probs=202.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|+++. +...+|+|+++... .......+.+|+.++++++|+||+++++.+.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 478899999999999999999873 45589999986543 222334566899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKKDT-----LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCc
Confidence 999999999999999999976532 567778889999999999999999999999999999999999999999998
Q ss_pred ccCCCCce----------------------------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHH
Q psy7505 243 IDKYPGDY----------------------------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWS 288 (394)
Q Consensus 243 ~~~~~~~~----------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwS 288 (394)
+....... ......+||+.|+|||++.+.. ++.++||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------~~~~~DvwS 221 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-------YNKLCDWWS 221 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-------CCCchhhhh
Confidence 64321100 0012347899999999987654 788999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCcCCCCCCCCChHHHHHHHhhhcCC--c-cccchhhhhh
Q psy7505 289 FGVLLWEIFEFGKLPYAELSDDQVITRVFGT-EALRLPAPRAVNSHVDVAARNCLVTS--E-LRVKIGDTGS 356 (394)
Q Consensus 289 lG~il~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~p~~~~~~~~~l~~~cl~~~--p-~r~~~~e~~~ 356 (394)
|||++|||++ |..||.+.+..+...++... ....+|....+++++.+++.+++... + .||++.|+..
T Consensus 222 lGvil~ell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 222 LGVIMYEMLI-GYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred hHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 9999999998 99999998888888877653 22234433457889999998865532 2 2578888754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=348.06 Aligned_cols=273 Identities=32% Similarity=0.568 Sum_probs=217.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
|.++.++|++.+.||+|+||.||+|.+.+.... .+...||+|+++..........+..|+.+++++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKS--ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccc--cccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 788899999999999999999999987543221 234589999987655444444456899999999 89999999998
Q ss_pred EEe-CCceEEEEeeCCCCCHHHHHhhcchh--------------------------------------------------
Q psy7505 159 CLE-SDPWLLVFESCSRGDLKEFLLSNEAS-------------------------------------------------- 187 (394)
Q Consensus 159 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~-------------------------------------------------- 187 (394)
|.. +..++++|||+++|+|.++|......
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 864 45789999999999999998653210
Q ss_pred ------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCcee-eeCCccCCc
Q psy7505 188 ------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPV 260 (394)
Q Consensus 188 ------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~ 260 (394)
....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++........ ..+...++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 0113567778899999999999999999999999999999999999999999998765333222 122335567
Q ss_pred ccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhcCCCcCCCCCCCCChHHHHHHH
Q psy7505 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI-TRVFGTEALRLPAPRAVNSHVDVAAR 339 (394)
Q Consensus 261 ~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~p~~~~~~~~~l~~ 339 (394)
.|+|||++.+.. ++.++|||||||++|||++.|..||.+....+.+ ..+..+. +...|..+++++.+++.
T Consensus 240 ~y~aPE~~~~~~-------~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ 310 (337)
T cd05054 240 KWMAPESIFDKV-------YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--RMRAPEYATPEIYSIML 310 (337)
T ss_pred cccCcHHhcCCC-------CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--CCCCCccCCHHHHHHHH
Confidence 899999987655 7889999999999999997699999876544433 3333333 55567788999999999
Q ss_pred hhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 340 NCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 340 ~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+||+.+|+ ||++.|++..|..++.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999998 9999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=337.49 Aligned_cols=243 Identities=19% Similarity=0.284 Sum_probs=196.4
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.|+..+.||+|+||.||+|.++. ....||+|.+.... .......+.+|+.++++++|+||+++++++.+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec-------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC
Confidence 36778999999999999999873 34589999876543 1222334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++|||||++|+|.+++..... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 99999999999999988864321 125677788899999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD----QVITRVFGT 319 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~----~~~~~i~~~ 319 (394)
....... .....|+..|||||++.+.. ++.++|||||||++|||++ |+.||.+.... ++...+...
T Consensus 151 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05631 151 QIPEGET--VRGRVGTVGYMAPEVINNEK-------YTFSPDWWGLGCLIYEMIQ-GQSPFRKRKERVKREEVDRRVKED 220 (285)
T ss_pred EcCCCCe--ecCCCCCCCccCHhhhcCCC-------CCcccCchhHHHHHHHHHh-CCCCCCCCCcchhHHHHHHHhhcc
Confidence 5432221 22346788999999987654 7889999999999999998 99999876542 222223222
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
....+..++..+.+++++||..+|+ |+++
T Consensus 221 ---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 221 ---QEEYSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred ---cccCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 4456678899999999999999998 8873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=345.60 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=201.1
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 168 (394)
+.||+|+||.||+++.+. .+..||+|++.... .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEE
Confidence 368999999999999863 45589999987543 223334556899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCC
Q psy7505 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~ 248 (394)
|||+++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~Ey~~~g~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRERV-----FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 999999999998865432 567777889999999999999999999999999999999999999999998653222
Q ss_pred ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC
Q psy7505 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 249 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~ 328 (394)
. .......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|.
T Consensus 149 ~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~---~~~~p~ 216 (328)
T cd05593 149 A-ATMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME---DIKFPR 216 (328)
T ss_pred c-cccccccCCcCccChhhhcCCC-------CCccCCccccchHHHHHhh-CCCCCCCCCHHHHHHHhccC---CccCCC
Confidence 1 1122346889999999987654 7889999999999999998 99999988887777776554 456778
Q ss_pred CCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.++..+.+++++||..+|+ |+ ++.+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 8999999999999999998 75 666665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.59 Aligned_cols=260 Identities=30% Similarity=0.512 Sum_probs=216.3
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|++.+++|++.+.||+|+||.||+|.+.+ ...|++|.++..... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN--------TTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVC 70 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecC--------CeEEEEEeeCCCccc--HHHHHHHHHHHHHCCCCCccceeEEE
Confidence 46778999999999999999999998752 236889988654322 22356899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
...+.+++||||+++|+|.+++..... ..+++.....++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~df 147 (261)
T cd05068 71 TLEEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADF 147 (261)
T ss_pred ecCCCeeeeeecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCc
Confidence 999999999999999999999976431 12567778899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++................+..|+|||.+.... ++.++||||||+++|||++.|+.||.+....+++..+..+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-------FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred ceEEEccCCcccccCCCcCceeccCccccccCC-------CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 998755432221111223345799999886554 7889999999999999997799999998888888777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +++.+..++..+.+++.+||..+|+ ||++.++...|+.+
T Consensus 221 ~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 Y--RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C--CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 4 5667778899999999999999997 99999999988764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=330.34 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=203.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
-++|+.+..|++|+||.||+|+++ .+...||+|.++.+.. ..--...++|+.++.+++|||||.+-.+...
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk-------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDK-------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccC-------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 467888999999999999999988 4556899999887652 1111223699999999999999999998874
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
-+.+|||||||.. ||..+|...+. .+....+..++.|+++|+.|||.+.|+|||||++|+|+++.|.+||+|||
T Consensus 148 ~~d~iy~VMe~~Eh-DLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEH-DLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred ccceeeeeHHHHHh-hHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccc
Confidence 3569999999987 99999976542 26677888899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT- 319 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~- 319 (394)
+|+...... ...+..+.|.+|.|||++.+... |+.++||||+|||+.||++ +++-|.+.+..+.+.+|+..
T Consensus 223 LAR~ygsp~-k~~T~lVVTLWYRaPELLLG~~t------yst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 223 LAREYGSPL-KPYTPLVVTLWYRAPELLLGAKT------YSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred hhhhhcCCc-ccCcceEEEeeecCHHHhcCCcc------cCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHHHHHHHHh
Confidence 998765432 22334577999999999998774 9999999999999999998 99999999887777666431
Q ss_pred -CCc--------CCC------C------------CC-CCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 320 -EAL--------RLP------A------------PR-AVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 320 -~~~--------~~~------~------------p~-~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+- .+| + +. .+++.-.+++..+|..||+ |-|+.|-+
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 110 001 1 11 2567888999999999998 77887753
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.42 Aligned_cols=265 Identities=26% Similarity=0.441 Sum_probs=214.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|++.+.||+|+||+||+|.+..... ....++++|.............+..|+..+++++||||+++++++. +
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGD---SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCC---ceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 45778889999999999999999863221 1223578888765443333344567888899999999999999875 4
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
...++++||+++|+|.+++..... .+++.....++.||+.||.|||+++++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 567899999999999999975432 2567778889999999999999999999999999999999999999999998
Q ss_pred ccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 243 IDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 243 ~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+....... .......++..|+|||.+.... ++.++|||||||++|||+++|..||.+....++...+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-------~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~- 228 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGR-------YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE- 228 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCC-------cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-
Confidence 75433221 1222345677899999986654 78899999999999999977999999888777666666555
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+++.+..++..+.+++.+||..+|. ||++.|+...|..+..+
T Consensus 229 -~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 -RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 5666778889999999999999998 99999999988887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=350.93 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=211.2
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...+..++|++.+.||+|+||.||+|+++. ....+|+|.+.... .......+.+|+.+++.++||||++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~ 109 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKS-------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 344567899999999999999999999873 45589999886432 223334466899999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+++.+|+|||||++|+|.+++.... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~------l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL 183 (370)
T cd05596 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYD------IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183 (370)
T ss_pred EEEecCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999986542 456667788999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...............||+.|||||++..... ...++.++|||||||++|||++ |..||.+.+....+..+
T Consensus 184 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i 259 (370)
T cd05596 184 ADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG---DGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKI 259 (370)
T ss_pred EeccceeeccCCCcccCCCCCCCcCeECHHHhccCCC---CCCCCCceeeeehhHHHHHHHh-CCCCcCCCCHHHHHHHH
Confidence 9999987543332222334578999999999865421 1127889999999999999998 99999998887777777
Q ss_pred hcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc---ccchhhhhh
Q psy7505 317 FGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL---RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~---r~~~~e~~~ 356 (394)
..+. ...++....++.++.+++++||..+|+ |+++.|++.
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 260 MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 6542 233444446899999999999998886 668888753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=345.66 Aligned_cols=248 Identities=18% Similarity=0.243 Sum_probs=204.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.+|++.+.||+|+||.||+|+++. ....||+|+++.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence 368899999999999999999873 345899999875431 22333466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+||||||+++|+|.+++...+. +.+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLGV-----LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 999999999999999999976532 566777889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA- 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~- 321 (394)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.....
T Consensus 149 ~~~~~----~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 216 (333)
T cd05600 149 KGIVT----YANSVVGSPDYMAPEVLRGKG-------YDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKYWKET 216 (333)
T ss_pred ccccc----ccCCcccCccccChhHhcCCC-------CCCccceecchHHHhhhhh-CCCCCCCCCHHHHHHHHHhcccc
Confidence 65432 223456888999999987654 7889999999999999998 9999999888777666654321
Q ss_pred cCCCCC----CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+.. ..++.++.+++++||..+|+ |+++.+++.
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 111211 15689999999999998887 778888864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=337.16 Aligned_cols=266 Identities=31% Similarity=0.594 Sum_probs=217.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|.+.+.||+|+||.||+|++.+... ......||+|.++..........+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAP--GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCC--CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 3557778899999999999998764321 12345799999876655444455778999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcch-----------hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEA-----------SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~ 232 (394)
..++++||+.+++|.+++..... .....++...+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999999853211 0011256667788999999999999999999999999999999999
Q ss_pred eEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
.+||+|||+++........ ..+...+++.|+|||.+.... ++.++|||||||++|||++.|..||.+....+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-------FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-------CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999998755333221 223334567899999986554 78899999999999999987899999988888
Q ss_pred HHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 312 VITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 312 ~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
++..+..+. ..+.+..++..+.+++..||+.+|+ ||++.+++..|+.
T Consensus 235 ~~~~i~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQ--VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCC--cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 888887765 4566788999999999999999998 9999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=351.47 Aligned_cols=251 Identities=19% Similarity=0.299 Sum_probs=200.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.|++++.||+|+||+||+|+++. ++..+|+|++.... .......+.+|+.++++++|+|||++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD-------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence 57889999999999999999873 45589999986543 2333445678999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|+|||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRMEV-----FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 99999999999999999976532 5666777889999999999999999999999999999999999999999875
Q ss_pred cCCCCc---e-------------------------------------------eeeCCccCCcccccccccccCCCCccc
Q psy7505 244 DKYPGD---Y-------------------------------------------YVHGEVALPVRWCAPESLLCSDTSIQT 277 (394)
Q Consensus 244 ~~~~~~---~-------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~ 277 (394)
...... . .......||..|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----- 224 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG----- 224 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-----
Confidence 321000 0 0012346899999999987654
Q ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCcCCCCCCCCChHHHHHHHhhhc--CCcc-ccchhh
Q psy7505 278 CTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT-EALRLPAPRAVNSHVDVAARNCLV--TSEL-RVKIGD 353 (394)
Q Consensus 278 ~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~p~~~~~~~~~l~~~cl~--~~p~-r~~~~e 353 (394)
++.++|||||||++|||++ |..||......+....+... ....++....+++++.+++.+++. .++. |+++.|
T Consensus 225 --~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 225 --YTQLCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred --CCCccceeehhhHHHHHHh-CCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 7889999999999999998 99999988776665555432 223445455789999999998544 4443 788888
Q ss_pred hhh
Q psy7505 354 TGS 356 (394)
Q Consensus 354 ~~~ 356 (394)
++.
T Consensus 302 ~l~ 304 (381)
T cd05626 302 IKA 304 (381)
T ss_pred Hhc
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=329.09 Aligned_cols=253 Identities=32% Similarity=0.571 Sum_probs=210.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|++++ ...+++|.++..... ...+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~--------~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG--------QYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC--------CCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4678999999999999999998763 225889987654321 233568999999999999999999999888
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||+.+|+|.+++..... .+.+..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.++
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccce
Confidence 99999999999999999976432 25677788999999999999999999999999999999999999999999887
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
..............++..|++||.+.+.. ++.++|||||||++|||++.|..||......++...+..+. +
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-------~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--~ 219 (256)
T cd05113 149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSK-------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL--R 219 (256)
T ss_pred ecCCCceeecCCCccChhhCCHHHHhcCc-------ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC--C
Confidence 55443332222334567899999986554 78899999999999999977999999888888877777665 5
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
...+...++.+.+++.+||..+|. ||++.+++..|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 556677889999999999999997 999999987763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=336.25 Aligned_cols=267 Identities=33% Similarity=0.520 Sum_probs=216.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
+|++.+.||+|+||.||+|+........ ....+++|.+...........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRA--GYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCC--cceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4677889999999999999876432211 22368888887655444445567899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchh-------------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7505 166 LLVFESCSRGDLKEFLLSNEAS-------------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNC 226 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~Ni 226 (394)
+++|||+.+|+|.+++...... ....+++...+.++.|++.||.|||+++++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998753211 012256777889999999999999999999999999999
Q ss_pred EEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q psy7505 227 LVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305 (394)
Q Consensus 227 Ll~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~ 305 (394)
|+++++.+||+|||+++.......+. .....++..|+|||.+.... ++.++|||||||++|||+++|..||.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-------~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-------YTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-------cchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999987543322211 12234567899999886554 78899999999999999977999999
Q ss_pred CCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 306 ELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 306 ~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+....++...+..+. +.+.+..++..+.+++..||+.+|+ ||++.+++..|+++..
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 232 GIAPERLFNLLKTGY--RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCHHHHHHHHhCCC--CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 988888777766554 6667888999999999999999998 9999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=330.76 Aligned_cols=263 Identities=40% Similarity=0.696 Sum_probs=202.3
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|.+.+. .....+++|.++..........+.+|+.++++++||||+++++++.+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-----YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCC-----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 3589999999999987531 23457888888765544444456789999999999999999999998889999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++...........++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++........
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 99999999999764322112234556678899999999999999999999999999999999999999999865433332
Q ss_pred eee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC-
Q psy7505 251 YVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR- 328 (394)
Q Consensus 251 ~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~- 328 (394)
... ....++..|+|||++...........++.++|||||||++|||++.|..||......+.......+...+++.|.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 222 234567789999998643211111226789999999999999996699999888777765554444433444433
Q ss_pred --CCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 329 --AVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 329 --~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
..++.+.++|++|| .+|+ ||++.|+...|.
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 56788999999999 5787 999999987663
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=349.88 Aligned_cols=250 Identities=17% Similarity=0.304 Sum_probs=202.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence 478899999999999999999873 34589999987543 223334466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKDT-----FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccc
Confidence 999999999999999999976532 567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCcee-------------------------------------eeCCccCCcccccccccccCCCCcccCCCCcchh
Q psy7505 243 IDKYPGDYY-------------------------------------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCN 285 (394)
Q Consensus 243 ~~~~~~~~~-------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~D 285 (394)
......... ......||+.|+|||++.... ++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~D 221 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-------YNKECD 221 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-------CCCeee
Confidence 643211000 011235899999999986654 788999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc-ccc---hhhhh
Q psy7505 286 VWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL-RVK---IGDTG 355 (394)
Q Consensus 286 iwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~---~~e~~ 355 (394)
||||||++|||++ |..||.+.+..+....+.... ....+....+++.+.+++++|+. +|. |++ +.|++
T Consensus 222 iwSlG~il~el~~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 222 WWSLGVIMYEMLV-GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred eecchhHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 9999999999998 999999988887777776532 22333334678999999999997 665 887 66664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=332.75 Aligned_cols=267 Identities=36% Similarity=0.608 Sum_probs=216.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+|.++.... ......|++|.............+.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDG--DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCC--CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 346789999999999999999999874211 113457888887755544444556789999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchh--hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---eEEE
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEAS--REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL---RVKI 236 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~---~vKl 236 (394)
.+..++||||+++|+|.+++...+.. ....+++..++.++.||+.||.|||+++++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 89999999999999999999765321 112367778889999999999999999999999999999998764 6999
Q ss_pred ccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
+|||+++........... ....+..|+|||++.... ++.++|||||||++|||++.|..||.+.+..++...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-------FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-------cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999998765332222211 223356799999986554 789999999999999999769999999888887777
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+..+. +...|..++..+.+++++||+.+|+ ||++.++++.|+
T Consensus 234 ~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGG--RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 76654 5566788999999999999999998 999999988875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=343.20 Aligned_cols=238 Identities=20% Similarity=0.307 Sum_probs=197.9
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+++..... .....||+|+++... .......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccC----CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence 57999999999999865321 245589999887543 22223345689999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. +.+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 78 ILEYLSGGELFMHLEREGI-----FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred EEeCCCCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999999999976543 45566677899999999999999999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......|++.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+.+..+..+ ....|
T Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-G~~pf~~~~~~~~~~~~~~~---~~~~~ 220 (323)
T cd05584 153 EGT-VTHTFCGTIEYMAPEILMRSG-------HGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKILKG---KLNLP 220 (323)
T ss_pred CCC-cccccCCCccccChhhccCCC-------CCCcceecccHHHHHHHhc-CCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence 221 122346889999999987654 6789999999999999998 99999998888888887766 46677
Q ss_pred CCCChHHHHHHHhhhcCCcc-cc
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RV 349 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~ 349 (394)
..++..+.+++++||+.+|+ |+
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~ 243 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRL 243 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcC
Confidence 88999999999999999998 77
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=341.36 Aligned_cols=238 Identities=23% Similarity=0.376 Sum_probs=195.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhcc-CCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRR-LRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. +...||+|.++... ..........|..++.. .+||||+++++++..++.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 369999999999999873 34579999887543 11222233456666654 489999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. +++.....++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 74 v~e~~~gg~L~~~~~~~~~-----~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSGR-----FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 9999999999999876532 56667788999999999999999999999999999999999999999999865432
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
.. .......||..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+++..+... ....|
T Consensus 149 ~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~---~~~~~ 216 (316)
T cd05592 149 GE-GKASTFCGTPDYIAPEILKGQK-------YNESVDWWSFGVLLYEMLI-GQSPFHGEDEDELFDSILND---RPHFP 216 (316)
T ss_pred CC-CccccccCCccccCHHHHcCCC-------CCCcccchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence 22 2223457889999999987654 7889999999999999998 99999999888888777654 45567
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
..++.++.+++++||..+|+ |+++.
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 78999999999999999998 88875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=320.15 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=207.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|.|+.|+++.++ .++...++|++.... .....+.+.+|+.|.+.|+|||||+|++.+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~-------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc-------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 577888899999999999988776 455667777665433 222334467999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~vKl~DF 239 (394)
...|||+|+|.||+|..-|-.. ...++..+-.++.||+.+|.|+|.++|||||+||+|+|+.+. .-+||+||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeeccc
Confidence 9999999999999998655432 235677778899999999999999999999999999999654 35999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+|.....+ .......||+.|||||++.... |+..+|||+.||+||-|+. |.+||.+.+...++++|..|
T Consensus 158 GvAi~l~~g--~~~~G~~GtP~fmaPEvvrkdp-------y~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 158 GLAIEVNDG--EAWHGFAGTPGYLSPEVLKKDP-------YSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred ceEEEeCCc--cccccccCCCcccCHHHhhcCC-------CCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhcc
Confidence 999877633 2445678999999999987766 8999999999999999997 99999999999999999887
Q ss_pred CCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 320 EALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 320 ~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
.. .++ .-..+++++++|+++||..||. |.|+.|.
T Consensus 228 ~y-d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 228 AY-DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred cc-CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 53 333 3458999999999999999997 8887664
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=331.17 Aligned_cols=267 Identities=27% Similarity=0.413 Sum_probs=216.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+|++..... .....||+|.++..........+.+|+.+++.++|+||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGE---NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCC---ccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 346789999999999999999999763221 11235889998765554444556789999999999999999999975
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
...+++|||+++|+|.++++.... .+++...+.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence 457899999999999999976422 256677888999999999999999999999999999999999999999999
Q ss_pred CccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++......... .....++..|+|||.+.+.. ++.++|||||||++|||+++|..||......++...+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRR-------FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCC-------CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 87553322211 11223466799999986654 78899999999999999987999999887777766666654
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
..+.+..++..+.+++.+||..+|+ ||++.|++..|..+..+.
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 --RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 5566778999999999999999998 999999999988876553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=329.40 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=215.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|+++... .....+++|.++..........+.+|+.++++++||||+++++++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPG----KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCC----CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 467888999999999999999875321 2234688898876554444556778999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||+++|+|.+++..... .++......++.|++.||.|||+++++||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 99999999999999999976432 25666778899999999999999999999999999999999999999999987
Q ss_pred cCCCCceeee--CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 244 DKYPGDYYVH--GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 244 ~~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
.......... ....++..|+|||.+.+.. ++.++|+|||||++||+++.|..||.+....+....+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-------~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~- 226 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY- 226 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCc-------cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-
Confidence 5533222111 1123356799999986654 78899999999999998866999999888777777777664
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+.+.+..+++.+.+++.+||+.+|. ||++.+++..|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 6677778899999999999999998 99999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=327.21 Aligned_cols=250 Identities=30% Similarity=0.536 Sum_probs=205.8
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+||+|+||.||+|.++.. .....+++|+++... .......+.+|+.+++.++|+||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-----KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecC-----CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 589999999999987532 234578999886544 2333445678999999999999999999885 457899999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... +++.....++.|++.||.|||++||+||||||.|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 76 LAELGPLNKFLQKNKH-----VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred cCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 9999999999975432 56777889999999999999999999999999999999999999999999876533322
Q ss_pred ee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC
Q psy7505 251 YV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 251 ~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~ 328 (394)
.. .....++..|+|||.+.... ++.++|||||||++|||++.|..||.+....++...+..+. +++.|.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--~~~~~~ 221 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYK-------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--RMECPQ 221 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCC-------cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--CCCCCC
Confidence 11 11223457899999886544 67899999999999999976999999988888888887665 567778
Q ss_pred CCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
.++.++.++|++||+.+|+ ||++.+|...|+.+
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 8999999999999999998 99999999888764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=356.49 Aligned_cols=254 Identities=17% Similarity=0.196 Sum_probs=209.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
...|.+.+.||+|+||.||+|..... ....|++|.+.... ......+.+|+.+++.++|||||++++++..++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~------~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSD------PKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCC------CCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 34599999999999999999987531 13467777664433 233345668999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+||||||+++|+|.++|...... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 999999999999999988653211 1125667778899999999999999999999999999999999999999999987
Q ss_pred cCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 244 DKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 244 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... ......+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+++..+..+.
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~el~t-g~~Pf~~~~~~~~~~~~~~~~-- 287 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKR-------YSKKADMWSLGVILYELLT-LHRPFKGPSQREIMQQVLYGK-- 287 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCC-------CCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC--
Confidence 5433221 1233456899999999987654 7889999999999999998 999999988888888887765
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..+.|..++..+.+++.+||..+|+ ||++.+++
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 4456778899999999999999998 99988875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=339.59 Aligned_cols=250 Identities=18% Similarity=0.261 Sum_probs=202.5
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+++++. ....+|+|.+...........+.+|++++++++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKP-------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECC-------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 456899999999999999999999873 3457888888765444444557799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
++.+++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAKR-----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 9999999999999999999976432 56677788999999999999986 69999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV---- 316 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i---- 316 (394)
++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||......++...+
T Consensus 150 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 218 (331)
T cd06649 150 VSGQLIDS---MANSFVGTRSYMSPERLQGTH-------YSVQSDIWSMGLSLVELAI-GRYPIPPPDAKELEAIFGRPV 218 (331)
T ss_pred cccccccc---ccccCCCCcCcCCHhHhcCCC-------CCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhcccc
Confidence 98654322 122346788999999987654 7889999999999999998 99999776554432221
Q ss_pred ------------------------------------------hcCCCcCCCC-CCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 317 ------------------------------------------FGTEALRLPA-PRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 317 ------------------------------------------~~~~~~~~~~-p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
.... +... ...++.++.+++++||+.||+ ||++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ 296 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 296 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCCcccCCCHH
Confidence 1111 1111 124678999999999999998 99999
Q ss_pred hhhh
Q psy7505 353 DTGS 356 (394)
Q Consensus 353 e~~~ 356 (394)
|++.
T Consensus 297 ell~ 300 (331)
T cd06649 297 MLMN 300 (331)
T ss_pred HHhc
Confidence 9864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=340.89 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=198.0
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHH---hccCCCcceeceeeEEEe
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATP---YRRLRHVNILRLMAACLE 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~---l~~l~HpnIv~l~~~~~~ 161 (394)
|++.+.||+|+||.||+|.++. .+..||+|.++... .......+.+|+.+ ++.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~ 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence 5678999999999999999873 45589999987543 12222334456544 467789999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+|+||||+++|+|..++... .+++.....++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999999999999888643 257777888999999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+....... .......|+..|||||++.+.. ++.++|||||||++|||++ |+.||.+.+..+++..+..+
T Consensus 148 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~-- 216 (324)
T cd05589 148 CKEGMGFG-DRTSTFCGTPEFLAPEVLTETS-------YTRAVDWWGLGVLIYEMLV-GESPFPGDDEEEVFDSIVND-- 216 (324)
T ss_pred CccCCCCC-CcccccccCccccCHhHhcCCC-------CCcccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--
Confidence 86432221 1223456888999999987654 7889999999999999998 99999998888888887766
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
....|..++..+.+++++||..+|. |++.
T Consensus 217 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 217 -EVRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 3456778999999999999999998 8753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=333.51 Aligned_cols=270 Identities=34% Similarity=0.610 Sum_probs=219.2
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|.+.+.||+|+||.||+|++...... .....+++|.++....... ..+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~--~~~~~~~~k~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPT--KDKMLVAVKALKDPTLAAR-KDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCC--CcceeeEEEecCCccHHHH-HHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 3457789999999999999999987543221 2333677888765443332 345689999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
.+..++||||+++|+|.+++..+... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 99999999999999999999765321 1112567778899999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
++.+||+|||++.......... .....++..|+|||.+.+.. ++.++|||||||++|||+++|..||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-------FTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999987554333222 22335577899999987654 788999999999999999779999998888
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+.+..+..+. ....+..++..+.+++.+||+.+|+ ||++.++++.|.++..
T Consensus 232 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 232 TEVIECITQGR--VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHhCCC--CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 88877776664 3445667899999999999999998 9999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=329.89 Aligned_cols=265 Identities=30% Similarity=0.496 Sum_probs=219.0
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++.+.||+|+||.||+|.+.... .....|++|.............+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPE----NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCC----CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 456788999999999999999999876321 2234688888776554444455678999999999999999999987
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+ +..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCc
Confidence 5 567899999999999999976432 25677788899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+++.......+......++..|+|||.+.... ++.++|||||||++|||++.|..||.+.+..+....+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRR-------FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCC-------CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 98655433322222334456799999876544 78899999999999999866999999988888777777665
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+++.+..++..+.+++.+||..+|. ||++.+++..|+++..
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 6677889999999999999999998 9999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=327.03 Aligned_cols=251 Identities=25% Similarity=0.506 Sum_probs=206.9
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEee
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFES 171 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 171 (394)
.||+|+||.||+|.++.. .....|++|++...........+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-----KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecC-----CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 489999999999987632 1233688998876655444555779999999999999999999886 4578999999
Q ss_pred CCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCcee
Q psy7505 172 CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251 (394)
Q Consensus 172 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~ 251 (394)
+++|+|.+++..... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 76 ASGGPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 999999999975322 2567778899999999999999999999999999999999999999999998654332211
Q ss_pred ee--CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCC
Q psy7505 252 VH--GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRA 329 (394)
Q Consensus 252 ~~--~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~ 329 (394)
.. ....++..|+|||.+.... ++.++|||||||++|||+++|..||.+....++...+..+. +.+.|..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 222 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRK-------FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--RLDCPAE 222 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCC-------CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--CCCCCCC
Confidence 11 1123356899999986554 78899999999999999966999999998888888887775 5677888
Q ss_pred CChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 330 VNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 330 ~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+++++.+++.+||..+|+ ||++.+|...|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999998 99999999888764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=356.62 Aligned_cols=260 Identities=19% Similarity=0.212 Sum_probs=213.8
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
......++|++.+.||+|+||.||+|++.. ....||+|.+.... .......+.+|+.++..++|+||+++++
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~ 98 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVS-------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcC-------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence 334557899999999999999999998763 34589999886543 3444455678999999999999999988
Q ss_pred EEEeCC--------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 158 ACLESD--------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 158 ~~~~~~--------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
.+...+ .+++||||+++|+|.++|...... ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 99 ~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC 177 (496)
T ss_pred ceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe
Confidence 776432 368999999999999999754221 12367777888999999999999999999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 230 SELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
.++.+||+|||+++...... ........||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------~s~k~DVwSlGvilyeLlt-G~~Pf~~~~ 249 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-------YSKKADMFSLGVLLYELLT-LKRPFDGEN 249 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCCC
Confidence 99999999999987543211 11123457889999999987654 7899999999999999998 999999988
Q ss_pred HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+++..+..+. ..+.|..+++++.+++++||..+|. ||++.+++.
T Consensus 250 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 250 MEEVMHKTLAGR--YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 888888887765 4567788999999999999999998 999998864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=340.51 Aligned_cols=242 Identities=21% Similarity=0.364 Sum_probs=201.4
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCC-cceeceeeEEEeC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRH-VNILRLMAACLES 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~ 162 (394)
+|++.+.||+|+||.||+|+++. ....||+|+++... .......+..|..++..++| ++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Confidence 57889999999999999999873 34579999887543 22233445688999998866 4688899999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+||||+++|+|.+++...+. +.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVGK-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 999999999999999999976532 566677889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......||..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 149 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~--- 216 (324)
T cd05587 149 KENIFGGK-TTRTFCGTPDYIAPEIIAYQP-------YGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSIMEH--- 216 (324)
T ss_pred eecCCCCC-ceeeecCCccccChhhhcCCC-------CCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC---
Confidence 64322111 122346889999999987654 7889999999999999998 99999999888888888765
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
....|..++.++.+++++||..+|. |++.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4566788999999999999999998 8775
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=334.98 Aligned_cols=272 Identities=36% Similarity=0.637 Sum_probs=214.0
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCccc---------ccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcce
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEE---------STGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---------~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 152 (394)
++.++|++.+.||+|+||.||++.+..... ........+++|.++..........+.+|+.+++.++|+||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 567889999999999999999987653221 11123346889988765544444556799999999999999
Q ss_pred eceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhh------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7505 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNC 226 (394)
Q Consensus 153 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~Ni 226 (394)
+++++++..++..++||||+++|+|.+++....... ...+++.....++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997643211 11245667888999999999999999999999999999
Q ss_pred EEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q psy7505 227 LVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE-FGKLPY 304 (394)
Q Consensus 227 Ll~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t-~g~~Pf 304 (394)
|++.++.+||+|||++.......... .+...++..|++||....+. ++.++|||||||++|||++ .|..||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-------FTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-------ccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999999999987543332211 22234467899999876554 7889999999999999996 267899
Q ss_pred CCCCHHHHHHHHhc-----CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 305 AELSDDQVITRVFG-----TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 305 ~~~~~~~~~~~i~~-----~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
...+..+++..... +....++.+..+++.+.+++.+||..+|+ ||++.|+.+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 88776665543311 12224566778899999999999999998 9999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=327.95 Aligned_cols=263 Identities=29% Similarity=0.474 Sum_probs=216.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|+..+.||+|+||.||+|+.+... .....+++|.++..........+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPG----RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCC----CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 4567888999999999999999986321 223478889887654444445567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++..... .+++.....++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence 999999999999999999975422 2566777889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 243 IDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
.......... ......+..|+|||++.... ++.++|||||||++|||++.|..||...+..++...+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~ 227 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-------FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCC-------cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC
Confidence 6543222111 11122345799999986554 78899999999999999876999998888878777776654
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+.+.+..++..+.+++.+||+.+|+ ||++.+++..|.+++
T Consensus 228 --~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 --RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 6677778899999999999999998 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=325.67 Aligned_cols=249 Identities=35% Similarity=0.577 Sum_probs=205.0
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|+++. ....+++|.............+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEec-------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 368999999999999863 3457889987655444444556799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++...+. .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 74 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 74 LVQGGDFLTFLRTEGP----RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred eccCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 9999999999975432 156677888999999999999999999999999999999999999999999865432221
Q ss_pred eeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCC
Q psy7505 251 YVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRA 329 (394)
Q Consensus 251 ~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~ 329 (394)
.... ....+..|+|||.+.... ++.++|||||||++|||++.|..||......+....+..+. +.+.+..
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 220 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGR-------YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--RLPCPEL 220 (252)
T ss_pred cccCCCCCCceeecCchhhcCCC-------CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--CCCCccc
Confidence 1111 113345699999986654 78899999999999999976899998888777766665554 5567778
Q ss_pred CChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 330 VNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 330 ~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
++..+.+++++||+.+|+ ||++.++...|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 899999999999999998 999999988875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.42 Aligned_cols=259 Identities=31% Similarity=0.561 Sum_probs=216.7
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+-+..+|++.+.||+|+||.||+|.++. ...+++|.+....... ...+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~--------~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKN--------RVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLISLFAVCS 72 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecC--------CCcEEEEeccccchhh-HHHHHHHHHHHhcCCCcchhheeeeEe
Confidence 3456788999999999999999999873 3478888876554322 234568999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
..+.+++||||+++|+|.+++...... .+++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEcccc
Confidence 999999999999999999999764221 25677788899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++........ ......++..|+|||.+.... ++.++||||||+++|+|++.|+.||.+.+..+++..+..+.
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-------~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05148 150 LARLIKEDVY-LSSDKKIPYKWTAPEAASHGT-------FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY 221 (261)
T ss_pred chhhcCCccc-cccCCCCceEecCHHHHccCC-------CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC
Confidence 9865433222 222334567899999986554 77899999999999999976899999888888877777654
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+.+.+..+++.+.+++.+||..+|+ ||++.++.+.|+.+
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 6677889999999999999999998 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=339.92 Aligned_cols=242 Identities=21% Similarity=0.353 Sum_probs=201.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLES 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 162 (394)
+|.+.+.||+|+||.||+|+++. ....||+|.++... ..........|..++..+ +|++|+++++++.+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC
Confidence 57889999999999999999873 34578999887543 122223345677777776 689999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 999999999999999999876532 566778889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+....... ......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..++...+...
T Consensus 149 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--- 216 (323)
T cd05616 149 KENMWDGV-TTKTFCGTPDYIAPEIIAYQP-------YGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH--- 216 (323)
T ss_pred eecCCCCC-ccccCCCChhhcCHHHhcCCC-------CCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHHHHhC---
Confidence 65322211 223456889999999987654 7899999999999999998 99999999888888888765
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
....|..++.++.+++++||+.+|. |++.
T Consensus 217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 4566778999999999999999998 8775
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=329.01 Aligned_cols=260 Identities=31% Similarity=0.548 Sum_probs=209.2
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC----
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES---- 162 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 162 (394)
.+.+.||+|+||.||+|++.... ....+|+|.++... .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~-----~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDD-----SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred ccccccCcccCceEEEeEEccCC-----CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 45678999999999999986321 22368888876543 333344567899999999999999999987532
Q ss_pred --CceEEEEeeCCCCCHHHHHhhcch-hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 163 --DPWLLVFESCSRGDLKEFLLSNEA-SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 163 --~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
...+++|||+.+|+|.+++..... .....+++.....++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 246899999999999998854321 11223577778899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 240 GSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 240 G~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
|+++..........+ ...++..|++||.+.... ++.++|||||||++|||++.|..||.+....++...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-------YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCC-------cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 998765443332222 224567899999986554 788999999999999999768999999888888887777
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+. +.+.+..++..+.+++.+||+.+|+ ||++.+++..|+++
T Consensus 230 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GN--RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 65 4566778999999999999999997 99999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=328.03 Aligned_cols=260 Identities=29% Similarity=0.503 Sum_probs=213.5
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|.++.++|++.++||+|+||.||+|++.+ ...|++|.++..... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecC--------CceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 46778899999999999999999998753 125889988753321 12356899999999999999999987
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. .+..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+||
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 71 S-EEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred C-CCCcEEEEEcCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccC
Confidence 5 4568999999999999999975421 12566777889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|.+...............++..|+|||++.... ++.++|||||||++|||++.|..||.+....++...+..+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccCC-------CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 998654433322222345567899999876554 7889999999999999997688999988888877777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
. ..+.+..++..+.+++.+||+.+|+ ||++.++.+.|+.+.
T Consensus 220 ~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 Y--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred C--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4 4566678899999999999999997 999999999888653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=341.74 Aligned_cols=246 Identities=17% Similarity=0.235 Sum_probs=197.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
+|++.+.||+|+||.||+++..... ..+..||+|+++... .......+.+|+.+++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH----DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 4788999999999999999865211 245588999886532 122233456899999999 69999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++||||+++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRDN-----FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 9999999999999999999976432 56677788999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHh
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DDQVITRVF 317 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~~~~~~i~ 317 (394)
++..............||..|||||++.+.. .++.++|||||||++|||++ |..||.... ..++...+.
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 224 (332)
T cd05614 152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKG------GHGKAVDWWSLGILIFELLT-GASPFTLEGERNTQSEVSRRIL 224 (332)
T ss_pred CccccccCCCccccccCCccccCHHHhcCCC------CCCCccccccchhhhhhhhc-CCCCCCCCCCCCCHHHHHHHHh
Confidence 8754333322233457899999999986543 16789999999999999998 999996432 334444454
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
.. ..+.|..++..+.+++++||..+|+ |++
T Consensus 225 ~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 255 (332)
T cd05614 225 KC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLG 255 (332)
T ss_pred cC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 43 4566778999999999999999998 884
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=332.84 Aligned_cols=263 Identities=32% Similarity=0.491 Sum_probs=213.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|..+... ....+++|.++..........+.+|+.+++++ +||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-----LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-----CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 67889999999999999999876321 12246777776544333344567899999999 7999999999999989
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhh-----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASR-----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~ 232 (394)
.+++||||+++|+|.+++....... ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999999999999997643111 11256777888999999999999999999999999999999999
Q ss_pred eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
.+||+|||++..... .........+..|+|||++.... ++.++|||||||++|||++.|..||.+....++
T Consensus 157 ~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSV-------YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227 (297)
T ss_pred eEEECCcCCCccccc--eeccCCCCcCccccCchhhccCC-------CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999998854221 11111223355799999986554 788999999999999999769999999888888
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
...+..+. ..+.|..++..+.+++.+||..+|. ||++.+++..|..+..
T Consensus 228 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 228 YEKLPQGY--RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 87776654 5566778999999999999999998 9999999988877775
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.39 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=209.2
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
....++|++.+.||+|+||.||+++++. ....+|+|++.... .......+.+|+.+++.++||||++++++
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKS-------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4557889999999999999999999873 34578999886432 22333456689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+++.+|+|||||++|+|.+++.... +++.....++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~~------~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999996542 45667788999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+|...............||+.|||||++..... ...++.++|||||||++|||++ |..||.+.+....+..+..
T Consensus 186 FG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 186 FGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG---DGYYGRECDWWSVGVFLFEMLV-GDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred cccceecccCCceecccCCCCcccCCHHHHhccCC---CCCCCcccCEEeehHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence 99987654333323345678999999999865421 1126789999999999999998 9999998887777777765
Q ss_pred CC-CcCCCCCCCCChHHHHHHHhhhcCCcc---ccchhhhhh
Q psy7505 319 TE-ALRLPAPRAVNSHVDVAARNCLVTSEL---RVKIGDTGS 356 (394)
Q Consensus 319 ~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~---r~~~~e~~~ 356 (394)
.. .+.++....++..+.+++..||..++. |+++.|++.
T Consensus 262 ~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 262 HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred CCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 32 233444446799999999999986654 567877754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=343.64 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=209.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|+.+. .+..||+|.++... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 468899999999999999999873 34589999887543 223444567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCC
Confidence 999999999999999999976521 2567777889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-A 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-~ 321 (394)
...............+|+.|+|||++...... ....++.++|||||||++|||++ |..||.+....+.+..+.... .
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~~~~ 227 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMNFQRF 227 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeecc-CCCCCCCCCHHHHHHHHHcCCCc
Confidence 76544333333344688899999998643211 12237889999999999999998 999999888777777776543 2
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
...+....++..+.++++.||. +|. |+++.+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 2344455789999999999998 886 99998876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=329.98 Aligned_cols=266 Identities=37% Similarity=0.630 Sum_probs=216.0
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|.+.++||+|+||.||++....... ......+++|.++.... .....+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLP--EQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCC--CCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 346788999999999999999998653211 12344688888765443 333456789999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhh----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASR----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
.+..+++|||+++|+|.+++....... ...+++..+..++.|++.||.|||++|++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997653210 0125667788899999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
+.+||+|||++........+.. ....+++.|+|||.+.+.. ++.++|||||||++|||+++|..||......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 231 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-------FTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-------cCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence 9999999999865443332222 2234467899999987654 7889999999999999997799999888887
Q ss_pred HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+....+..+. ....+..+++.+.+++.+||+.+|. ||++.|+...|+
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGR--ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCc--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 7777776665 4566778999999999999999998 999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=344.38 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=201.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
-..++|.-...||+|+||.||+|...+ +..||||.+....... ...|.+|+.++.+++|||+|+|+|||.+
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~--------~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSD--------GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECC--------CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 345677777889999999999999873 2589999887665432 2237799999999999999999999999
Q ss_pred CC-ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEcCCCeEEEc
Q psy7505 162 SD-PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED---GFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 162 ~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
.+ ..+||+|||++|+|.++|...... .++|..++.|+.++|+||+|||.. .|||||||++|||+|+++.+||+
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 88 499999999999999999875432 479999999999999999999985 39999999999999999999999
Q ss_pred cCCCCccCCC-CceeeeCCc-cCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---H---
Q psy7505 238 DTGSSIDKYP-GDYYVHGEV-ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS---D--- 309 (394)
Q Consensus 238 DFG~a~~~~~-~~~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~---~--- 309 (394)
|||+|+.... .... ... .||..|+|||++..+. .+.++|||||||+|.||+| |+.+..... .
T Consensus 220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~-------lt~KsDVySFGVvllElit-gr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGK-------LTEKSDVYSFGVVLLELIT-GRKAVDQSRPRGELSL 289 (361)
T ss_pred CccCcccCCccccce--eeecCCCCccCChhhhccCC-------cCcccccccchHHHHHHHh-CCcccCCCCCcccccH
Confidence 9999976543 2221 122 7889999999987654 7889999999999999998 987776432 1
Q ss_pred HHH-HHHHhcCCCcCCCCCC----CCC-----hHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 310 DQV-ITRVFGTEALRLPAPR----AVN-----SHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 310 ~~~-~~~i~~~~~~~~~~p~----~~~-----~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.+- ...+..+....+-.|. ..+ ..+..+..+|++.+|+ ||+|.+|+..|..+.
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111 1122222211121121 122 2356788999999998 999999998885544
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=327.44 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=212.2
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|+++.++|++.+.||+|+||.||+|.... ...+++|.+....... ..+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~~k~~~~~~~~~--~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNG--------NTKVAVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecC--------CceeEEEEecCCCCCH--HHHHHHHHHHHhcCCCceEEEEeEE
Confidence 56778899999999999999999998752 2368888876543221 2366899999999999999999988
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. .+..+++|||+++|+|.+++..... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+||
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 71 S-EEPIYIVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred C-CCCcEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCc
Confidence 5 4568999999999999999976422 12567778899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++...............++..|+|||.+.... ++.++||||||+++|||++.|..||.+.+..+....+..+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-------FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcCC-------CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 998654333222222334566799999886554 7889999999999999997689999988888887777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
. +.+.+...+..+.+++++||..+|+ ||++.++.+.|++
T Consensus 220 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 Y--RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C--CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4 5667788899999999999999998 9999999888765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=346.05 Aligned_cols=261 Identities=20% Similarity=0.312 Sum_probs=210.3
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...+..++|++.+.||+|+||.||+|+++. +...+|+|++.... .......+.+|+.+++.++||||++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 345667999999999999999999999873 44578999876432 223334566899999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+++.+|+|||||++|+|.+++.... ++...+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999986542 456667788999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...............||+.|||||++..... ...++.++|||||||++|||++ |..||.+.+.......+
T Consensus 184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i 259 (371)
T cd05622 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG---DGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKI 259 (371)
T ss_pred EeCCceeEcCcCCcccccCcccCccccCHHHHhccCC---CccCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999987654333223335578999999999865421 1127889999999999999998 99999998887777777
Q ss_pred hcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc---ccchhhhhh
Q psy7505 317 FGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL---RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~---r~~~~e~~~ 356 (394)
.... ...++.+..++..+.+++..|+..++. |+++.|+..
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 260 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred HcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 6543 234455567899999999999985444 456777654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=327.03 Aligned_cols=252 Identities=32% Similarity=0.560 Sum_probs=208.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|.++. ...+++|........ ...+.+|+.++++++|+||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~--------~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG--------KIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC--------CccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 4568889999999999999998752 236788887643321 123558999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++++|.+++..... .+++.....++.|++.||.|||++|++||||||+||+++.++.+||+|||+++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccce
Confidence 99999999999999999975432 25677788999999999999999999999999999999999999999999987
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
..............++..|+|||.+.+.. ++.++|||||||++|||++.|..||...+..+....+..+. +
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~ 219 (256)
T cd05059 149 YVLDDQYTSSQGTKFPVKWAPPEVFDYSR-------FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY--R 219 (256)
T ss_pred ecccccccccCCCCCCccccCHHHhccCC-------CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC--c
Confidence 55433322222223456799999987654 78899999999999999976899999888888877776654 5
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
.+.|..++.++.+++.+||..+|+ ||++.|++..|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 667778999999999999999998 99999998775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.36 Aligned_cols=251 Identities=19% Similarity=0.286 Sum_probs=200.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++++.||+|+||.||+|+.+. ....||+|.+.... .......+.+|+.++++++|||||++++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 468899999999999999998873 44589999886533 222334567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKYDT-----FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999999976532 566677788999999999999999999999999999999999999999998
Q ss_pred ccCCCCc------------e----------------------------------eeeCCccCCcccccccccccCCCCcc
Q psy7505 243 IDKYPGD------------Y----------------------------------YVHGEVALPVRWCAPESLLCSDTSIQ 276 (394)
Q Consensus 243 ~~~~~~~------------~----------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~ 276 (394)
+...... . .......||+.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---- 224 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG---- 224 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC----
Confidence 5321100 0 0001236889999999987654
Q ss_pred cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCcCCCCCCCCChHHHHHHHhhhcCCcc-c---cch
Q psy7505 277 TCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT-EALRLPAPRAVNSHVDVAARNCLVTSEL-R---VKI 351 (394)
Q Consensus 277 ~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r---~~~ 351 (394)
++.++|||||||++|||++ |..||.+....+.+..+... ....+|....++.++.+++.+|+. +|. | +++
T Consensus 225 ---~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 225 ---YGQECDWWSLGAIMFECLI-GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred ---CCCceeeEecchhhhhhhc-CCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 7889999999999999998 99999988877777666543 222334444688999999999998 554 4 477
Q ss_pred hhhhh
Q psy7505 352 GDTGS 356 (394)
Q Consensus 352 ~e~~~ 356 (394)
.|++.
T Consensus 300 ~~~l~ 304 (377)
T cd05629 300 HEIKS 304 (377)
T ss_pred HHHhc
Confidence 77653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=328.46 Aligned_cols=262 Identities=31% Similarity=0.535 Sum_probs=212.7
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc-
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP- 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~- 164 (394)
|++.+.||+|+||.||+|...... .....||+|.++... .......+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD----GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC----CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 457788999999999999876311 234579999887543 33344456799999999999999999998876554
Q ss_pred -----eEEEEeeCCCCCHHHHHhhcchh-hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 165 -----WLLVFESCSRGDLKEFLLSNEAS-REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 165 -----~~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
.+++|||+++|+|..++...... ....+++.....++.|++.||.|||+++++||||||+||++++++.+||+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 79999999999999998653211 112357777888999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 239 TGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
||+++.......+... ...++..|+|||.+.... ++.++|||||||++|||++.|..||.+....+++..+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-------YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCC-------CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9998765443322221 223466799999986554 78899999999999999976899999988888888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
.+. ....|..++..+.+++++||+.+|+ ||++.|+...|+.+
T Consensus 230 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGN--RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCC--CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 765 5566788999999999999999998 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.34 Aligned_cols=273 Identities=31% Similarity=0.560 Sum_probs=216.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
|.++.++|++.+.||+|+||.||+|.+.+.... .....||||.++..........+.+|+.++.++ +|+||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCcc--ccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 678899999999999999999999997643321 234579999987655444445567899999999 78999999998
Q ss_pred EEe-CCceEEEEeeCCCCCHHHHHhhcchh--------------------------------------------------
Q psy7505 159 CLE-SDPWLLVFESCSRGDLKEFLLSNEAS-------------------------------------------------- 187 (394)
Q Consensus 159 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~-------------------------------------------------- 187 (394)
+.. +..+++|||||++|+|.+++......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 865 45689999999999999999753210
Q ss_pred ------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce-eeeC
Q psy7505 188 ------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY-YVHG 254 (394)
Q Consensus 188 ------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~ 254 (394)
....+++.....++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 001245666778999999999999999999999999999999999999999999875432221 1222
Q ss_pred CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCcCCCCCCCCChH
Q psy7505 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEALRLPAPRAVNSH 333 (394)
Q Consensus 255 ~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~p~~~~~~ 333 (394)
...++..|+|||.+.... ++.++|||||||++|||++.|..||.+.... +....+..+. +++.|..+++.
T Consensus 240 ~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 310 (343)
T cd05103 240 DARLPLKWMAPETIFDRV-------YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPE 310 (343)
T ss_pred CCCCCcceECcHHhcCCC-------CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC--CCCCCCCCCHH
Confidence 334566799999986654 7889999999999999997699999876543 3344444444 55666778889
Q ss_pred HHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 334 VDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 334 ~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+.+++.+||+.+|+ ||++.|++..|+.+..
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999998 9999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=326.65 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=214.7
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|++..++|++.++||+|+||.||+|..+. ...+++|.+....... ..+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~--------~~~~a~K~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNG--------HTKVAIKSLKQGSMSP--EAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCC--------CceEEEEEecCCCCcH--HHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 57788999999999999999999998652 3478999887544322 2356899999999999999999987
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. .+..+++|||+.+|+|.+++...... .++......++.|++.||.|||+.|++||||||+||++++++.++|+||
T Consensus 71 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 71 T-QEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred c-cCCcEEEEEcCCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccC
Confidence 5 46789999999999999998754321 2566778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++...............++..|+|||++.... ++.++||||||+++|||++.|+.||.+.+..++...+..+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05067 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-------FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219 (260)
T ss_pred cceeecCCCCcccccCCcccccccCHHHhccCC-------cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence 998654433322223334567899999986554 6789999999999999996699999988888877777655
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +.+.+..++.++.+++++||..+|+ ||++.++...|..+
T Consensus 220 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 220 Y--RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred C--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 4 5677788899999999999999998 99999998888653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=342.64 Aligned_cols=241 Identities=20% Similarity=0.307 Sum_probs=199.7
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 168 (394)
+.||+|+||.||+++++. .+..||+|+++... .......+.+|+.+++.++||||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEE
Confidence 369999999999999763 45589999887543 222233456899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
|||+++|+|.+++..... +++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 999999999998865432 5677788899999999999997 7999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..+ ....|
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~t-G~~Pf~~~~~~~~~~~i~~~---~~~~p 216 (325)
T cd05594 149 DGA-TMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME---EIRFP 216 (325)
T ss_pred CCc-ccccccCCcccCCHHHHccCC-------CCCccccccccceeeeecc-CCCCCCCCCHHHHHHHHhcC---CCCCC
Confidence 211 122346889999999987654 7889999999999999998 99999988887777776554 45667
Q ss_pred CCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
..+++.+.+++++||+.||+ |+ ++.+++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 88999999999999999998 75 677765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=339.63 Aligned_cols=239 Identities=19% Similarity=0.294 Sum_probs=198.5
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. ....||+|+++... .......+..|..++..+ +||||+++++++...+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEE
Confidence 369999999999999873 34589999887543 122233445788887766 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. +++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~Ey~~~g~L~~~i~~~~~-----l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 9999999999999876533 56677788999999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+++..+..+ ....|
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~---~~~~~ 216 (320)
T cd05590 149 NGK-TTSTFCGTPDYIAPEILQEML-------YGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILND---EVVYP 216 (320)
T ss_pred CCC-cccccccCccccCHHHHcCCC-------CCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC---CCCCC
Confidence 211 223456889999999986554 7889999999999999998 99999999888888888766 45567
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
..++.++.+++++||..||+ |+++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 78999999999999999998 888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.07 Aligned_cols=249 Identities=18% Similarity=0.285 Sum_probs=198.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.|++++.||+|+||.||+|+.+. ....+|+|.+.... .......+.+|+.++++++|+|||++++++.+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD-------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC-------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence 57889999999999999999873 44578999886543 2233345678999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMGI-----FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999999999999976532 5666778889999999999999999999999999999999999999999874
Q ss_pred cCCCC----------------------------------------------ceeeeCCccCCcccccccccccCCCCccc
Q psy7505 244 DKYPG----------------------------------------------DYYVHGEVALPVRWCAPESLLCSDTSIQT 277 (394)
Q Consensus 244 ~~~~~----------------------------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~ 277 (394)
..... .........||+.|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----- 224 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG----- 224 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-----
Confidence 22100 000011246889999999987654
Q ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc---hh
Q psy7505 278 CTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT-EALRLPAPRAVNSHVDVAARNCLVTSEL-RVK---IG 352 (394)
Q Consensus 278 ~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~---~~ 352 (394)
++.++|||||||++|||++ |+.||.+.+..+....+... .....|....+++++.+++.+++ .+|+ |++ +.
T Consensus 225 --~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 225 --YTQLCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred --CCCeeeEEechHHHHHHHh-CCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 7889999999999999998 99999988877766666543 22344444578899999998875 4887 665 55
Q ss_pred hhh
Q psy7505 353 DTG 355 (394)
Q Consensus 353 e~~ 355 (394)
++.
T Consensus 301 ei~ 303 (382)
T cd05625 301 EIK 303 (382)
T ss_pred HHh
Confidence 543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=326.95 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=215.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|.++... .....|++|.++..........+..|+.+++.++||||+++++++.+++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCC----CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 456889999999999999999987422 2234689999876654545556779999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++|+|.+++..... .+++...+.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 99999999999999999976422 25667788899999999999999999999999999999999999999999886
Q ss_pred cCCCCcee--eeCCcc--CCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 244 DKYPGDYY--VHGEVA--LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 244 ~~~~~~~~--~~~~~~--~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
........ ...... .+..|+|||.+.... ++.++|||||||++|||++.|..||.+.+..++...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~ 227 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCc-------ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 44322111 111111 245799999986554 7889999999999999887799999998888888777655
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +++.+..++..+.+++.+||..+|. ||++.+++..|+++
T Consensus 228 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y--RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4 6677788999999999999999998 99999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=332.25 Aligned_cols=269 Identities=34% Similarity=0.568 Sum_probs=217.0
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.|.+..++|.+.+.||+|+||.||+|.+..... ......+|+|.++..........+.+|+.+++++ +|+||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSK--SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCC--CCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 456677899999999999999999998643211 1234578999887655444445567999999999 8999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++...+..++||||+++|+|.++++.... ..+++.....++.|++.||.|||+++|+|+||||+|||++.++.+||+
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence 99999999999999999999999975422 125677788899999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Q psy7505 238 DTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR- 315 (394)
Q Consensus 238 DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~- 315 (394)
|||++........ .......++..|+|||.+.... ++.++|||||||++|||++.|..||.+....+.+..
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCC-------CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 9999875433322 1222334567899999986654 788999999999999999768999988775544433
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+..+. +.+.+...+..+.+++++||..+|+ ||++.|++..|.++
T Consensus 257 ~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGY--RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCC--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 33332 4555677889999999999999998 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.20 Aligned_cols=238 Identities=20% Similarity=0.305 Sum_probs=197.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. .+..||+|+++... .......+..|..++..+ +||||+++++++.+.+.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECC-------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEE
Confidence 369999999999999873 34589999887543 222333455788888765 89999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|..++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 74 v~E~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999999876533 56667788999999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......|+..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+..+ ....|
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i~~~---~~~~p 216 (321)
T cd05591 149 NGV-TTTTFCGTPDYIAPEILQELE-------YGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESILHD---DVLYP 216 (321)
T ss_pred CCc-cccccccCccccCHHHHcCCC-------CCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence 221 223446888999999986654 7889999999999999998 99999999988888888776 34556
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
..++.++.+++++||..+|+ |++..
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 77899999999999999998 88443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=339.42 Aligned_cols=241 Identities=19% Similarity=0.278 Sum_probs=196.4
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHH-HHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEA-TPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||+||+|+++ ..+..||+|++.... .......+..|. .+++.++||||+++++++...+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEE
Confidence 36999999999999987 345589999986543 111222233444 45688999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|..++...+. +++.....++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRERS-----FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 9999999999999876532 56667778999999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+ ....+
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~ 216 (323)
T cd05575 149 HSK-TTSTFCGTPEYLAPEVLRKQP-------YDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNILNK---PLRLK 216 (323)
T ss_pred CCC-ccccccCChhhcChhhhcCCC-------CCccccccccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence 211 223446888999999987654 7889999999999999998 99999998888888877765 34556
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..++..+.+++++||+.+|. |+++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 67899999999999999998 88876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=331.48 Aligned_cols=268 Identities=34% Similarity=0.612 Sum_probs=217.9
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
++.++|++.+.||+|+||.||+|.+.+... +.....+++|.+...........+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLP--YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCC--CCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 456789999999999999999999764211 123458899988765544444557789999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchh-----------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEAS-----------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
++..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 89999999999999999999753210 0112456677889999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||++.......... ......+..|+|||.+.+.. ++.++|||||||++|||++.|..|
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-------YTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-------CCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999886543332211 12223456799999886654 788999999999999999778899
Q ss_pred CCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 304 f~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
|.+....++...+..+. .++.+..++..+.+++.+||+.+|+ ||++.|++..|++
T Consensus 233 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 233 YYGMAHEEVIYYVRDGN--VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 98888888887777665 4556778899999999999999998 9999999988863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.03 Aligned_cols=250 Identities=19% Similarity=0.292 Sum_probs=200.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++++.||+|+||.||+|+.+. .+..||+|++.... .......+.+|+.+++.++|+||+++++.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD-------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 368999999999999999999873 35589999886533 122234466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 999999999999999999976532 566677788999999999999999999999999999999999999999987
Q ss_pred ccCCCC------------------------------------------ceeeeCCccCCcccccccccccCCCCcccCCC
Q psy7505 243 IDKYPG------------------------------------------DYYVHGEVALPVRWCAPESLLCSDTSIQTCTV 280 (394)
Q Consensus 243 ~~~~~~------------------------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~ 280 (394)
...... .........||+.|||||++.+.. +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~ 221 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-------Y 221 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-------C
Confidence 422100 000011346889999999987655 7
Q ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc-cc---chhhhh
Q psy7505 281 TEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL-RV---KIGDTG 355 (394)
Q Consensus 281 ~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~---~~~e~~ 355 (394)
+.++|||||||++|||++ |+.||.+....+....+.... ...++....++..+.+++.+|+. +|. |+ ++.+++
T Consensus 222 ~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell 299 (376)
T cd05598 222 TQLCDWWSVGVILYEMLV-GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIK 299 (376)
T ss_pred Ccceeeeeccceeeehhh-CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 889999999999999998 999999988777666655432 22334445788999999999774 776 87 677765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.34 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=207.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+.++..++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence 468899999999999999999873 45589999987543 112334567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+||||+++|+|.+++...+. ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRKDV-----FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCC
Confidence 999999999999999999976522 567778889999999999999999999999999999999999999999998
Q ss_pred ccCCCCc----------------------------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHH
Q psy7505 243 IDKYPGD----------------------------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294 (394)
Q Consensus 243 ~~~~~~~----------------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~ 294 (394)
....... ........||+.|+|||++.+.. ++.++|||||||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ 221 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-------YGLECDWWSLGVILY 221 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-------CCCceeeEecchhhh
Confidence 6543322 01122346889999999987664 789999999999999
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHhcC-CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc-hhhhhh
Q psy7505 295 EIFEFGKLPYAELSDDQVITRVFGT-EALRLPAPRAVNSHVDVAARNCLVTSEL-RVK-IGDTGS 356 (394)
Q Consensus 295 el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-~~e~~~ 356 (394)
||++ |+.||.+....+....+... ....++....+++.+.+++++||. +|. |++ +.+++.
T Consensus 222 ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 222 EMLY-GFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hhcc-CCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 9998 99999998877777776551 223444445579999999999997 887 999 888864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=335.96 Aligned_cols=267 Identities=30% Similarity=0.456 Sum_probs=213.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
..++|++.+.||+|+||.||+|.++.. .....+++|.++..........+.+|+.++.++ +|+||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKD-----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccC-----CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 357889999999999999999998631 122255777766544444445567899999999 89999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhh-----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASR-----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
++.+|+||||+++|+|.+++...+... ...+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 999999999999999999997653211 113567778899999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
++.+||+|||++..... ........++..|+|||.+.... ++.++|||||||++|||+|.|..||.+.+..
T Consensus 160 ~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 160 NYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSV-------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred CCcEEeCccccCcccch--hhhcccCCCcccccCHHHHhccC-------CcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999998853211 11111123456799999886544 7789999999999999997699999888877
Q ss_pred HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
+....+..+. +++.+..+++.+.+++.+||+.+|+ ||++.+++..|..+....
T Consensus 231 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 231 ELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHHHhcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 7777665543 5556677899999999999999998 999999999888776543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=333.06 Aligned_cols=252 Identities=19% Similarity=0.238 Sum_probs=197.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|+++. ....+|+|.++... .......+.+|+.+++.++||||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 368899999999999999999873 34578999886543 2223344568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||++++.|..+..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred EEEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 9999999999877665543221 25667778899999999999999999999999999999999999999999987
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA-- 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~-- 321 (394)
..............++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07848 149 NLSEGSNANYTEYVATRWYRSPELLLGAP-------YGKAVDMWSVGCILGELSD-GQPLFPGESEIDQLFTIQKVLGPL 220 (287)
T ss_pred cccccccccccccccccccCCcHHHcCCC-------CCCchhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCC
Confidence 65333222223346788999999987654 7889999999999999998 9999988765544333221100
Q ss_pred ----------------cCCCC-----------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 ----------------LRLPA-----------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ----------------~~~~~-----------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+. ...++..+.+++++||..||+ |+++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111 123678899999999999998 999988763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=332.93 Aligned_cols=252 Identities=18% Similarity=0.282 Sum_probs=198.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+.+. +...||+|.++..........+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL-------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC-------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4679999999999999999998873 345889998865432222334568999999999999999999999988
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++ +|.+++...+. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred eEEEEEeCCCc-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCccee
Confidence 99999999975 99999865432 24666778899999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL- 322 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~- 322 (394)
....... ......++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07871 152 AKSVPTK-TYSNEVVTLWYRPPDVLLGST------EYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHLIFRLLGTP 223 (288)
T ss_pred eccCCCc-cccCceecccccChHHhcCCc------ccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence 5432221 122345678899999986532 27889999999999999998 99999988766655444321100
Q ss_pred -----------------CCC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 -----------------RLP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 -----------------~~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..+ ....++.++.+++++||..||. |+|+.|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 001 0124678899999999999998 99999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=331.21 Aligned_cols=272 Identities=36% Similarity=0.611 Sum_probs=216.9
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCccccc---------CcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcce
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEEST---------GRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~---------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 152 (394)
++.++|++.+.||+|+||.||+|++....... ......|++|.+...........+.+|+.++++++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 34678899999999999999999886433211 112346889988766544445567799999999999999
Q ss_pred eceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhh------hhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7505 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASRE------ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNC 226 (394)
Q Consensus 153 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~Ni 226 (394)
+++++++..++.++++|||+++++|.+++........ ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999999976542111 1367778889999999999999999999999999999
Q ss_pred EEcCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC-CCCCC
Q psy7505 227 LVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF-GKLPY 304 (394)
Q Consensus 227 Ll~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~-g~~Pf 304 (394)
+++.++.+||+|||++......... ......++..|+|||.+.... ++.++|||||||++|||++. |..||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-------FTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-------CCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999998754433322 223345677899999986654 78899999999999999863 67899
Q ss_pred CCCCHHHHHHHHhcC-----CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 305 AELSDDQVITRVFGT-----EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~-----~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
...+..+++..+... ....++.+..++.++.+++.+||+.+|. ||++.|++..|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 888777776655432 2223455667889999999999999998 9999999888753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=336.36 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=195.7
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhcc-CCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRR-LRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||+||+|+++. ....||+|.++.... .........|..++.. ++||||+++++++.+.+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEE
Confidence 369999999999999873 345799998876431 1222234467777765 599999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++..... +++.....++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 74 v~ey~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 9999999999999976432 55667778999999999999999999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+++..+..+ ....|
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~---~~~~~ 216 (316)
T cd05619 149 GDA-KTCTFCGTPDYIAPEILLGQK-------YNTSVDWWSFGVLLYEMLI-GQSPFHGHDEEELFQSIRMD---NPCYP 216 (316)
T ss_pred CCC-ceeeecCCccccCHHHHcCCC-------CCchhhhhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC---CCCCC
Confidence 211 122346788999999987654 7889999999999999998 99999998888887777554 33456
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchh-hh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIG-DT 354 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~-e~ 354 (394)
..++..+.+++.+||..+|+ |+++. ++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 67899999999999999998 88986 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=336.78 Aligned_cols=237 Identities=24% Similarity=0.377 Sum_probs=197.9
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||+||+|+++. ....+|+|.++... .......+.+|..+++.+ +||||+++++++...+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 369999999999999873 34579999887543 222333456788888877 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|..++...+. +++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSGR-----FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 9999999999999876532 56777888999999999999999999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..++...+... ....|
T Consensus 149 ~~~-~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslGvil~~l~~-G~~pf~~~~~~~~~~~i~~~---~~~~~ 216 (318)
T cd05570 149 GGV-TTSTFCGTPDYIAPEILSYQP-------YGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSILED---EVRYP 216 (318)
T ss_pred CCC-cccceecCccccCHHHhcCCC-------CCcchhhhhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence 221 122346788999999987654 7889999999999999998 99999998888887777665 34567
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
..++..+.+++++||..+|+ |+++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCC
Confidence 78999999999999999998 8888
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=323.65 Aligned_cols=259 Identities=30% Similarity=0.518 Sum_probs=211.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|+++.++|.+.+.||+|+||.||+|.+.+ ...+++|.+...... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNG--------TTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVV 70 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcC--------CceEEEEEcccCCcc--HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45677889999999999999999998763 125788877654322 23356899999999999999999987
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. .+..+++|||+.+|+|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+||
T Consensus 71 ~-~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 71 S-EEPIYIVTEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred c-CCCcEEEEEcCCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCC
Confidence 5 4668999999999999999975422 12466677889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++...............++..|+|||.+.... ++.++|||||||++|||++.|..||.+....+....+..+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-------FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccCC-------cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 998654333322222334567799999876554 7889999999999999997689999998888877777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. ..+.+...+..+.+++++||..+|+ ||++.++.+.|+++
T Consensus 220 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 220 Y--RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred C--CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 4 5566778999999999999999998 99999999888753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.34 Aligned_cols=261 Identities=36% Similarity=0.611 Sum_probs=200.7
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEee
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFES 171 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 171 (394)
+||+|+||.||+|+.... .....+++|.++..........+.+|+.+++.++||||+++++.+.+....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD-----TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcC-----CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 599999999999976531 223456677766554444455677999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce-
Q psy7505 172 CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY- 250 (394)
Q Consensus 172 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~- 250 (394)
+++|+|.+++.+.... ...........++.||+.||.|||+++++||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 77 CELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999999764321 11234556678899999999999999999999999999999999999999998754322211
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCC---CC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP---AP 327 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~p 327 (394)
.......++..|+|||++...........++.++|||||||++|||++.|..||...+..+.+..+..+....++ .+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 112234667889999998643221122236789999999999999997678899888887777776555433332 33
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
...++.+.++++.|| .+|+ ||++.+++..|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 457889999999999 5687 999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.81 Aligned_cols=267 Identities=27% Similarity=0.444 Sum_probs=220.2
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|++.+.||+|+||.||+|.++.... .....+++|..+..........+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGE---KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCC---CcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 346788999999999999999999764221 12336888888766544444556789999999999999999999987
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
...++||||+++|+|.+++..+... +++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDN----IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 7899999999999999999765321 56777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++.......... ....++..|+|||.+.... ++.++|+|||||++||+++.|..||.+....++...+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRI-------YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCC-------cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Confidence 876543322111 1223456799999876544 77899999999999999977999999988888877777665
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
..+.|..++..+.+++.+||..+|. ||++.++++.|.++..+.
T Consensus 229 --~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 229 --RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 5677788899999999999999998 999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.26 Aligned_cols=246 Identities=18% Similarity=0.276 Sum_probs=197.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. ....+|+|++.... .......+.++..+++.++||||+++++++...+.+|+
T Consensus 1 ~~lg~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEE
Confidence 369999999999999873 34478999886543 11222233233445788999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. +.......++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 9999999999999976532 45556677899999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+... ....+
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~---~~~~~ 216 (325)
T cd05602 149 HNG-TTSTFCGTPEYLAPEVLHKQP-------YDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNK---PLQLK 216 (325)
T ss_pred CCC-CcccccCCccccCHHHHcCCC-------CCCccccccccHHHHHHhc-CCCCCCCCCHHHHHHHHHhC---CcCCC
Confidence 111 123456889999999987654 7889999999999999998 99999998888887777654 34556
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
..++..+.+++++||+.+|. |+++.+.+..+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 68899999999999999998 8988765544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.05 Aligned_cols=271 Identities=35% Similarity=0.599 Sum_probs=212.1
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCccc-------ccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceec
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEE-------STGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~-------~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
++.++|++.+.||+|+||.||+|++.+..+ ........|++|..+..........+.+|++++++++|+||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 567889999999999999999998754221 0112233588998876554444455779999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhh-------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASR-------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
+++++...+..++||||+++|+|.+++....... ...+++.....++.|++.||.|||+++++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999996532100 012456677889999999999999999999999999999
Q ss_pred EcCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC-CCCCCC
Q psy7505 228 VTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF-GKLPYA 305 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~-g~~Pf~ 305 (394)
++.++.+||+|||++......... ..+...++..|+|||++.... ++.++|||||||++|||++. |..||.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-------FTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-------cCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999998754333222 222334567899999987654 78899999999999999862 568998
Q ss_pred CCCHHHHHHHHhc-----CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 306 ELSDDQVITRVFG-----TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 306 ~~~~~~~~~~i~~-----~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
..+..+++..+.. +.......+..+++.+.+++++||+.+|+ ||++.+++..|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 8777666544321 22223445667889999999999999998 999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=335.41 Aligned_cols=238 Identities=22% Similarity=0.309 Sum_probs=195.6
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhcc-CCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRR-LRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. ++..||+|.++.... .........|..++.. ++||||+++++++.+++.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEE
Confidence 369999999999999873 445899998875431 1222334567777765 499999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+.+|+|.+++...+. ++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~E~~~~g~L~~~i~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKGR-----FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 9999999999999876432 56667788999999999999999999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+ ....|
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGvil~el~~-g~~Pf~~~~~~~~~~~~~~~---~~~~~ 216 (316)
T cd05620 149 GDN-RASTFCGTPDYIAPEILQGLK-------YTFSVDWWSFGVLLYEMLI-GQSPFHGDDEDELFESIRVD---TPHYP 216 (316)
T ss_pred CCC-ceeccCCCcCccCHHHHcCCC-------CCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC---CCCCC
Confidence 111 123456889999999987654 7889999999999999998 99999998888887777654 34556
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
..++.++.+++++||..||+ |+++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 77899999999999999998 88875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.64 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=201.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVF 169 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 169 (394)
+.||+|+||.||+++..... ..+..+|+|+++... .......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP----DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 57999999999999864211 245589999887543 2222334568999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCc
Q psy7505 170 ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249 (394)
Q Consensus 170 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~ 249 (394)
||+.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 78 DFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred cCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99999999999965432 5777788999999999999999999999999999999999999999999987543321
Q ss_pred eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCC
Q psy7505 250 YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRA 329 (394)
Q Consensus 250 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~ 329 (394)
. ......|+..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+..+ ....|..
T Consensus 153 ~-~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i~~~---~~~~p~~ 220 (318)
T cd05582 153 K-KAYSFCGTVEYMAPEVVNRRG-------HTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMILKA---KLGMPQF 220 (318)
T ss_pred C-ceecccCChhhcCHHHHcCCC-------CCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHHHcC---CCCCCCC
Confidence 1 122456888999999987654 6789999999999999998 99999998888888877665 4567788
Q ss_pred CChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 330 VNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 330 ~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
++..+.+++++||+.+|+ |+++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 999999999999999998 998655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.14 Aligned_cols=269 Identities=33% Similarity=0.636 Sum_probs=218.5
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
++.++|++.+.||+|+||.||+|+.+.... ......+++|.+...........+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEE--EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCc--CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 346788999999999999999999875432 123447888888665544344456789999999999999999999998
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhh----hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASR----EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
.+..++||||+++|+|.+++....... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 889999999999999999997654111 0125777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++...............++..|+|||.+.+.. ++.++||||||+++|+|++.|..||.+....++...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-------FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCC-------CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 99998654433333333345567799999886554 67899999999999999976889998888777777766
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
.+. ...+.+..++..+.+++.+||+.+|. ||++.|++..|.+
T Consensus 233 ~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGK-LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCC-cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 543 34566778899999999999999998 9999999888753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=322.58 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=205.0
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE-eCCceEEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL-ESDPWLLVF 169 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lv~ 169 (394)
+.||+|+||.||+|.+.... .....+++|.+...........+.+|+.+++.++||||+++++++. .++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD----GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCC----CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 35899999999999875321 2345789998765444444455678999999999999999999876 455689999
Q ss_pred eeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCc
Q psy7505 170 ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249 (394)
Q Consensus 170 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~ 249 (394)
||+.+|+|.+++...... ........++.|++.||.|||+++++||||||+|||++.++.+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 77 PYMKHGDLRNFIRSETHN----PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred ecCCCCCHHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999999754221 3445567888999999999999999999999999999999999999999986543322
Q ss_pred eee---eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCC
Q psy7505 250 YYV---HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326 (394)
Q Consensus 250 ~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 326 (394)
... .....++..|+|||.+.... ++.++|||||||++|||++.|.+||...+..+....+..+. .++.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 223 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQK-------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--RLLQ 223 (262)
T ss_pred ceeecccccCcCCccccChhHhccCc-------cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CCCC
Confidence 111 11234567899999886554 78899999999999999985678888888777777776665 5566
Q ss_pred CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 327 PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 327 p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+..++..+.+++.+||..+|+ ||++.|++..|+++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 778899999999999999998 9999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.39 Aligned_cols=270 Identities=30% Similarity=0.526 Sum_probs=221.6
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+.+++|++.+.||+|+||.||+|.+.... ......|++|.++..........+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~---~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK---PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC---CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 45788999999999999999999987321 122457889988766555556667799999999999999999998765
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhh---hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASR---EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+...++++||+++|+|.+++....... ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 567899999999999999997642210 1236777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 238 DTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
|||+++.......... ....++..|+|||++.... ++.++|||||||++||+++.|+.||.+....++...+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-------YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-------CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 9999976544333222 2234567799999986554 7889999999999999997799999988887877777
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+. +++.+..+++++.+++.+||..+|+ ||++.+++..|..+..
T Consensus 233 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGY--RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCC--CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 6654 5566677899999999999999998 9999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=326.01 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=202.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcc-eeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVN-ILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~ 161 (394)
...|+.+++||+|+||+||+|+.+ .++..||+|.++.... +..-....+|+.+++.|+|+| ||+|++++.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~-------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK-------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe-------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 345667788999999999999988 3456899999876654 222233469999999999999 9999999998
Q ss_pred CC------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 162 SD------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 ~~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
.+ .+++|+||+.. ||.+++....... ..++...+..+++||+.||.|||+++|+||||||.||||+++|.+|
T Consensus 83 ~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred cccccccceEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEe
Confidence 77 79999999976 9999998764211 2245577889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||+|+...-.... -....+|.+|.|||++.+... |+..+||||+|||++||++ ++.-|.+.++.+.+.+
T Consensus 161 laDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~------Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTS------YSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFR 232 (323)
T ss_pred eeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCc------CCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Confidence 9999999865422211 223467889999999988753 8999999999999999998 9999999998877766
Q ss_pred HhcCCC---------------cCCCC-----CC-------CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEA---------------LRLPA-----PR-------AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~---------------~~~~~-----p~-------~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
|..--+ ...+. +. .......+++.+||+.+|. |.++...+.
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 653211 01111 11 2224788999999999998 888877654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=322.30 Aligned_cols=259 Identities=29% Similarity=0.505 Sum_probs=214.0
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|+++.++|++.+.||+|+||.||+|.+.. ...+++|.+..... ....+.+|+.++++++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~--------~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNK--------HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecC--------CccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 67889999999999999999999998652 23688887765432 233466899999999999999999998
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.. ...+++|||+++|+|.+++...... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+||
T Consensus 71 ~~-~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 71 TK-EPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred cC-CCeEEEEEeCCCCcHHHHHHhCCcc---ccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCC
Confidence 87 7789999999999999999764221 2456677889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|.+...............++..|+|||++.... ++.++|+|||||++|+|++.|..||.+.+..++...+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05073 147 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-------FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219 (260)
T ss_pred cceeeccCCCcccccCCcccccccCHhHhccCC-------cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 988654333222222234556799999986554 7789999999999999997689999998888777777666
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. .++.+...+.++.+++.+||..+|+ ||++.++...|+.+
T Consensus 220 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 220 Y--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred C--CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 4 5566778899999999999999997 99999999888764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=336.84 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=216.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.-|.+.+.||+|.|++|-+|++- .++.+||||++.+.. +......+.+|+..|+-++|||||+||.+.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV-------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh-------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 34777889999999999999876 567799999997765 3334444569999999999999999999999889
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCeEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT-SELRVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~-~~~~vKl~DFG~a 242 (394)
.+|||+|+-.+|||++||.++.. .+.+..+..++.||+.|+.|||.-.+|||||||+|+.+- .-|.|||+|||++
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccc
Confidence 99999999999999999977633 378888999999999999999999999999999998775 4589999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
-.+.++. ...+.||+..|-|||++.+..| ..+++||||||||||.|+. |+.||...++.+.+.+|+..
T Consensus 167 Nkf~PG~--kL~TsCGSLAYSAPEILLGDsY------DAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTmImDC--- 234 (864)
T KOG4717|consen 167 NKFQPGK--KLTTSCGSLAYSAPEILLGDSY------DAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTMIMDC--- 234 (864)
T ss_pred ccCCCcc--hhhcccchhhccCchhhhcCcc------CCcchhhhHHHHHHHHHHh-CCCccccccchhhhhhhhcc---
Confidence 7766654 2346789999999999998875 3579999999999999996 99999999999999999877
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+...|..++.++.+||+.||+.+|+ |-+..+|+
T Consensus 235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred cccCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 6788999999999999999999998 67777775
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.77 Aligned_cols=249 Identities=18% Similarity=0.270 Sum_probs=199.5
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+|.++. ....+++|.++..........+.+|++++++++|+||++++++|.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKP-------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECC-------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 457889999999999999999999873 3447888887765444444556799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
++.+++||||+++|+|.+++...+. ++......++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999999999999976532 56667778999999999999985 79999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV---- 316 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i---- 316 (394)
++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||......++...+
T Consensus 150 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 218 (333)
T cd06650 150 VSGQLIDS---MANSFVGTRSYMSPERLQGTH-------YSVQSDIWSMGLSLVEMAI-GRYPIPPPDAKELELMFGCPV 218 (333)
T ss_pred cchhhhhh---ccccCCCCccccCHHHhcCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCcchhHHHHHhcCcc
Confidence 98644221 122346788999999987654 7889999999999999998 99999765543332111
Q ss_pred ----------------------------------------hcCCCcCCCCC-CCCChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 317 ----------------------------------------FGTEALRLPAP-RAVNSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 317 ----------------------------------------~~~~~~~~~~p-~~~~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
.... ....+ ...+.++.+++.+||+.||+ ||++.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el 296 (333)
T cd06650 219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL 296 (333)
T ss_pred cCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH
Confidence 1111 01111 13567899999999999998 9999998
Q ss_pred h
Q psy7505 355 G 355 (394)
Q Consensus 355 ~ 355 (394)
+
T Consensus 297 l 297 (333)
T cd06650 297 M 297 (333)
T ss_pred h
Confidence 5
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=322.31 Aligned_cols=254 Identities=31% Similarity=0.573 Sum_probs=210.5
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|.+...+|++.+.||+|+||.||+|..+ +..+++|..+.... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVI 68 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEc---------CCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4566788999999999999999999765 33678888765432 23456899999999999999999976
Q ss_pred E-eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 160 L-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 160 ~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
. .++..+++|||+++|+|.++++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred EcCCCceEEEEECCCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecC
Confidence 4 456789999999999999999764321 256677788999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++....... .....+..|+|||++.... ++.++|||||||++|||++.|+.||......++...+..
T Consensus 146 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 214 (256)
T cd05082 146 FGLTKEASSTQ----DTGKLPVKWTAPEALREKK-------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214 (256)
T ss_pred CccceeccccC----CCCccceeecCHHHHccCC-------CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 99886543221 2234456799999986554 778999999999999999769999998888888777766
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
+. ....+..++..+.+++.+||..+|+ ||++.++++.|+.+
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 GY--KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CC--CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 65 4556678999999999999999998 99999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=322.89 Aligned_cols=260 Identities=33% Similarity=0.553 Sum_probs=216.3
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|+++.++|++.+.||+|+||.||+|.+++ ...+++|.+...... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNG--------TTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcC--------CceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 56788999999999999999999998753 236889988754322 22356899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
......++||||+++++|.+++...... .++...+..++.|++.||.|||+++++|+||||+||+++.++.+||+||
T Consensus 71 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~---~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGK---KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred ecCCceEEEEeccCCCCHHHHHhccccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcc
Confidence 9888999999999999999999764311 2566777889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++...............++..|+|||.+.+.. ++.++|||||||++|||++.|+.||.+......+..+..+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05034 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYGR-------FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220 (261)
T ss_pred ccceeccchhhhhhhccCCCccccCHHHhccCC-------cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 988654332222122223456799999987554 6789999999999999997799999998888888887766
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +.+.+..++..+.+++.+||..+|+ ||++.++...|+.+
T Consensus 221 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 221 Y--RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred C--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 4 5677778899999999999999998 99999999888753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=319.36 Aligned_cols=248 Identities=32% Similarity=0.576 Sum_probs=206.1
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|.... ...+++|.+...........+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~~--------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD--------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecC--------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 368999999999998642 347899988766544444456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... .+.+.....++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 9999999999865422 156677788999999999999999999999999999999999999999999865433222
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAV 330 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~ 330 (394)
.......++..|+|||++.... ++.++||||||+++|||++.|..||.+.........+..+. +...+..+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 219 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGR-------YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKC 219 (250)
T ss_pred ccCCCCCCcccccCHHHhccCC-------CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCC
Confidence 2222234466799999986554 77899999999999999977999999888777777776654 55667789
Q ss_pred ChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 331 NSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 331 ~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+..+.+++.+||..+|+ ||++.|+...|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 99999999999999998 999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.16 Aligned_cols=243 Identities=20% Similarity=0.362 Sum_probs=201.1
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCC-CcceeceeeEEEeC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLR-HVNILRLMAACLES 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 162 (394)
+|++.+.||+|+||.||+|+++. .+..||+|+++... .......+..|..+++.+. |++|+++++++.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG-------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence 46778999999999999999873 45589999887543 2222334557888888774 67788899999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence 999999999999999999876532 567778899999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+....... ......||..|+|||++.+.. ++.++|||||||++|||++ |..||.+....++...+..+
T Consensus 149 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~--- 216 (323)
T cd05615 149 KEHMVDGV-TTRTFCGTPDYIAPEIIAYQP-------YGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSIMEH--- 216 (323)
T ss_pred cccCCCCc-cccCccCCccccCHHHHcCCC-------CCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC---
Confidence 65332221 123446888999999987654 7889999999999999998 99999998888888887765
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
....|..++..+.+++.+||+.+|. |++..
T Consensus 217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 4566778999999999999999998 87753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=331.00 Aligned_cols=266 Identities=26% Similarity=0.449 Sum_probs=214.7
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|+..+.||+|+||.||+|.+..... .....+++|.+...........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGE---TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCC---cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 346788889999999999999998864222 12236788888765544444456789999999999999999999875
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
...++++||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccc
Confidence 457899999999999999876432 146667788999999999999999999999999999999999999999999
Q ss_pred CccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++........ ......++..|+|||.+.+.. ++.++|||||||++|||+++|..||.+....+....+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-------FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCC-------CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 8754322211 122234567899999986554 78899999999999999977999998887776666665554
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+++.+..++..+.+++..||..+|+ ||++.+++..|.++.++
T Consensus 229 --~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 --RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 5666778889999999999999998 99999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=320.84 Aligned_cols=253 Identities=32% Similarity=0.541 Sum_probs=208.9
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
++||+|+||.||+|.+.... .....+++|.............+.+|+.+++.++|+|||++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS----GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccC----CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 46999999999999876322 1235789998876664444455679999999999999999999876 457899999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... +++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 76 LAPLGPLLKYLKKRRE-----IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred eCCCCcHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999976542 56777889999999999999999999999999999999999999999999875533322
Q ss_pred eeeC--CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC
Q psy7505 251 YVHG--EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 251 ~~~~--~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~ 328 (394)
.... ...++..|+|||.+.... ++.++|||||||++|||++.|..||...+..++...+..+. +++.|.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 221 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGK-------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--RLPRPE 221 (257)
T ss_pred ccccccCccccccccCHHHhcCCC-------CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cCCCCC
Confidence 1111 112346799999886554 78899999999999999976999999988888877776665 567788
Q ss_pred CCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.++..+.+++.+||..+|+ ||++.++.+.|+++-
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8999999999999999998 999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.00 Aligned_cols=258 Identities=24% Similarity=0.280 Sum_probs=201.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
..|...+.||+|+||.|+.+.++ .++..||||++.+.. .....+.-.+|+.++++++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~-------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDK-------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred ceecccccccCcceeeEEEEEEc-------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 44555789999999999999988 355699999887433 33333445699999999999999999999875
Q ss_pred ---CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 162 ---SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 162 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
-+.+|+|+|+|. -||.+.|+.+.. ++...+..++.|+++||.|+|+.+|+||||||.|+|++.+..+||+|
T Consensus 95 ~~~f~DvYiV~elMe-tDL~~iik~~~~-----L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 95 RDKFNDVYLVFELME-TDLHQIIKSQQD-----LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred ccccceeEEehhHHh-hHHHHHHHcCcc-----ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 246899999995 499999987643 66777888999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 239 TGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
||+|+...... ....+....|.+|.|||++.... .|+.++||||.|||+.||++ |++-|.|.+..+.+..|.
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~------~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSS------EYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccc------cccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHHH
Confidence 99998764321 11123456788999999986544 39999999999999999998 999998876544433332
Q ss_pred cC-----------------------CCcCCCCC-----CCCChHHHHHHHhhhcCCcc-ccchhhhh--hhhhcCC
Q psy7505 318 GT-----------------------EALRLPAP-----RAVNSHVDVAARNCLVTSEL-RVKIGDTG--SSIDKYP 362 (394)
Q Consensus 318 ~~-----------------------~~~~~~~p-----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~--~~l~~~~ 362 (394)
.- .+...+.| ++.++.+.+|+.++|..||. |+|+.|.+ ..|..+.
T Consensus 242 ~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 242 ELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 11 01111111 47788999999999999998 89998875 3344443
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=336.87 Aligned_cols=237 Identities=19% Similarity=0.328 Sum_probs=191.9
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. ....||+|+++... .......+.+|..++..+ +||||+++++++.+.+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEE
Confidence 368999999999999873 34589999987643 223334466899999888 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
|||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~~~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 9999999999998865532 67778889999999999999999999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH-HHHHHhc
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS--------DDQ-VITRVFG 318 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~--------~~~-~~~~i~~ 318 (394)
... ......||..|+|||++.+.. ++.++|||||||++|||++ |+.||.... ..+ +...+..
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 149 PGD-TTSTFCGTPNYIAPEILRGED-------YGFSVDWWALGVLMFEMMA-GRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred CCC-ccccccCCccccCHHHHcCCC-------CCCccceechHHHHHHHHH-CCCCcccccccccccccchHHHHHHHHc
Confidence 111 223457889999999987654 7889999999999999998 999996321 122 3333443
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
+ .+..|..++..+.+++++||..+|. |+++
T Consensus 220 ~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 220 K---QIRIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred C---CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 3 4566788999999999999999998 8763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=324.15 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=205.7
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEEEEe
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
.||+|+||.||+|+++... ....+++|.++..........+.+|+.+++++ +||||+++++++...+.+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDG-----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCC-----CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 5899999999999986321 22356788776544334444566899999999 89999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhh-----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 171 SCSRGDLKEFLLSNEASR-----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
|+++|+|.+++....... ...+++.....++.|++.||.|||++|++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999997643210 112567778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++..... .........+..|+|||++.... ++.++|||||||++|||++.|..||.+.+..+....+..+
T Consensus 157 gl~~~~~~--~~~~~~~~~~~~y~apE~~~~~~-------~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 227 (270)
T cd05047 157 GLSRGQEV--YVKKTMGRLPVRWMAIESLNYSV-------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227 (270)
T ss_pred CCccccch--hhhccCCCCccccCChHHHccCC-------CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence 98853211 11111123356799999986554 7889999999999999996699999988887777777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
. +++.+..++..+.+++.+||..+|. ||++.|++..|.++.
T Consensus 228 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 Y--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C--CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 4 5566778899999999999999998 999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=319.97 Aligned_cols=255 Identities=33% Similarity=0.601 Sum_probs=214.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|.+..++|++.+.||+|+||.||+|... +..|++|..+.... ....+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~---------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~ 69 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR---------GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVV 69 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec---------CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 3456788999999999999999999865 34789998876654 334466899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+..++||||+++|+|.+++...... .+++.....++.|++.||.|||+++++||||||+||+++.++.+||+||
T Consensus 70 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~ 146 (256)
T cd05039 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDF 146 (256)
T ss_pred cCCCCeEEEEEecCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccc
Confidence 9889999999999999999999765321 2577788899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|.++...... .....+..|+|||.+.... ++.++||||||+++|||++.|..||......++...+..+
T Consensus 147 g~~~~~~~~~----~~~~~~~~~~ape~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 215 (256)
T cd05039 147 GLAKEASQGQ----DSGKLPVKWTAPEALREKK-------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG 215 (256)
T ss_pred cccccccccc----ccCCCcccccCchhhcCCc-------CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 9987552211 1223456799999986554 6789999999999999997699999998888887777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +...+..+++.+.+++++||..+|+ ||++.|+++.|+++
T Consensus 216 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 Y--RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C--CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 4 5566778899999999999999997 99999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=336.62 Aligned_cols=246 Identities=17% Similarity=0.242 Sum_probs=198.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHH-HHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEA-TPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||+||+|+++ ..+..+|+|++.... .......+..|. .+++.++||||+++++++..++.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEE
Confidence 36999999999999976 244589999886543 122222333454 45778999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|..++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 9999999999998876532 56777788999999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......|+..|||||++.+.. ++.++|||||||++|||++ |..||...+..++...+..+ .+..+
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~~~~~---~~~~~ 216 (325)
T cd05604 149 QSD-TTTTFCGTPEYLAPEVIRKQP-------YDNTVDWWCLGAVLYEMLY-GLPPFYCRDVAEMYDNILHK---PLVLR 216 (325)
T ss_pred CCC-CcccccCChhhCCHHHHcCCC-------CCCcCccccccceehhhhc-CCCCCCCCCHHHHHHHHHcC---CccCC
Confidence 211 123446889999999987654 7889999999999999998 99999998888888877765 34455
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
...+..+.+++++||..+|. |+++.+.+..+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 67889999999999999998 8888755544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=334.38 Aligned_cols=238 Identities=20% Similarity=0.271 Sum_probs=193.9
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHH-HHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEA-TPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. .+..+|+|++.... .......+..|. .+++.++||||+++++++.+.+.+|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEE
Confidence 369999999999999863 34578999886543 112222233444 46788999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
|||||++|+|..++..... +.+.....++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRERC-----FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 9999999999988865432 45666778899999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......|++.|+|||++.... ++.++|||||||++|||++ |..||.+.+..++...+..+ .+..|
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~---~~~~~ 216 (321)
T cd05603 149 PEE-TTSTFCGTPEYLAPEVLRKEP-------YDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNILHK---PLQLP 216 (321)
T ss_pred CCC-ccccccCCcccCCHHHhcCCC-------CCCcCcccccchhhhhhhc-CCCCCCCCCHHHHHHHHhcC---CCCCC
Confidence 221 123346788999999986554 7889999999999999998 99999998887877777665 45667
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
...+..+.+++.+||+.+|. |++..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 78899999999999999998 87764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=330.37 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=215.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.+-|.++.+||+|+||.||+|.++ ..+..+|||.+..+.+-.+ +..|+.+|++++.|++|++||.+...
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~-------EsG~v~AIK~VPV~sDLQE---IIKEISIMQQC~S~yVVKYYGSYFK~ 100 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHR-------ESGHVLAIKKVPVDTDLQE---IIKEISIMQQCKSKYVVKYYGSYFKH 100 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHh-------ccCcEEEEEecCccchHHH---HHHHHHHHHHcCCchhhhhhhhhccC
Confidence 3566788899999999999999887 4667899998876654332 56999999999999999999999988
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..+|||||||..|++.+.++-... .+.+..+..++...+.||+|||...-||||||.-|||++.+|..||+|||.|
T Consensus 101 sDLWIVMEYCGAGSiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred CceEeehhhcCCCcHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhcccc
Confidence 999999999999999999975432 3677788889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
..... .....+++.||+.|||||++..-. |+.++||||||++..||.. |++||.+..+...+.+|-...++
T Consensus 177 GQLTD-TMAKRNTVIGTPFWMAPEVI~EIG-------Y~~~ADIWSLGITaIEMAE-G~PPYsDIHPMRAIFMIPT~PPP 247 (502)
T KOG0574|consen 177 GQLTD-TMAKRNTVIGTPFWMAPEVIEEIG-------YDTKADIWSLGITAIEMAE-GRPPYSDIHPMRAIFMIPTKPPP 247 (502)
T ss_pred chhhh-hHHhhCccccCcccccHHHHHHhc-------cchhhhHhhhcchhhhhhc-CCCCcccccccceeEeccCCCCC
Confidence 64432 333455778999999999987655 8899999999999999997 99999999999888888777777
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+..|...++++.++++.||..+|+ |-++.++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLC 281 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHh
Confidence 7778889999999999999999998 76765543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=341.74 Aligned_cols=245 Identities=18% Similarity=0.308 Sum_probs=198.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|+.+. .+..||+|+++... .......+.+|+.++..++|+||+++++.+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 468889999999999999999873 45588999886432 223334566899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKDT-----LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCC
Confidence 999999999999999999976532 567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCce----------------------------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHH
Q psy7505 243 IDKYPGDY----------------------------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWS 288 (394)
Q Consensus 243 ~~~~~~~~----------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwS 288 (394)
........ .......||+.|+|||++.+.. ++.++||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-------~~~~~DiwS 221 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-------YNKLCDWWS 221 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-------CCCcceecc
Confidence 64321100 0011346899999999987655 788999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 289 FGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 289 lG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
|||++|||++ |..||.+.+..+.+.++.... ...+|....+++++.+++.+++. +|. |++
T Consensus 222 lGvilyel~t-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 222 LGVIMYEMLI-GYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred ccceeeeccc-CCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 9999999998 999999988888877776532 22333333578899999998764 776 765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.96 Aligned_cols=256 Identities=20% Similarity=0.289 Sum_probs=204.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+++++. ....+|+|++.... .......+.+|+.++..++|+||+++++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 478899999999999999999873 34478999886432 223334467899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+||||+++|+|.+++.+... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchh
Confidence 999999999999999999976322 2566677889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
...............||+.|||||++..... ....++.++|||||||++|||++ |+.||.+.+..+.+..+.... .
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~ 225 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMED--GKGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHK-E 225 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhcccc--CCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCCHHHHHHHHhCCC-c
Confidence 6543333222334578999999999864321 11237889999999999999998 999999988888877776543 1
Q ss_pred CCCCC---CCCChHHHHHHHhhhcCCccc---cchhhhh
Q psy7505 323 RLPAP---RAVNSHVDVAARNCLVTSELR---VKIGDTG 355 (394)
Q Consensus 323 ~~~~p---~~~~~~~~~l~~~cl~~~p~r---~~~~e~~ 355 (394)
+.+.| ..++..+.+++++|+..+++| +++.|+.
T Consensus 226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~ 264 (332)
T cd05623 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK 264 (332)
T ss_pred cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh
Confidence 33333 467999999999999876654 5666664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=351.88 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=227.2
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceE
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWL 166 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 166 (394)
+...++||+|+||.||+|.|--. ....+.+||+|++...........++.|+-+|.+|+|||+++|+|+|..+. +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pe---ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPE---GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecC---CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34456899999999999998632 224456899999988776655566789999999999999999999998755 89
Q ss_pred EEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 167 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
||++|++.|+|.+|++.++.. +.....+.|..||++||.|||+++++||||..+|+|+..-..+||.|||+++...
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDN----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHhcccchHHHHHHHhhcc----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999999986542 5666778899999999999999999999999999999999999999999998764
Q ss_pred CCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCC
Q psy7505 247 PGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325 (394)
Q Consensus 247 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 325 (394)
.... +.......++.|||-|.+.... |+.++|||||||++||++|+|..||.+....++-..+..|+ |++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~-------~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--RLs 920 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRK-------YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--RLS 920 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccC-------CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--cCC
Confidence 4332 3333446678899999987665 89999999999999999999999999999999988888887 899
Q ss_pred CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 326 APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 326 ~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
.|+.|+-.++.+|.+||..|++ ||+++++.+++.+...|.
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 9999999999999999999998 999999999888887764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.57 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=194.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+.+. ....||+|+++..........+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV-------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC-------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 4789999999999999999999862 345789998865443222334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+. |+|.+++..... .+....+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 9999999995 689888865422 15666778899999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhc--CC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFG--TE 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~--~~ 320 (394)
....... ......++..|+|||++.+.. .++.++|||||||++|||++ |..||.+.... +.+..+.. +.
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 223 (303)
T cd07869 152 AKSVPSH-TYSNEVVTLWYRPPDVLLGST------EYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKDIQDQLERIFLVLGT 223 (303)
T ss_pred eccCCCc-cCCCCcccCCCCChHHHcCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHHHHHHhCC
Confidence 4322211 122346788899999986533 27889999999999999998 99999876532 22222211 00
Q ss_pred C------------------cCCCCC---------CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 321 A------------------LRLPAP---------RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 321 ~------------------~~~~~p---------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
. .....+ ...+..+.+++++||+.||+ |+|+.|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 0 000001 12346788999999999998 99998875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=320.07 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=208.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
+|++.+.||+|+||.||+++++. ....+++|.++..........+.+|+.+++.++|+||+++++.+.+++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 47889999999999999999873 34578899876544334444566899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||+++|+|.+++..... ..++......++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 999999999999999865322 12566778889999999999999999999999999999999999999999988654
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCC
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 325 (394)
..... ......++..|+|||++.+.. ++.++|+||||+++|+|++ |..||...+.......+..+. ..+
T Consensus 151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~-------~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~~ 219 (255)
T cd08219 151 TSPGA-YACTYVGTPYYVPPEIWENMP-------YNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGS--YKP 219 (255)
T ss_pred ccccc-ccccccCCccccCHHHHccCC-------cCchhhhhhhchhheehhh-ccCCCCCCCHHHHHHHHhcCC--CCC
Confidence 32221 122345778899999986554 7889999999999999998 999999888777777776665 445
Q ss_pred CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 326 APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 326 ~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
.|..++..+.+++++||..+|+ ||++.+++.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 6778899999999999999998 9999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.96 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=203.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+++++. ....||+|++.... .......+.+|..++..++|+||+++++++.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 478999999999999999999873 34478999886532 233344567889999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..|+||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccce
Confidence 999999999999999999976321 2566677889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
...............|++.|+|||++.+.... ...++.++|||||||++|||++ |+.||.+.+..+.+..+.... .
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~-~ 225 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDG--MGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHE-E 225 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccC--CCCCCCcccEEeeehhhhhhhh-CCCCccCCCHHHHHHHHHcCC-C
Confidence 75543332223345689999999998653211 1127789999999999999998 999999888777777776542 1
Q ss_pred CCCCCC---CCChHHHHHHHhhhcCCcccc---chhhhh
Q psy7505 323 RLPAPR---AVNSHVDVAARNCLVTSELRV---KIGDTG 355 (394)
Q Consensus 323 ~~~~p~---~~~~~~~~l~~~cl~~~p~r~---~~~e~~ 355 (394)
+++.|. .++..+.+++++|+..+++|+ ++.++.
T Consensus 226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~ 264 (331)
T cd05624 226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFK 264 (331)
T ss_pred cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHh
Confidence 344443 468999999999999776653 455553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=326.35 Aligned_cols=242 Identities=19% Similarity=0.278 Sum_probs=195.4
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.|++.+.||+|+||.||++.+.. ....||+|.+.... .......+.+|+.+++.++||||+++++.+.+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC
Confidence 37788999999999999998762 34589999886543 1222334568999999999999999999999989
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 99999999999999988865322 125777788899999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHhcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV----ITRVFGT 319 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~----~~~i~~~ 319 (394)
....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+...... ...+..+
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~-------~~~~~Diws~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05605 151 EIPEGET--IRGRVGTVGYMAPEVVKNER-------YTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVKREEVERRVKED 220 (285)
T ss_pred ecCCCCc--cccccCCCCccCcHHhcCCC-------CCccccchhHHHHHHHHHH-CCCCCCCCchhhHHHHHHHHhhhc
Confidence 5432221 12346788999999986554 7889999999999999998 9999988654332 2223222
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
....+..++..+.+++.+||..||+ |++
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred ---ccccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 3445667899999999999999998 894
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.62 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=213.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCC-CcceeceeeEEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLR-HVNILRLMAACL 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 160 (394)
...|++.+.||+|.||.||+|+.+. ++..+|+|.+.+... ......+.+|+.+|+++. |||||.++++|.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~-------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS-------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC-------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 5779999999999999999999884 355889998876552 222345679999999998 999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CeEEE
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE----LRVKI 236 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~----~~vKl 236 (394)
+...+++|||+|.||+|++.|... . +++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-----~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-----H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-----c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEE
Confidence 999999999999999999999765 1 6778888999999999999999999999999999999654 47999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|..... .......+||+.|+|||++.... |+..+||||+||++|.|++ |..||.+.+..+....|
T Consensus 181 ~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~-------y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~~~~~~~i 250 (382)
T KOG0032|consen 181 IDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRP-------YGDEVDVWSIGVILYILLS-GVPPFWGETEFEIFLAI 250 (382)
T ss_pred eeCCCceEccC--CceEeeecCCccccCchhhcCCC-------CCcccchhHHHHHHHHHhh-CCCCCcCCChhHHHHHH
Confidence 99999987655 22445678999999999997655 8999999999999999997 99999999988888888
Q ss_pred hcCCC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.. ...+....++..+.++++.++..||. |.++.+++.
T Consensus 251 ~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 251 LRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 87753 11222347899999999999999998 889988876
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.40 Aligned_cols=237 Identities=20% Similarity=0.334 Sum_probs=190.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|+++. ....+|+|+++... .......+.+|+.++.++ +||||+++++++...+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEE
Confidence 369999999999999873 34578999887543 223334456788887766 89999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|..++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~~~~~~~-----l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 9999999999998866532 56777888999999999999999999999999999999999999999999865322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------C-HHHHHHHHhc
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL--------S-DDQVITRVFG 318 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~--------~-~~~~~~~i~~ 318 (394)
... ......||..|+|||++.+.. ++.++|||||||++|||++ |..||... . ...+...+..
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 149 PGD-TTSTFCGTPNYIAPEILRGED-------YGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred CCC-ccccccCCccccCHHHHcCCC-------CCCccceecccHHHHHHhh-CCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 111 223456889999999987654 7889999999999999998 99999531 1 1223344444
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
. ....|..++..+.+++++||..+|+ |+++
T Consensus 220 ~---~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 K---QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C---CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 3 4567788999999999999999998 8874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=334.26 Aligned_cols=252 Identities=18% Similarity=0.236 Sum_probs=192.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
+|++.+.||+|+||.||+|+++. .+..||+|.++... .......+.+|+.++++++||||+++++++...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 48889999999999999999863 45589999886432 2222334568999999999999999999986432
Q ss_pred ----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 164 ----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 164 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+|+|||||. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 74 REFKDIYVVFELME-SDLHQVIKANDD-----LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccC
Confidence 4799999995 699999876532 567778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 240 GSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 240 G~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|+++....... .......+|..|+|||++..... .++.++|||||||++|||++ |+.||.+.+....+..+.
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-----~~~~~~DvwSlGvvl~el~t-g~~pf~~~~~~~~~~~~~ 221 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS-----KYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLIT 221 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhcccc-----ccCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Confidence 99875422211 11123467889999999864211 27889999999999999998 999998766433222111
Q ss_pred c-----------------------CCCcCCCC-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 G-----------------------TEALRLPA-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~-----------------------~~~~~~~~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ......+. -..+++.+.+++++||..+|+ ||++.|++.
T Consensus 222 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 222 DLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 00000111 124677899999999999998 999998863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=333.24 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=202.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+++.+. ....||+|++.... .......+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 478999999999999999999873 34589999986432 233344567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+||||+++|+|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCce
Confidence 999999999999999999965321 2566777889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA- 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~- 321 (394)
...............||+.|||||++...... ...++.++|||||||++|||++ |+.||.+.+..+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDG--KGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHKEH 226 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhcccc--ccCCCCcceeehhhhHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCc
Confidence 65443332222234688999999998643211 1127889999999999999998 9999998887777766654321
Q ss_pred cCCC-CCCCCChHHHHHHHhhhcCCcc---ccchhhhh
Q psy7505 322 LRLP-APRAVNSHVDVAARNCLVTSEL---RVKIGDTG 355 (394)
Q Consensus 322 ~~~~-~p~~~~~~~~~l~~~cl~~~p~---r~~~~e~~ 355 (394)
..++ ....++..+.+++++|+..+++ |+++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l 264 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFK 264 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 1222 2235789999999999876554 45666664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=328.12 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=193.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccC---CCcceeceeeEEE
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRL---RHVNILRLMAACL 160 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~ 160 (394)
++|++.+.||+|+||.||+|++.. ..+..||+|.++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 468889999999999999998752 1234688888764331 11112234666666554 7999999999986
Q ss_pred e-----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 161 E-----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 161 ~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
. ...+++||||+. |+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~k 150 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 150 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEE
Confidence 2 456899999996 5999998754221 256777889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||++...... .......++..|+|||++.... ++.++|||||||++|||++ |..||.+....+.+..
T Consensus 151 l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~ 220 (290)
T cd07862 151 LADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSS-------YATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGK 220 (290)
T ss_pred EccccceEeccCC--cccccccccccccChHHHhCCC-------CCCccchHHHHHHHHHHHc-CCCCcCCCCHHHHHHH
Confidence 9999998654322 1223446788999999986554 7889999999999999998 9999998887776666
Q ss_pred HhcCCCcCC----C--------------------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRL----P--------------------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~----~--------------------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+........ + ....++..+.+++.+||+.+|+ ||++.|++.
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 643211000 0 0124677889999999999998 999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=346.88 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=205.8
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEee
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFES 171 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 171 (394)
.||+|.||+||-|+++. +....|||-+....+... .-+..|+.+.++|+|.|||+++|.+..++.+-|.||-
T Consensus 582 VLGKGTYG~VYA~RD~~-------tqvrIaIKEIpekdsr~~-QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD-------TQVRIAIKEIPEKDSREV-QPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeecccc-------ceeEEEeeecccccchhh-ccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 59999999999999883 444778888765544333 3456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEEccCCCCccCCCCce
Q psy7505 172 CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 172 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl~DFG~a~~~~~~~~ 250 (394)
.+||+|.++|+.....-. -.+...-.+..||+.||.|||++.|||||||.+|+||+. .|.+||+|||.++.... -.
T Consensus 654 VPGGSLSsLLrskWGPlK--DNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-in 730 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLK--DNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-IN 730 (1226)
T ss_pred CCCCcHHHHHHhccCCCc--cchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CC
Confidence 999999999986532111 145556678999999999999999999999999999975 69999999998876432 22
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAV 330 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~ 330 (394)
-++.++.||..|||||++..+.-+ |+.++|||||||++.||.| |++||-+....+....-.+.....+|+|..+
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RG-----YG~aADIWS~GCT~vEMAT-GrPPF~ElgspqAAMFkVGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRG-----YGKAADIWSFGCTMVEMAT-GRPPFVELGSPQAAMFKVGMYKVHPPIPEEL 804 (1226)
T ss_pred ccccccccchhhhChHhhccCCcC-----CCchhhhhhccceeEeecc-CCCCeeecCChhHhhhhhcceecCCCCcHHH
Confidence 345567899999999999876533 9999999999999999998 9999998876655444445666688999999
Q ss_pred ChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 331 NSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 331 ~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+.+++++|.+|+..+|. ||++.+++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhc
Confidence 99999999999999997 99999875
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=305.98 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=211.7
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+....++++++..||.|+.|.|++++.+ .++...|||.+.......+.++++..+.++.+- +.|.||+.+|
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~r-------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFR-------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEc-------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence 44445677788889999999999999998 345588999998887666666677778776665 5899999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEE
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+|..+..++|.||.|.. .+..+++.-... +++..+-.+...++.||.||.+ ++|||||+||+|||+|+.|.+|+
T Consensus 159 yFi~n~dV~IcMelMs~-C~ekLlkrik~p----iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKl 233 (391)
T KOG0983|consen 159 YFITNTDVFICMELMST-CAEKLLKRIKGP----IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKL 233 (391)
T ss_pred EEeeCchHHHHHHHHHH-HHHHHHHHhcCC----chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEe
Confidence 99999999999999854 666666543221 5666777788889999999975 58999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITR 315 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~ 315 (394)
||||+|-...... ..+..+|.+.|||||.+.-... ..|+.++||||||++|+||.| |..||.+.+ +.+++.+
T Consensus 234 CDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~~~----~kYDiRaDVWSlGITlveLaT-g~yPy~~c~tdFe~ltk 306 (391)
T KOG0983|consen 234 CDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPPDK----PKYDIRADVWSLGITLVELAT-GQYPYKGCKTDFEVLTK 306 (391)
T ss_pred ecccccceeeccc--ccccccCCccccCccccCCCCC----Cccchhhhhhhhccchhhhhc-ccCCCCCCCccHHHHHH
Confidence 9999986543322 3334567788999999976532 249999999999999999998 999999854 7789999
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
|++.+++.++.-..+++.+.+++..||..|+. ||.-.+++
T Consensus 307 vln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 307 VLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred HHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 99988777777778999999999999999997 88876654
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=320.13 Aligned_cols=243 Identities=20% Similarity=0.326 Sum_probs=211.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+.-++|++++.||+|.||+|.+|+-+. +++.+|+|++++.- ...+.+.-+.|-.+|+..+||.+..|...|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKa-------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKA-------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecc-------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 445788999999999999999999873 55688999998764 233333445789999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
+..+++|+||||..||.|+-+|... ..+++.....+..+|+.||.|||+++||.||||.+|+|+|.+|++||+||
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeec
Confidence 9999999999999999999888553 34677778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+++...... ....+.|||+.|+|||++.... |+.++|+|.+||++|||+. |+.||...+...++..|+.+
T Consensus 313 GLCKE~I~~g-~t~kTFCGTPEYLAPEVleDnD-------YgraVDWWG~GVVMYEMmC-GRLPFyn~dh~kLFeLIl~e 383 (516)
T KOG0690|consen 313 GLCKEEIKYG-DTTKTFCGTPEYLAPEVLEDND-------YGRAVDWWGVGVVMYEMMC-GRLPFYNKDHEKLFELILME 383 (516)
T ss_pred ccchhccccc-ceeccccCChhhcCchhhcccc-------ccceeehhhhhHHHHHHHh-ccCcccccchhHHHHHHHhh
Confidence 9997643322 2345789999999999998876 8999999999999999997 99999999888888888766
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCccc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSELR 348 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~r 348 (394)
.+.+|+.+++++..|+..+|..+|+.
T Consensus 384 ---d~kFPr~ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 384 ---DLKFPRTLSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred ---hccCCccCCHHHHHHHHHHhhcChHh
Confidence 57889999999999999999999983
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=343.98 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=193.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.+..+|++.+.||+|+||.||+|.+.. ....||+|.+..... ...+|+.+|+.++|||||++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICID-------TSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECC-------CCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEee
Confidence 346789999999999999999999863 345789998754332 22479999999999999999998753
Q ss_pred C--------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-
Q psy7505 162 S--------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL- 232 (394)
Q Consensus 162 ~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~- 232 (394)
. ..+++||||+++ +|.+++..... ....++...+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC
Confidence 2 246799999975 78777754211 112266777888999999999999999999999999999998664
Q ss_pred eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
.+||+|||+|+....... .....+|..|+|||++.+.. .++.++|||||||++|||++ |.+||.+.+..+.
T Consensus 209 ~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~ 279 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGAT------NYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQ 279 (440)
T ss_pred ceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHH
Confidence 799999999975533221 12346688899999986543 27899999999999999998 9999998876655
Q ss_pred HHHHhcCC--------------------------CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 313 ITRVFGTE--------------------------ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 313 ~~~i~~~~--------------------------~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+.++.... .++...|...+.++.+++.+||..+|. |+++.|++
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 44432210 001113446788999999999999998 99998886
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.74 Aligned_cols=250 Identities=20% Similarity=0.304 Sum_probs=208.1
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|.++. ....+++|.+.... .......+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 47788999999999999999873 34578888876432 33444556789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++++|.+++..... ..++......++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEccccccee
Confidence 9999999999999999976421 1256777788999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
....... .....++..|+|||++.... ++.++|+|||||++|||++ |+.||......+....+..+. ..
T Consensus 151 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~ 219 (256)
T cd08529 151 LSDNTNF-ANTIVGTPYYLSPELCEDKP-------YNEKSDVWALGVVLYECCT-GKHPFDANNQGALILKIIRGV--FP 219 (256)
T ss_pred ccCccch-hhccccCccccCHHHhcCCC-------CCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC--CC
Confidence 4433221 22345678899999987654 6789999999999999998 999999888877777777665 44
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..++..+.+++++||+.+|+ ||++.+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 55568899999999999999998 999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=310.72 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=211.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------cHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------SQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
+.|.-.+.||+|..+.|-+|..+ .++...|+|++.... .....+.-++|+.||+++ .||||+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k-------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHK-------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhc-------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 44555678999999999988876 345577777775432 111222235799999998 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
++++.+..+++|+|.|+.|.|+++|.+.- .+++.....+++|+..|+.|||.++||||||||+|||++++.++||
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEE
Confidence 99999999999999999999999997542 3778888999999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|.....+. .....|||+.|+|||.+.++.+. +...|+..+|+||+|||+|-|+. |.+||......-++..|
T Consensus 165 sDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e-~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 165 SDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYE-NHPGYSKEVDEWACGVIMYTLLA-GCPPFWHRKQMLMLRMI 240 (411)
T ss_pred eccceeeccCCch--hHHHhcCCCcccChhheeeeccc-CCCCccchhhHHHHHHHHHHHHc-CCCchhHHHHHHHHHHH
Confidence 9999998776655 23467999999999999987653 33348999999999999999998 99999887666667778
Q ss_pred hcCCC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 FGTEA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 ~~~~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
++|.. .+-|...+++..+++|+.+||+.||. |.|..|.+
T Consensus 241 meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 241 MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 77642 33344568999999999999999998 99988875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=323.65 Aligned_cols=241 Identities=18% Similarity=0.247 Sum_probs=191.7
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||+|+||+||+|.++. ++..+|+|.+...... .....+..|+.+++.++|+||+++++++..++.+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRA-------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEcc-------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEe
Confidence 6999999999999873 4458899988654321 122345689999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 74 ~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 74 IMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred CCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9999999988854321 112267778888999999999999999999999999999999999999999999865433221
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhcCCCcCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----DQVITRVFGTEALRLPA 326 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~ 326 (394)
......++..|+|||++.+.. ++.++|||||||++|||++ |+.||..... .++...+..+ ....
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~---~~~~ 220 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEE-------YDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRILND---SVTY 220 (280)
T ss_pred -cccccCCCcCccCHHHhcCCC-------CCccccHHHHHHHHHHHHh-CCCCCCCCCcchhHHHHHHhhccc---CCCC
Confidence 122346788999999987654 7889999999999999998 9999976542 2333333332 3455
Q ss_pred CCCCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 327 PRAVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 327 p~~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
|..++..+.+++.+||..+|+ |+++.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 678899999999999999998 886544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=316.29 Aligned_cols=272 Identities=28% Similarity=0.466 Sum_probs=236.4
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
+..+.++++++...+-+|.||.||.|.|+..+.. ...+.|.+|.++...++.....++.|...+..+.|||+..+.++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~--n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY--NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCc--chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455677888888999999999999999843333 33447889999999998888889999999999999999999999
Q ss_pred EEe-CCceEEEEeeCCCCCHHHHHhhcch---hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 159 CLE-SDPWLLVFESCSRGDLKEFLLSNEA---SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 159 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+.. ....+.++.++..|+|..||+..+. .....+.....+.++.|++.||.|||++||||.||..+|++|++..+|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 865 4567889999999999999983221 112235556778899999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCc-cCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEV-ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+|=.+++..++.++.+.+.. ..++.||+||.+.... |+.++|+|||||+||||+|.|+.||.+.++.++.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-------yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-------YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-------hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 9999999999999888766544 5688999999998776 8899999999999999999999999999999999
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
..+..|+ |+..|-+||+++..+|..||+..|+ ||++.++..-|.++
T Consensus 509 ~ylkdGy--RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 509 HYLKDGY--RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHhccc--eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 9999887 9999999999999999999999998 99999988766654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.11 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=202.3
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC--C
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES--D 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~ 163 (394)
.|++.+.||+|+||+||++.++... ......||+|.++..........+.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPAN---DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hceeceecccCCCcEEEEeeEcccc---CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 3488899999999999998765322 1234578999887654433444566899999999999999999988653 3
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||+++|+|.+++.... +++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~------l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 5899999999999999996542 5777788999999999999999999999999999999999999999999987
Q ss_pred cCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Q psy7505 244 DKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD----------- 310 (394)
Q Consensus 244 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~----------- 310 (394)
........ ......++..|+|||.+.... ++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENK-------FSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQ 227 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccC-------CCcccccHHHHHHHHHHHh-CCCCCCCCcchhhhhhcccccc
Confidence 54332211 111224556799999886554 7789999999999999998 99998653211
Q ss_pred ----HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 311 ----QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 311 ----~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.+...+..+ ...+.+..++..+.+++.+||+.+|+ ||++.+++..|+++.
T Consensus 228 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 228 MTVVRLIELLERG--MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cchhhhhhhhhcC--CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111112222 24566778899999999999999998 999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.61 Aligned_cols=253 Identities=32% Similarity=0.525 Sum_probs=208.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|.+.. ...+++|.++...... ..+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~--------~~~~~~k~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE--------KRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC--------CCeEEEEECCCCCCCH--HHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 4578889999999999999998752 2368888876543221 23568999999999999999999999989
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+.+|+|.+++..... .+.+..+..++.|++.|+.|||+++++||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCccee
Confidence 99999999999999999875422 15667778899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
..............++..|+|||.+.+.. ++.++|||||||++|||++.|..||......+....+..+. +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-------~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~ 219 (256)
T cd05112 149 FVLDDQYTSSTGTKFPVKWSSPEVFSFSK-------YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--R 219 (256)
T ss_pred ecccCcccccCCCccchhhcCHhHhccCC-------cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--C
Confidence 54333222222334567899999987554 77899999999999999976899999888888887776664 5
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
...|...+..+.+++++||+.+|+ ||++.|++..|+
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 555677899999999999999998 999999988763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=330.25 Aligned_cols=239 Identities=18% Similarity=0.302 Sum_probs=192.5
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||+||+|+.+. ....+|+|+++... .......+.+|+.++.++ +||||+++++++.+.+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEE
Confidence 369999999999999873 34578999987653 223334566888888888 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQRK-----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 9999999999998865432 67777889999999999999999999999999999999999999999999864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHhcCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL------SDDQVITRVFGTEA 321 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~------~~~~~~~~i~~~~~ 321 (394)
... ......||..|+|||++.+.. ++.++|||||||++|||++ |..||... ...+.+..+....
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~- 218 (327)
T cd05617 149 PGD-TTSTFCGTPNYIAPEILRGEE-------YGFSVDWWALGVLMFEMMA-GRSPFDIITDNPDMNTEDYLFQVILEK- 218 (327)
T ss_pred CCC-ceecccCCcccCCHHHHCCCC-------CCchheeehhHHHHHHHHh-CCCCCCccCCCcccccHHHHHHHHHhC-
Confidence 111 123456889999999987654 7889999999999999998 99999632 2223333333333
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
....|..++..+.+++++||..+|+ |+++.
T Consensus 219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 4566788999999999999999998 87753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=336.12 Aligned_cols=246 Identities=18% Similarity=0.181 Sum_probs=190.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|++++.||+|+||.||+|.++ .+...||+|.... ..+.+|+.++++++|||||++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~-------~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDN-------KTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEEC-------CCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 45678999999999999999999987 3455889986532 124589999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+...++|||++. ++|..++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAKRN-----IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCc
Confidence 999999999995 699998865432 56677888999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-------DDQVIT 314 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-------~~~~~~ 314 (394)
|+..............||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.. ....+.
T Consensus 229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 229 ACFPVDINANKYYGWAGTIATNAPELLARDP-------YGPAVDIWSAGIVLFEMAT-CHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred ccccccccccccccccCccCCCChhhhcCCC-------CCcHHHHHHHHHHHHHHHH-CCCCcCCcccccccCchhHHHH
Confidence 8643222211223457899999999987654 7899999999999999998 887764321 111111
Q ss_pred HHhc--CC-----------------------CcCCC--CC-----CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 315 RVFG--TE-----------------------ALRLP--AP-----RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 315 ~i~~--~~-----------------------~~~~~--~p-----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+.. +. ....+ .| ..++.++.+++++||+.||+ ||++.|++
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 1110 00 00000 00 13466889999999999998 99999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=320.83 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=209.0
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.+.+.|++++.||+|+||.||+|++.. ....+++|.+...... ....+.+|+.+++.++|+||+++++.+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~-------~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKE-------TGALAAAKVIETKSEE-ELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECC-------CCceEEEEEeccCCHH-HHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 356789999999999999999998863 3447888887655433 33345689999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+++||||+++|+|..++.+... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcc
Confidence 9999999999999999988765322 256777888999999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+....... .......++..|+|||++..... ....++.++|||||||++|||++ |..||...+..+...++.....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 232 (292)
T cd06644 157 SAKNVKTL-QRRDSFIGTPYWMAPEVVMCETM--KDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEP 232 (292)
T ss_pred ceeccccc-cccceecCCccccCceeeccccc--cCCCCCchhhhHhHHHHHHHHhc-CCCCCccccHHHHHHHHhcCCC
Confidence 76432211 11123356778999999864331 12237889999999999999998 9999988777666666665554
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+..++..+.+++++||..+|+ ||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 45566778889999999999999998 999998863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=315.19 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=203.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc----HHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS----QAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++|++.+.||+|+||.||+|... .....+++|.+..... ......+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 74 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR 74 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence 46788899999999999999876 2345788888754321 122334678999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
.++.+++||||+++++|.+++..... ++......++.|++.||.|||+.||+||||+|+||+++.++.+||+|||
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 99999999999999999999876432 5666778899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeee--CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 241 SSIDKYPGDYYVH--GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 241 ~a~~~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
++........... ....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+....+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 221 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-------YGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIAT 221 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCC-------CCchhhhHHHHHHHHHHHh-CCCCccccchHHHHHHHhc
Confidence 9865432211111 2235677899999987654 7789999999999999998 9999988766655555443
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. .....|..++..+.+++++||..+|+ ||++.|++.
T Consensus 222 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 222 QP-TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred cC-CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 32 24566778999999999999999998 999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.27 Aligned_cols=246 Identities=17% Similarity=0.255 Sum_probs=193.4
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||+|+||.||+++.+. .+..+++|.+..... ......+..|++++++++||||+++++++.++..+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEcc-------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEe
Confidence 6999999999999873 355789998764321 1122334579999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 74 ~~~g~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 74 LMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred cCCCCCHHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 99999999888654321 156667788999999999999999999999999999999999999999999865433221
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhcCCCcCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----DQVITRVFGTEALRLPA 326 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~ 326 (394)
.....++..|+|||++.... ++.++|||||||++|||++ |..||.+... .++........ ... .
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslGv~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~-~ 218 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEP-------YSYPVDWFAMGCSIYEMVA-GRTPFKDHKEKVAKEELKRRTLEDE-VKF-E 218 (277)
T ss_pred --eeccCCCCCccCHHHHccCC-------CCCchhHHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHHHhhccc-ccc-c
Confidence 22346788999999986654 7889999999999999998 9999976432 33344443332 111 2
Q ss_pred CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 327 PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 327 p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
...++.++.+++++||+.+|+ ||++.|+++.+..
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 246889999999999999998 9999887644443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=320.21 Aligned_cols=247 Identities=22% Similarity=0.255 Sum_probs=188.7
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC--
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD-- 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 163 (394)
.|.-.+.+|.|+||.||+|.... ....||||..-.+... -.+|+++|+.++|||||+|..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e-------~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE-------TEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC-------CCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 46667899999999999999873 3458999887555432 247999999999999999998887422
Q ss_pred ---ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEEccC
Q psy7505 164 ---PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGDT 239 (394)
Q Consensus 164 ---~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl~DF 239 (394)
...+||||++. +|+++++...... ..++.-.+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+|||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccC
Confidence 34689999987 9999998521111 113444566788999999999999999999999999999976 99999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG- 318 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~- 318 (394)
|.|+....++.. .....|..|.|||.+.+... |+.+.||||.|||+.||+- |++-|.|.+..+.+..|.+
T Consensus 171 GSAK~L~~~epn--iSYicSRyYRaPELifga~~------Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 171 GSAKVLVKGEPN--ISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVMAELLK-GQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred CcceeeccCCCc--eeEEEeccccCHHHHcCccc------cCceeEEhhhhHHHHHHhc-CCcccCCCCHHHHHHHHHHH
Confidence 999876544422 12234567999999988763 9999999999999999996 9999999886655443322
Q ss_pred --CCC-------------cCCC----------CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 319 --TEA-------------LRLP----------APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 319 --~~~-------------~~~~----------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
... .+.| ....+++++.+++.++|+.+|. |-+..|++
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 110 0001 1236788999999999999998 66655543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=320.76 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=205.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+.|++.+.||+|+||.||+|.+.. ....+++|.+...... ....+.+|+.+++.++|+||+++++++..++.
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKE-------TGVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECC-------CCeEEEEEEeCCCCHH-HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 446778889999999999999873 3346778877544332 33345689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|..++..... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELER----PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 9999999999999988764321 256777888999999999999999999999999999999999999999999865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
..... .......++..|+|||++..... ....++.++|||||||++|||++ |..||...+..+....+.......+
T Consensus 153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd06643 153 NTRTI-QRRDSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPPTL 228 (282)
T ss_pred ccccc-cccccccccccccCHhhccccCC--CCCCCCccchhhhHHHHHHHHcc-CCCCccccCHHHHHHHHhhcCCCCC
Confidence 43221 12233467888999999853321 12237789999999999999997 9999998887777666666554456
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+.|..++.++.+++++||..+|. ||++.+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 66778899999999999999998 99998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=314.61 Aligned_cols=256 Identities=39% Similarity=0.653 Sum_probs=213.4
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|.+.... .....+++|.+...........+.+|+.+++.++|+||+++++++..+..+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD----GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCC----CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 36899999999999987321 22558899998876654445567799999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchh----hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 171 SCSRGDLKEFLLSNEAS----REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
|+++|+|.+++...... ....+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999999764110 01226788889999999999999999999999999999999999999999999987654
Q ss_pred CCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCC
Q psy7505 247 PGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325 (394)
Q Consensus 247 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 325 (394)
.... .......++..|+|||.+.... ++.++|||||||++|||++.|..||.+....++...+..+. +.+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~ 227 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGI-------FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RLP 227 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCC-------cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCC
Confidence 3321 1122345677899999886653 78899999999999999986799999998888888887765 677
Q ss_pred CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 326 APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 326 ~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
.|..++..+.+++.+||..+|+ ||++.|++..|+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7888999999999999999998 999999988763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.65 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=211.7
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
|.++|++.+.||+|+||.||+|.++. ....+++|........ ....+.+|+.++++++|+||+++++++..+
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKE-------TGLFAAAKIIQIESEE-ELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcC-------CCcEEEEEEEeeCCHH-HHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 35678899999999999999999863 3447888887654333 233466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..|+||||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccc
Confidence 999999999999999999875422 2677788899999999999999999999999999999999999999999987
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... .......++..|+|||.+..... ....++.++|||||||++|||++ |+.||.+....+.+..+..+...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~--~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 226 (280)
T cd06611 151 AKNKSTL-QKRDTFIGTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLLKILKSEPP 226 (280)
T ss_pred hhhcccc-cccceeecchhhcCHHHHhhccc--CCCCCCccccHHHHHHHHHHHHh-CCCCcccCCHHHHHHHHhcCCCC
Confidence 5432221 11223457788999999864431 12236789999999999999998 99999998877777777777655
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..|..++.++.+++++||..+|. ||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 6667778999999999999999998 999998853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.13 Aligned_cols=258 Identities=37% Similarity=0.635 Sum_probs=206.9
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEee
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFES 171 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 171 (394)
.||+|+||.||+|+++.... .......+++|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILG-PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeeccccc-CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998864221 11223468888876554333344567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcchh--hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-----eEEEccCCCCcc
Q psy7505 172 CSRGDLKEFLLSNEAS--REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-----RVKIGDTGSSID 244 (394)
Q Consensus 172 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-----~vKl~DFG~a~~ 244 (394)
+++|+|.+++...... ....+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999754221 112256677888999999999999999999999999999999877 899999999865
Q ss_pred CCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 245 KYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 245 ~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
........ .....++..|+|||.+.... ++.++|||||||++|||++.|..||......+....+..+. +
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~ 231 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK-------FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG--R 231 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC-------cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC--c
Confidence 43332211 12234567899999987654 78899999999999999977999999888777777765554 5
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+..+..++..+.+++++||..+|. ||++.++.+.|+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 666778899999999999999998 999999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=313.66 Aligned_cols=253 Identities=31% Similarity=0.498 Sum_probs=208.0
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|.+... ......|++|.+...........+.+|+.++++++||||+++++++.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS----GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecC----CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 3689999999999998632 123346899998776653444556799999999999999999999988 88999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... ..+++.....++.|++.||.|||+++++||||||+||+++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999999976532 2257778888999999999999999999999999999999999999999999876533211
Q ss_pred --eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCC
Q psy7505 251 --YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 251 --~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~ 328 (394)
.......++..|+|||.+.... ++.++|||||||++|||+++|..||...+..++...+... ...++.+.
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~-------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRT-------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-GERLERPE 224 (257)
T ss_pred ceecccCCCCCceecCHHHhcccC-------cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCcCCCCc
Confidence 1112235667899999986654 7889999999999999997799999988888776666532 23566677
Q ss_pred CCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
.++..+.+++.+||..+|+ ||++.|+++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 8899999999999999998 999999988775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=317.83 Aligned_cols=247 Identities=20% Similarity=0.323 Sum_probs=190.5
Q ss_pred eeeeecceEEEEEEEcCcccc-----------------cCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceec
Q psy7505 92 EIGRGWFGKVVEGEARGLEES-----------------TGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~-----------------~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
.||+|+||.||+|.+...... .......|++|++......... .+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~-~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHH-HHHHHHHHHhcCCCCCeee
Confidence 599999999999986421110 1122346888888655433333 3558899999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-- 232 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-- 232 (394)
+++++.+.+..++||||+++|+|..++..... .+++..+..++.|++.||.|||+++|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999999875422 256667788999999999999999999999999999997643
Q ss_pred -----eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 233 -----RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 233 -----~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
.+|++|||++...... ....++..|+|||.+.... .++.++|||||||++|||+..|..||.+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~------~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGN------SLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCC------CCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 4899999987543221 1234567799999886532 27889999999999999953499999887
Q ss_pred CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 308 SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 308 ~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
...+....+.. ....|......+.++|++||+.+|+ ||++.+++..|
T Consensus 226 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 226 TPSEKERFYEK----KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ChHHHHHHHHh----ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 76655433322 2233445567899999999999998 99999998776
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.68 Aligned_cols=251 Identities=19% Similarity=0.229 Sum_probs=197.2
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
+|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 46778899999999999998762 34589999886532 2222334568999999999999999999998766
Q ss_pred ----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 164 ----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 164 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+|+||||+. ++|.+++..... ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 74 DPFEEIYVVTELMQ-SDLHKIIVSPQP-----LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred cccceEEEEeeccc-cCHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccc
Confidence 7899999996 589888865432 567778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+++..............++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 148 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~ 220 (372)
T cd07853 148 GLARVEEPDESKHMTQEVVTQYYRAPEILMGSR------HYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQQLDLITDL 220 (372)
T ss_pred cceeecccCccccCCCCCcCCCcCCHHHHcCCC------CCCcHHHHHhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHH
Confidence 998754332222222345678899999987643 26889999999999999998 99999888766554443221
Q ss_pred ----------------------CCcCC-------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 ----------------------EALRL-------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ----------------------~~~~~-------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... ......++++.+++.+||+.||+ ||++.|++.
T Consensus 221 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 221 LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred cCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00011 12235678899999999999998 999998864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=315.55 Aligned_cols=259 Identities=17% Similarity=0.253 Sum_probs=206.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccc--ccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED--ASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.+|++.+.||+|+||.||+|+++. ....|++|.++.. ........+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL-------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC-------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence 578899999999999999999863 3458889877542 2334444567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++...... ...++......++.|++.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 9999999999999999988643211 122566777889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS--DDQVITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~--~~~~~~~i~~~~ 320 (394)
........ ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||.... ..++...+....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T cd08228 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENG-------YNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLFSLCQKIEQCD 224 (267)
T ss_pred eeccchhH-HHhcCCCCccccChhhhccCC-------CCchhhHHHHHHHHHHHhc-CCCCCccccccHHHHHHHHhcCC
Confidence 65432221 112345777899999986554 6789999999999999998 999986543 344555554433
Q ss_pred CcCCCC-CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 321 ALRLPA-PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 321 ~~~~~~-p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
..+. +..++..+.+++++||..+|+ ||++.+++..++++.
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 2222 245788999999999999998 999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=359.05 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=222.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
...+++|.+++.||+|+||.|.+++.+. +...+|.|++.+.. ...+..+|..|-.+|..-+.+-||.++.+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~-------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKS-------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeec-------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3567999999999999999999999984 45578999887643 45566788899999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
|++...+|+|||||+||||..+|.+... +++.++..|+..|+.||.-||+.|.|||||||+|||||..|++||+|
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~-----~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDR-----LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCC-----ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999999977642 78888999999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||.+..+..+........+|||-|++||+|.....+ .+.|+..+|+||+||++|||+ +|..||...+..+.+-+|++
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~--~g~yG~ecDwWSlGV~~YEMl-yG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDG--KGEYGRECDWWSLGVFMYEML-YGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCC--ccccCCccchhhhHHHHHHHH-cCCCcchHHHHHHHHHHHhc
Confidence 999887776666666777999999999999865532 345999999999999999999 69999999888888888865
Q ss_pred C-CCcCCCCCCCCChHHHHHHHhhhcCCccccc---hhhh
Q psy7505 319 T-EALRLPAPRAVNSHVDVAARNCLVTSELRVK---IGDT 354 (394)
Q Consensus 319 ~-~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~~---~~e~ 354 (394)
- ..+.+|....+|+++++||+..+...+.|-. +.||
T Consensus 296 hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 296 HKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDI 335 (1317)
T ss_pred hhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHH
Confidence 3 2234443367999999999999988776644 6665
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.01 Aligned_cols=251 Identities=33% Similarity=0.537 Sum_probs=206.1
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.+..++|++.+.||+|+||.||+|... ...+++|..+.... ...+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~iK~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEYT---------GQKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGVIL 69 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecccC---------CCceEEEeecCcch---HHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 345578999999999999999988643 33688888765432 234568999999999999999999987
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
.+ ..++||||+++|+|.+++...... .++......++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 70 ~~-~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 70 HN-GLYIVMELMSKGNLVNFLRTRGRA---LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred CC-CcEEEEECCCCCCHHHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCc
Confidence 64 579999999999999999764321 25666778899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++....... .....+..|+|||.+.... ++.++|||||||++|||++.|..||.+.+..+....+..+.
T Consensus 146 ~~~~~~~~~----~~~~~~~~y~~pe~~~~~~-------~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 214 (254)
T cd05083 146 LARVGSMGV----DNSKLPVKWTAPEALKHKK-------FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY 214 (254)
T ss_pred cceeccccC----CCCCCCceecCHHHhccCC-------cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC
Confidence 886432211 1223356799999886554 78899999999999999976999999988888777776664
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
+++.+..++..+.+++++||..+|+ ||++.+++..|++
T Consensus 215 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 --RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 5566678899999999999999998 9999999888764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=322.31 Aligned_cols=243 Identities=21% Similarity=0.367 Sum_probs=209.4
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+...+|.++..||+|+||+|.+|..++.++ .+|||+++++- .....+.-+.|-.+|.-. +-|.+++++.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdE-------LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDE-------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcch-------hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 4567889999999999999999999886443 78899888764 222223334677777655 6789999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+|++-+++|+||||+.||||.-.|++.+. +.+..++.++.+|+-||-|||++|||.||||.+|||++.+|++||+
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEee
Confidence 99999999999999999999999987765 4566678899999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++....+.. .+.+.+||+.|+|||++.... |+.++|+|||||+||||+. |++||.+.+..++++.|.
T Consensus 493 DFGmcKEni~~~~-TTkTFCGTPdYiAPEIi~YqP-------YgksvDWWa~GVLLyEmla-GQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 493 DFGMCKENIFDGV-TTKTFCGTPDYIAPEIIAYQP-------YGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQAIM 563 (683)
T ss_pred ecccccccccCCc-ceeeecCCCcccccceEEecc-------cccchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Confidence 9999986544332 345679999999999998776 8999999999999999998 999999999999999997
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL 347 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~ 347 (394)
.- ....|..++.++.++.+..+..+|.
T Consensus 564 eh---nvsyPKslSkEAv~ickg~ltK~P~ 590 (683)
T KOG0696|consen 564 EH---NVSYPKSLSKEAVAICKGLLTKHPG 590 (683)
T ss_pred Hc---cCcCcccccHHHHHHHHHHhhcCCc
Confidence 65 5677899999999999999999996
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.12 Aligned_cols=253 Identities=16% Similarity=0.281 Sum_probs=197.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|.+.+.||+|+||.||+|+++. ....||+|.++..........+.+|+.++++++||||+++++++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL-------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC-------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 3679999999999999999998863 344789998865443222333568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++ +|.+++...+. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccce
Confidence 99999999975 89888865432 24666777899999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL- 322 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~- 322 (394)
....... ......++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 224 (309)
T cd07872 153 AKSVPTK-TYSNEVVTLWYRPPDVLLGSS------EYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELHLIFRLLGTP 224 (309)
T ss_pred ecCCCcc-ccccccccccccCCHHHhCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Confidence 5332221 112335678899999986533 27889999999999999998 99999887765554433221000
Q ss_pred -----------------CC---------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 -----------------RL---------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 -----------------~~---------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. .....++.++.+++++||..||+ |+++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 01135678899999999999998 999988753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=331.96 Aligned_cols=242 Identities=19% Similarity=0.243 Sum_probs=192.2
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC---CCcceeceeeEEEeCCceEE
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL---RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~l 167 (394)
||+|+||+||+|+++. .+..||+|++.... ..........|..++..+ +||||+++++++...+.+|+
T Consensus 1 lG~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECC-------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEE
Confidence 7999999999999873 45589999886432 112222234566666554 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 74 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKEGR-----FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 9999999999999876532 56777888999999999999999999999999999999999999999999865332
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......||..|||||++.+.. .++.++|||||||++|||++ |..||.+....+.+..+..+. .+++ .
T Consensus 149 ~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~-~ 218 (330)
T cd05586 149 DNK-TTNTFCGTTEYLAPEVLLDEK------GYTKHVDFWSLGVLVFEMCC-GWSPFYAEDTQQMYRNIAFGK-VRFP-K 218 (330)
T ss_pred CCC-CccCccCCccccCHHHHcCCC------CCCCccceeccccEEEEecc-CCCCCCCCCHHHHHHHHHcCC-CCCC-C
Confidence 221 123457889999999986543 16889999999999999998 999999988888877776653 2232 2
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+++.+.+++++||..+|+ |++..+.+.
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 248 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAV 248 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHH
Confidence 35789999999999999998 876544333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=310.97 Aligned_cols=249 Identities=32% Similarity=0.583 Sum_probs=205.5
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|.+.. ...|++|.............+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~--------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC--------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 368999999999998762 447889988765544344456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++++|.+++..... .++......++.|++.||.|||+++++||||||+|||++.++.+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 9999999999975422 146667788999999999999999999999999999999999999999999865432222
Q ss_pred eee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCC
Q psy7505 251 YVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRA 329 (394)
Q Consensus 251 ~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~ 329 (394)
... .....+..|+|||.+.+.. ++.++|||||||++|||++.|..||...........+..+. +++.|..
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 219 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGR-------YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--RMPAPQL 219 (251)
T ss_pred eeccccCcceeccCChHhhccCC-------CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--CCCCCcc
Confidence 211 1223356799999986554 78899999999999999986889999888777666665544 5667788
Q ss_pred CChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 330 VNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 330 ~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
++..+.+++++||..+|+ ||++.|++..|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 999999999999999998 9999999988763
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=352.69 Aligned_cols=264 Identities=20% Similarity=0.289 Sum_probs=205.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|++.. .+..||+|.+.... .......+.+|+.++++++||||+++++++.++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~-------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV-------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC-------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence 578999999999999999999863 35589999887543 233344567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchh------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEAS------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+..++||||++||+|.+++...... .....+....+.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEE
Confidence 9999999999999999998652110 0111344566788999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCc-----------------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC
Q psy7505 237 GDTGSSIDKYPGD-----------------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299 (394)
Q Consensus 237 ~DFG~a~~~~~~~-----------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~ 299 (394)
+|||+++...... ....+...||+.|||||++.+.. ++.++|||||||++|||+|
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-------~S~kSDIWSLGVILyELLT- 226 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-------ASESTDIYALGVILYQMLT- 226 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-------CCcHhHHHHHHHHHHHHHH-
Confidence 9999986541110 01112346899999999987654 7889999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc-chhhhhhhhhcCCC
Q psy7505 300 GKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RV-KIGDTGSSIDKYPG 363 (394)
Q Consensus 300 g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-~~~e~~~~l~~~~~ 363 (394)
|..||......++.................+++.+.+++.+||..+|+ |+ ++.++...|..+..
T Consensus 227 G~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 227 LSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999998766554433221111112222347889999999999999998 75 56677777777654
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.94 Aligned_cols=248 Identities=23% Similarity=0.417 Sum_probs=193.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+.||+|+||.||+|.++............+++|.+...... ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHH-HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 36899999999999986433221223446777877544322 22345589999999999999999999999899999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe--------EEEccCCCC
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--------VKIGDTGSS 242 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~--------vKl~DFG~a 242 (394)
|+++|+|.+++...+. .+++.....++.||+.||.|||++||+||||||+|||++.++. +|++|||++
T Consensus 80 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999976532 2566677889999999999999999999999999999987654 699999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCCHHHHHHHHhcCCC
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG-KLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g-~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
...... ....++..|+|||++.... .++.++|||||||++|||++ | ..||...+........ ..
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~l~~-g~~~~~~~~~~~~~~~~~-~~-- 220 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQ------NLSLAADKWSFGTTLWEIFS-GGDKPLSALDSQKKLQFY-ED-- 220 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCC------CCCchhhHHHHHHHHHHHHc-CCCCChhhccHHHHHHHH-Hc--
Confidence 644322 1235677899999986543 16789999999999999998 6 6787776655443322 22
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+...|...+.++.+++.+||+.+|+ ||++.+++..|+
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 3445566778999999999999998 999999988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=345.75 Aligned_cols=267 Identities=20% Similarity=0.271 Sum_probs=214.2
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-Ccceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l 155 (394)
...+++...++++.+.|.+|||+.||+|+.... +.++|+|.+-.. ++.....+.+|+++|++|. |+|||.+
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~-------~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKG-------GKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCC-------CceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 356688899999999999999999999998732 258899887655 4455556779999999995 9999999
Q ss_pred eeEEE-e---C---CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCE
Q psy7505 156 MAACL-E---S---DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNC 226 (394)
Q Consensus 156 ~~~~~-~---~---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~Ni 226 (394)
++... . + -.++|.||||.||.|-+++....... +.+..++.|+.|+++|+.+||... |||||||-+||
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~---lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENv 177 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR---LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENV 177 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc---CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhhe
Confidence 99432 1 1 25789999999999999997643322 788999999999999999999987 99999999999
Q ss_pred EEcCCCeEEEccCCCCccCCCCce------eee--CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 227 LVTSELRVKIGDTGSSIDKYPGDY------YVH--GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 227 Ll~~~~~vKl~DFG~a~~~~~~~~------~~~--~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
||+.+|..||||||.+........ +.. -....|+.|.|||++.- ..+..++.|+|||+|||+||.|+
T Consensus 178 Lls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl----ysg~pI~eKsDIWALGclLYkLC- 252 (738)
T KOG1989|consen 178 LLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL----YSGLPIGEKSDIWALGCLLYKLC- 252 (738)
T ss_pred EEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh----hcCCCCcchhHHHHHHHHHHHHH-
Confidence 999999999999998754322110 000 01245788999999853 22334899999999999999998
Q ss_pred CCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 299 FGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 299 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
|...||.+..... |+.+. +.+|..+..+..+++||+.||+.||. ||+|.+|+..+.++.+.
T Consensus 253 y~t~PFe~sg~la----Ilng~-Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 253 YFTTPFEESGKLA----ILNGN-YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred HhCCCcCcCccee----EEecc-ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 7999998765543 34443 46776678899999999999999998 99999999998888764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=318.84 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=204.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+..+|++.+.||+|+||.||+|..+. ....+++|.+........ ..+.+|+.+++.++|+||+++++.+..+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~v~ik~~~~~~~~~~-~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVA-------TGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECC-------CCcEEEEEEEecCCcchH-HHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 45789999999999999999998762 344788888765443322 3456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
...|+||||+++|+|.+++.... +.+.....++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 99999999999999999986532 456667889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||........+..+......
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 234 (296)
T cd06654 164 AQITPEQS-KRSTMVGTPYWMAPEVVTRKA-------YGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTP 234 (296)
T ss_pred hhcccccc-ccCcccCCccccCHHHHcCCC-------CCccchHHHHHHHHHHHHh-CCCCCCCCCHHHhHHHHhcCCCC
Confidence 65432221 112335778899999987554 6789999999999999998 99999887765544444333333
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++.+..++..+.+++++||..+|+ ||++.|++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 4455677889999999999999998 999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=328.41 Aligned_cols=248 Identities=19% Similarity=0.235 Sum_probs=191.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTV-------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcC-------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 5789999999999999999998763 45589999886543 223334456899999999999999999998754
Q ss_pred C------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 D------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+ .+|+||||+.+ +|.+.+... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl 164 (359)
T cd07876 93 KSLEEFQDVYLVMELMDA-NLCQVIHME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164 (359)
T ss_pred CCccccceeEEEEeCCCc-CHHHHHhcc-------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEE
Confidence 3 47999999965 677766432 455667788999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+
T Consensus 165 ~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 234 (359)
T cd07876 165 LDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQWNKV 234 (359)
T ss_pred ecCCCccccccCc--cCCCCcccCCCCCchhccCCC-------CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999986543221 122346788899999987654 7889999999999999998 99999877654332221
Q ss_pred hcC---------------------CCcCC------------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGT---------------------EALRL------------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~---------------------~~~~~------------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... ..... ......++.+.+++.+||..||+ ||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 110 00000 01123467889999999999998 999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=317.44 Aligned_cols=238 Identities=20% Similarity=0.326 Sum_probs=202.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||++.+.. ....+++|.+.... .......+.+|++++++++||||+++++++..+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 468899999999999999999873 34578999886543 223334567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++...+. ++......++.|++.||.|||++||+|+||+|+|||++.++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKSGR-----FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999999976532 567778889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+..+
T Consensus 149 ~~~~~~----~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~--- 213 (290)
T cd05580 149 KRVKGR----TYTLCGTPEYLAPEIILSKG-------YGKAVDWWALGILIYEMLA-GYPPFFDDNPIQIYEKILEG--- 213 (290)
T ss_pred cccCCC----CCCCCCCccccChhhhcCCC-------CCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---
Confidence 765433 22346788899999986554 6789999999999999998 99999888877777777655
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-cc
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RV 349 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~ 349 (394)
..+.|..++..+.+++++||..+|. |+
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHcc
Confidence 5667788899999999999999998 76
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=312.98 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=190.8
Q ss_pred ceeeeecceEEEEEEEcCcccc-----cCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 91 KEIGRGWFGKVVEGEARGLEES-----TGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~-----~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
+.||+|+||.||+|++...... .......|++|.+....... ...+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~-~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDI-SLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhH-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3689999999999986532211 11233467888876544332 33456889999999999999999999998899
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe-------EEEcc
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR-------VKIGD 238 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~-------vKl~D 238 (394)
++||||+++|+|..++..... .+++...+.++.||+.||.|||+++|+||||||+|||++.++. +|++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999998865322 2566778899999999999999999999999999999987654 89999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++...... ....++..|+|||.+.... .++.++|||||||++|||++.|..||.+....+.... ..
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSK------NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCC------CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-Hh
Confidence 9988644221 2234677899999886432 2788999999999999998448999987765554332 22
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
+ ........+..+.++|.+||..+|+ ||++.+++..|
T Consensus 224 ~---~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 G---QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c---CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2 2222334467899999999999998 99999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=317.03 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=203.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
...|++++.||+|+||.||+|++.... ......|++|.++..........+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCC---CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 345788899999999999999865211 1345579999987655444445577999999999999999999998875
Q ss_pred -CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 163 -DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 163 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
..+++||||+++|+|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcc
Confidence 568999999999999999965422 256777888999999999999999999999999999999999999999999
Q ss_pred CccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------------
Q psy7505 242 SIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL------------ 307 (394)
Q Consensus 242 a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~------------ 307 (394)
+........ .......++..|+|||++.+.. ++.++|||||||++|||++ +..|+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-------~~~~~Di~slG~il~ellt-~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-------FYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTH 227 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCC-------CCccccchhhhhhhhhhhc-CCCCCccccchhhhhccccc
Confidence 875433221 1222345677899999986554 7789999999999999998 65553211
Q ss_pred ---CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 308 ---SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 308 ---~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
........+..+. +.+.+..++..+.+++.+||+.+|+ ||++.|++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 228 GQMTVTRLVRVLEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccHHHHHHHHHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111222233333 5566778999999999999999998 99999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.65 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=200.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
.++|++.+.||+|+||.||+|..+.... .....|++|.++..... ....+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQD---NTGEVVAVKKLQHSTAE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcC---CCCcEEEEEEeccCCHH-HHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4688999999999999999998653221 23457899988655433 23446689999999999999999998754
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
...+++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 3468999999999999999975422 156777788999999999999999999999999999999999999999999
Q ss_pred CccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---------
Q psy7505 242 SIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD--------- 310 (394)
Q Consensus 242 a~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~--------- 310 (394)
+.......... .....++..|+|||++.+.. ++.++|||||||++|||++ |..++......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~-~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESK-------FSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCC-------cChHHHHHHHHHHHHHHhh-cCCcCCCcchhhhhhccccc
Confidence 87653322211 11123345699999986554 7889999999999999998 76554322110
Q ss_pred -------HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 311 -------QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 311 -------~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
.+...+..+ .+++.+..++..+.+++.+||..+|+ ||++.|++..|+++
T Consensus 227 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 227 QGQMIVYHLIELLKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccchHHHHHHHhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111222222 25566778999999999999999998 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=311.06 Aligned_cols=256 Identities=38% Similarity=0.654 Sum_probs=212.8
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
++.+.||+|+||.||+|++..... .....+++|.++..........+..|+.+++.++|+||+++++++.+.+..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSG---EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCC---CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 466889999999999999874221 22357999999776654344556789999999999999999999999899999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
+|||+++++|.+++...... .+++.....++.|++.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999999764321 156778889999999999999999999999999999999999999999999876544
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
...+......++..|+|||.+.... ++.++|||||||++|||++.|..||...+..++...+..+. ..+.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~-------~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 226 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGK-------FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--RLPKP 226 (258)
T ss_pred ccccccccCCCcccccChHHhccCC-------CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCC
Confidence 4333222233677899999885443 78899999999999999987899999888888888887765 56667
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
..++.++.+++.+||..+|+ ||++.|++..|
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 78999999999999999998 99999987654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.07 Aligned_cols=263 Identities=18% Similarity=0.250 Sum_probs=206.3
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecc-cccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE-DASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~-~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
-+.+....|+++++||+||.++||++...+ ...+|+|.+.. ..+.....-|.+|+..|.+| .|.+||+|+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~--------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD--------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC--------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 456778999999999999999999998642 23556655443 34555566678999999999 799999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+|-..++.+||||||-+ -||.+.|++..... ..-.+..++.|++.|+.++|.+||||.||||.|.|+- .|.+||
T Consensus 427 DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~----~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKL 500 (677)
T KOG0596|consen 427 DYEVTDGYLYMVMECGD-IDLNKILKKKKSID----PDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKL 500 (677)
T ss_pred eeeccCceEEEEeeccc-ccHHHHHHhccCCC----chHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEe
Confidence 99999999999999864 49999998764432 2125678999999999999999999999999999986 578999
Q ss_pred ccCCCCccCCCCcee-eeCCccCCcccccccccccCCCC----cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 237 GDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTS----IQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~----~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
+|||+|.....++.. .....+||+.||+||.+.+...+ .+....+.++||||||||||+|+ ||+.||....+..
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv-YgktPf~~~~n~~ 579 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV-YGKTPFGQIINQI 579 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH-hcCCchHHHHHHH
Confidence 999999876555433 23456999999999999876543 12334789999999999999999 6999998876443
Q ss_pred HHHHHhcCCCcCCCCCCCCChH-HHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFGTEALRLPAPRAVNSH-VDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~~~~~~~~~p~~~~~~-~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.....+......+++|..-+.. +.++|+.||+.||+ |+++.+++.
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3222333333456666544443 99999999999998 999988863
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.78 Aligned_cols=257 Identities=18% Similarity=0.286 Sum_probs=200.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+..+|++.+.||+|+||.||+|+++. ....|++|++....... ...+.+|+.++++++||||+++++++..+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~aik~~~~~~~~~-~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH-------TGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC-------CCeEEEEEEEecCccch-HHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 46789999999999999999999863 34478899886543222 23456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++...+. ++...+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGP-----LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999999999865432 566677889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-- 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-- 320 (394)
....... .......++..|+|||.+..... ..++.++|||||||++|||++ |..||......+....+....
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~----~~~~~~~Dvws~G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06646 154 AKITATI-AKRKSFIGTPYWMAPEVAAVEKN----GGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMSKSNFQ 227 (267)
T ss_pred eeecccc-cccCccccCccccCHhHcccccC----CCCcchhhHHHHHHHHHHHHh-CCCCccccchhhhheeeecCCCC
Confidence 6543211 11223457788999998753221 126789999999999999998 999997665444332222221
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
...+..+..++..+.+++++||..+|+ ||++.+++..|
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111222345788999999999999998 99999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=351.67 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=199.9
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+....+|++++.||+|+||.||+|+++. ....+++|.+.... .......+..|+.++++|+|||||+++++|
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~-------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR-------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECC-------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 3445799999999999999999999873 34478888776433 333444567899999999999999999998
Q ss_pred Ee--CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCEEEcC
Q psy7505 160 LE--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-------GFIHTDVAARNCLVTS 230 (394)
Q Consensus 160 ~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-------~iiHrDlk~~NiLl~~ 230 (394)
.. ...+|||||||++|+|.++|...... ...+++..++.++.||+.||.|||+. +||||||||+||||+.
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 65 35689999999999999999753211 12367788889999999999999984 5999999999999964
Q ss_pred -----------------CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHH
Q psy7505 231 -----------------ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293 (394)
Q Consensus 231 -----------------~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il 293 (394)
.+.+||+|||++....... ......+|+.|+|||++.+... .++.++|||||||+|
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~-----~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETK-----SYDDKSDMWALGCII 233 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCC-----CCCchhHHHHHHHHH
Confidence 2358999999987543222 1234468899999999865432 278899999999999
Q ss_pred HHHHcCCCCCCCCCCHHH-HHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 294 WEIFEFGKLPYAELSDDQ-VITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 294 ~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
|||++ |..||....... ++..+..+. .++ ....+..+.+||..||..+|. ||++.+++
T Consensus 234 YELLT-Gk~PF~~~~~~~qli~~lk~~p--~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 234 YELCS-GKTPFHKANNFSQLISELKRGP--DLP-IKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred HHHHH-CCCCCCcCCcHHHHHHHHhcCC--CCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99998 999998765443 344443332 222 235688999999999999998 99999987
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.93 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=204.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
|.++|++.+.||+|+||.||+|.... ....+++|........ ....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~~~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 1 PQEDYELIQRIGSGTYGDVYKARDIA-------TGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred CccceEEEEEecCCCceEEEEeEecC-------CCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 46789999999999999999999863 3347888888755433 334466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|++|||+++++|.+++..... .++...+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||++
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccc
Confidence 999999999999999999876421 2567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--C
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT--E 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~--~ 320 (394)
....... .......++..|+|||.+..... ..++.++|||||||++|||++ |..||.+.+..+....+... .
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~----~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd06613 149 AQLTATI-AKRKSFIGTPYWMAPEVAAVERK----GGYDGKCDIWALGITAIELAE-LQPPMFDLHPMRALFLISKSNFP 222 (262)
T ss_pred hhhhhhh-hccccccCCccccCchhhccccc----CCcCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Confidence 6543221 11223456778999999865411 127789999999999999998 99999988766555444333 1
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+..+...+.++.+++++||..+|. ||++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112223445678899999999999998 999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.70 Aligned_cols=256 Identities=17% Similarity=0.246 Sum_probs=204.9
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||++.++. ....|++|.+..... ......+.+|+.+++.++||||+++++.+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC
Confidence 368889999999999999999873 345789998765432 22334566899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++...+. +++.....++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCc
Confidence 999999999999999999976532 566677788899999999999999999999999999999999999999988
Q ss_pred ccCCCCce--------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 243 IDKYPGDY--------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 243 ~~~~~~~~--------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
+....... .......++..|+|||.+.... ++.++|+|||||++|||++ |..||.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~vl~el~~-g~~pf~~~~ 220 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-------YGKPVDWWAMGIILYEFLV-GCVPFFGDT 220 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence 63211100 0111235677899999986554 7889999999999999998 999999888
Q ss_pred HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
..++...+..+....+..+..++..+.+++++||+.+|+ ||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 221 PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 888877776554222222336889999999999999998 8887655554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.72 Aligned_cols=243 Identities=19% Similarity=0.267 Sum_probs=196.0
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
|+..+.||+|+||+||+|.+.. ....+|+|.+.... .......+.+|+.++++++|+||+.+++++..++.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA-------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC-------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence 6677889999999999999873 34588999886543 12223345689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|.+++...+.. .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 99999999999999888653221 267778889999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HhcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR----VFGTE 320 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~----i~~~~ 320 (394)
...... .....++..|+|||++.+.. ++.++|+|||||++|||++ |..||.+......... +..+
T Consensus 152 ~~~~~~--~~~~~g~~~~~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~P~~~~~~~~~~~~~~~~~~~~- 220 (285)
T cd05632 152 IPEGES--IRGRVGTVGYMAPEVLNNQR-------YTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLET- 220 (285)
T ss_pred cCCCCc--ccCCCCCcCccChHHhcCCC-------CCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhhcc-
Confidence 432221 12346788999999986654 7889999999999999998 9999988765433222 2222
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
....+..++..+.+++..||+.+|+ |+++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --ccccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 3344567889999999999999998 88854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=316.98 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=196.3
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
|+..+.||+|+||.||+|.++. +...+|+|.+.... .......+.+|+.++++++|+||+.+++.+.+++.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcC-------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence 6677889999999999999873 45588999876433 22223345689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+++||||+++|+|.+++..... ..++...+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 9999999999999998865322 1256777888999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcCCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD---QVITRVFGTEA 321 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~---~~~~~i~~~~~ 321 (394)
...... .....|+..|+|||++.... ++.++|||||||++|||++ |+.||...... +....+....
T Consensus 152 ~~~~~~--~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~~~~~~~~- 220 (285)
T cd05630 152 VPEGQT--IKGRVGTVGYMAPEVVKNER-------YTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKEV- 220 (285)
T ss_pred cCCCcc--ccCCCCCccccChHHHcCCC-------CCCccccHHHHHHHHHHHh-CCCCCCCCCccchHHHHHhhhhhh-
Confidence 432221 12346788999999987654 7889999999999999998 99999875421 2222222221
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccc-----hhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVK-----IGDTG 355 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-----~~e~~ 355 (394)
....+..++..+.+++++||+.+|+ |++ +.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~ 259 (285)
T cd05630 221 -QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK 259 (285)
T ss_pred -hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH
Confidence 2334667889999999999999998 888 55554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.35 Aligned_cols=251 Identities=18% Similarity=0.263 Sum_probs=208.0
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|+..+.||+|+||.||.++.. .....+++|.+.... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 4788999999999999999876 234578888776443 33334456699999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
++++||||++|+|.+++..... ..+++.....++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred EEEEEEecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 9999999999999999976421 1256777888999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||......+....+..+. ..
T Consensus 151 ~~~~~~-~~~~~~~~~~y~ape~~~~~~-------~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~--~~ 219 (256)
T cd08221 151 LGSEYS-MAETVVGTPYYMSPELCQGVK-------YNFKSDIWALGCVLYELLT-LKRTFDATNPLNLVVKIVQGN--YT 219 (256)
T ss_pred cccccc-cccccCCCccccCHhhcCCCC-------CCCcchhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCC--CC
Confidence 433221 222346788899999986554 6788999999999999998 999999888888777776664 34
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
+.+..++..+.+++.+||..+|. ||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 45577899999999999999997 9999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.77 Aligned_cols=207 Identities=27% Similarity=0.383 Sum_probs=176.6
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-C-----cceeceeeEE
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-H-----VNILRLMAAC 159 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~ 159 (394)
+|++.+.||+|+||.|.+|.++ .++..||||++++......+. ..|+.+|..|+ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-------~T~e~VAIKIiKN~k~f~~Q~--~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-------KTGEIVAIKIIKNKKRFLRQA--QIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEec-------CCCcEEEEEeeccChHHHHHH--HHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 6788999999999999999988 466699999999877554443 36888888885 3 4899999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--eEEEc
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL--RVKIG 237 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~--~vKl~ 237 (394)
...+++|||+|.+.. +|+++|+.+.... ++...+..++.||+.||.+||+.+|||+||||+||||.+-+ .|||+
T Consensus 258 ~fr~HlciVfELL~~-NLYellK~n~f~G---lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 258 YFRNHLCIVFELLST-NLYELLKNNKFRG---LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred ccccceeeeehhhhh-hHHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEE
Confidence 999999999999965 9999999875432 77888999999999999999999999999999999997654 69999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||.|.......+ +...+..|.|||+|.+.. |+.+.||||||||++||++ |.+-|.|.++.+.+..|.
T Consensus 334 DFGSSc~~~q~vy----tYiQSRfYRAPEVILGlp-------Y~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 334 DFGSSCFESQRVY----TYIQSRFYRAPEVILGLP-------YDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQLARII 401 (586)
T ss_pred ecccccccCCcce----eeeeccccccchhhccCC-------CCCccceeehhhhHHhHhc-CccccCCCCHHHHHHHHH
Confidence 9999876544332 344566799999999987 8999999999999999998 999999998877766554
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=314.92 Aligned_cols=250 Identities=19% Similarity=0.320 Sum_probs=206.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+..+|++.+.||.|+||.||+|.+.. .+..|++|.+....... ...+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVA-------TGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcC-------CCcEEEEEEEecccCch-HHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 45779999999999999999998762 34578899876544322 33456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++.... +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~------l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTETC------MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999999999886531 567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......++..|+|||.+.... ++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slGvil~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T cd06655 163 AQITPEQS-KRSTMVGTPYWMAPEVVTRKA-------YGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTP 233 (296)
T ss_pred hhcccccc-cCCCcCCCccccCcchhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCc
Confidence 65433221 122345677899999986654 6789999999999999998 99999888766655555444444
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+..+..++..+.+++++||..+|+ ||++.+++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 5566778899999999999999998 99999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=333.74 Aligned_cols=248 Identities=19% Similarity=0.281 Sum_probs=186.2
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC------CCcceec
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL------RHVNILR 154 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~ 154 (394)
.....+|++.+.||+|+||+||+|.+.. ....||||+++...... .....|+.+++.+ +|.+|++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRK-------RKEYCAVKIVRNVPKYT--RDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcC-------CCeEEEEEEEecchhhH--HHHHHHHHHHHHHhhcCcccCcceee
Confidence 4456889999999999999999999863 34579999986532211 1123455555444 4566899
Q ss_pred eeeEEEeC-CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCC
Q psy7505 155 LMAACLES-DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 155 l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~ 232 (394)
+++++... +.+|+|||++ +++|.+++.+.+. +.+..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP-----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD 269 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCC
Confidence 99998754 5789999998 6799998876532 5677788899999999999998 5999999999999998765
Q ss_pred ----------------eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHH
Q psy7505 233 ----------------RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296 (394)
Q Consensus 233 ----------------~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el 296 (394)
.+||+|||.+..... ......||..|||||++.+.. |+.++|||||||++|||
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~-------~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLG-------WMYSTDMWSMGCIIYEL 338 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCC-------CCcHHHHHHHHHHHHHH
Confidence 499999998754321 123457889999999997665 78999999999999999
Q ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCcCCC--------------------------CC--------------CCCChHHHH
Q psy7505 297 FEFGKLPYAELSDDQVITRVFGTEALRLP--------------------------AP--------------RAVNSHVDV 336 (394)
Q Consensus 297 ~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~p--------------~~~~~~~~~ 336 (394)
++ |+.||.+.+..+.+..+..... ++| .+ ....+.+.+
T Consensus 339 lt-G~~pf~~~~~~~~~~~i~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 416 (467)
T PTZ00284 339 YT-GKLLYDTHDNLEHLHLMEKTLG-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD 416 (467)
T ss_pred Hh-CCCCCCCCChHHHHHHHHHHcC-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence 98 9999988776554433321100 000 00 011345779
Q ss_pred HHHhhhcCCcc-ccchhhhhh
Q psy7505 337 AARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 337 l~~~cl~~~p~-r~~~~e~~~ 356 (394)
||++||+.||+ |+++.|++.
T Consensus 417 li~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 417 LIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHhCCcChhhCCCHHHHhc
Confidence 99999999998 999999874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=311.92 Aligned_cols=262 Identities=30% Similarity=0.528 Sum_probs=208.0
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC--
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD-- 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 163 (394)
|++.+.||+|+||.||+|.++.. ......+++|.++... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE----DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc----CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 45678899999999999987632 1345589999887543 3333444678999999999999999999886532
Q ss_pred ----ceEEEEeeCCCCCHHHHHhhcchh-hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 164 ----PWLLVFESCSRGDLKEFLLSNEAS-REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 164 ----~~~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
..++++||+.+|+|.+++...... ....++......++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 247899999999999887543211 112256677889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 239 TGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
||+++.......... ....++..|++||.+.... ++.++|||||||++|||++.|..||.+....++...+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-------YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCc-------cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 999876543332221 2234566799999886554 67899999999999999977899999888877777776
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
.+. .+..+..++..+.+++.+||+.+|+ ||++.++...|+++
T Consensus 230 ~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGN--RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 665 4455667889999999999999998 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=309.65 Aligned_cols=259 Identities=18% Similarity=0.252 Sum_probs=207.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|..+. .+..+++|.++... .......+.+|+.++++++|+||+++++++..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 578999999999999999999872 34578888775322 233344567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++...... ...++...+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence 9999999999999999998653221 122567778899999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS--DDQVITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~--~~~~~~~i~~~~ 320 (394)
........ ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.... ..++...+..+.
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T cd08224 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENG-------YNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEKCD 224 (267)
T ss_pred eeccCCCc-ccceecCCccccCHHHhccCC-------CCchhcHHHHHHHHHHHHH-CCCCcccCCccHHHHHhhhhcCC
Confidence 65432211 112235677899999986554 7789999999999999998 999986543 334455554443
Q ss_pred CcCCCCCC-CCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 321 ALRLPAPR-AVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 321 ~~~~~~p~-~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
..+.|. .++..+.+++.+||..+|+ ||++.+++..|+++.
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 334444 7888999999999999997 999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.28 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=214.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
...|.+...||+|.|++|.+|++. .+...||||.+.+... ......+.+|+++|+.|+|||||+++.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~-------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHI-------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEec-------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 466889999999999999999987 4566999999877662 22222355999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..+|+||||+.+|++++||.+++.. .+..+..++.|+.+|++|||+++|+|||||.+||||+.+..+||+|||++
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~-----~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRM-----KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccc-----hhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccc
Confidence 9999999999999999999988653 33567788999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
.....+. ...+.+|++.|.|||++.+..+ .+..+|+||+|++||-|+. |..||.+..-.++..+++.+
T Consensus 203 ~~~~~~~--~lqt~cgsppyAaPEl~~g~~y------~gpe~D~Wslgvvly~LV~-GsLPFDG~~lk~Lr~rvl~g--- 270 (596)
T KOG0586|consen 203 TFFDYGL--MLQTFCGSPPYAAPELFNGKKY------DGPEVDIWSLGVVLYALVE-GSLPFDGQNLKELRPRVLRG--- 270 (596)
T ss_pred eeecccc--cccccCCCCCccChHhhcCccc------CCcceehhhhhhhheeeee-cccccCCcccccccchheee---
Confidence 7665332 3456789999999999988774 5789999999999999997 99999999888887887776
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
++-+|..++.+..++++++|..+|. |.++.++.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhh
Confidence 5666777888999999999999998 88888775
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.64 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=206.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|.++. ....+++|.+..... ...+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE-------TGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC-------CCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 5788999999999999999999873 234788888765433 345679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|+++||+++++|.+++...+. .+++.....++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccch
Confidence 99999999999999999965432 25777888999999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....... ......++..|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+.......
T Consensus 148 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~s~G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd06612 148 QLTDTMA-KRNTVIGTPFWMAPEVIQEIG-------YNNKADIWSLGITAIEMAE-GKPPYSDIHPMRAIFMIPNKPPPT 218 (256)
T ss_pred hcccCcc-ccccccCCccccCHHHHhcCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCcchhhhhhhhccCCCCC
Confidence 5433221 122334677899999986654 7889999999999999998 999998877666555544443334
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+..++..+.+++++||+.+|+ ||++.|++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 555667889999999999999998 999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.05 Aligned_cols=265 Identities=24% Similarity=0.348 Sum_probs=205.4
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+....++|++.+.||+|+||.||+|.++. ....+++|.++..... ...+.+|+.+++.+ +|+||+++++
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKK-------NGSKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECC-------CCceeEEEeeccccch--HHHHHHHHHHHHHHhcCCCeeeeee
Confidence 334467899999999999999999999863 3447888887643322 22345788999998 7999999999
Q ss_pred EEE-----eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7505 158 ACL-----ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 158 ~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~ 232 (394)
++. .++.+++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC
Confidence 884 345689999999999999988643211 12256677788999999999999999999999999999999999
Q ss_pred eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
.+||+|||++........ ......++..|+|||++..... ....++.++|||||||++|||++ |+.||.+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~~~~~ 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQ--LDSTYDARCDVWSLGITAIELGD-GDPPLADLHPMRA 237 (286)
T ss_pred CEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhh--ccccccchhhhhhHHHHHHHHhc-CCCCCCCCchhHH
Confidence 999999999865432221 2223467888999999864321 11237889999999999999998 9999988776555
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
+..+..+....+..|..++..+.+++++||+.+|+ ||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 54444443334445667788999999999999998 9999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=326.84 Aligned_cols=246 Identities=21% Similarity=0.223 Sum_probs=188.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
...|.+.+.||+|+||.||+|.+.. ....|++|..... .+.+|+.++++|+|+|||++++++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-------~~~~vavK~~~~~-------~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-------YPQRVVVKAGWYA-------SSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-------CCCEEEEeccccc-------CHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 4579999999999999999999873 3457888853221 2358999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++|||++. |+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 234 ~~~lv~e~~~-~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEEccC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999995 699998865422 26777888999999999999999999999999999999999999999999986
Q ss_pred cCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC-CCCC-------CHHHHHH
Q psy7505 244 DKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YAEL-------SDDQVIT 314 (394)
Q Consensus 244 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P-f~~~-------~~~~~~~ 314 (394)
....... .......||..|||||++.+.. ++.++|||||||+||||++ |..| |... ...++..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-------~~~~sDvwSlGviL~El~~-g~~~lf~~~~~~~~~~~~~~l~~ 380 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDP-------YTPSVDIWSAGLVIFEAAV-HTASLFSASRGDERRPYDAQILR 380 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCC-------CCchHHHHHHHHHHHHHHH-cCCCcccCCcccccCCcHHHHHH
Confidence 5432211 1122356899999999987654 7889999999999999997 6543 3221 1233333
Q ss_pred HHhcCCCcCCCCC-------------------------------CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLPAP-------------------------------RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~~p-------------------------------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..........+ ..++..+.+|+.+||..||. ||++.|++.
T Consensus 381 ~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 381 IIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 3322110000000 13456789999999999998 999999864
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.03 Aligned_cols=244 Identities=19% Similarity=0.274 Sum_probs=194.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||+|+||.||+|.+.. ....+++|.+...........+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL-------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC-------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 467888999999999999998763 3457899988655433344456789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|..+.. +++.....++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 74 ~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 74 ISICTEFMDGGSLDVYRK---------IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEEEecCCCCChHHhhc---------CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 999999999999976531 34555678999999999999999999999999999999999999999999865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHh
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-------DQVITRVF 317 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-------~~~~~~i~ 317 (394)
.... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||..... .+....+.
T Consensus 145 ~~~~---~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 213 (279)
T cd06619 145 LVNS---IAKTYVGTNAYMAPERISGEQ-------YGIHSDVWSLGISFMELAL-GRFPYPQIQKNQGSLMPLQLLQCIV 213 (279)
T ss_pred cccc---cccCCCCChhhcCceeecCCC-------CCCcchHHHHHHHHHHHHh-CCCCchhhcccccccchHHHHHHHh
Confidence 4322 122346788899999987654 7889999999999999998 9999965321 22233333
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
......++ ....++++.+++.+||+.+|+ ||++.|++.
T Consensus 214 ~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 214 DEDPPVLP-VGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred ccCCCCCC-CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 33211221 234778999999999999998 999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.03 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=192.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.+.. ....||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAV-------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecC-------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 5789999999999999999998762 34578999886543 233334456899999999999999999998653
Q ss_pred C------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 D------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
. .+|+||||+++ +|.+++... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 89 KSLEEFQDVYLVMELMDA-NLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred ccccccceeEEEhhhhcc-cHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEE
Confidence 2 47999999965 777776532 456667789999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 161 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~ 230 (355)
T cd07874 161 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKV 230 (355)
T ss_pred eeCcccccCCCcc--ccCCccccCCccCHHHHcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999987543221 223346788999999987654 7889999999999999998 99999887654433322
Q ss_pred hcCCC---------------------c---CC---------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEA---------------------L---RL---------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~---------------------~---~~---------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... . .+ ..+...+..+.+++.+||..||+ ||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 11000 0 00 01122356789999999999998 999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=307.45 Aligned_cols=250 Identities=19% Similarity=0.288 Sum_probs=203.2
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe-CC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE-SD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 163 (394)
.|++.+.||+|+||.||++.++. ....+++|.+.... .......+.+|+.++++++|+||+++++.+.. +.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC
Confidence 47899999999999999999863 34478899886543 33344456789999999999999999998864 44
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++++|||+++++|.+++..... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceE
Confidence 68999999999999999976322 125677788999999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
...... .......++..|+|||++.... ++.++|||||||++|+|++ |+.||...+.......+..+. .
T Consensus 151 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~--~ 219 (257)
T cd08223 151 VLENQC-DMASTLIGTPYYMSPELFSNKP-------YNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGK--L 219 (257)
T ss_pred EecccC-CccccccCCcCccChhHhcCCC-------CCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC--C
Confidence 542221 1122345678899999987654 6789999999999999998 999998887777666666554 2
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.+..+++.+.+++.+||+.+|+ ||++.+++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 345667899999999999999998 999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=316.50 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=196.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||+|+||.||++.+.. +...+++|.++..........+.+|++++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 368899999999999999998763 3446888887655444444456789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+++||||+++|+|.+++...+. +++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKAGR-----IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred EEEEeeccCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 9999999999999999976532 5667778899999999999997 599999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV------- 316 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i------- 316 (394)
..... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||...+.......+
T Consensus 149 ~~~~~---~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 217 (308)
T cd06615 149 QLIDS---MANSFVGTRSYMSPERLQGTH-------YTVQSDIWSLGLSLVEMAI-GRYPIPPPDAKELEAMFGRPVSEG 217 (308)
T ss_pred ccccc---ccccCCCCcCccChhHhcCCC-------CCccchHHHHHHHHHHHHh-CCCCCCCcchhhHHHhhcCccccc
Confidence 44221 122346778899999986544 6789999999999999998 99999765433322211
Q ss_pred -----------------------------hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 317 -----------------------------FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 317 -----------------------------~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
.....+..+ ...++.++.+++.+||..+|+ ||++.+++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111 113677899999999999998 9999887543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=312.66 Aligned_cols=259 Identities=18% Similarity=0.249 Sum_probs=205.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.+|++.+.||+|+||.||+|+++. ....+++|.+.... .......+.+|+.+++.++|+||+++++++..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL-------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC-------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence 467788999999999999999762 34578898775432 223334567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..+++|||+++++|.+++...... ...+++...+.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 9999999999999999998743211 123567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCC
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD--DQVITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~--~~~~~~i~~~~ 320 (394)
........ ......++..|+|||.+.... ++.++||||||+++|||++ |..||.+... .+....+....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T cd08229 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENG-------YNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCD 224 (267)
T ss_pred hccccCCc-ccccccCCcCccCHHHhcCCC-------ccchhhHHHHHHHHHHHHh-CCCCcccccchHHHHhhhhhcCC
Confidence 65432221 112345778899999986554 6789999999999999998 9999976543 34444444332
Q ss_pred CcCCCC-CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 321 ALRLPA-PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 321 ~~~~~~-p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
..+. +..++..+.+++.+||..+|+ ||++.+|++.+.++.
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1222 346888999999999999998 999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=309.42 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=201.2
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--------HHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--------QAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
|.+...||+|+||.||+|.+.. ....+++|.+..... ......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNAS-------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74 (267)
T ss_pred ccccceeecCCCeEEEEEEecC-------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 5667889999999999998762 344788887754321 1122346689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+...+..++||||+++++|.+++...+. ++...+..++.|++.||.|||++|++||||+|+||+++.++.+||+|
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNNYGA-----FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHhccC-----ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecc
Confidence 9999999999999999999999976532 56667778999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCcee-----eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 239 TGSSIDKYPGDYY-----VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 239 FG~a~~~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+++........ ......++..|+|||.+.... ++.++|+|||||++|+|++ |..||.+....+.+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~ 221 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-------YTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAI 221 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCC-------CCchhhhHHHHHHHHHHhh-CCCCCCCccHHHHH
Confidence 9988655321110 111235677899999986654 6789999999999999998 99999987766655
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.... ....|..++..+.+++++||+.+|+ ||++.+++.
T Consensus 222 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 FKIGENA--SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHhccC--CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 5554443 4556678899999999999999998 999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.70 Aligned_cols=248 Identities=18% Similarity=0.231 Sum_probs=193.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++. ....||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI-------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC-------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 5789999999999999999998763 34578999886543 222333456899999999999999999988643
Q ss_pred ------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 ------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
..+|+||||+++ +|.+++... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 167 (364)
T cd07875 96 KSLEEFQDVYIVMELMDA-NLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167 (364)
T ss_pred ccccccCeEEEEEeCCCC-CHHHHHHhc-------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEE
Confidence 357999999965 788777532 455667789999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+
T Consensus 168 ~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 168 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKV 237 (364)
T ss_pred EeCCCccccCCCC--cccCCcccCCcCCHHHHhCCC-------CCchhhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999997543221 122346788999999987654 7889999999999999998 99999988766655544
Q ss_pred hcCCCcC-----------------------------------C----CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALR-----------------------------------L----PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~-----------------------------------~----~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....... . ......+..+.+++.+||+.||. |||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 3211000 0 00112345788999999999998 999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.12 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=207.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHH--HHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE--KLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..-|.-++.||.|+||.||-|++. .+...||||.+.-...+.. -..++.|+..|++|+|||+|.+.|+|..
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~-------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeecc-------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 344556788999999999999987 3455899998865543222 2235699999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
....|||||||- |+-.|+|.-++. .+.+..+..|+.+.+.||.|||+.+.||||||.-|||+++.|.|||+|||.
T Consensus 98 e~TaWLVMEYCl-GSAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 98 EHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred cchHHHHHHHHh-ccHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccc
Confidence 999999999995 477777754432 256667788999999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|....+. +.++||+.|||||++..... +.|+-++||||||++..||.. .++|+-.++....+..|..++.
T Consensus 173 Asi~~PA-----nsFvGTPywMAPEVILAMDE----GqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSALYHIAQNes 242 (948)
T KOG0577|consen 173 ASIMAPA-----NSFVGTPYWMAPEVILAMDE----GQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNES 242 (948)
T ss_pred hhhcCch-----hcccCCccccchhHheeccc----cccCCccceeeccchhhhhhh-cCCCccCchHHHHHHHHHhcCC
Confidence 8654332 35789999999999987653 359999999999999999997 9999999999999999988886
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+.++ ...++..+..++..||+.-|. |||..+++
T Consensus 243 PtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 243 PTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 5555 356788999999999999997 88877654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.88 Aligned_cols=252 Identities=18% Similarity=0.247 Sum_probs=193.4
Q ss_pred EEceeeee--cceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 89 YVKEIGRG--WFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 89 ~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
++++||+| +||+||+++.+ .++..||+|.++... .......+.+|+.+++.++|||||++++++..++..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeec-------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 45789999 78999999987 345689999987653 333445566899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||+++|+|.+++..+... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++|||.+...
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred EEEEeccCCCcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999999999999654221 2566777889999999999999999999999999999999999999999865332
Q ss_pred CCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 246 YPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 246 ~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
...... ......++..|+|||++..... .++.++|||||||++|||++ |..||.+....+.......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~ 225 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ-----GYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKLNG 225 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccC-----CCCchhhHHHHHHHHHHHHH-CCCCCCCcchhHHHHHHhcC
Confidence 111100 0111245667999999865321 27889999999999999998 99999877655544333322
Q ss_pred CCcC-------------------------------------------CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 320 EALR-------------------------------------------LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 320 ~~~~-------------------------------------------~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.... .+....+++.+.+++++||+.||+ ||++.|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 1100 011123567899999999999998 99999886
Q ss_pred h
Q psy7505 356 S 356 (394)
Q Consensus 356 ~ 356 (394)
.
T Consensus 306 ~ 306 (327)
T cd08227 306 N 306 (327)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=308.09 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=200.1
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-----cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-----SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+|++.+.||+|+||.||+|... .+..+|+|.++... .......+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence 4677889999999999999753 23478888876432 1222344678999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+..+++|||+++|+|.+++.+... +++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.+||+|||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRFGP-----LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccch
Confidence 99999999999999999999976532 4566777899999999999999999999999999999999999999999
Q ss_pred CCccCCCCc-----eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 241 SSIDKYPGD-----YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 241 ~a~~~~~~~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
++....... ........++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~ 219 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-------YGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFY 219 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCC-------CcchhhHHHHHHHHHHHHh-CCCccccCChHHHHHH
Confidence 886432111 00112235678899999986554 6789999999999999998 9999988765554444
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+........+.+..++..+.+++++||..+|. ||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44332234456778899999999999999998 999988753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=316.11 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=204.2
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
...+|++.+.||+|+||.||+|.... ....|++|.+....... ...+.+|+.+++.++|+||+++++++..+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA-------TGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC-------CCCEEEEEEEecCccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 35789999999999999999998762 34578999886544332 23456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++.+.. +++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 99999999999999999986532 456677889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+....+..+..+...
T Consensus 163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slGvil~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 233 (297)
T cd06656 163 AQITPEQS-KRSTMVGTPYWMAPEVVTRKA-------YGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTP 233 (297)
T ss_pred eEccCCcc-CcCcccCCccccCHHHHcCCC-------CCcHHHHHHHHHHHHHHHh-CCCCCCCCCcchheeeeccCCCC
Confidence 65432221 112335677899999987654 6789999999999999998 99999876654443333333333
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..|..++..+.+++.+||..+|+ ||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4455677889999999999999998 999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.02 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=203.9
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
..|+..+.||+|+||.||+|.++. ....|++|.+...........+.+|+.++++++|+||+++++++.+++.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 456677889999999999998863 3457899988755433444556789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|.+++.... ++......++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~~------l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAGP------FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEecCCCCcHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence 999999999999999987532 45566778899999999999999999999999999999999999999999865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
...... ......++..|+|||++.+.. ++.++|+|||||++|||++ |..||.+.........+..+. ..
T Consensus 151 ~~~~~~-~~~~~~~~~~y~apE~~~~~~-------~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~--~~ 219 (277)
T cd06640 151 LTDTQI-KRNTFVGTPFWMAPEVIQQSA-------YDSKADIWSLGITAIELAK-GEPPNSDMHPMRVLFLIPKNN--PP 219 (277)
T ss_pred ccCCcc-ccccccCcccccCHhHhccCC-------CccHHHHHHHHHHHHHHHH-CCCCCCCcChHhHhhhhhcCC--CC
Confidence 433221 122235677899999986554 6789999999999999998 999999887776665554443 33
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..++..+.+++++||..+|+ ||++.|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 44557888999999999999998 999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=319.06 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=205.2
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
+.+..+.|...+.||+|+||.||-|+.+. +++.+|.|.+.+.. ...-....++|..++.+++.+.||.+-.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvra-------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRA-------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEec-------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 34567888889999999999999999874 44466776664433 1112223468999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+|++.+.+|+||..|+||||.-+|.+.+. ..+++..++.++++|+.||++||..+||.|||||+|||+|+.|+++|+
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRIS 329 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRIS 329 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEee
Confidence 99999999999999999999998877653 237888899999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DDQVI 313 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~~~~ 313 (394)
|+|+|.....+... ...+||.+|||||++..+. |+..+|+|||||+||||+. |+.||.... ..++-
T Consensus 330 DLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~-------Y~~s~Dwf~lGCllYemi~-G~sPFr~~KeKvk~eEvd 399 (591)
T KOG0986|consen 330 DLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEV-------YDFSPDWFSLGCLLYEMIA-GHSPFRQRKEKVKREEVD 399 (591)
T ss_pred ccceEEecCCCCcc--ccccCcccccCHHHHcCCc-------ccCCccHHHHHhHHHHHHc-ccCchhhhhhhhhHHHHH
Confidence 99999877665532 3448999999999998776 8899999999999999997 999997654 33555
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RV 349 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~ 349 (394)
.++... ....|..++++++.+.+.+|+.||. |-
T Consensus 400 rr~~~~---~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 400 RRTLED---PEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred HHHhcc---hhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 555544 3455689999999999999999997 53
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=323.69 Aligned_cols=250 Identities=18% Similarity=0.195 Sum_probs=193.6
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+...+|.+++.||+|+||.||+|..++. ....+|++|.+.... ...+|+.++++++|||||++++++..
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-----~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGD-----EQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCC-----ccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee
Confidence 3467899999999999999999986532 234578888876432 23479999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+|+|||++. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence 999999999995 69999885432 267778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh
Q psy7505 242 SIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD---DQVITRVF 317 (394)
Q Consensus 242 a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~---~~~~~~i~ 317 (394)
+......... ......||..|+|||++.... ++.++|||||||++|||++ |+.||.+... ...+..+.
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~l~~i~ 303 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDP-------YCAKTDIWSAGLVLFEMSV-KNVTLFGKQVKSSSSQLRSII 303 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCC-------CCchhhHHHHHHHHHHHHH-CCCCCCCCCCCCcHHHHHHHH
Confidence 8654332221 122346889999999987654 7889999999999999998 9999976432 11111111
Q ss_pred c---CCC-----------------------cCCCCC-----CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 G---TEA-----------------------LRLPAP-----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~---~~~-----------------------~~~~~p-----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+ ... .....| ...+..+.+++++||..+|+ ||++.|++.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 304 RCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 000 001111 13466788999999999998 999999764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.61 Aligned_cols=255 Identities=18% Similarity=0.295 Sum_probs=199.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.++|++.+.||+|+||.||+|++.. ....+++|.++...... ...+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~-~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVN-------TGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcC-------CCcEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 35678888999999999999998763 34478899886554322 23356899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++...+. +++.....++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGP-----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceee
Confidence 999999999999999999876532 567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA- 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~- 321 (394)
...... ........++..|+|||++.... ...++.++|||||||++|||++ |..||.................
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06645 154 AQITAT-IAKRKSFIGTPYWMAPEVAAVER----KGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMTKSNFQ 227 (267)
T ss_pred eEccCc-ccccccccCcccccChhhhcccc----CCCCCchhhhHHHHHHHHHHhc-CCCCcccccchhhHHhhhccCCC
Confidence 644322 11122346788999999874221 1126789999999999999998 9999876654444333322211
Q ss_pred -cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........++..+.+++++||+.+|+ ||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11111235678899999999999998 999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=310.65 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=205.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||.|+||.||+|++.. ....+++|.+...........+.+|+.+++.++|+||+++++++.++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 357788899999999999999863 3458899988765433334446689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+++|+||+++|+|.+++... .+++.....++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999999999999754 256777888999999999999999999999999999999999999999999866
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
..... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+..+...
T Consensus 148 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~-------~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~-- 216 (274)
T cd06609 148 LTSTM-SKRNTFVGTPFWMAPEVIKQSG-------YDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLIPKNNPP-- 216 (274)
T ss_pred ecccc-cccccccCCccccChhhhccCC-------CCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHHHhhhcCCC--
Confidence 53321 1122345677899999987654 7889999999999999998 99999887777766666655422
Q ss_pred CCCCC-CChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRA-VNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~-~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.. ++..+.+++++||..+|+ ||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22333 788999999999999998 999988864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=307.48 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=198.7
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+++..+.+.....||+|+||.||+|.++. ....|++|.+....... ...+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~~k~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLS-------TQVRIAIKEIPERDSRY-VQPLHEEIALHSYLKHRNIVQYLGSD 74 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecC-------CCcEEEEEEecCCCHHH-HHHHHHHHHHHHhcCCCCeeeeeeee
Confidence 34455556566789999999999998763 34478898876554333 33466999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEEcc
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKIGD 238 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl~D 238 (394)
..++..++||||+++++|.+++...... ...+...+..++.|++.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 75 SENGFFKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred ccCCEEEEEEecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEec
Confidence 9999999999999999999999754211 00145566778899999999999999999999999999976 67999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHh
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV-ITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~-~~~i~ 317 (394)
||++........ ......++..|+|||++..... .++.++||||||+++|+|++ |..||........ ...+.
T Consensus 153 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~-----~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~~~~~~~~~~~ 225 (268)
T cd06624 153 FGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPR-----GYGAPADIWSLGCTIVEMAT-GKPPFIELGEPQAAMFKVG 225 (268)
T ss_pred chhheecccCCC-ccccCCCCccccChhhhccccc-----cCCchhhhHHHHHHHHHHHh-CCCCCccccChhhhHhhhh
Confidence 998864422211 1122356788999999865432 26789999999999999998 9999976543222 22221
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........|..+++++.+++++||..+|+ ||++.|++.
T Consensus 226 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 -MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11123455778899999999999999998 999998864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.78 Aligned_cols=253 Identities=17% Similarity=0.278 Sum_probs=197.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+++. ....||+|.++..........+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL-------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC-------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 4679999999999999999998863 344789998765443222334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||++ ++|.+++..... .++...+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 9999999997 599998875422 15666778899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE--- 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~--- 320 (394)
....... ......++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+....
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~------~~~~~~Dv~slG~~l~el~t-g~~~f~~~~~~~~~~~~~~~~~~~ 224 (301)
T cd07873 153 AKSIPTK-TYSNEVVTLWYRPPDILLGST------DYSTQIDMWGVGCIFYEMST-GRPLFPGSTVEEQLHFIFRILGTP 224 (301)
T ss_pred ccCCCCC-cccccceeecccCcHHHhCCC------CCccHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCC
Confidence 4322211 112234577899999986533 26789999999999999998 999998877655443322110
Q ss_pred ------------C---cCCC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ------------A---LRLP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ------------~---~~~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ...+ ....+++.+.+++++||..+|. |+++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0011 1135788899999999999998 999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=304.25 Aligned_cols=249 Identities=19% Similarity=0.297 Sum_probs=204.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++||||+++++.+..++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence 47889999999999999998863 45578898876543 33334556789999999999999999999998999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl~DFG~a~ 243 (394)
.++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 9999999999999999976421 125677788899999999999999999999999999999865 568999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
...... ......++..|+|||.+.... ++.++||||||+++|+|++ |..||.+.+.......+..+. .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~--~ 218 (256)
T cd08220 151 ILSSKS--KAYTVVGTPCYISPELCEGKP-------YNQKSDIWALGCVLYELAS-LKRAFEAANLPALVLKIMSGT--F 218 (256)
T ss_pred ecCCCc--cccccccCCcccCchhccCCC-------CCcccchHHHHHHHHHHHh-CCCCcccCchHHHHHHHHhcC--C
Confidence 543322 112345677899999986543 6789999999999999998 999999887777766666554 4
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.+..++..+.+++.+||..+|. ||++.|++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 456678899999999999999998 999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=309.61 Aligned_cols=257 Identities=20% Similarity=0.327 Sum_probs=200.3
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
+...|++.+.||+|+||.||+|.++. ....+++|......... ..+.+|+.+++++ +|+||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~aik~~~~~~~~~--~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK-------TGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYYGAFIK 74 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC-------CCcEEEEEEEEcCCccH--HHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence 35667888899999999999998873 34578899876543222 2345889999888 79999999999875
Q ss_pred C------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 162 S------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 ~------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
. ..+++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+|
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred cCCCCCCcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEE
Confidence 3 358999999999999999976422 1256777888999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||++....... .......++..|+|||++..... ....++.++|||||||++|||++ |..||...........
T Consensus 152 l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~~~~~~~~ 227 (272)
T cd06637 152 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL 227 (272)
T ss_pred EccCCCceeccccc-ccCCcccccccccCHhHhccccC--cCCCCCchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHH
Confidence 99999986542211 12233467888999999864321 12237889999999999999998 9999987766555444
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.... .+...+..++..+.+++.+||..+|. ||++.|++.
T Consensus 228 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNP-APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCC-CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 43322 12333456888999999999999998 999988754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=306.04 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=191.8
Q ss_pred ceeeeecceEEEEEEEcCcccc---cCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEES---TGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~---~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|.++..... .......+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 3689999999999998743211 0122235677776544332 3446689999999999999999999988 77899
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-------eEEEccCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-------RVKIGDTG 240 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-------~vKl~DFG 240 (394)
||||+++|+|.+++..... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 78 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999976532 256667888999999999999999999999999999999887 79999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++...... ....++..|+|||++..... .++.++|||||||++|||++.|..||...+..+.........
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~-----~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQA-----SLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCC-----CcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 98754331 12345567999999876521 278899999999999999975688888776444433332222
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
..+.+. ...+.+++++||..+|. ||++.|++..|.
T Consensus 224 --~~~~~~--~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 --RLPMPD--CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CCCCCC--chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 333332 37899999999999998 999999987763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=307.17 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=207.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||.|+||.||+|.... ....+++|.+...........+.+|+.+++.++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 468899999999999999998763 3447889988655433344556799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++..
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 9999999999999999976422 11256777888999999999999999999999999999999999999999998865
Q ss_pred CCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 245 KYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 245 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
....... ......++..|+|||++.... .++.++|+|||||++|||++ |+.||...+..+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~------~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 224 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVH------GYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQNDP 224 (267)
T ss_pred hccCccccccccccccCChhhcChHHHcccc------CcCcccchHhHhHHHHHHHh-CCCCccccChhhhHHHHhcCCC
Confidence 4432221 122335778899999986552 27889999999999999998 9999998887776666665543
Q ss_pred cCCCCC---CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAP---RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p---~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++.. ..+++.+.+++++||..+|+ ||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 333333 26788999999999999998 999988864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=312.31 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=204.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++++.||+|+||.||+|.+.. ....+++|.++..........+.+|+.++++++|+||+++++.+...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP-------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC-------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 367889999999999999999863 3457889987655444444556799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+++||||+++++|..++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9999999999999999875311 1126777888999999999999997 599999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHhcCC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT---RVFGTE 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~---~i~~~~ 320 (394)
..... ......++..|+|||.+.+.... ....++.++|||||||++|||++ |..||.......... .+..+.
T Consensus 152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 152 NLVAS---LAKTNIGCQSYMAPERIKSGGPN-QNPTYTVQSDVWSLGLSILEMAL-GRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred cccCC---ccccCCCccCccCcchhcCCCCC-ccCCCCcccchHhHHHHHHHHHh-CCCCCCCcchhhHHHHHHHHhhcC
Confidence 44221 12233567789999998654321 12236889999999999999998 999997765544333 333343
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++.++.+++.+||..+|+ ||++.+++.
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 --PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 3455667899999999999999998 999988864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=295.10 Aligned_cols=271 Identities=18% Similarity=0.253 Sum_probs=209.5
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.....+..++|.+.+.||+|||+.||+++.-. +...+|+|++.-...+ .....++|++..++++||||++++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s-------~~~~YAlKkI~c~~~~-~~e~~~rEid~~rkf~s~~vl~l~ 84 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLS-------TGHLYALKKILCHSQE-DIEEALREIDNHRKFNSPNVLRLV 84 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccC-------cccchhhheeeccchH-HHHHHHHHHHHHHhhCCcchHHHH
Confidence 45667889999999999999999999998542 3447888887655533 333456999999999999999999
Q ss_pred eEEEeCC-----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc
Q psy7505 157 AACLESD-----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVT 229 (394)
Q Consensus 157 ~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~ 229 (394)
++...+. ..||++.|...|+|.+.+...... ...+++...+.++.+|++||.+||+.. .+||||||.|||+.
T Consensus 85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls 163 (302)
T KOG2345|consen 85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS 163 (302)
T ss_pred HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec
Confidence 8876543 489999999999999999765332 224788889999999999999999998 99999999999999
Q ss_pred CCCeEEEccCCCCccCCCCceeee--------CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYYVH--------GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~~~--------~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
+.+.++|.|||.+....-.-.... ..-..|..|.|||.+...... ..+.++|||||||+||+|+ +|.
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~----ti~ertDIWSLGCtLYa~m-f~~ 238 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC----TITERTDIWSLGCTLYAMM-FGE 238 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc----ccccccchhhhhHHHHHHH-HcC
Confidence 999999999997754321100000 011346779999999876543 3789999999999999999 699
Q ss_pred CCCCCCCHH--HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 302 LPYAELSDD--QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 302 ~Pf~~~~~~--~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.||...-.. .+.-.+.+ ....+|.....++.+.++++.|++.||. ||++.+++..++.+.
T Consensus 239 sPfe~~~~~GgSlaLAv~n-~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 239 SPFERIYQQGGSLALAVQN-AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CcchHHhhcCCeEEEeeec-cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999643110 01111222 2234555556899999999999999997 999999999888764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=312.64 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=189.4
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-HHHHHHHHHHHHhcc---CCCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-AEKLFFLHEATPYRR---LRHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~~E~~~l~~---l~HpnIv~l~~~~~~ 161 (394)
+|++.+.||+|+||.||+|+++. ++..||+|.++..... .....+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 47889999999999999999873 4557899987643211 111122356666555 479999999999864
Q ss_pred -----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 162 -----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 162 -----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
...+++||||+++ +|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 74 SRTDRETKVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred ccCCCCceEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 2458999999974 89998865422 12567788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++....... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+.++
T Consensus 150 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~~l~~l~~-g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 150 ADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQST-------YATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKI 219 (288)
T ss_pred CccCccccccCcc--cCCCccccccccCchHhhCCC-------CCCcchhhhHHHHHHHHHh-CCcCcCCCCHHHHHHHH
Confidence 9999986543221 122345678899999986554 7889999999999999997 99999887766555444
Q ss_pred hcCCC----cCC--------------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEA----LRL--------------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~----~~~--------------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... ..+ .....++..+.+++.+||+.||+ ||++.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 220 FDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 32100 000 01125677889999999999998 999988763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.40 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=197.7
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHH-HHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK-LFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
|++++.||+|+||.||+++... ....+|+|........... ....+|+.++++++||||+++++++.+....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccc
Confidence 7889999999999999999873 4448999998776533332 2334699999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||+.+++|.+++.... .++...+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+...
T Consensus 74 ~~v~~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEEEEETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999997332 2677788899999999999999999999999999999999999999999998643
Q ss_pred CCCceeeeCCccCCcccccccccc-cCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhcCC-
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLL-CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS---DDQVITRVFGTE- 320 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~-~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~---~~~~~~~i~~~~- 320 (394)
. ..........++..|+|||++. ... ++.++||||+|+++|+|++ |..||.+.. ....+.+.....
T Consensus 149 ~-~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~Di~slG~il~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T PF00069_consen 149 S-ENNENFNPFVGTPEYMAPEVLQQGKK-------YTRKSDIWSLGIILYELLT-GKLPFEESNSDDQLEIIEKILKRPL 219 (260)
T ss_dssp T-STTSEBSSSSSSGGGSCHHHHTTTSS-------BSTHHHHHHHHHHHHHHHH-SSSSSTTSSHHHHHHHHHHHHHTHH
T ss_pred c-cccccccccccccccccccccccccc-------ccccccccccccccccccc-cccccccccchhhhhhhhhcccccc
Confidence 1 1112333456788999999986 333 7889999999999999998 999999873 333333332211
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..........+..+.+++++||..+|+ ||++.+++.
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111122348999999999999998 999998864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=310.17 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=207.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
.++|++.+.||+|+||.||+|++.... ......+|+|.++..........+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLG---DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCC---CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 456788899999999999999875321 134558999998766544334456799999999999999999999887
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
....+++|||+++|+|.+++..... .+++.....++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 5578999999999999999976532 256777888999999999999999999999999999999999999999999
Q ss_pred CccCCCCce-ee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---------
Q psy7505 242 SIDKYPGDY-YV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD--------- 310 (394)
Q Consensus 242 a~~~~~~~~-~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~--------- 310 (394)
+........ .. .....++..|++||.+.... ++.++|||||||++|||++ |..|+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-------~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 227 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-------FSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQ 227 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCC-------CCcccchHHHhhhhheeec-cCCCcccccchhcccccccc
Confidence 876542221 11 11224456799999886554 7789999999999999998 98888654321
Q ss_pred ------HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 311 ------QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 311 ------~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
.+...+..+ .+.+.+..++.++.+++.+||..+|+ ||++.|+++.|.++
T Consensus 228 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 228 GQMIVTRLLELLKEG--ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccHHHHHHHHHcC--CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 122223333 25666778899999999999999998 99999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.80 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=197.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.+|++.+.||+|+||.||+|.++. .+..|++|.+.... .......+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 74 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR 74 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence 578889999999999999998763 34578898775322 2233445678999999999999999999987
Q ss_pred eC--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 161 ES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 161 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+. ..++++|||+++|+|.+++..... ++......++.|++.||.|||+++|+|+||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 75 DPMERTLSIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred cCCCceEEEEEEecCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECc
Confidence 63 468899999999999999875432 45666778999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||++......... ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+......+..+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~ 221 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-------YGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKI 221 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCC-------CCcchhHHHHHHHHHHHhh-CCCCCCccchHHHHHHH
Confidence 9988643221111 111235677899999986544 6789999999999999998 99999887655555444
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... ......|...+..+.+++++||. +|+ ||++.|++.
T Consensus 222 ~~~-~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQ-PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcC-CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 432 22344567788899999999996 776 999988863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=304.62 Aligned_cols=250 Identities=16% Similarity=0.258 Sum_probs=206.6
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+++.+. .+..+++|.+.... .......+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence 47889999999999999998763 34478899876432 23333456789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+.+++|.+++...... .+++.....++.|++.||.|||+++++|+||+|+|||++.++.+||+|||++..
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred EEEEEecCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 99999999999999998754221 146667788999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
...... ......++..|+|||++.+.. ++.++|+|||||++|+|++ |..||......+....+..+. ..
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~-------~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~--~~ 219 (256)
T cd08218 151 LNSTVE-LARTCIGTPYYLSPEICENRP-------YNNKSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGS--YP 219 (256)
T ss_pred cCcchh-hhhhccCCccccCHHHhCCCC-------CCCccchhHHHHHHHHHHc-CCCCccCCCHHHHHHHHhcCC--CC
Confidence 432211 112235677899999986654 6789999999999999998 999998888877777776665 44
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..++..+.+++.+||..+|. ||++.|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 56778899999999999999998 999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.92 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=202.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+.|+..+.||+|+||.||+|.+.. ....|++|.+...........+.+|+.++++++|+||+++++++..++.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR-------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC-------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence 345566789999999999998762 3447899988755434444556789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|.+++.... +.+..+..++.|++.|+.|||+++++|+||+|+||+++.++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKPGP------LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEccCCCcHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 999999999999999986431 45667788999999999999999999999999999999999999999999865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
...... ......++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+.........+..+. ..
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~--~~ 219 (277)
T cd06642 151 LTDTQI-KRNTFVGTPFWMAPEVIKQSA-------YDFKADIWSLGITAIELAK-GEPPNSDLHPMRVLFLIPKNS--PP 219 (277)
T ss_pred ccCcch-hhhcccCcccccCHHHhCcCC-------CchhhhHHHHHHHHHHHHh-CCCCCcccchhhHHhhhhcCC--CC
Confidence 432221 112235677899999987654 6789999999999999998 999998777666655554443 23
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..++..+.+++.+||..+|+ ||++.|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 34456788999999999999998 999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=309.91 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=194.6
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|+.+. .+..|++|.++... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence 47889999999999999999863 34578999876433 12222345689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+++||||+. |+|.+++..... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred EEEEEecCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 999999997 689998865422 12267777888999999999999999999999999999999999999999998864
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA--- 321 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~--- 321 (394)
...... ......++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+....+....+.....
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~il~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd07861 151 FGIPVR-VYTHEVVTLWYRAPEVLLGSP------RYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPT 222 (285)
T ss_pred cCCCcc-cccCCcccccccChHHhcCCC------CcCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 322211 112234577899999876543 26789999999999999998 9999987765433322211000
Q ss_pred -----------------------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -----------------------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -----------------------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........++.++.+++++||..||. ||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 223 EDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00011235788999999999999998 999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=312.59 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=201.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|++.+.||+|+||+||++.+.. ....+++|++...........+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIP-------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcC-------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 35678889999999999999998762 34578888876554444445567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+.+++||||+++|+|.+++...+. +++.....++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCc
Confidence 999999999999999999876432 5677788899999999999997 6999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD----------- 310 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~----------- 310 (394)
+...... ......++..|+|||++.... ++.++|||||||++|+|++ |..||......
T Consensus 151 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 219 (284)
T cd06620 151 SGELINS---IADTFVGTSTYMSPERIQGGK-------YTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGIL 219 (284)
T ss_pred ccchhhh---ccCccccCcccCCHHHHccCC-------CCccchHHHHHHHHHHHHh-CCCCCcccchhhhhhhhhhHHH
Confidence 7543211 112346788999999986554 7789999999999999998 99999865431
Q ss_pred HHHHHHhcCCCcCCCCCC-CCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 311 QVITRVFGTEALRLPAPR-AVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~-~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
+.+..+.... ....+. .++..+.+++.+||..+|+ ||++.|++...
T Consensus 220 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 220 DLLQQIVQEP--PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHhhcc--CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 2333343332 122222 3788999999999999998 99999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=307.71 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=206.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
..-+.++|++.+.||+|+||.||+|..+. ....+++|.+...... ...+.+|+.+++++ +||||++++++
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~-------~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKK-------DGSLAAVKILDPISDV--DEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECC-------CCCEEEEEEecccccH--HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 33457889999999999999999998762 3457888887643322 22345788899988 89999999999
Q ss_pred EEeC-----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 159 CLES-----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 159 ~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
+... +..++||||+++|+|.++++.... ....+.+..+..++.|++.||.|||+++++||||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 8753 358999999999999998864311 1112567778889999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
+||+|||++........ ......++..|+|||++...... ...++.++|||||||++|||++ |+.||......+.+
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~~~~~~ 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQY--DYSYDARCDVWSLGITAIELGD-GDPPLFDMHPVKTL 242 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCc--ccccCCccchHHHHHHHHHHhh-CCCCCCCCcHHHHH
Confidence 99999998865432221 12234567889999998654311 1126789999999999999998 99999988776666
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+....+..+...+..+.+++.+||+.+|+ ||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 6666555445555667788999999999999998 999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=320.20 Aligned_cols=245 Identities=19% Similarity=0.270 Sum_probs=188.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|+++. ....||+|+..... ...|+.++++++|+||+++++++...+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG-------QPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC-------CCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 4579999999999999999999873 34478888754332 236899999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+. |+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred eeEEEEEccC-CcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 9999999995 699998865422 26777888999999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----------HHHH
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----------DQVI 313 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----------~~~~ 313 (394)
...... ......||..|+|||++.+.. ++.++|||||||++|||++++..+|..... ..+.
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~ 276 (357)
T PHA03209 206 FPVVAP--AFLGLAGTVETNAPEVLARDK-------YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276 (357)
T ss_pred ccccCc--ccccccccccccCCeecCCCC-------CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHH
Confidence 432221 122346788999999987654 788999999999999999866666654321 1111
Q ss_pred HHHh--cCCCcCCC---------------------C-------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVF--GTEALRLP---------------------A-------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~--~~~~~~~~---------------------~-------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+. ......++ . -..++..+.++|++||+.||+ ||++.|++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 277 KIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 1111 00000111 0 014566777899999999998 999998863
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.73 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=207.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
+.++|++.+.||+|+||.||+|.++. ....+++|.+...... ...+.+|+.+++++ +|+||+++++++..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK-------TGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC-------CCcEEEEEEEecCchh--HHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 46889999999999999999999863 3447888887654432 23466899999998 79999999999976
Q ss_pred CC------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 162 SD------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 ~~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
.. .+++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence 54 389999999999999998653211 12267777889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||++....... .......++..|+|||++...... ...++.++|||||||++|+|++ |..||........+..
T Consensus 154 l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 154 LVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQP--DASYDARSDVWSLGITAIELAD-GKPPLCDMHPMRALFK 229 (275)
T ss_pred ECCCccceecccch-hhhcCccccccccCHhHhcccccc--cCCccccccHHHhHHHHHHHHh-CCCCccccchHHHHHH
Confidence 99999886433221 112234577889999998654321 2237789999999999999998 9999988776666666
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+....+..+..++..+.+++++||..||+ ||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 66665445555566888999999999999998 999998864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.75 Aligned_cols=248 Identities=20% Similarity=0.291 Sum_probs=204.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+-|+..+.||+|+||.||+|.++. ....+|+|.............+.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 76 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR-------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 76 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC-------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe
Confidence 446677889999999999998762 3458899987654433444556789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|.+++.... +++.....++.|++.|+.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~l~~~i~~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred EEEEEEeCCCCcHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 999999999999999986431 46677788999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
...... ......++..|+|||.+.... ++.++|+|||||++|+|++ |..||...........+..+. ..
T Consensus 151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~-------~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~ 219 (277)
T cd06641 151 LTDTQI-KRNTFVGTPFWMAPEVIKQSA-------YDSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIPKNN--PP 219 (277)
T ss_pred cccchh-hhccccCCccccChhhhccCC-------CCchhhHHHHHHHHHHHHc-CCCCCCccchHHHHHHHhcCC--CC
Confidence 433221 122335677899999986544 6789999999999999998 999999887776666665543 33
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..++..+.+++.+||..+|. ||++.+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 44567889999999999999997 999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=313.16 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=201.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.+.|.....||+|+||.||++.... ....|++|.+...... ....+.+|+.+++.++|+||+++++.+..++
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH-------TGKQVAVKKMDLRKQQ-RRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC-------CCCEEEEEEEecchHH-HHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence 3445556779999999999998762 3457899987654433 3344668999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++++|.+++.... +++.....++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~------l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999999999885431 4566778899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
...... .......++..|+|||.+.... ++.++|||||||++|||++ |..||.+....+.+..+.......
T Consensus 167 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 237 (292)
T cd06658 167 QVSKEV-PKRKSLVGTPYWMAPEVISRLP-------YGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIRDNLPPR 237 (292)
T ss_pred hccccc-ccCceeecCccccCHHHHccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCc
Confidence 432211 1112235678899999986544 7789999999999999998 999998887776666554443334
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++....++..+.++++.||..+|. ||++.|++.
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 238 VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 444456788999999999999998 999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=319.25 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=193.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.+.. ....||+|.+..... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTR-------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECC-------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 4678999999999999999998763 445899998865432 22223355899999999999999999988643
Q ss_pred ------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 ------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
...|++||++ +++|.+++.... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~~~------l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKCQK------LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEE
Confidence 3579999998 779998875431 567778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..... .....+|..|+|||++.+.. .++.++|||||||++|||++ |..||.+....+.+..+
T Consensus 160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWM------HYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLKRI 228 (343)
T ss_pred cCCccceecCCC----cCCccccccccCchHhcCCc------cCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 999998754322 12346788999999986532 27889999999999999998 99999877655444333
Q ss_pred hcCCC----------------------cCCCC------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEA----------------------LRLPA------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~----------------------~~~~~------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... ...+. ....++.+.+++.+||..||+ |+++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21100 00010 124566788999999999997 999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.80 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=210.6
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHH-hccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP-YRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~ 156 (394)
.-+.|..++++-+..||.|+||+|++-.++ ..+...|||.++....+.++..++.|.+. |+.-+.||||++|
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk-------~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHK-------PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcC-------ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 456677888888899999999999998887 45668899999877766667777777764 5556899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vK 235 (394)
|++...+..||.||+|.- +|+.+-+.-.......+++..+-.+....+.||.||.. ..|||||+||+|||++..|.+|
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence 999999999999999965 77665544333333447777777777788999999975 5899999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVIT 314 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~ 314 (394)
|||||++...... ...+.-+|...|||||.+.....+ |+.++||||||++|||+.| |..||.+.+ ..+.+.
T Consensus 209 LCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~g-----yDiRSDvWSLGITL~EvAt-G~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 209 LCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKG-----YDIRSDVWSLGITLYEVAT-GNFPYRKWDSVFEQLC 280 (361)
T ss_pred eecccchHhHHHH--HHhhhccCCccccChhccCCccCC-----cchhhhhhhhcceEeeeec-CCCCcchHHHHHHHHH
Confidence 9999988543221 122223566679999999766532 8999999999999999998 999999876 446677
Q ss_pred HHhcCCCcCCCCCCC---CChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 315 RVFGTEALRLPAPRA---VNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~---~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
++..|..+.+..+.. .+..+..++..|+..|.. ||...++.
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk 325 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK 325 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhh
Confidence 788888777777665 788999999999999987 99887764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.24 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=197.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|+++. ....+++|.+.... .......+.+|+.++++++|+||+++++++..+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 468889999999999999999863 34578898875433 1222334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||++++.|..++..... +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred EEEEEEeccCccHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccce
Confidence 99999999999888887754322 5777888999999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE--- 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~--- 320 (394)
....... ......++..|+|||.+.+.. .++.++|||||||++|||++ |..||.+....+....+....
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07847 149 ILTGPGD-DYTDYVATRWYRAPELLVGDT------QYGPPVDVWAIGCVFAELLT-GQPLWPGKSDVDQLYLIRKTLGDL 220 (286)
T ss_pred ecCCCcc-cccCcccccccCCHHHHhCCC------CcCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Confidence 5433221 112335677899999986532 26789999999999999998 999998877655443332100
Q ss_pred ---------------CcCCCCC----------CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ---------------ALRLPAP----------RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ---------------~~~~~~p----------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+.+ ..++..+.+++.+||..+|+ ||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0011111 24578899999999999998 999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=310.56 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=202.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.... ....+++|.+...... .....+.+|+.+++.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence 468889999999999999998873 3457899988654422 2344567899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..|+||||+.+++|.+++..... ..+++.....++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchh
Confidence 999999999999999999875421 12567777889999999999999999999999999999999999999999987
Q ss_pred ccCCCCce----------------------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHH
Q psy7505 243 IDKYPGDY----------------------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294 (394)
Q Consensus 243 ~~~~~~~~----------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~ 294 (394)
........ .......|+..|+|||++.+.. ++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Di~slG~ll~ 223 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-------HGSAVDWWTLGILLY 223 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-------CCchHHHHHHHHHHH
Confidence 54321110 0111235678899999987654 678999999999999
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc----hhhhh
Q psy7505 295 EIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK----IGDTG 355 (394)
Q Consensus 295 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~----~~e~~ 355 (394)
+|++ |..||.+.+..+.+..+.... ..++.....+..+.+++++||+.+|+ ||+ +.|++
T Consensus 224 ~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 224 EMLY-GTTPFKGSNRDETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHhh-CCCCCCCCchHHHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 9998 999999888777666665432 23444444799999999999999998 999 55554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=329.72 Aligned_cols=262 Identities=15% Similarity=0.218 Sum_probs=185.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCc------------ccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGR------------TTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~------------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 151 (394)
.++|++++.||+|+||+||+|..+........ ....++.|.++. .......+.+|+.+|++++|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA--GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc--chHHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999999987532211000 000111111111 1222334678999999999999
Q ss_pred eeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 152 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
||++++++...+..|+|+|++. ++|.+++..................++.||+.||.|||++|||||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 588888765432111112234456789999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCC--
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK-LPYAELS-- 308 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~-~Pf~~~~-- 308 (394)
+.+||+|||+++..............||..|+|||++.+.. ++.++|||||||++|||++ |. .||.+..
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvil~ell~-~~~~p~~~~~~~ 375 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-------YCEITDIWSCGLILLDMLS-HDFCPIGDGGGK 375 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCccCCCCC
Confidence 99999999999765433333333457899999999987654 7889999999999999998 55 4554332
Q ss_pred HHHHHHHHhcCCC---cCCCC--------------------------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 309 DDQVITRVFGTEA---LRLPA--------------------------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 309 ~~~~~~~i~~~~~---~~~~~--------------------------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..+..... ..++. ...++..+.+++.+||..||+ ||++.|++.
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2222222211100 00000 013456778889999999998 999999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=312.04 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=202.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
+..|.....||+|+||.||+|.... ....|++|.+....... ...+.+|+.+++.++||||+++++++..++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 91 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKH-------SGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVVEMYKSYLVGE 91 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcC-------CCCEEEEEEEEecccch-HHHHHHHHHHHHhCCCCchhhhhhheeeCC
Confidence 3445556679999999999998762 34578999876543322 334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++++|..++.... +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred eEEEEEecCCCCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 9999999999999999875431 4666778899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
...... .......++..|+|||++.+.. ++.++|||||||++|||++ |+.||......+.+..+.......
T Consensus 166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 236 (297)
T cd06659 166 QISKDV-PKRKSLVGTPYWMAPEVISRTP-------YGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPK 236 (297)
T ss_pred hccccc-ccccceecCccccCHHHHccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCC
Confidence 432221 1122346778899999986654 7889999999999999998 999998877777666665443333
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+..++..+.+++++||..+|+ ||++.+++.
T Consensus 237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 237 LKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 444557888999999999999998 999998865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=309.44 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=202.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|.... ....+++|.+....... ...+.+|+.++++++||||+++++++...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-------TGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-------CCCEEEEEEeccccchH-HHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 4788999999999999999998652 34478888875443322 234568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..|+|+||+++|+|.+++.+.. ++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~------l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999999987542 4556677899999999999999999999999999999999999999999876
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....... ......++..|+|||.+.... ++.++|||||||++|+|++ |+.||...+..+.+..+..+....
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-------~~~~~Dv~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd06647 164 QITPEQS-KRSTMVGTPYWMAPEVVTRKA-------YGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPE 234 (293)
T ss_pred ccccccc-ccccccCChhhcCchhhccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCChhhheeehhcCCCCC
Confidence 5433222 122335778899999986554 6789999999999999998 999998876655444443343334
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++.+..++..+.+++++||..+|+ ||++.+++.
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 555667788999999999999998 999988863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=300.41 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=201.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|.... ....+++|.++.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 47888999999999999998762 345788998865543 2344556799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+++|+||+++++|.+++..... +++.....++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHGRI-----LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred EEEEEecCCCCcHHHHHhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 9999999999999999976432 45667778999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeC---CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhcCC
Q psy7505 245 KYPGDYYVHG---EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRVFGTE 320 (394)
Q Consensus 245 ~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i~~~~ 320 (394)
.......... ...++..|+|||++.+.. ...++.++||||||+++|||++ |..||.+.. .......+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 223 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGK----GKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNEFQIMFHVGAGH 223 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCC----CCCCCcccchHHHHHHHHHHHh-CCCCccCCcchHHHHHHHhcCC
Confidence 4332221111 245677899999986543 1126789999999999999998 999998764 334444444444
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
...+|....++..+.+++++||+.+|+ ||++.|++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 334444445689999999999999998 99998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=303.10 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=196.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.+|+..+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR 74 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence 357788999999999999998763 34578888775432 2223345678999999999999999999987
Q ss_pred e--CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 161 E--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 161 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+ .+.++++|||+++++|.+++..... ++......++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~~l~~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 75 DRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred cCCCCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 5 3568899999999999999976432 45666778999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |+.||......+.+..+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~i~~el~~-g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-------YGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAIFKI 221 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCC-------CCchhhhHHHHHHHHHHHH-CCCCccccchHHHHHHH
Confidence 999864322111 1111235678899999986554 7889999999999999998 99999887665554444
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.... .....|..+++.+.+++ +||..+|+ ||++.|++.
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 3222 23445667888999998 67888998 999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=301.14 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=206.0
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe--C
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE--S 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 162 (394)
+|++.+.||.|+||.||++.+.. .+..+++|.++... .......+..|++++++++|+||+++++++.. +
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 47888999999999999998763 34578888876433 34444556789999999999999999998864 4
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI-----EDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH-----~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
...+++|||+++|+|.+++...... ...+++...+.++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 5689999999999999999764211 123677788899999999999999 9999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++......... .....++..|+|||.+.... ++.++|+||||+++|+|++ |..||......++...+.
T Consensus 153 d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 223 (265)
T cd08217 153 DFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMS-------YDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASKIK 223 (265)
T ss_pred cccccccccCCccc-ccccccCCCccChhhhcCCC-------CCchhHHHHHHHHHHHHHH-CCCcccCcCHHHHHHHHh
Confidence 99998765433221 22345778899999986654 6789999999999999998 999999888777777776
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+. ....+...+..+.+++++||..+|+ ||++.++++
T Consensus 224 ~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 224 EGK--FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cCC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 654 3455678899999999999999997 999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=297.87 Aligned_cols=246 Identities=19% Similarity=0.287 Sum_probs=198.9
Q ss_pred CCCeEEE-ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 84 RQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
.++|.+. ++||-|-.|+|..|.++ .++.+.|+|++.+..+. ++|+++.-.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k-------~T~ekfALKvL~Ds~KA------RrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHK-------RTQEKFALKVLLDSPKA------RREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEec-------cchhhhHHHHHhcCHHH------HhHhhhhhhhcCCCceEEeehhhhh
Confidence 4566655 56999999999999988 46668999998765432 3677654444 79999999999864
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeE
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRV 234 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~v 234 (394)
...+.+|||.|.||+|+..|++.+.. .+.+..+..++.||+.|+.|||+.+|.||||||+|+|...+ ..+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcce
Confidence 34678999999999999999887653 26788889999999999999999999999999999999764 469
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----H
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----D 310 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----~ 310 (394)
||+|||+|+..... ....+.+-|+.|.|||++...+ |+..+|+||+||++|-|+. |.+||-.... .
T Consensus 204 KLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eK-------ydkscdmwSlgVimYIlLC-GyPPFYS~hg~aisp 273 (400)
T KOG0604|consen 204 KLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEK-------YDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISP 273 (400)
T ss_pred EecccccccccCCC--ccccCCcccccccCHHHhCchh-------cCCCCCccchhHHHHHhhc-CCCcccccCCccCCh
Confidence 99999999765432 2334567889999999987665 8899999999999999996 9999976543 3
Q ss_pred HHHHHHhcCCCcCCCCCC--CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEALRLPAPR--AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~--~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+|..|. +.+|.|+ .+++.++++|+.+|..+|. |-||.++++
T Consensus 274 gMk~rI~~gq-y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 GMKRRIRTGQ-YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHhHhhccC-ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 3456676664 3555553 7899999999999999997 889999864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=302.68 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=202.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---------cHHHHHHHHHHHHHhcc-CCCcceece
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---------SQAEKLFFLHEATPYRR-LRHVNILRL 155 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---------~~~~~~~~~~E~~~l~~-l~HpnIv~l 155 (394)
+|++.+.||+|+||.||+|.++. .....+++|.+.... .......+.+|+.++.+ ++||||+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~ 74 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY 74 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeE
Confidence 36778899999999999999874 123478888765321 12223335578887765 799999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~v 234 (394)
++++..++..+++|||+++++|.+++...... ...++...++.++.|++.||.|||+ .+++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred EeeEccCCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcE
Confidence 99999999999999999999999988542111 1225677788999999999999996 789999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++....... ......++..|++||.+.+.. ++.++||||||+++|||++ |+.||..........
T Consensus 154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-------~~~~~Dv~slG~ll~~l~~-g~~p~~~~~~~~~~~ 223 (269)
T cd08528 154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-------YGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLAT 223 (269)
T ss_pred EEecccceeeccccc--ccccccCcccCcChhhhcCCC-------CchHHHHHHHHHHHHHHHh-CCCcccccCHHHHHH
Confidence 999999986543332 223446778899999987554 7889999999999999998 999998877777666
Q ss_pred HHhcCCCcCCCCC-CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 315 RVFGTEALRLPAP-RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 315 ~i~~~~~~~~~~p-~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
.+..+. ..+.+ ..++..+.+++++||+.+|+ ||++.|+.+++.
T Consensus 224 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhhcc--CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 665543 22333 36789999999999999998 999999988774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=305.34 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=195.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHH-hccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP-YRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|+++. .+..||+|.++..........+..|+.+ ++.++||||+++++++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 468899999999999999999873 4558999988765422222233356554 66779999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.+|++|||++ |+|.+++...... ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999996 6898888653221 12367888889999999999999997 9999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhcCCC
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRVFGTEA 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i~~~~~ 321 (394)
....... ......++..|+|||.+.+... ...++.++|+|||||++|||++ |+.||.... ..+.+..+..+..
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd06617 152 GYLVDSV--AKTIDAGCKPYMAPERINPELN---QKGYDVKSDVWSLGITMIELAT-GRFPYDSWKTPFQQLKQVVEEPS 225 (283)
T ss_pred ccccccc--ccccccCCccccChhhcCCccc---ccccCccccchhhHHHHHHHHh-CCCCCCccccCHHHHHHHHhcCC
Confidence 6543211 1122356778999998865321 1236789999999999999998 999997543 2333444444432
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++ ...++..+.+++++||..+|+ ||++.+++.
T Consensus 226 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222 235789999999999999998 999988864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.50 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=201.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-HHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-AEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+++....||.|.||.||.|.... ++...|+|-++-.... .......+|..++..++|||+|++||+-.+.+.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~-------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLD-------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred eeccccccCCcceeeeEEeecCC-------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 34456789999999999998764 3335566655433211 112224589999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
++|.||||.+|+|.+.+...+. .++.....+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999999976543 44555667888999999999999999999999999999999999999999976
Q ss_pred CCCCceeeeC---CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhcCC
Q psy7505 245 KYPGDYYVHG---EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRVFGTE 320 (394)
Q Consensus 245 ~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i~~~~ 320 (394)
.........+ ...||+.|||||++.+... .....++||||+|||+.||+| |+.||...+ +-+++.++..|+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~----kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKG----KGHGGAADIWSLGCVVLEMAT-GKRPWAELDNEWAIMYHVAAGH 1458 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhccccc----CCCCcchhhhcccceEEEeec-CCCchhhccchhHHHhHHhccC
Confidence 5443212222 3478999999999987642 125679999999999999999 999999876 557788888887
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+++|..++++-.+++..||+.||+ |-++.+++
T Consensus 1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 6777888999999999999999999 54554544
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.45 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=200.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||+|+||.||+|.++. ....+++|.+...........+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP-------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC-------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence 357778899999999999999873 4457899988766544444556789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+++++||+++++|.+++.... ..++......++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 999999999999999997642 125666777899999999999999 999999999999999999999999999875
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhc
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-----SDDQVITRVFG 318 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-----~~~~~~~~i~~ 318 (394)
....... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||... ...+.+..+..
T Consensus 150 ~~~~~~~---~~~~~~~~y~~PE~~~~~~-------~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 218 (265)
T cd06605 150 QLVNSLA---KTFVGTSSYMAPERIQGND-------YSVKSDIWSLGLSLIELAT-GRFPYPPENDPPDGIFELLQYIVN 218 (265)
T ss_pred hhHHHHh---hcccCChhccCHHHHcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHHHhc
Confidence 4322111 1145677899999986654 7889999999999999998 99999765 23344555555
Q ss_pred CCCcCCCCCCC-CChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 319 TEALRLPAPRA-VNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 319 ~~~~~~~~p~~-~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+. ....+.. ++.++.++|.+||..+|+ ||++.+++
T Consensus 219 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 219 EP--PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred CC--CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 43 3333343 889999999999999998 99999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.82 Aligned_cols=248 Identities=20% Similarity=0.312 Sum_probs=198.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC---CcceeceeeEEEeC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR---HVNILRLMAACLES 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 162 (394)
.|++.+.||+|+||.||+|.+.. ....+++|.++..........+.+|+.+++.++ ||||+++++++..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 46677889999999999999862 345789998865543333344568888888886 99999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
...++||||+++++|.+++... .+++.....++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9999999999999999998653 2567778889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......++..|+|||.+..+. .++.++|+|||||++|+|++ |..||.+.........+.....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~- 219 (277)
T cd06917 149 ALLNQNSS-KRSTFVGTPYWMAPEVITEGK------YYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAMMLIPKSKP- 219 (277)
T ss_pred eecCCCcc-ccccccCCcceeCHHHhccCC------ccccchhHHHHHHHHHHHHh-CCCCCCCCChhhhhhccccCCC-
Confidence 65543321 122335778899999886433 26789999999999999998 9999988776655444433321
Q ss_pred CCCCCC-CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPR-AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~-~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+. ..+.++.+++++||..+|+ ||++.|++.
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 -PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 12222 3788999999999999998 999988864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=298.14 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=200.5
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
|+..+.||+|+||+||+|..+. ....|++|.+.... .......+.+|+.+++.++|+||+++++++..+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLD-------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE 74 (258)
T ss_pred ccccceeeecCCceEEEEEEcC-------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence 5567889999999999998862 34478888775432 122334466899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..++++|||+++++|.+++..... +++.....++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYGS-----FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999999976532 456677788999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... ......++..|++||.+.... .++.++|+|||||++|+|++ |..||......+....+.... .
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~------~~~~~~D~~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~-~ 219 (258)
T cd06632 150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQG------GYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIGRSK-E 219 (258)
T ss_pred eeccccc--cccccCCCcceeCHHHhcCCC------CCCchhhhHHHHHHHHHHHh-CCCCcccCcHHHHHHHHHhcc-c
Confidence 6543322 123446778899999975432 26789999999999999998 999998877655555544321 1
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..++..+.+++++||..+|. ||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 3445677899999999999999998 999998864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.16 Aligned_cols=244 Identities=22% Similarity=0.295 Sum_probs=200.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
+|++.+.||.|+||.||+|++.. ....+++|.+.... .......+.+|+.++++++||||+++++.+..++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC
Confidence 47889999999999999998762 34578999886543 2233445678999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+.+++|.+++..... +.+..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQKVK-----FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhcCC-----cCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 99999999999999999976522 5667788899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD---DQVITRVFGTE 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~---~~~~~~i~~~~ 320 (394)
...... ......++..|+|||.+.... ++.++|+||||+++|+|++ |..||...+. .++......
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-- 216 (258)
T cd05578 149 KVTPDT--LTTSTSGTPGYMAPEVLCRQG-------YSVAVDWWSLGVTAYECLR-GKRPYRGHSRTIRDQIRAKQET-- 216 (258)
T ss_pred ccCCCc--cccccCCChhhcCHHHHcccC-------CCCcccchhhHHHHHHHHh-CCCCCCCCCccHHHHHHHHhcc--
Confidence 543332 122345677899999986654 6789999999999999998 9999987763 333333322
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccch--hhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI--GDT 354 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~--~e~ 354 (394)
.....|..++..+.+++++||..+|. |+++ .|+
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDL 252 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHH
Confidence 25666778899999999999999998 9998 554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=303.92 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=201.3
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
.|...+.||+|++|.||+|..+. ....+++|.+....... ...+.+|+.+++.++|+||+++++++...+..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS-------TGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC-------CCCEEEEEEEeccchhH-HHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence 44555789999999999998763 34478888876443332 23356899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++++||+++++|.+++.... ++...+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||.+...
T Consensus 92 ~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 92 WVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEeccCCCCHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 99999999999999987631 466677889999999999999999999999999999999999999999987543
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCC
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 325 (394)
..... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+..+....+.
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd06648 166 SKEVP-RRKSLVGTPYWMAPEVISRLP-------YGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIRDNLPPKLK 236 (285)
T ss_pred ccCCc-ccccccCCccccCHHHhcCCC-------CCCcccHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHhcCCCCCc
Confidence 22211 122345778899999986554 7789999999999999998 99999887777776666655433444
Q ss_pred CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 326 APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 326 ~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..++..+.+++++||..+|+ ||++.+++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 4556889999999999999998 999988864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.01 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=197.6
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEE---EEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVF---VRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~va---vk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++..+||+|+|-+||+|.+. .++..|| +|.-+..........|..|+.+|+.|+|||||++|+++.+..
T Consensus 42 ~k~~evLGrGafKtVYka~De-------~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDE-------EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred eehhhhcccccceeeeecccc-------ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 356678999999999999875 2333444 343333334454566779999999999999999999998765
Q ss_pred c--eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEcCC-CeEEEcc
Q psy7505 164 P--WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED--GFIHTDVAARNCLVTSE-LRVKIGD 238 (394)
Q Consensus 164 ~--~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~--~iiHrDlk~~NiLl~~~-~~vKl~D 238 (394)
. +.+|+|.+..|+|..|+++++. .+...+..|++||+.||.|||++ .|||||||.+||+|+.+ |.|||+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 4 8899999999999999998765 56667889999999999999998 59999999999999765 8999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHh
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i~ 317 (394)
+|+|....... ...+.||+.|||||++... |+..+||||||+.+.||+| +..||.+.. +.+++.+|.
T Consensus 190 LGLAtl~r~s~---aksvIGTPEFMAPEmYEE~--------YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 190 LGLATLLRKSH---AKSVIGTPEFMAPEMYEEN--------YNELVDVYAFGMCMLEMVT-SEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred hhHHHHhhccc---cceeccCccccChHHHhhh--------cchhhhhhhhhHHHHHHHh-ccCChhhhCCHHHHHHHHH
Confidence 99997654332 2236899999999997522 8999999999999999999 999998865 778899998
Q ss_pred cCCCcCCC-CCCCCChHHHHHHHhhhcCCccccchhhhh
Q psy7505 318 GTEALRLP-APRAVNSHVDVAARNCLVTSELRVKIGDTG 355 (394)
Q Consensus 318 ~~~~~~~~-~p~~~~~~~~~l~~~cl~~~p~r~~~~e~~ 355 (394)
.|-. +. ...--.++++++|.+|+....+|+++.|++
T Consensus 258 SGiK--P~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL 294 (632)
T KOG0584|consen 258 SGIK--PAALSKVKDPEVREFIEKCLATKSERLSAKELL 294 (632)
T ss_pred cCCC--HHHhhccCCHHHHHHHHHHhcCchhccCHHHHh
Confidence 8852 21 122346799999999999977799998875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=303.65 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=198.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|++.. .+..|++|.+.... .......+.+|+.++++++||||+++++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 47889999999999999999863 34578889876544 22333446689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+ +++|.+++..... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred eEEEeccc-CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 99999999 9999999875431 267777889999999999999999999999999999999999999999998875
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc--
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL-- 322 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 322 (394)
.............++..|+|||.+.... .++.++|||||||++|||++ |.+||.+....+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (286)
T cd07832 149 FSEEEPRLYSHQVATRWYRAPELLYGAR------KYDPGVDLWAVGCIFAELLN-GSPLFPGENDIEQLAIVFRTLGTPN 221 (286)
T ss_pred ccCCCCCccccccCcccccCceeeeccc------cCCchhHHHHHHHHHHHHHc-CCcCcCCCCHHHHHHHHHHHcCCCC
Confidence 5433211122346778899999886433 26789999999999999998 99889877765555444321100
Q ss_pred ----------------CCC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 ----------------RLP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ----------------~~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+ .....+..+.+++++||..+|+ ||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 0124568899999999999998 999998864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.84 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=200.3
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+.+.|+..+.||+|+||.||+|+... .+..|++|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR-------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC-------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 35668888999999999999999763 34478898875432 2233344668999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+++..++||||+. |+|.+++..... .+++..+..++.|++.||.|||+++|+||||+|+||+++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecC
Confidence 9999999999997 588777754322 25677788899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++...... ....++..|+|||++.... ...++.++||||||+++|||++ |..||.+.........+..+.
T Consensus 161 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~----~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 230 (307)
T cd06607 161 SASLVSPA-----NSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQND 230 (307)
T ss_pred cceecCCC-----CCccCCccccCceeeeccC----CCCCCcccchHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Confidence 88654322 1335677899999885321 1127889999999999999998 999998887766666555443
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...++ +..++..+.+++++||..+|+ ||++.+++.
T Consensus 231 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 231 SPTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCC-chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 22222 345788999999999999998 999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.64 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=182.3
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--CCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE--SDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv 168 (394)
.+||+|+||.||+|+++.. .....+|+|.+....... .+.+|+.++++++||||+++++++.. +..+|++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-----~~~~~~aiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDG-----KDDRDYALKQIEGTGISM---SACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred cccccCCCeEEEEEEEccC-----CCCceEEEEEECCCCCcH---HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 5799999999999997632 234578999886543221 24589999999999999999999864 4568999
Q ss_pred EeeCCCCCHHHHHhhcchh----hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCeEEEccCC
Q psy7505 169 FESCSRGDLKEFLLSNEAS----REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV----TSELRVKIGDTG 240 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl----~~~~~vKl~DFG 240 (394)
|||+. ++|.+++...... ....++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99995 5899888643211 11136777788999999999999999999999999999999 456789999999
Q ss_pred CCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---------
Q psy7505 241 SSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD--------- 309 (394)
Q Consensus 241 ~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~--------- 309 (394)
+|+....... .......+|..|+|||++.+.. .++.++||||+||++|||++ |+.||.....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR------HYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYH 230 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCC------CcCchhhHHHHHHHHHHHHh-CCCCccCCccccccccccc
Confidence 9875432211 1123456788999999987643 27889999999999999998 9999964321
Q ss_pred HHHHHHHhcCCCc----------CCC-------------------------CCCCCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 310 DQVITRVFGTEAL----------RLP-------------------------APRAVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 310 ~~~~~~i~~~~~~----------~~~-------------------------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
.+.+..+...... .++ .....+..+.+++++||+.||+ |+|+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e 310 (317)
T cd07868 231 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH
Confidence 1111111110000 000 0012345688999999999998 999998
Q ss_pred hhh
Q psy7505 354 TGS 356 (394)
Q Consensus 354 ~~~ 356 (394)
++.
T Consensus 311 ~l~ 313 (317)
T cd07868 311 AMQ 313 (317)
T ss_pred Hhc
Confidence 764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=299.08 Aligned_cols=250 Identities=19% Similarity=0.298 Sum_probs=203.2
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|.++. .+..+++|.+.... .......+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence 47889999999999999999873 34478888876542 22233446689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~DFG~a~ 243 (394)
.++|+||+++++|.+++...... .+++.....++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQRGV---LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred EEEEEecCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence 99999999999999999764321 256777888999999999999999999999999999999885 57999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....... ......++..|+|||++.... ++.++|+|||||++|||++ |..||......+....+..+. .
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~ape~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~--~ 219 (257)
T cd08225 151 QLNDSME-LAYTCVGTPYYLSPEICQNRP-------YNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVLKICQGY--F 219 (257)
T ss_pred hccCCcc-cccccCCCccccCHHHHcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhccc--C
Confidence 5433221 122235778899999876544 6789999999999999998 999998877766666665554 3
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.+..++..+.+++++||..+|+ ||++.|++.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 445567889999999999999998 999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.63 Aligned_cols=249 Identities=20% Similarity=0.254 Sum_probs=205.9
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||+|+||.||+|+++. .+..+++|.+...........+.+|+..+.+++|+||+++++++...+.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence 367888999999999999999873 3557899988766543444556799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++||||+++++|.+++..... ++......++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKVGK-----IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred EEEEEEecCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccce
Confidence 9999999999999999976422 5677788999999999999999 999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHhcCC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL---SDDQVITRVFGTE 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~---~~~~~~~~i~~~~ 320 (394)
........ .....++..|+|||.+.... ++.++|+||||+++|+|++ |..||... ...+....+....
T Consensus 149 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~-------~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 219 (264)
T cd06623 149 VLENTLDQ-CNTFVGTVTYMSPERIQGES-------YSYAADIWSLGLTLLECAL-GKFPFLPPGQPSFFELMQAICDGP 219 (264)
T ss_pred ecccCCCc-ccceeecccccCHhhhCCCC-------CCchhhHHHHHHHHHHHHh-CCCCCccccccCHHHHHHHHhcCC
Confidence 54332211 11335677899999986553 7889999999999999998 99999877 4455555655443
Q ss_pred CcCCCCCCC-CChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRA-VNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~-~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+.. ++..+.+++++||..+|+ ||++.++++
T Consensus 220 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 220 --PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred --CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 4445556 899999999999999998 999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=306.11 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=196.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|.++. ....+++|.+.... .......+.+|+.+++.++||||+++++++.+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 468889999999999999999863 34478898875433 2223334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++++|..+...... +++.....++.|++.||.|||+.+++|+||+|+||++++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred eEEEEEecCCccHHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 99999999999999887654322 5677788899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA-- 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~-- 321 (394)
...... .......++..|+|||++.+.. .++.++|||||||++|||++ |..||......+....+.....
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~~l~el~~-g~~~~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07846 149 TLAAPG-EVYTDYVATRWYRAPELLVGDT------KYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQLYHIIKCLGNL 220 (286)
T ss_pred eccCCc-cccCcccceeeccCcHHhcccc------ccCchHhHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHhCCC
Confidence 543322 1122335677899999986432 26789999999999999998 9999987665443333221000
Q ss_pred ----------------cCCC----------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 ----------------LRLP----------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ----------------~~~~----------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+ ....++..+.+++++||..+|+ ||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 1236788999999999999998 999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=305.79 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=191.2
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|+++. .+..+++|.++... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence 47888999999999999999873 34478888876432 11222335589999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+++|+||+. |+|.+++..... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 74 LTLVFEYCD-QDLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred eEEEEecCC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 999999997 588888765322 257778889999999999999999999999999999999999999999999865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC-CCCCCHHHHHHHHhcCCC--
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YAELSDDQVITRVFGTEA-- 321 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P-f~~~~~~~~~~~i~~~~~-- 321 (394)
...... ......++..|+|||++.+.. .++.++|||||||++|||++ |..| |.+.+..+.+..+.....
T Consensus 149 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 149 FGIPVR-CYSAEVVTLWYRPPDVLFGAK------LYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred cCCCCC-CcCCCccccCCcChHHHhCCc------ccCcHHHHHHHHHHHHHHHh-cCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 432211 112234577899999986543 26789999999999999998 7666 555544443333321100
Q ss_pred --------------cCC----------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 --------------LRL----------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 --------------~~~----------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... .....++.++.+++++||..+|. ||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 01134678899999999999998 999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=303.96 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=198.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
+...|++.+.||+|+||.||+|+++. ....+++|........ ...+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVK-------TGQLAAIKVMDVTEDE--EEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcC-------CCcEEEEEEEecChHH--HHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45678888999999999999999863 3447888887544322 23355788888888 79999999999863
Q ss_pred ------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 162 ------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 ------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
.+.+|++|||+++|+|.+++...... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999764321 245666778899999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||++....... .......++..|+|||.+..... ....++.++|||||||++|||++ |..||.+....+.+..
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~--~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDEN--PDATYDYRSDIWSLGITAIEMAE-GAPPLCDMHPMRALFL 237 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccC--cCcCCCcccchhHHHHHHHHHHh-CCCCccccCHHhhhhh
Confidence 99999886432211 11223457788999999864321 12237889999999999999998 9999987766555444
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..... ....+..++..+.++|++||..+|. ||++.|++.
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 433321 1222446889999999999999998 999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=304.12 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=196.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|.++. ....|++|.++... .......+.+|++++++++|+||+++++++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 368899999999999999999873 34588999876543 2233345679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||++++.|..++..... ++...+..++.||+.||.|||+++++||||+|+||+++.++.+||+|||++.
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 74 RLYLVFEYVERTLLELLEASPGG-----LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred EEEEEEecCCCCHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 99999999998777666544321 5677788899999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE--- 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~--- 320 (394)
..............++..|+|||++.... .++.++||||||+++|+|++ |..||.+....+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 221 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLVGDT------NYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQLYLIQKCLGPL 221 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhcCCC------CcCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence 55433221122345677899999987652 27889999999999999998 999998766544333221100
Q ss_pred ---------------CcCC-----------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ---------------ALRL-----------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ---------------~~~~-----------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+ ..+..++.++.+++++||..+|+ ||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 12334588999999999999998 999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.38 Aligned_cols=252 Identities=20% Similarity=0.268 Sum_probs=197.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc---------HHHHHHHHHHHHHhccCCCcceecee
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---------QAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~---------~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
+|.+.+.||+|+||.||+|.... .+..+++|.++.... ......+.+|+.+++.++|+||++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeecC-------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 46778899999999999998762 344788887653211 11123456899999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++...+..++||||+++|+|.++++..+. ++...+..++.|++.||.|||+++++||||+|+||+++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEE
Confidence 999999999999999999999999976532 566677788999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 237 GDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 237 ~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
+|||++....... ........++..|+|||.+..... .++.++|+||||+++|||++ |..||......+.+..
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-----~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ-----GYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAIAAMFK 223 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccC-----CCCccchhHHHHHHHHHHHh-CCCCCcCcchHHHHHH
Confidence 9999886532211 111223457788999999865431 26789999999999999998 9999987666554444
Q ss_pred HhcCCCcCCCCC----CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.... .....+ ..++..+.+++.+||..+|+ ||++.|++.
T Consensus 224 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGNKR-SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhccc-cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 33221 122223 25688999999999999998 999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=303.79 Aligned_cols=253 Identities=18% Similarity=0.311 Sum_probs=192.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+.+. ....|++|.+...........+.+|+.++++++|+||+++++++.+++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL-------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC-------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 4678999999999999999999762 344789998865432222233458999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+.+ +|.+++..... .+.+..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~-~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 77 TLTLVFEYLDT-DLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred eEEEEEecCCC-CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccc
Confidence 99999999975 99998875432 25667788899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhcCCC-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRVFGTEA- 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i~~~~~- 321 (394)
........ .....++..|+|||++.+.. .++.++|||||||++|||++ |..||.+.. ..+.+..+.....
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~------~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07844 152 AKSVPSKT-YSNEVVTLWYRPPDVLLGST------EYSTSLDMWGVGCIFYEMAT-GRPLFPGSTDVEDQLHKIFRVLGT 223 (291)
T ss_pred ccCCCCcc-ccccccccccCCcHHhhcCc------ccCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHHHHHhcCC
Confidence 43221111 11223567899999876432 26789999999999999998 999997665 2232222211000
Q ss_pred -----------------cCCC----C-----CCCCC--hHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -----------------LRLP----A-----PRAVN--SHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -----------------~~~~----~-----p~~~~--~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+ . ...++ ..+.+++++||..+|+ ||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 01233 7788999999999998 999988753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.19 Aligned_cols=235 Identities=19% Similarity=0.295 Sum_probs=194.6
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||.|+||.||+|++.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+.+++.++++||
T Consensus 1 lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKS-------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECC-------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEe
Confidence 6999999999999863 34578999886543 22334456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... ++...+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~-----l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 74 YCLGGELWTILRDRGL-----FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred cCCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 9999999999976532 5666778899999999999999999999999999999999999999999887554332
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCcCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS--DDQVITRVFGTEALRLPAPR 328 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~p~ 328 (394)
......++..|++||.+.... ++.++|+||||+++|+|++ |..||.... ..+....+..+. .....|.
T Consensus 148 -~~~~~~~~~~~~~PE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 217 (262)
T cd05572 148 -KTWTFCGTPEYVAPEIILNKG-------YDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDILKGN-GKLEFPN 217 (262)
T ss_pred -ccccccCCcCccChhHhcCCC-------CCChhhhhhhHHHHHHHHh-CCCCcCCCCCCHHHHHHHHhccC-CCCCCCc
Confidence 122335677899999976544 6789999999999999998 999998776 566666665422 2566777
Q ss_pred CCChHHHHHHHhhhcCCcc-ccc
Q psy7505 329 AVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 329 ~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
.++..+.+++.+||..+|+ |++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcC
Confidence 7799999999999999998 888
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=296.10 Aligned_cols=251 Identities=22% Similarity=0.249 Sum_probs=199.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.+|.+.+.||+|+||.||+|.++. ....+++|.+.... .......+.+|+.++++++|+||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 74 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR 74 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence 578899999999999999998763 34578898764321 2233345678999999999999999999987
Q ss_pred eC--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 161 ES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 161 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+. +.++++|||+++++|.+++...+. +.......++.|++.||.|||+++++|+||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 75 DPEEKKLSIFVEYMPGGSIKDQLKAYGA-----LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECc
Confidence 64 458899999999999999875432 45666778999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCc--eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGD--YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||+++...... ........++..|+|||.+.+.. ++.++|+|||||++|||++ |+.||.+....+.+.++
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~ 221 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-------YGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKI 221 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCC-------CCccccHHHHHHHHHHHHh-CCCCCCccCHHHHHHHH
Confidence 99986542211 01112345778899999987654 6789999999999999998 99999987766655555
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCccccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSELRVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~~~~e~~~ 356 (394)
... ..+...|..+++.+.+++++||.....||++.+++.
T Consensus 222 ~~~-~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQ-PTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLR 260 (264)
T ss_pred HcC-CCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhc
Confidence 432 224556788999999999999996545999887653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=300.13 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=197.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--C
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE--S 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 162 (394)
++|...+.||.|++|.||+|.++. ....+++|.+...........+.+|++++++++||||++++++|.. .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 367889999999999999999873 3457899988755443444456789999999999999999999865 3
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++..... ....++......++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence 468999999999999998764321 1122566677889999999999999999999999999999999999999999988
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHh
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-----SDDQVITRVF 317 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-----~~~~~~~~i~ 317 (394)
....... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||... ...+....+.
T Consensus 153 ~~~~~~~---~~~~~~~~~y~~pE~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd06621 153 GELVNSL---AGTFTGTSFYMAPERIQGKP-------YSITSDVWSLGLTLLEVAQ-NRFPFPPEGEPPLGPIELLSYIV 221 (287)
T ss_pred ccccccc---cccccCCccccCHHHhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCcccCCCCChHHHHHHHh
Confidence 6443221 12335677899999986654 7889999999999999998 99999765 2344444444
Q ss_pred cCCCcCCCCC----CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
......++.. ...++.+.+++.+||..+|. ||++.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 3221122111 23457899999999999997 999998864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=302.07 Aligned_cols=240 Identities=19% Similarity=0.221 Sum_probs=184.1
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHH---HhccCCCcceeceeeEEEeCCceE
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEAT---PYRRLRHVNILRLMAACLESDPWL 166 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~ 166 (394)
.||+|+||.||++.+.. ....+|+|.+.... .......+.+|.. ++...+||||+.+++++...+..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECC-------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEE
Confidence 38999999999999862 34578999876543 1122222334433 344458999999999999889999
Q ss_pred EEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 167 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
+||||+++|+|.+++..++. +++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHGV-----FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999999999999876532 6777788899999999999999999999999999999999999999999986442
Q ss_pred CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCCcCC
Q psy7505 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD--DQVITRVFGTEALRL 324 (394)
Q Consensus 247 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~ 324 (394)
... .....++..|+|||.+..+. .++.++|||||||++|||++ |..||..... ...+....... ..
T Consensus 149 ~~~---~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~--~~ 216 (279)
T cd05633 149 KKK---PHASVGTHGYMAPEVLQKGT------AYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTV--NV 216 (279)
T ss_pred ccC---ccCcCCCcCccCHHHhcCCC------CCCchhhhHHHHHHHHHHHh-CCCCcCCCCCcCHHHHHHHhhcC--Cc
Confidence 221 12346788999999875322 26889999999999999998 9999975432 22222222222 44
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccc-----hhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVK-----IGDTG 355 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~-----~~e~~ 355 (394)
..|..++..+.+++++||..+|. |++ +.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 253 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVK 253 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 55678899999999999999998 774 65554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.61 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=206.2
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..+.|+....||+|+||.||+|.+.. ....+++|.+..... ....+.+|+.+++.++|+||+++++++...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA-------TGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc-------CCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 35678888999999999999999862 345788998865543 333456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++|+||+++++|.+++.... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999998653 12677778889999999999999999999999999999999999999999987
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......++..|++||.+.+.. ++.++|+|||||++|+|++ |..||...........+......
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-------~~~~~Dv~slGvil~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06614 164 AQLTKEKS-KRNSVVGTPYWMAPEVIKRKD-------YGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRALFLITTKGIP 234 (286)
T ss_pred hhhccchh-hhccccCCcccCCHhHhcCCC-------CCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Confidence 54322211 112234567899999986554 6889999999999999998 99999988776665555544433
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.+..++..+.+++++||+.+|. ||++.+++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 4444556889999999999999998 999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=302.53 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=194.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|+..+.||+|+||.||+|+++. .+..|++|.++... .......+.+|++++++++||||+++++++.+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 47888999999999999999863 34578999876443 22222345689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 999999996 689998865422 1256777889999999999999999999999999999999999999999998864
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC-
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR- 323 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~- 323 (394)
...... ......++..|+|||++.+.. .++.++|||||||++|||+| |+.||.+.+..+...++.......
T Consensus 150 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07860 150 FGVPVR-TYTHEVVTLWYRAPEILLGCK------YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPD 221 (284)
T ss_pred cccCcc-ccccccccccccCCeEEecCC------CCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 422211 112234567899999886543 15788999999999999998 999998776554433332211000
Q ss_pred ----------------C---------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 ----------------L---------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ----------------~---------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+ .....++..+.+++++||..||. ||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 01234678899999999999998 999988864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.11 Aligned_cols=251 Identities=19% Similarity=0.213 Sum_probs=196.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc----HHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS----QAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+|++.+.||+|+||.||+|.++. ....|++|.++.... ......+..|+.+++.++|+||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence 47788899999999999999863 345899998865442 2223345689999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+..++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+
T Consensus 74 ~~~~~lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 74 KSNINLVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred CCEEEEEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEcccee
Confidence 99999999999 889999997653 1267778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......++..|+|||.+.+.. .++.++|||||||++|||++ |..||.+....+.+.++.....
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~il~e~~~-g~~~~~~~~~~~~~~~~~~~~~ 220 (298)
T cd07841 149 ARSFGSPNR-KMTHQVVTRWYRAPELLFGAR------HYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALG 220 (298)
T ss_pred eeeccCCCc-cccccccceeeeCHHHHhCCC------CCCcHHHHHHHHHHHHHHHc-CCccccCCccHHHHHHHHHHcC
Confidence 865433221 112224567799999875432 26789999999999999998 8888887766555444432110
Q ss_pred c--------------------CCC-----CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 L--------------------RLP-----APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~--------------------~~~-----~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ..+ ....++..+.+++++||..+|+ ||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 000 1134577899999999999998 999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=304.04 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=194.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 162 (394)
.++|+..+.||+|+||.||++.++. ....+++|.+...........+.+|+.++.++. |+||+++++++..+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKP-------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECC-------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 3456677889999999999999873 345899998875543344455678999999995 99999999999998
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+..+++|||+.. +|.++...........+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 154 (288)
T cd06616 76 GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154 (288)
T ss_pred CcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecch
Confidence 999999999864 665543221111112266777889999999999999974 999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-~~~~~~i~~~~ 320 (394)
+........ .....++..|+|||++.... ...++.++|||||||++|||++ |+.||..... .+.+..+..+.
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 227 (288)
T cd06616 155 SGQLVDSIA--KTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVAT-GKFPYPKWNSVFDQLTQVVKGD 227 (288)
T ss_pred hHHhccCCc--cccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHh-CCCCchhcchHHHHHhhhcCCC
Confidence 864432211 12235677899999986552 0127889999999999999998 9999987652 23333333333
Q ss_pred CcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.++ .+..++.++.+++++||..+|+ ||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222 2235889999999999999998 999998864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.65 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=193.9
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-HHHHHHHHHHHHhccC-CCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-AEKLFFLHEATPYRRL-RHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.++. .+..|++|..+..... .....+.+|+.+++.+ +|+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 368889999999999999999873 3457899987654321 1223355899999999 569999999999876
Q ss_pred Cc-----eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEE
Q psy7505 163 DP-----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKI 236 (394)
Q Consensus 163 ~~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl 236 (394)
+. .|+||||+++ +|.+++..........+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+||
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEE
Confidence 65 8999999985 8999886543221123577788899999999999999999999999999999998 889999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++........ ......+++.|+|||.+.+.. .++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 153 ~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 153 ADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGST------HYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLLHI 224 (295)
T ss_pred eecccceecCCCcc-ccCCcccccCCCChHHhhCCC------CCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Confidence 99998865422111 111224567899999886432 26889999999999999998 99999887765554443
Q ss_pred hcCCC--c--C------------CC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEA--L--R------------LP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~--~--~------------~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... . . .+ ....++..+.+++++||..+|. ||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 32100 0 0 00 0135788999999999999998 999988764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.40 Aligned_cols=243 Identities=19% Similarity=0.265 Sum_probs=191.6
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||+|+||+||+|..+. .+..+++|.+.... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKA-------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcC-------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEe
Confidence 6999999999998763 34478888875432 12223345689999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++..... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK- 149 (277)
T ss_pred cCCCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-
Confidence 9999999999976532 125677788899999999999999999999999999999999999999999886543211
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhcCCCcCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----DQVITRVFGTEALRLPA 326 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~ 326 (394)
......++..|+|||++.+.. ++.++|||||||++|+|++ |+.||..... .++...+... ....
T Consensus 150 -~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 217 (277)
T cd05577 150 -KIKGRAGTPGYMAPEVLQGEV-------YDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVEKEELKRRTLEM---AVEY 217 (277)
T ss_pred -ccccccCCCCcCCHHHhcCCC-------CCchhhhHHHHHHHHHHhh-CCCCCCCCcccccHHHHHhccccc---cccC
Confidence 122335667899999986554 6789999999999999998 9999977543 2222222221 4456
Q ss_pred CCCCChHHHHHHHhhhcCCcc-ccchhh-hhhhh
Q psy7505 327 PRAVNSHVDVAARNCLVTSEL-RVKIGD-TGSSI 358 (394)
Q Consensus 327 p~~~~~~~~~l~~~cl~~~p~-r~~~~e-~~~~l 358 (394)
+..+++.+.+++++||+.+|. ||++.+ ....|
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 677899999999999999998 996665 44444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.61 Aligned_cols=256 Identities=18% Similarity=0.249 Sum_probs=200.7
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc---HHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---QAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
+|++.+.||+|+||.||+++..+.. .....+++|.++.... ......+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH----DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc----cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 4788899999999999999865322 2345788998865331 22233456899999999 69999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+...++||||+++|+|.+++..... +.+.....++.|++.||.|||+.+++||||||+||+++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQREH-----FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcCC-----cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence 9999999999999999999875432 55666778889999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHh
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DDQVITRVF 317 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~~~~~~i~ 317 (394)
++..............++..|+|||.+.+.... .+.++||||||+++|||++ |..||.... ..++...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 225 (288)
T cd05583 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG-----HDKAVDWWSLGVLTFELLT-GASPFTVDGEQNSQSEISRRIL 225 (288)
T ss_pred ccccccccccccccccCCccccCHHHhcCCCCC-----CcchhhhHHHHHHHHHHHh-CCCCcccCcccchHHHHHHHHH
Confidence 876443332223334577889999997654311 5679999999999999998 999996432 233334444
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
.. ..+.|..++..+.+++++||+.+|+ ||++.++...|.
T Consensus 226 ~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 226 KS---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cc---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 33 4566777899999999999999998 999887765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=299.32 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=191.1
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeC--C
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLES--D 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~ 163 (394)
|++.+.||+|+||.||+|..+. ....+++|.++............+|+.+++++. |+||+++++++.++ +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcC-------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 5678899999999999999863 345788998865432222222347888888884 99999999999987 8
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||+. |+|.+++..... .+++..+..++.|++.||.|||+++++||||||+||+++. +.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKR----PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence 8999999997 588888865421 2577788899999999999999999999999999999999 999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE--- 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~--- 320 (394)
........ ....++..|+|||.+.... .++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 148 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~~~~~~~~~~ 218 (282)
T cd07831 148 GIYSKPPY--TEYISTRWYRAPECLLTDG------YYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTP 218 (282)
T ss_pred ccccCCCc--CCCCCCcccCChhHhhcCC------CCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHHHHHHHcCCC
Confidence 54322211 1234677899999875433 26789999999999999998 999998877655443332110
Q ss_pred ------------CcCCCC-----------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ------------ALRLPA-----------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ------------~~~~~~-----------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...... ...++..+.+++.+||..+|+ ||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001111 125678999999999999998 999988864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.48 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=196.7
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-----cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-----SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+|+..+.||+|+||.||+|... .....+++|.+.... .......+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEc-------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence 3667788999999999999875 234578898876433 1223345678999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEccC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDT 239 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~DF 239 (394)
+.+.+++||||+++++|.+++.+.+. +++.....++.|++.||.|||++|++||||||+||+++.++ .+||+||
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSKYGA-----FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccc
Confidence 99999999999999999999975432 56677888999999999999999999999999999998776 6999999
Q ss_pred CCCccCCCCce---eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Q psy7505 240 GSSIDKYPGDY---YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD---DQVI 313 (394)
Q Consensus 240 G~a~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~---~~~~ 313 (394)
|.+........ .......++..|+|||.+.+.. ++.++||||+||++|+|++ |..||..... ...+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 220 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-------YGRSCDVWSVGCVIIEMAT-AKPPWNAEKHSNHLALI 220 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCC-------CCcccchHHHHHHHHHHHh-CCCCCCCCCCcchHHHH
Confidence 98865432211 1112345678899999986544 6789999999999999998 9999975442 2223
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..+.... .....|..++..+.+++.+||..+|. ||++.|++
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 221 FKIASAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred HHHhccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 2322221 13456677889999999999999998 99998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.65 Aligned_cols=252 Identities=17% Similarity=0.292 Sum_probs=189.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|.+.+.||+|+||.||+|..+. .+..+++|.+...........+.+|+.+++.++|+||+++++++..++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI-------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC-------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 4679999999999999999998863 345789998865443322234568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..|+||||+. ++|.+++..... .+.+..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 9999999995 688877754321 13455667789999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCC-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEA- 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~- 321 (394)
........ .....++..|+|||.+.+.. .++.++|||||||++|||++ |..||.+.... +.+..+.....
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07870 152 AKSIPSQT-YSSEVVTLWYRPPDVLLGAT------DYSSALDIWGAGCIFIEMLQ-GQPAFPGVSDVFEQLEKIWTVLGV 223 (291)
T ss_pred ccCCCCCC-CCCccccccccCCceeecCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHHHHcCC
Confidence 53221111 12234577899999986432 16778999999999999998 99999876532 22222211000
Q ss_pred -------------------cCCCCC---------CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 322 -------------------LRLPAP---------RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 322 -------------------~~~~~p---------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.....+ ...+..+.+++++||..+|. ||++.|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 000000 01256889999999999998 99998875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=299.88 Aligned_cols=247 Identities=17% Similarity=0.245 Sum_probs=193.5
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc---HHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---QAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
+|++.+.||+|+||.||+++..... ..+..||+|.++.... ......+.+|+.+++++ +|+||+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~----~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH----DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC----CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 4778899999999999999875311 2345789998865331 12223456899999999 69999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+..+++||||+++|+|.+++..... +.......++.|++.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRER-----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence 8899999999999999999976432 55667778888999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHh
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DDQVITRVF 317 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~~~~~~i~ 317 (394)
+...............++..|+|||.+..... .++.++||||||+++|+|++ |..||.... ..++...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 225 (290)
T cd05613 152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG-----GHDKAVDWWSMGVLMYELLT-GASPFTVDGEKNSQAEISRRIL 225 (290)
T ss_pred ceecccccccccccccCCcccCChhhccCCCC-----CCCccccHHHHHHHHHHHhc-CCCCCCcCCccccHHHHHHHhh
Confidence 86543322222223457788999999865332 16788999999999999998 999996432 233344443
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
.. ..+.|..++..+.+++++||+.+|+ |++
T Consensus 226 ~~---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 226 KS---EPPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred cc---CCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 33 3455677899999999999999998 763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=302.05 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=202.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
++.|+..+.||+|+||.||+|++.. ....+++|.+.... .......+.+|+.++++++|+|++++++++.+
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVR-------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcC-------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4557788899999999999999763 34478898876432 22233346689999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++..++||||+. |+|.+++..... .+++..+..++.|++.||.|||+++|+||||+|+||+++.++.+||+|||+
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCC
Confidence 999999999997 588887754322 256777788999999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+...... ....++..|+|||.+.... ...++.++|||||||++|||++ |..||.+......+..+..+..
T Consensus 172 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~----~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~ 241 (317)
T cd06635 172 ASIASPA-----NSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNES 241 (317)
T ss_pred ccccCCc-----ccccCCccccChhhhhcCC----CCCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhccC
Confidence 7643221 2335677899999975321 1126789999999999999998 9999988877666666655542
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
....+..++..+.+++.+||+.+|. ||++.+++..+-.+.
T Consensus 242 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 -PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 2223456788999999999999998 999999986544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=294.21 Aligned_cols=241 Identities=19% Similarity=0.256 Sum_probs=190.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHH-HhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEAT-PYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+.||+|+||.||+|..+. ....||+|.+..... ......+..|.. .....+|+||+++++++..++.+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecC-------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEE
Confidence 468999999999998863 344789998865331 111122234444 3455699999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++|+|.+++...+. ++...+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 75 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLGG-----LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 9999999999999976532 56777888999999999999999999999999999999999999999998864322
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-cCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA-LRLPA 326 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 326 (394)
.....++..|+|||.+.+.. ++.++||||||+++|||++ |..||...+..++...+..+.. .....
T Consensus 150 -----~~~~~~~~~y~~pe~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (260)
T cd05611 150 -----NKKFVGTPDYLAPETILGVG-------DDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEV 216 (260)
T ss_pred -----cccCCCCcCccChhhhcCCC-------CcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 12335677899999986554 6789999999999999998 9999998888777766654431 11223
Q ss_pred CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 327 PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 327 p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..++..+.+++.+||..+|+ ||++.++.+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 346889999999999999998 887655433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=298.65 Aligned_cols=245 Identities=20% Similarity=0.369 Sum_probs=203.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCC-CcceeceeeEEEe
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLR-HVNILRLMAACLE 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 161 (394)
++|++.+.||+|+||.||+|..+. ....+++|+..... .......+.+|+.++++++ |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC
Confidence 478899999999999999999873 45578999886532 2233345668999999998 9999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++..++||||+.+++|.+++...+. +++.....++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence 9999999999999999999976532 67778889999999999999999999999999999999999999999998
Q ss_pred CccCCCCce-------------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 242 SIDKYPGDY-------------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 242 a~~~~~~~~-------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
+........ .......++..|+|||++.... ++.++||||||+++|++++ |..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~ 220 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-------AGKSSDLWALGCIIYQMLT-GKP 220 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-------CChhhhHHHHHHHHHHHHh-CCC
Confidence 865432221 1122235678899999876544 6789999999999999998 999
Q ss_pred CCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 303 PYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 303 Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
||........+..+... ....|..+++.+.+++++||..+|. ||++.
T Consensus 221 p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 221 PFRGSNEYLTFQKILKL---EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred CCCCccHHHHHHHHHhc---CCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 99988776666666543 5567788899999999999999998 99993
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=270.52 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=197.0
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
.|.-.++||+|.||+||+|+.+. +...||+|.++.+. ++......++|+.+++.++|.|||+++++...++.
T Consensus 3 ~ydkmekigegtygtvfkarn~~-------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC-------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 45556889999999999999873 45588988876554 33333345699999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+.+|+|||.. +|..|...... .++...+..++.|+++||.|+|+++++||||||.|+||+.+|.+|++|||+++.
T Consensus 76 ltlvfe~cdq-dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 76 LTLVFEFCDQ-DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred eEEeHHHhhH-HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence 9999999965 99988865422 267778889999999999999999999999999999999999999999999986
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC-
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT--EA- 321 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~--~~- 321 (394)
..-.- .+-.....|.+|.+|.++.+... |+...|+||.||++.|+...|++-|.+.+..+.+.+|+.- ..
T Consensus 151 fgipv-rcysaevvtlwyrppdvlfgakl------y~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ 223 (292)
T KOG0662|consen 151 FGIPV-RCYSAEVVTLWYRPPDVLFGAKL------YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_pred cCCce-EeeeceeeeeeccCcceeeeeeh------hccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc
Confidence 54332 12233466899999999988764 8999999999999999998799999999877776666431 10
Q ss_pred -cCCC----------C---C---------CCCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 322 -LRLP----------A---P---------RAVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 322 -~~~~----------~---p---------~~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
...| . | +.++..-.+++++++.-+|. |.++.+
T Consensus 224 ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea 279 (292)
T KOG0662|consen 224 EDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA 279 (292)
T ss_pred cccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence 0111 0 1 13334556889999999997 777654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=295.83 Aligned_cols=243 Identities=19% Similarity=0.297 Sum_probs=197.9
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||+|+||.||+|++.. .+..+++|.+..... ......+.+|+.++++++|+||+++++.+..++..|++||
T Consensus 1 lg~g~~~~vy~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECC-------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEe
Confidence 6899999999999863 345889998865432 2333446689999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++|+|.+++...+ .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++........
T Consensus 74 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 999999999997643 257777889999999999999999999999999999999999999999998865432211
Q ss_pred -------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 251 -------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 251 -------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
.......++..|++||.+.... ++.++||||||+++|||++ |..||......+....+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-------~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~--- 217 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG-------HSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGK--- 217 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC-------CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC---
Confidence 0122335677899999986554 6789999999999999998 999999888888877776643
Q ss_pred CCCCCC--CChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 324 LPAPRA--VNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 324 ~~~p~~--~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
.+.|.. ++..+.+++++||+.+|+ ||++.++.+.|
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 333444 489999999999999998 99986555433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=290.56 Aligned_cols=247 Identities=17% Similarity=0.306 Sum_probs=205.1
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceec
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILR 154 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~ 154 (394)
..|.+..++|.++..||+|+|++|.+++++ .+.+.+|+|++++.. ..........|-.+..+. +||.+|-
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~-------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLK-------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehc-------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence 566788899999999999999999999987 345578888887654 222333344555555554 8999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
++.+|++..++++|.||.+||+|.-+++.++. ++++.+..+..+|+.||.|||++|||.||||.+|+|++..|++
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCce
Confidence 99999999999999999999999988876544 7788888999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCC-------CC
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA-------EL 307 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~-------~~ 307 (394)
||+|+|+++....... .+.+.+||+.|.|||++.+.. |++.+|+|+|||+++||++ |+.||. +.
T Consensus 391 kltdygmcke~l~~gd-~tstfcgtpnyiapeilrgee-------ygfsvdwwalgvlmfemma-grspfdivgm~n~d~ 461 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGD-TTSTFCGTPNYIAPEILRGEE-------YGFSVDWWALGVLMFEMMA-GRSPFDIVGMDNPDM 461 (593)
T ss_pred eecccchhhcCCCCCc-ccccccCCCcccchhhhcccc-------cCceehHHHHHHHHHHHHc-CCCCcceecCCCccc
Confidence 9999999976543322 355789999999999998887 8899999999999999998 999995 23
Q ss_pred CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc
Q psy7505 308 SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL 347 (394)
Q Consensus 308 ~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~ 347 (394)
+..+.+.++.-.. .+.+|+.++-.+..+++..|..||+
T Consensus 462 ntedylfqvilek--qiriprslsvkas~vlkgflnkdp~ 499 (593)
T KOG0695|consen 462 NTEDYLFQVILEK--QIRIPRSLSVKASHVLKGFLNKDPK 499 (593)
T ss_pred chhHHHHHHHhhh--cccccceeehhhHHHHHHhhcCCcH
Confidence 3445555544443 6677888888999999999999997
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=306.55 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=195.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
.++|++.+.||+|+||.||+|+++. .+..|++|.+...........+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP-------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC-------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 4679999999999999999998863 34589999886433333333456899999999999999999987654
Q ss_pred ----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 163 ----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 163 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
..+++||||+. ++|.+++.... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~~~------l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIKTQH------LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECc
Confidence 35799999996 48988886432 56667788999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||++......... ......++..|+|||.+.... .++.++|||||||++|+|++ |+.||.+.+....+..+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwslGvil~el~~-G~~~f~~~~~~~~~~~~ 222 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK------GYTKAIDIWSVGCILAEMLS-NRPLFPGKDYLHQLNLI 222 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9998654322211 112235678899999875432 26889999999999999998 99999776543322211
Q ss_pred hc---C--------------------C--CcCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh--hhcCCC
Q psy7505 317 FG---T--------------------E--ALRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS--IDKYPG 363 (394)
Q Consensus 317 ~~---~--------------------~--~~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~--l~~~~~ 363 (394)
.. . . ....+ .....+..+.++|++||..+|+ ||++.|++.. +..+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 11 0 0 00000 0124577899999999999998 9999998754 555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=295.39 Aligned_cols=212 Identities=22% Similarity=0.338 Sum_probs=174.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
...|+.+..||+|.||.||+|..+... +.....+|+|.++...+ ........+|+.+++.++|||||.|..+|..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n---~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTN---DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCC---cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 467888999999999999999765432 22344778888875531 1111123489999999999999999999987
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CeEEEc
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE----LRVKIG 237 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~----~~vKl~ 237 (394)
+..++|++||.+. ||.+.|+-+.......++...+..++.||+.|+.|||++-|+||||||.|||+..+ |.|||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 7889999999987 99999988766666678888999999999999999999999999999999999877 999999
Q ss_pred cCCCCccCCCC--ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 238 DTGSSIDKYPG--DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 238 DFG~a~~~~~~--~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
|||+++..... ..+....++.|++|.|||++.+... |+.+.||||.|||+.||+| -++-|.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h------YT~AiDvWAiGCIfaElLt-l~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH------YTKAIDVWAIGCIFAELLT-LEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccccc------ccchhhhHHHHHHHHHHHc-cCccccc
Confidence 99999865432 2233445678999999999998874 9999999999999999998 6666654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=299.05 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=202.9
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceec
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILR 154 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 154 (394)
....+.+..++|++.+.||+|+||.||+|.++. ....|++|.++..........+.+|+.++.++ +|+||++
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~ 78 (296)
T cd06618 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKK-------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78 (296)
T ss_pred cceeccCCcchheeeeEeeccCCeEEEEEEECC-------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHh
Confidence 344566778999999999999999999999873 34578999887544333333344677666666 5999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCe
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~ 233 (394)
+++++.++...|+||||+. ++|.+++..... .+++.....++.|++.||.|||+ .+|+||||+|+||+++.++.
T Consensus 79 ~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~ 153 (296)
T cd06618 79 CYGYFITDSDVFICMELMS-TCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN 153 (296)
T ss_pred hheeeecCCeEEEEeeccC-cCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC
Confidence 9999999999999999985 478777654221 25677778899999999999997 59999999999999999999
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQV 312 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~ 312 (394)
+||+|||++........ .....++..|+|||.+..... ...++.++||||||+++|||++ |+.||.... ..+.
T Consensus 154 ~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 227 (296)
T cd06618 154 VKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDP---NPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEV 227 (296)
T ss_pred EEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCC---ccccccchhHHHHHHHHHHHHh-CCCCCCcchhHHHH
Confidence 99999998865432211 112245678999999865431 1226789999999999999998 999997643 3455
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+.......++....++.++.+++.+||..+|+ ||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 66666554444454456789999999999999998 999988863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=289.65 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=203.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
+|+..+.||+|+||.||++.++. ....+++|.+..... .....+.+|+.++++++|+||+++++++..++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-------TGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-------CCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 47788999999999999999863 344788998876554 2334466899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++++||+++++|.+++.... ..+++.....++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+...
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999999987642 12577778889999999999999999999999999999999999999999988665
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCC
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLP 325 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 325 (394)
..... .....++..|++||.+.... ++.++||||||+++|+|++ |..||...+..+.+..+.......++
T Consensus 149 ~~~~~--~~~~~~~~~~~~PE~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 218 (253)
T cd05122 149 SDTKA--RNTMVGTPYWMAPEVINGKP-------YDYKADIWSLGITAIELAE-GKPPYSELPPMKALFKIATNGPPGLR 218 (253)
T ss_pred ccccc--ccceecCCcccCHHHHcCCC-------CCccccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhcCCCCcC
Confidence 43321 22345677899999986554 6789999999999999998 99999888665555544444333444
Q ss_pred CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 326 APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 326 ~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..++..+.+++++||..+|+ ||++.|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4455589999999999999998 999988864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=301.83 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=196.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
++|++.+.||+|+||.||+|.++. ....+++|.++.... ......+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK-------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC-------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 568888999999999999999873 344788888865432 22222345899999999999999999999877
Q ss_pred -CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 163 -DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 163 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+..|+||||+. ++|.+++..... .+++.....++.|++.||.|||+++++|+||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 78 LDKIYMVMEYVE-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred CCcEEEEehhcC-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence 88999999997 499998865432 267778889999999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......++..|+|||.+.+.. .++.++|||||||++|||++ |..||......+.+.++.....
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~ 224 (293)
T cd07843 153 AREYGSPLK-PYTQLVVTLWYRAPELLLGAK------EYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNKIFKLLG 224 (293)
T ss_pred eeeccCCcc-ccccccccccccCchhhcCCc------cccchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Confidence 875433211 112234567899999886543 15789999999999999998 9999988776655544332110
Q ss_pred ----------------------------cCCCCCCC-CChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 ----------------------------LRLPAPRA-VNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ----------------------------~~~~~p~~-~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.-..+.. +++.+.+++++||+.+|+ ||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00112222 588899999999999998 999998864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=321.23 Aligned_cols=259 Identities=21% Similarity=0.358 Sum_probs=220.1
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAAC 159 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 159 (394)
..+...+++.+.||.|.+|+||+++.+ ..+..+|+|++..+.+..+. ...|..+++.+ +|||++.++|++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~-------~~~~~aa~kI~~~~~d~deE--iE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHV-------KTGQLAAIKIMDPTEDEEEE--IELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeee-------ecCceeeeEeecCCccccHH--HHHHHHHHHhccCCCCcceEEEEE
Confidence 345677899999999999999999987 34557888888766543333 23577777777 899999999999
Q ss_pred Ee-----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 160 LE-----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 160 ~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
.. ++.+|||||||.+|+..|+++... ...+.+..+..|++.++.|+.+||.+.+||||+|-.|||++.+|.|
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcE
Confidence 75 567999999999999999998754 2337888889999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++..... +..+.++..||+.|||||++.+... ....|+..+|+||||++..||.. |.+|+.++.+...+.
T Consensus 163 KLvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~--~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 163 KLVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDES--PDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHPMRALF 238 (953)
T ss_pred EEeeeeeeeeeec-ccccccCcCCCcccccceeeecccC--CCCCcccccchhhccceeehhcC-CCCCccCcchhhhhc
Confidence 9999999876543 3344567789999999999998753 23348899999999999999997 999999999999999
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.|-.+.++++-.|...+.++.++|..||..|-+ ||++.+++
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 998888888888999999999999999999976 99887764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=293.39 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=206.2
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+++.+. ....+++|.+.... .......+.+|+.++++++|+||+++++++.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 47888999999999999998763 34578888876543 33334455689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++++|.+++..... ....+++.....++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999999999876321 112356777889999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
.... ......++..|++||.+.+.. ++.++|+||||+++|||++ |+.||...+..++...+..+. ..
T Consensus 153 ~~~~---~~~~~~~~~~~~~Pe~~~~~~-------~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~ 219 (256)
T cd08530 153 LKKN---MAKTQIGTPHYMAPEVWKGRP-------YSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYKVQRGK--YP 219 (256)
T ss_pred hccC---CcccccCCccccCHHHHCCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CC
Confidence 5333 112235677899999986654 6789999999999999998 999999988877777766554 34
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..++..+.+++.+||..+|+ ||++.|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 45567889999999999999998 999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=298.94 Aligned_cols=253 Identities=19% Similarity=0.311 Sum_probs=197.3
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
+|++.+.||+|++|.||+|+++. .+..|++|.++..........+.+|+.++++++|+||+++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 47889999999999999999863 34578999887654333334456899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||+++ +|.+++..... ...+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++...
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 999999985 99998876432 122677788899999999999999999999999999999999999999999988644
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-----
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE----- 320 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~----- 320 (394)
..... ......++..|++||.+.+.. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 151 ~~~~~-~~~~~~~~~~y~~PE~~~~~~------~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07836 151 GIPVN-TFSNEVVTLWYRAPDVLLGSR------TYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKIFRIMGTPTE 222 (284)
T ss_pred cCCcc-ccccccccccccChHHhcCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 22211 112234577899999886543 26789999999999999998 999998877655544433211
Q ss_pred ----------CcCCCC-----------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ----------ALRLPA-----------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ----------~~~~~~-----------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...... ...++..+.+++++||+.+|. ||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 124577889999999999998 999988763
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.21 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=208.4
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||++.+.. ....+++|.+.... .......+.+|+++++.++|+|++++++.+..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence 47888999999999999999863 34578899886554 22334456789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++|+||+++++|.+++...... ...++......++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 99999999999999999764210 12267778889999999999999999999999999999999999999999998865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
..... .......++..|+|||.+.... ++.++|+||+|+++|+|++ |..||......++...+..+. ..
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~-------~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~ 221 (258)
T cd08215 153 LSSTV-DLAKTVVGTPYYLSPELCQNKP-------YNYKSDIWSLGCVLYELCT-LKHPFEGENLLELALKILKGQ--YP 221 (258)
T ss_pred cccCc-ceecceeeeecccChhHhccCC-------CCccccHHHHHHHHHHHHc-CCCCCCCCcHHHHHHHHhcCC--CC
Confidence 43322 1223345677899999876554 6789999999999999997 999999888777777776554 44
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.|..++..+.+++++||..+|+ ||++.|++.
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 55668899999999999999998 999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.36 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=205.0
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
+|++.+.||+|+||.||+|+.+. ....+++|....... ......+.+|++++++++|+|++++++++.+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 47788999999999999998763 344788988866542 2334456799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.+++|||+++++|.+++..... +++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKFGP-----FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred EEEEEecCCCCcHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence 9999999999999999976522 57777888999999999999999999999999999999999999999999876
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
....... .....++..|+|||.+.... ++.++||||||+++|+|++ |..||...........+.... ..
T Consensus 149 ~~~~~~~-~~~~~~~~~y~~pe~~~~~~-------~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~ 217 (254)
T cd06627 149 LNDVSKD-DASVVGTPYWMAPEVIEMSG-------ASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDD--HP 217 (254)
T ss_pred cCCCccc-ccccccchhhcCHhhhcCCC-------CCcchhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhccC--CC
Confidence 5433221 22345677899999876543 6789999999999999998 999998877666555554443 45
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..++..+.+++.+||..+|+ ||++.|++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 56778899999999999999998 999988763
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.74 Aligned_cols=255 Identities=16% Similarity=0.135 Sum_probs=184.6
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH--HH--------HHHHHHHHHhccCCCcc
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--EK--------LFFLHEATPYRRLRHVN 151 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--~~--------~~~~~E~~~l~~l~Hpn 151 (394)
+..++|++.+.||+|+||.||+|.+.... .....+++|+........ +. .....+...+..++|+|
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDH----CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCc----ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 45678999999999999999999986431 113355566533222110 00 01123445567789999
Q ss_pred eeceeeEEEeCC----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 152 ILRLMAACLESD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 152 Iv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
|+++++++.... ..++++|++.. ++.+.+..... .++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC-----KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhcc-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999999776543 34678888743 67666654321 244556789999999999999999999999999999
Q ss_pred EcCCCeEEEccCCCCccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 228 VTSELRVKIGDTGSSIDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
++.++.+||+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||++ |.
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-------~~~~~DiwSlG~~l~el~~-g~ 230 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-------VTRRGDLESLGYCMLKWAG-IK 230 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-------CCcHHHHHHHHHHHHHHHh-CC
Confidence 999999999999998754322110 112236889999999987654 7899999999999999998 99
Q ss_pred CCCCCCC-HHH--------HHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 302 LPYAELS-DDQ--------VITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 302 ~Pf~~~~-~~~--------~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
.||.+.. ..+ .+.++..+ .. .+..++.++.++++.||..+|+ ||++.++...|
T Consensus 231 ~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 231 LPWKGFGHNGNLIHAAKCDFIKRLHEG---KI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCccccchHHHHHhHHHHHHHhhhh---hh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9998773 222 22333222 11 2346789999999999999998 99999987765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=295.80 Aligned_cols=239 Identities=18% Similarity=0.216 Sum_probs=185.8
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHH---HHHhccCCCcceeceeeEEEeCCceE
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHE---ATPYRRLRHVNILRLMAACLESDPWL 166 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~~ 166 (394)
.||+|+||.||+|.+.. ....||+|.+..... ......+..| +..++..+||||+.+++++.+.+.++
T Consensus 1 ~ig~g~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 73 (278)
T ss_pred CcccCCCeEEEEEEEec-------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEE
Confidence 38999999999998762 345789998754321 1111112233 34555678999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 167 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++....
T Consensus 74 ~v~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 74 FILDLMNGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999999999999886543 26777888999999999999999999999999999999999999999999986543
Q ss_pred CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhcCCCcC
Q psy7505 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS---DDQVITRVFGTEALR 323 (394)
Q Consensus 247 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~---~~~~~~~i~~~~~~~ 323 (394)
... .....++..|+|||++..+. .++.++||||+||++|||++ |..||.+.. ..+...... .. .
T Consensus 149 ~~~---~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~s~G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~--~ 215 (278)
T cd05606 149 KKK---PHASVGTHGYMAPEVLQKGV------AYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTL-TM--A 215 (278)
T ss_pred ccC---CcCcCCCcCCcCcHHhcCCC------CCCcccchHhHHHHHHHHHh-CCCCCCCCCccchHHHHHHhh-cc--C
Confidence 221 12346788999999986432 27789999999999999998 999998763 333333332 22 4
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
...|..++..+.+++++||..+|. |+ ++.|+.
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 556677899999999999999998 88 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=303.09 Aligned_cols=201 Identities=21% Similarity=0.315 Sum_probs=156.5
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--CCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE--SDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv 168 (394)
.+||+|+||.||+|+.+.. .....+|+|.+...... ..+.+|+.++++++||||+++++++.. +..+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-----~~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGIS---MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eEeccCCCeeEEEEEecCC-----CccceEEEEEecCCCCc---HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 5799999999999997632 23457889987654322 124589999999999999999999854 5678999
Q ss_pred EeeCCCCCHHHHHhhcchh----hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCeEEEccCC
Q psy7505 169 FESCSRGDLKEFLLSNEAS----REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV----TSELRVKIGDTG 240 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl----~~~~~vKl~DFG 240 (394)
|||+. ++|.+++...... ....+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99986 4888887643211 11235677788999999999999999999999999999999 456789999999
Q ss_pred CCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 241 SSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 241 ~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
+++....... .......+|..|+|||++.+.. .++.++|||||||++|||+| |+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwSlG~il~el~t-g~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR------HYTKAIDIWAIGCIFAELLT-SEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCC------ccCcHHHHHhHHHHHHHHHh-CCCCcccc
Confidence 9975433221 1122346788999999986543 27889999999999999998 99999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=299.66 Aligned_cols=246 Identities=19% Similarity=0.287 Sum_probs=199.5
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
+....||+|+||.||++..+. .+..|++|.+..... .....+.+|+.+++.++|+||+++++.+..++..++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKS-------SGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcC-------CCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEE
Confidence 334679999999999998863 445888988754333 234456789999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+++++|.+++.... +++.....++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 95 VMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEecCCCCcHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 999999999999875431 45666778999999999999999999999999999999999999999998754432
Q ss_pred CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCC
Q psy7505 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327 (394)
Q Consensus 248 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p 327 (394)
... ......++..|+|||.+.... ++.++|+|||||++|||++ |..||.+....+....+..+....+...
T Consensus 169 ~~~-~~~~~~~~~~y~~pE~~~~~~-------~~~~~Dv~slGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06657 169 EVP-RRKSLVGTPYWMAPELISRLP-------YGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPKLKNL 239 (292)
T ss_pred ccc-cccccccCccccCHHHhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCcccCCc
Confidence 211 112245678899999886544 6789999999999999998 9999988777666666554443344455
Q ss_pred CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 328 RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 328 ~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++..+.+++.+||..+|. ||++.|++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 67889999999999999998 999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=301.65 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=196.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+.++|++.+.||+|+||.||+|.++. ++..||+|.++.... ......+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTT-------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECC-------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 45789999999999999999999863 445789998764331 1111224579999999999999999999875
Q ss_pred C--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 162 S--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 162 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. +.+++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 78 KHLDSIFLVMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred CCCCeEEEEEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcc
Confidence 4 468999999964 8988886542 12567778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++......... .....++..|+|||.+.+.. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 153 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwslG~il~el~~-g~~~f~~~~~~~~~~~~~~~ 224 (309)
T cd07845 153 GLARTYGLPAKP-MTPKVVTLWYRAPELLLGCT------TYTTAIDMWAVGCILAELLA-HKPLLPGKSEIEQLDLIIQL 224 (309)
T ss_pred ceeeecCCccCC-CCcccccccccChhhhcCCC------CcCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Confidence 998654332111 11223466799999986533 26789999999999999998 99999988877766655431
Q ss_pred CC------------------cCCCC---------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EA------------------LRLPA---------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~------------------~~~~~---------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. ..++. ....++.+.++|++||..||+ ||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 10 00000 012578889999999999998 999988763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.26 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=193.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|.++. .+..+++|.+.... .......+.+|+.++++++|+||+++++++.+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC-------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 578999999999999999999863 34578999876443 2222334568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl~DFG~a 242 (394)
..++||||++ ++|.+++...... ..++..+..++.||+.||.|||+++++||||+|+||+++. ++.+||+|||++
T Consensus 75 ~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 75 RLYLVFEYLD-LDLKKHMDSSPDF---AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred eEEEEEeccc-ccHHHHHHhCCCC---CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9999999996 5888887654221 1356667788999999999999999999999999999985 567999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA- 321 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~- 321 (394)
........ ......++..|+|||.+.+.. .++.++|||||||++|+|+| |..||......+.+.++.....
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~------~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 222 (294)
T PLN00009 151 RAFGIPVR-TFTHEVVTLWYRAPEILLGSR------HYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGT 222 (294)
T ss_pred cccCCCcc-ccccCceeecccCHHHHhCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Confidence 64322111 112234567899999886533 26789999999999999998 9999987766555444332110
Q ss_pred -------------------cCCC------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -------------------LRLP------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -------------------~~~~------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.+ ....++..+.+++++||..+|+ ||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 1235678899999999999998 999988864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=306.51 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=191.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|+..+.||+|+||.||+|++.. .+..||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTV-------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECC-------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 5779999999999999999999863 45589999876432 222233455899999999999999999998643
Q ss_pred ------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 ------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
...|+||||+. |+|.+.+... ++......++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL 159 (353)
T cd07850 88 KSLEEFQDVYLVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 159 (353)
T ss_pred CCccccCcEEEEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEE
Confidence 35799999996 5888887543 456667788999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+....+..+
T Consensus 160 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 160 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWNKI 229 (353)
T ss_pred ccCccceeCCCCC--CCCCCcccccccCHHHHhCCC-------CCCchhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 9999987543322 122335677899999987654 7889999999999999998 99999877654433332
Q ss_pred hcCCC---------------------cCC--------------C-----CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 FGTEA---------------------LRL--------------P-----APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 ~~~~~---------------------~~~--------------~-----~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..... ... + .+...++.+.+++++||..||+ ||++.|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred HHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 21000 000 0 0113456789999999999998 99999986
Q ss_pred h
Q psy7505 356 S 356 (394)
Q Consensus 356 ~ 356 (394)
.
T Consensus 310 ~ 310 (353)
T cd07850 310 Q 310 (353)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.19 Aligned_cols=249 Identities=18% Similarity=0.261 Sum_probs=189.8
Q ss_pred ceeeee--cceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 91 KEIGRG--WFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 91 ~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
..||+| +||+||++++. ..+..||+|+..... .....+.+.+|+.+++.++||||++++++|..++..++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT-------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEc-------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEE
Confidence 456666 99999999886 345589999886543 33344567789999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~ 247 (394)
||||+.+|+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|++|||.+.....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred EEecccCCCHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 99999999999998764321 256667778999999999999999999999999999999999999999985422111
Q ss_pred Cc----e-e-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 248 GD----Y-Y-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 248 ~~----~-~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
.. . . ......++..|||||++.+... .++.++|||||||++|||++ |..||.+....+.......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY-----GYNVKSDIYSVGITACELAT-GRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCC-----CCCchhhHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHhcCCC
Confidence 00 0 0 0011234556999999865432 26889999999999999998 9999988765544433322211
Q ss_pred --------------------------------------------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 322 --------------------------------------------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 322 --------------------------------------------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+.+.+..++..+.+++++||+.||+ ||++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 01122334667899999999999998 99999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=299.77 Aligned_cols=255 Identities=19% Similarity=0.260 Sum_probs=194.8
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..++|++.+.||+|+||.||+|.++. .+..|++|.++... .......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD-------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC-------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 35778899999999999999999873 34478888886543 11222335589999999999999999999876
Q ss_pred CC----------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 162 SD----------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 162 ~~----------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
.. .+++||||+++ +|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~ 152 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV----HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK 152 (302)
T ss_pred cchhhhccccCCcEEEEEcccCc-cHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 54 78999999976 78887765321 25677888999999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
+.+||+|||++...............++..|+|||.+.... .++.++|||||||++|||++ |+.||......+
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~~Di~slG~~~~el~~-g~~~~~~~~~~~ 225 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE------RYGPAIDVWSCGCILGELFT-KKPIFQANQELA 225 (302)
T ss_pred CcEEeCcccccccccCCcccccccceeccCccChHHhcCCC------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Confidence 99999999988654332211111224466799999875432 26789999999999999998 999998776555
Q ss_pred HHHHHhc---CCCc-CC-----------------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFG---TEAL-RL-----------------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~---~~~~-~~-----------------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+.. +... .. .....++..+.+++.+||..+|. ||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4433322 1100 00 01224688999999999999998 999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=316.16 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=194.1
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC----
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD---- 163 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 163 (394)
...+.||+|+||.||+|+++ .++..||||..+........+...+|+++|++|+|+|||+++++-.+..
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnk-------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNK-------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred eehhhhcCCccceeeeeccc-------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 34567999999999999987 5677999999988665555556679999999999999999999876543
Q ss_pred --ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCC--eEEEc
Q psy7505 164 --PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT--SEL--RVKIG 237 (394)
Q Consensus 164 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~--~~~--~vKl~ 237 (394)
...+|||||++|||+..|.+..+ ...+++...+.+..+++.||.|||++||+||||||.||++- .+| .-||+
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 46899999999999999976432 23478888999999999999999999999999999999983 334 47999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DDQVI 313 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~~~~ 313 (394)
|||.|+...+++ ......||..|.+||++.... .|+..+|.|||||++||++| |..||-..- +.++.
T Consensus 167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~------~y~~tVDLWS~GvtlY~caT-G~lPF~p~~~pk~~~~~~ 237 (732)
T KOG4250|consen 167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQK------KYTATVDLWSFGVTLYECAT-GELPFIPFGGPKNNKEIM 237 (732)
T ss_pred cccccccCCCCC--eeeeecCchhhcChHHHhhcc------CcCceeehhhhhhHHHHHhc-cCCCCCcCCCccccchhh
Confidence 999999887666 334678999999999987522 28899999999999999999 999985322 33444
Q ss_pred HHHhcCC------------------CcCCCCCCCCChHHHH----HHHhhhcCCcc-cc--chhhhhhhhhcCC
Q psy7505 314 TRVFGTE------------------ALRLPAPRAVNSHVDV----AARNCLVTSEL-RV--KIGDTGSSIDKYP 362 (394)
Q Consensus 314 ~~i~~~~------------------~~~~~~p~~~~~~~~~----l~~~cl~~~p~-r~--~~~e~~~~l~~~~ 362 (394)
..+.... ...+|.|...+..+.. .+..+|..+++ |= .+.++++.+..++
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 4332211 1245666666665543 44445556665 43 4444444444443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=296.99 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=193.7
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
|++.+.||+|++|.||+|.++. .+..|++|.+..... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence 4567889999999999999863 345788998765431 12223356899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++...
T Consensus 74 ~iv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 74 YLVFEFLD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred EEEEeccC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 99999995 699999876532 12577788899999999999999999999999999999999999999999998643
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA---- 321 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~---- 321 (394)
..... ......++..|+|||++.+.. .++.++|||||||++|||++ |..||.+.+....+..+.....
T Consensus 150 ~~~~~-~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07835 150 GVPVR-TYTHEVVTLWYRAPEILLGSR------QYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLFRIFRTLGTPDE 221 (283)
T ss_pred CCCcc-ccCccccccCCCCCceeecCc------ccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 22111 111224567899999876542 26789999999999999998 9999987765444333322100
Q ss_pred ----------------cC------CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 ----------------LR------LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ----------------~~------~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. ......++..+.+++++||+.+|+ ||++.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 011245678899999999999998 999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=310.42 Aligned_cols=243 Identities=18% Similarity=0.277 Sum_probs=210.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
....+++.+..||-|+||.|-+++.+.. ....|+|++++.. +...+.....|-.+|...+.|.||++|..|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~-------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQ-------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEeccc-------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 4567788889999999999999887632 1245677776544 233333445899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.++..+|++||-|-||+|...|++.+. ++......++.-++.|+.|||++|||+|||||+|+|++.+|.+||.||
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence 999999999999999999999988765 556667788899999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+|+....+.. +-+++||+.|.|||++.... .+.++|.||||+++|||++ |.+||.+.++...++.|++|
T Consensus 565 GFAKki~~g~K--TwTFcGTpEYVAPEIILnKG-------HD~avDyWaLGIli~ELL~-G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 565 GFAKKIGSGRK--TWTFCGTPEYVAPEIILNKG-------HDRAVDYWALGILIYELLT-GSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred hhHHHhccCCc--eeeecCCcccccchhhhccC-------cchhhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHhh
Confidence 99988766553 34679999999999998876 6789999999999999998 99999999999999999988
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL 347 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~ 347 (394)
-. .+..|+.++....++|+++...+|.
T Consensus 635 id-~i~~Pr~I~k~a~~Lik~LCr~~P~ 661 (732)
T KOG0614|consen 635 ID-KIEFPRRITKTATDLIKKLCRDNPT 661 (732)
T ss_pred hh-hhhcccccchhHHHHHHHHHhcCcH
Confidence 63 6888999999999999999999997
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=292.25 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=196.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecc----cccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE----DASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+|.+.+.||+|+||.||++++... ...+++|+++. .........+.+|+.++++++||||+++++++.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA-------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC-------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence 478889999999999999987632 11233333332 1122222234578999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
....++||||+++++|.+++...... ...+++.....++.|++.||.|||++|++|+||||+||+++. +.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCc
Confidence 89999999999999999998753221 123677788899999999999999999999999999999975 5699999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......++..|+|||.+.... ++.++|+||||+++|+|++ |..||.+....+....+..+.
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-------~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~- 221 (260)
T cd08222 152 SRLLMGSCD-LATTFTGTPYYMSPEALKHQG-------YDSKSDIWSLGCILYEMCC-LAHAFEGQNFLSVVLRIVEGP- 221 (260)
T ss_pred eeecCCCcc-cccCCCCCcCccCHHHHccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcCC-
Confidence 865433221 222345677899999876544 6778999999999999998 999998877777766666554
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..++.++.++|++||..+|+ ||++.|++.
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 -TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 3445667889999999999999998 999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.96 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=194.9
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC--C
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES--D 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~ 163 (394)
|++.+.||+|+||.||+|++.. .+..+++|.+.... .......+.+|+.+++.++|+||+++++++... +
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC
Confidence 5678899999999999999873 34478899887653 222223456899999999999999999999887 7
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cEEEEeccccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence 89999999975 9998886542 126777788999999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL- 322 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~- 322 (394)
..............++..|+|||.+.+.. .++.++||||||+++|||++ |+.||......+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~~Dv~slG~~l~el~t-~~~p~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07840 149 PYTKRNSADYTNRVITLWYRPPELLLGAT------RYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKIFELCGSP 221 (287)
T ss_pred eccCCCcccccccccccccCCceeeEccc------cCChHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Confidence 55433211122234567899999876432 26789999999999999998 99999887766554444321100
Q ss_pred ---CC----------------C-------CCCC-CChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 ---RL----------------P-------APRA-VNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ---~~----------------~-------~p~~-~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. . .... ++..+.+++++||..+|. ||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0 0012 378899999999999998 999988864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.47 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=195.4
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLLVF 169 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~ 169 (394)
+.||+|+||.|-.|... .+...+|||++.+.........| +|++++.+. .|+||+.|+++|+++..+||||
T Consensus 84 e~LGeGAyasVqtcv~i-------~t~~EYAVKiidKq~gHsR~Rvf-REVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSI-------QTGKEYAVKIIDKQPGHSRSRVF-REVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhcCccceeeeeeeee-------ccchhhhhhhhhcCCchHHHHHH-HHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 56999999999988865 45668999999887665555555 999999888 7999999999999999999999
Q ss_pred eeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---eEEEccCCCCccCC
Q psy7505 170 ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL---RVKIGDTGSSIDKY 246 (394)
Q Consensus 170 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~---~vKl~DFG~a~~~~ 246 (394)
|-|.||.|..+|++... +++..+..+..+|+.||.|||.+||.||||||+|||-.+.. -||||||.+.....
T Consensus 156 EKm~GGplLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKH-----FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred ecccCchHHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 99999999999987643 67777888999999999999999999999999999987654 38999998764321
Q ss_pred C-Ccee-----eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------C-----
Q psy7505 247 P-GDYY-----VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-------S----- 308 (394)
Q Consensus 247 ~-~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-------~----- 308 (394)
. ++.. -..+.+|+..|||||+...-. .....|+.++|.||||||||-|++ |.+||.+. +
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv--~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFV--DQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhc--cccccccccccHHHHHHHHHHHHh-CCCCccCccCCcCCccCCCcc
Confidence 1 1111 112347788999999864311 112238999999999999999998 99999763 1
Q ss_pred ---HHHHHHHHhcCCCcCCCCCC----CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 309 ---DDQVITRVFGTEALRLPAPR----AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 309 ---~~~~~~~i~~~~~~~~~~p~----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...++..|..|. ..+|. .++.+.++++.++|..++. |-++..++.
T Consensus 308 r~CQ~~LFesIQEGk---YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGK---YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHHhccC---CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 234566777774 44443 7899999999999999997 666666643
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=291.16 Aligned_cols=239 Identities=20% Similarity=0.272 Sum_probs=183.4
Q ss_pred CeEEEce--eeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc-CCCcceeceeeEEEeC
Q psy7505 86 QLHYVKE--IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR-LRHVNILRLMAACLES 162 (394)
Q Consensus 86 ~~~~~~~--lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~ 162 (394)
+|++.+. ||+|+||.||+++.+. ....+++|......... .|+..... .+|+||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKP-------TQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcC-------CCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4444444 5999999999998763 34478888875432111 11211111 2799999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEccCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDTGS 241 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~DFG~ 241 (394)
+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999997653 267788889999999999999999999999999999999998 999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhcCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV-ITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~-~~~i~~~~ 320 (394)
+...... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.......+ ...+....
T Consensus 157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T PHA03390 157 CKIIGTP-----SCYDGTLDYFSPEKIKGHN-------YDVSFDWWAVGVLTYELLT-GKHPFKEDEDEELDLESLLKRQ 223 (267)
T ss_pred ceecCCC-----ccCCCCCcccChhhhcCCC-------CCchhhHHHHHHHHHHHHH-CCCCCCCCCcchhhHHHHHHhh
Confidence 8654322 1235678899999987654 7789999999999999998 9999986543322 11111111
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccc-hhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVK-IGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-~~e~~ 355 (394)
....+.+..++..+.+++.+||+.+|. |++ +.+++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 224 QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 124456668999999999999999998 875 56664
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=297.30 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=198.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+...|+..+.||+|+||.||+|+.+. ....+++|.+.... .......+.+|+.+++.++|+|++++++++.
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR-------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC-------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 34557778899999999999999863 34478888775422 2223334568999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
.....++||||+. |+|.+++..... .++...+..++.|++.||.|||+++++||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcc
Confidence 9999999999996 688887754322 15667778899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++...... ....++..|+|||.+.... ...++.++|||||||++|||++ |..||.+....+....+..+.
T Consensus 161 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 230 (308)
T cd06634 161 SASIMAPA-----NXFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNE 230 (308)
T ss_pred cceeecCc-----ccccCCccccCHHHHhhcc----cCCCCcccchHHHHHHHHHHHc-CCCCCccccHHHHHHHHhhcC
Confidence 88654322 1235677899999975321 1126789999999999999998 999998877666666555554
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
... ..+..++..+.+++++||..+|+ ||++.+++..
T Consensus 231 ~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 231 SPA-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCC-cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 221 22446888999999999999998 9999988754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=299.57 Aligned_cols=259 Identities=20% Similarity=0.357 Sum_probs=205.4
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHH----HHHHHHHHHhccCCCcceec
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEK----LFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~----~~~~~E~~~l~~l~HpnIv~ 154 (394)
..-.++|-++..||+|||++||+|.+-. ...-||||+-..... +..+ +-..+|..|.+.|+||-||+
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~-------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLT-------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccc-------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 3446788899999999999999998762 344788887543332 2222 22358999999999999999
Q ss_pred eeeEEE-eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEcC-
Q psy7505 155 LMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED--GFIHTDVAARNCLVTS- 230 (394)
Q Consensus 155 l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~--~iiHrDlk~~NiLl~~- 230 (394)
+|++|. +.+.+|-|+|||+|.||+-||+.++. +++..+..|+.||+.||.||.+. .|||-||||.|||+.+
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence 999996 66789999999999999999987754 67888899999999999999875 6999999999999954
Q ss_pred --CCeEEEccCCCCccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 231 --ELRVKIGDTGSSIDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 231 --~~~vKl~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
.|.+||+|||+++.+....+. .+...+||.||++||.+..+.. ....+.++||||.|||+|.++ ||+.
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgke---PPKIsnKVDVWSvGVIFyQCl-YGrK 682 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKE---PPKISNKVDVWSVGVIFYQCL-YGRK 682 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCC---CCccccceeeEeeehhhhhhh-ccCC
Confidence 478999999999877654432 3445689999999999876532 123789999999999999999 6999
Q ss_pred CCCCCC-HHHHH--HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 303 PYAELS-DDQVI--TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 303 Pf~~~~-~~~~~--~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
||...- ..+++ +-|++.....+|.-+.++++++++|++||+..-+ |....++.
T Consensus 683 PFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 683 PFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 997654 33443 2355555556777778999999999999999876 76666653
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=310.44 Aligned_cols=250 Identities=19% Similarity=0.305 Sum_probs=199.3
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
+-.....-|..++.||-|+||+|.+++.. .+...+|.|.+++.. ......-...|-+||..-+.+.||+||
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~Kv-------DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKV-------DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeec-------chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 33455677888899999999999999865 345688889886544 222233345788999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
..|++++.+|+||||++|||+..+|.+.+. +++..+..++.++..|+++.|..|+|||||||+|||||.+|++||
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceee
Confidence 999999999999999999999999976654 677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccC---------CCCc--------------------------------eeeeCCccCCcccccccccccCCCCc
Q psy7505 237 GDTGSSIDK---------YPGD--------------------------------YYVHGEVALPVRWCAPESLLCSDTSI 275 (394)
Q Consensus 237 ~DFG~a~~~---------~~~~--------------------------------~~~~~~~~~t~~y~aPE~l~~~~~~~ 275 (394)
+||||+.-+ ..++ .......+||..|+|||+|....
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--- 847 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--- 847 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC---
Confidence 999998311 0000 00011247899999999998776
Q ss_pred ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CcCCCCCCCCChHHHHHHHhhhcCCccc
Q psy7505 276 QTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-ALRLPAPRAVNSHVDVAARNCLVTSELR 348 (394)
Q Consensus 276 ~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~r 348 (394)
|+..+|+||.|||||||+- |+.||...++.+...+|.+-+ .+.++.-.+++.++.++|+++.+....|
T Consensus 848 ----~~q~cdwws~gvil~em~~-g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~R 916 (1034)
T KOG0608|consen 848 ----YTQLCDWWSVGVILYEMLV-GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSR 916 (1034)
T ss_pred ----ccccchhhHhhHHHHHHhh-CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhh
Confidence 7889999999999999995 999999888776666654422 2455555689999999888876654444
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.93 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=191.6
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
.|++.+.||+|+||.||+|.++.. .....+|+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 477889999999999999998731 135589999887632 011112345899999999999999999999987
Q ss_pred -CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC----CCeEEEc
Q psy7505 163 -DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS----ELRVKIG 237 (394)
Q Consensus 163 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~----~~~vKl~ 237 (394)
+.+++||||+.+ +|.+++..........++...+..++.|++.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 789999999975 7888775443222223567778889999999999999999999999999999999 8999999
Q ss_pred cCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Q psy7505 238 DTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ---- 311 (394)
Q Consensus 238 DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~---- 311 (394)
|||++........ .......++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.....
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR------HYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIKKSN 227 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCC------CCCcHHHHHHHHHHHHHHHh-cCCCCcCCcccccccc
Confidence 9999875432221 1122345678899999876543 26789999999999999998 999997654321
Q ss_pred -----HHHHHhcC-----------------------CCcCCCCC-----------CCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 312 -----VITRVFGT-----------------------EALRLPAP-----------RAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 312 -----~~~~i~~~-----------------------~~~~~~~p-----------~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
.+..+... .......+ ...+..+.+++++||..+|+ ||++
T Consensus 228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 307 (316)
T cd07842 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA 307 (316)
T ss_pred hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence 11111000 00011111 15667899999999999998 9999
Q ss_pred hhhhh
Q psy7505 352 GDTGS 356 (394)
Q Consensus 352 ~e~~~ 356 (394)
.|++.
T Consensus 308 ~eil~ 312 (316)
T cd07842 308 EEALE 312 (316)
T ss_pred HHHhc
Confidence 88764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=295.93 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=190.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
-++|++.+.||+|+||.||+|..+. ....||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK-------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC-------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 4679999999999999999999873 34588999875433 111222345899999999999999999998764
Q ss_pred C--------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 163 D--------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 163 ~--------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+ ..++||||+. ++|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL 158 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcE
Confidence 4 3599999996 488888865421 25677788999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 235 KIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
||+|||++......... ......++..|+|||.+.+.. .++.++||||||+++|||++ |..||.+.....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~~l~el~t-~~~~~~~~~~~~ 231 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER------DYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH 231 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc------ccCchhhhHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 99999988654322111 112234677899999876543 26789999999999999998 999998876554
Q ss_pred HHHHHhc--CCCc----------------CCCC-----------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFG--TEAL----------------RLPA-----------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~--~~~~----------------~~~~-----------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+.. +... .++. +...+..+.+++.+||..+|. ||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 4332221 1000 0000 112356778999999999998 999988763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.04 Aligned_cols=148 Identities=26% Similarity=0.350 Sum_probs=128.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.+.. ....||+|+++... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN-------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence 3689999999999999999999873 34589999886533 23333456789999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+||||||+.+|+|.+++...+. +.+..++.++.||+.||.|||.++||||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~~-----l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYGY-----FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 9999999999999999999975432 56667788999999999999999999999999999999999999999998
Q ss_pred Cc
Q psy7505 242 SI 243 (394)
Q Consensus 242 a~ 243 (394)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=284.33 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=203.3
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeC--
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLES-- 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 162 (394)
+|+..+.||+|++|.||+|..+. ....+++|....... ......+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 46778899999999999999873 345788888765542 23344567899999999999999999999988
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||.+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence 88999999999999999997653 2677778899999999999999999999999999999999999999999988
Q ss_pred ccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhcCC
Q psy7505 243 IDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i~~~~ 320 (394)
......... ......++..|++||.+.... ++.++||||||+++|+|++ |..||.... .......+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~- 219 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-------YGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGSS- 219 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHhcccc-
Confidence 655433221 122345677899999986654 6789999999999999998 999998876 33334444321
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
......|..++..+.+++.+||..+|+ ||++.|++.
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 224556778899999999999999998 999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=302.96 Aligned_cols=253 Identities=18% Similarity=0.243 Sum_probs=193.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
.++|++.+.||+|+||.||+|..+. .+..|++|.+..... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 76 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR-------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP 76 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence 3788999999999999999998773 355899998865431 1223345589999999999999999998863
Q ss_pred ---CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 162 ---SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 162 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
...+++||||+. |+|.+++..... +++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 77 GADFKDVYVVMDLME-SDLHHIIHSDQP-----LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred CCCCceEEEEEehhh-hhHHHHhccCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecc
Confidence 346899999995 699998865432 57777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCce---eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 239 TGSSIDKYPGDY---YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 239 FG~a~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
||++........ .......++..|+|||.+.... .++.++|||||||++|||++ |+.||.+.+....+..
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP------EYTTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQLKL 223 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCc------ccccccchHHHHHHHHHHHc-CCCccCCCChHHHHHH
Confidence 999865432211 1112346778899999975432 27889999999999999998 9999987664433222
Q ss_pred Hhc--C---------------------CCcCCCC-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFG--T---------------------EALRLPA-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~--~---------------------~~~~~~~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.. | .....+. ...++..+.+++++||+.+|+ ||++.+++.
T Consensus 224 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111 0 0001111 134688999999999999998 999988764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=300.66 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=193.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..+|.+.+.||+|+||.||+|+.. .++..|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS-------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP 76 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec-------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence 357899999999999999999976 345589999876532 111222345899999999999999999988654
Q ss_pred -----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 163 -----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 163 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
...|+||||+. ++|.+++...+. ++...+..++.|++.||.|||+++++||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 77 HREAFNDVYIVYELMD-TDLHQIIRSSQT-----LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred cccccCcEEEEEeCCC-CCHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEC
Confidence 34899999996 699998876532 5677788899999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++....... .......++..|+|||.+.... .++.++|||||||++|+|++ |+.||.+.+....+..+.
T Consensus 151 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 222 (337)
T cd07858 151 DFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCS------EYTTAIDVWSVGCIFAELLG-RKPLFPGKDYVHQLKLIT 222 (337)
T ss_pred cCccccccCCCc-ccccccccccCccChHHHhcCC------CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Confidence 999987543321 1122335677899999876432 16789999999999999997 999998765332222111
Q ss_pred c---C----------------------CCcCC---CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 318 G---T----------------------EALRL---PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 318 ~---~----------------------~~~~~---~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
. . ...+. .....++..+.+++++||..+|+ ||++.|++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0 00000 11236788999999999999998 9999998744
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.11 Aligned_cols=257 Identities=21% Similarity=0.256 Sum_probs=200.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
+|++.+.||+|+||.||+|+... ....+++|.+..... ......+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 47888999999999999999763 345789998765432 333345668999999999999999999998765
Q ss_pred ----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 164 ----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 164 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+|++|||++ ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 74 EDFNDVYIVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred ccccceEEEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 7899999997 58999887643 2677778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 240 GSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 240 G~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|++........ .......++..|+|||.+.+.. .++.++|+|||||++|+|++ |..||.+....+.+..+.
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS------RYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeeccc------CCCcchhHHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHH
Confidence 98875433321 1122335677899999987652 27889999999999999998 999998887666555443
Q ss_pred cCCCcCC----------------------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh--hhcCC
Q psy7505 318 GTEALRL----------------------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS--IDKYP 362 (394)
Q Consensus 318 ~~~~~~~----------------------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~--l~~~~ 362 (394)
....... .....++..+.+++++||+.+|. ||++.+++.. ++.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 3110000 01134678899999999999998 9999998742 44444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=292.40 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=195.1
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
|...+.||+|+||.||+|+... .+..+++|.+.... .......+.+|+.+++.++|||++++++++.+...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH-------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC-------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 5666789999999999998762 34578888876432 22233345689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.|+||||+. |+|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 999999996 588888765322 256677788999999999999999999999999999999999999999998754
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
... .....++..|+|||++.... ...++.++|||||||++|||++ |..||.+.........+........
T Consensus 171 ~~~-----~~~~~~~~~y~aPE~~~~~~----~~~~~~~sDv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (313)
T cd06633 171 SSP-----ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNDSPTL 240 (313)
T ss_pred cCC-----CCCccccccccChhhccccC----CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Confidence 322 12345677899999985321 1127789999999999999998 9999988876666665554432222
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....++..+.+++.+||+.+|. ||++.+++.
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2345678899999999999998 999998863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=268.71 Aligned_cols=236 Identities=21% Similarity=0.280 Sum_probs=187.8
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHh-ccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY-RRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l 155 (394)
...++++.+++.-+..||+|+||.|-+-++. ..+...|+|.++..-....++.+++|+.+. +....|.+|.+
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~-------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~F 110 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHI-------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHF 110 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeec-------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEe
Confidence 3447888999999999999999999888776 345578999888777666666677888764 45589999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~v 234 (394)
||...+...+||.||.|.. +|..|-++-- .....+++..+-+++..++.||.|||++ .+||||+||+||||+.+|+|
T Consensus 111 yGa~~regdvwIcME~M~t-Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqV 188 (282)
T KOG0984|consen 111 YGALFREGDVWICMELMDT-SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQV 188 (282)
T ss_pred ehhhhccccEEEeHHHhhh-hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcE
Confidence 9999999999999999976 8887765431 1222367777788999999999999987 89999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-SDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-~~~~~~ 313 (394)
|+||||+|-.....- ..+...|...|||||.+..+.. ...|+.++||||||+++.||.+ ++.||... ++.+.+
T Consensus 189 KiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n---~~gY~vksDvWSLGItmiElA~-lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 189 KICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELN---QKGYSVKSDVWSLGITMIEMAI-LRFPYESWGTPFQQL 262 (282)
T ss_pred EEcccccceeehhhh--HHHHhcCCCccCChhhcCcccC---cccceeehhhhhhhhhhhhhhh-ccccccccCCHHHHH
Confidence 999999985442211 1111345566999999976642 2359999999999999999998 99999875 578888
Q ss_pred HHHhcCCCcCCCCC
Q psy7505 314 TRVFGTEALRLPAP 327 (394)
Q Consensus 314 ~~i~~~~~~~~~~p 327 (394)
.++.+...+++|..
T Consensus 263 kqvVeep~P~Lp~~ 276 (282)
T KOG0984|consen 263 KQVVEEPSPQLPAD 276 (282)
T ss_pred HHHhcCCCCCCccc
Confidence 89988776666543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=290.85 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=193.2
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeCCce
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPW 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 165 (394)
|++.+.||+|+||.||+|+... ....|++|.+.............+|+..+++++ |+||+++++++.+++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 5678899999999999999863 344788998765543222233447899999998 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||+ +|+|.+++..... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred EEEEecC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 9999999 7899999876531 12577788899999999999999999999999999999999999999999988654
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA---- 321 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~---- 321 (394)
..... .....++..|+|||++.... .++.++|+||||+++|||++ |+.||......+....+.....
T Consensus 150 ~~~~~--~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~s~G~~l~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd07830 150 RSRPP--YTDYVSTRWYRAPEILLRST------SYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYKICSVLGTPTK 220 (283)
T ss_pred cCCCC--cCCCCCcccccCceeeecCc------CcCCccchhhHHHHHHHHHh-CCCccCCCChHHHHHHHHHhcCCCCh
Confidence 33221 12235677899999885432 26789999999999999998 9999987765544333221000
Q ss_pred --------------cCCC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 --------------LRLP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 --------------~~~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++ .....+..+.+++++||+.+|+ ||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 0112367899999999999998 999998864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=300.56 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=192.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.++. .+..+++|.+.... .......+.+|+.+++++ +|+||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR-------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC-------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 4678888999999999999998762 34478888775422 222223345899999999 99999999999865
Q ss_pred C--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 162 S--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 162 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. ..+|+||||++ ++|..++... .+.+.....++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~ 151 (337)
T cd07852 79 ENDKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADF 151 (337)
T ss_pred CCCceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeec
Confidence 3 36899999997 5999988654 1456667789999999999999999999999999999999999999999
Q ss_pred CCCccCCCCcee----eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 240 GSSIDKYPGDYY----VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 240 G~a~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|++......... ......++..|+|||.+.+.. .++.++|||||||++|+|++ |+.||.+....+...+
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~sDi~slG~~l~el~t-g~~pf~~~~~~~~~~~ 224 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGST------RYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLEK 224 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeeccc------cccccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence 988754332211 112235678899999876532 26789999999999999998 9999987665444333
Q ss_pred HhcCCCc-------------------------CC---CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 316 VFGTEAL-------------------------RL---PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 316 i~~~~~~-------------------------~~---~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
+...... .. .....++.++.+++.+||+.+|. ||++.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 2211100 00 11123688999999999999998 9999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=298.15 Aligned_cols=249 Identities=19% Similarity=0.226 Sum_probs=191.6
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHH-------------HHHHHHHHHHhccCCCcceec
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE-------------KLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~-------------~~~~~~E~~~l~~l~HpnIv~ 154 (394)
.+.+.||+|+||.||+|.++. ....||+|.++....... ...+.+|+.+++.++|+||++
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTL-------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred hhhhcccCCCceeEEEEEECC-------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 455779999999999999763 345788998764432110 113468999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+++++...+..++||||+. |+|.+++..... ++......++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-----LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 9999999999999999996 699999865422 5667788899999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCc-------------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 235 KIGDTGSSIDKYPGD-------------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~-------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
||+|||++....... ........++..|+|||.+.+.. .++.++|||||||++|||++ |.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~~l~el~t-g~ 231 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE------KYHFAVDMWSVGCIFAELLT-GK 231 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC------CCCcHHHHHHHHHHHHHHHh-CC
Confidence 999999886543111 00111224567899999986543 26789999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHhcCC--CcC--C---------------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 302 LPYAELSDDQVITRVFGTE--ALR--L---------------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 302 ~Pf~~~~~~~~~~~i~~~~--~~~--~---------------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.||.+....+.+..+.... ... + .....++..+.+++++||..+|+ ||++.|++
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 9999887666554443210 000 0 00124577899999999999998 99999986
Q ss_pred h
Q psy7505 356 S 356 (394)
Q Consensus 356 ~ 356 (394)
.
T Consensus 312 ~ 312 (335)
T PTZ00024 312 K 312 (335)
T ss_pred c
Confidence 4
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=283.51 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=197.8
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 170 (394)
||+|+||.||++.+.. .+..+++|.+.... .......+..|+.++++++|+||+++++.+..++..++|||
T Consensus 1 lg~G~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECC-------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEe
Confidence 6999999999999863 34578888876543 22234456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|+++++|.+++..... +++.....++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 74 ~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEGR-----FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 9999999999976532 56777788999999999999999999999999999999999999999998865433211
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAV 330 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~ 330 (394)
......++..|++||.+.+.. .+.++|+||||+++|+|++ |..||...+..+....+..+ .++.|..+
T Consensus 149 -~~~~~~~~~~~~~Pe~~~~~~-------~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 216 (250)
T cd05123 149 -RTNTFCGTPEYLAPEVLLGKG-------YGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYEKILKD---PLRFPEFL 216 (250)
T ss_pred -cccCCcCCccccChHHhCCCC-------CCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHhcC---CCCCCCCC
Confidence 122345677899999986554 6789999999999999998 99999888777777776653 67788888
Q ss_pred ChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 331 NSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 331 ~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
+..+.+++++||..+|+ ||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 99999999999999998 999854
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=297.17 Aligned_cols=249 Identities=19% Similarity=0.259 Sum_probs=184.3
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeeccc-ccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED-ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLV 168 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 168 (394)
.+.+|.|+++.|+ +.+ .+...||+|.++.. ........+.+|+.+++.++|+||+++++++...+..+++
T Consensus 7 ~~~~~~~~~v~~~--~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 7 GKCFEDLMIVHLA--KHK-------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hHhhcCCceEEEE--Eec-------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence 3444545554444 443 23458999988755 2344445677999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCC
Q psy7505 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~ 248 (394)
|||+++|+|.+++...... .+++.....++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPE---GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred EeccCCCCHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence 9999999999999764221 2566677789999999999999999999999999999999999999999987543221
Q ss_pred ce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 249 DY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 249 ~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
.. .......++..|+|||++..... .++.++|||||||++|||++ |..||........+.....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 228 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ-----GYNEKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKVRGTVP 228 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCC-----CCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCc
Confidence 11 11122345678999999865421 27889999999999999998 99999877654433221111100
Q ss_pred -------------------------------CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 -------------------------------RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 -------------------------------~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.+..++.++.+++++||..+|+ ||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0011123345788999999999998 999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=298.27 Aligned_cols=250 Identities=21% Similarity=0.264 Sum_probs=190.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
..+|.+.+.||.|+||.||+|..+ .++..|++|.+........ ..+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~-------~~~~~v~iK~i~~~~~~~~-~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS-------DCDKRVAVKKIVLTDPQSV-KHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC-------CCCcEEEEEEEecCCCchH-HHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 478999999999999999999886 3455788988765443222 3355899999999999999999876643
Q ss_pred -------------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 163 -------------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 163 -------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
...|+||||++ ++|.+++.... +++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~ 148 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGP------LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 35799999997 59998886431 56677888999999999999999999999999999997
Q ss_pred C-CCeEEEccCCCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 230 S-ELRVKIGDTGSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 230 ~-~~~vKl~DFG~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
. ++.+||+|||++......... ......++..|+|||.+.... .++.++|||||||++|||++ |+.||.+
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwSlGvil~el~~-g~~pf~~ 221 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN------NYTKAIDMWAAGCIFAEMLT-GKPLFAG 221 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCcc------ccCchhhHHHHHHHHHHHHh-CCCCCCC
Confidence 4 567999999988653221110 011224577899999875432 27789999999999999998 9999987
Q ss_pred CCHHHHHHHHhcCCC------------------------cCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 307 LSDDQVITRVFGTEA------------------------LRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 307 ~~~~~~~~~i~~~~~------------------------~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
....+....+..... .+.+ ....++.++.+++++||..+|+ ||++.|++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 222 AHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 765554443332210 0000 1135678899999999999998 99999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.17 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=196.3
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVF 169 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 169 (394)
+.||+|.||+||-|+++ ++++.||||++.+.. .......+++|+.||++++||.||.+...|++.+++++||
T Consensus 570 evLGSGQFG~VYgg~hR-------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR-------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred hhccCCcceeeecceec-------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 67999999999999988 567789999986544 2233345779999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeEEEccCCCCccCC
Q psy7505 170 ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKY 246 (394)
Q Consensus 170 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~vKl~DFG~a~~~~ 246 (394)
|-+ .||..+.|..... ..+++.....+..||+.||.|||.++|+|+||||+|||+.+. -.+||||||+|+...
T Consensus 643 EKl-~GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 643 EKL-HGDMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred hhh-cchHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 999 5587777754322 237888888999999999999999999999999999999765 379999999999875
Q ss_pred CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCC
Q psy7505 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326 (394)
Q Consensus 247 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 326 (394)
... ....+.||+.|+|||++.... |...-||||.|||+|--++ |..||.+.. ++-.+|.+...--+|.
T Consensus 719 Eks--FRrsVVGTPAYLaPEVLrnkG-------yNrSLDMWSVGVIiYVsLS-GTFPFNEdE--dIndQIQNAaFMyPp~ 786 (888)
T KOG4236|consen 719 EKS--FRRSVVGTPAYLAPEVLRNKG-------YNRSLDMWSVGVIIYVSLS-GTFPFNEDE--DINDQIQNAAFMYPPN 786 (888)
T ss_pred hhh--hhhhhcCCccccCHHHHhhcc-------ccccccceeeeEEEEEEec-ccccCCCcc--chhHHhhccccccCCC
Confidence 544 345678999999999998876 8889999999999999998 999998654 2334444443223344
Q ss_pred C-CCCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 327 P-RAVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 327 p-~~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
| ..++.++.++|..+|+..-. |-++..
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence 4 47899999999999998865 777654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.29 Aligned_cols=256 Identities=19% Similarity=0.275 Sum_probs=193.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
|++ ..+|.+.+.||+|+||.||+|+++. .+..||+|.++... .......+.+|+.+++.++|+||++++++
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKR-------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEeCC-------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 344 3579999999999999999999762 34588999876432 22222335689999999999999999999
Q ss_pred EEeCC------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7505 159 CLESD------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 159 ~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~ 232 (394)
+.... .+++||||+.. +|..++... +++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~ 154 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP-------LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC 154 (342)
T ss_pred ecccccCCCCceEEEEeccccc-CHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 87543 46999999964 787765321 45666778999999999999999999999999999999999
Q ss_pred eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
.+||+|||+++...... ....++..|+|||.+.+.. .++.++|||||||++|||++ |+.||.+.+....
T Consensus 155 ~~kL~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slGvil~el~~-g~~pf~~~~~~~~ 223 (342)
T cd07879 155 ELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWM------HYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQ 223 (342)
T ss_pred CEEEeeCCCCcCCCCCC----CCceeeecccChhhhcCcc------ccCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999986542211 1234567899999986532 26789999999999999998 9999988765554
Q ss_pred HHHHhcCCC----------------------cCCCC------CCCCChHHHHHHHhhhcCCcc-ccchhhhhhh--hhcC
Q psy7505 313 ITRVFGTEA----------------------LRLPA------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS--IDKY 361 (394)
Q Consensus 313 ~~~i~~~~~----------------------~~~~~------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~--l~~~ 361 (394)
+..+..... ...+. ....+..+.+++++||+.+|+ ||++.+++.. ++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 224 LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 443332110 00000 124667889999999999998 9999998732 4444
Q ss_pred C
Q psy7505 362 P 362 (394)
Q Consensus 362 ~ 362 (394)
.
T Consensus 304 ~ 304 (342)
T cd07879 304 R 304 (342)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.21 Aligned_cols=254 Identities=19% Similarity=0.239 Sum_probs=190.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++. ....+++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK-------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC-------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence 5789999999999999999999873 34478888775432 111112345899999999999999999987543
Q ss_pred C--------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 163 D--------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 163 ~--------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
. .+++||||+.+ +|...+..... .+++..+..++.|++.||.|||++||+||||||+||++++++.+
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~----~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDH-DLSGLLENPSV----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred cccccccCceEEEEEecCCc-CHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 3 46999999965 78877764321 26777888999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceee----------eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 235 KIGDTGSSIDKYPGDYYV----------HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~----------~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
||+|||+++......... .....++..|+|||.+.+.. .++.++|||||||++|||++ |+.||
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~il~el~~-g~~~~ 227 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER------RYTTAVDIWGIGCVFAEMFT-RRPIL 227 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC------ccCchhHhHHHHHHHHHHHh-CCCCC
Confidence 999999886543221110 01224567799999876532 26789999999999999998 99999
Q ss_pred CCCCHHHHHHHHhcCCCcC--------------------CCCC-------CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 305 AELSDDQVITRVFGTEALR--------------------LPAP-------RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~~~~~--------------------~~~p-------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.+..+....+....... ...+ ....+.+.+++++||..+|+ ||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 8877665544443211000 0000 23446788999999999998 999888753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.50 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=194.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++...||+|+||.||+|++.. ....+++|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK-------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC-------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 5679999999999999999999873 34578999876532 222223355899999999999999999988765
Q ss_pred Cc------eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 DP------WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~~------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+. +++|+||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL 159 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEE
Confidence 54 89999999 56999988653 1567778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...... .....++..|+|||.+.... .++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i 228 (343)
T cd07851 160 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWM------HYNQTVDIWSVGCIMAELLT-GKTLFPGSDHIDQLKRI 228 (343)
T ss_pred cccccccccccc----ccCCcccccccCHHHHhCCC------CCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence 999998654322 12335677899999885432 26789999999999999998 99999887766555444
Q ss_pred hcCCCc----------------------CC------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEAL----------------------RL------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~----------------------~~------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...... .. ......+..+.+++++||..+|+ ||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 332100 00 00124588999999999999998 999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=286.40 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=191.5
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccC---CCcceeceeeEEEeC
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRL---RHVNILRLMAACLES 162 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~ 162 (394)
|++.+.||+|+||.||+|+++. ....+++|.++.... ......+.+|+.+++++ +|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 5678899999999999999873 345889998864332 12222344677666555 699999999999987
Q ss_pred Cc-----eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 163 DP-----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 163 ~~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+. ++++|||+.+ +|.+++...... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+
T Consensus 74 ~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 74 RTDRELKLTLVFEHVDQ-DLATYLSKCPKP---GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred cCCCCceeEEEehhccc-CHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEe
Confidence 76 9999999974 899988654221 25777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++........ .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+.++.
T Consensus 150 dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~-------~~~~~Di~s~G~~l~~l~~-~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 150 DFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSS-------YATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIF 219 (287)
T ss_pred ccCcceeccCCcc--cccccccccccChHHhccCC-------CCCcchhhhHHHHHHHHHh-CCCcccCCChHHHHHHHH
Confidence 9998865432221 12234677899999987654 6789999999999999998 999999888776665554
Q ss_pred cCCC----cCCC---------------C-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEA----LRLP---------------A-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~----~~~~---------------~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.... ...+ . ...++..+.+++++||+.+|. ||++.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 220 DVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 3110 0000 0 013457788999999999998 999988763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=293.08 Aligned_cols=247 Identities=20% Similarity=0.281 Sum_probs=192.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|... ..+..||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 567999999999999999999876 245589999875432 222233456899999999999999999998765
Q ss_pred C------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 D------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
. .+++||||+ +++|.+++.... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~------l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKHEK------LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence 4 358999999 679998886431 567778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...... .....++..|+|||.+.+.. .++.++|+|||||++|+|++ |..||.+.........+
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILNWM------HYTQTVDIWSVGCIMAEMLT-GKPLFKGHDHLDQLMEI 228 (343)
T ss_pred eecccccccccC----ccccccCCcccCHHHHhCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 999998654321 12335677899999986432 26789999999999999998 99999877654443332
Q ss_pred hcCCCc-------------------CC---------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 FGTEAL-------------------RL---------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 ~~~~~~-------------------~~---------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
...... .+ .....++..+.+++.+|+..+|+ ||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 211000 00 01235778899999999999998 99999886
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.84 Aligned_cols=237 Identities=23% Similarity=0.334 Sum_probs=193.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc-CCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR-LRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~ 162 (394)
.++|.+...+|.|+|+.|..|.... +.+..++|++.+...+. .+|+.++.. -+||||+++++++.++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~-------t~~~~~vkii~~~~~~~-----~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSP-------TDQEPAVKIISKRADDN-----QDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccc-------cccchhheecccccccc-----ccccchhhhhcCCCcceeecceecCC
Confidence 5778888889999999999998873 44567788876653221 245544443 4899999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE-cCCCeEEEccCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV-TSELRVKIGDTGS 241 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl-~~~~~vKl~DFG~ 241 (394)
...|+|||++.||-|.+.+..... .. ..+..|+.+|+.|+.|||++|||||||||+|||+ ++.|+++|+|||.
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEech
Confidence 999999999999998888876532 12 4566799999999999999999999999999999 5889999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~ 320 (394)
++..... ..+.+-|..|.|||++.... |+.++||||||++||+|++ |..||...... ++..++..+
T Consensus 463 a~~~~~~----~~tp~~t~~y~APEvl~~~~-------yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~~i~~~- 529 (612)
T KOG0603|consen 463 WSELERS----CDTPALTLQYVAPEVLAIQE-------YTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHTRIQMP- 529 (612)
T ss_pred hhhCchh----hcccchhhcccChhhhccCC-------CCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHHhhcCC-
Confidence 8765433 22346678899999997544 8999999999999999998 99999877655 666666443
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
++...+|.++++|+++||+.+|. |+++.++.
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 23378999999999999999998 89998875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.21 Aligned_cols=250 Identities=19% Similarity=0.246 Sum_probs=194.4
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-HHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-AEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
|++.+.||+|++|.||+|.... .+..+++|.++..... .....+.+|+.++++++|+||+++++++..++.+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence 4567889999999999998762 3457888887654322 2334456899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||.+...
T Consensus 74 ~~v~e~~~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 74 YLVFEFMDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred EEEEeccCC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 999999975 9998887642 12677778899999999999999999999999999999999999999999988655
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc---
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL--- 322 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--- 322 (394)
..... ......++..|+|||.+.+.. .++.++|+||||+++|+|++ |+.||.+.+..+.+.++......
T Consensus 149 ~~~~~-~~~~~~~~~~~~~PE~~~~~~------~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd05118 149 GSPVR-PYTHYVVTRWYRAPELLLGDK------GYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFKIFRTLGTPDP 220 (283)
T ss_pred CCCcc-cccCccCcccccCcHHHhcCC------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCch
Confidence 43321 111234667899999986542 27889999999999999998 99999887765544443221000
Q ss_pred ---------------CC---------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 ---------------RL---------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ---------------~~---------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. .....++.++.+++++||..+|. ||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 01124678999999999999998 999998864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=294.12 Aligned_cols=248 Identities=18% Similarity=0.245 Sum_probs=190.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|... ..+..||+|.++... .......+.+|+.++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEc-------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 577999999999999999999876 234589999886543 222233456899999999999999999988643
Q ss_pred ------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 ------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+..+++++++ +++|.+++.... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~~------l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEE
Confidence 3478888887 779988876432 566677889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...... .....++..|+|||.+.+.. .++.++|||||||++|||++ |+.||........+..+
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~------~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWM------HYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 230 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCcc------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 999998654221 12345677899999875422 26789999999999999998 99999876654433332
Q ss_pred hcCCC----------------------cCCCC------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEA----------------------LRLPA------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~----------------------~~~~~------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... ...+. ....+..+.+++.+||..+|. |+++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 21110 00111 113577899999999999998 999888763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=289.07 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=195.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc--CCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR--LRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~ 161 (394)
..++.+.+.||+|.||+||+|+|++ ..||||++....+ ..+| +|.+|++. |+|+||+.+++.-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrG---------e~VAVKiF~srdE---~SWf-rEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRG---------EDVAVKIFSSRDE---RSWF-RETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hheeEEEEEecCccccceeeccccC---------CceEEEEecccch---hhhh-hHHHHHHHHHhccchhhhhhhcccc
Confidence 4788999999999999999999984 3799999865432 2233 67777665 599999999987654
Q ss_pred CC----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEc
Q psy7505 162 SD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED--------GFIHTDVAARNCLVT 229 (394)
Q Consensus 162 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~--------~iiHrDlk~~NiLl~ 229 (394)
++ .+|||++|-+.|+|+|||..+. ++....+.++..+|.||++||.. .|.|||||+.|||+.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~t------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNRNT------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhhcc------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 33 5899999999999999998753 56667788999999999999974 599999999999999
Q ss_pred CCCeEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC----C--
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF----G-- 300 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~----g-- 300 (394)
.+|.+-|+|+|+|......... ..+..+||.+|||||+|...-.. +...--..+||||||.|+||++.+ |
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~-~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINM-KHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcCh-hhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 9999999999999654433222 12345899999999999764321 111112479999999999999631 2
Q ss_pred ---CCCCCCCC----HHHHHHHHhcCCCcCCCCCCCCCh-----HHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 301 ---KLPYAELS----DDQVITRVFGTEALRLPAPRAVNS-----HVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 301 ---~~Pf~~~~----~~~~~~~i~~~~~~~~~~p~~~~~-----~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
++||.+.. ..+-+.++.--..+|+..|..... .+..+|+.||..||. |-|+=-+-..|.++.
T Consensus 430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 57886653 344556665555567777654332 466899999999998 888766666666555
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=291.32 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=189.0
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccC-CCcceeceeeEEEeC-
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRL-RHVNILRLMAACLES- 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 162 (394)
+|++.+.||+|+||.||++++.... ....+|+|.+.... .......+.+|+.+++++ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 4788899999999999999987321 14478999876432 222233456899999999 699999999875432
Q ss_pred ---CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 163 ---DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 163 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
..+++++||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRSGQP-----LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence 45789999986 699998865432 567778889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 240 GSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 240 G~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
|++......... ......++..|+|||++.+.. .++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~~Di~slGv~l~~l~~-g~~pf~~~~~~~~~~~~ 222 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ------SYTKAIDVWSVGCILAELLG-RKPVFKGKDYVDQLNQI 222 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCC------CCCcHHHHHHHHHHHHHHHh-CCcCCCCCCHHHHHHHH
Confidence 998754322111 112235788899999875432 27889999999999999997 99999876644443322
Q ss_pred hcCC-------------------------CcCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 FGTE-------------------------ALRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 ~~~~-------------------------~~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.... ....+ ....++..+.+++.+||..+|+ ||++.|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 2110 00011 1124578899999999999998 99999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=289.30 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=189.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
.++|++.+.||+|+||.||+|..+. ....|++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQL-------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECC-------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 5679999999999999999998773 44578899775432 22222335589999999999999999999875
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+..+++|||+ +++|.+++.... +.......++.|++.||.|||+++|+||||+|+|||++.++.+||+|||+
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTSRP------LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 56789999999 569998886432 34555667899999999999999999999999999999999999999998
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF---- 317 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~---- 317 (394)
+...... .....++..|+|||.+.... .++.++|||||||++|+|++ |+.||...........+.
T Consensus 155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~il~el~t-g~~~f~~~~~~~~~~~~~~~~~ 223 (328)
T cd07856 155 ARIQDPQ----MTGYVSTRYYRAPEIMLTWQ------KYDVEVDIWSAGCIFAEMLE-GKPLFPGKDHVNQFSIITDLLG 223 (328)
T ss_pred ccccCCC----cCCCcccccccCceeeeccC------CcCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Confidence 8643221 12234567899999875432 27889999999999999998 999998765432211110
Q ss_pred -----------cCC--------CcCCCCC-----CCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 318 -----------GTE--------ALRLPAP-----RAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 318 -----------~~~--------~~~~~~p-----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
.+. ....+.| ..++..+.++|++||+.+|+ ||++.+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0011111 35678999999999999998 9999888643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=284.02 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=194.1
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
|++.+.||+|+||.||+|+... ....+++|...... .......+..|+.+++.++|+||+++++++.+.+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecC-------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence 4567889999999999999873 35588999887653 222223455899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++...
T Consensus 74 ~~v~e~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 74 YLVFEYCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred EEEecCcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 99999997 59999997652 12677788899999999999999999999999999999999999999999988654
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA---- 321 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~---- 321 (394)
..... .......+..|+|||.+.... .++.++|||||||++|||++ |..||.+....+.+..+.+...
T Consensus 149 ~~~~~-~~~~~~~~~~~~aPE~~~~~~------~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07829 149 GIPLR-TYTHEVVTLWYRAPEILLGSK------HYSTAVDIWSVGCIFAEMIT-GKPLFPGDSEIDQLFKIFQILGTPTE 220 (282)
T ss_pred CCCcc-ccCccccCcCcCChHHhcCCc------CCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHHHhCCCcH
Confidence 33221 111234466799999986542 27889999999999999998 9999988776555444332100
Q ss_pred -------------cCCC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -------------LRLP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -------------~~~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++ .....+..+.+++++||..+|+ ||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 0123477899999999999998 999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.49 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=191.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe---
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE--- 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 161 (394)
.+|+.++.||+||||.||+++++ -.+..+|||++........-..+.+|+.++.+|+|||||++|..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNK-------lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNK-------LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeec-------ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 56777889999999999999988 45668999998776644444556699999999999999999811110
Q ss_pred --------------------------------------------------------------------------------
Q psy7505 162 -------------------------------------------------------------------------------- 161 (394)
Q Consensus 162 -------------------------------------------------------------------------------- 161 (394)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ----------------------------C--------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHH
Q psy7505 162 ----------------------------S--------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205 (394)
Q Consensus 162 ----------------------------~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~ 205 (394)
. ..+||=||||+.-.|.++++.+.... .....++++++|+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREIL 707 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHH
Confidence 0 12588999999988888888775421 3456778999999
Q ss_pred HHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC---------C-------C-ceeeeCCccCCccccccccc
Q psy7505 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY---------P-------G-DYYVHGEVALPVRWCAPESL 268 (394)
Q Consensus 206 ~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~---------~-------~-~~~~~~~~~~t~~y~aPE~l 268 (394)
.||.|+|++|||||||||.||++++++.|||+|||+|.... . + .....+...||.-|+|||++
T Consensus 708 EGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 708 EGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999999999999999999999999999999999996511 0 0 01123345789999999998
Q ss_pred ccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCcCCCCCCC----CChHHHHHHHhhhc
Q psy7505 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE-LSDDQVITRVFGTEALRLPAPRA----VNSHVDVAARNCLV 343 (394)
Q Consensus 269 ~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~p~~----~~~~~~~l~~~cl~ 343 (394)
.+..- ..|+.|+||||||||++||+- ||.- +.-..++..+..+ .+|.|.. --++-..+|+.+++
T Consensus 788 ~~~~~----~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g---~iP~~~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 788 SDTSS----NKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKG---SIPEPADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccccc----ccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccC---CCCCCcccccccchHHHHHHHHHhc
Confidence 76531 349999999999999999983 4643 3344556666544 5565522 22355689999999
Q ss_pred CCcc-ccchhhhhh
Q psy7505 344 TSEL-RVKIGDTGS 356 (394)
Q Consensus 344 ~~p~-r~~~~e~~~ 356 (394)
.||. |||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 9997 999998863
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=282.13 Aligned_cols=262 Identities=25% Similarity=0.346 Sum_probs=196.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc--CCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR--LRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~ 161 (394)
...+++.+.||+|.||.||+|++. ...||||++.... ++.|.+|-.|++. +.|+||++++++-..
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~---------~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD---------NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc---------CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 456778889999999999999987 3489999986543 3345677777665 489999999998776
Q ss_pred CC----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEE
Q psy7505 162 SD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED---------GFIHTDVAARNCLV 228 (394)
Q Consensus 162 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~---------~iiHrDlk~~NiLl 228 (394)
.. .++||+||.+.|+|.+||+.+. ++|....+++..+++||+|||+. .|+|||||++|||+
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv 349 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV 349 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence 55 7899999999999999998773 68888899999999999999973 59999999999999
Q ss_pred cCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC------
Q psy7505 229 TSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK------ 301 (394)
Q Consensus 229 ~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~------ 301 (394)
.+++.+-|+|||+|.....+.... ....+||.+|||||+|.+... ++....-.+.||||+|.|||||+++..
T Consensus 350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgain-l~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAIN-LQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcc-cccHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 999999999999998765433211 123589999999999987642 111112257999999999999987322
Q ss_pred -----CCCCC-----CCHHHHHHHHhcCCCcCCCCCCC-----CChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 302 -----LPYAE-----LSDDQVITRVFGTEALRLPAPRA-----VNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 302 -----~Pf~~-----~~~~~~~~~i~~~~~~~~~~p~~-----~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
.||.. .+..++...+... ..|+.+|.. -...+.+.+..||..|++ |-|+.=+.+++.++..-.
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~k-K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVRK-KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHhh-ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 12221 1223333333322 124444432 234688999999999998 999887777777777544
Q ss_pred e
Q psy7505 366 Y 366 (394)
Q Consensus 366 ~ 366 (394)
.
T Consensus 508 ~ 508 (534)
T KOG3653|consen 508 E 508 (534)
T ss_pred C
Confidence 3
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.22 Aligned_cols=245 Identities=19% Similarity=0.263 Sum_probs=185.1
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCce
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 165 (394)
.+.....||+|+||.||+|+++. ....||+|.++...... ..|++++++++|||||+++|+|.+.+..
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~-----~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIK-------NGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECC-------CCcEEEEEEccCCcccc-----HHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 34556789999999999999862 34588999886543211 2467889999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI---EDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
++|||||++|+|.++++. +++..+..++.|++.||.||| +.+|+||||||+||+++.++..++. ||.+
T Consensus 759 ~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999953 466677889999999999999 6799999999999999998888775 6654
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH---HHHh
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD--DQVI---TRVF 317 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~--~~~~---~~i~ 317 (394)
..... .....++..|||||++.+.. ++.++|||||||++|||+| |+.||..... ..+. ....
T Consensus 830 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-------~~~~sDv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 830 GLLCT-----DTKCFISSAYVAPETRETKD-------ITEKSDIYGFGLILIELLT-GKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred ccccc-----CCCccccccccCcccccCCC-------CCcccchhhHHHHHHHHHh-CCCCCCcccCCCCcHHHHHHHhc
Confidence 32211 12235678899999987654 7899999999999999998 9999854211 1111 1111
Q ss_pred cCCC------cCC----CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 318 GTEA------LRL----PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 318 ~~~~------~~~----~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.... ..+ +.+.....++.+++.+||+.+|+ ||++.|++..|+++...
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 1100 011 11112233577899999999998 99999999999988754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=270.25 Aligned_cols=221 Identities=19% Similarity=0.238 Sum_probs=174.9
Q ss_pred ecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEeeCCCC
Q psy7505 96 GWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRG 175 (394)
Q Consensus 96 G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 175 (394)
|.||.||+++++. +...+++|.++.... ..+|...+....||||+++++++.+.+..++||||+++|
T Consensus 4 g~~~~v~~~~~~~-------~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTR-------TQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEcc-------CCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 8999999999873 455799998865432 123444445567999999999999999999999999999
Q ss_pred CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCC
Q psy7505 176 DLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE 255 (394)
Q Consensus 176 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~ 255 (394)
+|.+++..... +++.....++.|++.||.|||+++|+||||||+||+++.++.+|++|||.+....... ..
T Consensus 71 ~L~~~l~~~~~-----l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~ 141 (237)
T cd05576 71 KLWSHISKFLN-----IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DG 141 (237)
T ss_pred CHHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----cc
Confidence 99999865432 6777788999999999999999999999999999999999999999999875443211 12
Q ss_pred ccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHH
Q psy7505 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVD 335 (394)
Q Consensus 256 ~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~ 335 (394)
..++..|+|||.+.... ++.++||||+||++|||++ |..|+...... +... ..+..|..+++.+.
T Consensus 142 ~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~-g~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~ 206 (237)
T cd05576 142 EAVENMYCAPEVGGISE-------ETEACDWWSLGAILFELLT-GKTLVECHPSG-----INTH--TTLNIPEWVSEEAR 206 (237)
T ss_pred CCcCccccCCcccCCCC-------CCchhhHHHHHHHHHHHHH-CcchhhcCchh-----cccc--cccCCcccCCHHHH
Confidence 23456799999876544 6789999999999999998 99887543211 1111 13456678899999
Q ss_pred HHHHhhhcCCcc-ccchhh
Q psy7505 336 VAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 336 ~l~~~cl~~~p~-r~~~~e 353 (394)
+++.+||+.||+ |+++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 999999999998 888643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=267.95 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=192.3
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecc-cccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKE-DASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.+......|+-..+||+|.||+||+|+.+. ++.+|++|++-. ...+.--..-++|+.++..|+|+|++.+..
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n-------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliE 83 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKN-------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcC-------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHH
Confidence 344556777778899999999999999874 444677665432 112111122358999999999999999998
Q ss_pred EEEe--------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 158 ACLE--------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 158 ~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
.|.. ...+|+||.+|.. ||.-+|.... ..++...+..++.++..||.|+|.+.|+|||+|++|+||+
T Consensus 84 ic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 84 ICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT 158 (376)
T ss_pred HHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc
Confidence 8864 2358999999977 9998886432 1266777889999999999999999999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
.+|.+||+|||+++........ +-+..+.|.+|.+||.+.+.+. |+.+.|||..|||+.||+| |.+-+++
T Consensus 159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~------yg~~iDiWgAgCimaeMwt-rspimqg 231 (376)
T KOG0669|consen 159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE------YGPPIDIWGAGCIMAEMWT-RSPIMQG 231 (376)
T ss_pred CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccc------cCCcchhHhHHHHHHHHHc-cCccccC
Confidence 9999999999999754332211 1123466899999999988763 8999999999999999998 8888888
Q ss_pred CCHHHHHHHHhc--CCC----------------cCC-CCCC-------------CCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 307 LSDDQVITRVFG--TEA----------------LRL-PAPR-------------AVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 307 ~~~~~~~~~i~~--~~~----------------~~~-~~p~-------------~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
.++.+.+..|.. |.- ..+ |.|. .-.++..+++.+++..||. |+.+.+
T Consensus 232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 877766544421 110 000 1111 1234778999999999998 777665
Q ss_pred h
Q psy7505 354 T 354 (394)
Q Consensus 354 ~ 354 (394)
+
T Consensus 312 a 312 (376)
T KOG0669|consen 312 A 312 (376)
T ss_pred h
Confidence 4
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=294.10 Aligned_cols=266 Identities=17% Similarity=0.208 Sum_probs=172.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE--
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA-- 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~-- 158 (394)
.+..++|.+.+.||+|+||.||+|++..... .....||+|.+........ ...| .++...+.+++.+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~---~~~~~vAvK~~~~~~~~e~---~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQS---KKEGKYVLKKATEYGAVEI---WMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCcc---ccCcEEEEEEecccchhHH---HHHH--HHHhhchhhHHHHHHhhh
Confidence 3457899999999999999999999874211 2255899998764332111 1111 1222233333333222
Q ss_pred ----EEeCCceEEEEeeCCCCCHHHHHhhcchhh---------------hhhhhHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7505 159 ----CLESDPWLLVFESCSRGDLKEFLLSNEASR---------------EALLEQGITIKMAIDVATGLSYMIEDGFIHT 219 (394)
Q Consensus 159 ----~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHr 219 (394)
.......+|||||+.+|+|.+++....... ........+..++.|++.||.|||+++|+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 234567999999999999999997542100 0001123455789999999999999999999
Q ss_pred CCCCCCEEEcC-CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcc---------------cCCCCcc
Q psy7505 220 DVAARNCLVTS-ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQ---------------TCTVTEK 283 (394)
Q Consensus 220 Dlk~~NiLl~~-~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~---------------~~~~~~~ 283 (394)
||||+|||++. ++.+||+|||+|+....+..+......+++.|||||.+........ ...++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5899999999997654443344445677889999997654322111 0124567
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------cC--------CCCCCCCChHHHHHHHhhhcCC
Q psy7505 284 CNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA----------LR--------LPAPRAVNSHVDVAARNCLVTS 345 (394)
Q Consensus 284 ~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~----------~~--------~~~p~~~~~~~~~l~~~cl~~~ 345 (394)
+|||||||+||||++ +..++... ..+....+..... .+ +...........+|+.+||+.|
T Consensus 360 ~DVwSlGviL~el~~-~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAF-PNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHh-CcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 899999999999996 77665432 1111111111100 00 0000111233458999999999
Q ss_pred cc-ccchhhhhh
Q psy7505 346 EL-RVKIGDTGS 356 (394)
Q Consensus 346 p~-r~~~~e~~~ 356 (394)
|+ ||++.+++.
T Consensus 438 P~kR~ta~e~L~ 449 (566)
T PLN03225 438 GRQRISAKAALA 449 (566)
T ss_pred cccCCCHHHHhC
Confidence 98 999998864
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=273.17 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=192.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC--c----ceeceee
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH--V----NILRLMA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H--p----nIv~l~~ 157 (394)
..+|.++..+|+|.||+|.+|.++. ....||+|+++.-....+.. +-|+.++.++.+ | -+|.+.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~-------~~~~vAlKIik~V~kYreAa--~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRE-------TKEHVALKIIKNVDKYREAA--LIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecC-------CCceehHHHHHHHHHHhhHH--HHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 6889999999999999999999873 35589999988765444333 358888988832 2 2788889
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-------
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS------- 230 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~------- 230 (394)
+|.-.++.|||+|.+ |-++++||.++.... ++...+..|+.|++.++.|||+.+++|-||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~---fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIP---FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccc---cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 998899999999998 459999999875432 667788899999999999999999999999999999842
Q ss_pred -------------CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHH
Q psy7505 231 -------------ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297 (394)
Q Consensus 231 -------------~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~ 297 (394)
+..+||+|||.|....... ...+.|..|.|||++.+-. ++..+||||+||||+|++
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLG-------wS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLG-------WSQPCDVWSIGCILVELY 303 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccC-------cCCccCceeeeeEEEEee
Confidence 2348999999987654433 3456788999999999877 889999999999999999
Q ss_pred cCCCCCCCCCCHHH---HHHHHhcCCCc---------------CCCCCC-------------------------CCChHH
Q psy7505 298 EFGKLPYAELSDDQ---VITRVFGTEAL---------------RLPAPR-------------------------AVNSHV 334 (394)
Q Consensus 298 t~g~~Pf~~~~~~~---~~~~i~~~~~~---------------~~~~p~-------------------------~~~~~~ 334 (394)
| |..-|..-++.+ ++++|++--+. ++.-|. .-..++
T Consensus 304 t-G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 304 T-GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred c-cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 8 999888766554 34444321100 111111 011268
Q ss_pred HHHHHhhhcCCcc-ccchhhhh
Q psy7505 335 DVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 335 ~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+|++++|..||. |+|+.|.+
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred HHHHHHHHccCccccccHHHHh
Confidence 8999999999998 88988864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=280.93 Aligned_cols=274 Identities=19% Similarity=0.234 Sum_probs=186.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCccc---------ccCcccceEEEEeecccccHHHHHH-------------HH
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEE---------STGRTTSKVFVRILKEDASQAEKLF-------------FL 138 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---------~~~~~~~~vavk~~~~~~~~~~~~~-------------~~ 138 (394)
.+..++|.+.++||+|+||.||+|.+..... ........||||.++........++ ..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 3467899999999999999999997632211 0112345799999865432221111 22
Q ss_pred HHHHHhccCCCcce-----eceeeEEEe--------CCceEEEEeeCCCCCHHHHHhhcchhh-----------------
Q psy7505 139 HEATPYRRLRHVNI-----LRLMAACLE--------SDPWLLVFESCSRGDLKEFLLSNEASR----------------- 188 (394)
Q Consensus 139 ~E~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~~----------------- 188 (394)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++|+......
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666677766544 677787753 356899999999999999997532100
Q ss_pred --hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCccccccc
Q psy7505 189 --EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266 (394)
Q Consensus 189 --~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE 266 (394)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 011245567788999999999999999999999999999999999999999998654332222111223467899999
Q ss_pred ccccCCCCccc---------------CCCCcchhHHHHHHHHHHHHcCCCC-CCCCCCHHH--H--------HHHHhcCC
Q psy7505 267 SLLCSDTSIQT---------------CTVTEKCNVWSFGVLLWEIFEFGKL-PYAELSDDQ--V--------ITRVFGTE 320 (394)
Q Consensus 267 ~l~~~~~~~~~---------------~~~~~~~DiwSlG~il~el~t~g~~-Pf~~~~~~~--~--------~~~i~~~~ 320 (394)
.+......... .....+.||||+||++|||++ |.. ||.+..... . ..+...+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~-~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV-PELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh-CCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98643211000 001235799999999999997 764 776432111 0 11122233
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCc---c-ccchhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSE---L-RVKIGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p---~-r~~~~e~~ 355 (394)
...++....+++...+++.++|..+| . |+++.|++
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 33455556788999999999999876 3 88988875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=256.11 Aligned_cols=237 Identities=26% Similarity=0.424 Sum_probs=190.3
Q ss_pred cceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEeeCCCCC
Q psy7505 97 WFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGD 176 (394)
Q Consensus 97 ~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~ 176 (394)
+||.||+|.+.. .+..+++|+............+.+|+..+++++|+||+++++.+......+++|||+.+++
T Consensus 1 ~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKK-------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 589999999873 3447899988765533324456799999999999999999999999899999999999999
Q ss_pred HHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCc
Q psy7505 177 LKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEV 256 (394)
Q Consensus 177 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~ 256 (394)
|.+++..... ++......++.+++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 74 L~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 146 (244)
T smart00220 74 LFDLLKKRGR-----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTF 146 (244)
T ss_pred HHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccc
Confidence 9999876432 4666778899999999999999999999999999999999999999999886543322 22234
Q ss_pred cCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCcCCCCCC-CCChHH
Q psy7505 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE-LSDDQVITRVFGTEALRLPAPR-AVNSHV 334 (394)
Q Consensus 257 ~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~p~-~~~~~~ 334 (394)
.++..|++||.+.... ++.++||||||+++|+|++ |..||.. .....+...+..+.. ...... .++.++
T Consensus 147 ~~~~~~~~pE~~~~~~-------~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 217 (244)
T smart00220 147 VGTPEYMAPEVLLGKG-------YGKAVDVWSLGVILYELLT-GKPPFPGDDQLLELFKKIGKPKP-PFPPPEWKISPEA 217 (244)
T ss_pred cCCcCCCCHHHHccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCC-CCccccccCCHHH
Confidence 5677899999986444 6789999999999999998 9999987 444455555444331 121112 288999
Q ss_pred HHHHHhhhcCCcc-ccchhhhhh
Q psy7505 335 DVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 335 ~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+++++||..+|+ ||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 9999999999998 999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=260.03 Aligned_cols=206 Identities=21% Similarity=0.291 Sum_probs=163.4
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-----
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD----- 163 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 163 (394)
-+.||-|+||+||...+. +.+..|+.|++..-. .-...+.+.+|+.++..++|.|++..++..+...
T Consensus 58 DRPIGYGAFGVVWsVTDP-------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDP-------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCcccccceeEEEeccCC-------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 356999999999988765 445578877765433 2222223349999999999999999998876533
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|+++|.|.. ||.+.|-... .++...+..+..||++||.|||+.||+||||||-|+|++++..+||||||+++
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccc
Confidence 46889999965 8988885432 26677778889999999999999999999999999999999999999999998
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
.....+....+.-..|..|.|||++.+.+. |+.++||||.|||+.|++. .+.-|...++.+.+..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRh------Ys~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARR------YTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQM 269 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchh------hcCccceehhhHHHHHHHh-hhhhhhccChHHHHHH
Confidence 765544333333356778999999998873 9999999999999999996 8888988776555443
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=275.30 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=166.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH---HH----HHHHHHHHHhccCC---Ccceec
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA---EK----LFFLHEATPYRRLR---HVNILR 154 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~---~~----~~~~~E~~~l~~l~---HpnIv~ 154 (394)
.+|..++.+|+|+||.|++|.++. ....|+||++.+..--. .+ -..-.|++||..|+ |+||++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~-------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE-------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred ccceeeeeccccccceEEEeeecc-------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 568899999999999999999983 35588999987654111 00 01235999999997 999999
Q ss_pred eeeEEEeCCceEEEEeeCC-CCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 155 LMAACLESDPWLLVFESCS-RGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
++++|++++.+||+||--. +-||+++|..... +.+..+..++.||+.|+.+||++||||||||-+|+.++.+|.
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~-----m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR-----MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhhccCc-----cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence 9999999999999999754 4499999965433 677788899999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
+||+|||.|.....+.. ..+.||+.|.|||++.+..+ .+..-|||++|++||-++ |.+.||.+
T Consensus 709 ~klidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y------~gk~qdiwalgillytiv-ykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKY------LGKPQDIWALGILLYTIV-YKENPYYN 771 (772)
T ss_pred EEEeeccchhhhcCCCc---ceeeeeccccchhhhCCCcc------CCCcchhhhhhheeeEEE-eccCCCcC
Confidence 99999998765444332 24578999999999988875 577899999999999998 68999864
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=279.72 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=204.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
|+++|+++..+|+|+||.||+++++ .+....|+|+++......... ...|+-+++..+|||||.++|.+...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~-------~s~elaavkvVkLep~dd~~~-iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDK-------RSGELAAVKVVKLEPGDDFSG-IQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred CccchhheeeecCCcccchhhhccc-------ccCchhhheeeeccCCccccc-cccceeeeecCCCcChHHHHhhhhhh
Confidence 5789999999999999999999988 355577888887766433322 34789999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+||+||||.+|+|.+.-+-.+ .+++.....++++.+.|+.|||++|-+|||||-.|||+++.|.+|++|||.+
T Consensus 85 dklwicMEycgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCch
Confidence 99999999999999998664433 2677777888999999999999999999999999999999999999999987
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE-- 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~-- 320 (394)
..... .......+.||+.|||||+-.-++. +.|...+|||++|++..|+-. -+.|-.+..+.+.+....+..
T Consensus 160 aqita-ti~KrksfiGtpywmapEvaaverk----ggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr~l~LmTkS~~q 233 (829)
T KOG0576|consen 160 AQITA-TIAKRKSFIGTPYWMAPEVAAVERK----GGYNQLCDIWALGITAIELGE-LQPPLFDLHPMRALFLMTKSGFQ 233 (829)
T ss_pred hhhhh-hhhhhhcccCCccccchhHHHHHhc----ccccccccccccccchhhhhh-cCCcccccchHHHHHHhhccCCC
Confidence 54322 2223445689999999998765432 238899999999999999976 778877777777766554432
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGD 353 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e 353 (394)
.+.+..+...++.+.++++.|+..+|+ ||+..-
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaek 267 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEK 267 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhh
Confidence 233444567888999999999999998 888653
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=276.53 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=184.6
Q ss_pred EceeeeecceE-EEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCCceEE
Q psy7505 90 VKEIGRGWFGK-VVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 90 ~~~lG~G~fg~-V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 167 (394)
.+.+|.|+-|+ ||+|.+. ++.||||.+-... ..+..+|++.++.- +|||||++|+.-.+....||
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye---------~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE---------GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred HHHcccCCCCcEEEEEeeC---------CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 35688998886 6888876 3479998775433 22345899988887 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---C--CeEEEccCCCC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---E--LRVKIGDTGSS 242 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~--~~vKl~DFG~a 242 (394)
+.|.|.. +|.+++...+.... ....-..+.+..|++.||++||+.+||||||||.||||+. + .+++|+|||+|
T Consensus 581 alELC~~-sL~dlie~~~~d~~-~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 581 ALELCAC-SLQDLIESSGLDVE-MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EehHhhh-hHHHHHhccccchh-hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9999965 99999977411111 1111234677889999999999999999999999999976 3 57899999999
Q ss_pred ccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 243 IDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+....+.. .+..+..||-+|+|||++.... -+.++||+|+||++|..++.|..||.+...++ ..|+.+.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-------~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~ 729 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-------KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGN 729 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccc-------cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCc
Confidence 87655443 3345668899999999998776 35699999999999999998899998765544 3444443
Q ss_pred Cc--CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 321 AL--RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 321 ~~--~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.- .+.....+ ++.+||.+|+..+|. ||++.+|+
T Consensus 730 ~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 730 YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 21 11111222 899999999999998 99999885
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=236.82 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=183.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 162 (394)
.++|++.+++|+|.|++||.|..- ....+++||+++.-. ++.+.+|+.+|..|. ||||++|+++..+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~-------~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINI-------TNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred cchHHHHHHHcCccHhhHhccccc-------CCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 578999999999999999999865 234588999998643 333569999999995 99999999999864
Q ss_pred --CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEEccC
Q psy7505 163 --DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGDT 239 (394)
Q Consensus 163 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl~DF 239 (394)
....||+||..+.|...+-.. +....+..++.+++.||.|||++||+|||+||.|++||.. ..++|+|.
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred cccCchhHhhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeec
Confidence 457899999998877665432 4455667899999999999999999999999999999976 46999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC-CCCCCHHHHHHHH--
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YAELSDDQVITRV-- 316 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P-f~~~~~~~~~~~i-- 316 (394)
|+|-....+..+.. ...+..|-.||++..-.. |+.+-|+|||||+|..|+- .+-| |.+.++.+.+.+|
T Consensus 178 GLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~------YDYSLD~WS~GcmlA~miF-rkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNV--RVASRYFKGPELLVDYQM------YDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred chHhhcCCCceeee--eeehhhcCCchheeechh------ccccHHHHHHHHHHHHHHh-ccCcccCCCCCHHHHHHHHH
Confidence 99977666554422 233445778999976543 8899999999999999995 6555 5666655443332
Q ss_pred -hcCCC-------cCCCCC-----------------------C-CCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 -FGTEA-------LRLPAP-----------------------R-AVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 -~~~~~-------~~~~~p-----------------------~-~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
++... +.+..+ . -+++++.+++.++|..|-+ |+|+.|-+
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 22110 111111 1 2356788888888888876 88877653
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=246.02 Aligned_cols=245 Identities=19% Similarity=0.250 Sum_probs=183.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..+|.-++.+|.|.- .|.-+.+. .....|++|.+.... ....+ ...+|..+|..++|+||++++.+|..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~-------v~~~~v~ikk~~~pf~n~~~ak-ra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ-------VLGRPVAIKKLSRPFQNQTHAK-RAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh-------hccCceehhhhcCccccCccch-hhhhhhhhhhhhcccceeeeeeccCc
Confidence 456777788898888 55555443 345578887765433 11122 23489999999999999999999975
Q ss_pred CC------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 162 SD------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 ~~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
.. .+|+|||||.. +|.+.+... ++......+..|++.|+.|||+.||+||||||+||++..++.+|
T Consensus 87 ~~~l~~~~e~y~v~e~m~~-nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDA-NLCQVILME-------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred cccHHHHHhHHHHHHhhhh-HHHHHHHHh-------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhhee
Confidence 43 47999999965 999888633 55666778999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|.|||+|+..... ...+....+..|.|||++.+.. |...+||||+||++.||++ |..-|.+.+..+.+.+
T Consensus 159 i~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~-------~ke~vdiwSvGci~gEli~-~~Vlf~g~d~idQ~~k 228 (369)
T KOG0665|consen 159 ILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGELIL-GTVLFPGKDHIDQWNK 228 (369)
T ss_pred eccchhhcccCcc--cccCchhheeeccCchheeccC-------CcccchhhhhhhHHHHHhh-ceEEecCchHHHHHHH
Confidence 9999999765433 3344456777899999998776 7889999999999999997 9998887654443333
Q ss_pred HhcCCC---------------------cC---CCC---------------CCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 316 VFGTEA---------------------LR---LPA---------------PRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 316 i~~~~~---------------------~~---~~~---------------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+..--+ ++ +.+ +..-...+.+++.++|..+|+ |.++.|++
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 221000 00 000 112234688999999999998 88998875
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=256.76 Aligned_cols=212 Identities=22% Similarity=0.307 Sum_probs=172.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC------Ccceece
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR------HVNILRL 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l 155 (394)
+-...|.+....|+|-|+.|..|.+.. .+..||||++.+...- .+.=+.|+++|++|+ --|+++|
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~-------r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQA-------RGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccC-------CCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 345778888899999999999998873 3448999999765421 122248999999994 3579999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRV 234 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~v 234 (394)
+..|...+++|||+|-+.- +|.+.|++.+.. ..+....+..|+.|+..||..|...||+|.||||+|||++.. ..+
T Consensus 500 ~r~F~hknHLClVFE~Lsl-NLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLSL-NLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHhhhcceeEEEehhhhc-hHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 9999999999999998854 999999886543 235666788899999999999999999999999999999876 568
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||||||.|.....+..+ ....+-.|.|||++.+.. |+...|+||.||+||||+| |+.-|.+.++.+++.
T Consensus 577 KLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~-------yd~~iD~WSvgctLYElYt-GkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 577 KLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLP-------YDYPIDTWSVGCTLYELYT-GKILFPGRTNNQMLR 645 (752)
T ss_pred eeccCcccccccccccc---HHHHHHhccCcceeecCc-------ccCCccceeeceeeEEeec-cceecCCCCcHHHHH
Confidence 99999988665444321 223345699999999877 7889999999999999998 999999999888765
Q ss_pred HH
Q psy7505 315 RV 316 (394)
Q Consensus 315 ~i 316 (394)
..
T Consensus 646 l~ 647 (752)
T KOG0670|consen 646 LF 647 (752)
T ss_pred HH
Confidence 43
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=238.21 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=179.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeE-EEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAA-CLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~ 161 (394)
.+.|.+.+.||+|.||++.+|++++ ....+++|.+.... ...+.|.+|..---.| .|.||+.-|++ |+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~-------s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ-------SKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC-------CceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 4678889999999999999999984 45578888775543 2233456787655455 79999998875 677
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCeEEEccC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDT 239 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~--~~~vKl~DF 239 (394)
.+.+.++|||++.|||..-+...+ +.+.....++.|+++|+.|+|++++||||||.+||||-. ..+||||||
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence 788889999999999998876543 455667789999999999999999999999999999943 358999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--H--HHH
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ--V--ITR 315 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~--~--~~~ 315 (394)
|+++.....-. ...-+..|.+||++.-... ......+..|+|.||+++|.++| |.+||+.....+ . +.+
T Consensus 168 G~t~k~g~tV~----~~~~~~~y~~pe~~~~~~n--e~~~~~ps~D~WqfGIi~f~clt-G~~PWQka~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 168 GLTRKVGTTVK----YLEYVNNYHAPELCDTVVN--EKLVVNPSTDIWQFGIIFFYCLT-GKFPWQKASIMDKPYWEWEQ 240 (378)
T ss_pred ccccccCceeh----hhhhhcccCCcHHHhhccc--cceEecccccchheeeeeeeeec-CCCcchhhhccCchHHHHHH
Confidence 98865432211 1122345899998754321 12235778999999999999998 999997543111 1 122
Q ss_pred HhcCCCcCCCC-CCCCChHHHHHHHhhhcCCcccc
Q psy7505 316 VFGTEALRLPA-PRAVNSHVDVAARNCLVTSELRV 349 (394)
Q Consensus 316 i~~~~~~~~~~-p~~~~~~~~~l~~~cl~~~p~r~ 349 (394)
-.++...++|. -..+++.+..+.++-|..+++||
T Consensus 241 w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 241 WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred HhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 22332223332 24678899999999999999966
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=231.92 Aligned_cols=216 Identities=26% Similarity=0.371 Sum_probs=172.0
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceE
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWL 166 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 166 (394)
|.+.+.||+|++|.||+|.... ....+++|.............+.+|+..+++++|+|++++++++......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 4567889999999999999863 344789998876554323445678999999999999999999999889999
Q ss_pred EEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 167 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
+++||+++++|.+++...... +++.....++.+++.++.|||+++++|+||++.||+++.++.++|+|||.+....
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGK----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred EEEeccCCCCHHHHHHhcccC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 999999999999999765321 4566777889999999999999999999999999999999999999999886554
Q ss_pred CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHH-HHHHHHhcCC
Q psy7505 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE-LSDD-QVITRVFGTE 320 (394)
Q Consensus 247 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~-~~~~-~~~~~i~~~~ 320 (394)
...........++..|++||.+. .. ..++.++||||||+++|||++ |+.||.+ ..+. ++.+.+..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~-~~-----~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLL-GG-----KGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CcccccccceeccCCcCCHhHhc-CC-----CCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHHHhcCC
Confidence 33200112234566799999874 11 126779999999999999998 9999987 4444 5666676664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=221.06 Aligned_cols=212 Identities=28% Similarity=0.448 Sum_probs=174.5
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEeeC
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESC 172 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 172 (394)
||+|++|.||++.... ....+++|.............+.+|+..++.+.|++|+++++++......+++|||+
T Consensus 1 l~~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKK-------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecC-------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 6899999999999863 244788998876654323345679999999999999999999999888999999999
Q ss_pred CCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEEccCCCCccCCCCcee
Q psy7505 173 SRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKIGDTGSSIDKYPGDYY 251 (394)
Q Consensus 173 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl~DFG~a~~~~~~~~~ 251 (394)
.+++|.+++.... ..++...+..++.+++.++.|||+++++|+||+|.||+++. ++.++|+|||.+........
T Consensus 74 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 74 EGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 9999999987542 12566778889999999999999999999999999999999 89999999998865433221
Q ss_pred eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCC
Q psy7505 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVN 331 (394)
Q Consensus 252 ~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~ 331 (394)
......+...|++||.+.... .++.+.|+|++|+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~------~~~~~~D~~~lg~~~~~l----------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKG------YYSEKSDIWSLGVILYEL----------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccC------CCCchhhhHHHHHHHHHH-----------------------------------
Confidence 111234556799999986541 267899999999999999
Q ss_pred hHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 332 SHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 332 ~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
..+.+++..|+..+|. ||++.+++..
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 6889999999999998 9999988754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-29 Score=231.28 Aligned_cols=135 Identities=22% Similarity=0.336 Sum_probs=109.5
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-----C---ccee
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-----H---VNIL 153 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv 153 (394)
|...+|.+.++||-|.|++||+|.+. ....-||+|+.+......+ ..+.|+.+|++++ | .+||
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDt-------q~~r~VAlKVvKSAqhYtE--aAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDT-------QNKRYVALKVVKSAQHYTE--AALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeec-------cCCeEEEEEEEehhhHHHH--HHHHHHHHHHHHHhcCCCCCCCceee
Confidence 44688999999999999999999987 3455899999876543322 2358999998872 3 3699
Q ss_pred ceeeEEEe----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEE
Q psy7505 154 RLMAACLE----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLV 228 (394)
Q Consensus 154 ~l~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl 228 (394)
+|++.|.. +.++|||+|++ |.+|..+|...... .++...+..|+.||+.||.|||.+ ||||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 99999975 45899999999 56899998765332 267778899999999999999964 99999999999998
Q ss_pred c
Q psy7505 229 T 229 (394)
Q Consensus 229 ~ 229 (394)
.
T Consensus 222 ~ 222 (590)
T KOG1290|consen 222 C 222 (590)
T ss_pred e
Confidence 4
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=265.57 Aligned_cols=194 Identities=15% Similarity=0.104 Sum_probs=137.6
Q ss_pred cCCC-cceeceeeEE-------EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCce
Q psy7505 146 RLRH-VNILRLMAAC-------LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFI 217 (394)
Q Consensus 146 ~l~H-pnIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~ii 217 (394)
.+.| .||++++++| .....++++|||+ +++|.++|.... ..++...++.++.||+.||.|||++||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3456 6888899887 2334678889988 569999996532 1267778889999999999999999999
Q ss_pred ecCCCCCCEEEcC-------------------CCeEEEccCCCCccCCCCc---------------eeeeCCccCCcccc
Q psy7505 218 HTDVAARNCLVTS-------------------ELRVKIGDTGSSIDKYPGD---------------YYVHGEVALPVRWC 263 (394)
Q Consensus 218 HrDlk~~NiLl~~-------------------~~~vKl~DFG~a~~~~~~~---------------~~~~~~~~~t~~y~ 263 (394)
||||||+||||+. ++.+||+|||+++...... ........+|+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999964 3456666777664321000 00011135688899
Q ss_pred cccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhc
Q psy7505 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLV 343 (394)
Q Consensus 264 aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~ 343 (394)
|||++.+.. |+.++|||||||+||||++ |..|+.... ..+..+.... ..+...........++..||.
T Consensus 183 APE~~~~~~-------~~~~sDVwSlGviL~ELl~-~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 183 SPEEDNGSS-------SNCASDVYRLGVLLFELFC-PVSSREEKS--RTMSSLRHRV--LPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred ChhhhccCC-------CCchhhhhhHHHHHHHHhh-CCCchhhHH--HHHHHHHHhh--cChhhhhcCHHHHHHHHHhCC
Confidence 999987665 7899999999999999998 888875432 2222222211 111111224456788999999
Q ss_pred CCcc-ccchhhhhh
Q psy7505 344 TSEL-RVKIGDTGS 356 (394)
Q Consensus 344 ~~p~-r~~~~e~~~ 356 (394)
.+|. ||++.|++.
T Consensus 251 ~~P~~Rps~~eil~ 264 (793)
T PLN00181 251 PEPSCRPSMSELLQ 264 (793)
T ss_pred CChhhCcChHHHhh
Confidence 9998 999999863
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=214.56 Aligned_cols=253 Identities=21% Similarity=0.383 Sum_probs=200.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
-.++.++.+|.+...|+.|+|+|.+. .+++|+++... .......|..|.-.++-+.||||+.++|.|...
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgn---------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGN---------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCc---------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 45566778899999999999999853 34456655433 223334466788888999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCeEEEc--c
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVTSELRVKIG--D 238 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~~~~~vKl~--D 238 (394)
..+.++..||+.|+|+..|++.... ..+...+++++.++++||.|||+-. |..-.|.+..++||++...||+ |
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad 336 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD 336 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc
Confidence 9999999999999999999876432 3577788999999999999999863 4444699999999999877764 3
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
--++.. .....-.+.||+||.+.....+. --.++|+|||.+++||+.| .+.||.+.++.+.-.+|.
T Consensus 337 ~kfsfq--------e~gr~y~pawmspealqrkped~----n~raadmwsfaillwel~t-revpfadlspmecgmkia- 402 (448)
T KOG0195|consen 337 TKFSFQ--------EVGRAYSPAWMSPEALQRKPEDL----NIRAADMWSFAILLWELNT-REVPFADLSPMECGMKIA- 402 (448)
T ss_pred ceeeee--------ccccccCcccCCHHHHhcCchhc----chhhhhHHHHHHHHHHhhc-cccccccCCchhhhhhhh-
Confidence 322211 01122346799999998776443 2368999999999999998 999999999999876663
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
-+.+|..+|+.++.++..+|.-|...||. ||.+..++..|++..
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 23469999999999999999999999997 999999999888753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=205.51 Aligned_cols=161 Identities=19% Similarity=0.223 Sum_probs=123.3
Q ss_pred CCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeC
Q psy7505 175 GDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG 254 (394)
Q Consensus 175 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~ 254 (394)
|+|.+++...+. .+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------
Confidence 799999976422 2688889999999999999999998 999999999999999 9988654321
Q ss_pred CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCcCC----CCCCC
Q psy7505 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEALRL----PAPRA 329 (394)
Q Consensus 255 ~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~----~~p~~ 329 (394)
...+++.|||||++.+.. ++.++|||||||++|||++ |+.||...... ..+..+..+..... +.+..
T Consensus 63 ~~~g~~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQS-------YTEKADIYSLGITLYEALD-YELPYNEERELSAILEILLNGMPADDPRDRSNLES 134 (176)
T ss_pred cCCCcccccChHHhcCCC-------CcchhhHHHHHHHHHHHHh-CCCCccccchhcHHHHHHHHHhccCCccccccHHH
Confidence 225678999999997665 7889999999999999998 99999765432 33333332221111 12233
Q ss_pred CCh--HHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 330 VNS--HVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 330 ~~~--~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
++. .+.+++++||..+|+ ||++.+++..+...
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 444 699999999999998 99999998766543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=220.70 Aligned_cols=182 Identities=14% Similarity=0.093 Sum_probs=131.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccc----ccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED----ASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
..+|.+.+.||+|+||+||+|+++.. ....+|||.+... ........+.+|+.+|++++|+|||..+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGD------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCC------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 57799999999999999999987631 2335788876533 122334557799999999999999853322
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEcCCCeEEEcc
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDV-AARNCLVTSELRVKIGD 238 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDl-k~~NiLl~~~~~vKl~D 238 (394)
.+..|||||||+|++|.. +... . ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~~~--------~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-ARPH--------G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hCcc--------c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 256899999999999973 2111 0 1246789999999999999999999 99999999999999999
Q ss_pred CCCCccCCCCcee-e------eCCccCCcccccccccccCCCCcccCCCCcchhHH
Q psy7505 239 TGSSIDKYPGDYY-V------HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVW 287 (394)
Q Consensus 239 FG~a~~~~~~~~~-~------~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~Diw 287 (394)
||+|+........ . .....++..|+|||.+....... ....+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~-~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKI-LARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhcc-ccccccccCcE
Confidence 9999754332210 0 12345677899999987654221 11233446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=203.25 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=191.2
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH--HHHHHHHHHHHhccCCCc-ceeceeeEEEeCC
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--EKLFFLHEATPYRRLRHV-NILRLMAACLESD 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~ 163 (394)
|.+.+.||.|+||.||++.+. ..+++|.+....... ....+.+|+.++..+.|+ +|+++++.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence 677889999999999999876 367788776655322 344567899999999988 7999999997777
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~DFG~a 242 (394)
..+++++|+.+++|.+++...... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .+|++|||.+
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 789999999999999777654311 1256667788999999999999999999999999999999988 7999999998
Q ss_pred ccCCCCcee-----eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHH
Q psy7505 243 IDKYPGDYY-----VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----DQVI 313 (394)
Q Consensus 243 ~~~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----~~~~ 313 (394)
+........ ......++..|++||.+.... ...++...|+||+|++++++++ |..||..... .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~~~~~~~~~~ 224 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLT-GLPPFEGEKNSSATSQTL 224 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccccHHHHH
Confidence 644332221 234567889999999987631 0126789999999999999997 9999877763 4444
Q ss_pred HHHhcCCCc--CCCCCCCC----ChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEAL--RLPAPRAV----NSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~--~~~~p~~~----~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+...... ..+..... ...+.+++..++..+|. |.+..+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 444433211 11111121 25789999999999997 777655443
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=212.02 Aligned_cols=201 Identities=21% Similarity=0.307 Sum_probs=160.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 162 (394)
.+.|..+++||+|.|++||++.+... ......||+|.+........ +.+|+++|..+ .+.||+++.+++..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~----~~~~~~valk~i~~ts~p~r---i~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQ----DTKRRYVALKAIYRTSSPSR---ILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhh----ccccceEeeeecccccCchH---HHHHHHHHHHhccchhhhcchhhhccC
Confidence 57788899999999999999988741 12455889998876554332 56899999888 799999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEEccCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGDTGS 241 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl~DFG~ 241 (394)
+.+.+||||++..+..++...- +...+..+++.++.||.++|.+|||||||||.|+|.+.. +.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~l--------~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRSL--------SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhcC--------CHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechh
Confidence 9999999999998888888653 344566789999999999999999999999999999864 6778999999
Q ss_pred CccC-----------------C-----------------CCceee---------eCCccCCcccccccccccCCCCcccC
Q psy7505 242 SIDK-----------------Y-----------------PGDYYV---------HGEVALPVRWCAPESLLCSDTSIQTC 278 (394)
Q Consensus 242 a~~~-----------------~-----------------~~~~~~---------~~~~~~t~~y~aPE~l~~~~~~~~~~ 278 (394)
|... . ...+++ .....||++|.|||++..-..
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~----- 254 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR----- 254 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC-----
Confidence 8510 0 001111 112478999999999975432
Q ss_pred CCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 279 TVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 279 ~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
-+.++||||.|||+.-+++ ++.||-.
T Consensus 255 -QttaiDiws~GVI~Lslls-~~~PFf~ 280 (418)
T KOG1167|consen 255 -QTTAIDIWSAGVILLSLLS-RRYPFFK 280 (418)
T ss_pred -cCCccceeeccceeehhhc-ccccccc
Confidence 5789999999999999998 8888743
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-27 Score=225.59 Aligned_cols=227 Identities=20% Similarity=0.264 Sum_probs=181.3
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCC-CcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E 170 (394)
+|+|+||.|++++..+... ....++.|++++.. ..........|..++..++ ||.+|+++..++.+...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~d----a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGAD----AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhcccc----ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 7999999999886543332 23345555554433 1111112235777778886 9999999999999999999999
Q ss_pred eCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce
Q psy7505 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY 250 (394)
Q Consensus 171 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~ 250 (394)
|..+|+|...+.+... +.......+...++.|+.++|+.+|+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 78 ~~rgg~lft~l~~~~~-----f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVM-----FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred hcccchhhhccccCCc-----hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999999988865533 44555566778899999999999999999999999999999999999999976544332
Q ss_pred eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCC
Q psy7505 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAV 330 (394)
Q Consensus 251 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~ 330 (394)
. +||..|||||++.+ ...++|+||||++++||+| |..||.. ++..+|.+. .++.|+..
T Consensus 153 ~-----cgt~eymApEI~~g---------h~~a~D~ws~gvl~fellt-g~~pf~~----~~~~~Il~~---~~~~p~~l 210 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIING---------HLSAADWWSFGVLAFELLT-GTLPFGG----DTMKRILKA---ELEMPREL 210 (612)
T ss_pred c-----ccchhhhhhHhhhc---------cCCcccchhhhhhHHHHhh-CCCCCch----HHHHHHhhh---ccCCchhh
Confidence 2 88999999999872 4578999999999999998 9999988 667777665 68889999
Q ss_pred ChHHHHHHHhhhcCCccccc
Q psy7505 331 NSHVDVAARNCLVTSELRVK 350 (394)
Q Consensus 331 ~~~~~~l~~~cl~~~p~r~~ 350 (394)
+..++.+++.++..+|..+.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHh
Confidence 99999999999999998443
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=204.34 Aligned_cols=258 Identities=15% Similarity=0.151 Sum_probs=185.2
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC----cceeceeeEE-E
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH----VNILRLMAAC-L 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~ 160 (394)
+|.+.+.||+|+||.||+|...... ...+|+|........... .+..|..++..+.. .++..+++.. .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~------~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK------NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRS 91 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC------CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence 8999999999999999999976321 235777766554322111 24467777777752 5788888888 4
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-----CeEE
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-----LRVK 235 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-----~~vK 235 (394)
....-+|||+.+ |.+|.++..... ...++......++.|++.+|.+||+.|++||||||.|+++... ..+.
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEE
Confidence 667789999998 669999876553 2236778889999999999999999999999999999999865 3589
Q ss_pred EccCCCCc--cCCCCc-----eee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 236 IGDTGSSI--DKYPGD-----YYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 236 l~DFG~a~--~~~~~~-----~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
|.|||+|+ ...... ..+ .....||.+|+++....+.. .+.+.|+||++-++.|++. |..||.+
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-------~~r~DDles~~Y~l~el~~-g~LPW~~ 239 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-------QGRRDDLESLFYMLLELLK-GSLPWEA 239 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-------cCCchhhhhHHHHHHHHhc-CCCCCcc
Confidence 99999998 321111 111 12345899999999876655 6789999999999999996 9999987
Q ss_pred CCHHHHHHHHhcC-CCcCCC-CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 307 LSDDQVITRVFGT-EALRLP-APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 307 ~~~~~~~~~i~~~-~~~~~~-~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
........++... ...... .....+.++..++..+-..+.. +|....+...|....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 240 LEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred ccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 6643222222111 111222 2344567778888777777765 888777766655544
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=227.52 Aligned_cols=252 Identities=20% Similarity=0.207 Sum_probs=181.0
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEee-cccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceE
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL-KEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWL 166 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~-~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 166 (394)
.....+|.|++|.|+.+......+..... .+.++ . ...........+..|..+-..|.|+|++..+..+.+.....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~--~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEK--EFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhh--hhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 45667999999988877766433222111 22222 1 11111111122557888889999999999888887766666
Q ss_pred EEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 167 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
-+||||++ ||+.++...+. +....+-.++.|++.|+.|+|+.||.|||||++|++++.+|.+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~-----~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGK-----LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcccc-----cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 66999999 99999977522 4555667789999999999999999999999999999999999999999875432
Q ss_pred CC-c--eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHhcCCC
Q psy7505 247 PG-D--YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFGTEA 321 (394)
Q Consensus 247 ~~-~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~--~~~i~~~~~ 321 (394)
.. + .......+|+-.|+|||++.+..+ ....+||||.|+++..|.+ |+.||.-....+- ......++.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~y------dpr~vDiwS~~ii~~~m~~-~~~~Wk~a~~~~~~~~~~~~~~~~ 544 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEY------DPRAVDVWSCGIIYICMIL-GRFPWKVAKKSDNSFKTNNYSDQR 544 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCccccccccc------CcchhhhhhccceEEEEec-CCCccccccccccchhhhcccccc
Confidence 11 1 133445678888999999988774 3568999999999999997 9999975543322 111111111
Q ss_pred c----CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 322 L----RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 322 ~----~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
. .......++.+.+.+|.++|+.+|. |.++.+++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 0 1122246788899999999999998 88998886
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=184.11 Aligned_cols=273 Identities=16% Similarity=0.196 Sum_probs=194.4
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC-cceeceeeEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH-VNILRLMAAC 159 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~ 159 (394)
.+....|.++++||+|+||.+|+|... ..+..||||+-........ +..|..+.+.|+| ..|..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i-------~~ge~VAiK~Es~~a~hpq---L~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISI-------TSGEEVAIKLESSKAKHPQ---LLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeec-------cCCceEEEEeecccCCCcc---hhHHHHHHHHhccCCCCchhhhhc
Confidence 355788999999999999999999876 3456899998766553332 4578888888865 4566677777
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeEEE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKI 236 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~vKl 236 (394)
.+...-.+||+.+ |.+|.++..- ....++...++-++-|++.-++|+|.++.|||||||+|.|+.-+ ..+-+
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred cccccceeeeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEE
Confidence 7778889999998 6799888742 23346677778889999999999999999999999999999644 46889
Q ss_pred ccCCCCccCCCCc------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 237 GDTGSSIDKYPGD------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 237 ~DFG~a~~~~~~~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
+|||+|+...+.. +.......||.+|.+--...+.. -+.+-|+=|+|.+|.... .|..||++....
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-------qSRRDDmeSvgYvLmYfn-rG~LPWQglka~ 227 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-------QSRRDDMESVGYVLMYFN-RGSLPWQGLKAA 227 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-------hhhhhhhhhhcceeeeee-cCCCcccccchh
Confidence 9999997654322 12223457899998866554443 357889999999988776 499999998754
Q ss_pred HH---HHHHhcCCCcCCCC-----CCCCChHHHHHHHhhhcCCcc-ccc---hhhhhhhhhcCCCcceeeCcccCCceec
Q psy7505 311 QV---ITRVFGTEALRLPA-----PRAVNSHVDVAARNCLVTSEL-RVK---IGDTGSSIDKYPGDYYVHGEVALPVRWC 378 (394)
Q Consensus 311 ~~---~~~i~~~~~~~~~~-----p~~~~~~~~~l~~~cl~~~p~-r~~---~~e~~~~l~~~~~~~~~~~~~~~~~~~~ 378 (394)
.- ..+|.+. ++.. ....|.++...+.-|=..--+ .|. +.+++..|-.-++- .-.....|.
T Consensus 228 tk~QKyEkI~Ek---K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~-----~~d~iyDW~ 299 (341)
T KOG1163|consen 228 TKKQKYEKISEK---KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH-----QYDYIYDWT 299 (341)
T ss_pred hHHHHHHHHHHh---hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc-----cCCeEeeHH
Confidence 33 4445433 2322 357889999999998555443 333 45555554443322 123345555
Q ss_pred cCcccc
Q psy7505 379 APESLL 384 (394)
Q Consensus 379 ~~es~~ 384 (394)
..+..+
T Consensus 300 ~lkqk~ 305 (341)
T KOG1163|consen 300 MLKQKS 305 (341)
T ss_pred HHHHHh
Confidence 554433
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=201.02 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=164.5
Q ss_pred hccCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCc-eecCCC
Q psy7505 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGF-IHTDVA 222 (394)
Q Consensus 144 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~i-iHrDlk 222 (394)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+...... +++.....+.++|+.||.|||...| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~----~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK----LDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC----ccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 46789999999999999999999999999999999999764322 5666677889999999999998766 999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccCCCC-ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDKYPG-DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
..|++++..+.+||+|||+....... .........-...|.|||.+............+.++||||||++++|+++ ..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~-r~ 155 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF-RS 155 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh-cc
Confidence 99999999999999999987554210 00011111223459999999875432222225678999999999999997 88
Q ss_pred CCCCCC----CHHHHHHHHhc-CCC-cCCCCC--CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 302 LPYAEL----SDDQVITRVFG-TEA-LRLPAP--RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 302 ~Pf~~~----~~~~~~~~i~~-~~~-~~~~~p--~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
-||... ...+++.++.+ +.. .++... ..+++.+..++++||..+|. ||++..+...+..+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 899763 34577777766 332 122111 14566899999999999998 99999988777766653
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=188.95 Aligned_cols=193 Identities=20% Similarity=0.305 Sum_probs=137.3
Q ss_pred CCcceeceeeEEEeC---------------------------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHH
Q psy7505 148 RHVNILRLMAACLES---------------------------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200 (394)
Q Consensus 148 ~HpnIv~l~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 200 (394)
+|||||+++++|.+. ..+|+||--.+. +|.+|+-.+.. +.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~------s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR------SYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC------chHHHHHH
Confidence 599999999998752 247999988865 99999976542 33445568
Q ss_pred HHHHHHHHHHHHhCCceecCCCCCCEEEc--CCC--eEEEccCCCCccCCCCc---eeeeC--CccCCcccccccccccC
Q psy7505 201 AIDVATGLSYMIEDGFIHTDVAARNCLVT--SEL--RVKIGDTGSSIDKYPGD---YYVHG--EVALPVRWCAPESLLCS 271 (394)
Q Consensus 201 ~~qi~~gl~yLH~~~iiHrDlk~~NiLl~--~~~--~vKl~DFG~a~~~~~~~---~~~~~--~~~~t~~y~aPE~l~~~ 271 (394)
+.|+++|+.|||.+||.|||||++|||+. +++ .+.|+|||.+....... .+.+. ...|.-.-||||+....
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 89999999999999999999999999983 443 57899999875332211 11111 22455668999987654
Q ss_pred CCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 272 DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 272 ~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
....-...| .++|.|+.|.+.||+++ ...||.+.....+-.+-+... --++.|..+++.+++++..+|+.||. |++
T Consensus 427 PGp~avvny-~kAD~WA~GalaYEIfg-~~NPFY~rGem~L~~r~Yqe~-qLPalp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 427 PGPNAVVNY-EKADTWAAGALAYEIFG-RSNPFYKRGEMLLDTRTYQES-QLPALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCceeecc-chhhhhhhhhhHHHHhc-cCCcccccchheechhhhhhh-hCCCCcccCChHHHHHHHHHhcCCccccCC
Confidence 321111123 48999999999999997 778887643332211112221 13456889999999999999999997 665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=181.44 Aligned_cols=172 Identities=13% Similarity=0.127 Sum_probs=128.0
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHH--H------HHHHHHHHhccCCCcceec
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK--L------FFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~--~------~~~~E~~~l~~l~HpnIv~ 154 (394)
-..+|...+.||.|+||.||+.... ...+++|.+......... . .+.+|+..+.++.|++|..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~---------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD---------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC---------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 4688999999999999999986432 336999998755422211 1 1568999999999999999
Q ss_pred eeeEEEeC--------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7505 155 LMAACLES--------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNC 226 (394)
Q Consensus 155 l~~~~~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~Ni 226 (394)
..+++... +..+|||||++|.+|.++.. ++. ....+++.+|..||+.|++|||+||.|+
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Ni 166 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNF 166 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHE
Confidence 99886643 35899999999999988742 121 2345899999999999999999999999
Q ss_pred EEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHH
Q psy7505 227 LVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297 (394)
Q Consensus 227 Ll~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~ 297 (394)
+++.+| ++|+|||......... ... .++... .|+.++|+||||+++.-..
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~-------a~d------~~vler-------~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRK-------AKD------RIDLER-------HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchh-------hHH------HHHHHh-------HhcccccccceeEeehHHH
Confidence 999988 9999999765331111 000 011111 2667899999999877554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=179.32 Aligned_cols=138 Identities=17% Similarity=0.163 Sum_probs=103.1
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--H-----------------------HHHHHHHHHHHhc
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--A-----------------------EKLFFLHEATPYR 145 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~-----------------------~~~~~~~E~~~l~ 145 (394)
..||+|+||.||+|... .+..||+|+++..... . ......+|+..+.
T Consensus 3 ~~ig~G~~~~Vy~a~~~--------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05147 3 GCISTGKEANVYHATTA--------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK 74 (190)
T ss_pred CccccccceEEEEEECC--------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 56999999999999874 2448999998754311 0 0122345999999
Q ss_pred cCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHH-HhCCceecCCCCC
Q psy7505 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM-IEDGFIHTDVAAR 224 (394)
Q Consensus 146 ~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yL-H~~~iiHrDlk~~ 224 (394)
++.|+++.....+.. . ..+|||||+++++|...+.... .++......++.|++.+|.|+ |+.||+||||||+
T Consensus 75 ~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 75 RLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred HHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 998877644333222 2 2389999999887765533222 156667888999999999999 7999999999999
Q ss_pred CEEEcCCCeEEEccCCCCcc
Q psy7505 225 NCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~ 244 (394)
|||++ ++.++|+|||+|..
T Consensus 148 NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred HEEEE-CCcEEEEEcccccc
Confidence 99998 57899999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=207.45 Aligned_cols=209 Identities=20% Similarity=0.292 Sum_probs=156.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|..++.|..|+||.||..+++. +.+..|.|+-+... +++. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~-------trqrfa~kiNkq~l-------ilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE-------TRQRFAMKINKQNL-------ILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc-------cccchhhcccccch-------hhhc--cccccCCccee----------
Confidence 5788899999999999999999873 33355654332211 1111 23333444444
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
||-...++.-+. ++. +.+.+++|||+.||+|||+||+|+||+.-|++|++|||+++
T Consensus 136 -----------gDc~tllk~~g~-----lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGP-----LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred -----------chhhhhcccCCC-----Ccc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhh
Confidence 565555554322 111 23789999999999999999999999999999999999986
Q ss_pred cCCCCc--------------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 244 DKYPGD--------------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 244 ~~~~~~--------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
...... ......++||+.|.|||++.... |+..+|||++|+|+||.+- |..||.+.++
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-------ygkpvdwwamGiIlyeFLV-gcvpffGdtp 263 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-------YGKPVDWWAMGIILYEFLV-GCVPFFGDTP 263 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-------cCCCccHHHHHHHHHHHhe-eeeeccCCCH
Confidence 432211 11223468999999999998776 8999999999999999996 9999999999
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCccccc
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRVK 350 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~~ 350 (394)
.+++..++.....-+......++++++++.++|..+|..|.
T Consensus 264 eelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 264 EELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 99998887765444455667899999999999999997443
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=175.75 Aligned_cols=240 Identities=16% Similarity=0.194 Sum_probs=177.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAAC 159 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 159 (394)
.+..-.|.+.++||+|+||+.++|+.- -.+..||||.-........ +..|...++.| ..+.|...|-+-
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl-------~nne~VAIKfEPrkS~APQ---LrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNL-------YNNEPVAIKFEPRKSEAPQ---LRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred eEecccceeccccccCcceeeeccccc-------ccCceEEEEeccccCCcch---HHHHHHHHHHHcCCCCCCceeeec
Confidence 455778999999999999999999876 3456899997654432221 34577777766 568888888777
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-----eE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-----RV 234 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-----~v 234 (394)
..+.+-.||||++ |.+|.|+..-.+ ..++...+.-++.|++.-++|+|++..|.|||||+|.||...+ .+
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceE
Confidence 7777788999998 668888774332 2367777888999999999999999999999999999997643 58
Q ss_pred EEccCCCCccCCCCc------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 235 KIGDTGSSIDKYPGD------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
-|+|||+|+...+.. +.-.....||.+||+--.-.+.. -+.+-|+=|||-+++..+. |..||.+..
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-------QSRRDDLEaLGHvFmYFLR-GsLPWQGLK 240 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-------QSRRDDLEALGHVFMYFLR-GSLPWQGLK 240 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-------hhhhhhHHHhhhhhhhhcc-CCCcccccc
Confidence 899999997654332 22234568999999987766655 4678899999999888885 999999976
Q ss_pred H---HHHHHHHhcCCCcCCCC----CCCCChHHHHHHHhhhcCC
Q psy7505 309 D---DQVITRVFGTEALRLPA----PRAVNSHVDVAARNCLVTS 345 (394)
Q Consensus 309 ~---~~~~~~i~~~~~~~~~~----p~~~~~~~~~l~~~cl~~~ 345 (394)
. .+-.++|-.. .+... ..++|.++..-|+-.=..+
T Consensus 241 A~tnK~kYeKIGe~--Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~ 282 (449)
T KOG1165|consen 241 ADTNKEKYEKIGET--KRSTPIEVLCEGFPEEFATYLRYVRRLD 282 (449)
T ss_pred CcchHHHHHHhccc--cccCCHHHHHhcCHHHHHHHHHHHHhcC
Confidence 3 4445555222 22221 2467777776666554333
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=172.31 Aligned_cols=139 Identities=17% Similarity=0.141 Sum_probs=105.2
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-------------------------HHHHHHHHHHHHHh
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-------------------------QAEKLFFLHEATPY 144 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-------------------------~~~~~~~~~E~~~l 144 (394)
...||+|+||.||+|++. ++..||||+++.... ......+.+|...+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 73 (190)
T cd05145 2 NGCISTGKEANVYHARTG--------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNL 73 (190)
T ss_pred CceeecCCCcEEEEEEcC--------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHH
Confidence 357999999999999864 245899998875421 01122345789999
Q ss_pred ccCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHH-HhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCC
Q psy7505 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEF-LLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVA 222 (394)
Q Consensus 145 ~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk 222 (394)
.++.|++|.....+... ..+|||||++++++... +... .++......++.|++.++.++|+ +||+|||||
T Consensus 74 ~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk 145 (190)
T cd05145 74 KRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS 145 (190)
T ss_pred HHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999987554444332 24899999998865443 3322 14555677899999999999999 999999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
|+|||++ ++.++|+|||++...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceec
Confidence 9999999 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=169.62 Aligned_cols=186 Identities=13% Similarity=0.041 Sum_probs=129.2
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH---HHHHHHHHHHHHhccC-CCcceeceeeEEEeCCc
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ---AEKLFFLHEATPYRRL-RHVNILRLMAACLESDP 164 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 164 (394)
....||+|+||+|+++... ..+++.+.+....-. .....+.+|+++|++| +|++|.+++++ +.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~---------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~ 72 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGG---------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG 72 (218)
T ss_pred cceeecCCCcceEEEeecC---------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence 3567999999999966542 235655555444321 1122467899999999 45889999886 44
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEcCCCeEEEccCCCCc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDV-AARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDl-k~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++|||+.|.+|.+.+... ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|.
T Consensus 73 ~~lvmeyI~G~~L~~~~~~~------------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPRG------------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred EEEEEeeecCccHHhhhhhh------------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 79999999999987644211 1236678999999999999999999 7999999999999999999997
Q ss_pred cCCCCce----ee--------eCCccCCcccccccccccCCCCcccCCCC-cchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 244 DKYPGDY----YV--------HGEVALPVRWCAPESLLCSDTSIQTCTVT-EKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 244 ~~~~~~~----~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~~~~-~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
....... .. ......++.|++|+.-.... ..+ ...++++.|+-+|.++| +..++.+
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~------~~~~~~~~w~~~g~~~~~~~~-~~~~~~~ 209 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK------RTSWIRELWFATGKPVYRFVT-RRVLHWE 209 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc------cchhHHHHHHHhcchHHHHHh-ccCCccc
Confidence 4332210 00 00112344566665432211 022 56788899999999999 7766544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=169.71 Aligned_cols=133 Identities=14% Similarity=0.165 Sum_probs=99.7
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-----CCcceeceeeEEEeCC--
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-----RHVNILRLMAACLESD-- 163 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~-- 163 (394)
+.||+|+||.||. +.. .. ..+||+........ ...+.+|+.+++.+ +||||++++|++.++.
T Consensus 8 ~~LG~G~~~~Vy~--hp~-------~~-~k~IKv~~~~~~~~-~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPE-------DA-QRCIKIVYHRGDGG-DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred ceecCCCceEEEE--CCC-------Cc-CeEEEEEeccccch-HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 5799999999995 331 22 23588776543222 23467999999999 6799999999998863
Q ss_pred -c-eEEEEee--CCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEEcCC----CeE
Q psy7505 164 -P-WLLVFES--CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL-SYMIEDGFIHTDVAARNCLVTSE----LRV 234 (394)
Q Consensus 164 -~-~~lv~E~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl-~yLH~~~iiHrDlk~~NiLl~~~----~~v 234 (394)
. +.+|||| +.+|+|.+++.+.. +++. ..++.|++.++ .|||+++|+||||||+|||++.. +.+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcE
Confidence 3 3478999 55899999996532 2332 24567888888 89999999999999999999743 479
Q ss_pred EEccCCCC
Q psy7505 235 KIGDTGSS 242 (394)
Q Consensus 235 Kl~DFG~a 242 (394)
+|+||+.+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995533
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.8e-21 Score=171.35 Aligned_cols=245 Identities=19% Similarity=0.276 Sum_probs=146.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCC----------cce
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRH----------VNI 152 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~H----------pnI 152 (394)
..+.....||.|+|+.||.+++. .++...++|+..... .....+.+.+|.-....+.+ -.+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~-------~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDV-------ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred eEEEEccccccCCceEEEEEEEc-------cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 35667788999999999999987 455678888764332 22223334444433333222 112
Q ss_pred eceeeEEE---------eCC--------ceEEEEeeCCCCCHHHHHhhcchh--hhhhhhHHHHHHHHHHHHHHHHHHHh
Q psy7505 153 LRLMAACL---------ESD--------PWLLVFESCSRGDLKEFLLSNEAS--REALLEQGITIKMAIDVATGLSYMIE 213 (394)
Q Consensus 153 v~l~~~~~---------~~~--------~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~gl~yLH~ 213 (394)
+.-++... ... ..+++|+-+. +||.+++..-... ....+.......+..|+++.+++||+
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22222221 111 2467888774 5998886531110 01123334455677899999999999
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCC-CCcccCCCCcchhHHHHHHH
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD-TSIQTCTVTEKCNVWSFGVL 292 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~~~~~~~DiwSlG~i 292 (394)
.|++|+|||++|++++.+|.+.|+||+..... +..+.. ...+..|.+||...... +......++.+.|.|+||++
T Consensus 164 ~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~--g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 164 YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRA--GTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TTEEEST-SGGGEEE-TTS-EEE--GGGEEET--TEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cceEecccceeeEEEcCCCCEEEcChHHHeec--Cceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999999999855332 232222 23346699999775431 11122347889999999999
Q ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcccc
Q psy7505 293 LWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRV 349 (394)
Q Consensus 293 l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~ 349 (394)
+|.|.+ |..||.......... ..+.....+|+.++.||+.+|+.+|.+|
T Consensus 240 ly~lWC-~~lPf~~~~~~~~~~-------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWC-GRLPFGLSSPEADPE-------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHH-SS-STCCCGGGSTSG-------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHH-ccCCCCCCCcccccc-------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999997 999998764322111 1233444889999999999999999743
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=195.82 Aligned_cols=250 Identities=20% Similarity=0.221 Sum_probs=170.9
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+++..+.||++.|=+|.+|+++. ..|+||+.-+.. -...... +.|++ ...++|||++.+..+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e---------G~vVvKVFvk~~p~~sL~~~~qr-L~~ik-~~l~~~pn~lPfqk~~~t 92 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE---------GLVVVKVFVKQDPTISLRPFKQR-LEEIK-FALMKAPNCLPFQKVLVT 92 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC---------ceEEEEEEeccCCCCCchHHHHH-HHHHH-HHhhcCCcccchHHHHHh
Confidence 68889999999999999998762 135566553332 2222222 35555 556699999999888777
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
..-.|||=+|... +|+|.|.... .+..-+..-|+.|++.||.-+|..||.|+|||.+||||++-.-+-|+||..
T Consensus 93 ~kAAylvRqyvkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 93 DKAAYLVRQYVKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hHHHHHHHHHHhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccc
Confidence 7778889899865 9999986432 245555667899999999999999999999999999999888899999985
Q ss_pred CccCCC-----Cc--eeeeCCccCCcccccccccccCC--CC-cccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 242 SIDKYP-----GD--YYVHGEVALPVRWCAPESLLCSD--TS-IQTCT-VTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 242 a~~~~~-----~~--~~~~~~~~~t~~y~aPE~l~~~~--~~-~~~~~-~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
-+..+. .+ ++..+... -..|+|||.+.... .+ ..... .+++.||||+||++.||++-|+++|.- .
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrR-RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---S 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRR-RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---S 242 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCc-eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---H
Confidence 432211 11 12222222 23599999987632 11 11112 678999999999999999989999852 1
Q ss_pred HHHHHHhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhh
Q psy7505 311 QVITRVFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSS 357 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~ 357 (394)
+++.. ..|...... ...--+..++.++..|++.+|. |-++.|.+..
T Consensus 243 QL~aY-r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 QLLAY-RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhH-hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111 111100000 0000123688999999999998 8899887544
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-20 Score=189.28 Aligned_cols=249 Identities=17% Similarity=0.166 Sum_probs=172.7
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC---Ccceec
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR---HVNILR 154 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~ 154 (394)
.++++..+.|.+.+.||+|+||+||+|.... +..||+|+-+....+..- -=.+++.+|+ -+.|..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~--------~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN--------GKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC--------CcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHH
Confidence 3556677889999999999999999998762 558999987765533211 0123333443 234666
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC----
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---- 230 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---- 230 (394)
+..+..-.+.-+||+||.+.|+|.+++...+ ..++..++.++.|++.-+..||..+|||+||||+|.||..
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 6666666777899999999999999997443 3678888999999999999999999999999999999953
Q ss_pred ---CCeEEEccCCCCccCC--CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q psy7505 231 ---ELRVKIGDTGSSIDKY--PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305 (394)
Q Consensus 231 ---~~~vKl~DFG~a~~~~--~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~ 305 (394)
...++|+|||.|..+. .... .-....+|-.+-.+|+..+.. ++..+|-|.|.-+++-|+- |+.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~-~F~~~~~td~f~C~EM~~grp-------WtYq~DyfGlAa~~h~mLF-G~y--- 901 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGT-KFKAVWHTDLFDCIEMREGRP-------WTYQIDYFGLAATVHVMLF-GKY--- 901 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCc-EEeeeeccccchhHHHhcCCC-------CchhhhhHHHHHHHHHHHH-HHH---
Confidence 2359999999886542 1211 112345566688899876654 8999999999999999994 862
Q ss_pred CCCHHHHHHHHhcCCCcCCC--CCCCCChH-HHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 306 ELSDDQVITRVFGTEALRLP--APRAVNSH-VDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 306 ~~~~~~~~~~i~~~~~~~~~--~p~~~~~~-~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
++ +.+|...... +++....+ +.++...+|..+-. -|.+.++...+.+...
T Consensus 902 -------~q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 902 -------ME-VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -------HH-hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 12 3344321111 23333333 44677777773321 4556666555555443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.4e-20 Score=163.72 Aligned_cols=145 Identities=18% Similarity=0.148 Sum_probs=106.1
Q ss_pred CCeEEEceeeeecceEEEEEE-EcCcccccCcccceEEEEeeccccc-----------------------HHHHHHHHHH
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGE-ARGLEESTGRTTSKVFVRILKEDAS-----------------------QAEKLFFLHE 140 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~~~~~~~~~vavk~~~~~~~-----------------------~~~~~~~~~E 140 (394)
..|.+.+.||+|+||.||+|. .. ..+..||+|+.+.... ......+.+|
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~-------~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFD-------GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecC-------CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 357788899999999999998 32 2355899998864321 0112335689
Q ss_pred HHHhccCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC-ceec
Q psy7505 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG-FIHT 219 (394)
Q Consensus 141 ~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-iiHr 219 (394)
+.+++++.+. ++.+...+.. ...+|||||+++++|......... ........++.|++.++.+||++| |+||
T Consensus 101 ~~~L~~L~~~-~i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 101 FRNLQRLYEA-GVPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKDVE-----PEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHHHHHHHhc-CCCCCeeeEe-cCceEEEEEecCCcccccccccCC-----cchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 9999999753 3333333322 235899999999888765432211 233445678999999999999999 9999
Q ss_pred CCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 220 DVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 220 Dlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
||||+||+++ ++.++|+|||.+..
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999999999 88999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=157.96 Aligned_cols=135 Identities=17% Similarity=0.198 Sum_probs=109.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-------HHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-------QAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
+.||+|++|.||+|.+. +..+++|....... ......+.+|+.++..+.|++|.....++.+.+
T Consensus 2 ~~l~~G~~~~vy~~~~~---------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL---------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEeeC---------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence 56999999999999864 22677886543221 112234568999999999999888777777778
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..+++|||++|++|.+++.... . ....++.+++.+|.++|+.+++|+|++|.|||++ ++.++|+|||.+.
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 8999999999999999885431 1 4567888999999999999999999999999999 7889999999875
Q ss_pred c
Q psy7505 244 D 244 (394)
Q Consensus 244 ~ 244 (394)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=156.26 Aligned_cols=131 Identities=15% Similarity=0.161 Sum_probs=103.6
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
.||+|+||.||+|.+. ...+++|...... .......+.+|+.+++.+.|+++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~~---------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL---------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeecC---------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence 3899999999999854 2367788754321 11122445689999999998876665556666777
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CEEEEEEECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 899999999999998875421 0 5788999999999999999999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-19 Score=177.77 Aligned_cols=138 Identities=19% Similarity=0.181 Sum_probs=105.6
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEE-Eeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vav-k~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
...+.||+|+||.||+|.+.+.. ...++.+ |...... .......+.+|+.+++.++|++|+....++.+...
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~-----~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRD-----AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred CccceeccCCcEEEEEEeecCcc-----ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 45688999999999999876321 1011111 1111111 11223456789999999999999988888777778
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++++|.+++.. ...++.|++.+|.|||+.+++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~~-------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEG-------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHHH-------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8999999999999988741 23578899999999999999999999999999 577899999998854
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=150.14 Aligned_cols=136 Identities=15% Similarity=0.120 Sum_probs=102.2
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH---------------------HHHHHHHHHHHHhc
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ---------------------AEKLFFLHEATPYR 145 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~---------------------~~~~~~~~E~~~l~ 145 (394)
|.+.+.||+|+||.||+|... .+..|+||+....... .......+|..++.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 666788999999999999864 2447899976543200 01112457888888
Q ss_pred cCCCcc--eeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7505 146 RLRHVN--ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223 (394)
Q Consensus 146 ~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~ 223 (394)
.+.|.+ +...++ ....++||||+++++|...... .....++.+++.++.++|+.||+||||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCc
Confidence 887774 344433 2456899999999999765421 11235778999999999999999999999
Q ss_pred CCEEEcCCCeEEEccCCCCccC
Q psy7505 224 RNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
+||+++.++.++|+|||.+...
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-19 Score=168.88 Aligned_cols=172 Identities=17% Similarity=0.297 Sum_probs=127.0
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+||.|++|..++|.++|.......+ .+......++.|++.|+.| ++.+|||+||.||....+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~--~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEE--RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccc--cchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 58899999999999999975433222 3455677889999999999 999999999999999999999999999876
Q ss_pred cCCCCc-----eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 244 DKYPGD-----YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 244 ~~~~~~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
...... ....+...||.+||+||.|.+.. |+.++||||||++|+|++..-...+... ..+..+..
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-------y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~ 474 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-------YSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRD 474 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhh-------hhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhhc
Confidence 544333 22344568899999999998876 8999999999999999996222222211 12223333
Q ss_pred CCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 319 TEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 319 ~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
| .+| +-... ++-..++++++...|. ||++.++
T Consensus 475 g---~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 G---IIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred C---CCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 3 333 22232 3456899999999997 8855443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-19 Score=181.58 Aligned_cols=254 Identities=18% Similarity=0.248 Sum_probs=183.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCC-CcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLR-HVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 161 (394)
...|.+.+.||+|+|+.|-...... .....+++|.+.... ..........|..+-+.+. |.|++++++...+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSR------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcC------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 4556666779999999998776542 223345555544332 1111122234666666775 9999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHH-hhcchhhhhhhhHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCC-eEEEcc
Q psy7505 162 SDPWLLVFESCSRGDLKEFL-LSNEASREALLEQGITIKMAIDVATGLSYMI-EDGFIHTDVAARNCLVTSEL-RVKIGD 238 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH-~~~iiHrDlk~~NiLl~~~~-~vKl~D 238 (394)
.+..++++||..+|++...+ ...... ......-.++.|+..|+.|+| ..++.|||+||+|.+++..+ .+|++|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~----~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTG----TSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred CcccccccCcccccccccccccCCccC----CCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCC
Confidence 99999999999999999888 333201 233345678899999999999 99999999999999999999 999999
Q ss_pred CCCCccCCC--CceeeeCCccC-CcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Q psy7505 239 TGSSIDKYP--GDYYVHGEVAL-PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI-- 313 (394)
Q Consensus 239 FG~a~~~~~--~~~~~~~~~~~-t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~-- 313 (394)
||+|..... +........+| ++.|+|||...+..+ .....|+||.|+++.-+++ |..|+.........
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~------~~~~~d~~S~g~~l~~~~~-g~~p~~~~~~~~~~~~ 241 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY------RGPSVDVWSLGIVLSAMLT-GELPWDFPSRKDGRYS 241 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhh------cCCCccccccccccccccc-CCCCccccccccccce
Confidence 999865543 33333344567 889999999876432 5678999999999999998 99998765433321
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
..+.............++....+++.+++..+|. |.++.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 242 SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred eecccccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 1111111112444567888999999999998887 7777766
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.3e-17 Score=140.28 Aligned_cols=135 Identities=19% Similarity=0.184 Sum_probs=91.6
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH--HHH---------------------HHHHHHHHhcc
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--EKL---------------------FFLHEATPYRR 146 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~---------------------~~~~E~~~l~~ 146 (394)
.+.||+|+||.||+|... ....||||+.+...... ... ....|...+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 73 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKR 73 (187)
T ss_pred CcccccccceeEEEEECC--------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHH
Confidence 457999999999999865 23479999876533111 000 01245555555
Q ss_pred CCCcc--eeceeeEEEeCCceEEEEeeCCCCCHHH-HHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCC
Q psy7505 147 LRHVN--ILRLMAACLESDPWLLVFESCSRGDLKE-FLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVA 222 (394)
Q Consensus 147 l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk 222 (394)
+.+.. +.+.+++ ...++||||+++|++.. .+.... .. .....++.+++.++.++|. ++|+|||||
T Consensus 74 l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~ 142 (187)
T cd05119 74 LYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLVHGDLS 142 (187)
T ss_pred HHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCC
Confidence 53332 3333332 34689999999965432 121110 00 3456788999999999999 999999999
Q ss_pred CCCEEEcCCCeEEEccCCCCcc
Q psy7505 223 ARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
|+||+++ ++.++|+|||.+..
T Consensus 143 p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred hhhEEEE-CCcEEEEECccccc
Confidence 9999999 88999999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=140.75 Aligned_cols=134 Identities=16% Similarity=0.118 Sum_probs=96.9
Q ss_pred eee-eecceEEEEEEEcCcccccCcccceEEEEeecccc------------cHHHHHHHHHHHHHhccCCCcce--ecee
Q psy7505 92 EIG-RGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA------------SQAEKLFFLHEATPYRRLRHVNI--LRLM 156 (394)
Q Consensus 92 ~lG-~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~------------~~~~~~~~~~E~~~l~~l~HpnI--v~l~ 156 (394)
.|| .|+.|+||.+... ...+++|...... .......+.+|+.++.+|.|++| +..+
T Consensus 38 ~lg~~~g~gtv~~v~~~---------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl 108 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP---------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI 108 (239)
T ss_pred eeecCCCCccEEEEEeC---------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence 466 6777888777654 2256666554211 11223345689999999988875 6667
Q ss_pred eEEEeC-C---ceEEEEeeCCC-CCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 157 AACLES-D---PWLLVFESCSR-GDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 157 ~~~~~~-~---~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
++.... . ..++||||+++ ++|.+++.... ++. ..+.+++.+|.+||++||+||||||.|||++.+
T Consensus 109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~------l~~----~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 109 AARVVRHGLFYRADILIERIEGARDLVALLQEAP------LSE----EQWQAIGQLIARFHDAGVYHADLNAHNILLDPD 178 (239)
T ss_pred eeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC------CCH----HHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC
Confidence 664432 2 23599999997 69999886431 222 235689999999999999999999999999998
Q ss_pred CeEEEccCCCCcc
Q psy7505 232 LRVKIGDTGSSID 244 (394)
Q Consensus 232 ~~vKl~DFG~a~~ 244 (394)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.3e-16 Score=129.47 Aligned_cols=130 Identities=16% Similarity=0.074 Sum_probs=104.7
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC--cceeceeeEEEeCCceEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH--VNILRLMAACLESDPWLL 167 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~l 167 (394)
++.||+|.++.||++...+ ..+++|....... ...+.+|+..++.+.| .++.++++++...+..++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~---------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD---------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70 (155)
T ss_pred ceecccccccceEEEEecC---------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence 4679999999999998752 3688888765543 2345689999999976 588999988887788999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED---GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+|||+.++.+..+ +......++.+++.++.++|.. +++|+|++++|||++..+.+++.|||.+.
T Consensus 71 v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 71 LMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9999998877654 1112345677899999999984 79999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.6e-15 Score=141.23 Aligned_cols=253 Identities=18% Similarity=0.159 Sum_probs=172.3
Q ss_pred eecCCCeEEEceeee--ecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 81 QFPRQQLHYVKEIGR--GWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~--G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
++..+.+...+.+|. |.+|.||.+...+ ......+++|.-+.... ......-++|+.-.+++ .|+|.|+.+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTN-----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCc-----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccC
Confidence 455667777888999 9999999988732 13344666665332221 11111123677666666 699999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEEcCC-
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT----GLSYMIEDGFIHTDVAARNCLVTSE- 231 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~----gl~yLH~~~iiHrDlk~~NiLl~~~- 231 (394)
..+..++..++-+|+|. .+|..+...-... ++...++....+... |+.++|+.+++|-|+||+||++..+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~----~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNF----LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhccccc----CCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc
Confidence 99999999999999995 6888887654332 344555666677777 9999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceee----eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC-CCCCC
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYV----HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK-LPYAE 306 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~-~Pf~~ 306 (394)
...+++|||+......+.... ....-+...|++||++.+. ++.+.|++|+|.+..+... |. .|-.+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--------~~~~~di~sl~ev~l~~~l-~~~~~~~g 330 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--------ATFASDIFSLGEVILEAIL-GSHLPSVG 330 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--------cchHhhhcchhhhhHhhHh-hcccccCC
Confidence 789999999876554433211 1111344569999998654 6889999999999999886 54 33333
Q ss_pred CCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCccccchhhhh
Q psy7505 307 LSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRVKIGDTG 355 (394)
Q Consensus 307 ~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~r~~~~e~~ 355 (394)
... .+..+-.++ +........+..+...+..++..++.++-..+++
T Consensus 331 ~~~--~W~~~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~ 376 (524)
T KOG0601|consen 331 KNS--SWSQLRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQIL 376 (524)
T ss_pred CCC--Ccccccccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHH
Confidence 111 111111121 2333444556677778888888888844334443
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-15 Score=149.67 Aligned_cols=251 Identities=16% Similarity=0.150 Sum_probs=177.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
-+++.+.+-+-+|++|.++.+.-.+...........++-|+.+.+... .+.+-.++-..+||.+++..-.+....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s-----~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYES-----IRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccc-----cCCccCccccCCCCceecccCCCCCCC
Confidence 455666677788889988877654322111111112222222221111 123333333456788887766666677
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..+|+++|..+|+|...|+..+. .+......+...+..+++|||...++|||++|.|+|+..+|..+++|||+..
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccc
Confidence 89999999999999999987642 2333344566678899999999999999999999999999999999998331
Q ss_pred -cCCC-----------------------------CceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHH
Q psy7505 244 -DKYP-----------------------------GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293 (394)
Q Consensus 244 -~~~~-----------------------------~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il 293 (394)
.... +.........+|+.|.+||.+.+.. .+..+|+|++|+++
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-------hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-------HGSAADWWSSGVCL 1025 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-------CCCcchhhhhhhhh
Confidence 1100 0001122346788999999998876 57899999999999
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 294 WEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 294 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
+|.++ |..||......+++..+.++...-..-|...+.++++++...+..++. |-.+.
T Consensus 1026 ~e~l~-g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLT-GIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhc-CCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99998 999999999999998888775444445667888999999999999886 65543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.4e-14 Score=136.18 Aligned_cols=140 Identities=19% Similarity=0.203 Sum_probs=93.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHH------------------------------------
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK------------------------------------ 134 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~------------------------------------ 134 (394)
+.||+|++|.||+|+.++ +..||||+.+........
T Consensus 123 ~plasaSigQVh~A~l~~--------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l 194 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD--------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL 194 (437)
T ss_pred cceeeeehhheEEEEecC--------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence 469999999999999863 358999998754311100
Q ss_pred ---HHHHHHHHHhccC----CCcceeceeeEEE-eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHH
Q psy7505 135 ---LFFLHEATPYRRL----RHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206 (394)
Q Consensus 135 ---~~~~~E~~~l~~l----~HpnIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~ 206 (394)
..+.+|+..+.++ .|.+-|.+-.++. .....+|||||++|++|.++....... .. ...++.+++.
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~----~~---~~~ia~~~~~ 267 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG----LD---RKALAENLAR 267 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC----CC---HHHHHHHHHH
Confidence 0133455544444 2333333333332 234568999999999998876432110 11 1234445544
Q ss_pred -HHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 207 -GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 207 -gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
.+..+|..|++|+|++|.||+++.++.++++|||++...
T Consensus 268 ~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 268 SFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 467789999999999999999999999999999988654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=136.43 Aligned_cols=144 Identities=18% Similarity=0.210 Sum_probs=91.4
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH---------------------------------
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--------------------------------- 132 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--------------------------------- 132 (394)
+|+. +.||+|++|.||+|+.+. ++..||||+.+......
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~-------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKD-------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECC-------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 3444 679999999999999873 35589999997542110
Q ss_pred HHHH------HHHHHHHhccC----CCcceeceeeEEEe-CCceEEEEeeCCCCCHHHH--HhhcchhhhhhhhHHHHHH
Q psy7505 133 EKLF------FLHEATPYRRL----RHVNILRLMAACLE-SDPWLLVFESCSRGDLKEF--LLSNEASREALLEQGITIK 199 (394)
Q Consensus 133 ~~~~------~~~E~~~l~~l----~HpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~--l~~~~~~~~~~~~~~~~~~ 199 (394)
.... +.+|+..+.++ .+.+.|.+-.++.+ ....+|||||+.|+.|.++ +...+... ..+.......
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~-~~la~~~v~~ 271 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM-KLLAERGVEV 271 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH-HHHHHHHHHH
Confidence 0111 23344333333 23333333333322 3456799999999999874 33332211 1233334444
Q ss_pred HHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----eEEEccCCCCccC
Q psy7505 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL----RVKIGDTGSSIDK 245 (394)
Q Consensus 200 ~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~----~vKl~DFG~a~~~ 245 (394)
++.|+ ...|++|+|++|.||+++.+| .+++.|||+....
T Consensus 272 ~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 272 FFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 45554 458999999999999999888 9999999987544
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-13 Score=123.10 Aligned_cols=196 Identities=19% Similarity=0.197 Sum_probs=131.7
Q ss_pred HHhccCCCcceeceeeEEEeC-----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC--
Q psy7505 142 TPYRRLRHVNILRLMAACLES-----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-- 214 (394)
Q Consensus 142 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-- 214 (394)
.-+-++.|.|||+++.|+.+. .+..++.|||..|+|.+||++....... +....+.+++.||+.||.|||+.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a-~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKA-LFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhh-hhHHHHHHHHHHHHhhhhhhhccCC
Confidence 344556899999999998764 3578999999999999999886543333 56667788999999999999986
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCccCCC--Cceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHH
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP--GDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGV 291 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~--~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~ 291 (394)
-|+|+++..+-|++..+|.+||.--.....-.. ..... .....+-++|.+||.-.... .+.++|||+||+
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-------~~~a~dIy~fgm 270 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN-------TTGASDIYKFGM 270 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc-------cccchhhhhhhH
Confidence 599999999999999999999853221110000 00000 00113345788998643222 467899999999
Q ss_pred HHHHHHcCCCCC-CCCCC---HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 292 LLWEIFEFGKLP-YAELS---DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 292 il~el~t~g~~P-f~~~~---~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
...||.. +..- -.+.+ ..+-+..+.-+. . ...-..++++|+...|. ||++.+++
T Consensus 271 cAlemai-lEiq~tnseS~~~~ee~ia~~i~~l----e-----n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 271 CALEMAI-LEIQSTNSESKVEVEENIANVIIGL----E-----NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHHHH-heeccCCCcceeehhhhhhhheeec----c-----CccccCcCcccccCCCCCCcchhhhh
Confidence 9999986 6643 33322 122222222111 0 11223578889999997 88887764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=132.03 Aligned_cols=244 Identities=18% Similarity=0.198 Sum_probs=169.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccC-CCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRL-RHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 159 (394)
....+|.++..||.|.|+.|+.+..+. .....+++|.+.+.. ......+-+.|+.+...+ .|.++++++..+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRP------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecC------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 455678899999999999999887442 223467777766554 222222334666655555 688999998888
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEEcc
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGD 238 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl~D 238 (394)
......||-.|||.++++...+.- ...+++...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred cccccccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccc
Confidence 888888899999999988776622 1225666778899999999999999999999999999999886 7889999
Q ss_pred CCCCccCCCCceeeeCCccCCcccc-cccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWC-APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK-LPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~-aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~-~Pf~~~~~~~~~~~i 316 (394)
||....... ........-+++ ..|++.... .+..++|++|||..+.|.++ |. .+..+.. ...+
T Consensus 411 ~~~~t~~~~----~~~~~~~~~r~~p~~~~~~e~~------~~~~~~~~~sl~~~~~e~~~-~~~ls~~~~~----~~~i 475 (524)
T KOG0601|consen 411 FGCWTRLAF----SSGVFHHIDRLYPIAEILLEDY------PHLSKADIFSLGLSVDEAIT-GSPLSESGVQ----SLTI 475 (524)
T ss_pred cccccccce----ecccccccccccccchhhcccc------cccccccccccccccccccc-CcccCccccc----ceee
Confidence 997743211 111112223455 255554332 26789999999999999987 54 2332221 1223
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
..+ ..+........++.+.+.....++. ||.+.++
T Consensus 476 ~~~---~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 476 RSG---DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred ecc---cccCCCchHHhhhhhhhhhcCCccccchhhhhh
Confidence 334 3455555557888888888888888 5666554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-12 Score=110.21 Aligned_cols=127 Identities=17% Similarity=0.066 Sum_probs=90.9
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCccee-ceeeEEEeCCceEEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNIL-RLMAACLESDPWLLV 168 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv 168 (394)
++.|+.|.++.||+++.. ...+++|........ ...+.+|+.+++.+.+.+++ +++++. ....++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~---------~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---------NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEEC---------CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence 356899999999998864 336888887554321 11234788888887554544 444443 3345899
Q ss_pred EeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 169 FESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGF-----IHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 169 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~i-----iHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
|||++|.++.+.- . .. .....+++.+|..||+.++ +|+|+++.||+++ ++.++++|||.+.
T Consensus 70 ~e~i~G~~l~~~~----~-----~~----~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED----F-----SD----PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc----c-----cC----HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999998876430 0 01 1245688999999999885 9999999999999 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.3e-11 Score=117.10 Aligned_cols=162 Identities=20% Similarity=0.226 Sum_probs=113.8
Q ss_pred cceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHH
Q psy7505 117 TSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196 (394)
Q Consensus 117 ~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 196 (394)
...|.|...+.... .......+-++.|+.++||||+++++.+...+.+|||+|-+. -|..++.+.+ ...
T Consensus 37 ~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--------~~~ 105 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--------KEE 105 (690)
T ss_pred CCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--------HHH
Confidence 44566666555444 222234567788999999999999999999999999999874 6777776543 112
Q ss_pred HHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCc
Q psy7505 197 TIKMAIDVATGLSYMI-EDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSI 275 (394)
Q Consensus 197 ~~~~~~qi~~gl~yLH-~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~ 275 (394)
...-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++......... ......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~--- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE--- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc---
Confidence 2335679999999997 678999999999999999999999999866432211100 00000111256666542221
Q ss_pred ccCCCCcchhHHHHHHHHHHHHcCC
Q psy7505 276 QTCTVTEKCNVWSFGVLLWEIFEFG 300 (394)
Q Consensus 276 ~~~~~~~~~DiwSlG~il~el~t~g 300 (394)
-..|.|-|||++||++. |
T Consensus 182 ------~s~D~~~Lg~li~el~n-g 199 (690)
T KOG1243|consen 182 ------WSIDSWGLGCLIEELFN-G 199 (690)
T ss_pred ------cchhhhhHHHHHHHHhC-c
Confidence 24799999999999996 7
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.2e-11 Score=101.47 Aligned_cols=142 Identities=14% Similarity=0.172 Sum_probs=91.7
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------------------------cHHHHHHHHHHHHHhc
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------------------------SQAEKLFFLHEATPYR 145 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------------------------~~~~~~~~~~E~~~l~ 145 (394)
..||.|-=+.||.|....... .......+|||+.+... .........+|+..|+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~-~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 3 GCISTGKESVVLHANGGSNET-EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CccccCcceEEEEEecCcccc-cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 458999999999997542100 00123477888765321 0011112237888888
Q ss_pred cCCC--cceeceeeEEEeCCceEEEEeeCCCCCHHH-HHhhcchhhhhhhhHHHHHHHHHHHHHHHHHH-HhCCceecCC
Q psy7505 146 RLRH--VNILRLMAACLESDPWLLVFESCSRGDLKE-FLLSNEASREALLEQGITIKMAIDVATGLSYM-IEDGFIHTDV 221 (394)
Q Consensus 146 ~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yL-H~~~iiHrDl 221 (394)
++.. -++-..+++ ..-+|||||+.++.+.. .+++. . ++......+..+++.+|..| |..|+||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-~-----~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-K-----LNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-c-----cCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 8732 345555544 45689999997654422 22221 1 22233455678999999988 8999999999
Q ss_pred CCCCEEEcCCCeEEEccCCCCcc
Q psy7505 222 AARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 222 k~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
++.|||+. ++.+.|+|||.|..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCcee
Confidence 99999997 46799999997743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-10 Score=95.39 Aligned_cols=131 Identities=17% Similarity=0.128 Sum_probs=90.3
Q ss_pred eeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 92 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
.+++|+=+.++.+.+.+. .+++|.-.... ..-....-.+|+.++.+++--.|..-.=+..+.+.
T Consensus 3 ~i~~GAEa~i~~~~~~g~---------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~ 73 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL---------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN 73 (204)
T ss_pred hhhCCcceeEEeeeccCc---------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence 478899999998876531 34444322211 11222334579998888743333222233445667
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
..|+|||.+|-.|.++|.... ..++..+-.-+.-||..||+|+||.++||++..++ +-++|||++..
T Consensus 74 ~~I~me~I~G~~lkd~l~~~~------------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEAR------------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CEEEEEEeCChhHHHHHHhcc------------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 789999999988888886541 23455666677789999999999999999998766 89999999853
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.3e-10 Score=94.29 Aligned_cols=143 Identities=18% Similarity=0.172 Sum_probs=99.0
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEEEeec-----ccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-----EDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~-----~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.+..|-+|+-+.|+++.+.+ ...+||.-. ... ..-.+....+|+.++.++.--.|.--.=++.+
T Consensus 11 ~l~likQGAEArv~~~~~~G---------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG---------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeeccCC---------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence 34668899999999998874 233444322 111 12223345689998888754444333445566
Q ss_pred CCceEEEEeeCCC-CCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---eEEEc
Q psy7505 162 SDPWLLVFESCSR-GDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL---RVKIG 237 (394)
Q Consensus 162 ~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~---~vKl~ 237 (394)
...-.|+|||.+| -++.+|+....... ........++..|-.-+.-||.++|||+||..+||++..++ .+-++
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEE
Confidence 6777899999976 38899987753321 11222256778888889999999999999999999997765 35799
Q ss_pred cCCCCc
Q psy7505 238 DTGSSI 243 (394)
Q Consensus 238 DFG~a~ 243 (394)
|||++.
T Consensus 159 dfgls~ 164 (229)
T KOG3087|consen 159 DFGLSS 164 (229)
T ss_pred eecchh
Confidence 999874
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.3e-09 Score=99.27 Aligned_cols=216 Identities=14% Similarity=0.157 Sum_probs=143.5
Q ss_pred ceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe----CCceEEEEeeCC
Q psy7505 98 FGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE----SDPWLLVFESCS 173 (394)
Q Consensus 98 fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~E~~~ 173 (394)
-.+-|++... ..+..++.|.+..+......+ ...-++.++++.|+|||.+.++|.. +..+++|++|.+
T Consensus 289 ~~Ttyk~~s~-------~DG~~YvLkRlhg~r~~~~nk-~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 289 SITTYKATSN-------VDGNAYVLKRLHGDRDQSTNK-DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred cceeEeeeec-------cCCceeeeeeeccccccCccc-chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 3455766654 334467777773332211111 1245678899999999999999873 457899999988
Q ss_pred C-CCHHHHHhhcchhh----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 174 R-GDLKEFLLSNEASR----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 174 ~-g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+ ++|.++--...... ...+++..++.++.|+..||.++|+.|..-+-|.+.+||++.+.+++|+..|..
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 6 48887654432211 123567888999999999999999999999999999999999889999877754
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCCHHHH-HHHHhcCC
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK-LPYAELSDDQV-ITRVFGTE 320 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~-~Pf~~~~~~~~-~~~i~~~~ 320 (394)
-....+. . |.+... .+-|.=-||.++.-|.| |. .-+......+. +..|.
T Consensus 441 Dvl~~d~-------------~--~~le~~----------Qq~D~~~lG~ll~aLAt-~~~ns~~~d~~~~s~~~~I~--- 491 (655)
T KOG3741|consen 441 DVLQEDP-------------T--EPLESQ----------QQNDLRDLGLLLLALAT-GTENSNRTDSTQSSHLTRIT--- 491 (655)
T ss_pred eeecCCC-------------C--cchhHH----------hhhhHHHHHHHHHHHhh-cccccccccchHHHHHHHhh---
Confidence 3222111 0 222211 35688899999999998 63 33333333333 33332
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCccccchhhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSELRVKIGDTGSS 357 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~r~~~~e~~~~ 357 (394)
...+.++.+++.-+...+++..++.|++..
T Consensus 492 -------~~yS~D~rn~v~yl~s~~~~~ksI~~llp~ 521 (655)
T KOG3741|consen 492 -------TTYSTDLRNVVEYLESLNFREKSIQDLLPM 521 (655)
T ss_pred -------hhhhHHHHHHHHHHHhcCcccccHHHHHHH
Confidence 234567777777777777766666666543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.5e-10 Score=98.31 Aligned_cols=139 Identities=20% Similarity=0.184 Sum_probs=89.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC--cceeceeeEEEeC---Cce
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH--VNILRLMAACLES---DPW 165 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~---~~~ 165 (394)
+.||.|.++.||++...+ +..+++|.............+.+|+.+++.+.+ .++.+++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~~--------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEecC--------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 568999999999987642 236888886544321112235688999988865 3456677766543 267
Q ss_pred EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH---------------------------------
Q psy7505 166 LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI--------------------------------- 212 (394)
Q Consensus 166 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH--------------------------------- 212 (394)
++||||++|++|.+.+.... ++......++.+++.+|..||
T Consensus 76 ~~v~e~i~G~~l~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 76 FYVMERVDGRVLRDRLLRPE------LSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred eEEEEEeCCEecCCCCCCCC------CCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 89999999988766442000 111112222233333333332
Q ss_pred -----------------------hCCceecCCCCCCEEEcC--CCeEEEccCCCCc
Q psy7505 213 -----------------------EDGFIHTDVAARNCLVTS--ELRVKIGDTGSSI 243 (394)
Q Consensus 213 -----------------------~~~iiHrDlk~~NiLl~~--~~~vKl~DFG~a~ 243 (394)
...++|+|+.+.|||++. ++.+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235799999999999998 6678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.8e-08 Score=88.95 Aligned_cols=104 Identities=16% Similarity=0.140 Sum_probs=72.5
Q ss_pred HHHHHHHhccCCCcc--eeceeeEEEe-----CCceEEEEeeCCCC-CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHH
Q psy7505 137 FLHEATPYRRLRHVN--ILRLMAACLE-----SDPWLLVFESCSRG-DLKEFLLSNEASREALLEQGITIKMAIDVATGL 208 (394)
Q Consensus 137 ~~~E~~~l~~l~Hpn--Iv~l~~~~~~-----~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl 208 (394)
+.+|...+.+|..-+ +....++... ...-+||||++++- +|.+++...... .........++.+++..+
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~---~~~~~~~~~ll~~la~~i 151 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN---PPDPRLKRMLIKRVATMV 151 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc---CCCHHHHHHHHHHHHHHH
Confidence 346766666552222 2333344432 23468999999876 799988542111 123344557888999999
Q ss_pred HHHHhCCceecCCCCCCEEEcC-------CCeEEEccCCCCc
Q psy7505 209 SYMIEDGFIHTDVAARNCLVTS-------ELRVKIGDTGSSI 243 (394)
Q Consensus 209 ~yLH~~~iiHrDlk~~NiLl~~-------~~~vKl~DFG~a~ 243 (394)
.-||..||+|+||++.|||++. ++.+.++||+.+.
T Consensus 152 ~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 152 RDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999999975 4679999999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.3e-08 Score=85.95 Aligned_cols=98 Identities=19% Similarity=0.228 Sum_probs=61.5
Q ss_pred HHHHHHHHHhccCCCc--ceeceeeEEEeCCceEEEEeeCC--CCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHH
Q psy7505 135 LFFLHEATPYRRLRHV--NILRLMAACLESDPWLLVFESCS--RGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210 (394)
Q Consensus 135 ~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~y 210 (394)
....+|...|.++..- ++-+.+++. .-+|||||++ |..+.. |.... +.......++.+++..+..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~------~~~~~~~~~~~~il~~~~~ 121 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD------LSPEEPKELLEEILEEIIK 121 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG------GGGSTHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc------ccchhHHHHHHHHHHHHHH
Confidence 3456899999998655 455555442 3479999998 544543 32221 1111233466677776655
Q ss_pred -HHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 211 -MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 211 -LH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+|..||+|+||.+.|||++.+ .+.|+|||.+..
T Consensus 122 ~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 122 MLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 579999999999999999987 899999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.2e-09 Score=103.74 Aligned_cols=146 Identities=18% Similarity=0.188 Sum_probs=100.8
Q ss_pred HHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeee-----C---CccCCcccccccccccCC
Q psy7505 202 IDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-----G---EVALPVRWCAPESLLCSD 272 (394)
Q Consensus 202 ~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~-----~---~~~~t~~y~aPE~l~~~~ 272 (394)
.+++.|+.|+|. .++||++|.|++|.++.++..||+.|+.+........+-. . -..-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 346699999996 4899999999999999999999999997754332111100 0 011235699999987743
Q ss_pred CCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 273 TSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR-VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 273 ~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
.+.++|++|+||++|-+...|+.-+........... ...+.....-....+++++.+-+.+++..++. ||+
T Consensus 186 -------~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 186 -------NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred -------ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 678999999999999998536555544322221111 11122223344578999999999999999987 996
Q ss_pred hhhh
Q psy7505 351 IGDT 354 (394)
Q Consensus 351 ~~e~ 354 (394)
+..+
T Consensus 259 ~~~l 262 (700)
T KOG2137|consen 259 LDLL 262 (700)
T ss_pred hhhh
Confidence 5443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-07 Score=82.11 Aligned_cols=101 Identities=21% Similarity=0.199 Sum_probs=73.0
Q ss_pred HHHHHHhccCC--CcceeceeeEEEeC----CceEEEEeeCCCC-CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHH
Q psy7505 138 LHEATPYRRLR--HVNILRLMAACLES----DPWLLVFESCSRG-DLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210 (394)
Q Consensus 138 ~~E~~~l~~l~--HpnIv~l~~~~~~~----~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~y 210 (394)
.+|...+..|. .=.+.+.+++.... ...+||+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 59 ~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 59 KREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARLIAK 133 (206)
T ss_pred HHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHHHHH
Confidence 45666555552 22244445555432 2358999999874 79999875321 2233455678899999999
Q ss_pred HHhCCceecCCCCCCEEEcCCC---eEEEccCCCCc
Q psy7505 211 MIEDGFIHTDVAARNCLVTSEL---RVKIGDTGSSI 243 (394)
Q Consensus 211 LH~~~iiHrDlk~~NiLl~~~~---~vKl~DFG~a~ 243 (394)
||++||+|+|+++.|||++.++ .+.++||+.++
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 9999999999999999999887 79999999664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.2e-07 Score=85.83 Aligned_cols=193 Identities=15% Similarity=0.162 Sum_probs=126.7
Q ss_pred eEEEEeeCCCC-CHHHHHhhc-chhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 165 WLLVFESCSRG-DLKEFLLSN-EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 165 ~~lv~E~~~~g-~L~~~l~~~-~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+.|..+++- -+..++.-. +...-....|...++.++.++.+..-||+.|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 66788877664 233333211 1111223678889999999999999999999999999999999999999998864321
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHH
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-------DDQVITR 315 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-------~~~~~~~ 315 (394)
.....+..+ ....|...|.+||.-.-.. +.+..-+...|-|.||+++++++-.|+-||++.. +.| ..
T Consensus 165 qi~~ng~~~--~cpVg~~eftPPElQ~~~s--f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 165 QINANGTLH--LCPVGVSEFTPPELQTLPS--FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eeccCCceE--ecccCccccCCHHHhcccc--ccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 111222221 2335667899999754211 2222346789999999999999865699998863 111 11
Q ss_pred HhcC--------CCcCCCCCC-----CCChHHHHHHHhhhcCC--cc-ccchhhhhhhhhcCCC
Q psy7505 316 VFGT--------EALRLPAPR-----AVNSHVDVAARNCLVTS--EL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 316 i~~~--------~~~~~~~p~-----~~~~~~~~l~~~cl~~~--p~-r~~~~e~~~~l~~~~~ 363 (394)
|..| .....|.|. .+++.++.+..+|+... +. ||+...-+..|.++..
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111 111233332 56789999999999876 44 9998766666655543
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-08 Score=99.71 Aligned_cols=200 Identities=14% Similarity=0.050 Sum_probs=134.3
Q ss_pred cccCCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc
Q psy7505 72 QNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151 (394)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 151 (394)
.+.+++...+-+..-+...+..++|+++++++.+... +. ....+.+... . ...-++++|.+++|||
T Consensus 229 kS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpta-------ek-lL~h~fvs~~----l--~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 229 KSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTA-------EK-LLQHPFVSQT----L--SRRLAIELLDKVNNPN 294 (829)
T ss_pred ccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCCh-------hh-heeceeeccc----h--hhHHHHHHHHHccCCC
Confidence 3444554444455556667889999999999776431 11 1113332221 1 1235788999999999
Q ss_pred -eeceeeEEEeCCceEEEEeeCCCC-CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 152 -ILRLMAACLESDPWLLVFESCSRG-DLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 152 -Iv~l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
.+..++-+..+...+++|+++.+| +...-. ...+..+.+-......+.-.++++|+|+.--+||| |||..
T Consensus 295 ~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~----~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s 366 (829)
T KOG0576|consen 295 PVVRYLEDYDGEDYLWIPMRICSTGRSSALEM----TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS 366 (829)
T ss_pred CcccccccCCcccccchhhhhhcCCccccccC----ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc
Confidence 788888777778899999999887 222111 01111133333344555667899999998778999 77766
Q ss_pred CCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
+ +..|..||+......... ......++..|+|||+...+. +....|.||+|+-..+|.. |..|-
T Consensus 367 ~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~-------~~~~p~~~~~~~~~~~~ap-~~pPr 430 (829)
T KOG0576|consen 367 E-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENT-------IDGCPDSGSLAVSAIQMAP-GLPPR 430 (829)
T ss_pred c-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccc-------cccCCCccCCCcchhhcCC-CCCCC
Confidence 5 669999999875443322 345567889999999987766 7788999999987777764 66553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=75.50 Aligned_cols=140 Identities=16% Similarity=0.116 Sum_probs=91.9
Q ss_pred eeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-----HHHHHHHHHHHHHhccCCCcc--eeceeeEEEe----
Q psy7505 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-----QAEKLFFLHEATPYRRLRHVN--ILRLMAACLE---- 161 (394)
Q Consensus 93 lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~---- 161 (394)
-|+||-+-|+.-...+ ..+.+|.-..... ..-...|.+|...+.+|..-+ +.+.......
T Consensus 26 ~~rgG~SgV~r~~~~g---------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~ 96 (216)
T PRK09902 26 YRRNGMSGVQCVERNG---------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEG 96 (216)
T ss_pred cCCCCcceEEEEEeCC---------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCC
Confidence 3668888888766542 1466775542110 011223568888888774322 3333311111
Q ss_pred CCceEEEEeeCCC-CCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe--EEEcc
Q psy7505 162 SDPWLLVFESCSR-GDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--VKIGD 238 (394)
Q Consensus 162 ~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~--vKl~D 238 (394)
.-.-+||+|-+.+ -||.+++.+....+ .+......++.+++..+.-||+.|+.|+|+-+.|||++..|. ++++|
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~---~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAVSP---YSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCcCC---cchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEE
Confidence 1236899997764 48999886542211 244445678889999999999999999999999999986666 99999
Q ss_pred CCCCcc
Q psy7505 239 TGSSID 244 (394)
Q Consensus 239 FG~a~~ 244 (394)
|--++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 986643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.7e-07 Score=78.86 Aligned_cols=132 Identities=19% Similarity=0.140 Sum_probs=88.2
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------------------c--HHHHHHHHHHHHHhccC
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------------------S--QAEKLFFLHEATPYRRL 147 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------------------~--~~~~~~~~~E~~~l~~l 147 (394)
+...||-|-=+.||.|... .+.++++|.=+... + ........+|.+.|.+|
T Consensus 95 iG~~IGvGKEsdVY~~~~~--------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP--------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred hccccccCccceEEEEECC--------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 5678999999999999875 34478887544221 1 11112235788888888
Q ss_pred CCc--ceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7505 148 RHV--NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARN 225 (394)
Q Consensus 148 ~Hp--nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~N 225 (394)
.-. .|.+-+++ +.-.+||||..|-.|...=.. ....-.++..|+.-+.-+-..||||+|+..=|
T Consensus 167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~----------~en~~~il~~il~~~~~~~~~GiVHGDlSefN 232 (304)
T COG0478 167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLD----------VENPDEILDKILEEVRKAYRRGIVHGDLSEFN 232 (304)
T ss_pred hhcCCCCCCcccc----ccceeeeehcccceeecccCc----------ccCHHHHHHHHHHHHHHHHHcCccccCCchhe
Confidence 543 45555544 567899999998666643211 11111233344444444448899999999999
Q ss_pred EEEcCCCeEEEccCCCC
Q psy7505 226 CLVTSELRVKIGDTGSS 242 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a 242 (394)
|+++.+|.+.++||--+
T Consensus 233 IlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 233 ILVTEDGDIVVIDWPQA 249 (304)
T ss_pred EEEecCCCEEEEeCccc
Confidence 99999999999999744
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.8e-06 Score=83.98 Aligned_cols=139 Identities=19% Similarity=0.195 Sum_probs=88.9
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHH-------------------------------------
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE------------------------------------- 133 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~------------------------------------- 133 (394)
+-|+.++-|.||+|+++. +..||||+.+.+-....
T Consensus 131 ~PiAsASIaQVH~A~L~s--------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred CchhhhhHhhheeEEecC--------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 458999999999999984 55899999876432110
Q ss_pred --HHHHHHHHHHhccC----CCcceeceeeEEE-eCCceEEEEeeCCCCCHHHH--HhhcchhhhhhhhHHHHHHHHHHH
Q psy7505 134 --KLFFLHEATPYRRL----RHVNILRLMAACL-ESDPWLLVFESCSRGDLKEF--LLSNEASREALLEQGITIKMAIDV 204 (394)
Q Consensus 134 --~~~~~~E~~~l~~l----~HpnIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~--l~~~~~~~~~~~~~~~~~~~~~qi 204 (394)
+-.+.+|+.-+.++ +...=|++-.++. -.+.-.|+|||+.|-.+.++ ++..+.... .+.......++.
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k-~ia~~~~~~f~~-- 279 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK-ELAELLVRAFLR-- 279 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH-HHHHHHHHHHHH--
Confidence 01133455544443 2222233333332 24566899999999888877 444333211 122222222222
Q ss_pred HHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 205 ~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
-+-..|++|.|.-|-||+++.+|.+-+.|||+....
T Consensus 280 -----q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 280 -----QLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -----HHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 234479999999999999999999999999987544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.4e-05 Score=69.69 Aligned_cols=137 Identities=16% Similarity=0.212 Sum_probs=84.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHH--------HHHHHHHhccC---CCcce
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--------FLHEATPYRRL---RHVNI 152 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~--------~~~E~~~l~~l---~HpnI 152 (394)
..+|...+.+-......|.+-... +...++|..+......++.+ ..+++..+.++ .--..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~---------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID---------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC---------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 466777777776666667655543 34677777665442222211 12233322222 22233
Q ss_pred eceeeEEEe-----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 153 LRLMAACLE-----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 153 v~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
+.++.+... ....+|+|||++|..|.++.. +++ .+...+..++.-||+.|+.|+|..|.|++
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 333333322 234578999999988866532 111 13345667889999999999999999999
Q ss_pred EcCCCeEEEccCCCCc
Q psy7505 228 VTSELRVKIGDTGSSI 243 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~ 243 (394)
++.++ +++.||+..+
T Consensus 168 v~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKR 182 (229)
T ss_pred EECCc-EEEEECcccc
Confidence 98655 9999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=71.99 Aligned_cols=137 Identities=12% Similarity=0.150 Sum_probs=78.5
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc--eeceeeEEEeCCceEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN--ILRLMAACLESDPWLLV 168 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv 168 (394)
..||+|..+.||+.. ....++|.......... ..+|.++++.+..-. +.+.+++....+...+|
T Consensus 7 ~~i~~G~t~~~y~~~-----------~~~~VlR~~~~~~~~~~---i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-----------TGKWMLKLYNPGFDKET---IKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEec-----------CCCEEEEeCCCCCCHHH---HHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence 468999999999732 11455677654332222 357888888775332 45667777777788999
Q ss_pred EeeCCCCC-HHHHHhhcc------------------hh--hhhhhhHHHHHHHHH----------HHHH-HHHHHH----
Q psy7505 169 FESCSRGD-LKEFLLSNE------------------AS--REALLEQGITIKMAI----------DVAT-GLSYMI---- 212 (394)
Q Consensus 169 ~E~~~~g~-L~~~l~~~~------------------~~--~~~~~~~~~~~~~~~----------qi~~-gl~yLH---- 212 (394)
||+++|.+ +...+.... .. ....+.. ....+.. .+.. ...+|.
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 99998863 222221100 00 0000000 0000000 0111 112222
Q ss_pred hCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 213 ~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
...++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 12578999999999999888 9999999663
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.1e-05 Score=65.72 Aligned_cols=131 Identities=18% Similarity=0.191 Sum_probs=87.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCccee-ceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNIL-RLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~ 163 (394)
......+.||+|.+|.||+|.+++ ..+|+|+-+.+.... .+..|++++..+.--++- +++.+ +
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~---------~~~a~Kvrr~ds~r~---~l~kEakiLeil~g~~~~p~vy~y----g 85 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRG---------GEVALKVRRRDSPRR---NLEKEAKILEILAGEGVTPEVYFY----G 85 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccC---------ceEEEEEecCCcchh---hHHHHHHHHHHhhhcCCCceEEEe----c
Confidence 334456789999999999999984 268888876665332 356888888887655543 33333 2
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCCEEEcCCCeEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVA-ARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk-~~NiLl~~~~~vKl~DFG~a 242 (394)
.-++.|||..|-.|.+.-... +. .-...++..-.-|-..||-|..|. |...+|..++.+-|+||-.|
T Consensus 86 ~~~i~me~i~G~~L~~~~~~~--------~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 86 EDFIRMEYIDGRPLGKLEIGG--------DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhhhhhhhhcCcchhhhhhcc--------cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccch
Confidence 334669999988887654321 11 122335555445667799999875 44455555558999999977
Q ss_pred c
Q psy7505 243 I 243 (394)
Q Consensus 243 ~ 243 (394)
.
T Consensus 154 t 154 (201)
T COG2112 154 T 154 (201)
T ss_pred h
Confidence 5
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.5e-05 Score=64.18 Aligned_cols=131 Identities=16% Similarity=0.213 Sum_probs=85.5
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---------------cHHHHHHHHHHHHHhccC------CC
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---------------SQAEKLFFLHEATPYRRL------RH 149 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---------------~~~~~~~~~~E~~~l~~l------~H 149 (394)
..||+|+.-.||.--. .....||+..... .........+|+.-...+ .+
T Consensus 7 ~~i~~G~~R~cy~HP~----------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~ 76 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD----------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW 76 (199)
T ss_pred cccccCCCceEEECCC----------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence 4599999999994321 2245577776554 000112233555544444 48
Q ss_pred cceeceeeEEEeCCceEEEEeeCC------CCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7505 150 VNILRLMAACLESDPWLLVFESCS------RGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223 (394)
Q Consensus 150 pnIv~l~~~~~~~~~~~lv~E~~~------~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~ 223 (394)
.+|.+++|+.+++--..+|+|... .-+|.+++.+.. ++. .+...+-.-..||-+.+|+.+||+|
T Consensus 77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~ 146 (199)
T PF10707_consen 77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE----ELRQALDEFKRYLLDHHIVIRDLNP 146 (199)
T ss_pred cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH----HHHHHHHHHHHHHHHcCCeecCCCc
Confidence 899999999999888999999753 236888886543 222 1222233344688999999999999
Q ss_pred CCEEEcCCC----eEEEcc-CCC
Q psy7505 224 RNCLVTSEL----RVKIGD-TGS 241 (394)
Q Consensus 224 ~NiLl~~~~----~vKl~D-FG~ 241 (394)
.||++.... .+.|+| ||-
T Consensus 147 ~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ccEEEEecCCCceEEEEEeCCCC
Confidence 999996432 577777 663
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.5e-05 Score=79.74 Aligned_cols=82 Identities=13% Similarity=0.124 Sum_probs=53.3
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-Ccce--eceeeEEEeC---C
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNI--LRLMAACLES---D 163 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~ 163 (394)
++.++.|.++.+|+...... .....+++|+............+.+|+.+|+.+. |.+| .+++++|.+. +
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-----~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-----GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-----CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 46789999999998776421 1112455665433221111224568999999985 6664 7777777654 4
Q ss_pred ceEEEEeeCCCCC
Q psy7505 164 PWLLVFESCSRGD 176 (394)
Q Consensus 164 ~~~lv~E~~~~g~ 176 (394)
..|+||||++|..
T Consensus 118 ~~flVME~v~G~~ 130 (822)
T PLN02876 118 TAFYIMEYLEGRI 130 (822)
T ss_pred CceEEEEecCCcc
Confidence 6789999998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00014 Score=62.78 Aligned_cols=127 Identities=18% Similarity=0.176 Sum_probs=88.1
Q ss_pred CCCeEEEceeeeecc-eEEEEEEEcCcccccCcccceEEEEeeccc-----------ccH---------HHHHHHHHHHH
Q psy7505 84 RQQLHYVKEIGRGWF-GKVVEGEARGLEESTGRTTSKVFVRILKED-----------ASQ---------AEKLFFLHEAT 142 (394)
Q Consensus 84 ~~~~~~~~~lG~G~f-g~V~~~~~~~~~~~~~~~~~~vavk~~~~~-----------~~~---------~~~~~~~~E~~ 142 (394)
..++++++.||.|.- |.||+++.. +..+|+|+.+.- ... ....-|..|..
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~---------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECR 106 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID---------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECR 106 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC---------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHH
Confidence 378899999999999 999999876 337889983220 000 11123557777
Q ss_pred HhccC---CCcce--eceeeEEEeC------------------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHH
Q psy7505 143 PYRRL---RHVNI--LRLMAACLES------------------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199 (394)
Q Consensus 143 ~l~~l---~HpnI--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 199 (394)
...+| .+.++ |+.+||..-. ....||.||.+... . +. ..
T Consensus 107 AfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~-------~~----~~ 168 (207)
T PF13095_consen 107 AFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------P-------LQ----IR 168 (207)
T ss_pred hhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------c-------cc----hh
Confidence 66666 45556 9999998422 12467888876643 0 11 12
Q ss_pred HHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 200 ~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
-+.++.+-|..+|..||+-+|+++.|.. .-||+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 3456778888999999999999999986 3588999954
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.5e-05 Score=66.50 Aligned_cols=95 Identities=21% Similarity=0.179 Sum_probs=74.3
Q ss_pred HHHHHhccCCC-cceeceeeEEEeCCceEEEEeeCCCCCHHHH---HhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-
Q psy7505 139 HEATPYRRLRH-VNILRLMAACLESDPWLLVFESCSRGDLKEF---LLSNEASREALLEQGITIKMAIDVATGLSYMIE- 213 (394)
Q Consensus 139 ~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~- 213 (394)
.|.-+|+.+.+ +++.+++|+|- + ++|.||...+++... +... ...+|..+..++.+++..+.+++.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~-----~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQF-----LQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccc-----cccCHHHHHHHHHHHHHHHHHHhcC
Confidence 57777888865 69999999993 2 578899987766421 1110 014677888999999999999977
Q ss_pred --CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 --DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 --~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..+.-.|++++|+-++++|++|+.|....
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 45888999999999999999999999855
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00028 Score=62.76 Aligned_cols=78 Identities=14% Similarity=0.187 Sum_probs=51.4
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCc--ceeceeeEEEe---CCc
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV--NILRLMAACLE---SDP 164 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~~~ 164 (394)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ...
T Consensus 2 i~~l~~G~~n~~~~v~~~~---------~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD---------GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEETT---------SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEECC---------cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 4679999999999988652 37888886554 2223345777777777322 34566654432 334
Q ss_pred eEEEEeeCCCCCHHH
Q psy7505 165 WLLVFESCSRGDLKE 179 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~ 179 (394)
.+++|++++|..+..
T Consensus 70 ~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEESSEEHHH
T ss_pred ceEEEEEeccccccc
Confidence 789999999988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00021 Score=63.25 Aligned_cols=135 Identities=21% Similarity=0.136 Sum_probs=84.4
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-----------------------HHHHHHHHHHHHhccC
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-----------------------AEKLFFLHEATPYRRL 147 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-----------------------~~~~~~~~E~~~l~~l 147 (394)
-.|+.|--+.||+|... ....+|+|+.+..... ....+..+|..-|+++
T Consensus 54 g~istGKEA~Vy~a~~~--------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~ 125 (268)
T COG1718 54 GCISTGKEANVYLAETG--------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRA 125 (268)
T ss_pred eeecCCcceEEEeeccC--------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 35777888889998753 2447899988754321 1112234566655555
Q ss_pred C--CcceeceeeEEEeCCceEEEEeeCCCC-CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCC
Q psy7505 148 R--HVNILRLMAACLESDPWLLVFESCSRG-DLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAA 223 (394)
Q Consensus 148 ~--HpnIv~l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~ 223 (394)
. +-.+-+-+++. .-.|||||+... .-.-.|++.. +.......+..+++.+|.-|-. .++||+||..
T Consensus 126 ~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~------~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 126 YEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP------LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred HHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC------cCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 2 22233333332 236999998653 1111121111 1122455667788888887765 8999999999
Q ss_pred CCEEEcCCCeEEEccCCCCcc
Q psy7505 224 RNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG~a~~ 244 (394)
=|||+. ++.+.|+|||-|..
T Consensus 196 yNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred hheEEE-CCeEEEEECccccc
Confidence 999999 88899999997643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00017 Score=65.01 Aligned_cols=75 Identities=11% Similarity=0.131 Sum_probs=47.1
Q ss_pred eeeecc-eEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeCCceEEEEe
Q psy7505 93 IGRGWF-GKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPWLLVFE 170 (394)
Q Consensus 93 lG~G~f-g~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E 170 (394)
|-.|.+ ..||+.... +..+++|...... ...+.+|+.+++.+. +--+.+++++...++..++|||
T Consensus 6 ~~~g~~~~~v~~~~~~---------~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDGK---------NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcCC---------CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence 344444 788877543 1257777765432 112346777777662 3345566777766667899999
Q ss_pred eCCCCCHHHH
Q psy7505 171 SCSRGDLKEF 180 (394)
Q Consensus 171 ~~~~g~L~~~ 180 (394)
+++|.+|...
T Consensus 73 ~i~G~~l~~~ 82 (244)
T cd05150 73 AVPGVPAAAL 82 (244)
T ss_pred eeCCccHhHh
Confidence 9998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.73 E-value=4.3e-06 Score=89.31 Aligned_cols=163 Identities=12% Similarity=0.025 Sum_probs=111.9
Q ss_pred HHHHHHHHHHHhccCCCcceeceeeEEEe--CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHH
Q psy7505 133 EKLFFLHEATPYRRLRHVNILRLMAACLE--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210 (394)
Q Consensus 133 ~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~y 210 (394)
.++..+.|....+...|++++..+.-... +...+..++|+.+|++++.|.+....... +....+.....+...+..-
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~-ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD-LDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc-chhchHHHHHHHHHhccch
Confidence 33444556666777899999887665543 34578999999999999998765332222 2222222222232555555
Q ss_pred HHhC-----CceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchh
Q psy7505 211 MIED-----GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCN 285 (394)
Q Consensus 211 LH~~-----~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~D 285 (394)
+|+. -.+|++||+-|.+|..+-.+|++++|+.+..... ....+...+++.|+.+++...-. ++.++|
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik-------~t~rsd 1422 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIK-------FTKRSD 1422 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHh-------hhhHHH
Confidence 5543 2789999999999999999999999998733222 22234456677899998865443 777799
Q ss_pred HHHHHHHHHHHHcCCCCCCC
Q psy7505 286 VWSFGVLLWEIFEFGKLPYA 305 (394)
Q Consensus 286 iwSlG~il~el~t~g~~Pf~ 305 (394)
+|..|+.+|+.-. |..+|-
T Consensus 1423 ilr~s~~ly~rs~-~n~~fi 1441 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSD-GNAYFI 1441 (2724)
T ss_pred HHHHHHHHHHHhc-ccHHHH
Confidence 9999999999875 776654
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00021 Score=70.70 Aligned_cols=136 Identities=16% Similarity=0.201 Sum_probs=84.2
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH------------------------------------HH
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA------------------------------------EK 134 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~------------------------------------~~ 134 (394)
+.||.-+.|.||+|+.++ +..||||+-+..-... .+
T Consensus 167 ~piaaASlaQVhrA~L~~--------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN--------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred chhhhcchhheEEEEecC--------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 468999999999999984 5589999877543211 00
Q ss_pred HHHHHHHHHhcc----CCCcc------eeceeeEEEeCCceEEEEeeCCCCCHHH--HHhhcchhhhhhhhHHHHHHHHH
Q psy7505 135 LFFLHEATPYRR----LRHVN------ILRLMAACLESDPWLLVFESCSRGDLKE--FLLSNEASREALLEQGITIKMAI 202 (394)
Q Consensus 135 ~~~~~E~~~l~~----l~Hpn------Iv~l~~~~~~~~~~~lv~E~~~~g~L~~--~l~~~~~~~~~~~~~~~~~~~~~ 202 (394)
..|.+|++-..+ +.|-+ |-++|-.+ ...-.|+||||+|..+.+ +|.+++..+. . ++.
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~------~---i~~ 307 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPH------D---ILN 307 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHH------H---HHH
Confidence 113344443322 34544 33333222 245689999999986654 5555543322 1 222
Q ss_pred HHHHHHH-HHHhCCceecCCCCCCEEEcC----CCeEEEccCCCCccC
Q psy7505 203 DVATGLS-YMIEDGFIHTDVAARNCLVTS----ELRVKIGDTGSSIDK 245 (394)
Q Consensus 203 qi~~gl~-yLH~~~iiHrDlk~~NiLl~~----~~~vKl~DFG~a~~~ 245 (394)
.+.++.. -+-..|++|+|=-|-||++.. ++.+.+-|||+....
T Consensus 308 ~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 308 KLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 2222221 223468999999999999984 568999999987543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00034 Score=73.74 Aligned_cols=193 Identities=20% Similarity=0.176 Sum_probs=123.9
Q ss_pred HHHHHhccCCCcceeceeeEEEeCCce----EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC
Q psy7505 139 HEATPYRRLRHVNILRLMAACLESDPW----LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED 214 (394)
Q Consensus 139 ~E~~~l~~l~HpnIv~l~~~~~~~~~~----~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~ 214 (394)
-|...+.++.|+|++.+++|-...... .+..|+|..-++...+..-+. .+......+..++..|+.|+|+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-----i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-----IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-----cCHHHHHHHHHHHhhhHHHHHHh
Confidence 466677888999999999987654332 344588988888888865433 45566677888999999999998
Q ss_pred CceecCCCCC---CEEEcCCCeEEEc--cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHH
Q psy7505 215 GFIHTDVAAR---NCLVTSELRVKIG--DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSF 289 (394)
Q Consensus 215 ~iiHrDlk~~---NiLl~~~~~vKl~--DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSl 289 (394)
...|.-|..+ +-..+..+.+.++ ||+.+.......... ....+..|.++|....... ......|+|.+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~-----~~~r~~dL~~l 378 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTA-----KKSRLTDLWCL 378 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccc-----hhhhhhHHHHH
Confidence 6666655555 3344555667776 888776543332211 1122334777877655442 13445799999
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 290 GVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 290 G~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
|..+..+.. |..+-. .......++ +..+.....+...+|+..+.+ |....++++
T Consensus 379 gll~~~~~~-~~~i~~---~~~~~~~~l---------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 379 GLLLLQLSQ-GEDISE---KSAVPVSLL---------DVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHhhhhh-cCcccc---cccchhhhh---------ccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999986 542211 001111111 122222677888899988887 777777654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00081 Score=60.30 Aligned_cols=29 Identities=28% Similarity=0.222 Sum_probs=25.0
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+++|+|+.+.|||++.++..-|.||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999877666799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0062 Score=58.69 Aligned_cols=84 Identities=17% Similarity=0.076 Sum_probs=51.6
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----c--HHHHHHHHHHHHHhccC---CCcceeceeeEEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----S--QAEKLFFLHEATPYRRL---RHVNILRLMAACL 160 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~ 160 (394)
.+.||.|.++.||++...+ ....++||.-.... . .....+...|...|+.+ .-.++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~-------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-- 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE-------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-- 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCC-------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--
Confidence 4679999999999998752 11267888743111 0 01222344677777665 22456777766
Q ss_pred eCCceEEEEeeCCCCC-HHHHHh
Q psy7505 161 ESDPWLLVFESCSRGD-LKEFLL 182 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~-L~~~l~ 182 (394)
+.+..++||||+++.. +.+.|.
T Consensus 102 D~~~~~lVME~L~~~~~lr~~Ll 124 (401)
T PRK09550 102 DEELAVTVMEDLSDHKILRKGLI 124 (401)
T ss_pred CCCCCEEEEecCCCccHHHHHHh
Confidence 3456789999998754 444443
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.00021 Score=68.92 Aligned_cols=60 Identities=38% Similarity=0.533 Sum_probs=46.4
Q ss_pred HHHHHHHhhhcCCccccchhhhhhhhhcCCCc-ceeeCcccCCceeccCccccccccceecc
Q psy7505 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTC 393 (394)
Q Consensus 333 ~~~~l~~~cl~~~p~r~~~~e~~~~l~~~~~~-~~~~~~~~~~~~~~~~es~~~~~~~~~~~ 393 (394)
+-+..+++||..+...-.++|+.-.- -+.++ |......++|++|+|||+++-++||+||-
T Consensus 326 HRDLAARNiLV~~~~~vKIsDFGLAr-~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSD 386 (468)
T KOG0197|consen 326 HRDLAARNILVDEDLVVKISDFGLAR-LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSD 386 (468)
T ss_pred chhhhhhheeeccCceEEEccccccc-ccCCCceeecCCCCCCceecCHHHHhhCCcccccc
Confidence 33456888998888888888985333 33334 44667799999999999999999999983
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0073 Score=53.96 Aligned_cols=29 Identities=24% Similarity=0.202 Sum_probs=25.6
Q ss_pred CceecCCCCCCEEEcC-CCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTS-ELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~-~~~vKl~DFG~a~ 243 (394)
.++|+|+.+.|||++. ++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6899999999999998 5789999998663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0032 Score=57.24 Aligned_cols=28 Identities=32% Similarity=0.259 Sum_probs=24.9
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++|+|+.+.|||++.++ +.|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999877 7899999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.021 Score=53.32 Aligned_cols=29 Identities=24% Similarity=0.240 Sum_probs=26.3
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.+++|+|+.+.|++++.++.+.|.||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccc
Confidence 58999999999999998887789999965
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.013 Score=54.59 Aligned_cols=29 Identities=21% Similarity=0.233 Sum_probs=25.6
Q ss_pred CceecCCCCCCEEEcCC----CeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSE----LRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~----~~vKl~DFG~a~ 243 (394)
.++|+|+.+.|||++.+ +.++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999874 789999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.077 Score=49.82 Aligned_cols=30 Identities=23% Similarity=0.190 Sum_probs=25.7
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++|+|+.+.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999976666899999663
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.036 Score=51.39 Aligned_cols=140 Identities=14% Similarity=-0.016 Sum_probs=75.9
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCc--ceeceee------EEEe
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV--NILRLMA------ACLE 161 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~------~~~~ 161 (394)
.+.|..|....+|+.... ...+++|+.... .. ..+..|+.++..|.+. .+.+.+. +...
T Consensus 19 i~~i~~G~~n~~y~v~~~---------~~~~vLr~~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 19 FEGISAGIENTNYFVTTD---------SGRYVLTLFEKV-SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred eecccCccccceEEEEeC---------CCcEEEEEcCCC-Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 456777888899987543 125677876542 11 1234566666666322 2334332 1223
Q ss_pred CCceEEEEeeCCCCCHHH----HHhhcc-------hh----h-h----hhhhHHHH----------HHHHHHHHHHHHHH
Q psy7505 162 SDPWLLVFESCSRGDLKE----FLLSNE-------AS----R-E----ALLEQGIT----------IKMAIDVATGLSYM 211 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~----~l~~~~-------~~----~-~----~~~~~~~~----------~~~~~qi~~gl~yL 211 (394)
++..++|++|++|..+.. ....-+ .. . . ....+... ......+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 456789999998866421 111000 00 0 0 00000000 00111122334444
Q ss_pred Hh-------CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 212 IE-------DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 212 H~-------~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.. .+++|+|+.+.|||++.++.+.|.||+.+
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 32 47999999999999999877899999865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.00057 Score=69.52 Aligned_cols=58 Identities=47% Similarity=0.797 Sum_probs=50.4
Q ss_pred HHHHHhhhcCCccccchhhhhhhhhcCCCcceeeC-cccCCceeccCccccccccceec
Q psy7505 335 DVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQT 392 (394)
Q Consensus 335 ~~l~~~cl~~~p~r~~~~e~~~~l~~~~~~~~~~~-~~~~~~~~~~~es~~~~~~~~~~ 392 (394)
+...|+||.-+----.|.|+.-.-+.+..|||... ..++|+|||+||||.-++||.+|
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS 686 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES 686 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh
Confidence 34578888877777788999888889999999664 79999999999999999999988
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.02 Score=55.98 Aligned_cols=144 Identities=19% Similarity=0.315 Sum_probs=87.1
Q ss_pred HHHHHHhccCCCcceeceeeEEEe-CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCc
Q psy7505 138 LHEATPYRRLRHVNILRLMAACLE-SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGF 216 (394)
Q Consensus 138 ~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~i 216 (394)
+-..+.++.+.|+|...++++... ..+..+|||++. -+|.+++...... . .+++ .+++
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~-----~-----------~s~~----~~~~ 88 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK-----D-----------ESLL----AHGV 88 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc-----h-----------hhhc----cccc
Confidence 456778889999999999888753 345889999995 4999988654210 0 0111 2333
Q ss_pred eecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHH
Q psy7505 217 IHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296 (394)
Q Consensus 217 iHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el 296 (394)
.|-. ..+++| -+. + .| |-. .+.|+||||+|.++.|+
T Consensus 89 ~~~~------------~~~~td-~~~------t-----------~~--~~~------------~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 89 LHLN------------IIYITD-HFL------T-----------KY--PSP------------IGPKSDVWSLGFIILEL 124 (725)
T ss_pred ceeh------------hhhccc-ccc------c-----------cC--CCC------------CCcchhhhhHHHHHHHH
Confidence 3321 233333 000 0 01 111 23589999999999999
Q ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCcCCCC-----------CCCCChHHHHHHHhhhcCCcc-cc
Q psy7505 297 FEFGKLPYAELSDDQVITRVFGTEALRLPA-----------PRAVNSHVDVAARNCLVTSEL-RV 349 (394)
Q Consensus 297 ~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------p~~~~~~~~~l~~~cl~~~p~-r~ 349 (394)
.- |..-+......+....+.+-. ..+. -..++..+..+...|+-..|. ||
T Consensus 125 ~L-~~~l~~~~~~s~~l~~i~k~~--~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 125 YL-GISLEAELTESEYLEILLKYY--TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred HH-hhHHHHHHHHHHHHHHHHHhc--cCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 84 887777666555544443321 1111 124566677788888888876 55
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.027 Score=52.41 Aligned_cols=106 Identities=11% Similarity=0.000 Sum_probs=66.0
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC---cceeceeeEEEe--
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH---VNILRLMAACLE-- 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~-- 161 (394)
..-.+.||+|..+.||+.... ..++++|..+.... ...+..|+..++.|.- -.+.++++++..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~---------~~~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~ 83 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS---------QGNPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ 83 (297)
T ss_pred hheeeecCCccceeEEEEEcC---------CCCEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence 344567999999999976542 11456676443211 1245688888877732 356777777654
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED 214 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~ 214 (394)
.+..+||||+++++++.+.. ........+..+++.+|.-||+.
T Consensus 84 ~~g~~~LVmE~i~G~~~~~~~----------~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 84 SPGPDVLLLERLRGVSVEAPA----------RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred cCCCeEEEEeccCCEecCCCC----------CCHHHHHHHHHHHHHHHHHHhCC
Confidence 36689999999998776411 01111223445666777777763
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.0055 Score=60.65 Aligned_cols=57 Identities=40% Similarity=0.699 Sum_probs=42.5
Q ss_pred HHHHHhhhcCCccccchhhhhhhhhcCCC--cceeeCcccCCceeccCccccccccceecc
Q psy7505 335 DVAARNCLVTSELRVKIGDTGSSIDKYPG--DYYVHGEVALPVRWCAPESLLCSDTSIQTC 393 (394)
Q Consensus 335 ~~l~~~cl~~~p~r~~~~e~~~~l~~~~~--~~~~~~~~~~~~~~~~~es~~~~~~~~~~~ 393 (394)
+...+.||.-.-.--.++|+. |..++. .|.......+||+|+|||++--|+|||||-
T Consensus 390 DLAARNCLVgEnhiVKvADFG--LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSD 448 (1157)
T KOG4278|consen 390 DLAARNCLVGENHIVKVADFG--LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 448 (1157)
T ss_pred hhhhhhccccccceEEeeccc--hhhhhcCCceecccCccCcccccCcccccccccccchh
Confidence 345678887766656667764 444443 444557799999999999999999999983
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.079 Score=50.40 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=25.3
Q ss_pred CceecCCCCCCEEEcC-CCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTS-ELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~-~~~vKl~DFG~a~ 243 (394)
.++|+|+++.|||++. ++.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6899999999999986 4689999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.17 Score=46.68 Aligned_cols=76 Identities=17% Similarity=0.233 Sum_probs=42.7
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC---CCcceeceeeEEEeCC
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL---RHVNILRLMAACLESD 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~ 163 (394)
.+-.+.+|.|....+|+... ....++||+...... .+|..|+.-|+.| .--.+.+.+++....+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~---------~~~~~FvK~~~~~~~----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~ 85 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT---------DGGSYFVKVNSESGR----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDD 85 (288)
T ss_dssp --EEEEE--SSSSEEEEEET---------TS-EEEEEEEEGGGC----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred eeeeEecCCCChhheEEEEC---------CCccEEEEecChhhH----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence 34456789899999997762 234788998763322 2244566555555 3445778888877777
Q ss_pred ceEEEEeeCCCC
Q psy7505 164 PWLLVFESCSRG 175 (394)
Q Consensus 164 ~~~lv~E~~~~g 175 (394)
.-+|||||++.+
T Consensus 86 ~~fLlle~l~~~ 97 (288)
T PF03881_consen 86 DAFLLLEFLEMG 97 (288)
T ss_dssp CCEEEEE-----
T ss_pred CceEEEEeecCC
Confidence 779999998776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.066 Score=46.88 Aligned_cols=135 Identities=15% Similarity=0.203 Sum_probs=80.1
Q ss_pred eEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHH
Q psy7505 119 KVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198 (394)
Q Consensus 119 ~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 198 (394)
..++|++..-.-......+..+..++.+++ .|+++..- .+..+.+++|+|-.-... . .
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~--------------~----~ 144 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN--------------F----S 144 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc--------------h----h
Confidence 344555544332222334557788888775 47777632 344577999999542110 0 0
Q ss_pred HHHHHHHHHHHHHHh--CCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcc
Q psy7505 199 KMAIDVATGLSYMIE--DGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQ 276 (394)
Q Consensus 199 ~~~~qi~~gl~yLH~--~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~ 276 (394)
.++..=+.+|.-.|+ .+.+|+|..|+||+-|..|.+||.|-+.-. .. ++.|.--|+.
T Consensus 145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll---~~----------~V~~vN~~Y~-------- 203 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL---EN----------QVNMVNIEYE-------- 203 (308)
T ss_pred HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh---hh----------eeeEEeeecc--------
Confidence 111111355666684 479999999999999999999999988321 11 1124332211
Q ss_pred cCCCCcchhHHHHHHHHHHHHc
Q psy7505 277 TCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 277 ~~~~~~~~DiwSlG~il~el~t 298 (394)
..+.++.+-+|=..+.++..
T Consensus 204 --~lT~~aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 204 --SLTQEAEVKVFVKSCLKLVE 223 (308)
T ss_pred --ccChHHHHHHHHHHHHHHHH
Confidence 14567777777777777764
|
The function of this family is unknown. |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.0078 Score=63.72 Aligned_cols=57 Identities=42% Similarity=0.619 Sum_probs=44.5
Q ss_pred HHHhhhcCCccccchhhhhhhhhcCCCcceeeCc-ccCCceeccCccccccccceecc
Q psy7505 337 AARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPESLLCSDTSIQTC 393 (394)
Q Consensus 337 l~~~cl~~~p~r~~~~e~~~~l~~~~~~~~~~~~-~~~~~~~~~~es~~~~~~~~~~~ 393 (394)
..++||......-.+.|+.-.-+-+..+||+... +.+|.||||||++.+.+|+.||-
T Consensus 829 AaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSD 886 (1025)
T KOG1095|consen 829 AARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSD 886 (1025)
T ss_pred hhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccc
Confidence 4677776666445788886555667778887755 59999999999999999999983
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.03 Score=51.77 Aligned_cols=131 Identities=14% Similarity=0.101 Sum_probs=79.7
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccc-------------------ccHHH--HHHHHHHHHHhc
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED-------------------ASQAE--KLFFLHEATPYR 145 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~-------------------~~~~~--~~~~~~E~~~l~ 145 (394)
+.+...||-|--+.||.+.+... ...++|.-+.. ..+.. .....+|...|+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G--------~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG--------NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK 165 (465)
T ss_pred hhhccccccccccceEEEecCCC--------CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence 34567899999999999876521 12333321100 01111 111246888888
Q ss_pred cCC-Ccc-eeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7505 146 RLR-HVN-ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223 (394)
Q Consensus 146 ~l~-Hpn-Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~ 223 (394)
.|. |-. |.+-++ .++-++|||++.+-.|.+.-+-. +... +...+..-+.-|-.+|+||+|..-
T Consensus 166 aL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~---ly~~lm~~Iv~la~~GlIHgDFNE 230 (465)
T KOG2268|consen 166 ALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE--------DPPT---LYDDLMGLIVRLANHGLIHGDFNE 230 (465)
T ss_pred HHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecC--------ChHH---HHHHHHHHHHHHHHcCceecccch
Confidence 773 322 223333 35678999999887776543111 1111 112222333457789999999999
Q ss_pred CCEEEcCCCeEEEccCC
Q psy7505 224 RNCLVTSELRVKIGDTG 240 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG 240 (394)
=||++++++.++++||-
T Consensus 231 FNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 231 FNIMVKDDDKIVVIDFP 247 (465)
T ss_pred heeEEecCCCEEEeech
Confidence 99999999999999997
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.4 Score=46.35 Aligned_cols=81 Identities=16% Similarity=0.080 Sum_probs=48.7
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--------HHHHHHHHHHHHHhccC---CCcceeceeeE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--------QAEKLFFLHEATPYRRL---RHVNILRLMAA 158 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~~E~~~l~~l---~HpnIv~l~~~ 158 (394)
.+.||.|....||+.... ...++||.-..... ..... ..|+..|+.+ ...++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~---------~~svVVKqa~p~~r~vga~wpl~~~R~--~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS---------SGSFVIKQALPYIRCIGESWPMTKERA--YFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC---------CccEEEEeCCccccCCCccccCCccHH--HHHHHHHHHhhhcCCCCCCeEEEE
Confidence 577999999999987653 12467776541110 11111 2345555443 23467788888
Q ss_pred EEeCCceEEEEeeCCC--CCHHHHHhh
Q psy7505 159 CLESDPWLLVFESCSR--GDLKEFLLS 183 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~--g~L~~~l~~ 183 (394)
+. +.-+++|||+++ -.|.+-+..
T Consensus 106 de--d~~vlvME~L~~~~~ilr~~Ll~ 130 (418)
T PLN02756 106 DR--TMALIGMRYLEPPHIILRKGLIA 130 (418)
T ss_pred CC--CCCEEEEeecCCcceehhhhhcc
Confidence 75 446789999977 246555543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.21 Score=45.86 Aligned_cols=29 Identities=17% Similarity=0.252 Sum_probs=24.4
Q ss_pred CceecCCCCCCEEEcCCCe-EEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELR-VKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~-vKl~DFG~a~ 243 (394)
.++|+|+.+.|||++.++. .-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 5899999999999997554 5699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.37 Score=45.55 Aligned_cols=27 Identities=22% Similarity=0.298 Sum_probs=24.0
Q ss_pred ceecCCCCCCEEEcC-CCeEEEccCCCC
Q psy7505 216 FIHTDVAARNCLVTS-ELRVKIGDTGSS 242 (394)
Q Consensus 216 iiHrDlk~~NiLl~~-~~~vKl~DFG~a 242 (394)
..|.|+-+.|||++. ++.++++||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 689999999999975 478999999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.24 Score=46.99 Aligned_cols=31 Identities=16% Similarity=0.259 Sum_probs=25.3
Q ss_pred hCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 213 ~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
...++|+||-+.||+++.++ ++++|+..+..
T Consensus 191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 34689999999999997765 78999986643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.89 E-value=1.4 Score=41.06 Aligned_cols=29 Identities=7% Similarity=-0.013 Sum_probs=26.4
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
+++|+|+.+.|+|++.++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999889999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.55 Score=44.53 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=79.3
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------------------------cHHHHHHHHHHHHHhc
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------------------------SQAEKLFFLHEATPYR 145 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------------------------~~~~~~~~~~E~~~l~ 145 (394)
..|..|--+.||.+.... +..+|||+.+... ....+.+...|+.-|.
T Consensus 150 GCiSTGKEANVYHat~~d--------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk 221 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEED--------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK 221 (520)
T ss_pred cccccCccceeEeeecCC--------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence 446778888899877542 3357888776321 1112223345666666
Q ss_pred cCCCcceeceeeEEEeCCceEEEEeeCCCCC-HHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHH-HhCCceecCCCC
Q psy7505 146 RLRHVNILRLMAACLESDPWLLVFESCSRGD-LKEFLLSNEASREALLEQGITIKMAIDVATGLSYM-IEDGFIHTDVAA 223 (394)
Q Consensus 146 ~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yL-H~~~iiHrDlk~ 223 (394)
+|+.-.| ..-.-..- ..-.|||+|+.... -.-.|+... ++...+..+-.|++.-|.-| +..+.||.||.-
T Consensus 222 Rl~~aGI-P~PePIlL-k~hVLVM~FlGrdgw~aPkLKd~~------ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE 293 (520)
T KOG2270|consen 222 RLNNAGI-PCPEPILL-KNHVLVMEFLGRDGWAAPKLKDAS------LSTSKARELYQQCVRIMRRLYQKCRLVHADLSE 293 (520)
T ss_pred HHHhcCC-CCCCceee-ecceEeeeeccCCCCcCccccccc------CChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence 6543322 11111111 12368999985321 112222211 33334455556777777766 667999999999
Q ss_pred CCEEEcCCCeEEEccCCCCc
Q psy7505 224 RNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG~a~ 243 (394)
=|+|+- +|.+-|+|.+-|.
T Consensus 294 fN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 294 FNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred hhheEE-CCEEEEEEccccc
Confidence 999885 5779999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.25 Score=47.50 Aligned_cols=86 Identities=19% Similarity=0.094 Sum_probs=48.4
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----c-HHHHHHHHHHHHHhccCC--Cc-ceeceeeEEEe
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----S-QAEKLFFLHEATPYRRLR--HV-NILRLMAACLE 161 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~-~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~ 161 (394)
.+.||.|.-.-||++.+.. ....|+||.-.... + .....+..-|...|+.+. -| ++.++|.+ +
T Consensus 34 ~~eigdGnlN~VfrV~~~~-------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D 104 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D 104 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C
Confidence 5779999999999998741 11256676532111 0 001112234666665541 23 45556544 4
Q ss_pred CCceEEEEeeCCCC-CHHHHHhhc
Q psy7505 162 SDPWLLVFESCSRG-DLKEFLLSN 184 (394)
Q Consensus 162 ~~~~~lv~E~~~~g-~L~~~l~~~ 184 (394)
.....+|||+++.. .|.+.|.++
T Consensus 105 ~e~~~~vMEdL~~~~ilR~~Li~G 128 (409)
T PRK12396 105 SVMNCCVMEDLSDHTILRTALINH 128 (409)
T ss_pred cHHhhHHHHhCcccHHHHHHHHcC
Confidence 55667899999653 466665543
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.026 Score=55.70 Aligned_cols=45 Identities=42% Similarity=0.754 Sum_probs=32.0
Q ss_pred ccchhhhhhhhhcCCCccee-eCcccCCceeccCccccccccceec
Q psy7505 348 RVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQT 392 (394)
Q Consensus 348 r~~~~e~~~~l~~~~~~~~~-~~~~~~~~~~~~~es~~~~~~~~~~ 392 (394)
-..++|+.-.-.=+..+|+. .+..-+|+||||||||+-++|+-+|
T Consensus 675 ~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaS 720 (807)
T KOG1094|consen 675 TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTAS 720 (807)
T ss_pred cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchh
Confidence 34455553333334456664 4678999999999999999999776
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.91 Score=42.46 Aligned_cols=31 Identities=13% Similarity=0.056 Sum_probs=27.6
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCccC
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~ 245 (394)
.++|+|+.+.|++++..+-+-|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 5899999999999999988999999987543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.32 Score=45.95 Aligned_cols=73 Identities=16% Similarity=0.124 Sum_probs=46.9
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..|++|++- |+.|.- +.. ..+.+...++.+.+.-+.-+..+ ..=|||+--.||||+ +|.|-|+||-+|
T Consensus 300 y~yl~~kdh-gt~is~-ik~--------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IKA--------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-eec--------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 356777764 444432 211 12334455665544444334333 578999999999999 999999999999
Q ss_pred ccCCC
Q psy7505 243 IDKYP 247 (394)
Q Consensus 243 ~~~~~ 247 (394)
+....
T Consensus 369 Rl~~~ 373 (488)
T COG5072 369 RLSYS 373 (488)
T ss_pred ecccC
Confidence 85443
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.45 Score=45.68 Aligned_cols=60 Identities=22% Similarity=0.232 Sum_probs=39.0
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHH-HHHhCCceecCCCCCCEEEcC
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS-YMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~-yLH~~~iiHrDlk~~NiLl~~ 230 (394)
..|+=+|..|-++..++..... ++.....++.--+.|+. -|--.+.+|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~------pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQ------PEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcccC------hHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3566678888899999875432 12233334433344543 335578999999999999853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.30 E-value=0.38 Score=44.79 Aligned_cols=28 Identities=32% Similarity=0.356 Sum_probs=24.6
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.+++|+|+.+.||+++. +.+.|.||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 66889999955
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=90.80 E-value=0.1 Score=53.62 Aligned_cols=56 Identities=43% Similarity=0.647 Sum_probs=37.6
Q ss_pred HHHhhhcCCccccchhhhhhhhhcCCCcceeeC--cccCCceeccCccccccccceec
Q psy7505 337 AARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG--EVALPVRWCAPESLLCSDTSIQT 392 (394)
Q Consensus 337 l~~~cl~~~p~r~~~~e~~~~l~~~~~~~~~~~--~~~~~~~~~~~es~~~~~~~~~~ 392 (394)
.+|..|..+-+--.++|+.-.-.-...+++... .+++|++||||||+....|+.||
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kS 502 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKS 502 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccc
Confidence 344444444444446666544444555666543 34599999999999999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 394 | ||||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-39 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-38 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-38 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-38 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-38 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-38 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-38 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-38 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-38 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-38 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-38 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-38 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-38 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-38 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-38 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-38 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-37 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-37 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-37 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-37 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-37 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-37 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-36 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-36 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-36 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-36 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-36 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-36 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-36 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-36 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-36 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-36 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-36 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-36 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-36 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-36 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-36 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-36 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-35 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-35 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-34 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-34 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-34 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-34 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-34 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-34 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-34 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-34 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-34 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-34 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-34 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-34 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-34 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-34 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-34 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-34 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-34 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-34 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-33 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-33 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-33 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-33 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-33 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-33 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-33 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-32 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-32 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-32 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-32 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-32 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-32 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-32 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-32 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-32 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-32 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-32 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-32 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-32 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-32 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-32 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-32 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-32 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-32 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-32 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-32 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-31 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-31 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-31 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-31 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-31 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-31 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-31 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-30 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-30 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-30 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-30 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-30 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-30 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-29 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-29 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-29 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-29 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-29 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-29 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-29 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-29 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-29 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-29 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-29 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-29 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-29 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-29 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-28 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-28 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-28 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-28 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-28 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-28 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-28 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-28 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-28 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-28 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-28 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-28 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-28 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-28 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-28 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-28 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-28 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-27 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-27 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-27 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-27 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-27 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-27 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-27 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-27 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-27 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-27 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-27 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-27 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-27 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-27 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-27 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-27 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-27 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-27 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-27 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-26 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-26 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-26 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-25 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-25 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-25 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-25 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-25 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-24 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-24 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-24 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-24 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-24 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-24 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-24 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-23 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-22 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-22 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-14 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-04 |
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 7e-79
Identities = 92/256 (35%), Positives = 140/256 (54%), Gaps = 17/256 (6%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
E++ R+++ +E+G+G FG V EG A+G+ + T V ++ + E AS E++ FL
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFL 76
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN-----EASREALLE 193
+EA+ + +++RL+ + P L++ E +RGDLK +L S A
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-V 252
I+MA ++A G++Y+ + F+H D+AARNC+V + VKIGD G + D Y DYY
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
G+ LPVRW +PESL T +VWSFGV+LWEI + PY LS++QV
Sbjct: 197 GGKGLLPVRWMSPESLKDG-------VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 313 ITRVFGTEALRLPAPR 328
+ V E L P
Sbjct: 250 LRFV--MEGGLLDKPD 263
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 29/53 (54%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNC+V + VKIGD G + D Y DYY G+ LPVRW +PESL
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 9e-79
Identities = 91/273 (33%), Positives = 132/273 (48%), Gaps = 31/273 (11%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
++PR + YV++IG G FG+V + A GL T V V++LKE+AS +
Sbjct: 38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM--VAVKMLKEEASADMQA 95
Query: 136 FFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG 195
F EA + NI++L+ C P L+FE + GDL EFL S L
Sbjct: 96 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 196 IT-------------------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236
+ +A VA G++Y+ E F+H D+A RNCLV + VKI
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 215
Query: 237 GDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWE 295
D G S + Y DYY G A+P+RW PES+ + T + +VW++GV+LWE
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-------RYTTESDVWAYGVVLWE 268
Query: 296 IFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
IF +G PY ++ ++VI V + L P
Sbjct: 269 IFSYGLQPYYGMAHEEVIYYV--RDGNILACPE 299
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 26/53 (49%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV + VKI D G S + Y DYY G A+P+RW PES+
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 1e-77
Identities = 91/265 (34%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
R+ + +E+G G FGKV E L + + V V+ LK+ + A +
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKML--VAVKALKD-PTLAARK 62
Query: 136 FFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG 195
F EA L+H +I++ C + DP ++VFE GDL +FL ++ L++
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 196 IT-----------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
+ +A +A+G+ Y+ F+H D+A RNCLV + L VKIGD G S D
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 245 KYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
Y DYY V G LP+RW PES++ T + +VWSFGV+LWEIF +GK P
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYR-------KFTTESDVWSFGVILWEIFTYGKQP 235
Query: 304 YAELSDDQVITRVFGTEALRLPAPR 328
+ +LS+ +VI + T+ L PR
Sbjct: 236 WFQLSNTEVIECI--TQGRVLERPR 258
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 30/53 (56%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV + L VKIGD G S D Y DYY V G LP+RW PES++
Sbjct: 156 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 208
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 3e-77
Identities = 77/260 (29%), Positives = 121/260 (46%), Gaps = 23/260 (8%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + +++E+G FGKV +G G G T V ++ LK+ A + F HE
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAP--GEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT--- 197
A RL+H N++ L+ + P ++F CS GDL EFL+ +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 198 --------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249
+ + +A G+ Y+ +H D+A RN LV +L VKI D G + Y D
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 250 YY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
YY + G LP+RW APE+++ + ++WS+GV+LWE+F +G PY S
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYG-------KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 309 DDQVITRVFGTEALRLPAPR 328
+ V+ + LP P
Sbjct: 236 NQDVVEMI--RNRQVLPCPD 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 25/53 (47%), Positives = 33/53 (62%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RN LV +L VKI D G + Y DYY + G LP+RW APE+++
Sbjct: 151 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM 203
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 4e-77
Identities = 98/264 (37%), Positives = 131/264 (49%), Gaps = 23/264 (8%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
D+ R+ + E+G G FGKV E L + V V+ LKE AS++ +
Sbjct: 32 DACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKML--VAVKALKE-ASESARQ 88
Query: 136 FFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG 195
F EA L+H +I+R C E P L+VFE GDL FL S+ + L
Sbjct: 89 DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 196 IT----------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245
+ +A VA G+ Y+ F+H D+A RNCLV L VKIGD G S D
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208
Query: 246 YPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
Y DYY V G LP+RW PES+L T + +VWSFGV+LWEIF +GK P+
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYR-------KFTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 305 AELSDDQVITRVFGTEALRLPAPR 328
+LS+ + I + T+ L PR
Sbjct: 262 YQLSNTEAIDCI--TQGRELERPR 283
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 31/53 (58%), Positives = 34/53 (64%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV L VKIGD G S D Y DYY V G LP+RW PES+L
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 233
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 4e-77
Identities = 92/258 (35%), Positives = 133/258 (51%), Gaps = 17/258 (6%)
Query: 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF 136
S + PR+ + ++ +G G FG+V EG+ G+ +V V+ L E S+ ++L
Sbjct: 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL--QVAVKTLPEVCSEQDELD 79
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLEQ 194
FL EA + H NI+R + L+S P ++ E + GDLK FL S+ + L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGDYY 251
+ +A D+A G Y+ E+ FIH D+AARNCL+T KIGD G + D Y YY
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 252 -VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310
G LPV+W PE+ + T K + WSFGVLLWEIF G +PY S+
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG-------IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 311 QVITRVFGTEALRLPAPR 328
+V+ V T R+ P+
Sbjct: 253 EVLEFV--TSGGRMDPPK 268
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 25/56 (44%), Positives = 31/56 (55%), Gaps = 4/56 (7%)
Query: 333 HVDVAARNCLVTSE---LRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNCL+T KIGD G + D Y YY G LPV+W PE+ +
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 9e-77
Identities = 97/319 (30%), Positives = 141/319 (44%), Gaps = 26/319 (8%)
Query: 16 NPLASSPEVSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWF 75
+ + E F + L T P Y
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRT---STIMTDYNPNYCFAGKTSSISDLK- 66
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
+ PR+ + ++ +G G FG+V EG+ G+ +V V+ L E S+ ++L
Sbjct: 67 -----EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL--QVAVKTLPEVCSEQDEL 119
Query: 136 FFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN--EASREALLE 193
FL EA + H NI+R + L+S P ++ E + GDLK FL S+ + L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGDY 250
+ +A D+A G Y+ E+ FIH D+AARNCL+T KIGD G + D Y Y
Sbjct: 180 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 251 Y-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
Y G LPV+W PE+ + T K + WSFGVLLWEIF G +PY S+
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEG-------IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
Query: 310 DQVITRVFGTEALRLPAPR 328
+V+ V T R+ P+
Sbjct: 293 QEVLEFV--TSGGRMDPPK 309
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 25/56 (44%), Positives = 31/56 (55%), Gaps = 4/56 (7%)
Query: 333 HVDVAARNCLVTSE---LRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNCL+T KIGD G + D Y YY G LPV+W PE+ +
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 2e-75
Identities = 89/308 (28%), Positives = 147/308 (47%), Gaps = 27/308 (8%)
Query: 34 QQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEI 93
+ S+ S PL + + P + +S + +++FPR +L K +
Sbjct: 35 ESSSSMNSNTPLVRITTRLSSTADTPMLA-----GVSEYELPEDPKWEFPRDKLTLGKPL 89
Query: 94 GRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNI 152
G G FG+VV EA G+++ + V V++LK+DA++ + + E + + +H NI
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSN-------EASREALLEQGIT----IKMA 201
+ L+ AC + P ++ E S+G+L+E+L + + E+ +T +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPV 260
+A G+ Y+ IH D+AARN LVT +KI D G + D DYY LPV
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W APE+L T + +VWSFGVL+WEIF G PY + +++ + E
Sbjct: 270 KWMAPEALFDR-------VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--KE 320
Query: 321 ALRLPAPR 328
R+ P
Sbjct: 321 GHRMDKPA 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 25/53 (47%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARN LVT +KI D G + D DYY LPV+W APE+L
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 278
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 7e-75
Identities = 83/263 (31%), Positives = 134/263 (50%), Gaps = 22/263 (8%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR +L K +G G FG+VV EA G+++ + V V++LK+DA++ + +
Sbjct: 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88
Query: 139 HEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN-------EASREA 190
E + + +H NI+ L+ AC + P ++ E S+G+L+E+L +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 191 LLEQGIT----IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246
+ E+ +T + +A G+ Y+ IH D+AARN LVT +KI D G + D
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 247 PGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305
DYY LPV+W APE+L T + +VWSFGVL+WEIF G PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261
Query: 306 ELSDDQVITRVFGTEALRLPAPR 328
+ +++ + E R+ P
Sbjct: 262 GIPVEELFKLL--KEGHRMDKPA 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 25/53 (47%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARN LVT +KI D G + D DYY LPV+W APE+L
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-74
Identities = 90/308 (29%), Positives = 138/308 (44%), Gaps = 30/308 (9%)
Query: 40 ISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQ------FPRQQLHYVKEI 93
+ F + H+ + E + M E PR +L K +
Sbjct: 20 LYFNGMGYYH--HHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPL 77
Query: 94 GRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNI 152
G G FG+VV EA GL++ +KV V++LK DA++ + + E + + +H NI
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT-----------IKMA 201
+ L+ AC + P ++ E S+G+L+E+L + + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPV 260
VA G+ Y+ IH D+AARN LVT + +KI D G + D + DYY LPV
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 257
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W APE+L T + +VWSFGVLLWEIF G PY + +++ + E
Sbjct: 258 KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--KE 308
Query: 321 ALRLPAPR 328
R+ P
Sbjct: 309 GHRMDKPS 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLL 384
H D+AARN LVT + +KI D G + D + DYY LPV+W APE+L
Sbjct: 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 5e-74
Identities = 88/271 (32%), Positives = 130/271 (47%), Gaps = 31/271 (11%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+++FPR+ L K +G G FGKVV+ A L+ G TT V V++LKE+AS +E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDL 73
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
L E +++ H ++++L AC + P LL+ E G L+ FL + L G +
Sbjct: 74 LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 198 -------------------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238
I A ++ G+ Y+ E +H D+AARN LV ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 239 TGSSIDKYPGDYYVHGEVA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
G S D Y D YV +PV+W A ESL + Q+ +VWSFGVLLWEI
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIV 246
Query: 298 EFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
G PY + +++ + R+ P
Sbjct: 247 TLGGNPYPGIPPERLFNLL--KTGHRMERPD 275
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 25/53 (47%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LV ++KI D G S D Y D YV +PV+W A ESL
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-73
Identities = 90/259 (34%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
FPR L + K +G G FGKVVE A GL + V V++LK A EK + E
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK--VAVKMLKSTAHADEKEALMSEL 100
Query: 142 TPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT--- 197
L +H NI+ L+ AC P L++ E C GDL FL E I
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 198 ------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
+ + VA G++++ IH DVAARN L+T+ KIGD G + D Y
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 252 -VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY-AELSD 309
V G LPV+W APES+ C T + +VWS+G+LLWEIF G PY L +
Sbjct: 221 IVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 310 DQVITRVFGTEALRLPAPR 328
+ V + ++ P
Sbjct: 274 SKFYKLV--KDGYQMAQPA 290
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 26/53 (49%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H DVAARN L+T+ KIGD G + D Y V G LPV+W APES+
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-72
Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 21/276 (7%)
Query: 61 YSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKV 120
+S LV + S + + R L K +G G FG V+EG + + T+ KV
Sbjct: 10 HSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG----TSLKV 65
Query: 121 FVRILKED-ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW-----LLVFESCSR 174
V+ +K D +SQ E FL EA + H N++RL+ C+E +++
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 175 GDLKEFLLSNEA-SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233
GDL +LL + + + +K +D+A G+ Y+ F+H D+AARNC++ ++
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185
Query: 234 VKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVL 292
V + D G S Y GDYY +PV+W A ESL T K +VW+FGV
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-------VYTSKSDVWAFGVT 238
Query: 293 LWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+WEI G PY + + ++ + RL P
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYL--LHGHRLKQPE 272
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 23/53 (43%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNC++ ++ V + D G S Y GDYY +PV+W A ESL
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-72
Identities = 77/260 (29%), Positives = 122/260 (46%), Gaps = 22/260 (8%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLF 136
+ P QQ + +G+G FG V E + + + S KV V++LK D + ++
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSF----VKVAVKMLKADIIASSDIEE 71
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPW------LLVFESCSRGDLKEFLLSNEASRE- 189
FL EA + H ++ +L+ L S +++ GDL FLL++
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 190 ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249
L ++ +D+A G+ Y+ FIH D+AARNC++ ++ V + D G S Y GD
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 250 YY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
YY LPV+W A ESL + T +VW+FGV +WEI G+ PYA +
Sbjct: 192 YYRQGCASKLPVKWLALESLADN-------LYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244
Query: 309 DDQVITRVFGTEALRLPAPR 328
+ ++ + RL P
Sbjct: 245 NAEIYNYL--IGGNRLKQPP 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNC++ ++ V + D G S Y GDYY LPV+W A ESL
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 1e-71
Identities = 87/269 (32%), Positives = 138/269 (51%), Gaps = 26/269 (9%)
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK 134
+D+S+++FPR +L K +GRG FG+V+E +A G++++ T V V++LKE A+ +E
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT--VAVKMLKEGATHSEH 74
Query: 135 LFFLHEATPYRRL-RHVNILRLMAACLESD-PWLLVFESCSRGDLKEFLLSNEASREALL 192
+ E + H+N++ L+ AC + P +++ E C G+L +L S
Sbjct: 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 193 EQGIT-----------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241
I + VA G+ ++ IH D+AARN L++ + VKI D G
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 242 SIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG 300
+ D Y YV G+ LP++W APE++ T + +VWSFGVLLWEIF G
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDR-------VYTIQSDVWSFGVLLWEIFSLG 247
Query: 301 KLPYAELS-DDQVITRVFGTEALRLPAPR 328
PY + D++ R+ E R+ AP
Sbjct: 248 ASPYPGVKIDEEFCRRL--KEGTRMRAPD 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 23/53 (43%), Positives = 33/53 (62%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLL 384
H D+AARN L++ + VKI D G + D Y YV G+ LP++W APE++
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-71
Identities = 87/266 (32%), Positives = 124/266 (46%), Gaps = 27/266 (10%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++FPR +L + K +G G FGKVVE A GL +S T V V++LK A E+ +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMT--VAVKMLKPSAHLTEREALM 74
Query: 139 HEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
E L H+NI+ L+ AC P L++ E C GDL FL S
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 198 -------------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
+ + VA G++++ IH D+AARN L+T KI D G + D
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 245 KYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
YV G LPV+W APES+ C T + +VWS+G+ LWE+F G P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 304 YAELS-DDQVITRVFGTEALRLPAPR 328
Y + D + + E R+ +P
Sbjct: 248 YPGMPVDSKFYKMI--KEGFRMLSPE 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 24/53 (45%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLL 384
H D+AARN L+T KI D G + D YV G LPV+W APES+
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-71
Identities = 72/250 (28%), Positives = 117/250 (46%), Gaps = 23/250 (9%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
++ + L ++KE+G G FG V G+ RG V ++++KE + ++ F+
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRG--------QYDVAIKMIKEGSMSEDE--FI 67
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA L H +++L C + P ++ E + G L +L + +
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLL 123
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
+M DV + Y+ F+H D+AARNCLV + VK+ D G S +Y
Sbjct: 124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 183
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
PVRW PE L+ S S K ++W+FGVL+WEI+ GK+PY ++ + +
Sbjct: 184 PVRWSPPEVLMYSKFSS-------KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-- 234
Query: 319 TEALRLPAPR 328
+ LRL P
Sbjct: 235 AQGLRLYRPH 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 22/52 (42%), Positives = 27/52 (51%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARNCLV + VK+ D G S +Y PVRW PE L+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-71
Identities = 77/250 (30%), Positives = 121/250 (48%), Gaps = 18/250 (7%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++ R+++ + IG G FG V +G V ++ K S + + FL
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMS----PENPALAVAIKTCKNCTSDSVREKFL 64
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA R+ H +I++L+ E+ P ++ E C+ G+L+ FL + S L+ I
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS----LDLASLI 119
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
A ++T L+Y+ F+H D+AARN LV+S VK+GD G S YY + L
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W APES+ T +VW FGV +WEI G P+ + ++ VI R+
Sbjct: 180 PIKWMAPESINFR-------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-- 230
Query: 319 TEALRLPAPR 328
RLP P
Sbjct: 231 ENGERLPMPP 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 24/52 (46%), Positives = 31/52 (59%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV+S VK+GD G S YY + LP++W APES+
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-70
Identities = 89/291 (30%), Positives = 131/291 (45%), Gaps = 29/291 (9%)
Query: 40 ISFEPLPTLVPPQHNVKRPPAYSEELVRQLS--MQNWFDSSEFQFPRQQLHYVKEIGRGW 97
F +P L+ H + + L ++ + ++ + L ++IGRG
Sbjct: 73 EGFPSIPLLI--DHLLST----QQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGN 126
Query: 98 FGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157
FG+V G R + V V+ +E K FL EA ++ H NI+RL+
Sbjct: 127 FGEVFSGRLRA-------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFI 217
C + P +V E GD FL + A L ++M D A G+ Y+ I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 218 HTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQ 276
H D+AARNCLVT + +KI D G S ++ G Y G +PV+W APE ++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-------ALN 288
Query: 277 TCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ + +VWSFG+LLWE F G PY LS+ Q V + RLP P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV--EKGGRLPCP 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQ 391
H D+AARNCLVT + +KI D G S ++ G Y G +PV+W APE+L S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 392 T 392
+
Sbjct: 296 S 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 5e-70
Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 18/250 (7%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
++ R+ + + +G G+FG+V EG V V+ K+D + K F+
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTN----HKGEKINVAVKTCKKDCTLDNKEKFM 61
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA + L H +I++L+ E +P ++ E G+L +L N+ S L+ +
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS----LKVLTLV 116
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
++ + ++Y+ +H D+A RN LV S VK+GD G S DYY L
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W +PE SI T +VW F V +WEI FGK P+ L + VI +
Sbjct: 177 PIKWMSPE-------SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-- 227
Query: 319 TEALRLPAPR 328
+ RLP P
Sbjct: 228 EKGDRLPKPD 237
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 23/52 (44%), Positives = 29/52 (55%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+A RN LV S VK+GD G S DYY LP++W +PES+
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-70
Identities = 79/250 (31%), Positives = 116/250 (46%), Gaps = 23/250 (9%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
++ +L +V+EIG G FG V G KV ++ ++E A E F+
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN--------KDKVAIKTIREGAMSEED--FI 51
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA +L H +++L CLE P LV E G L ++L + +
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLL 107
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
M +DV G++Y+ E IH D+AARNCLV +K+ D G + Y
Sbjct: 108 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 167
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
PV+W +PE S S K +VWSFGVL+WE+F GK+PY S+ +V+ +
Sbjct: 168 PVKWASPEVFSFSRYSS-------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-- 218
Query: 319 TEALRLPAPR 328
+ RL PR
Sbjct: 219 STGFRLYKPR 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 18/52 (34%), Positives = 24/52 (46%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARNCLV +K+ D G + Y PV+W +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 5e-70
Identities = 87/272 (31%), Positives = 123/272 (45%), Gaps = 32/272 (11%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+++FPR+ L + K +G G FGKV+ A G+ ++ V V++LKE A +E+
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ--VAVKMLKEKADSSEREAL 95
Query: 138 LHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
+ E +L H NI+ L+ AC S P L+FE C GDL +L S +
Sbjct: 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 197 T------------------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238
+ A VA G+ ++ +H D+AARN LVT VKI D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 239 TGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
G + D YV G LPV+W APESL T K +VWS+G+LLWEIF
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIF 268
Query: 298 EFGKLPYAELS-DDQVITRVFGTEALRLPAPR 328
G PY + D + ++ P
Sbjct: 269 SLGVNPYPGIPVDANFYKLI--QNGFKMDQPF 298
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 27/53 (50%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLL 384
H D+AARN LVT VKI D G + D YV G LPV+W APESL
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 7e-70
Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 23/248 (9%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ R+++ +KE+G G FG V G+ +G V V+++KE + ++ F E
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKG--------QYDVAVKMIKEGSMSEDE--FFQE 53
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
A +L H +++ C + P +V E S G L +L S+ LE ++M
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEM 109
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
DV G++++ FIH D+AARNCLV +L VK+ D G + Y PV
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W APE S K +VW+FG+L+WE+F GK+PY ++ +V+ +V ++
Sbjct: 170 KWSAPEVFHYFKYSS-------KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--SQ 220
Query: 321 ALRLPAPR 328
RL P
Sbjct: 221 GHRLYRPH 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 21/52 (40%), Positives = 26/52 (50%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARNCLV +L VK+ D G + Y PV+W APE
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-69
Identities = 75/254 (29%), Positives = 108/254 (42%), Gaps = 21/254 (8%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
R H + IG+G FG V GE + + ++ L + FL
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYID----QAQNRIQCAIKSLSRITEMQQVEAFL 70
Query: 139 HEATPYRRLRHVNILRLMAACLESDP-WLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
E R L H N+L L+ L + ++ GDL +F+ S + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDL 126
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV---HG 254
I + VA G+ Y+ E F+H D+AARNC++ VK+ D G + D +YY H
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
LPV+W A ESL T K +VWSFGVLLWE+ G PY + +
Sbjct: 187 HARLPVKWTALESLQTY-------RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 315 RVFGTEALRLPAPR 328
+ + RLP P
Sbjct: 240 FL--AQGRRLPQPE 251
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 23/55 (41%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV---HGEVALPVRWCAPESLL 384
H D+AARNC++ VK+ D G + D +YY H LPV+W A ESL
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 6e-69
Identities = 77/250 (30%), Positives = 125/250 (50%), Gaps = 23/250 (9%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++ R + ++G G +G+V EG + + V V+ LKED + E+ FL
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTMEVEE--FL 57
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA + ++H N+++L+ C P+ ++ E + G+L ++L + + +
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL---L 114
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA- 257
MA +++ + Y+ + FIH D+AARNCLV VK+ D G S GD Y A
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAK 173
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
P++W APESL + SI K +VW+FGVLLWEI +G PY + QV +
Sbjct: 174 FPIKWTAPESLAYNKFSI-------KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL- 225
Query: 318 GTEALRLPAP 327
+ R+ P
Sbjct: 226 -EKDYRMERP 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 25/53 (47%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARNCLV VK+ D G S GD Y A P++W APESL
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 185
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-69
Identities = 61/247 (24%), Positives = 109/247 (44%), Gaps = 18/247 (7%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
+ +K +G G FG V +G + V ++ L+E S L EA
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+ + ++ RL+ CL L+ + G L +++ ++ + + +
Sbjct: 69 YVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWC 123
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPV 260
+ +A G++Y+ + +H D+AARN LV + VKI D G + + H E +P+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W A E SI T + +VWS+GV +WE+ FG PY + ++ + + +
Sbjct: 184 KWMALE-------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--EK 234
Query: 321 ALRLPAP 327
RLP P
Sbjct: 235 GERLPQP 241
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LV + VKI D G + + H E +P++W A ES+L
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-68
Identities = 75/257 (29%), Positives = 109/257 (42%), Gaps = 21/257 (8%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
+H+ + IGRG FG V G + V+ L E
Sbjct: 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK----IHCAVKSLNRITDIGEVS 71
Query: 136 FFLHEATPYRRLRHVNILRLMAACLESD-PWLLVFESCSRGDLKEFLLSNEASREALLEQ 194
FL E + H N+L L+ CL S+ L+V GDL+ F+ + +
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTV 127
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG 254
I + VA G+ Y+ F+H D+AARNC++ + VK+ D G + D Y +YY
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH 187
Query: 255 EVA---LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
LPV+W A ESL T K +VWSFGVLLWE+ G PY +++
Sbjct: 188 NKTGAKLPVKWMALESLQTQ-------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
Query: 312 VITRVFGTEALRLPAPR 328
+ + + RL P
Sbjct: 241 ITVYL--LQGRRLLQPE 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 23/55 (41%), Positives = 31/55 (56%), Gaps = 3/55 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA---LPVRWCAPESLL 384
H D+AARNC++ + VK+ D G + D Y +YY LPV+W A ESL
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-68
Identities = 81/318 (25%), Positives = 123/318 (38%), Gaps = 26/318 (8%)
Query: 20 SSPEVSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQN-----W 74
+S I P G+ E +L + + + LS N
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK 134
+H+ + IGRG FG V G + V+ L E
Sbjct: 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK----IHCAVKSLNRITDIGEV 134
Query: 135 LFFLHEATPYRRLRHVNILRLMAACLESD-PWLLVFESCSRGDLKEFLLSNEASREALLE 193
FL E + H N+L L+ CL S+ L+V GDL+ F+ + +
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PT 190
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV- 252
I + VA G+ ++ F+H D+AARNC++ + VK+ D G + D Y ++
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 253 --HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310
LPV+W A ESL T K +VWSFGVLLWE+ G PY +++
Sbjct: 251 HNKTGAKLPVKWMALESLQTQ-------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303
Query: 311 QVITRVFGTEALRLPAPR 328
+ + + RL P
Sbjct: 304 DITVYL--LQGRRLLQPE 319
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV---HGEVALPVRWCAPESLL 384
H D+AARNC++ + VK+ D G + D Y ++ LPV+W A ESL
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-68
Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 26/255 (10%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + L + + +G+G F K+ +G R + + ++V +++L + + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEA 62
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
A+ +L H +++ C+ D +LV E G L +L N+ + +++
Sbjct: 63 ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEV 118
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--------VKIGDTGSSIDKYPGDYYV 252
A +A + ++ E+ IH +V A+N L+ E +K+ D G SI P D
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
+ W PE + + WSFG LWEI G P + L +
Sbjct: 179 -----ERIPWVPPECIENPKNL------NLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 313 ITRVFGTEALRLPAP 327
+ + +LPAP
Sbjct: 228 LQFY--EDRHQLPAP 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 16/60 (26%), Positives = 23/60 (38%), Gaps = 13/60 (21%)
Query: 333 HVDVAARNCLVTSELR--------VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H +V A+N L+ E +K+ D G SI P D + W PE +
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-----ERIPWVPPECIE 190
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-68
Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 23/249 (9%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
E++ PR+ L V+ +G G FG+V G G +KV V+ LK+ + + FL
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG--------HTKVAVKSLKQGSMSPDA--FL 56
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA ++L+H ++RL A + +P ++ E G L +FL + + + + +
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL---L 112
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
MA +A G++++ E +IH D+ A N LV+ L KI D G + +Y
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W APE++ +I K +VWSFG+LL EI G++PY +++ +VI +
Sbjct: 173 PIKWTAPEAINYGTFTI-------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-- 223
Query: 319 TEALRLPAP 327
R+ P
Sbjct: 224 ERGYRMVRP 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 7e-13
Identities = 17/52 (32%), Positives = 25/52 (48%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+ A N LV+ L KI D G + +Y P++W APE++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-67
Identities = 74/249 (29%), Positives = 119/249 (47%), Gaps = 20/249 (8%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
+ K IG G FG+V +G + S+G+ V ++ LK ++ +++ FL EA
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKT---SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ H NI+RL + P +++ E G L +FL + + M
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLR 154
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS---IDKYPGDYYVHGEVALP 259
+A G+ Y+ ++H D+AARN LV S L K+ D G S D Y G +P
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG-KIP 213
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
+RW APE++ T +VWSFG+++WE+ +G+ PY ELS+ +V+ +
Sbjct: 214 IRWTAPEAISYR-------KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--N 264
Query: 320 EALRLPAPR 328
+ RLP P
Sbjct: 265 DGFRLPTPM 273
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 23/55 (41%), Positives = 29/55 (52%), Gaps = 4/55 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS---IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV S L K+ D G S D Y G +P+RW APE++
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG-KIPIRWTAPEAIS 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-67
Identities = 77/249 (30%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++ R+++ + IG G FG V +G V ++ K S + + FL
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMS----PENPAMAVAIKTCKNCTSDSVREKFL 439
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA R+ H +I++L+ E +P ++ E C+ G+L+ FL + S L+ I
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS----LDLASLI 494
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
A ++T L+Y+ F+H D+AARN LV+S VK+GD G S YY + L
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W APES+ T +VW FGV +WEI G P+ + ++ VI R+
Sbjct: 555 PIKWMAPESINFR-------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-- 605
Query: 319 TEALRLPAP 327
RLP P
Sbjct: 606 ENGERLPMP 614
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 24/51 (47%), Positives = 31/51 (60%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV+S VK+GD G S YY + LP++W APES+
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-67
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 37/297 (12%)
Query: 40 ISFEPLPTLV--------PPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVK 91
F L LV H + S+ + L+ W + PR+ L
Sbjct: 137 TQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAW------EIPRESLRLEV 190
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
++G+G FG+V G G T++V ++ LK E FL EA ++LRH
Sbjct: 191 KLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEK 240
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM 211
+++L A E +P +V E S+G L +FL L + + MA +A+G++Y+
Sbjct: 241 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQIASGMAYV 296
Query: 212 IEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCS 271
++H D+ A N LV L K+ D G + +Y P++W APE+ L
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 272 DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+I K +VWSFG+LL E+ G++PY + + +V+ +V R+P P
Sbjct: 357 RFTI-------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--ERGYRMPCPP 404
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 18/60 (30%), Positives = 28/60 (46%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+ A N LV L K+ D G + +Y P++W APE+ L +I++
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-67
Identities = 75/261 (28%), Positives = 107/261 (40%), Gaps = 30/261 (11%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + IG G FG+V++ + ++ +KE AS+ + F E
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRM-----DAAIKRMKEYASKDDHRDFAGE 75
Query: 141 ATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT-- 197
+L H NI+ L+ AC L E G+L +FL +
Sbjct: 76 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 198 ---------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248
+ A DVA G+ Y+ + FIH D+AARN LV KI D G S
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---Q 192
Query: 249 DYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
+ YV LPVRW A ESL S T +VWS+GVLLWEI G PY +
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYS-------VYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245
Query: 308 SDDQVITRVFGTEALRLPAPR 328
+ ++ ++ + RL P
Sbjct: 246 TCAELYEKL--PQGYRLEKPL 264
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 24/53 (45%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLL 384
H D+AARN LV KI D G S + YV LPVRW A ESL
Sbjct: 165 HRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLN 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-67
Identities = 83/260 (31%), Positives = 135/260 (51%), Gaps = 29/260 (11%)
Query: 69 LSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED 128
++ Q+ F S + ++L ++ IG+G FG V+ G+ RG +KV V+ +K D
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG---------NKVAVKCIKND 55
Query: 129 ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEAS 187
A+ FL EA+ +LRH N+++L+ +E L +V E ++G L ++L S S
Sbjct: 56 ATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 188 REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYP 247
L +K ++DV + Y+ + F+H D+AARN LV+ + K+ D G + +
Sbjct: 113 V---LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--- 166
Query: 248 GDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
LPV+W APE+L S K +VWSFG+LLWEI+ FG++PY +
Sbjct: 167 -ASSTQDTGKLPVKWTAPEALREKKFST-------KSDVWSFGILLWEIYSFGRVPYPRI 218
Query: 308 SDDQVITRVFGTEALRLPAP 327
V+ RV + ++ AP
Sbjct: 219 PLKDVVPRV--EKGYKMDAP 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 19/52 (36%), Positives = 27/52 (51%), Gaps = 4/52 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV+ + K+ D G + + LPV+W APE+L
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALR 187
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-67
Identities = 76/249 (30%), Positives = 118/249 (47%), Gaps = 19/249 (7%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
++H K IG G G+V G R G+ V ++ LK ++ ++ FL EA
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLR----VPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+ + H NI+RL ++V E G L FL +++ + M
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGML 157
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALP 259
V G+ Y+ + G++H D+AARN LV S L K+ D G S ++ P Y +P
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
+RW APE++ S +VWSFGV++WE+ +G+ PY +++ VI+ V
Sbjct: 218 IRWTAPEAIAFRTFSS-------ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--E 268
Query: 320 EALRLPAPR 328
E RLPAP
Sbjct: 269 EGYRLPAPM 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV S L K+ D G S ++ P Y +P+RW APE++
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-65
Identities = 74/250 (29%), Positives = 120/250 (48%), Gaps = 19/250 (7%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + K +G G FG+V G + + V ++ LK ++ ++ FL E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKL----PSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
A+ + H NI+RL +S P ++V E G L FL ++A + M
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGM 152
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVAL 258
+A+G+ Y+ + G++H D+AARN L+ S L K+ D G ++ P Y +
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P+RW +PE +I T +VWS+G++LWE+ +G+ PY E+S+ VI V
Sbjct: 213 PIRWTSPE-------AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-- 263
Query: 319 TEALRLPAPR 328
E RLP P
Sbjct: 264 DEGYRLPPPM 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 19/54 (35%), Positives = 29/54 (53%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+ S L K+ D G ++ P Y +P+RW +PE++
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 23/264 (8%)
Query: 65 LVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRI 124
++ PR+ L ++G+G FG+V G G T++V ++
Sbjct: 247 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKT 298
Query: 125 LKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN 184
LK E FL EA ++LRH +++L A E +P +V E S+G L +FL
Sbjct: 299 LKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE 355
Query: 185 EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
L + + MA +A+G++Y+ ++H D+ A N LV L K+ D G +
Sbjct: 356 TGKYLRLPQL---VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+Y P++W APE+ L +I K +VWSFG+LL E+ G++PY
Sbjct: 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTI-------KSDVWSFGILLTELTTKGRVPY 465
Query: 305 AELSDDQVITRVFGTEALRLPAPR 328
+ + +V+ +V R+P P
Sbjct: 466 PGMVNREVLDQV--ERGYRMPCPP 487
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 18/60 (30%), Positives = 28/60 (46%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+ A N LV L K+ D G + +Y P++W APE+ L +I++
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 7e-65
Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 18/246 (7%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
+ +K +G G FG V +G + V ++ L+E S L EA
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ + ++ RL+ CL L+ + G L +++ ++ + + + +
Sbjct: 70 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCV 124
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVR 261
+A G++Y+ + +H D+AARN LV + VKI D G + + H E +P++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W A E SI T + +VWS+GV +WE+ FG PY + ++ + + +
Sbjct: 185 WMALE-------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--EKG 235
Query: 322 LRLPAP 327
RLP P
Sbjct: 236 ERLPQP 241
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LV + VKI D G + + H E +P++W A ES+L
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-65
Identities = 74/257 (28%), Positives = 124/257 (48%), Gaps = 21/257 (8%)
Query: 72 QNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ 131
+ +++ R + ++G G +G+V EG + + V V+ LKED +
Sbjct: 207 GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTME 259
Query: 132 AEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL 191
E+ FL EA + ++H N+++L+ C P+ ++ E + G+L ++L +
Sbjct: 260 VEE--FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317
Query: 192 LEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
+ + MA +++ + Y+ + FIH ++AARNCLV VK+ D G S Y
Sbjct: 318 VVL---LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
H P++W APESL + SI K +VW+FGVLLWEI +G PY + Q
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSI-------KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 312 VITRVFGTEALRLPAPR 328
V + + R+ P
Sbjct: 428 VYELL--EKDYRMERPE 442
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 24/60 (40%), Positives = 32/60 (53%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H ++AARNCLV VK+ D G S Y H P++W APESL + SI++
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 9e-65
Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 18/247 (7%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
F +L +K +G G FG V +G V ++++++ + +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
L H +I+RL+ C S LV + G L + + + + L + +
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWG 121
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPV 260
+ +A G+ Y+ E G +H ++AARN L+ S +V++ D G + P D + A P+
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W A E SI T + +VWS+GV +WE+ FG PYA L +V + +
Sbjct: 182 KWMALE-------SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--EK 232
Query: 321 ALRLPAP 327
RL P
Sbjct: 233 GERLAQP 239
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 18/53 (33%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H ++AARN L+ S +V++ D G + P D + A P++W A ES+
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-64
Identities = 88/298 (29%), Positives = 143/298 (47%), Gaps = 41/298 (13%)
Query: 40 ISFEPLPTLV--------PPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVK 91
+ FE L LV + +P ++ Q+ F S + ++L ++
Sbjct: 144 VYFENLMQLVEHYTTDADGLCTRLIKPKVMEG----TVAAQDEFYRSGWALNMKELKLLQ 199
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN 151
IG+G FG V+ G+ RG +KV V+ +K DA+ FL EA+ +LRH N
Sbjct: 200 TIGKGEFGDVMLGDYRG---------NKVAVKCIKNDATAQA---FLAEASVMTQLRHSN 247
Query: 152 ILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
+++L+ +E L +V E ++G L ++L S S +K ++DV + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDVCEAMEY 304
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
+ + F+H D+AARN LV+ + K+ D G + + LPV+W APE+L
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALRE 360
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
S K +VWSFG+LLWEI+ FG++PY + V+ RV + ++ AP
Sbjct: 361 KKFST-------KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--EKGYKMDAPD 409
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARN LV+ + K+ D G + + LPV+W APE+L S ++
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKKFSTKS 367
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 7e-64
Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 34/267 (12%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
F ++ L ++++G G FGKV + T +V V+ LK ++
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGD---NTGEQVAVKSLKPESGGNHIADLK 71
Query: 139 HEATPYRRLRHVNILRLMAACLES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
E R L H NI++ C E + L+ E G LKE+L N+ +
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQ 127
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHG 254
+K A+ + G+ Y+ ++H D+AARN LV SE +VKIGD G + I+ Y V
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK------------- 301
+ PV W APE + +VWSFGV L E+ +
Sbjct: 188 DRDSPVFWYAPE-------CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
Query: 302 -LPYAELSDDQVITRVFGTEALRLPAP 327
+ +++ +++ + E RLP P
Sbjct: 241 GPTHGQMTVTRLVNTL--KEGKRLPCP 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 26/54 (48%), Positives = 32/54 (59%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV SE +VKIGD G + I+ Y V + PV W APE L+
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-63
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 36/265 (13%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
F ++ L ++++G G FGKV + TG V V+ LK DA + + E
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM---VAVKALKADAGPQHRSGWKQE 83
Query: 141 ATPYRRLRHVNILRLMAACLESD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
R L H +I++ C ++ LV E G L+++L + LL
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL----- 138
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYY-VHGEV 256
A + G++Y+ +IH D+AARN L+ ++ VKIGD G + G +YY V +
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK--------------L 302
PV W APE ++ +VWSFGV L+E+ +
Sbjct: 198 DSPVFWYAPE-------CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
Query: 303 PYAELSDDQVITRVFGTEALRLPAP 327
+++ ++ + RLP P
Sbjct: 251 AQGQMTVLRLTELL--ERGERLPRP 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 24/54 (44%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPG-DYY-VHGEVALPVRWCAPESLL 384
H D+AARN L+ ++ VKIGD G + G +YY V + PV W APE L
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 24/290 (8%)
Query: 40 ISFEPLPTLVPP-QHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWF 98
+F L LV + Q ++ ++ PR+ L K++G G F
Sbjct: 142 STFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQF 201
Query: 99 GKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158
G+V +KV V+ +K + E FL EA + L+H +++L A
Sbjct: 202 GEVWMATYNK--------HTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIH 218
+ +P ++ E ++G L +FL S+E S++ L + I + +A G++++ + +IH
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIH 307
Query: 219 TDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTC 278
D+ A N LV++ L KI D G + +Y P++W APE++ +I
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI--- 364
Query: 279 TVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
K +VWSFG+LL EI +G++PY +S+ +VI + R+P P
Sbjct: 365 ----KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--ERGYRMPRPE 408
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 17/51 (33%), Positives = 26/51 (50%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+ A N LV++ L KI D G + +Y P++W APE++
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 67/270 (24%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
QF + L +++++G+G FG V L T V V+ L+ + + F
Sbjct: 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPL---QDNTGEVVAVKKLQHSTEEHLRDF-E 90
Query: 139 HEATPYRRLRHVNILRLMAACLESD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
E + L+H NI++ C + L+ E G L+++L ++ ++
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIK 146
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE 255
++ + G+ Y+ +IH D+A RN LV +E RVKIGD G + + +YY E
Sbjct: 147 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 256 VA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF--------------- 299
P+ W APE S+ + +VWSFGV+L+E+F +
Sbjct: 207 PGESPIFWYAPE-------SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 300 GKLPYAELSDDQVITRVFGTEALRLPAPRA 329
G ++ +I + RLP P
Sbjct: 260 GNDKQGQMIVFHLIELL--KNNGRLPRPDG 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 25/54 (46%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+A RN LV +E RVKIGD G + + +YY E P+ W APESL
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-61
Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 22/248 (8%)
Query: 83 PRQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
R L E+G G FG V +G R ++ V +++LK+ +A+ + EA
Sbjct: 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQI-----DVAIKVLKQGTEKADTEEMMREA 61
Query: 142 TPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
+L + I+RL+ C + +LV E G L +FL+ + ++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELL 116
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALP 259
V+ G+ Y+ E F+H D+AARN L+ + KI D G S + Y P
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
++W APE I + + +VWS+GV +WE +G+ PY ++ +V+ +
Sbjct: 177 LKWYAPE-------CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--E 227
Query: 320 EALRLPAP 327
+ R+ P
Sbjct: 228 QGKRMECP 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 18/54 (33%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+ + KI D G S + Y P++W APE +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 76/249 (30%), Positives = 114/249 (45%), Gaps = 21/249 (8%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHE 140
+ L ++++G G FG V GE T V V+ LK D + F+ E
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDA----PSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
L H N++RL L P +V E G L + L ++ G +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRY 126
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVAL 258
A+ VA G+ Y+ FIH D+AARN L+ + VKIGD G + + Y + +
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P WCAPE S++T T + + W FGV LWE+F +G+ P+ L+ Q++ ++
Sbjct: 187 PFAWCAPE-------SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-D 238
Query: 319 TEALRLPAP 327
E RLP P
Sbjct: 239 KEGERLPRP 247
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 22/54 (40%), Positives = 29/54 (53%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+ + VKIGD G + + Y + +P WCAPESL
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 36/266 (13%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
QF + L +++++G+G FG V L T V V+ L+ + + F E
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPL---QDNTGEVVAVKKLQHSTEEHLRDF-ERE 61
Query: 141 ATPYRRLRHVNILRLMAACLES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
+ L+H NI++ C + L+ E G L+++L ++ ++ +
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLL 117
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEV 256
+ + G+ Y+ +IH D+A RN LV +E RVKIGD G + + + + V
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF---------------GK 301
P+ W APE S+ + +VWSFGV+L+E+F + G
Sbjct: 178 ESPIFWYAPE-------SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 302 LPYAELSDDQVITRVFGTEALRLPAP 327
++ +I + RLP P
Sbjct: 231 DKQGQMIVFHLIELL--KNNGRLPRP 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 23/54 (42%), Positives = 30/54 (55%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+A RN LV +E RVKIGD G + + + + V P+ W APESL
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-61
Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 35/269 (13%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
F + L Y+ ++G+G FG V L + T + V V+ L+ ++ F
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGD---NTGALVAVKQLQHSGPDQQRDF-Q 72
Query: 139 HEATPYRRLRHVNILRLMAACLES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
E + L I++ LV E G L++FL + A L+
Sbjct: 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASR 128
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE 255
+ + + G+ Y+ +H D+AARN LV SE VKI D G + + DYYV E
Sbjct: 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 256 VA-LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA--------- 305
P+ W APE S+ + + +VWSFGV+L+E+F + +
Sbjct: 189 PGQSPIFWYAPE-------SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 306 -----ELSDDQVITRVFGTEALRLPAPRA 329
+ +++ + E RLPAP A
Sbjct: 242 GCERDVPALSRLLELL--EEGQRLPAPPA 268
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 27/54 (50%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVA-LPVRWCAPESLL 384
H D+AARN LV SE VKI D G + + DYYV E P+ W APESL
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-60
Identities = 76/249 (30%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 83 PRQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHE 140
R+ L KE+G G FG V +G + + V V+ILK +A A K L E
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQM-----KKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
A ++L + I+R++ C + W+LV E G L ++L N ++ + I++
Sbjct: 69 ANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IEL 122
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVAL 258
V+ G+ Y+ E F+H D+AARN L+ ++ KI D G S + Y
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
PV+W APE I + K +VWSFGVL+WE F +G+ PY + +V +
Sbjct: 183 PVKWYAPE-------CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-- 233
Query: 319 TEALRLPAP 327
+ R+ P
Sbjct: 234 EKGERMGCP 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 19/54 (35%), Positives = 26/54 (48%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN L+ ++ KI D G S + Y PV+W APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-57
Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 22/301 (7%)
Query: 30 PGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHY 89
P + + P P + + P + S + R L
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339
Query: 90 VK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR 148
E+G G FG V +G R ++ V +++LK+ +A+ + EA +L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQI-----DVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
+ I+RL+ C + +LV E G L +FL+ + ++ V+ G+
Sbjct: 395 NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGM 449
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPE 266
Y+ E F+H ++AARN L+ + KI D G S + Y P++W APE
Sbjct: 450 KYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
I + + +VWS+GV +WE +G+ PY ++ +V+ + + R+
Sbjct: 510 -------CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--EQGKRMEC 560
Query: 327 P 327
P
Sbjct: 561 P 561
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 17/54 (31%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWCAPESLL 384
H ++AARN L+ + KI D G S + Y P++W APE +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-53
Identities = 85/280 (30%), Positives = 121/280 (43%), Gaps = 24/280 (8%)
Query: 52 QHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEE 111
H+ Y L Q D + P L+ ++IG G FG V E G +
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD- 62
Query: 112 STGRTTSKVFVRILKEDASQAEKL-FFLHEATPYRRLRHVNILRLMAACLESDPWLLVFE 170
V V+IL E AE++ FL E +RLRH NI+ M A + +V E
Sbjct: 63 --------VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114
Query: 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM--IEDGFIHTDVAARNCLV 228
SRG L L + A + L++ + MA DVA G++Y+ +H ++ + N LV
Sbjct: 115 YLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 229 TSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWS 288
+ VK+ D G S K P W APE L EK +V+S
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFLSSKSAAGTP-EWMAPEVLRDE-------PSNEKSDVYS 224
Query: 289 FGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
FGV+LWE+ + P+ L+ QV+ V G + RL PR
Sbjct: 225 FGVILWELAT-LQQPWGNLNPAQVVAAV-GFKCKRLEIPR 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 16/51 (31%), Positives = 21/51 (41%), Gaps = 1/51 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H ++ + N LV + VK+ D G S K P W APE L
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP-EWMAPEVL 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 63/255 (24%), Positives = 115/255 (45%), Gaps = 22/255 (8%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
+ +++ P Q+ + IG G FG V +G+ G V V++L A ++L
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----------DVAVKMLNVTAPTPQQL 64
Query: 136 F-FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQ 194
F +E R+ RHVNIL M +V + C L L ++E E
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETK----FEM 119
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVH 253
I +A A G+ Y+ IH D+ + N + + VKIGD G ++ +
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
+++ + W APE + D++ + + +V++FG++L+E+ G+LPY+ +++ I
Sbjct: 180 EQLSGSILWMAPEVIRMQDSN----PYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQI 234
Query: 314 TRVFGTEALRLPAPR 328
+ G +L +
Sbjct: 235 IEMVGRGSLSPDLSK 249
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 13/52 (25%), Positives = 25/52 (48%), Gaps = 1/52 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+ + N + + VKIGD G ++ + +++ + W APE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 65/260 (25%), Positives = 99/260 (38%), Gaps = 41/260 (15%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF---FLH 139
+L + IG G FGKV G E V V+ + D +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDE---------VAVKAARHDPDEDISQTIENVRQ 55
Query: 140 EATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
EA + L+H NI+ L CL+ LV E G L L + L+
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILV------N 109
Query: 200 MAIDVATGLSY---MIEDGFIHTDVAARNCLVTSELR--------VKIGDTGSSIDKYPG 248
A+ +A G++Y IH D+ + N L+ ++ +KI D G + + +
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
A W APE + S ++ +VWS+GVLLWE+ G++P+ +
Sbjct: 170 TKM---SAAGAYAWMAPEVIRAS-------MFSKGSDVWSYGVLLWELLT-GEVPFRGID 218
Query: 309 DDQVITRVFGTEALRLPAPR 328
V V L LP P
Sbjct: 219 GLAVAYGV-AMNKLALPIPS 237
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-48
Identities = 55/265 (20%), Positives = 95/265 (35%), Gaps = 35/265 (13%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
F L + + +G+G FG+ ++ R T + ++ L + ++ F
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE-------TGEVMVMKELIRFDEETQR-TF 54
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
L E R L H N+L+ + + + E G L+ + S ++
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQR 110
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD--------------TGSSI 243
+ A D+A+G++Y+ IH D+ + NCLV V + D G
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
K P + V P W APE + EK +V+SFG++L EI
Sbjct: 171 LKKPDRKKRYTVVGNP-YWMAPEMINGRS-------YDEKVDVFSFGIVLCEIIG-RVNA 221
Query: 304 YAELSDDQVITRVFGTEALRLPAPR 328
+ + + L P
Sbjct: 222 DPDYLPRTMDFGLNVRGFLDRYCPP 246
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 17/65 (26%), Positives = 22/65 (33%), Gaps = 15/65 (23%)
Query: 333 HVDVAARNCLVTSELRVKIGD--------------TGSSIDKYPGDYYVHGEVALPVRWC 378
H D+ + NCLV V + D G K P + V P W
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP-YWM 189
Query: 379 APESL 383
APE +
Sbjct: 190 APEMI 194
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-46
Identities = 53/263 (20%), Positives = 104/263 (39%), Gaps = 29/263 (11%)
Query: 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF 136
+ +QL+++ ++ G++ +G +G + + V++LK K
Sbjct: 2 NKHSGIDFKQLNFLTKLNENHSGELWKGRWQGND---------IVVKVLKVRDWSTRKSR 52
Query: 137 -FLHEATPYRRLRHVNILRLMAACLESDPWLL--VFESCSRGDLKEFLLSNEASREALLE 193
F E R H N+L ++ AC + G L L ++
Sbjct: 53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VD 109
Query: 194 QGITIKMAIDVATGLSYM--IEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
Q +K A+D+A G++++ +E + +R+ ++ ++ +I
Sbjct: 110 QSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----- 164
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
W APE+L ++WSF VLLWE+ ++P+A+LS+ +
Sbjct: 165 -SPGRMYAPAWVAPEALQKKPEDT----NRRSADMWSFAVLLWELVT-REVPFADLSNME 218
Query: 312 VITRVFGTEALRLPAPRAVNSHV 334
+ +V E LR P ++ HV
Sbjct: 219 IGMKV-ALEGLRPTIPPGISPHV 240
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-46
Identities = 58/285 (20%), Positives = 115/285 (40%), Gaps = 28/285 (9%)
Query: 51 PQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLE 110
P+ N+ A S + + Q E+ P +QL + IG+G FG+V G G
Sbjct: 2 PEMNLSLLSARS---FPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-- 56
Query: 111 ESTGRTTSKVFVRILKEDASQAEKL-FFLHEATPYRRLRHVNILRLMAACLESDPWLLVF 169
+V +R++ + ++L F E YR+ RH N++ M AC+ ++
Sbjct: 57 --------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108
Query: 170 ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229
C L + + L+ T ++A ++ G+ Y+ G +H D+ ++N
Sbjct: 109 SLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164
Query: 230 SELRVKIGDTG-SSIDKYPGDYYVHGEVALPV---RWCAPESL--LCSDTSIQTCTVTEK 283
+V I D G SI ++ + APE + L DT ++
Sbjct: 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223
Query: 284 CNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+V++ G + +E+ + P+ + +I ++ ++ +
Sbjct: 224 SDVFALGTIWYELHA-REWPFKTQPAEAIIWQM--GTGMKPNLSQ 265
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 32/255 (12%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
S +++ + +GRG FG V + + R + V ++ ++ ++ + F
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD---------VAIKQIESESERKA---F 48
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
+ E R+ H NI++L ACL +P LV E G L L E
Sbjct: 49 IVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHA 104
Query: 198 IKMAIDVATGLSY---MIEDGFIHTDVAARNCLVTSELRV-KIGDTGSSIDKYPGDYYVH 253
+ + + G++Y M IH D+ N L+ + V KI D G++ D
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
G W APE S +EKC+V+S+G++LWE+ + P+ E+
Sbjct: 165 G----SAAWMAPEVFEGS-------NYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFR 212
Query: 314 TRVFGTEALRLPAPR 328
R P +
Sbjct: 213 IMWAVHNGTRPPLIK 227
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-41
Identities = 62/268 (23%), Positives = 104/268 (38%), Gaps = 41/268 (15%)
Query: 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGE--ARGLEESTGRTTSKVFVRILKEDASQAEK 134
S ++ Y K+IG+G FG V +G V ++ L S+ E
Sbjct: 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSV---------VAIKSLILGDSEGET 61
Query: 135 LF------FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR 188
F E L H NI++L P +V E GDL LL
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP- 118
Query: 189 EALLEQGITIKMAIDVATGLSYM--IEDGFIHTDVAARNCLVTS-----ELRVKIGDTGS 241
++ + +++ +D+A G+ YM +H D+ + N + S + K+ D G
Sbjct: 119 ---IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301
S + G +W APE++ + + TEK + +SF ++L+ I G+
Sbjct: 176 SQQSVHSVSGLLG----NFQWMAPETIGAEEE-----SYTEKADTYSFAMILYTILT-GE 225
Query: 302 LPYAELSDDQV-ITRVFGTEALRLPAPR 328
P+ E S ++ + E LR P
Sbjct: 226 GPFDEYSYGKIKFINMIREEGLRPTIPE 253
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-41
Identities = 81/316 (25%), Positives = 121/316 (38%), Gaps = 72/316 (22%)
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARG--------------LEESTGRTTSKV 120
+D+S+++FPR +L K +GRG FG+V+E +A G L+E + +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 121 FVR---ILKEDAS-------------QAEKLFFLHEATPYRRLRH--------------- 149
+ IL L + E + L
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 150 -----------VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT- 197
I + L+S S + K E L +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 198 ----IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV- 252
I + VA G+ ++ IH D+AARN L++ + VKI D G + D Y YV
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQ 311
G+ LP++W APE +I T + +VWSFGVLLWEIF G PY + D++
Sbjct: 252 KGDARLPLKWMAPE-------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 312 VITRVFGTEALRLPAP 327
R+ E R+ AP
Sbjct: 305 FCRRL--KEGTRMRAP 318
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 64/280 (22%), Positives = 112/280 (40%), Gaps = 52/280 (18%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY 144
+Q+ VK+IG+G +G+V G+ RG KV V++ + + E Y
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRG---------EKVAVKVFFTTEEAS----WFRETEIY 83
Query: 145 --RRLRHVNILRLMAACLESDP----WLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
+RH NIL +AA ++ L+ + G L ++L S +++L
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML------ 137
Query: 199 KMAIDVATGLSYMIEDGF--------IHTDVAARNCLVTSELRVKIGDTGSSI----DKY 246
K+A +GL ++ + F H D+ ++N LV I D G ++ D
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF--------- 297
D + V R+ PE +L + +++SFG++LWE+
Sbjct: 198 EVDIPPNTRVGTK-RYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
Query: 298 EFGKLPYAELSDDQV----ITRVFGTEALRLPAPRAVNSH 333
E +LPY +L + + + LR P +S
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 54/281 (19%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY 144
+ + + IG+G FG+V G+ RG +V V+I E+ + EA Y
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWRG---------EEVAVKIFSSR----EERSWFREAEIY 88
Query: 145 --RRLRHVNILRLMAACLESD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
LRH NIL +AA + + LV + G L ++L + E ++
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------ 142
Query: 199 KMAIDVATGLSYMIED--------GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG-- 248
K+A+ A+GL+++ + H D+ ++N LV I D G ++
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 249 --DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF--------- 297
D + V R+ APE +L +++ ++ ++++ G++ WEI
Sbjct: 203 TIDIAPNHRVGTK-RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 298 EFGKLPYAEL-----SDDQVITRVFGTEALRLPAPRAVNSH 333
E +LPY +L S +++ V + LR P S
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVV-CEQKLRPNIPNRWQSC 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 56/280 (20%), Positives = 110/280 (39%), Gaps = 52/280 (18%)
Query: 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY 144
+ + ++ +G+G +G+V G +G V V+I ++ + E Y
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQG---------ENVAVKIFSSRDEKS----WFRETELY 54
Query: 145 --RRLRHVNILRLMAACLESD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
LRH NIL +A+ + S L+ G L ++L + L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------ 108
Query: 199 KMAIDVATGLSYMIEDGF--------IHTDVAARNCLVTSELRVKIGDTGSSIDKYPG-- 248
++ + +A+GL+++ + F H D+ ++N LV + I D G ++
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 249 --DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF--------- 297
D + V R+ APE +L + ++ ++W+FG++LWE+
Sbjct: 169 QLDVGNNPRVGTK-RYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 298 EFGKLPYAELSDDQV----ITRVFGTEALRLPAPRAVNSH 333
E K P+ ++ + + +V + R P S
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 60/299 (20%)
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK 134
+SE L ++ IGRG +G V +G V V++ Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE---------RPVAVKVFSFANRQN-- 51
Query: 135 LFFLHEATPYR--RLRHVNILRLMAACLESD-----PWLLVFESCSRGDLKEFLLSNEAS 187
F++E YR + H NI R + +LLV E G L ++L + +
Sbjct: 52 --FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD 109
Query: 188 REALLEQGITIKMAIDVATGLSYMIED---------GFIHTDVAARNCLVTSELRVKIGD 238
+ ++A V GL+Y+ + H D+ +RN LV ++ I D
Sbjct: 110 WVSSC------RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 239 TGSSIDKYPGDYYVHGEVALP-------VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGV 291
G S+ GE +R+ APE L + + ++ ++++ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 292 LLWEIF------------EFGKLPYAEL-----SDDQVITRVFGTEALRLPAPRAVNSH 333
+ WEIF ++ + + + + V E R P A +
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV-SREKQRPKFPEAWKEN 281
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 61/295 (20%), Positives = 104/295 (35%), Gaps = 52/295 (17%)
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK 134
+ F L ++ RG FG V + + V V+I Q+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN---------EYVAVKIFPIQDKQSW- 63
Query: 135 LFFLHEATPYRRLRHVNILRLMAACLESD----PWLLVFESCSRGDLKEFLLSNEASREA 190
+E ++H NIL+ + A L+ +G L +FL +N S
Sbjct: 64 -QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE 122
Query: 191 LLEQGITIKMAIDVATGLSYMIEDGF----------IHTDVAARNCLVTSELRVKIGDTG 240
L +A +A GL+Y+ ED H D+ ++N L+ + L I D G
Sbjct: 123 LC------HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 241 SSIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF- 297
++ G HG+V R+ APE L + ++++ G++LWE+
Sbjct: 177 LALKFEAGKSAGDTHGQVGTR-RYMAPEVL--EGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 298 ---------EFGKLPYAEL-----SDDQVITRVFGTEALRLPAPRAVNSHVDVAA 338
+ LP+ E S + + V + R H +A
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV-VHKKKRPVLRDYWQKHAGMAM 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-23
Identities = 59/247 (23%), Positives = 92/247 (37%), Gaps = 30/247 (12%)
Query: 72 QNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDA 129
+F + +++++G G F V E G + RIL +
Sbjct: 16 NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVE--------GLHDGHFYALKRILCHEQ 67
Query: 130 SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW----LLVFESCSRGDLKEFLLSNE 185
E+ EA +R H NILRL+A CL L+ RG L + +
Sbjct: 68 QDREEA--QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125
Query: 186 ASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245
L E I + + + + GL + G+ H D+ N L+ E + + D GS
Sbjct: 126 DKGNFLTEDQI-LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
Query: 246 YPGDYYVHGEVALPVRW--------CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
+ L APE L S S C + E+ +VWS G +L+ +
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPE--LFSVQS--HCVIDERTDVWSLGCVLYAMM 240
Query: 298 EFGKLPY 304
FG+ PY
Sbjct: 241 -FGEGPY 246
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 45/284 (15%), Positives = 93/284 (32%), Gaps = 31/284 (10%)
Query: 45 LPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEG 104
L L P +Y Q + +EFQ + ++ +G G F +V E
Sbjct: 31 LSGLSKPV------SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 105 EARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164
L ++ + K +++ K A+ E + ++ +A L +
Sbjct: 85 TQGDLNDA--KNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141
Query: 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224
+LV E S G L + + + E ++ QG+ I A+ + + + + IH D+
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201
Query: 225 NCLVTSELR-----------VKIGDTGSSIDK--YPGDYYVHGEVALPVRWCAPESLLCS 271
N ++ + + + D G SID +P + E L
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF-QCVEML--- 257
Query: 272 DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
+ + + ++ + FG + +
Sbjct: 258 ----SNKPWNYQIDYFGVAATVYCML-FGTYMKVKNEGGECKPE 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 45/247 (18%), Positives = 98/247 (39%), Gaps = 25/247 (10%)
Query: 75 FDSSEFQFPRQQL-HY--VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDA 129
D Q + Y +++IG G FGK + + + +V I
Sbjct: 11 VDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVK--------STEDGRQYVIKEINISRM 62
Query: 130 SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASRE 189
S E+ E ++H NI++ + E+ +V + C GDL + + A +
Sbjct: 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKG 119
Query: 190 ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249
L ++ + + + L ++ + +H D+ ++N +T + V++GD G +
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 250 YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
+ P + +PE +C + K ++W+ G +L+E+ K + S
Sbjct: 180 ELARACIGTPY-YLSPE--ICENKP-----YNNKSDIWALGCVLYELCT-LKHAFEAGSM 230
Query: 310 DQVITRV 316
++ ++
Sbjct: 231 KNLVLKI 237
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 6e-18
Identities = 40/294 (13%), Positives = 77/294 (26%), Gaps = 48/294 (16%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLF 136
S ++L V+ + G V + + KVF + S+ E+L
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVF----LVRDVERLEDFALKVFTMGAENSRSELERL- 109
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPW--------------------------LLVFE 170
RL + P LL+
Sbjct: 110 -HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 171 SCSRGDLKEF--LLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228
+ S DL+ L + + + + G +H N +
Sbjct: 169 AAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI 227
Query: 229 TSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWS 288
+ R+ +GD + G ++PV + E L T T T N W
Sbjct: 228 MPDGRLMLGDVSAL--WKVGTRGP--ASSVPVTYAPREFLNA-----STATFTHALNAWQ 278
Query: 289 FGVLLWEIFEFGKLPYAELSD--DQVITRVFGTEALRLPAPRAVNSHVDVAARN 340
G+ ++ ++ LP+ ++ R + + +
Sbjct: 279 LGLSIYRVW-CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT 331
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+GRG FGKV +G L + T V V+ LKE+ +Q +L F E H N+
Sbjct: 38 LGRGGFGKVYKGR---LADGT-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
LRL C+ LLV+ + G + L S+ L+ ++A+ A GL+Y+
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP-LDWPKRQRIALGSARGLAYLH 148
Query: 213 EDG---FIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
+ IH DV A N L+ E +GD G + D +V V + APE L
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL- 207
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEI 296
T +EK +V+ +GV+L E+
Sbjct: 208 ------STGKSSEKTDVFGYGVMLLEL 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 50/275 (18%), Positives = 94/275 (34%), Gaps = 26/275 (9%)
Query: 33 DQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKE 92
+ R ++ E L + S F +Q +
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSR 64
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRL-RH 149
+G G +G+V + + +++ R + ++ L E + ++ +H
Sbjct: 65 LGHGSYGEVFKV--------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
+RL A E L E C L++ EA +L E + D L+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHC---EAWGASLPEAQV-WGYLRDTLLALA 171
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
++ G +H DV N + R K+GD G ++ + P R+ APE L
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDP-RYMAPE--L 227
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ +V+S G+ + E+ +LP+
Sbjct: 228 LQGSY------GTAADVFSLGLTILEVACNMELPH 256
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
IG G FGKV +G L + KV ++ ++SQ + F E RH ++
Sbjct: 47 IGHGVFGKVYKGV---LRDGA-----KVALKRRTPESSQGIEEF-ETEIETLSFCRHPHL 97
Query: 153 LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI 212
+ L+ C E + +L+++ G+LK L ++ ++ +++ I A GL Y+
Sbjct: 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM-SWEQRLEICIGAARGLHYLH 156
Query: 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR----WCAPESL 268
IH DV + N L+ KI D G S H ++ V+ + PE
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTH--LSTVVKGTLGYIDPEYF 213
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
+ +TEK +V+SFGV+L+E+
Sbjct: 214 I-------KGRLTEKSDVYSFGVVLFEV 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 40/232 (17%), Positives = 84/232 (36%), Gaps = 41/232 (17%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVR-ILKEDASQAEKLFFLHEATPYRRLR 148
++ +GRG FG V E + + ++ + + + E +L
Sbjct: 10 IQCLGRGGFGVVFEA--------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 149 HVNILRLMAACLESDPWL------------LVFESCSRGDLKEFLLSNEASREALLEQGI 196
H I+R A LE + + + C + +LK+++ N E+ +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSV 119
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG--------SSIDKYPG 248
+ + + +A + ++ G +H D+ N T + VK+GD G
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 249 DYYVHGEVALPV---RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
+ V + +PE S + K +++S G++L+E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPE--QIHGNSY-----SHKVDIFSLGLILFELL 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 21/218 (9%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RI-LKEDASQAEKLFFLHEATPYRR 146
K+IGRG F +V R G ++ + + + + E ++
Sbjct: 37 EKKIGRGQFSEVY----RAACLLDG----VPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L H N+++ A+ +E + +V E GDL + + + + E+ + K + + +
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKYFVQLCS 147
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266
L +M +H D+ N +T+ VK+GD G H V P + +PE
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPE 206
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ K ++WS G LL+E+ + P+
Sbjct: 207 --RIHENG-----YNFKSDIWSLGCLLYEMAA-LQSPF 236
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 57/269 (21%), Positives = 103/269 (38%), Gaps = 46/269 (17%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV---RILKEDASQAEKLFFLHEATPYR 145
+ EIGRG F V +GL+ T V V + +++E+ F EA +
Sbjct: 30 FDIEIGRGSFKTVY----KGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLK 80
Query: 146 RLRHVNILRLMAACL---ESDPWLLVF-ESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
L+H NI+R + + +++ E + G LK +L + + +L
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-----SWC 135
Query: 202 IDVATGLSYMIEDG--FIHTDVAARNCLVTSEL-RVKIGDTG-SSIDKYPGDYYVHGEVA 257
+ GL ++ IH D+ N +T VKIGD G +++ + V G
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE 195
Query: 258 LPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
+ APE + E +V++FG+ + E+ + PY+E + I R
Sbjct: 196 ----FMAPE--------MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRV 242
Query: 318 GTEALRLPAPRAVNSHVDVAARN----CL 342
+ P + + + C+
Sbjct: 243 TSGVK----PASFDKVAIPEVKEIIEGCI 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 37/265 (13%), Positives = 79/265 (29%), Gaps = 37/265 (13%)
Query: 91 KEIGRGWFGKVVEGEARGLEE-------STGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
+G+ +E + E ++ +KE+ + L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL--RGIKNQ 141
Query: 144 YRRLRHVNILRLMAACL-------------ESDPW------LLVFESCSRGDLKEFLLSN 184
+ H+ + E D W L + E LLS+
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201
Query: 185 EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
++ ++L+ +++ + V L+ + G +HT + + ++ V +
Sbjct: 202 SSTHKSLVHH-ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 258
Query: 245 KYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
G V G P A L +T + W+ G+ ++ I+ L
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQH--HPTLMTFAFDTWTLGLAIYWIWC-ADL 315
Query: 303 PYAELSDDQVITRVFGTEALRLPAP 327
P + + +F +P P
Sbjct: 316 PNTDDAALGGSEWIF-RSCKNIPQP 339
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 38/243 (15%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEK-LFFLHEATPYRRLR 148
K +G G G VV GR V V R+L + A + L E+
Sbjct: 21 KILGYGSSGTVVFQG-----SFQGR---PVAVKRMLIDFCDIALMEIKLLTES-----DD 67
Query: 149 HVNILRLMAACLESDP--WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI--DV 204
H N++R C E+ + E C+ +L++ + S S E L Q +++ +
Sbjct: 68 HPNVIRYY--CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSE-------------LRVKIGDTGSSIDKYPGDYY 251
A+G++++ IH D+ +N LV++ LR+ I D G G
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 252 VHGEVALPV---RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
+ P W APE L S+ +T +++S G + + I GK P+ +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 309 DDQ 311
+
Sbjct: 245 SRE 247
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 50/236 (21%), Positives = 92/236 (38%), Gaps = 27/236 (11%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVR--ILKEDASQAEKLFFLHEATPYRRL 147
+ IG G +G+ + ++ K+ V + ++AEK + E R L
Sbjct: 11 LYTIGTGSYGRCQKIR--------RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 148 RHVNILRLMAACLESDPWLL--VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
+H NI+R ++ L V E C GDL + R+ L E+ + +++ +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLT 121
Query: 206 TGLSYM-----IEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
L +H D+ N + + VK+GD G + + V P
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
+ +PE + S EK ++WS G LL+E+ P+ S ++ ++
Sbjct: 182 -YMSPE--QMNRMS-----YNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKI 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 44/239 (18%), Positives = 84/239 (35%), Gaps = 56/239 (23%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
++ IG G FG+V + R K +V +K EK E +L H
Sbjct: 16 IELIGSGGFGQVFKA--------KHRIDGKTYV--IKRVKYNNEKA--EREVKALAKLDH 63
Query: 150 VNILRLMAACLESDPWL----------------LVFESCSRGDLKEFLLSNEASREALLE 193
VNI+ D + E C +G L++++ E R L+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLD 120
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--------IDK 245
+ + +++ + G+ Y+ I+ D+ N + +VKIGD G +
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
G + +PE S ++ ++++ G++L E+ +
Sbjct: 181 SKGTLR----------YMSPE--QISSQDY-----GKEVDLYALGLILAELLHVCDTAF 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 52/251 (20%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLH 139
+ H +++IG G FG V + R ++ R K A ++ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKC--------VKRLDGCIYAIKRSKKPLAGSVDEQNALR 59
Query: 140 EATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
E + L +H +++R +A E D L+ E C+ G L + + N E +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL-K 118
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVT-------------------SELRVKIGDT 239
+ + V GL Y+ +H D+ N ++ +++ KIGD
Sbjct: 119 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 240 G-----SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294
G SS GD R+ A E L + T K ++++ + +
Sbjct: 179 GHVTRISSPQVEEGD----------SRFLANEVLQ------ENYTHLPKADIFALALTVV 222
Query: 295 EIFEFGKLPYA 305
LP
Sbjct: 223 CAAGAEPLPRN 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 45/310 (14%), Positives = 101/310 (32%), Gaps = 45/310 (14%)
Query: 42 FEPLPTLVPPQHNVKRPPAYSEELVRQL--SMQNWFDSSEFQFPRQQLHYVKEIGRGWFG 99
F +P + A + L + Q + SE + L +G+
Sbjct: 28 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPY 87
Query: 100 KVVEGEARGLEESTGRT-TSKVF--------------------VRILKEDASQAEKLFFL 138
+E ++ TG + V +R+L+ +Q + L
Sbjct: 88 AYLEAT----DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 139 HEATPYRRLRHVNILRLMAACL-ESDPW------LLVFESCSRGDLKEFLLSNEASREAL 191
P+ ++ +++ L E D W L + E LLS+ ++ ++L
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 192 LEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 251
+ +++ + V L+ + G +HT + + ++ V + G
Sbjct: 204 VHH-ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGARV 260
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQT----CTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
++ + PE T +T + W+ G++++ I+ LP +
Sbjct: 261 ---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW-CADLPITKD 316
Query: 308 SDDQVITRVF 317
+ +F
Sbjct: 317 AALGGSEWIF 326
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 25/242 (10%)
Query: 76 DSSEFQFPRQQLHY--VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE 133
DSS + + Y + IG G V V ++ + + Q
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCAPKKEK---VAIKRINLEKCQTS 56
Query: 134 KLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRG---DLKEFLLSNEASREA 190
L E + H NI+ + + D LV + S G D+ + +++ +
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 191 LLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGD 249
+L++ + +V GL Y+ ++G IH DV A N L+ + V+I D G S+ GD
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 250 YYVHGE----VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305
+ V P W APE + Q K ++WSFG+ E+ G PY
Sbjct: 177 ITRNKVRKTFVGTP-CWMAPEVME------QVRGYDFKADIWSFGITAIELAT-GAAPYH 228
Query: 306 EL 307
+
Sbjct: 229 KY 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 55/261 (21%), Positives = 95/261 (36%), Gaps = 35/261 (13%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRL-R 148
+G G G +V RG+ R V V RIL E S A++ E R
Sbjct: 30 DVLGHGAEGTIV---YRGM--FDNR---DVAVKRILPECFSFADR-----EVQLLRESDE 76
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H N++R + + E C+ L+E++ ++ I + +GL
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ----KDFAHLGLEPITLLQQTTSGL 131
Query: 209 SYMIEDGFIHTDVAARNCLVT-----SELRVKIGDTGSSIDKYPGDYYVHGEVALP--VR 261
+++ +H D+ N L++ +++ I D G G + +P
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
W APE L T +++S G + + + G P+ + Q + G +
Sbjct: 192 WIAPEMLSEDCKE----NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACS 246
Query: 322 LRLPAPRAVNSHVDVAARNCL 342
L P H DV AR +
Sbjct: 247 LDCLHP---EKHEDVIARELI 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 39/237 (16%), Positives = 80/237 (33%), Gaps = 37/237 (15%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+G+G V G + TG +++ + + E ++L H
Sbjct: 15 DILGQGATANVFRGR----HKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 151 NILRLMAA--CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
NI++L A + +L+ E C G L L L + + + DV G+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGM 125
Query: 209 SYMIEDGFIHTDVAARNCLVTS----ELRVKIGDTGSSIDKYPGD---------YYVHGE 255
+++ E+G +H ++ N + + K+ D G++ + + Y+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL--- 182
Query: 256 VALPVRWCAPESLLCSDTSIQTCTV-TEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
P+ + ++WS GV + G LP+ +
Sbjct: 183 --------HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-TGSLPFRPFEGPR 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 52/270 (19%), Positives = 101/270 (37%), Gaps = 44/270 (16%)
Query: 70 SMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKE 127
Q+ F + +L + + G F V E + + + + R+L
Sbjct: 13 RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQ--------DVGSGREYALKRLLSN 64
Query: 128 DASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPW-------LLVFESCSRGDLKE 179
+ + + + E ++L H NI++ +A L+ +G L E
Sbjct: 65 EEEKNRAI--IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122
Query: 180 FLLSNEASREALLEQGITIKMAIDVATGLSYM--IEDGFIHTDVAARNCLVTSELRVKIG 237
FL SR L + +K+ + +M + IH D+ N L++++ +K+
Sbjct: 123 FLK-KMESRGPLSCDTV-LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 238 DTGSS--IDKYPGDYYVHGEVALP---VRWC------APESLLCSDTSIQTCTVTEKCNV 286
D GS+ I YP + AL + PE + S + EK ++
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE--IIDLYS--NFPIGEKQDI 236
Query: 287 WSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
W+ G +L+ + F + P+ +D R+
Sbjct: 237 WALGCILYLLC-FRQHPF----EDGAKLRI 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 48/253 (18%), Positives = 93/253 (36%), Gaps = 29/253 (11%)
Query: 67 RQLSMQNWFDSSEFQFPRQQLHY--VKEIGRGW--FGKVVEGEARGLEESTGRTTSKVFV 122
M+N + F + Y + IG+G+ V + TG V V
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVN----LARYKPTGEY---VTV 57
Query: 123 RILKEDASQAEKLFFL-HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL 181
R + +A E + FL E + H NI+ A + + +V + G K+ +
Sbjct: 58 RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117
Query: 182 LSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241
+ + E I + V L Y+ G++H V A + L++ + +V + S
Sbjct: 118 --CTHFMDGMNELAIAYILQ-GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 242 S-------IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294
+ + + V + W +PE L + K +++S G+
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQ-----GYDAKSDIYSVGITAC 228
Query: 295 EIFEFGKLPYAEL 307
E+ G +P+ ++
Sbjct: 229 ELAN-GHVPFKDM 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+ +G G FG V+ R + + TG +V ++ +++ S + + E ++L H
Sbjct: 20 ERLGTGGFGYVL----RWIHQDTGE---QVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 151 NILRL------MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
N++ + +D LL E C GDL+++L E L++G + D+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDI 130
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD---------YYV 252
++ L Y+ E+ IH D+ N ++ L KI D G + + G+ Y+
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
E+ ++ T + WSFG L +E G P+
Sbjct: 191 APEL------------------LEQKKYTVTVDYWSFGTLAFECI-TGFRPF 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 40/243 (16%), Positives = 81/243 (33%), Gaps = 37/243 (15%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+G+G V G + TG +++ + + E ++L H
Sbjct: 15 DILGQGATANVFRGR----HKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 151 NILRLMAA--CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
NI++L A + +L+ E C G L L L + + + DV G+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGM 125
Query: 209 SYMIEDGFIHTDVAARNCLVTS----ELRVKIGDTGSSIDKYPGD---------YYVHGE 255
+++ E+G +H ++ N + + K+ D G++ + + Y+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL--- 182
Query: 256 VALPVRWCAPESLLCSDTSIQTCTV-TEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314
P+ + ++WS GV + G LP+ +
Sbjct: 183 --------HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-TGSLPFRPFEGPRRNK 233
Query: 315 RVF 317
V
Sbjct: 234 EVM 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 56/257 (21%), Positives = 100/257 (38%), Gaps = 45/257 (17%)
Query: 60 AYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK 119
A+S MQN E F + + +IG+G FG+V +G++ T +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLE-----KIGKGSFGEVF----KGIDNRTQKV--- 49
Query: 120 VFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKE 179
V ++I+ + ++ E E T + + + + L+ ++ E G +
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 109
Query: 180 FLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239
L L E I + ++ GL Y+ + IH D+ A N L++ VK+ D
Sbjct: 110 LLEPG-----PLDETQIATILR-EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163
Query: 240 GSS------IDK---YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFG 290
G + K + G + W APE I+ K ++WS G
Sbjct: 164 GVAGQLTDTQIKRNTFVGTPF----------WMAPEV-------IKQSAYDSKADIWSLG 206
Query: 291 VLLWEIFEFGKLPYAEL 307
+ E+ G+ P++EL
Sbjct: 207 ITAIELAR-GEPPHSEL 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 53/299 (17%), Positives = 98/299 (32%), Gaps = 34/299 (11%)
Query: 35 QPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIG 94
Q HS+ S + P + L+ + E++ + + +G
Sbjct: 9 QAHSLASL-AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 95 RGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILR 154
RG FG+V R ++ TG V+ ++ + + E+L L I+
Sbjct: 68 RGSFGEVH----RMKDKQTGFQ---CAVKKVRLEVFRVEELVAC------AGLSSPRIVP 114
Query: 155 LMAACLESDPWLLVF-ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE 213
L A E W+ +F E G L + + E + GL Y+
Sbjct: 115 LYGAVREGP-WVNIFMELLEGGSLGQLIKQMGCLPEDR-----ALYYLGQALEGLEYLHT 168
Query: 214 DGFIHTDVAARNCLVTSE-LRVKIGDTGSSIDKYPGDYYVHGEVALPVR----WCAPESL 268
+H DV A N L++S+ R + D G ++ P + APE
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-- 226
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ K ++WS ++ + G P+ + + ++ P
Sbjct: 227 -----VVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEPPPIREIP 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 66/292 (22%), Positives = 104/292 (35%), Gaps = 44/292 (15%)
Query: 24 VSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFP 83
+S + + P R + + V +L ++ D P
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--D------P 52
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL--HEA 141
+ ++EIG G FG V + V ++ + Q+ + + E
Sbjct: 53 EKLFSDLREIGHGSFGAVY----FARDVRNSEV---VAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 142 TPYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
++LRH N ++ L E WL V E C G + L ++ L E I
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWL-VMEYCL-GSASDLLEVHKKP---LQEVEIAAVT 160
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDK---YPGDYYVHGE 255
GL+Y+ IH DV A N L++ VK+GD GS+ + + G Y
Sbjct: 161 H-GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY---- 215
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
W APE +L D K +VWS G+ E+ E K P +
Sbjct: 216 ------WMAPEVILAMDEG----QYDGKVDVWSLGITCIELAE-RKPPLFNM 256
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 46/232 (19%), Positives = 81/232 (34%), Gaps = 45/232 (19%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+ +G+G FG+VV+ R ++ ++ + + L E L H
Sbjct: 11 IAVLGQGAFGQVVKARNA----LDSR---YYAIKKIRHTEEKLSTI--LSEVMLLASLNH 61
Query: 150 VNILRLMAACLESDPWL-------------LVFESCSRGDLKEFLLSNEASREALLEQGI 196
++R AA LE ++ + E C G L + + S ++
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDE 117
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE 255
++ + LSY+ G IH D+ N + VKIGD G + D
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 256 VALPVR------------WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWE 295
LP + A E + T EK +++S G++ +E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATE--VLDGTG----HYNEKIDMYSLGIIFFE 223
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 41/228 (17%), Positives = 88/228 (38%), Gaps = 26/228 (11%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRLRH 149
K+IG G KV + + + E+A + +E +L+
Sbjct: 62 KQIGSGGSSKVFQV--------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 150 --VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
I+RL + +V E C DL +L ++++ ++
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL----KKKKSIDPWERKSYWK-NMLEA 167
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL--PVRWCAP 265
+ + + G +H+D+ N L+ +K+ D G + P V + + + P
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV-NYMPP 225
Query: 266 ESLLCSDTSIQTCT----VTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
E++ +S + ++ K +VWS G +L+ + +GK P+ ++ +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIIN 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 42/218 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVF-VRILKEDASQAEKLFFLHEATPYRRLR 148
+E+G G F V + E+STG +K R + + E + R++
Sbjct: 18 EELGSGQFAIVK----KCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI+ L +L+ E S G+L +FL A +E+L E+ + G+
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEE-ATSFIKQILDGV 128
Query: 209 SYMIEDGFIHTDVAARNCLVTSE----LRVKIGDTGSSIDKYPGD---------YYVHGE 255
+Y+ H D+ N ++ + +K+ D G + + G +V
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV--- 185
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE + + + ++WS GV+
Sbjct: 186 --------APEIVNYE-------PLGLEADMWSIGVIT 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 35/214 (16%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA------EKLFFLHEATPYRR 146
+G G FG V +G V V+ L + F E +
Sbjct: 39 MGEGGFGVVYKGYVNNTT---------VAVKKLAAMVDITTEELKQQ---FDQEIKVMAK 86
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
+H N++ L+ + D LV+ G L + L L + K+A A
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS--CLDGTPPLSWHMRCKIAQGAAN 144
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR----W 262
G++++ E+ IH D+ + N L+ KI D G + + + +
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA-SEKFAQTV--MTSRIVGTTAY 201
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296
APE+L +T K +++SFGV+L EI
Sbjct: 202 MAPEAL--------RGEITPKSDIYSFGVVLLEI 227
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 42/218 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVF-VRILKEDASQAEKLFFLHEATPYRRLR 148
+E+G G F V + E+STG +K R + + E + R++
Sbjct: 18 EELGSGQFAIVK----KCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H N++ L +L+ E S G+L +FL A +E+L E+ + G+
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEA-TSFIKQILDGV 128
Query: 209 SYMIEDGFIHTDVAARNCLVTSE----LRVKIGDTGSSIDKYPGD---------YYVHGE 255
+Y+ H D+ N ++ + +K+ D G + + G +V
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV--- 185
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE + + + ++WS GV+
Sbjct: 186 --------APEIVNY-------EPLGLEADMWSIGVIT 208
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 40/228 (17%), Positives = 88/228 (38%), Gaps = 26/228 (11%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRLRH 149
K+IG G KV + + + E+A + +E +L+
Sbjct: 15 KQIGSGGSSKVFQV--------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 150 --VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
I+RL + +V E C DL +L ++++ ++
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL----KKKKSIDPWERKSYWK-NMLEA 120
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL--PVRWCAP 265
+ + + G +H+D+ N + + +K+ D G + P V + + + P
Sbjct: 121 VHTIHQHGIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV-NYMPP 178
Query: 266 ESLLCSDTSIQTCT----VTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
E++ +S + ++ K +VWS G +L+ + +GK P+ ++ +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIIN 225
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 55/244 (22%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRLR 148
K++G G +G+V+ + T I K S + L E + L
Sbjct: 43 KKLGSGAYGEVLLC--------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLS----NEASREALLEQGITIKMAIDV 204
H NI++L + + LV E G+L + ++ NE +++Q V
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ---------V 145
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYV 252
+G++Y+ + +H D+ N L+ S + +KI D G S YY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
APE L EKC+VWS GV+L+ I G P+ +D ++
Sbjct: 206 -----------APEVLRKK--------YDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEI 245
Query: 313 ITRV 316
+ +V
Sbjct: 246 LRKV 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 40/228 (17%), Positives = 88/228 (38%), Gaps = 26/228 (11%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRLRH 149
K+IG G KV + + + E+A + +E +L+
Sbjct: 34 KQIGSGGSSKVFQV--------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 150 --VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
I+RL + +V E C DL +L ++++ ++
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL----KKKKSIDPWERKSYWK-NMLEA 139
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL--PVRWCAP 265
+ + + G +H+D+ N + + +K+ D G + P V + + + P
Sbjct: 140 VHTIHQHGIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV-NYMPP 197
Query: 266 ESLLCSDTSIQTCT----VTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
E++ +S + ++ K +VWS G +L+ + +GK P+ ++ +
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIIN 244
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 54/267 (20%), Positives = 89/267 (33%), Gaps = 42/267 (15%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE-- 133
+Q L + E+G G G+V + TG + +R
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVW----KMRFRKTGHVIAVKQMRRSGNKEENKRIL 71
Query: 134 -KLFFLHEATPYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREAL 191
L + + I++ + +D ++ E K E +
Sbjct: 72 MDLDVVL-----KSHDCPYIVQCFGTFITNTDVFI-AMELMGTCAEKLKKRMQGPIPERI 125
Query: 192 LEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDTG------SSID 244
L KM + + L Y+ E G IH DV N L+ ++K+ D G
Sbjct: 126 LG-----KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 245 K--YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
K G + APE + D + + + +VWS G+ L E+ G+
Sbjct: 181 KDRSAGCAA----------YMAPERIDPPDPTKPDYDI--RADVWSLGISLVELAT-GQF 227
Query: 303 PYAELSDD-QVITRVFGTEALRLPAPR 328
PY D +V+T+V E LP
Sbjct: 228 PYKNCKTDFEVLTKVLQEEPPLLPGHM 254
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 43/215 (20%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+E+G G FG V R E +TG +K ++ S E + E LRH
Sbjct: 163 EELGTGAFGVVH----RVTERATGNNFAAKF---VMTPHESDKETV--RKEIQTMSVLRH 213
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
++ L A + + ++++E S G+L E + + E ++ V GL
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEA-VEYMRQVCKGLC 269
Query: 210 YMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGSSIDKYPGD---------YYVHGEVAL 258
+M E+ ++H D+ N + T+ +K+ D G + P +
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA------ 323
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE + V ++WS GVL
Sbjct: 324 -----APEVA-------EGKPVGYYTDMWSVGVLS 346
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 34/235 (14%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + V E+G G FGKV + + TG ++++ S+ E ++ E
Sbjct: 17 PNEVWEIVGELGDGAFGKVY----KAKNKETGAL---AAAKVIETK-SEEELEDYIVEIE 68
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
H I++L+ A ++ E C G + + L E I +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCR- 124
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS------IDK---YPGDYYVH 253
+ L+++ IH D+ A N L+T E +++ D G S + K + G Y
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-- 182
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
W APE ++C +++ K ++WS G+ L E+ + + P+ EL+
Sbjct: 183 --------WMAPEVVMCE--TMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELN 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 49/237 (20%), Positives = 94/237 (39%), Gaps = 45/237 (18%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P+++ ++IG+G G V ++ +TG+ +V +R + Q +K ++E
Sbjct: 18 PKKKYTRFEKIGQGASGTVY----TAMDVATGQ---EVAIRQMNLQ-QQPKKELIINEIL 69
Query: 143 PYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
R ++ NI+ + + L + W+ V E + G L + + + E I +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTET-----CMDEGQIAA-VC 122
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALP 259
+ L ++ + IH D+ + N L+ + VK+ D G I
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQS 171
Query: 260 VR--------WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
R W APE + K ++WS G++ E+ E G+ PY +
Sbjct: 172 KRSTMVGTPYWMAPE-------VVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNEN 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 41/220 (18%)
Query: 88 HYV--KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
++ +++G G FG V E R S+G + ++ + +D SQ E +
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEER----SSGL---ERVIKTINKDRSQVPMEQIEAEIEVLK 75
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
L H NI+++ + +V E+C G+L E ++S +A +AL E + M +
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM-KQMM 134
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYVH 253
L+Y +H D+ N L +KI D G + + Y+
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM- 193
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE VT KC++WS GV++
Sbjct: 194 ----------APEVFKRD--------VTFKCDIWSAGVVM 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 49/296 (16%), Positives = 95/296 (32%), Gaps = 62/296 (20%)
Query: 21 SPEVSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEF 80
+ S+ P + ++ + +EL + + ++
Sbjct: 39 AFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ---- 94
Query: 81 QFPRQQLHYV--KEIGRGWFGKVVEGEARGLEESTGR-----TTSKVFVRILKEDASQAE 133
Y IGRG V +TG R L + +
Sbjct: 95 -------KYDPKDVIGRGVSSVVRRCV----HRATGHEFAVKIMEVTAER-LSPEQLEEV 142
Query: 134 KLFFLHEATPYRRLR-HVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEA 186
+ E R++ H +I+ L+ + S LVF+ +G+L K L E
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET 202
Query: 187 SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246
+ + +S++ + +H D+ N L+ +++++ D G S
Sbjct: 203 R-----------SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 247 PGD---------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
PG+ Y+ APE L CS ++ ++W+ GV+L
Sbjct: 252 PGEKLRELCGTPGYL-----------APEILKCSMDETHP-GYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 41/224 (18%), Positives = 79/224 (35%), Gaps = 48/224 (21%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGR-----TTSKVFVRILKEDASQAEKLFFLHEATPYR 145
+ +GRG V + T + + Q + L E R
Sbjct: 23 EILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 146 RL-RHVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITI 198
++ H NI++L + + LVF+ +G+L K L E + ++
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK--IMRA---- 132
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD--------- 249
+ + + + +H D+ N L+ ++ +K+ D G S PG+
Sbjct: 133 -----LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 250 YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
Y+ APE + CS ++ ++WS GV++
Sbjct: 188 SYL-----------APEIIECSMNDNHPG-YGKEVDMWSTGVIM 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 55/268 (20%), Positives = 104/268 (38%), Gaps = 35/268 (13%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
+ F + L + EIGRG +G V + + + +G+ + V+ ++ + E+
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVN----KMVHKPSGQI---MAVKRIRSTVDEKEQK 65
Query: 136 FFLHE-ATPYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLE 193
L + R I++ A E D W + E S +F + + ++
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCW-ICMELMS-TSFDKFYKYVYSVLDDVIP 123
Query: 194 QGITIKMAIDVATGLSYMIEDG-FIHTDVAARNCLVTSELRVKIGDTG------SSIDK- 245
+ I K+ + L+++ E+ IH D+ N L+ +K+ D G SI K
Sbjct: 124 EEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 246 -YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
G + APE + S + + +VWS G+ L+E+ G+ PY
Sbjct: 184 RDAGCRP----------YMAPERIDPSASRQ---GYDVRSDVWSLGITLYELAT-GRFPY 229
Query: 305 AEL-SDDQVITRVFGTEALRLPAPRAVN 331
+ S +T+V + +L
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQLSNSEERE 257
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 52/286 (18%), Positives = 92/286 (32%), Gaps = 62/286 (21%)
Query: 62 SEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGR------ 115
E+ ++L + + E+G G G V + + +G
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVF----KVSHKPSGLVMARKL 65
Query: 116 ----TTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL-ESDPWLLVFE 170
+ +I++E L LHE I+ A + + + E
Sbjct: 66 IHLEIKPAIRNQIIRE-------LQVLHEC------NSPYIVGFYGAFYSDGEIS-ICME 111
Query: 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFI-HTDVAARNCLVT 229
G L + L E +L K++I V GL+Y+ E I H DV N LV
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 166
Query: 230 SELRVKIGDTGSSIDKYPGDYYVHGEVALPVR--------WCAPESLLCSDTSIQTCTVT 281
S +K+ D G V G++ + + +PE +Q +
Sbjct: 167 SRGEIKLCDFG-----------VSGQLIDSMANSFVGTRSYMSPE-------RLQGTHYS 208
Query: 282 EKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ ++WS G+ L E+ G+ P ++
Sbjct: 209 VQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQVEGDAAET 253
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 42/218 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVF-VRILKEDASQAEKLFFLHEATPYRRLR 148
+E+G G F V + E+STG +K R K + E + + ++
Sbjct: 17 EELGSGQFAVVK----KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H N++ L +L+ E + G+L +FL A +E+L E+ + + G+
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEA-TEFLKQILNGV 127
Query: 209 SYMIEDGFIHTDVAARNCLVTSE----LRVKIGDTGSSIDKYPGD---------YYVHGE 255
Y+ H D+ N ++ R+KI D G + G+ +V
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV--- 184
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE + + + ++WS GV+
Sbjct: 185 --------APEIVNYE-------PLGLEADMWSIGVIT 207
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
PR L +IG G G V E+ +GR +V V+++ Q +L F +E
Sbjct: 43 PRLLLDSYVKIGEGSTGIVC----LAREKHSGR---QVAVKMMDLRKQQRRELLF-NEVV 94
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R +H N++ + + L + ++ E G L + + L E+ I +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIAT-VCE 148
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPV 260
V L+Y+ G IH D+ + + L+T + RVK+ D G I K +P
Sbjct: 149 AVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-----------DVPK 197
Query: 261 R--------WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
R W APE I + ++WS G+++ E+ + G+ PY S
Sbjct: 198 RKSLVGTPYWMAPE-------VISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDS 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 55/222 (24%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+E+G+G F V ++TG + K+ I + S + EA R+L+H
Sbjct: 35 EELGKGAFSVVRRCV----HKTTGLEFAAKI---INTKKLSARDFQKLEREARICRKLQH 87
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAID 203
NI+RL + E LVF+ + G+L +EF +AS ++Q
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQ--------- 136
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD---------YY 251
+ ++Y +G +H ++ N L+ S+ VK+ D G +I+ + Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+ +PE L ++ ++W+ GV+L
Sbjct: 197 L-----------SPEVLKKD-------PYSKPVDIWACGVIL 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 45/219 (20%), Positives = 82/219 (37%), Gaps = 41/219 (18%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVR---ILKEDASQAEKLFFLHEATPYRR 146
K +G G G+V E T + + ++ + + L E ++
Sbjct: 141 KTLGSGACGEVKLAF----ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
L H I+++ +++ + +V E G+L + ++ N+ +EA +
Sbjct: 197 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCKLYFYQMLL 250
Query: 207 GLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYVHG 254
+ Y+ E+G IH D+ N L++S + +KI D G S Y+
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL-- 308
Query: 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE L S+ T + WS GV+L
Sbjct: 309 ---------APEVL----VSVGTAGYNRAVDCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 56/245 (22%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKL-FFLHEATPYRRL 147
+ +G+G FG+V+ + T + I K Q L E ++L
Sbjct: 32 RVLGKGSFGEVILC--------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLS----NEASREALLEQGITIKMAID 203
H NI++L + + LV E + G+L + ++S +E ++ Q
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--------- 134
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YY 251
V +G++YM ++ +H D+ N L+ S + ++I D G S YY
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
+ APE L + EKC+VWS GV+L+ I G P+ ++
Sbjct: 195 I-----------APEVLHGT--------YDEKCDVWSTGVILY-ILLSGCPPFNGANEYD 234
Query: 312 VITRV 316
++ +V
Sbjct: 235 ILKKV 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 56/222 (25%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+G+G FG+V++ + R T + + KV I K A + L E ++L H
Sbjct: 28 CMLGKGSFGEVLKCKDR----ITQQEYAVKV---INKASAKNKDTSTILREVELLKKLDH 80
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAID 203
NI++L +S + +V E + G+L ++ ++A+ ++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----------RIIKQ 129
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YY 251
V +G++YM + +H D+ N L+ S + +KI D G S YY
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+ APE L + EKC+VWS GV+L
Sbjct: 190 I-----------APEVLRGT--------YDEKCDVWSAGVIL 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 52/267 (19%), Positives = 87/267 (32%), Gaps = 51/267 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
IG+G +G V E T + K+ + + + E ++L H
Sbjct: 32 GAIGQGSYGVVRVAI----ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI------- 202
NI RL + LV E C G L + L +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 203 ----------------------------DVATGLSYMIEDGFIHTDVAARNCLVTS--EL 232
+ + L Y+ G H D+ N L ++
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 233 RVKIGDTGSSIDKYPGDYYVHGEVALPV---RWCAPESLLCSDTSIQTCTVTEKCNVWSF 289
+K+ D G S + Y + + + + APE L ++ S KC+ WS
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-----GPKCDAWSA 262
Query: 290 GVLLWEIFEFGKLPYAELSDDQVITRV 316
GVLL + G +P+ ++D I++V
Sbjct: 263 GVLLH-LLLMGAVPFPGVNDADTISQV 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 47/222 (21%), Positives = 80/222 (36%), Gaps = 57/222 (25%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+E+G G FG V R +E++TGR +K I + +E + +L H
Sbjct: 57 EELGSGAFGVVH----RCVEKATGRVFVAKF---INTPYPLDKYTV--KNEISIMNQLHH 107
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL------KEFLLS-NEASREALLEQGITIKMAI 202
++ L A + +L+ E S G+L +++ +S E + Q
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN--YMRQ-------- 157
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGSSIDKYPGD---------YY 251
GL +M E +H D+ N + + VKI D G + P + +
Sbjct: 158 -ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE + V ++W+ GVL
Sbjct: 217 A-----------APEIVDRE-------PVGFYTDMWAIGVLG 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 54/221 (24%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRLR 148
+G+G FG+V++ R T + + I K A + L E ++L
Sbjct: 28 CMLGKGSFGEVLKC--------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLS----NEASREALLEQGITIKMAIDV 204
H NI++L +S + +V E + G+L + ++ +E +++Q V
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ---------V 130
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYV 252
+G++YM + +H D+ N L+ S + +KI D G S YY+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE L + EKC+VWS GV+L
Sbjct: 191 -----------APEVLRGT--------YDEKCDVWSAGVIL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 46/218 (21%), Positives = 81/218 (37%), Gaps = 42/218 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVF-VRILKEDASQAEKLFFLHEATPYRRLR 148
+E+G G F V + ++ TG+ +K R L + E R +R
Sbjct: 11 EELGSGQFAIVRKCR----QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI+ L +L+ E S G+L +FL A +E+L E + + G+
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEA-TQFLKQILDGV 121
Query: 209 SYMIEDGFIHTDVAARNCLVTSE----LRVKIGDTGSSIDKYPGD---------YYVHGE 255
Y+ H D+ N ++ + R+K+ D G + G+ +V
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV--- 178
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE + + + ++WS GV+
Sbjct: 179 --------APEIVNY-------EPLGLEADMWSIGVIT 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 6e-10
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 55/222 (24%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+E+G+G F V ++TG + K+ I + S + EA R+L+H
Sbjct: 12 EELGKGAFSVVRRCV----HKTTGLEFAAKI---INTKKLSARDFQKLEREARICRKLQH 64
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAID 203
NI+RL + E LVF+ + G+L +EF +AS ++Q
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQ--------- 113
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD---------YY 251
+ ++Y +G +H ++ N L+ S+ VK+ D G +I+ + Y
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+ +PE L ++ ++W+ GV+L
Sbjct: 174 L-----------SPEVLKKD-------PYSKPVDIWACGVIL 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 51/270 (18%), Positives = 93/270 (34%), Gaps = 54/270 (20%)
Query: 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGR----------TTSKVFVRILKEDA 129
+ L + E+GRG +G V + +G+ S+ R+L +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVE----KMRHVPSGQIMAVKRIRATVNSQEQKRLLMD-- 55
Query: 130 SQAEKLFFLHEATPYRRLRHVNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASR 188
L R + + A E D W + E L +F
Sbjct: 56 -----LDISM-----RTVDCPFTVTFYGALFREGDVW-ICMELMD-TSLDKFYKQVIDKG 103
Query: 189 EALLEQGITIKMAIDVATGLSYM-IEDGFIHTDVAARNCLVTSELRVKIGDTG------S 241
+ + E + K+A+ + L ++ + IH DV N L+ + +VK+ D G
Sbjct: 104 QTIPEDILG-KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162
Query: 242 SIDK--YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299
+ K G + APE + + K ++WS G+ + E+
Sbjct: 163 DVAKDIDAGCKP----------YMAPERINPEL---NQKGYSVKSDIWSLGITMIELAI- 208
Query: 300 GKLPYAELSDD-QVITRVFGTEALRLPAPR 328
+ PY Q + +V + +LPA +
Sbjct: 209 LRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 48/217 (22%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+++GRG FG V R +E S+ +T FV++ D + E + RH
Sbjct: 11 EDLGRGEFGIVH----RCVETSSKKTYMAKFVKVKGTDQVLVK-----KEISILNIARHR 61
Query: 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEAS---REALLEQGITIKMAIDVATG 207
NIL L + + +++FE S D+ E + ++ RE + V
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQVCEA 114
Query: 208 LSYMIEDGFIHTDVAARNCLVTSE--LRVKIGDTGSSIDKYPGD---------YYVHGEV 256
L ++ H D+ N + + +KI + G + PGD Y
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY---- 170
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE V+ ++WS G L+
Sbjct: 171 -------APEVHQHD-------VVSTATDMWSLGTLV 193
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 26/222 (11%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRLRHVN 151
+G+G +G V G + S + + I + D+ ++ L E ++ L+H N
Sbjct: 30 LGKGTYGIVY----AGRDLSNQVR---IAIKEIPERDSRYSQPL--HEEIALHKHLKHKN 80
Query: 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYM 211
I++ + + E+ + E G L LL ++ EQ I + GL Y+
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGF-YTKQILEGLKYL 138
Query: 212 IEDGFIHTDVAARNCLVTSEL-RVKIGDTGSS---IDKYPGDYYVHGEVALPVRWCAPES 267
++ +H D+ N L+ + +KI D G+S P G + + APE
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ----YMAPEI 194
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309
+ + ++WS G + E+ GK P+ EL +
Sbjct: 195 IDKGPRG-----YGKAADIWSLGCTIIEMAT-GKPPFYELGE 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 48/221 (21%)
Query: 88 HYV--KEIGRGWFGKVVEGEARGLEESTGRTT-SKVFVRILKEDASQAEKLFFLHEATPY 144
+Y IGRG +G+V ++ T +K I K ++ E
Sbjct: 10 YYTLENTIGRGSWGEVKIAV----QKGTRIRRAAKK---IPKYFVEDVDRFK--QEIEIM 60
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L H NI+RL ++ LV E C+ G+L E ++ RE+ + +K +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSA 118
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYV 252
++Y + H D+ N L + + +K+ D G + PG YYV
Sbjct: 119 ---VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+P+ L +C+ WS GV++
Sbjct: 176 -----------SPQVLEGL--------YGPECDEWSAGVMM 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 54/197 (27%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
++LRH N++ L+ C + W LVFE + + L E L Q + + +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYL-FQI 133
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-----SSIDKYPGDYYVHGEVALP 259
G+ + IH D+ N LV+ VK+ D G ++ PG+ Y EVA
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA----PGEVYDD-EVA-- 186
Query: 260 VRWC-APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD------ 309
RW APE L+ ++ +VW+ G + E+
Sbjct: 187 TRWYRAPELLVGDVKYGKAV---------DVWAIGC----LV-------TEMFMGEPLFP 226
Query: 310 -----DQV--ITRVFGT 319
DQ+ I G
Sbjct: 227 GDSDIDQLYHIMMCLGN 243
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 44/226 (19%), Positives = 86/226 (38%), Gaps = 57/226 (25%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPYR 145
+ + +G G FG+V + E E +TG +K+ I +K +E +
Sbjct: 91 VSKTEILGGGRFGQVHKCE----ETATGLKLAAKI---IKT--RGMKDKEEVKNEISVMN 141
Query: 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLS-NEASREALLEQGITI 198
+L H N+++L A + +LV E G+L + + L+ + ++Q
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL--FMKQ---- 195
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGSSIDKYPGD------- 249
+ G+ +M + +H D+ N L + ++KI D G + P +
Sbjct: 196 -----ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 250 --YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
++ APE + V+ ++WS GV+
Sbjct: 251 TPEFL-----------APEVVNYD-------FVSFPTDMWSVGVIA 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 45/235 (19%)
Query: 83 PRQQLHYV--KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLH 139
PR + YV + +G+G F K E + T + K+ + L Q EK+
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEIS----DADTKEVFAGKIVPKSLLLKPHQREKMS--M 64
Query: 140 EATPYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITI 198
E + +R L H +++ E + ++ +V E C R L E R+AL E
Sbjct: 65 EISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEP-EAR 118
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDY------- 250
+ G Y+ + IH D+ N + +L VKIGD G ++ +Y G+
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 251 --YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
Y+ APE L S + +VWS G +++ GK P
Sbjct: 179 PNYI-----------APEVLSKKGHS-------FEVDVWSIGCIMYT-LLVGKPP 214
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 51/268 (19%), Positives = 97/268 (36%), Gaps = 58/268 (21%)
Query: 50 PPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGL 109
H+ R Y + + ++ + E + + V+++G G +G+V+ + +
Sbjct: 4 HHHHSSGRENLYFQGI--AINPGMYVRKKEGKI-GESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 110 EE-------STGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162
+ + K E++ +E + + L H NI++L +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI--YNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQG-ITIKMAIDV----ATGLSYMIEDGFI 217
+ LV E G+L F E ++ + A ++ +G+ Y+ + +
Sbjct: 119 KYFYLVTEFYEGGEL--F--------EQIINRHKFDECDAANIMKQILSGICYLHKHNIV 168
Query: 218 HTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYVHGEVALPVRWCAP 265
H D+ N L+ + L +KI D G S YY+ AP
Sbjct: 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI-----------AP 217
Query: 266 ESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
E L EKC+VWS GV++
Sbjct: 218 EVLKKK--------YNEKCDVWSCGVIM 237
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 43/225 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+ +G+G F K E + T + K+ + L Q EK+ E + +R L H
Sbjct: 47 RFLGKGGFAKCFEIS----DADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAH 100
Query: 150 VNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
+++ E + ++ +V E C R L E R+AL E + G
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEP-EARYYLRQIVLGC 154
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDY---------YVHGEVAL 258
Y+ + IH D+ N + +L VKIGD G ++ +Y G+ Y+
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI------ 208
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303
APE L S + +VWS G +++ GK P
Sbjct: 209 -----APEVLSKKGHS-------FEVDVWSIGCIMYT-LLVGKPP 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 54/197 (27%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
++L+H N++ L+ LVFE C + L + + + E +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSIT-WQT 111
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-----SSIDKYPGDYYVHGEVALP 259
+++ + IH DV N L+T +K+ D G + P DYY EVA
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG----PSDYYDD-EVA-- 164
Query: 260 VRWC-APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-------- 307
RW +PE L+ + +VW+ G +F AEL
Sbjct: 165 TRWYRSPELLVGDTQYGPPV---------DVWAIGC----VF-------AELLSGVPLWP 204
Query: 308 --SD-DQV--ITRVFGT 319
SD DQ+ I + G
Sbjct: 205 GKSDVDQLYLIRKTLGD 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 48/236 (20%), Positives = 91/236 (38%), Gaps = 45/236 (19%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRI--LKEDASQAEKLFFLHE 140
P + ++++G G +G V + + T V ++ ++ D + K E
Sbjct: 27 PEEVFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVPVESDLQEIIK-----E 74
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
+ ++ ++++ + ++ +V E C G + + + + L E I +
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIAT-I 130
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS------IDK---YPGDYY 251
GL Y+ IH D+ A N L+ +E K+ D G + + K G +
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
W APE IQ ++WS G+ E+ E GK PYA++
Sbjct: 191 ----------WMAPE-------VIQEIGYNCVADIWSLGITAIEMAE-GKPPYADI 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 52/280 (18%), Positives = 82/280 (29%), Gaps = 61/280 (21%)
Query: 34 QQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEI 93
H S L T ++ A + L W D S E+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 94 GRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRLRHVN 151
GRG V + T K + + K + E RL H N
Sbjct: 62 GRGATSIVYRC--------KQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPN 109
Query: 152 ILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAIDVA 205
I++L LV E + G+L K + +A+ +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-----------DAVKQIL 158
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD---------YYVH 253
++Y+ E+G +H D+ N L + + +KI D G S Y
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC- 217
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE L C + ++WS G++
Sbjct: 218 ----------APEILRG-------CAYGPEVDMWSVGIIT 240
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 53/259 (20%), Positives = 91/259 (35%), Gaps = 60/259 (23%)
Query: 91 KEIGRGWFGKV------VEGE--------------ARGLEESTGRTTSKVFVRILKEDAS 130
EIG+G +G V + G ++ +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 131 QAEKLFFLHEATPYRRLRHVNILRL--MAACLESDPWLLVFESCSRGDLKEFL----LSN 184
E+++ E ++L H N+++L + D +VFE ++G + E LS
Sbjct: 79 PIEQVY--QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 185 EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
+ +R D+ G+ Y+ IH D+ N LV + +KI D G S +
Sbjct: 137 DQAR----------FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 245 KYPGDYYVHGEVALPVRWC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298
D + APESL + + +VW+ GV L+ F
Sbjct: 187 FKGSDALLS-------NTVGTPAFMAPESLSETRKIFS----GKALDVWAMGVTLY-CFV 234
Query: 299 FGKLPYAELSDDQVITRVF 317
FG+ P+ D+ I +
Sbjct: 235 FGQCPF----MDERIMCLH 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 46/213 (21%), Positives = 72/213 (33%), Gaps = 29/213 (13%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVF-------VRILKEDASQAEKLFFLHEATP 143
+ IG+G F V R T + F + E L EA+
Sbjct: 30 EVIGKGPFSVVRRC--------INRETGQQFAVKIVDVAKFTSSPGLSTEDLK--REASI 79
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
L+H +I+ L+ +VFE DL ++ + E +
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-VASHYMRQ 138
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
+ L Y ++ IH DV L+ S+ VK+G G +I G V P
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+ APE + + +VW GV+L
Sbjct: 199 -FMAPEVVKREPYG-------KPVDVWGCGVIL 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 28/182 (15%), Positives = 63/182 (34%), Gaps = 20/182 (10%)
Query: 127 EDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEA 186
+S + + N + + + + C + +LK+++ N
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRR 155
Query: 187 SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG------ 240
E G+ + + I +A + ++ G +H D+ N T + VK+GD G
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 241 --SSIDKYPGDYYVHGEVALPV---RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWE 295
+ V + +PE + + K +++S G++L+E
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPE--QIHGNNY-----SHKVDIFSLGLILFE 268
Query: 296 IF 297
+
Sbjct: 269 LL 270
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 53/245 (21%), Positives = 99/245 (40%), Gaps = 49/245 (20%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL----FFL 138
P V+ +G G +G+V +G TG+ ++++ + E++ L
Sbjct: 22 PAGIFELVELVGNGTYGQVY----KGRHVKTGQL---AAIKVMDVTGDEEEEIKQEINML 74
Query: 139 HEATPYRRLRHVNI-------LRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREAL 191
+ + H NI ++ ++ WL V E C G + + + + + + L
Sbjct: 75 KKYS-----HHRNIATYYGAFIKKNPPGMDDQLWL-VMEFCGAGSVTDLIKNTKGNT--L 126
Query: 192 LEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS------IDK 245
E+ I ++ GLS++ + IH D+ +N L+T VK+ D G S + +
Sbjct: 127 KEEWIAYICR-EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 246 ---YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
+ G Y W APE + C + T K ++WS G+ E+ E G
Sbjct: 186 RNTFIGTPY----------WMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAE-GAP 232
Query: 303 PYAEL 307
P ++
Sbjct: 233 PLCDM 237
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 57/226 (25%)
Query: 88 HYV--KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL---KEDASQAEKLFFLHEAT 142
+Y K IG+G F KV TGR +V ++I+ + + + +KLF E
Sbjct: 16 NYRLLKTIGKGNFAKV----KLARHILTGR---EVAIKIIDKTQLNPTSLQKLF--REVR 66
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN------EASREALLEQGI 196
+ L H NI++L L+ E S G++ ++L+++ EA Q
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS--KFRQ-- 122
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD------- 249
+ + + Y + +H D+ A N L+ +++ +KI D G S + G
Sbjct: 123 -------IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG 175
Query: 250 --YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
Y E+ ++ PE +VWS GV+L
Sbjct: 176 APPYAAPELFQGKKYDGPEV-----------------DVWSLGVIL 204
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 44/225 (19%), Positives = 77/225 (34%), Gaps = 53/225 (23%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVR---ILKEDASQAEKLFFLHEATPYRR 146
K +G G G+V E T + + K+ + + L E ++
Sbjct: 16 KTLGSGACGEVKLAF----ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKM 200
L H I+++ +++ + +V E G+L + L Q
Sbjct: 72 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL--YFYQ------ 122
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD-------- 249
+ + Y+ E+G IH D+ N L++S + +KI D G S
Sbjct: 123 ---MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 250 -YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
Y+ APE L+ T+ + WS GV+L
Sbjct: 180 PTYL-----------APEVLVSVGTA----GYNRAVDCWSLGVIL 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 56/223 (25%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+E+G+G F V G+ + + I + S + EA R L+H
Sbjct: 17 EELGKGAFSVVRRCVKV----LAGQEYAAMI---INTKKLSARDHQKLEREARICRLLKH 69
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAID 203
NI+RL + E L+F+ + G+L +E+ +AS ++Q
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH--CIQQ--------- 118
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD----------Y 250
+ + + + G +H ++ N L+ S+ VK+ D G +I+
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 251 YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
Y+ +PE L + ++W+ GV+L
Sbjct: 179 YL-----------SPEVLRKD-------PYGKPVDLWACGVIL 203
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 40/286 (13%), Positives = 92/286 (32%), Gaps = 54/286 (18%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY----- 144
++ + +G F K++ L E + ++ ++ + ++ F
Sbjct: 36 IRTLNQGKFNKII------LCEKDNK---FYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 145 -----------RRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREAL- 191
+++ L + + + +++E + +F +
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 192 --LEQGITIKMAIDVATGLSYM-IEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248
+ + + V SY+ E H DV N L+ RVK+ D G S +Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES--EYMV 203
Query: 249 DYYVHGEVALPVRWC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
D + G PE S ++ K ++WS G+ L+ + +
Sbjct: 204 DKKIKG-------SRGTYEFMPPEFF-----SNESSYNGAKVDIWSLGICLYV-MFYNVV 250
Query: 303 P-YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL 347
P ++S ++ + + P R + ++ + L
Sbjct: 251 PFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFL 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 7e-09
Identities = 64/267 (23%), Positives = 95/267 (35%), Gaps = 62/267 (23%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK----EDASQAEKLFFLHEATPYRR 146
+ +G+G FG V AR E+ + + +++L E A +L E
Sbjct: 15 RPLGKGKFGNVYL--AR--EKQSKF---ILALKVLFKAQLEKAGVEHQL--RREVEIQSH 65
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFL-----LSNEASREALLEQGITIKMA 201
LRH NILRL ++ L+ E G + L + +
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------TYI 115
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
++A LSY IH D+ N L+ S +KI D G S VH +
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---------VHAPSSRRTD 166
Query: 262 WC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF--GKLPYAELSDDQVI 313
C PE I+ EK ++WS GVL +EF GK P+ + +
Sbjct: 167 LCGTLDYLPPE-------MIEGRMHDEKVDLWSLGVLC---YEFLVGKPPFEANTYQETY 216
Query: 314 TRVFGTEALRLPAPRAVNSHVDVAARN 340
R+ E P V AR+
Sbjct: 217 KRISRVE-FTFP------DFVTEGARD 236
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 57/280 (20%), Positives = 106/280 (37%), Gaps = 68/280 (24%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+G+G F V A TG + K+ + A +++ +E + +L+H
Sbjct: 17 NLLGKGSFAGVYR--AE--SIHTGLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIHCQLKH 70
Query: 150 VNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSN-------EASREALLEQGITIKMA 201
+IL L E ++ LV E C G++ +L + EA + Q
Sbjct: 71 PSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQ------- 120
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDY---------Y 251
+ TG+ Y+ G +H D+ N L+T + +KI D G ++ K P + Y
Sbjct: 121 --IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF--GKLPYAELSD 309
+ +PE S + +VWS G + + G+ P+ +
Sbjct: 179 I-----------SPEIATRSAHG-------LESDVWSLGCMF---YTLLIGRPPFDTDTV 217
Query: 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRV 349
+ +V + +P S + + A++ L+ LR
Sbjct: 218 KNTLNKVVLAD-YEMP------SFLSIEAKD-LIHQLLRR 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 60/265 (22%), Positives = 96/265 (36%), Gaps = 58/265 (21%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEATPYRRLR 148
+ +G+G FG V AR E+ + +++L + + E + E LR
Sbjct: 20 RPLGKGKFGNVYL--AR--EKQNKF---IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFL-----LSNEASREALLEQGITIKMAID 203
H NILR+ + L+ E RG+L + L + S +
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----------TFMEE 122
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+A L Y E IH D+ N L+ + +KI D G S VH C
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---------VHAPSLRRRTMC 173
Query: 264 ------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF--GKLPYAELSDDQVITR 315
PE I+ T EK ++W GVL +EF G P+ S + R
Sbjct: 174 GTLDYLPPE-------MIEGKTHDEKVDLWCAGVLC---YEFLVGMPPFDSPSHTETHRR 223
Query: 316 VFGTEALRLPAPRAVNSHVDVAARN 340
+ + L+ P + +++
Sbjct: 224 IVNVD-LKFP------PFLSDGSKD 241
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 56/221 (25%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+ +G G F +V + R TG+ K I K A + L +E ++++H
Sbjct: 15 EVLGSGAFSEVFLVKQR----LTGKLFALKC---IKKSPAFRDSSLE--NEIAVLKKIKH 65
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAID 203
NI+ L + + LV + S G+L + +AS +++Q
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQ--------- 114
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGD--------YYV 252
V + + Y+ E+G +H D+ N L + ++ I D G S + G YV
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV 174
Query: 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE L S + + WS GV+
Sbjct: 175 -----------APEVLAQKPYS-------KAVDCWSIGVIT 197
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 42/217 (19%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRT-TSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
KE+GRG F V + + +STG+ +K + K Q + LHE +
Sbjct: 35 KELGRGKFAVVR----QCISKSTGQEYAAKF---LKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 150 V-NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
++ L + +L+ E + G++ L E + E I++ + G+
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCL--PELAEMVSEN-DVIRLIKQILEGV 144
Query: 209 SYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD---------YYVHGEV 256
Y+ ++ +H D+ +N L++S +KI D G S Y+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL---- 200
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
APE L +T ++W+ G++
Sbjct: 201 -------APEILNYD-------PITTATDMWNIGIIA 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 74/288 (25%), Positives = 110/288 (38%), Gaps = 68/288 (23%)
Query: 54 NVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHY--VKEIGRGWFGKVVEGEARGLEE 111
N RP Y S + + + Y V+++GRG + +V E
Sbjct: 15 NTHRPREY----WDYESHVVEWGNQD--------DYQLVRKLGRGKYSEVFEAINI---- 58
Query: 112 STGRTTSKVFVRILK-EDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPW---- 165
KV V+ILK + E LR NI+ L + DP
Sbjct: 59 ---TNNEKVVVKILKPVKKKKI-----KREIKILENLRGGPNIITLA--DIVKDPVSRTP 108
Query: 166 LLVFESCSRGDLKEFL--LSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223
LVFE + D K+ L++ R + E +K L Y G +H DV
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYE---ILK-------ALDYCHSMGIMHRDVKP 158
Query: 224 RNCLVTSELR-VKIGDTGSSIDKYPGDYYVHGEVALPVRWC-APESLLCS---DTSIQTC 278
N ++ E R +++ D G + +PG Y VA R+ PE L+ D S+
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-RVA--SRYFKGPELLVDYQMYDYSL--- 212
Query: 279 TVTEKCNVWSFGVLLWEIFEFGKLPYAELSD--DQV--ITRVFGTEAL 322
++WS G +L + F K P+ D DQ+ I +V GTE L
Sbjct: 213 ------DMWSLGCMLASMI-FRKEPFFHGHDNYDQLVRIAKVLGTEDL 253
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 25/245 (10%), Positives = 60/245 (24%), Gaps = 52/245 (21%)
Query: 92 EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEATPYRRLRH 149
G + + L+ + R V + + + + L R+
Sbjct: 38 FHGGVPPLQFW----QALDTALDRQ---VALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
+ R++ L+V E G L+E ++ + A+ + +A
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI-------RAMQSLAAAAD 143
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
G + V+ + V + D
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----TMPD-------------------- 178
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRA 329
+ ++ G L+ + + P E + A + P
Sbjct: 179 ----------ANPQDDIRGIGASLYALLV-NRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227
Query: 330 VNSHV 334
++ +
Sbjct: 228 IDRDI 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/227 (19%), Positives = 75/227 (33%), Gaps = 68/227 (29%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRIL---KEDASQAEKLFFLHEATPYRR 146
++IG G + + T+ F V+I+ K D ++ ++ R
Sbjct: 28 EDIGVGSYSVCKRC--------IHKATNMEFAVKIIDKSKRDPTEEIEIL-------LRY 72
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKM 200
+H NI+ L + +V E G+L ++F EAS +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA-----------V 121
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSE----LRVKIGDTGSSIDKYPGD------- 249
+ + Y+ G +H D+ N L E ++I D G + +
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 250 ---YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+V APE L C++WS GVLL
Sbjct: 182 YTANFV-----------APEVLERQG-------YDAACDIWSLGVLL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 46/248 (18%)
Query: 71 MQNWFDSSEFQFPRQQLHYVK--EIGRGWFGKVVEGEARGLEESTGRTTSKVFV---RIL 125
M +DS E F + Y K +IG+G FG+V + TG+ V ++L
Sbjct: 1 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEV----FKARHRKTGQ-----KVALKKVL 51
Query: 126 KEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWL--------LVFESCSRGDL 177
E+ + + L E + L+H N++ L+ C LVF+ C DL
Sbjct: 52 MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL 110
Query: 178 KEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237
L ++ ++ + GL Y+ + +H D+ A N L+T + +K+
Sbjct: 111 AGLL----SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166
Query: 238 DTG-----SSIDKYPGDYYVHGEVALPVRWCAPESLLCS---DTSIQTCTVTEKCNVWSF 289
D G S + Y + V L R PE LL I ++W
Sbjct: 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELLLGERDYGPPI---------DLWGA 215
Query: 290 GVLLWEIF 297
G ++ E++
Sbjct: 216 GCIMAEMW 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 47/221 (21%), Positives = 75/221 (33%), Gaps = 41/221 (18%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRIL-KEDASQAEKLFFLHEATPYRRLR 148
+G G +V TS+ + V+I+ K+ ++F E + +
Sbjct: 19 DVLGEGAHARVQTC--------INLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQ 68
Query: 149 -HVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMA 201
H N+L L+ E D + LVFE G + + EAS +
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-----------VV 117
Query: 202 IDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGDYYVHGEVAL 258
DVA+ L ++ G H D+ N L VKI D
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 259 PVRWC------APESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+ C APE + ++C++WS GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIY--DKRCDLWSLGVIL 216
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 47/244 (19%), Positives = 87/244 (35%), Gaps = 74/244 (30%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---QAEK----LFFLHEAT 142
V+++G G F V A+ + + V ++I++ D AE L +++A
Sbjct: 24 VRKLGWGHFSTVW--LAKDM-----VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 143 PYRRLR--HVNILRLMAA-----------CLESDPWLLVFESCSRGDLKEFLLSNEASRE 189
+ +IL+L+ +VFE +L + E
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVV-------MVFEVLGE-NLLALIKKYE---- 124
Query: 190 ALLEQGITI----KMAIDVATGLSYM-IEDGFIHTDVAARNCLVTSELR------VKIGD 238
+GI + +++ + GL YM G IHTD+ N L+ +KI D
Sbjct: 125 ---HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 239 TGSSIDKYPGDYYVHGEVALPV-----RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
G++ + + R +PE LL + ++WS L+
Sbjct: 182 LGNAC-------WYDEHYTNSIQTREYR--SPEVLLGAPWG-------CGADIWSTACLI 225
Query: 294 WEIF 297
+E+
Sbjct: 226 FELI 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 58/308 (18%), Positives = 102/308 (33%), Gaps = 84/308 (27%)
Query: 14 FVNPLASSPEVSIFPPPGADQQPHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQN 73
N SP V P P P P P PP ++ P + + Q+
Sbjct: 2 LSNSQGQSPPV---PFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNA 58
Query: 74 WFDSSEFQFPRQQLHYV--KEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRIL--KED 128
D + V + +G G GKV++ + T + F +++L
Sbjct: 59 IID----------DYKVTSQVLGLGINGKVLQI--------FNKRTQEKFALKMLQDCPK 100
Query: 129 ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW----LLVFESCSRGDLKEFLLSN 184
A + +L +R + +I+R++ L+V E G+L F
Sbjct: 101 ARREVELH-------WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--F---- 147
Query: 185 EASREALLEQGITI-------KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR---V 234
+ ++G ++ + + Y+ H DV N L TS+ +
Sbjct: 148 ----SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203
Query: 235 KIGDTGSSIDKYPGD---------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCN 285
K+ D G + + + YYV APE L + C+
Sbjct: 204 KLTDFGFAKETTSHNSLTTPCYTPYYV-----------APEVLGPEKYD-------KSCD 245
Query: 286 VWSFGVLL 293
+WS GV++
Sbjct: 246 MWSLGVIM 253
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 51/224 (22%), Positives = 84/224 (37%), Gaps = 62/224 (27%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLR- 148
K +G G F + + + + + K+ I K + +K E T +
Sbjct: 17 KPLGEGSFSICRKCVHK----KSNQAFAVKI---ISKRMEANTQK-----EITALKLCEG 64
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDL------KEFLLSNEASREALLEQGITIKMAI 202
H NI++L + LV E + G+L K+ EAS ++
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY--------IMR--- 113
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD---------- 249
+ + +S+M + G +H D+ N L T E L +KI D G + K P +
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 250 YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
+Y APE L + E C++WS GV+L
Sbjct: 174 HYA-----------APELLNQNGYD-------ESCDLWSLGVIL 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 35/188 (18%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L+H NI+RL LVFE C + DLK++ ++ L + + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFL-FQL 110
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG----SSIDKYPGDYYVHGEVALPV 260
GL + +H D+ +N L+ +K+ + G I P Y V L
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVTLWY 167
Query: 261 RWCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY----AELSDDQV- 312
R P+ L + TSI ++WS G + E+ G+ P DQ+
Sbjct: 168 R--PPDVLFGAKLYSTSI---------DMWSAGCIFAELANAGR-PLFPGNDVD--DQLK 213
Query: 313 -ITRVFGT 319
I R+ GT
Sbjct: 214 RIFRLLGT 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 51/286 (17%)
Query: 51 PQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKE--IGRGWFGKVVEGEARG 108
P + VK P V ++ + + +++ Y IG G FG V +
Sbjct: 9 PLNGVKLNPLDDPNKVIKVLASDGKTGEQ-----REIAYTNCKVIGNGSFGVVFQA---- 59
Query: 109 LEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWL- 166
+ +V + ++L++ K F E R ++H N++ L A +
Sbjct: 60 ----KLVESDEVAIKKVLQD------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 167 -----LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI-DVATGLSYMIEDGFIHTD 220
LV E + ++ + + IK+ + + L+Y+ G H D
Sbjct: 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM--LLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 221 VAARNCLVTSE-LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC-APESLLCS---DTSI 275
+ +N L+ +K+ D GS+ G+ V + R+ APE + + T+I
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS-YIC--SRYYRAPELIFGATNYTTNI 223
Query: 276 QTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV--ITRVFGT 319
++WS G ++ E+ + L E DQ+ I +V GT
Sbjct: 224 ---------DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 50/195 (25%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L H NI+ L+ LVFE + DLK+ L + ++ L + I I + +
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYL-YQL 128
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG----SSIDKYPGDYYVHGEVALPV 260
G+++ + +H D+ +N L+ S+ +K+ D G I P Y H V L
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI---PVRSYTHEVVTLWY 185
Query: 261 RWCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL---------- 307
R AP+ L+ S TS+ ++WS G IF AE+
Sbjct: 186 R--APDVLMGSKKYSTSV---------DIWSIGC----IF-------AEMITGKPLFPGV 223
Query: 308 SD-DQV--ITRVFGT 319
+D DQ+ I + GT
Sbjct: 224 TDDDQLPKIFSILGT 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 48/235 (20%), Positives = 87/235 (37%), Gaps = 70/235 (29%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-----EDASQAEK--LFFLHEAT 142
+K IG+G FG+VV + + + V +++++ + E L L +
Sbjct: 102 LKVIGKGSFGQVV----KAYDHKVHQH---VALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 143 PYRRLRHVNILRLMAA-------CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG 195
+ N++ ++ C+ FE S +L E + N+ QG
Sbjct: 155 KDNTM---NVIHMLENFTFRNHICM-------TFELLSM-NLYELIKKNK-------FQG 196
Query: 196 ITI----KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--VKIGDTGSS--IDKYP 247
++ K A + L + ++ IH D+ N L+ + R +K+ D GSS +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 248 GDY-----YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
Y Y R APE +L ++WS G +L E+
Sbjct: 257 YTYIQSRFY---------R--APEVILG-------ARYGMPIDMWSLGCILAELL 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 48/234 (20%), Positives = 87/234 (37%), Gaps = 47/234 (20%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK---------EDASQAEKLFFLHEA 141
+G G FG V ++ + +V V+ +K + + K+ E
Sbjct: 30 SPLGSGAFGFVWTAV----DKEKNK---EVVVKFIKKEKVLEDCWIEDPKLGKVT--LEI 80
Query: 142 TPYRRLRHVNILRLMAACLESDPWL-LVFESCSRG-DLKEFLLSN------EASREALLE 193
R+ H NI++++ E+ + LV E G DL F+ + AS +
Sbjct: 81 AILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY--IFR 137
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH 253
Q + + + Y+ IH D+ N ++ + +K+ D GS+ +
Sbjct: 138 Q---------LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFY 187
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307
CAPE L+ + +WS GV L+ + F + P+ EL
Sbjct: 188 TFCGTIEY-CAPEVLM------GNPYRGPELEMWSLGVTLYTLV-FEENPFCEL 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 4e-06
Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 32/186 (17%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L+H NI++L +LVFE + DLK+ L + L + + +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFL-LQL 109
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG----SSIDKYPGDYYVHGEVALPV 260
G++Y + +H D+ +N L+ E +KI D G I P Y H V L
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI---PVRKYTHEIVTLWY 166
Query: 261 RWCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY--AELSDDQV--I 313
R AP+ L+ S T+I ++WS G + E+ P DQ+ I
Sbjct: 167 R--APDVLMGSKKYSTTI---------DIWSVGCIFAEMVN--GTPLFPGVSEADQLMRI 213
Query: 314 TRVFGT 319
R+ GT
Sbjct: 214 FRILGT 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 47/196 (23%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLS-NEASREALLEQGITIKMAID 203
+ L+H NI+RL + LVFE DLK+++ S + LE +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG----SSIDKYPGDYYVHGEVALP 259
+ GL++ E+ +H D+ +N L+ ++K+GD G I P + + V L
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI---PVNTFSSEVVTLW 173
Query: 260 VRWCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL--------- 307
R AP+ L+ S TSI ++WS G I AE+
Sbjct: 174 YR--APDVLMGSRTYSTSI---------DIWSCGC----IL-------AEMITGKPLFPG 211
Query: 308 -SD-DQV--ITRVFGT 319
+D +Q+ I + GT
Sbjct: 212 TNDEEQLKLIFDIMGT 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 54/252 (21%), Positives = 92/252 (36%), Gaps = 42/252 (16%)
Query: 93 IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI 152
+GRG +G V + A+ + + + LK+ + E R L+H N+
Sbjct: 29 VGRGTYGHVYK--AKRKDGKDDKDYA------LKQIEGTGISMSACREIALLRELKHPNV 80
Query: 153 LRLMAACLE-SDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKM----AIDVAT 206
+ L L +D + L+F+ DL + + AS+ + M +
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSEL----RVKIGDTG-SSIDKYPGDYYVHGE---VAL 258
G+ Y+ + +H D+ N LV E RVKI D G + + P + V
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF---------EFGKLPYAELSD 309
R APE LL + T + ++W+ G + E+ +
Sbjct: 200 WYR--APELLLGARH--YTKAI----DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 310 DQV--ITRVFGT 319
DQ+ I V G
Sbjct: 252 DQLDRIFNVMGF 263
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 14/153 (9%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEATPYRRL 147
V ++G G V E L V ++ + + E+ F E +L
Sbjct: 16 VDKLGGGGMSTVYLAEDTIL----NIK---VAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
H NI+ ++ E D + LV E L E++ L I + G
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDG 123
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240
+ + + +H D+ +N L+ S +KI D G
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG 156
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKEDA--SQAEKLFFLHEATPYR 145
+K IGRG F +V + + T +V+ ++I+ + + E F E R
Sbjct: 65 ILKVIGRGAFSEVAVVKMKQ--------TGQVYAMKIMNKWDMLKRGEVSCFREE----R 112
Query: 146 R-LRHVN---ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
L + + I +L A + + LV E GDL LLS R I +MA
Sbjct: 113 DVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGER-------IPAEMA 164
Query: 202 I----DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA 257
++ + + G++H D+ N L+ +++ D GS + K D V VA
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL-KLRADGTVRSLVA 223
Query: 258 LPVRWC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YAE 306
+PE L T + +C+ W+ GV +E+F +G+ P YA+
Sbjct: 224 -----VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYAD 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 5e-05
Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 26/160 (16%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L+H NI+ L LVFE + DLK++L + + + + + +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNIINMHNVKLFL-FQL 109
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG----SSIDKYPGDYYVHGEVALPV 260
GL+Y +H D+ +N L+ +K+ D G SI P Y + V L
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI---PTKTYDNEVVTLWY 166
Query: 261 RWCAPESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIF 297
R P+ LL S T I ++W G + +E+
Sbjct: 167 R--PPDILLGSTDYSTQI---------DMWGVGCIFYEMA 195
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 55/249 (22%), Positives = 87/249 (34%), Gaps = 59/249 (23%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLH---EATPYRRL 147
+G G +GKV E + T + V+ILK+ + + E RRL
Sbjct: 11 DLLGEGSYGKVKEVL----DSETLC---RRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 148 RHVNILRL---MAACLESDPWL-LVFESCSRGDLKEF-------LLSNEASREALLEQGI 196
RH N+++L + E + +V E C G + +A Q I
Sbjct: 64 RHKNVIQLVDVLYN--EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG--YFCQLI 119
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHG 254
GL Y+ G +H D+ N L+T+ +KI G + + + D
Sbjct: 120 D---------GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR- 169
Query: 255 EVALPVRWC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
PE DT K ++WS GV L+ I G P+
Sbjct: 170 ------TSQGSPAFQPPEIANGLDTFSGF-----KVDIWSAGVTLYNITT-GLYPF---- 213
Query: 309 DDQVITRVF 317
+ I ++F
Sbjct: 214 EGDNIYKLF 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 45/227 (19%), Positives = 79/227 (34%), Gaps = 66/227 (29%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL--KEDASQAEKLFFLHEATPYRRLR 148
+ +G G GKV+E R TG+ K +++L A Q ++
Sbjct: 35 QVLGLGVNGKVLECFHR----RTGQ---KCALKLLYDSPKARQEVDHH-------WQASG 80
Query: 149 HVNILRLMAAC----LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI------ 198
+I+ ++ L++ E G+L F + E+G
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGEL--F--------SRIQERGDQAFTEREA 130
Query: 199 -KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD----- 249
++ D+ T + ++ H DV N L TS+ +K+ D G + +
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190
Query: 250 ---YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLL 293
YYV APE L + C++WS GV++
Sbjct: 191 YTPYYV-----------APEVLGPEK-------YDKSCDMWSLGVIM 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 73/256 (28%)
Query: 88 HYV--KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK----EDASQAEKLFFLHEA 141
HYV +G G FGKV GE + TG KV V+IL K+ E
Sbjct: 12 HYVLGDTLGVGTFGKVKIGE----HQLTGH---KVAVKILNRQKIRSLDVVGKIK--REI 62
Query: 142 TPYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSN------EASREALLEQ 194
+ RH +I++L + + +V E S G+L +++ + EA R L +Q
Sbjct: 63 QNLKLFRHPHIIKLYQ-VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR--LFQQ 119
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG 254
++ + Y +H D+ N L+ + + KI D G S + ++
Sbjct: 120 ILS---------AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLR- 168
Query: 255 EVALPVRWC------APESL-------LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301
C APE + D +WS GV+L+ + G
Sbjct: 169 ------TSCGSPNYAAPEVISGRLYAGPEVD-------------IWSCGVILYALLC-GT 208
Query: 302 LPYAELSDDQVITRVF 317
LP+ DD+ + +F
Sbjct: 209 LPF----DDEHVPTLF 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 47/255 (18%)
Query: 83 PRQQLHY--VKEIGRGWFGKVVEGEARGLEESTGRTTS--KVFVRILKEDASQAEKLFFL 138
Q++ Y K IG G FG V + A+ + +G + KV +K F
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQ--AKLCD--SGELVAIKKVLQ----------DKRFKN 95
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWL------LVFESCSRGDLKEFLLSNEASREALL 192
E R+L H NI+RL S LV + + +++ L
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP 154
Query: 193 EQGITIKMAI-DVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 250
I +K+ + + L+Y+ G H D+ +N L+ + +K+ D GS+ G+
Sbjct: 155 V--IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 251 YVHGEVALPVRWC-APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306
V + R+ APE + + +SI +VWS G +L E+ + +
Sbjct: 213 NVS-YIC--SRYYRAPELIFGATDYTSSI---------DVWSAGCVLAELLLGQPIFPGD 260
Query: 307 LSDDQV--ITRVFGT 319
DQ+ I +V GT
Sbjct: 261 SGVDQLVEIIKVLGT 275
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 49/198 (24%), Positives = 72/198 (36%), Gaps = 56/198 (28%)
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ L H NI+ L+ A LVF+ DL+ + + + L I M +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYM-LMT 121
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-----SSIDKYPGDYYVHGEVALP 259
GL Y+ + +H D+ N L+ +K+ D G S P Y H +V
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS----PNRAYTH-QV--- 173
Query: 260 V-RWC-APESLLCS---DTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL------- 307
V RW APE L + + ++W+ G I AEL
Sbjct: 174 VTRWYRAPELLFGARMYGVGV---------DMWAVGC----IL-------AELLLRVPFL 213
Query: 308 ---SD-DQV--ITRVFGT 319
SD DQ+ I GT
Sbjct: 214 PGDSDLDQLTRIFETLGT 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 44/249 (17%), Positives = 82/249 (32%), Gaps = 64/249 (25%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-------EDASQAEKLFFLHEATP 143
+G G FG V G S V ++ ++ + ++ E
Sbjct: 49 PLLGSGGFGSVYSGI----RVSDNL---PVAIKHVEKDRISDWGELPNGTRVP--MEVVL 99
Query: 144 YRRLRHV--NILRLMAACLESDPWLLVFESCS-RGDLKEFLLSNEASREALLEQGITIKM 200
+++ ++RL+ D ++L+ E DL +F+ A +E L
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSF 154
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLV-TSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
V + + G +H D+ N L+ + +K+ D GS Y
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTD------ 207
Query: 260 VRWC------APESLLC-------SDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306
+ PE + + VWS G+LL+++ G +P+
Sbjct: 208 --FDGTRVYSPPEWIRYHRYHGRSAA-------------VWSLGILLYDMV-CGDIPF-- 249
Query: 307 LSDDQVITR 315
D+ I R
Sbjct: 250 -EHDEEIIR 257
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 59/249 (23%), Positives = 86/249 (34%), Gaps = 67/249 (26%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
VK+IG G FG + T V V+ ++ A+ E + E +R LRH
Sbjct: 25 VKDIGSGNFGVARLMRDK----LTKE---LVAVKYIERGAAIDENVQ--REIINHRSLRH 75
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN------EASREALLEQGITIKMAID 203
NI+R L ++ E S G+L E + + EA +Q +
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF--FFQQLL------- 126
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
+G+SY H D+ N L+ R+KI D G S P
Sbjct: 127 --SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------QPKS 176
Query: 262 WC------APESLL-------CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
APE LL +D VWS GV L+ + G P+
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIAD-------------VWSCGVTLYVML-VGAYPF---- 218
Query: 309 DDQVITRVF 317
+D R +
Sbjct: 219 EDPEEPRDY 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 65/252 (25%)
Query: 88 HYV--KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK----EDASQAEKLFFLHEA 141
HY+ +G G FGKV G+ E TG KV V+IL K+ E
Sbjct: 17 HYILGDTLGVGTFGKVKVGK----HELTGH---KVAVKILNRQKIRSLDVVGKIR--REI 67
Query: 142 TPYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSN------EASREALLEQ 194
+ RH +I++L + + + +V E S G+L +++ N E+ R L +Q
Sbjct: 68 QNLKLFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR--LFQQ 124
Query: 195 GITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY---- 250
++ G+ Y +H D+ N L+ + + KI D G S G++
Sbjct: 125 ILS---------GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 251 -----YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305
Y EV + PE ++WS GV+L+ + G LP+
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEV-----------------DIWSSGVILYALL-CGTLPF- 216
Query: 306 ELSDDQVITRVF 317
DD + +F
Sbjct: 217 ---DDDHVPTLF 225
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 72/237 (30%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-----EDASQAEK--LFFLHEAT 142
IG+G FG+VV + + V ++I+K + +Q E L +++
Sbjct: 59 DSLIGKGSFGQVV----KAYDRVEQEW---VAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 143 PYRRLRHVNILRLMAA-------CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG 195
+ I+ L CL VFE S +L + L + +G
Sbjct: 112 TEMKY---YIVHLKRHFMFRNHLCL-------VFEMLSY-NLYDLLRNTN-------FRG 153
Query: 196 ITI----KMAIDVATGLSYM--IEDGFIHTDVAARNCLVTSELR--VKIGDTGSS--IDK 245
+++ K A + T L ++ E IH D+ N L+ + R +KI D GSS + +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 246 YPGDY-----YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
Y Y EV L + + ++WS G +L E+
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLA------------------IDMWSLGCILVEMH 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 20/158 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF---FLHEATPYRR 146
+ +G G +V R V V++L+ D ++ F F EA
Sbjct: 17 GEILGFGGMSEVHLARDLRD----HRD---VAVKVLRADLARDPS-FYLRFRREAQNAAA 68
Query: 147 LRHVNILRLMAACLESDPWL----LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
L H I+ + P +V E L++ + E + I++
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIA 123
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240
D L++ ++G IH DV N ++++ VK+ D G
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 161
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 41/274 (14%)
Query: 42 FEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKV 101
F+ L L +V Y + + +Q W + + +G+G FG+V
Sbjct: 142 FQELTRLTHEYLSVAPFADYLDSIYFNRFLQ-WKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 102 VEGEARGLEESTGRTTSKVF-VRILK---------EDASQAEKLFFLHEATPYRRLRHVN 151
+ R T K++ + L+ E + EK + +
Sbjct: 201 CACQVRA--------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF------- 245
Query: 152 ILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSY 210
+ +A E+ L LV + GDLK F + + +A + + A ++ GL
Sbjct: 246 -VVSLAYAYETKDALCLVLTLMNGGDLK-FHIYHM--GQAGFPEARAVFYAAEICCGLED 301
Query: 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLC 270
+ + ++ D+ N L+ ++I D G ++ G + G V + APE +
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTV-GYMAPEVVKN 359
Query: 271 SDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
T + W+ G LL+E+ G+ P+
Sbjct: 360 ER-------YTFSPDWWALGCLLYEMIA-GQSPF 385
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 49/278 (17%), Positives = 95/278 (34%), Gaps = 49/278 (17%)
Query: 50 PPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKE------------IGRGW 97
+ + Q Q + DS F Q + +GRG
Sbjct: 138 AGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGG 197
Query: 98 FGKVVEGEARGLEESTGRTTSKVF-VRILK---------EDASQAEKLFFLHEATPYRRL 147
FG+V + + T K++ + L + EK + +
Sbjct: 198 FGEVFACQMKA--------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF--- 246
Query: 148 RHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
+ +A E+ L LV + GD++ + + N ++ I + +
Sbjct: 247 -----IVSLAYAFETKTDLCLVMTIMNGGDIR-YHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266
GL ++ + I+ D+ N L+ + V+I D G +++ G G P + APE
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP-GFMAPE 359
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
LL + + ++ GV L+E+ + P+
Sbjct: 360 LLLGEE-------YDFSVDYFALGVTLYEMIA-ARGPF 389
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 47/241 (19%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVF-VRILKEDA--SQAEKLFFLHE 140
R+ +K IGRG FG+V + + KVF ++IL + +AE F E
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKN--------ADKVFAMKILNKWEMLKRAETACFREE 124
Query: 141 ATPYRR-LRHVN---ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
R L + + I L A + + LV + GDL LLS E +
Sbjct: 125 ----RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSK-------FEDRL 172
Query: 197 TIKMAI----DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV 252
+MA ++ + + + ++H D+ N L+ +++ D GS + K D V
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL-KLMEDGTV 231
Query: 253 HGEVALPVRWC------APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YA 305
VA +PE L + C+ WS GV ++E+ +G+ P YA
Sbjct: 232 QSSVA-----VGTPDYISPEILQAMEGGKGRYGPE--CDWWSLGVCMYEML-YGETPFYA 283
Query: 306 E 306
E
Sbjct: 284 E 284
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 6e-04
Identities = 45/296 (15%), Positives = 84/296 (28%), Gaps = 80/296 (27%)
Query: 36 PHSIISFEPLPTLVPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGR 95
P SI+S E + H + A +L F + + +V+E+ R
Sbjct: 42 PKSILSKEEI------DHIIMSKDA--VSGTLRL-----FWTLLSKQEEMVQKFVEEVLR 88
Query: 96 ---GWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF-FLHEATPY--RRLRH 149
+ ++ E R T ++++ Q ++L+ Y RL+
Sbjct: 89 INYKFLMSPIKTEQRQPSMMT-----RMYI-------EQRDRLYNDNQVFAKYNVSRLQP 136
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDL---KEFLLSNEASREALLEQGITIKMAIDVAT 206
LR L +L+ G L K ++ + L + KM +
Sbjct: 137 YLKLRQALLELRPAKNVLID-----GVLGSGKTWVAL-----DVCLSYKVQCKMDFKI-- 184
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA------LPV 260
+ + ++ L L +I +S + + + L
Sbjct: 185 ---FWLNLKNCNSPETVLEMLQK--LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG-KLPYAELSDDQVITR 315
LL NV + W F K+ L + TR
Sbjct: 240 SKPYENCLLVLL------------NVQNAKA--WNAFNLSCKI----L----LTTR 273
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 9/101 (8%)
Query: 145 RRLRHVNILRLMAACLESDPWL-----LVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
H N++RLM C S LVFE + DL+ +L + + L
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAETIKD 124
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240
+ GL ++ + +H D+ N LVTS VK+ D G
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.96 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.53 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.0 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 92.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 83.48 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-65 Score=472.30 Aligned_cols=271 Identities=34% Similarity=0.613 Sum_probs=231.6
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.|++++|.+.++||+|+||+||+|++++... ...+..||||+++..... ....|.+|+.+|++|+|||||+++|+|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~--~~~~~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCP--EQDKILVAVKTLKDASDN-ARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC------CEEEEEEEECSCCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCccc--CCCCEEEEEEEeCCCChH-HHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 6788999999999999999999999874322 124558999999865543 3445679999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchh--------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEAS--------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~ 232 (394)
+++.+|||||||++|+|.++|+..+.. ....+++..++.++.||+.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999875421 112368888999999999999999999999999999999999999
Q ss_pred eEEEccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
.+||+|||+|+........... ...||+.|||||++.+.. |+.++|||||||+||||+|.|+.||.+.+..+
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-------~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-------FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-------CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999865544443333 347899999999998765 89999999999999999987999999999999
Q ss_pred HHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 312 VITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 312 ~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
++..+..+. +++.|..+++++.++|.+||+.||+ ||++.|+...|+++..
T Consensus 239 ~~~~i~~~~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 VIECITQGR--VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCC--CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 999998886 6788899999999999999999998 9999999999887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-65 Score=473.87 Aligned_cols=272 Identities=31% Similarity=0.587 Sum_probs=231.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.+++..++++.++||+|+||+||+|++.+... ......||||+++..........|.+|+.+|++++|||||+++|+|
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~--~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAP--GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC---------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCcc--CCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 35678899999999999999999999864321 2345589999997665444445678999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl 228 (394)
.+++.++||||||++|+|.++|...... ....+++..++.++.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999754211 11236788889999999999999999999999999999999
Q ss_pred cCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 229 TSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 229 ~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
++++.+||+|||+|+.....+.. ..+...||+.|||||++.+.. |+.++|||||||+||||+|+|..||.+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-------~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-------FSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-------CCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865443332 234568899999999998765 8999999999999999998899999999
Q ss_pred CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 308 SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 308 ~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+..+++..+..+. +++.|..+++.+.++|.+||+.||+ ||++.||++.|+++.
T Consensus 252 ~~~~~~~~i~~~~--~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 252 SNQDVVEMIRNRQ--VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp CHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CHHHHHHHHHcCC--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 9999999998876 7788999999999999999999998 999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-64 Score=472.42 Aligned_cols=274 Identities=37% Similarity=0.616 Sum_probs=227.2
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
...+.+++|.+.++||+|+||+||+|++++... ......||||+++..... ....|.+|+.+|++++|||||+++|+
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vAvK~l~~~~~~-~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP--EQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC-----CEEEEEEEESCCSHH-HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCccc--CCCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 446778999999999999999999999875321 134568999999765433 34457799999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhh----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASR----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl 228 (394)
|.+++.+|||||||++|+|.++|+...... ...+++..++.++.||+.||.|||+++||||||||+||||
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999998753211 1236788899999999999999999999999999999999
Q ss_pred cCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 229 TSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 229 ~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
+.++.+||+|||+|+........ ..+...||+.|||||++.+.. |+.++|||||||+||||+|+|+.||.+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-------~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-------FTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-------CCccccccchHHHHHHHHcCCCCCCCCC
Confidence 99999999999999865444332 234467899999999987765 8999999999999999998799999999
Q ss_pred CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 308 SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 308 ~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+..+++..+..+. +++.|..+++++.++|++||+.||+ ||++.||++.|+.+...
T Consensus 265 ~~~~~~~~i~~g~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 265 SNTEAIDCITQGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CHHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcCC--CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 9999999998886 7888999999999999999999998 99999999999887643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-63 Score=458.43 Aligned_cols=268 Identities=26% Similarity=0.363 Sum_probs=217.2
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
...|+++.+++++.++||+|+||+||+|++++ .||||+++... .......|.+|+.+|++++|||||++
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~----------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l 97 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG----------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLF 97 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS----------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC----------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 45789999999999999999999999998752 58999887543 44445567899999999999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
+|++.+ +.+|||||||++|+|.++|..... .+++..++.++.||+.||.|||+++||||||||+|||++.++.+|
T Consensus 98 ~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~K 172 (307)
T 3omv_A 98 MGYMTK-DNLAIVTQWCEGSSLYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVK 172 (307)
T ss_dssp EEEECS-SSCEEEEECCSSCBHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEE
T ss_pred EEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEE
Confidence 998864 678999999999999999976432 267888899999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 236 IGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 236 l~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
|+|||+|+...... .......+||+.|||||++.+... ..|+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 173 i~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~----~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~~~~~~ 247 (307)
T 3omv_A 173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN----NPFSFQSDVYSYGIVLYELMT-GELPYSHINNRDQII 247 (307)
T ss_dssp ECCCSSCBC------------CCCCTTSCCHHHHHCCSS----CCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHH
T ss_pred EeeccCceecccCCcceeecccccCCCccCHHHhhccCC----CCCCcHHHhHhHHHHHHHHHH-CCCCCCCCChHHHHH
Confidence 99999997654322 222345689999999999975431 138999999999999999999 999999877655444
Q ss_pred -HHhcCCCc-C-CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 315 -RVFGTEAL-R-LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 315 -~i~~~~~~-~-~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.+..+... . ...+..+++.+.++|.+||+.+|+ ||++.|++..|+.+...
T Consensus 248 ~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 248 FMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 44444311 1 234568999999999999999998 99999999998877543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-63 Score=472.83 Aligned_cols=278 Identities=31% Similarity=0.576 Sum_probs=236.3
Q ss_pred CCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC-ccee
Q psy7505 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH-VNIL 153 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv 153 (394)
++.+.|+|++++|++.+.||+|+||+||+|++++.... .....||||.++..........+.+|+.+|++++| ||||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~--~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSST--TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcc--cCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 44567999999999999999999999999998865432 23457999999887766666667899999999955 9999
Q ss_pred ceeeEEEe-CCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7505 154 RLMAACLE-SDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDV 221 (394)
Q Consensus 154 ~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDl 221 (394)
+++|+|.+ ++.+|||||||++|+|.++|+..... ....+++..++.++.||+.||.|||+++||||||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDL 211 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 211 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCcc
Confidence 99999976 45799999999999999999865321 1123678888999999999999999999999999
Q ss_pred CCCCEEEcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC
Q psy7505 222 AARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG 300 (394)
Q Consensus 222 k~~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g 300 (394)
||+|||++.++.+||+|||+|+...... ....+..+||+.|||||++.+.. |+.++|||||||+||||+|.|
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-------y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-------YTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHTTTS
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-------CCCcccEeehHHHHHHHHhCC
Confidence 9999999999999999999998764433 34455668899999999998765 899999999999999999879
Q ss_pred CCCCCCCCH-HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 301 KLPYAELSD-DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 301 ~~Pf~~~~~-~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+.||.+.+. .++...+..+. +++.|..+++++.++|.+||+.||+ ||++.|+++.|++++.
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~--~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 999998764 45556666665 7888999999999999999999998 9999999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=458.87 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=219.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.+.|++.++||+|+||+||+|+++ .++..||||+++...... ...+.+|+.+|++++|||||+++++|.++
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGCSS-GGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhHhcEEeEEeecCcCeEEEEEEEC-------CCCCEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4678999999999999999999987 345689999986544222 23356999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++.... +++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~~~------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCc
Confidence 99999999999999999997542 677888899999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+...... ....+.+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++..+..+...
T Consensus 218 ~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~-------y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~ 288 (346)
T 4fih_A 218 AQVSKEV-PRRKSLVGTPYWMAPELISRLP-------YGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPP 288 (346)
T ss_dssp EECCSSS-CCBCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCC
T ss_pred eecCCCC-CcccccccCcCcCCHHHHCCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCC
Confidence 7654332 2234678999999999987665 8899999999999999998 99999999999999988887666
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++.+..+++++.+|+++||+.||+ |+++.|++.
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 6777788999999999999999998 999988753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=451.17 Aligned_cols=248 Identities=16% Similarity=0.327 Sum_probs=218.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
++|++++.||+|+||+||+|+++ .++..||+|++.... .......+.+|+.+|++|+|||||+++++|.++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 67999999999999999999987 345689999987543 122234567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||+||+|.++|.+.+. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 999999999999999999976543 678888999999999999999999999999999999999999999999999
Q ss_pred ccCCCC-ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 243 IDKYPG-DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 243 ~~~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+..... ......+.+||+.|||||++.+.. |+.++||||+||++|||++ |+.||.+.+..+++.+|.++
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-------y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~-- 249 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-------ACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAKIIKL-- 249 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-------BCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT--
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCC-------CCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC--
Confidence 865432 223345678999999999998765 8899999999999999998 99999999999999999877
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+..|..+++++.+|+++||+.||+ |+++.|+.
T Consensus 250 -~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 4667889999999999999999998 99998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-62 Score=459.06 Aligned_cols=252 Identities=15% Similarity=0.252 Sum_probs=213.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
-++|++++.||+|+||+||+|+++ .++..||||++.... .......+.+|+.+|++|+|||||++++++.++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST-------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET-------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 478999999999999999999987 345689999986543 444555678999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||+||+|.++|...+.. .+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999999754321 2567778899999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+...... ......+||+.|||||++.+.. |+.++|||||||+||||++ |+.||.+.+..+++.++..+.
T Consensus 173 ~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~-------y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~-- 241 (350)
T 4b9d_A 173 RVLNSTV-ELARACIGTPYYLSPEICENKP-------YNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKIISGS-- 241 (350)
T ss_dssp SCCCHHH-HHHHHHHSCCTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTC--
T ss_pred eeecCCc-ccccccCCCccccCHHHHCCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCC--
Confidence 7653221 1223457999999999997665 8899999999999999998 999999999999999998876
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.+..+++++.+||++||+.||+ ||++.|+++
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4466788999999999999999998 999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=464.61 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=220.0
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+++.|+++++||+|+||+||+|+++ .++..||||++....... ...+.+|+.+|++++|||||+++++|.++
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEESTTCSS-GGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhHhcEeeeEeccCcCcEEEEEEEC-------CCCCEEEEEEEeccchhH-HHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 4688999999999999999999987 345689999986544222 23456999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||+||+|.+++.... +++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~~------l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccc
Confidence 99999999999999999997542 677788899999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+...... ....+.+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++..+..+...
T Consensus 295 ~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~-------y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~ 365 (423)
T 4fie_A 295 AQVSKEV-PRRKSLVGTPYWMAPELISRLP-------YGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPP 365 (423)
T ss_dssp EECCSSC-CCBCCCEECTTTCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCC
T ss_pred eECCCCC-ccccccccCcCcCCHHHHCCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCC
Confidence 7654322 2334668999999999987665 8899999999999999998 99999999999999998887766
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++.+..+++++.+||++||+.||+ |+++.|++.
T Consensus 366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7777889999999999999999998 999988753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=452.50 Aligned_cols=257 Identities=18% Similarity=0.226 Sum_probs=218.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
...+.|++.++||+|+||+||+|+++ .++..||||+++.... ..+|+.+|++|+|||||++++++.+
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~-------~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEEC-------CCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34567899999999999999999987 3456899999875432 2479999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEccCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDTG 240 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~DFG 240 (394)
++.+|||||||+||+|.++|++.+. +++..+..++.||+.||.|||++|||||||||+||||+.+| .+||+|||
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~~-----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMGC-----LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred CCEEEEEEeccCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCC
Confidence 9999999999999999999976533 67888899999999999999999999999999999999988 69999999
Q ss_pred CCccCCCCce----eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 241 SSIDKYPGDY----YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 241 ~a~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|+....... ......+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++.++
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-------y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i 268 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-------CDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKI 268 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSSTTTCCSCCHHHH
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCC-------CCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHH
Confidence 9976543221 1223458999999999997765 8899999999999999998 99999998877788888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+.......|..+++.+.+++++||+.||+ |||+.|++..|...+.+
T Consensus 269 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 269 ASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 7765433456789999999999999999998 99999998887766543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=432.92 Aligned_cols=247 Identities=21% Similarity=0.333 Sum_probs=202.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.+|++.+.||+|+||+||+|+++ .++..||+|++.... .......+.+|+.+|++++|||||++++++.++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT-------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT-------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 57999999999999999999987 345689999986543 222334577999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+||||||| +|+|.++|.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~~~ivmEy~-~g~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYA-GNELFDYIVQRDK-----MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECC-CEEHHHHHHHSCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred CEEEEEEeCC-CCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCC
Confidence 9999999999 6899999977643 678888999999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+...... ...+.+||+.|||||++.+..+ ++.++||||+||++|||++ |+.||.+.+..+++..+..+
T Consensus 160 ~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y------~~~~~DiwSlGvily~llt-g~~PF~~~~~~~~~~~i~~~--- 227 (275)
T 3hyh_A 160 NIMTDGN--FLKTSCGSPNYAAPEVISGKLY------AGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKNISNG--- 227 (275)
T ss_dssp -----------------CTTSCHHHHSSSSC------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT---
T ss_pred eecCCCC--ccCCeeECcccCChhhhcCCCC------CCChhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcC---
Confidence 7653322 2345689999999999977652 4689999999999999998 99999999988888888776
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++.|..+++++.+++++||+.||+ |+|+.|+++
T Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 4667889999999999999999998 999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-61 Score=444.52 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=207.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+..++|++++.||+|+||+||+|++... ..+...||+|+++... .......+.+|+.+|++++|||||++++++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISG----SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSS----TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccC----CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 3457899999999999999999987531 1345689999986543 1111223568999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+++.+|||||||+||+|.++|.+.+. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~-----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999999976543 6788889999999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+|+...... ....+.+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++.++.++
T Consensus 172 la~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~-------y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~- 241 (304)
T 3ubd_A 172 LSKESIDHE-KKAYSFCGTVEYMAPEVVNRRG-------HTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMILKA- 241 (304)
T ss_dssp EEEC------CCCCSCCCCGGGCCHHHHHTSC-------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-
T ss_pred cceeccCCC-ccccccccCcccCCHHHhccCC-------CCCCCcccchHHHHHHHHh-CCCCCCCcCHHHHHHHHHcC-
Confidence 997543322 2234568999999999997765 8899999999999999998 99999999999999999877
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
.++.|..+++++.+++++||+.||+ |+++
T Consensus 242 --~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 5677889999999999999999998 8885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=432.82 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=203.7
Q ss_pred eEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe----
Q psy7505 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE---- 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---- 161 (394)
|++.++||+|+||+||+|+++. ++..||+|.+.... .......+.+|+.+|++|+|||||+++++|.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred EEeeeEEecCcCcEEEEEEECC-------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 4778899999999999999873 45589999886544 44455567899999999999999999999975
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcC-CCeEEEcc
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVTS-ELRVKIGD 238 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~~-~~~vKl~D 238 (394)
++.+|||||||++|+|.++|.+.+. +++..+..++.||+.||.|||+++ ||||||||+||||+. +|.+||+|
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence 3458999999999999999976532 677888899999999999999998 999999999999985 79999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHh
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-~~~~~~i~ 317 (394)
||+|+...... ..+.+||+.|||||++.+ . |+.++|||||||++|||+| |+.||.+... .++...+.
T Consensus 176 FGla~~~~~~~---~~~~~GTp~YmAPE~~~~-~-------y~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 176 LGLATLKRASF---AKAVIGTPEFMAPEMYEE-K-------YDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp TTGGGGCCTTS---BEESCSSCCCCCGGGGGT-C-------CCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHT
T ss_pred CcCCEeCCCCc---cCCcccCccccCHHHcCC-C-------CCcHHHHHHHHHHHHHHHH-CCCCCCCCCcHHHHHHHHH
Confidence 99997543322 234689999999998753 2 8899999999999999998 9999987654 45555665
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+. .....+..+++++.+++.+||+.||+ |||+.|++.
T Consensus 244 ~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 SGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCC-CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 543 22344667889999999999999998 999998864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=417.60 Aligned_cols=250 Identities=19% Similarity=0.322 Sum_probs=192.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
++|++++.||+|+||+||+|+++. ++..||||+++....+.....+.+|+.+|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV-------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT-------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECC-------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 468999999999999999999873 455899999876665555566789999999999999999999997654
Q ss_pred -----------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7505 164 -----------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 164 -----------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~ 232 (394)
.+|||||||++|+|.+++.......+ .....++.++.||+.||.|||++|||||||||+|||++.+|
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~--~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE--RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGG--SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCCh--hHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC
Confidence 37999999999999999987543221 34556778999999999999999999999999999999999
Q ss_pred eEEEccCCCCccCCCCce-----------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 233 RVKIGDTGSSIDKYPGDY-----------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~-----------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
.+||+|||+|+....... ....+.+||+.|||||++.+.. |+.++|||||||++|||++
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-------y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-------YSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCC-------CCTHHHHHHHHHHHHHHHS---
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-------CCCHHHHHHHHHHHHHHcc---
Confidence 999999999976543221 1123457999999999997665 8899999999999999995
Q ss_pred CCCCCCCH-HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 302 LPYAELSD-DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 302 ~Pf~~~~~-~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
||.+... ...+..+.... ..+.+...++.+.+++++||+.||+ ||++.|+++
T Consensus 226 -Pf~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRNLK--FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -CCSSHHHHHHHHHHHHTTC--CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccHHHHHHHHHhcCC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7765322 23344444432 2222345567788999999999998 999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=416.52 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
++|.+.++||+|+||+||+|+++ +..||||+++..... ...+..|+..+.+++|||||+++|++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~---------g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---------TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 46889999999999999999875 347999998765422 222346777788899999999999998754
Q ss_pred ---ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEcCCC
Q psy7505 164 ---PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED--------GFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 164 ---~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~--------~iiHrDlk~~NiLl~~~~ 232 (394)
.+|||||||++|+|.++|+... +++..+..++.|++.||.|||++ +||||||||+|||++.++
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~~------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CceEEEEEecCCCCCcHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence 5799999999999999997652 56777889999999999999987 999999999999999999
Q ss_pred eEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC-----
Q psy7505 233 RVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY----- 304 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf----- 304 (394)
.+||+|||+|+........ .....+||+.|||||++.+... .....|+.++|||||||+||||+| |..||
T Consensus 146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~-~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~~~~~~ 223 (303)
T 3hmm_A 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHED 223 (303)
T ss_dssp CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTBCCC
T ss_pred CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccc-ccCCccChhHhhhhHHHHHHHHHH-CCCCCCcccc
Confidence 9999999999765433222 1224579999999999975421 111126789999999999999998 86554
Q ss_pred -----CCC-----CHHHHHHHHhcCCCcCCCCCCC-----CChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 305 -----AEL-----SDDQVITRVFGTEALRLPAPRA-----VNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 305 -----~~~-----~~~~~~~~i~~~~~~~~~~p~~-----~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+. ...++...+. ....+++.|.. ++..+.++|++||+.||+ |||+.|+++.|+++.+
T Consensus 224 ~~~p~~~~~~~~~~~~~~~~~~~-~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 224 YQLPYYDLVPSDPSVEEMRKVVC-EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHT-TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchhcccccchHHHHHHHHh-cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 322 1233333333 33345555543 334788999999999998 9999999999988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=422.15 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=207.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
.++|++++.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+|++|+|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRR-------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 468999999999999999999987 345689999997554 33334456799999999999999999999864
Q ss_pred -----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 162 -----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 162 -----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
.+.+|||||||. |+|.++|...+. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~-----l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQP-----LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEE
Confidence 357899999995 689999976543 678888999999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCc---eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 237 GDTGSSIDKYPGD---YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 237 ~DFG~a~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
+|||+|+...... .....+.+||+.|||||++.+..+ |+.++||||+||++|||++ |+.||.+.+..+.+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~------~~~~~DiWSlG~il~ell~-G~~pF~g~~~~~~l 272 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE------YTQAIDLWSVGCIFGEMLA-RRQLFPGKNYVHQL 272 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC------CCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCC------CCChhheehhHHHHHHHHH-CCCCCCCCCHHHHH
Confidence 9999997653321 122345689999999999876542 7899999999999999998 99999999988887
Q ss_pred HHHhcCCCc-----------------------CCCC-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEAL-----------------------RLPA-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~-----------------------~~~~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..|...... ..+. ...+++++.+|+++||..||+ |+|+.|++.
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 776542110 0011 135788999999999999998 999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=427.79 Aligned_cols=245 Identities=17% Similarity=0.184 Sum_probs=204.7
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-----cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-----SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
+..++|++++.||+|+||+||+|+++ .++..||+|+++... ..........++.+++.++|||||+++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~-------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred CchHHeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 44688999999999999999999987 355689999986532 111111122456788899999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
++|.+.+.+|||||||+||+|.++|.+.+. +++..+..++.||+.||.|||++|||||||||+||||+.+|.+||
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~~-----l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEe
Confidence 999999999999999999999999976543 678888999999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL---SDDQVI 313 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~---~~~~~~ 313 (394)
+|||+|+...... ..+.+||+.|||||++..+. .|+.++|||||||++|||++ |..||.+. ...++.
T Consensus 334 ~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~------~y~~~vDiWSLGvilYEmLt-G~~PF~~~~~~~~~~i~ 403 (689)
T 3v5w_A 334 SDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGV------AYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEID 403 (689)
T ss_dssp CCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTC------CCCTHHHHHHHHHHHHHHHH-SSCTTCGGGCCCHHHHH
T ss_pred cccceeeecCCCC---CCCccCCcCccCHHHHhCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence 9999997654332 34568999999999986432 28999999999999999998 99999764 344556
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
..+... .+..|..+++++.+|+++||+.||. |++.
T Consensus 404 ~~i~~~---~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 404 RMTLTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HHHHHC---CCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred HhhcCC---CCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 666555 5677889999999999999999998 7773
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=425.55 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=215.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++++.||+|+||+||+|+++ .++..||+|+++..... ....+.+|+.+|+.|+|||||+++++|.+++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~-------~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 368999999999999999999987 34568999998765433 3445679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--CeEEEccCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE--LRVKIGDTGS 241 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~--~~vKl~DFG~ 241 (394)
.+|||||||+||+|.++|..... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEEeecCCCcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 99999999999999999965322 26788889999999999999999999999999999999864 8999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+........ ...+||+.|||||++.+.. |+.++|||||||++|||++ |..||.+.+..+++..+..+..
T Consensus 304 a~~~~~~~~~--~~~~GT~~y~APEv~~~~~-------y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~i~~~~~ 373 (573)
T 3uto_A 304 TAHLDPKQSV--KVTTGTAEFAAPEVAEGKP-------VGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDW 373 (573)
T ss_dssp CEECCTTSEE--EEECSSGGGCCHHHHTTCC-------BCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTTCC
T ss_pred eeEccCCCce--eeeEECccccCHHHhCCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHhCCC
Confidence 9876544432 3457999999999997765 8899999999999999998 9999999999999998887642
Q ss_pred -cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+.+..+++++.+||++||+.||. |+++.|++.
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223357899999999999999998 999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=399.01 Aligned_cols=250 Identities=16% Similarity=0.171 Sum_probs=196.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 162 (394)
.+.|++.+.||+|+||+||+|+++.. ..+...||+|.+....... .+.+|+++|+.+ +|||||+++++|.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~vAiK~i~~~~~~~---~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQ----VGPEEKIALKHLIPTSHPI---RIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBT----TSCEEEEEEEEECTTSCHH---HHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEccc----CCCCCEEEEEEEccccCHH---HHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 46799999999999999999987621 1345689999886654332 246899999988 799999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEEccCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKIGDTGS 241 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl~DFG~ 241 (394)
+.+|||||||++|+|.+++.. +++..+..++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~--------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNS--------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTT--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CEEEEEEeCCCcccHHHHHcC--------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999999842 5677788999999999999999999999999999999877 8999999999
Q ss_pred CccCCCCce---------------------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHH
Q psy7505 242 SIDKYPGDY---------------------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294 (394)
Q Consensus 242 a~~~~~~~~---------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~ 294 (394)
|+....... ......+||+.|||||++.+... |+.++||||+||++|
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~------y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPN------QTTAIDMWSAGVIFL 238 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSC------CCTHHHHHHHHHHHH
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC------CCCccchhhhHHHHH
Confidence 964332110 11223579999999999976542 789999999999999
Q ss_pred HHHcCCCCCCCCC-CHHHHHHHHhc--C-----------------------------------C--------------Cc
Q psy7505 295 EIFEFGKLPYAEL-SDDQVITRVFG--T-----------------------------------E--------------AL 322 (394)
Q Consensus 295 el~t~g~~Pf~~~-~~~~~~~~i~~--~-----------------------------------~--------------~~ 322 (394)
||++ |+.||... +..+.+.+|.. | . ..
T Consensus 239 ell~-G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 317 (361)
T 4f9c_A 239 SLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT 317 (361)
T ss_dssp HHHH-TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred HHHH-CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence 9998 99998543 44444433321 0 0 00
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..+....+++++.+|+++||+.||+ |+|+.|++
T Consensus 318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred cccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 1122346789999999999999998 99998876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=401.38 Aligned_cols=278 Identities=31% Similarity=0.559 Sum_probs=235.3
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
...+.+..++|++.+.||+|+||.||+|++.+...........||+|+++..........+.+|+.+|+++ +|||||++
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 34567888999999999999999999999875444344456689999998776665566678999999999 89999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
++++.+.+.+|+||||+++|+|.+++...... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 99999999999999999999999999875321 0112567778899999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||+++........ ......+|+.|+|||++.+.. ++.++|||||||++|||++.|..|
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-------YTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-------CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-------CCcHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999755433221 122335678899999987654 889999999999999999779999
Q ss_pred CCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 304 f~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
|.+....++...+..+. +.+.|..++..+.++|++||..+|. ||++.|+++.|++++.
T Consensus 306 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 306 YPGIPVEELFKLLKEGH--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp STTCCGGGHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99998888888887775 6677889999999999999999998 9999999999988763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=399.83 Aligned_cols=267 Identities=33% Similarity=0.534 Sum_probs=230.6
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceece
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
....|.+..++|++.+.||+|+||.||+|+++. .+..||+|.++..........+.+|+.+|++++|||||++
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 177 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRA-------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEec-------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 456788999999999999999999999999873 3458999998866555555556799999999999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
++++.+.+.+++|||||++|+|.++++..+. .++...+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~k 253 (377)
T 3cbl_A 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLK 253 (377)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEecCCCcEEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEE
Confidence 9999999999999999999999999975432 267778889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeC-CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHG-EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
|+|||+++........... ...+++.|+|||++.... ++.++|||||||++|||++.|..||.+.+..++..
T Consensus 254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~ 326 (377)
T 3cbl_A 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-------YSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326 (377)
T ss_dssp ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-------EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999765443322221 223567899999987654 78899999999999999987999999999988888
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.+..+. +++.|..+++.+.++|++||..+|+ ||++.+++..|+++.
T Consensus 327 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 327 FVEKGG--RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 887776 7888899999999999999999998 999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=390.70 Aligned_cols=279 Identities=32% Similarity=0.542 Sum_probs=238.3
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
...|+++.++|.+.+.||+|+||.||+|++.+..+........||+|+++..........+.+|+.+++++ +|||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 45678889999999999999999999999876554444556689999998776666656677999999999 99999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
++++.+.+.+++||||+++|+|.+++...... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 99999999999999999999999999865311 0122677888999999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++.|..|
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-------YTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-------CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-------CCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999976543222 1223346678899999987654 789999999999999999779999
Q ss_pred CCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 304 f~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
|.+....++...+..+. +...|..++..+.+++++||+.+|+ ||++.|+++.|+++...
T Consensus 294 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 294 YPGVPVEELFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp STTCCHHHHHHHHHTTC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999888887776 6677889999999999999999998 99999999999888753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=400.20 Aligned_cols=265 Identities=28% Similarity=0.486 Sum_probs=228.3
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...|+++.++|++.+.||+|+||.||+|.++. ...||||+++..... ...+.+|+.+|++++|||||+++
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~l~ 249 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK--------HTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLH 249 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT--------TEEEEEEEECTTSBC--HHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECC--------ccEEEEEEecCCCcc--HHHHHHHHHHHhhCCCCCEeeEE
Confidence 56789999999999999999999999999862 347999998765432 23467999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++. .+.++||||||.+|+|.++|+.... ..++...++.++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp EEEC-SSSCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEE
T ss_pred EEEe-CCccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEE
Confidence 9986 6789999999999999999975422 12566778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..............+|+.|+|||++.... ++.++|||||||++|||+++|+.||.+.+..+++..+
T Consensus 326 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 398 (454)
T 1qcf_A 326 ADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-------FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398 (454)
T ss_dssp CSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred eeCCCceEcCCCceeccCCCcccccccCHHHhccCC-------CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999765433322223345678899999987655 7899999999999999998799999999999998888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+. +++.|..+++.+.++|++||..||+ ||++.+++..|+.+...
T Consensus 399 ~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ERGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HcCC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 7775 7888999999999999999999998 99999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=380.48 Aligned_cols=267 Identities=28% Similarity=0.466 Sum_probs=227.6
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++...+|++.+.||+|+||.||+|+++... .....||||.++..........+.+|+.++++++||||+++++++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPG----QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTT----SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCC----CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 566789999999999999999999986322 2344699999987665555666789999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred eCCccEEEeeCCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 99999999999999999999975422 26777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCc--eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 241 SSIDKYPGD--YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 241 ~a~~~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
+++...... ........+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+....++...+..
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-------FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCC-------CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 997653322 12222335677899999987654 788999999999999999779999999999999888887
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+. +++.+..++..+.++++.||..+|+ ||++.++++.|+.+...
T Consensus 270 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 270 GY--RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC--CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 75 7788889999999999999999998 99999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=377.06 Aligned_cols=275 Identities=31% Similarity=0.425 Sum_probs=217.5
Q ss_pred hcccccCCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccC
Q psy7505 69 LSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRL 147 (394)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l 147 (394)
+..+...+..+++++.++|++.+.||+|+||.||+|++. +..||+|++.... .......+.+|+.+++++
T Consensus 21 ~~~~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l 91 (309)
T 3p86_A 21 LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH---------GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91 (309)
T ss_dssp -----------CBCCGGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC
T ss_pred ceeccCCCcccccCChhHceeeeEeecCCCeEEEEEEEC---------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC
Confidence 334445566788899999999999999999999999865 3368999986554 334445567999999999
Q ss_pred CCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCC
Q psy7505 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARN 225 (394)
Q Consensus 148 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~N 225 (394)
+||||+++++++.+.+.+++||||+++|+|.+++..... ...+++..++.++.|++.||.|||++| |+||||||+|
T Consensus 92 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~N 169 (309)
T 3p86_A 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169 (309)
T ss_dssp CCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGG
T ss_pred CCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhh
Confidence 999999999999999999999999999999999986532 223677888899999999999999999 9999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~ 305 (394)
||++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 170 Ill~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ellt-g~~Pf~ 240 (309)
T 3p86_A 170 LLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEP-------SNEKSDVYSFGVILWELAT-LQQPWG 240 (309)
T ss_dssp EEECTTCCEEECCCC------------------CCTTSCHHHHTTCC-------CCTTHHHHHHHHHHHHHHH-CCCTTT
T ss_pred EEEeCCCcEEECCCCCCcccccc-ccccccCCCCccccChhhhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCC
Confidence 99999999999999998654322 12233457889999999987665 7889999999999999998 999999
Q ss_pred CCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 306 ELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 306 ~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+.+..+....+.... .+.+.|..+++.+.+++++||..+|+ ||++.++++.|+.+...
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 241 NLNPAQVVAAVGFKC-KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSCHHHHHHHHHHSC-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCHHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 998888776664322 26777889999999999999999998 99999999999988865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=371.70 Aligned_cols=268 Identities=29% Similarity=0.515 Sum_probs=216.6
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.+|++..++|++.+.||+|+||.||+|.+.... .....|++|..+..........+.+|+.++++++||||+++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCC----CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 467888999999999999999999999986422 2345789999877665555566779999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++. .+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEEC
Confidence 984 5678999999999999999975432 25777788999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++..............+|+.|+|||++.... ++.++|||||||++|||++.|..||.+....++...+.
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~ 231 (281)
T 1mp8_A 159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231 (281)
T ss_dssp C-------------------CCGGGCCHHHHHHCC-------CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred ccccccccCcccccccccCCCcccccChhhcccCC-------CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence 99999765443333333345677899999987654 78899999999999999965999999998888888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+. +.+.+..+++.+.+++++||..+|+ ||++.|+++.|+++..
T Consensus 232 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 232 NGE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 775 6677889999999999999999998 9999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=402.77 Aligned_cols=267 Identities=28% Similarity=0.510 Sum_probs=232.0
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...|++..++|++.+.||+|+||.||+|+++. ....||||.++..... ...+.+|+.+|++++|||||+++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~ 282 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLL 282 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGG-------GTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcC-------CCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEE
Confidence 35688899999999999999999999999873 3558999998765432 23467999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
++|.+.+.++||||||++|+|.++|+..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 283 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCcEEEEEEccCCCCHHHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEE
Confidence 9999999999999999999999999864321 2567778899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..............+|+.|+|||++.... ++.++|||||||++|||+++|..||.+.+..++...+
T Consensus 360 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~ 432 (495)
T 1opk_A 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432 (495)
T ss_dssp CCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred eecccceeccCCceeecCCCcCCcceeCHhHHhcCC-------CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999876544444444456778999999987654 7899999999999999998799999999888888877
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+. +++.|..+++.+.++|++||+.+|+ ||++.+++..|+.+...
T Consensus 433 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 433 EKDY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HcCC--CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 7665 7788899999999999999999998 99999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=377.30 Aligned_cols=249 Identities=20% Similarity=0.339 Sum_probs=216.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..+|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHI-------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 578999999999999999999986 345589999986544 334444567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|+|||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~-----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred CEEEEEEECCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999999976533 677788899999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... .....+||+.|+|||++.+..+ .+.++|||||||++|||++ |+.||.+.+..++...+..+
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~--- 229 (328)
T 3fe3_A 162 NEFTVGG--KLDAFCGAPPYAAPELFQGKKY------DGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERVLRG--- 229 (328)
T ss_dssp GGGSSSC--GGGTTSSSGGGCCHHHHHTCCC------CSHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC---
T ss_pred eecCCCC--ccccccCCcceeCcccccCCCc------CCchhhhhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC---
Confidence 7554332 2235578999999999976652 3579999999999999998 99999999999988888877
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++..+.+++++||..||. ||++.|+++
T Consensus 230 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4567788999999999999999998 999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=393.80 Aligned_cols=265 Identities=29% Similarity=0.500 Sum_probs=222.5
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...|+++.++|++.+.||+|+||.||+|.+++ ...||||+++..... ...+.+|+.+|++++||||++++
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~ 245 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLY 245 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT--------TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECC--------CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEE
Confidence 56789999999999999999999999999863 236999998765422 22367999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+ +.++||||||++|+|.+++..... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 246 ~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcC-CceEEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEE
Confidence 99876 779999999999999999975321 22677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..............+|+.|+|||++.... ++.++|||||||++|||++.|+.||.+....+++..+
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHhcCC-------CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999765443333333446678899999987655 7899999999999999998799999999999999888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+. +++.|..+++.+.++|.+||..+|+ ||++.++...|+.+...
T Consensus 395 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 395 ERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 8776 7888899999999999999999998 99999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=362.64 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=227.1
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+++..++|++.+.||+|+||.||+|++++ ...||+|+++...... ..+.+|+.++++++||||++++++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKG--------QYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT--------TEEEEEEEECBTTBCH--HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecC--------ceeEEEEEeccCCCcH--HHHHHHHHHHHhCCCCCEeeEEEE
Confidence 457788999999999999999999998763 3368999987655322 235689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+..++||||+++|+|.+++...+. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 72 CSKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECC
T ss_pred EccCCceEEEEEccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEcc
Confidence 9999999999999999999999976422 267778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++...............+|+.|+|||++.+.. ++.++|||||||++|||++.|..||......+....+..
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 220 (268)
T 3sxs_A 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-------YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220 (268)
T ss_dssp TTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-------EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred CccceecchhhhhcccCCCcCcccCCHHHHhccC-------CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence 9999766555444444556678899999987654 778999999999999999769999999998888888877
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+. ....|..+++.+.+++++||+.+|. ||++.|+++.|+++.+
T Consensus 221 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 221 GH--RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TC--CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CC--CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 75 6667788899999999999999998 9999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=365.59 Aligned_cols=263 Identities=32% Similarity=0.549 Sum_probs=224.8
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
+..|.+..++|++.+.||+|+||.||+|++.. ...||+|++....... ..+.+|+.++++++||||++++
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~ 71 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLN--------KDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLY 71 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETT--------TEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEE
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecC--------CCeEEEEEecccccCH--HHHHHHHHHHHhCCCCCEeeEE
Confidence 35678889999999999999999999999862 3368999987655322 2356999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+.+..++||||+++|+|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 147 (269)
T 4hcu_A 72 GVCLEQAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 147 (269)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEE
T ss_pred EEEecCCceEEEEEeCCCCcHHHHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEe
Confidence 999999999999999999999999976432 2577778899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...............+|..|+|||++.+.. ++.++|||||||++|||++.|..||.+....++...+
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~ 220 (269)
T 4hcu_A 148 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220 (269)
T ss_dssp CCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccccccccccccccCcccccccCCHHHhcCCC-------CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999998765443333333446677899999987655 7899999999999999997689999999999988888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
..+. +...|..++..+.+++++||..+|+ ||++.++++.|+++.
T Consensus 221 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 221 STGF--RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCc--cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 7775 6667788999999999999999998 999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=377.97 Aligned_cols=275 Identities=33% Similarity=0.584 Sum_probs=229.8
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+.+..++|++.+.||+|+||.||+|++++... ......||+|+++..........+.+|+.++++++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP--YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSST--TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCC--CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45678999999999999999999999874321 1234589999998766555556678999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhh-------------------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASR-------------------EALLEQGITIKMAIDVATGLSYMIEDGFIHTD 220 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-------------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrD 220 (394)
.+.+.+++||||+++|+|.+++....... ...+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999998642110 12367778889999999999999999999999
Q ss_pred CCCCCEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC
Q psy7505 221 VAARNCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299 (394)
Q Consensus 221 lk~~NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~ 299 (394)
|||+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|||+++
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-------YTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-------cCcccccHHHHHHHHHHHhc
Confidence 999999999999999999999865432222 1223346788999999987655 78999999999999999977
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 300 GKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 300 g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
|..||.+....++...+..+. ..+.|..++..+.+++++||..+|. ||++.++++.|+++...+
T Consensus 273 g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 273 GLQPYYGMAHEEVIYYVRDGN--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TCCTTTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCcCCCCChHHHHHHHhCCC--cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 999999999988888887775 5567789999999999999999998 999999999999988754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=370.99 Aligned_cols=277 Identities=32% Similarity=0.541 Sum_probs=232.3
Q ss_pred CCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceec
Q psy7505 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
.....|+++.++|.+.+.||+|+||.||+|++..... ......||+|+++..........+.+|+.++++++||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKG--RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGG--CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCc--ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceee
Confidence 3456788999999999999999999999999853221 12345899999987665555566779999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-------------------hhhhhhHHHHHHHHHHHHHHHHHHHhCC
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEAS-------------------REALLEQGITIKMAIDVATGLSYMIEDG 215 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~ 215 (394)
+++++.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999865321 0122677788899999999999999999
Q ss_pred ceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHH
Q psy7505 216 FIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294 (394)
Q Consensus 216 iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~ 294 (394)
|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||++.+.. ++.++|||||||++|
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ 243 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-------YTTQSDVWSFGVLLW 243 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-------ECHHHHHHHHHHHHH
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-------cCchhhHHHHHHHHH
Confidence 9999999999999999999999999987654333222 23346678899999987654 789999999999999
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 295 EIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 295 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
||++.|..||.+....++...+..+. ..+.+..+++.+.+++++||..||. ||++.|+++.|+++.
T Consensus 244 el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 244 EIVTLGGNPYPGIPPERLFNLLKTGH--RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHhhcCC--cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99976999999988888877777665 5677789999999999999999998 999999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=392.09 Aligned_cols=257 Identities=32% Similarity=0.571 Sum_probs=221.1
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
..|++..++|++.+.||+|+||.||+|.++ +..||||+++.... ...+.+|+.+|++++|||||++++
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~---------~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~ 253 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEESSCTT---SHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec---------CCeEEEEEeCCchH---HHHHHHHHHHHHhccCCCEEEEEE
Confidence 467888999999999999999999999876 23799999986542 234679999999999999999999
Q ss_pred EEEeCC-ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 158 ACLESD-PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 158 ~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
++...+ .++||||||++|+|.+++...+. ..++...++.++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 254 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 330 (450)
T 1k9a_A 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKV 330 (450)
T ss_dssp EEECTTSCEEEEEECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEE
T ss_pred EEEcCCCceEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEE
Confidence 987655 79999999999999999986532 12467778899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..... .....+++.|+|||++.+.. ++.++|||||||++|||+++|..||.+.+..++...+
T Consensus 331 ~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~-------~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 399 (450)
T 1k9a_A 331 SDFGLTKEASST----QDTGKLPVKWTAPEALREKK-------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399 (450)
T ss_dssp CCCTTCEECC----------CCCTTTSCHHHHHSSC-------CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred eeCCCccccccc----ccCCCCCcceeCHHHhcCCC-------CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999998754221 12235678899999987655 7899999999999999998799999999888888888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
..+. +++.|..+++.+.++|++||..+|. ||++.+++..|+.+.
T Consensus 400 ~~~~--~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 400 EKGY--KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 7776 7888899999999999999999998 999999999988764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=374.65 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=211.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
..++|++++.||+|+||+||+|+.+. ++..||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKA-------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 35789999999999999999999873 45589999987543 1112234568999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+.+|+||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999999975432 5777788999999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+
T Consensus 151 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~- 220 (337)
T 1o6l_A 151 LCKEGISDGA-TMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME- 220 (337)
T ss_dssp TCBCSCCTTC-CBCCCEECGGGCCGGGGSSSC-------BCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-
T ss_pred chhhcccCCC-cccccccChhhCChhhhcCCC-------CCchhhcccchhHHHHHhc-CCCCCCCCCHHHHHHHHHcC-
Confidence 9975432221 233557899999999987654 7899999999999999998 99999998888888888765
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.+..|..+++++.+++++||+.||+ |+ ++.|+.
T Consensus 221 --~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~ 259 (337)
T 1o6l_A 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH
Confidence 4566788999999999999999998 77 677775
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=373.86 Aligned_cols=279 Identities=30% Similarity=0.557 Sum_probs=234.2
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceec
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILR 154 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 154 (394)
....|+++.++|++.+.||+|+||.||+|++.+...........||+|+++..........+.+|+.+++++ +||||++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 356788899999999999999999999999875544334456689999998766555556677999999999 9999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~ 223 (394)
+++++.+.+.+++||||+++|+|.+++...... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 999999999999999999999999999865321 112257778889999999999999999999999999
Q ss_pred CCEEEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 224 RNCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
+|||++.++.+||+|||++.......... .....+|+.|+|||++.+.. ++.++|||||||++|||++.|..
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-------YTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-------cChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999987654433222 22335678899999987654 78899999999999999977999
Q ss_pred CCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 303 PYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 303 Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
||.+....++...+..+. +.+.+..++..+.+++++||..+|. ||++.|+++.|+++..
T Consensus 259 p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 259 PYPGIPVEELFKLLKEGH--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp SSTTCCHHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCcCCHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999888888877765 5667788999999999999999998 9999999999998864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=386.12 Aligned_cols=276 Identities=34% Similarity=0.554 Sum_probs=228.0
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.++..++|++.+.||+|+||.||+|++.+... ......||||.++..........+.+|+.++++++|||||++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN--DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCC--CCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35678999999999999999999999764321 1345589999997665555555677999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchh--hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---eE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEAS--REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL---RV 234 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~---~v 234 (394)
.+.+..++|||||++|+|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999764321 112256777889999999999999999999999999999999554 59
Q ss_pred EEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+....++.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-------FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCC-------CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999864321111 1122346788999999987665 7899999999999999997699999999999999
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcce
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYY 366 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~ 366 (394)
..+..+. +.+.+..++..+.+++++||+.+|. ||++.++++.|+.+..+..
T Consensus 297 ~~i~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 EFVTSGG--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHcCC--CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 8888776 6677889999999999999999998 9999999999988876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=382.86 Aligned_cols=267 Identities=28% Similarity=0.474 Sum_probs=216.2
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++...+|++.+.||+|+||.||+|+++.. ......||||.++..........+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLP----SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCT----TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecC----CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45678899999999999999999987621 13455799999987665555566789999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 99999999999999999999976532 26777788999999999999999999999999999999999999999999
Q ss_pred CCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 241 SSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 241 ~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
+++........ ......+++.|+|||++.+.. ++.++|||||||++|||+++|+.||.+....++...+..
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ---------------------CTTSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCC-------cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 98765332211 111224567899999987655 789999999999999999779999999999888888877
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+. +++.+..++..+.+++.+||+.+|. ||++.++++.|+++...
T Consensus 266 ~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GY--RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TE--ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC--CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 65 6777889999999999999999998 99999999999887643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=378.02 Aligned_cols=246 Identities=19% Similarity=0.317 Sum_probs=206.7
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
+..++|++.+.||+|+||+||+|+++. ++..||+|+++... .......+.+|..+++.+ +||||++++++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKE-------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcC-------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 446889999999999999999999873 45589999987643 222233456899999888 79999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|||||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999999999976532 67778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+|+...... ......+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+++..+..
T Consensus 168 FG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 168 FGMCKEGICNG-VTTATFCGTPDYIAPEILQEML-------YGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILN 238 (353)
T ss_dssp CTTCBCSCC----------CCGGGCCHHHHHHHH-------CTTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred ccceeecccCC-ccccccCCCcCeEChhhcCCCC-------cCCccCCCcchHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Confidence 99997543222 2234557899999999987654 7899999999999999998 9999999999999999887
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
+ .+..|..++..+.+++++||..+|. |+++
T Consensus 239 ~---~~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 239 D---EVVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp C---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred C---CCCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 7 4667788999999999999999998 8887
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=404.43 Aligned_cols=267 Identities=25% Similarity=0.458 Sum_probs=222.1
Q ss_pred CCceecCCCeEEEc-eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..+.+.++++.+.+ .||+|+||.||+|.++.. .....||||+++..........+.+|+.+|++++|||||+++
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 402 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECS-----SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecC-----CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45667788888877 899999999999988632 234579999998754333344567999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.. +.++||||||.+|+|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 403 ~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL 477 (613)
T 2ozo_A 403 GVCQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI 477 (613)
T ss_dssp EEEES-SSEEEEEECCTTCBHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred EEecc-CCeEEEEEeCCCCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEE
Confidence 99976 679999999999999999975422 2677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
+|||+++........ ......+|+.|+|||++.... ++.++|||||||++|||+++|+.||.+.+..++..
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-------~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~ 550 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC-------CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 999999765432221 112234567899999987655 88999999999999999977999999999999998
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+..+. +++.|..+++.+.++|.+||..+|+ ||++.+++..|+.+..
T Consensus 551 ~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 551 FIEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp HHHTTC--CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 888876 7788899999999999999999998 9999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=369.01 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=214.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|++.+.||+|+||.||+|++. ..+..||+|.+....... ...+.+|+.+++.++||||+++++++..+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBT-------TTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhceeeeeeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4678999999999999999999876 345589999886544322 23456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++|||||.+|+|.+++.... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999999997642 566778899999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+......
T Consensus 164 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 234 (297)
T 3fxz_A 164 AQITPEQS-KRSTMVGTPYWMAPEVVTRKA-------YGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTP 234 (297)
T ss_dssp EECCSTTC-CBCCCCSCGGGCCHHHHHCSC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSC
T ss_pred eecCCccc-ccCCccCCcCccChhhhcCCC-------CCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 75543322 233457899999999987665 7899999999999999998 99999998887777666655555
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..|..++..+.+++++||+.||+ ||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6777889999999999999999998 999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=369.30 Aligned_cols=282 Identities=34% Similarity=0.568 Sum_probs=235.2
Q ss_pred cCCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCccee
Q psy7505 74 WFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNIL 153 (394)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv 153 (394)
.+..++|++..++|++.+.||+|+||.||+|++++... ......||+|.+...........+.+|+.++++++||||+
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVK--DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEET--TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccC--CCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34567888999999999999999999999998863211 1345589999998766555555677999999999999999
Q ss_pred ceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhh-----hhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7505 154 RLMAACLESDPWLLVFESCSRGDLKEFLLSNEASRE-----ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228 (394)
Q Consensus 154 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl 228 (394)
++++++.+++..++||||+++|+|.+++...+.... ..++...++.++.|++.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 999999999999999999999999999976432100 113667788899999999999999999999999999999
Q ss_pred cCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 229 TSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 229 ~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
+.++.+||+|||++.......... .....+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-------FTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-------CCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999999999987543333222 22335678899999987654 7899999999999999998689999999
Q ss_pred CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcce
Q psy7505 308 SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYY 366 (394)
Q Consensus 308 ~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~ 366 (394)
...++...+..+. ..+.+..++..+.+++++||..+|. ||++.|++..|++......
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 245 SNEQVLRFVMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp CHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred CHHHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 9888888887765 5567789999999999999999998 9999999999999886443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=398.90 Aligned_cols=265 Identities=29% Similarity=0.500 Sum_probs=228.0
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...|++..++|++.+.||+|+||.||+|.+++ ...||||+++..... ...+.+|+.+|++++|||||+++
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~ 328 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLY 328 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT--------TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC--------CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEE
Confidence 46788999999999999999999999999863 236999998765432 22367999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+ +.+|||||||.+|+|.++|..... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 329 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 404 (535)
T 2h8h_A 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 404 (535)
T ss_dssp EEECS-SSCEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEee-ccceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEE
Confidence 99876 779999999999999999975321 22677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..............+++.|+|||++.... ++.++|||||||+||||++.|+.||.+....+++..+
T Consensus 405 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 405 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp CCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred cccccceecCCCceecccCCcCcccccCHHHhccCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999765433222223345678899999987655 7899999999999999998799999999999999888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+. +++.|..++..+.++|++||..+|+ ||++.++++.|+.+...
T Consensus 478 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 478 ERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 8776 7788899999999999999999998 99999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=379.08 Aligned_cols=276 Identities=32% Similarity=0.567 Sum_probs=226.5
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
...|+++.++|++.+.||+|+||.||+|++.+... ......||||.++..........+.+|+.+++++ +|||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK--TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccc--cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44678899999999999999999999999764322 2345689999998766655556678999999999 89999999
Q ss_pred eeEEEeCC-ceEEEEeeCCCCCHHHHHhhcchhh----------------------------------------------
Q psy7505 156 MAACLESD-PWLLVFESCSRGDLKEFLLSNEASR---------------------------------------------- 188 (394)
Q Consensus 156 ~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~---------------------------------------------- 188 (394)
++++.+.+ .+++|||||++|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 4999999999999999998653210
Q ss_pred ---------------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCc-eee
Q psy7505 189 ---------------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYV 252 (394)
Q Consensus 189 ---------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~ 252 (394)
...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 1116777888999999999999999999999999999999999999999999997543322 233
Q ss_pred eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCcCCCCCCCCC
Q psy7505 253 HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEALRLPAPRAVN 331 (394)
Q Consensus 253 ~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~p~~~~ 331 (394)
.....+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+.... .+...+..+. ..+.|..++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 322 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRV-------YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTT 322 (359)
T ss_dssp C--CEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCC
T ss_pred ccccCCCceeEChhhhcCCC-------CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--CCCCCCCCC
Confidence 34457788999999987654 7899999999999999996699999887643 4444454444 667788899
Q ss_pred hHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 332 SHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 332 ~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+.+.+++.+||..+|. ||++.|+++.|++++.
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999998 9999999999988763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=362.98 Aligned_cols=262 Identities=18% Similarity=0.245 Sum_probs=214.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
-.++|++.+.||+|+||.||+|++.. ....||+|.+.... .......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTI-------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT-------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECC-------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 35789999999999999999999863 45589999875432 3444456779999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+++.+++||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999999976532 6777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++...............||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 228 (294)
T 4eqm_A 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-------TDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDS 228 (294)
T ss_dssp SSTTC-------------CCSSCCHHHHHTCC-------CCTTHHHHHHHHHHHHHHH-SSCSSCSSCHHHHHHHHHSSC
T ss_pred CccccccccccccCccccCccccCHhHhcCCC-------CCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcc
Confidence 99765443333334457899999999987655 7889999999999999998 999999988877766655553
Q ss_pred CcCC--CCCCCCChHHHHHHHhhhcCCcc-cc-chhhhhhhhhcCCCc
Q psy7505 321 ALRL--PAPRAVNSHVDVAARNCLVTSEL-RV-KIGDTGSSIDKYPGD 364 (394)
Q Consensus 321 ~~~~--~~p~~~~~~~~~l~~~cl~~~p~-r~-~~~e~~~~l~~~~~~ 364 (394)
.... ..+..+++.+.+++.+||..+|. || ++.++.+.|.+++..
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 2211 23467899999999999999998 87 788999999998865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=373.69 Aligned_cols=266 Identities=26% Similarity=0.423 Sum_probs=216.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+|++..... ....+|++|.++..........+.+|+.++++++||||+++++++.+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCc---eEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 456889999999999999999999864322 22346788888655544444556799999999999999999999986
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+ ..++|+||+.+|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 5 58899999999999999976532 267777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
|+....... .......+|+.|+|||++.+.. ++.++|||||||++|||++.|+.||.+....++...+..+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCC-------CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC
Confidence 875433222 2222345678899999987665 78999999999999999977999999988888877777665
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+.+.+..++..+.+++.+||+.+|. ||++.+++..|+++..+
T Consensus 237 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 6778889999999999999999998 99999999999888765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=371.92 Aligned_cols=280 Identities=29% Similarity=0.513 Sum_probs=211.4
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.++.++.++|++.+.||+|+||.||+|+++... .....||+|+++... .......+.+|+.++++++||||++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 91 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQED----GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccC----CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhh
Confidence 456788899999999999999999999876322 222378999987653 223344567999999999999999999
Q ss_pred eEEEeCCce------EEEEeeCCCCCHHHHHhhcchhh-hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 157 AACLESDPW------LLVFESCSRGDLKEFLLSNEASR-EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 157 ~~~~~~~~~------~lv~E~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
+++...+.. ++||||+.+|+|.+++....... ...+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171 (323)
T ss_dssp EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence 999876654 99999999999999997543211 11267778889999999999999999999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
.++.+||+|||+++......... .....+++.|+|||++.+.. ++.++|||||||++|||++.|..||.+..
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-------YTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCC-------CCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999999997654333222 22335677899999987665 78999999999999999976899999999
Q ss_pred HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcceeeCc
Q psy7505 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYYVHGE 370 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~~~~~ 370 (394)
..++...+..+. ..+.+..+++.+.+++++||..||+ ||++.+++..|++++........
T Consensus 245 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 245 NAEIYNYLIGGN--RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp GGGHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred hHHHHHHHhcCC--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 888888887776 6677889999999999999999998 99999999999998875544433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=362.71 Aligned_cols=264 Identities=28% Similarity=0.506 Sum_probs=223.6
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
...|.+..++|++.+.||+|+||.||+|.+++ ...||+|+++...... ..+.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRG--------QYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETT--------TEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcC--------CCeEEEEEecCCCCCH--HHHHHHHHHHhcCCCCCEeeEE
Confidence 35678889999999999999999999998763 3368999987655322 2356999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+.+.+++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl 161 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEE
Confidence 999999999999999999999999976322 2677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...............+|+.|+|||++.+.. ++.++|||||||++|||++.|+.||......+....+
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 234 (283)
T 3gen_A 162 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234 (283)
T ss_dssp CSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-------CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccCCccCcccCCHHHhccCC-------CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH
Confidence 999998765443333233445678899999987655 7889999999999999997699999999988888888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+. +...|..+++.+.+++++||..+|. ||++.++++.|.++..
T Consensus 235 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 235 AQGL--RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccc--CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 7765 6667788999999999999999998 9999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=373.19 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=211.2
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+..++|++.+.||+|+||.||+|+++. ++..||+|+++.... ......+..|..++..+ +||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK-------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 3456899999999999999999999873 455899999875431 11223345788888876 9999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++.+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEe
Confidence 99999999999999999999999976432 6777788999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+++..+.
T Consensus 161 DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 161 DFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQK-------YNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp CCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred EChhhhhcccCCC-cccCCCCCcccCChhhhcCCC-------CCChhhhHHHHHHHHHHhc-CCCCCCCCCHHHHHHHHH
Confidence 9999975432221 234568899999999987654 7899999999999999998 999999999988888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchh-hhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG-DTG 355 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~-e~~ 355 (394)
.+ ....|..+++.+.+++++||..+|+ |+++. |+.
T Consensus 232 ~~---~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 MD---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HC---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred hC---CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 66 4556788999999999999999998 89987 664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=374.47 Aligned_cols=252 Identities=18% Similarity=0.294 Sum_probs=205.2
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHH-hccCCCcceeceeeEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATP-YRRLRHVNILRLMAAC 159 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~ 159 (394)
..++|++++.||+|+||+||+|+++. ....||+|+++... .......+.+|..+ ++.++|||||++++++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKA-------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETT-------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 35789999999999999999999873 45589999987654 22223334567766 5778999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+.+|+|||||++|+|.+++...+. +.+..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999999999976432 566777889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+++...... ......+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+
T Consensus 184 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 184 GLCKENIEHN-STTSTFCGTPEYLAPEVLHKQP-------YDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp CBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCTTCCSBHHHHHHHHHHS
T ss_pred ccccccccCC-CccccccCCccccCHHHhCCCC-------CCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Confidence 9997532221 1234568899999999987654 7899999999999999998 99999999988888888776
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhh
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSI 358 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l 358 (394)
.+..+..++..+.+++++||+.||. |+++.+.+..+
T Consensus 255 ---~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 255 ---PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp ---CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ---ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 4566788999999999999999998 88876544333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=367.63 Aligned_cols=269 Identities=29% Similarity=0.482 Sum_probs=222.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.++..++|++.+.||+|+||.||+|+++... +.....||+|.++..........+.+|+.++++++||||+++++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCC---CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4677899999999999999999999986422 1234469999998766555555677999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence 999999999999999999999976422 2677788899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 240 GSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 240 G~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|+++....... .......+|..|+|||++.+.. ++.++|||||||++|||++.|..||.+....++...+.
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-------FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCC-------CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 99876433221 1112234577899999987654 78899999999999999977999999999988888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.+. +++.+..++..+.+++++||..+|+ ||++.++++.|+++...
T Consensus 265 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 265 DGF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TTC--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCC--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 765 6777889999999999999999998 99999999999887754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.86 Aligned_cols=268 Identities=28% Similarity=0.464 Sum_probs=221.8
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
..+.+..++|.+.+.||+|+||.||+|++.... .....||+|.+...........+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHK----GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTT----CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCC----CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 356677899999999999999999999976322 2344699999887655555566779999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++.+ +..++||||+++|+|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 81 IIEE-EPTWIIMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEEC
T ss_pred EEcC-CCCEEEEecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeC
Confidence 9865 567999999999999999975422 25677788899999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++...............++..|+|||++.+.. ++.++|||||||++|||+++|+.||......+....+.
T Consensus 156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~ 228 (281)
T 3cc6_A 156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-------FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228 (281)
T ss_dssp CCCGGGCC---------CCCCCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH
T ss_pred ccCCCcccccccccccccCCCCcceeCchhhccCC-------CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh
Confidence 99998765443333333446678899999986654 78899999999999999976999998888777777776
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+. +.+.+..+++.+.+++++||..+|+ ||++.|+++.|+++..
T Consensus 229 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 229 KGD--RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC--CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 665 6677888999999999999999998 9999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=370.27 Aligned_cols=246 Identities=21% Similarity=0.348 Sum_probs=209.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
+..++|++.+.||+|+||.||+|+++. ++..||+|+++.... ......+.+|..++..+ +||||++++++
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKG-------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 456889999999999999999999873 455899999875431 11223456899999888 89999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 90 FQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEe
Confidence 9999999999999999999999976432 67778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+++..+..
T Consensus 165 FG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~ 235 (353)
T 2i0e_A 165 FGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQP-------YGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIME 235 (353)
T ss_dssp CTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCC-------BSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred CCcccccccCCc-ccccccCCccccChhhhcCCC-------cCCcccccchHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Confidence 999975432221 234568899999999987654 7899999999999999998 9999999999899888887
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
+ .+..|..++..+.+++++||..+|. |+++
T Consensus 236 ~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 236 H---NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp C---CCCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred C---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 6 4567789999999999999999998 8853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=366.45 Aligned_cols=246 Identities=18% Similarity=0.279 Sum_probs=211.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
..++|++.+.||+|+||.||+|+.+. .+..||+|+++..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRH-------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 35789999999999999999999873 4558999998754311 12234568999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecC
Confidence 99999999999999999999976533 5677788899999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+++..... ....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+..+
T Consensus 152 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~- 218 (318)
T 1fot_A 152 FAKYVPDV----TYTLCGTPDYIAPEVVSTKP-------YNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA- 218 (318)
T ss_dssp SCEECSSC----BCCCCSCTTTCCHHHHTTCC-------BCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHC-
T ss_pred cceecCCc----cccccCCccccCHhHhcCCC-------CCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-
Confidence 99754322 23457899999999987654 7889999999999999998 99999999888888888776
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.+..|..+++++.+++++||..+|. |+ ++.|+.
T Consensus 219 --~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 219 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 4566788999999999999999998 77 666665
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=372.30 Aligned_cols=278 Identities=33% Similarity=0.537 Sum_probs=223.5
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
..+|+++.++|++.+.||+|+||.||+|++.+... ......||+|.++..........+.+|+.+++++ +||||+++
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISK--TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSS--SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeecccc--CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 34678899999999999999999999999853221 1244589999997655444445677999999999 99999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh------------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCce
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS------------------REALLEQGITIKMAIDVATGLSYMIEDGFI 217 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~ii 217 (394)
++++...+.+++||||+++|+|.+++...... ....+++..++.++.||+.||.|||++||+
T Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 194 (344)
T 1rjb_A 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194 (344)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99999999999999999999999999765321 012257778889999999999999999999
Q ss_pred ecCCCCCCEEEcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHH
Q psy7505 218 HTDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296 (394)
Q Consensus 218 HrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el 296 (394)
||||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+.. ++.++|||||||++|||
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~el 267 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-------YTIKSDVWSYGILLWEI 267 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHH
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-------CChhHhHHHHHHHHHHH
Confidence 99999999999999999999999987543322 22334456788899999987654 78999999999999999
Q ss_pred HcCCCCCCCCCCHHHHH-HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 297 FEFGKLPYAELSDDQVI-TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 297 ~t~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
++.|..||.+....+.+ ..+..+. +.+.|..+++.+.+++++||..+|. ||++.|+++.|..+....
T Consensus 268 ~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 268 FSLGVNPYPGIPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HcCCCCCcccCCcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 97699999887754443 3344443 6677888999999999999999998 999999999999988653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=363.23 Aligned_cols=267 Identities=26% Similarity=0.427 Sum_probs=213.2
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.++..++|++.+.||+|+||.||+|++..... ..+..||+|++...... ....+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD---NTGEVVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCS---SCCEEEEEEEESCCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccC---CCCcEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35668999999999999999999999753221 34568999998765433 334467999999999999999999998
Q ss_pred Ee--CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 160 LE--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 160 ~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
.. ...+++|||||++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEc
Confidence 65 3568999999999999999976532 26777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Q psy7505 238 DTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD----- 310 (394)
Q Consensus 238 DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~----- 310 (394)
|||++........ .......++..|+|||++.+.. ++.++|||||||++|||++ |..||......
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~ 228 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-------FSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMI 228 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHH-TTCTTCSHHHHHHHHH
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCC-------CChHHHHHHHHHHHHHHHh-cccccCCChHHHHhhh
Confidence 9999976533221 1222335677899999987665 7899999999999999998 98887643211
Q ss_pred -----------HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 311 -----------QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 311 -----------~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.+...+..+. +.+.|..+++.+.+++++||..+|+ ||++.|+++.|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 229 GNDKQGQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CTTCCTHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCccccchhHHHHHHHHhccC--cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 2333444444 6778889999999999999999998 99999999999887644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=399.48 Aligned_cols=267 Identities=29% Similarity=0.493 Sum_probs=220.2
Q ss_pred CCCceecCCCeEEEc-eeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceec
Q psy7505 77 SSEFQFPRQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
..++.+....+.+.. .||+|+||.||+|.++.. .....||||+++.... ......+.+|+.+|++++|||||+
T Consensus 360 ~~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 434 (635)
T 4fl3_A 360 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434 (635)
T ss_dssp CSSSBCCGGGEEEEEEEEEECSSEEEEEEEEECS-----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccchhccccCCEeccCCCEEEEEEEEcCC-----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 345667777777654 799999999999977531 2345899999976542 222345679999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+++++. .+.++||||||.+|+|.+++..... +++..++.++.||+.||.|||++|||||||||+|||++.++.+
T Consensus 435 l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~-----l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~ 508 (635)
T 4fl3_A 435 MIGICE-AESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 508 (635)
T ss_dssp EEEEEE-SSSEEEEEECCTTEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred EEEEEe-cCCEEEEEEccCCCCHHHHHhhCCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCE
Confidence 999996 4568999999999999999976532 5777888999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 235 KIGDTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
||+|||+|+....... .......+|+.|+|||++.... ++.++|||||||++|||+++|+.||.+....++
T Consensus 509 kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-------~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 581 (635)
T 4fl3_A 509 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581 (635)
T ss_dssp EECCTTHHHHTTC-------------CGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC-------CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999876543322 1222335678899999997655 889999999999999999779999999999999
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
...+..+. +++.|..++.++.++|+.||..+|+ ||++.+++..|+++..
T Consensus 582 ~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 582 TAMLEKGE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 98888876 7788889999999999999999998 9999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=368.47 Aligned_cols=260 Identities=20% Similarity=0.270 Sum_probs=211.0
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
..+..++|.+.+.||+|+||.||+|+++. ....||+|.+.... ......+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-------~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 76 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRE-------TGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVL 76 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETT-------TCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECC-------CCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence 34667899999999999999999999873 35588999876543 33344567999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+++..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 77 YKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADF 152 (310)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCC
T ss_pred ecCCeeEEEEEecCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeec
Confidence 999999999999999999999976422 2677788899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceee-------------eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 240 GSSIDKYPGDYYV-------------HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 240 G~a~~~~~~~~~~-------------~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
|++.......... .....||+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~-g~~~~~~ 224 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-------YDEKVDVFSFGIVLCEIIG-RVNADPD 224 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-TCCSSTT
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-------CCcHHHHHHHHHHHHHHhc-CCCCCcc
Confidence 9987543322111 11457899999999987654 7899999999999999998 9988875
Q ss_pred CCHHHH-----HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 307 LSDDQV-----ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 307 ~~~~~~-----~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
...... ..... ....|..+++.+.+++++||..||+ ||++.++++.|+.+...
T Consensus 225 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 225 YLPRTMDFGLNVRGFL-----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TSCBCTTSSBCHHHHH-----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhHHHHhhhhhccc-----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 432110 11111 1234678899999999999999998 99999999999888753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=372.16 Aligned_cols=268 Identities=26% Similarity=0.440 Sum_probs=219.6
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.+..++|++.+.||+|+||.||+|++..... ....+|++|.+...........+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGE---SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTC---SCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCc---eEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3457899999999999999999999874322 2234588888754432222223458999999999999999999986
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
++..++||||+.+|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 5679999999999999999976522 25667788999999999999999999999999999999999999999999
Q ss_pred CCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 241 SSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 241 ~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
+++....... .......+|..|+|||++.+.. ++.++|||||||++|||++.|..||.+....++...+..+
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-------YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred cccccCcccccccccCCCCcccccChHHhccCC-------CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 9976543322 1223446778899999987665 7899999999999999997799999998888888888776
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
. +++.|..++..+.+++++||..+|. ||++.|+++.|+++..+.
T Consensus 234 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 234 E--RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp C--BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred C--CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 5 6777888999999999999999998 999999999999988654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=357.77 Aligned_cols=268 Identities=25% Similarity=0.464 Sum_probs=225.9
Q ss_pred CCceecCCCeEEEc-eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..+.+..++|.+.+ .||+|+||.||+|.++.. .....||+|.++..........+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccC-----CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 35677788998887 899999999999987532 234579999998766555556677999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++ ..+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 77 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl 151 (287)
T 1u59_A 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 151 (287)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEE
T ss_pred EEe-cCCCcEEEEEeCCCCCHHHHHHhCCc----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEE
Confidence 999 55679999999999999999965422 2677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
+|||++.......... .....+|+.|+|||++.+.. ++.++|||||||++|||+++|+.||.+....++..
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 224 (287)
T 1u59_A 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 224 (287)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH
T ss_pred CcccceeeeccCcceeeccccccccccccCHHHhccCC-------CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999987654332221 22335678899999986554 78899999999999999976999999998888888
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.+..+. +.+.|..+++.+.+++++||..+|. ||++.++++.|.++...
T Consensus 225 ~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 225 FIEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp HHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCC--cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 887765 5677889999999999999999998 99999999999988754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=374.93 Aligned_cols=247 Identities=20% Similarity=0.333 Sum_probs=204.5
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+..++|++++.||+|+||+||+|+++. +...||+|+++... .......+.+|..++.++ +|||||++++
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 120 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKK-------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence 4556899999999999999999999873 45589999987653 222233456888888876 8999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++.+.+.+|||||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 121 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999976432 6777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---------C
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL---------S 308 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~---------~ 308 (394)
|||+|+...... ......+||+.|+|||++.+.. ++.++|||||||++|||++ |+.||... .
T Consensus 196 DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~-------~~~~~DiwslGvllyell~-G~~Pf~~~~~~~~~~~~~ 266 (396)
T 4dc2_A 196 DYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGED-------YGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNT 266 (396)
T ss_dssp CCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSTTTTC------CC
T ss_pred ecceeeecccCC-CccccccCCcccCCchhhcCCC-------CChHHHHHHHHHHHHHHHh-CCCCCcccccccccchhh
Confidence 999997533222 1234568999999999997765 7899999999999999998 99999643 2
Q ss_pred HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
...+...+..+ .+..|..++..+.+++++||+.||. |+++
T Consensus 267 ~~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 267 EDYLFQVILEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHhcc---ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 23345555554 5677889999999999999999998 8875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=370.53 Aligned_cols=248 Identities=17% Similarity=0.244 Sum_probs=213.1
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
....++|++++.||+|+||.||+|+++. .+..||+|+++.... ......+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 109 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE-------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECC-------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4456899999999999999999999873 455899999865431 1122345689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|+||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 110 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcc
Confidence 9999999999999999999999976432 67777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+++..... ....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..
T Consensus 185 Fg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~ 252 (350)
T 1rdq_E 185 FGFAKRVKGR----TWTLCGTPEALAPEIILSKG-------YNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp CTTCEECSSC----BCCCEECGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred cccceeccCC----cccccCCccccCHHHhcCCC-------CCCcCCEecccHhHhHHhh-CCCCCCCCCHHHHHHHHHc
Confidence 9999765332 23457899999999987654 7899999999999999998 9999999999898888887
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc-----hhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK-----IGDTG 355 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-----~~e~~ 355 (394)
+ .+..|..++..+.+++++||+.||. |++ +.|+.
T Consensus 253 ~---~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~ 292 (350)
T 1rdq_E 253 G---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp C---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred C---CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence 7 4667788999999999999999998 877 55654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=355.27 Aligned_cols=261 Identities=31% Similarity=0.538 Sum_probs=222.8
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
+|.+..++|++.+.||+|+||.||+|++.. ...||+|.++...... ..+.+|+.++++++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN--------KDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETT--------TEEEEEEEECTTTBCH--HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecC--------CCeEEEEEccccCCCH--HHHHHHHHHHHhCCCCCEeeEEEE
Confidence 577888999999999999999999999862 3378999987655322 235699999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 72 CLEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECC
T ss_pred EccCCCeEEEEeCCCCCcHHHHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcc
Confidence 9999999999999999999999976432 256777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++...............++..|+|||++.+.. ++.++||||||+++|||++.|..||.+....++...+..
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~ 220 (267)
T 3t9t_A 148 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220 (267)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccChhhhcCCC-------ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 9998765433222223345677899999987654 788999999999999999768999999998888888877
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+. +...|..++..+.+++++||..+|+ ||++.++++.|+++.
T Consensus 221 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 221 GF--RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp TC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 65 5666788999999999999999998 999999999998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=360.57 Aligned_cols=266 Identities=29% Similarity=0.524 Sum_probs=230.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
..|++..++|++.+.||+|+||.||+|.++ .....||+|.+....... ..+.+|+.++++++||||+++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEG-------GGTEEEEEEEECSCSTHH--HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEec-------CCCEEEEEEecCcCHHHH--HHHHHHHHHHHhCCCCCEeeEEE
Confidence 578889999999999999999999999987 345589999987655432 34568999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++.+.+.+++||||+.+|+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTT---TSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccC---CccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999764322 26777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++...............+|+.|+|||++.+.. ++.++|||||||++|+|++.|..||.+....++...+.
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~ 226 (288)
T 3kfa_A 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226 (288)
T ss_dssp CCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred cCccceeccCCccccccCCccccCcCChhhhccCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 99999766554444445556778899999987655 78999999999999999976999999988888777776
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
... +.+.|..+++.+.+++++||..+|. ||++.++++.|+++...
T Consensus 227 ~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 227 KDY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccC--CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 664 6677889999999999999999998 99999999999887654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=356.61 Aligned_cols=264 Identities=30% Similarity=0.498 Sum_probs=225.0
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.++|+++.++|++.+.||+|+||.||+|++++ ...||+|.++..... ...+.+|+.++++++||||++++
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~ 74 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNG--------HTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLY 74 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETT--------TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcC--------CcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEE
Confidence 46799999999999999999999999998753 347899988765422 23466999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++. .+..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 75 ~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 75 AVVT-QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp EEEC-SSSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEc-CCCcEEEEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEE
Confidence 9986 4568999999999999999965421 13677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++...............++..|+|||++.+.. ++.++|||||||++|||++.|+.||.+....+++..+
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-------FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CCCcccccccCcccccccCCCCccCccChhhhccCC-------CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 999999766544433334446678899999987554 7889999999999999997689999999988888888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+. +...+..+++.+.+++++||..+|+ ||++.++++.|+++..
T Consensus 224 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 224 ERGY--RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccc--CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7765 5677789999999999999999998 9999999999888764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=368.50 Aligned_cols=250 Identities=19% Similarity=0.278 Sum_probs=211.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH-----HHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA-----EKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+.|++.+.||+|+||.||+|+++. ++..||+|+++...... ....+.+|+.++++++||||++++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 83 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS-------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV 83 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC-------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence 5779999999999999999999873 45589999887543211 12346799999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----eE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL----RV 234 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~----~v 234 (394)
+.+.+.+++|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 84 YENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTCSC-----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCE
Confidence 9999999999999999999999976532 67778889999999999999999999999999999998877 79
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+.
T Consensus 159 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGvil~~ll~-g~~Pf~~~~~~~~~~ 228 (361)
T 2yab_A 159 KLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEP-------LGLEADMWSIGVITYILLS-GASPFLGDTKQETLA 228 (361)
T ss_dssp EECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHH
T ss_pred EEEecCCceEcCCCC--ccccCCCCccEECchHHcCCC-------CCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 999999997654332 223457899999999987654 7899999999999999998 999999999988888
Q ss_pred HHhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+.. .++ .+..+++.+.+++++||..||. ||++.|++.
T Consensus 229 ~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 229 NITAVSY-DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcCC-CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8876631 222 1257899999999999999998 999998863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=379.85 Aligned_cols=259 Identities=20% Similarity=0.305 Sum_probs=215.6
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceee
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
+.+..++|++.+.||+|+||+||+|+++. +...||+|+++..... .....+.+|+.+++.++|||||++++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS-------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECC-------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34567899999999999999999999873 4558999998653211 11123568999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+|.+.+.+|||||||++|+|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~------~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEe
Confidence 9999999999999999999999997542 5677788899999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+|+.............+||+.|+|||++..... ...++.++|||||||++|||++ |..||.+.+..+.+.++.
T Consensus 211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~---~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG---DGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTT---TCEEETHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHH
T ss_pred ccceeEeeccCCcccccCCcCCccccCHHHhhccCC---CcCCCCcceEecchHHHHHHHh-CCCCCCCCChhhHHHHHH
Confidence 999997665554444556789999999999875431 1126789999999999999998 999999999888888887
Q ss_pred cCC-CcCCCCCCCCChHHHHHHHhhhcCCcc---ccchhhhh
Q psy7505 318 GTE-ALRLPAPRAVNSHVDVAARNCLVTSEL---RVKIGDTG 355 (394)
Q Consensus 318 ~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~---r~~~~e~~ 355 (394)
.+. ...+|....++.++.+++++||..+|+ |+++.|+.
T Consensus 287 ~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 287 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp THHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred hccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 642 234555568999999999999997775 56888876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=366.64 Aligned_cols=266 Identities=26% Similarity=0.432 Sum_probs=216.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+|++..... ....+|++|.+...........+.+|+.++++++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTC---SCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCc---eEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 457899999999999999999999874332 22335788887654433333446799999999999999999999986
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+ ..++|+||+.+|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~-~~~~v~~~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 89 S-TVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S-SEEEEECCCSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred C-CceEEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 5 48899999999999999976432 256777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+....++...+..+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCC-------CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 976433221 1122335677899999987655 78999999999999999977999999998888887777665
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+++.+..++..+.+++++||..+|. ||++.|+++.|+++..+
T Consensus 237 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 --RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 6778889999999999999999998 99999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=375.65 Aligned_cols=264 Identities=28% Similarity=0.484 Sum_probs=210.3
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe-CC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-SD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 163 (394)
..|++.+.||+|+||.||+|++.... .....||+|.++..........+.+|+.++++++|||||++++++.. ++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETT----TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCC----CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 34678899999999999999976321 23446899988765544455567799999999999999999998754 56
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CeEEEEECCCCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccc
Confidence 78999999999999999976432 15667778899999999999999999999999999999999999999999997
Q ss_pred cCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 244 DKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 244 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
........ ......+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+....++...+..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~ 313 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-------FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCC-------CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence 55332221 112345678899999987655 78999999999999999986789998887777777777765
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
+...|..++..+.++|++||..+|+ ||++.|+++.|+++...+
T Consensus 314 --~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 6677889999999999999999998 999999999998877553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=363.38 Aligned_cols=276 Identities=32% Similarity=0.532 Sum_probs=226.8
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
...|+++.++|++.+.||+|+||.||+|++.+... ......||+|.++..........+.+|+.+++++ +||||+++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK--SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccc--cchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 34578889999999999999999999999753221 1345589999998766555556678999999999 99999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS-------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVA 222 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk 222 (394)
++++.+.+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||++||+|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 99999999999999999999999999865321 01126777888999999999999999999999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
|+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|||++.|.
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-------CChHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999876543332 2233446678899999987654 7899999999999999997699
Q ss_pred CCCCCCCHHHHH-HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 302 LPYAELSDDQVI-TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 302 ~Pf~~~~~~~~~-~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.||.+....+.. ..+..+. +...+..++..+.+++++||..+|. ||++.|+++.|+++..
T Consensus 246 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 246 SPYPGMPVDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp CSSTTCCSSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccchhHHHHHhccCC--CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 999887644433 3333333 5566788999999999999999998 9999999999988764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=365.60 Aligned_cols=246 Identities=20% Similarity=0.331 Sum_probs=206.0
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
+..++|++.+.||+|+||.||+|+++. ++..||+|+++... .......+.+|..+++++ +|||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKK-------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 346789999999999999999999873 45589999987653 334445567899999887 89999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999999976432 67778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---------CH
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL---------SD 309 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~---------~~ 309 (394)
||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||... ..
T Consensus 154 FG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 224 (345)
T 3a8x_A 154 YGMCKEGLRPGD-TTSTFCGTPNYIAPEILRGED-------YGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTE 224 (345)
T ss_dssp GGGCBCSCCTTC-CBCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTTTC-------CH
T ss_pred ccccccccCCCC-cccccCCCccccCccccCCCC-------CChHHhHHHHHHHHHHHHh-CCCCcCCcccccccccccH
Confidence 999975332221 234568899999999987654 7899999999999999998 99999752 23
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
..+...+..+ .+..|..++..+.+++++||..||. |+++
T Consensus 225 ~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 225 DYLFQVILEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 3445555554 4567788999999999999999998 8875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=357.49 Aligned_cols=267 Identities=30% Similarity=0.511 Sum_probs=220.6
Q ss_pred CCCceecCCCeEEEc-eeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceec
Q psy7505 77 SSEFQFPRQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
+.++.+..++|.+.+ .||+|+||.||+|.+... .....||+|+++.... ......+.+|+.+++.++||||++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 82 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECS-----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCC-----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 456677889999998 999999999999976521 2355899999876542 223445679999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+++++ ..+..++||||+++|+|.+++..... ++...+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 83 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp EEEEE-ESSSEEEEEECCTTEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred EEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcC-----CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE
Confidence 99999 56789999999999999999976532 5677788999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeee--CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVH--GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
||+|||++........... ....+++.|+|||++.+.. ++.++|||||||++|||++.|..||.+....++
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 229 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC-------CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999876543332222 2235578899999987654 678999999999999999769999999998888
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
...+..+. +.+.|..+++.+.+++++||..+|+ ||++.++++.|+++..
T Consensus 230 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 230 TAMLEKGE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp HHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 88887765 5677889999999999999999998 9999999999988764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=363.00 Aligned_cols=254 Identities=18% Similarity=0.300 Sum_probs=204.9
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.+..++|++.+.||+|+||.||+|+.... ...+..||+|+++... .......+.+|+.+++.++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTG----ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSS----TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEecc----CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 45578999999999999999999987521 1245689999987653 1223334568999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++.+.+.+|+|||||++|+|.+++...+. +.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREGI-----FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEE
Confidence 99999999999999999999999975432 5667788899999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 164 Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 164 DFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSG-------HNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp CCSCC-----------CTTSSCCTTSCHHHHTTSC-------CCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred eCCcccccccCC-ccccccCCCcCccCHhhCcCCC-------CCCcccchhHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
Confidence 999986533222 1233457899999999987654 7889999999999999998 999999998888888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.+ .+..|..++..+.+++++||..+|. |+ ++.|++
T Consensus 235 ~~---~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 235 KC---KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp HT---CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred hC---CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 66 4667788999999999999999998 87 455554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=382.96 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=212.6
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++.+.||+|+||+||+|+++. ....||+|+++..... .....+.+|..++..++|||||+++++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKN-------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcC-------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4567899999999999999999999873 3458999998653311 112235689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
|.+.+.+|||||||++|+|.+++..... .+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFED----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999999976321 267788889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+|+.............+||+.|||||++..... ....|+.++|||||||++|||++ |+.||.+.+..+.+.++..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG--GKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHT--SCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHT
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhccc--CCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhh
Confidence 99997665544444455689999999999863110 01127899999999999999998 9999999998888888865
Q ss_pred CCCcCCCCC---CCCChHHHHHHHhhhcCCcc---ccchhhhh
Q psy7505 319 TEALRLPAP---RAVNSHVDVAARNCLVTSEL---RVKIGDTG 355 (394)
Q Consensus 319 ~~~~~~~~p---~~~~~~~~~l~~~cl~~~p~---r~~~~e~~ 355 (394)
... +++.| ..+++.+.++|++||..+|+ |+++.|+.
T Consensus 296 ~~~-~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil 337 (437)
T 4aw2_A 296 HKE-RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFK 337 (437)
T ss_dssp HHH-HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH
T ss_pred ccc-cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHh
Confidence 321 23333 45899999999999998876 46777775
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=368.26 Aligned_cols=275 Identities=32% Similarity=0.545 Sum_probs=225.3
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|+++.++|++.+.||+|+||.||+|.+...... .....||+|.++..........+.+|+.+++++ +||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKE--DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSS--CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcc--cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 35788899999999999999999999998753321 233479999998766555556677999999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhh---------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASR---------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
+++.+.+.+++||||+++|+|.+++....... ...++...++.++.|++.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 99999999999999999999999997643210 112467788899999999999999999999999999999
Q ss_pred EcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 228 VTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
++.++.+||+|||++....... ........+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-------CChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999987543222 22233446678899999987654 789999999999999999768999988
Q ss_pred CCHHHHHHHH-hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 307 LSDDQVITRV-FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 307 ~~~~~~~~~i-~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
......+..+ ..+. ..+.|..++..+.+++++||+.+|. ||++.|+++.|+++..
T Consensus 270 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 270 ILVNSKFYKLVKDGY--QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp CCSSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 7654444333 3333 5667788999999999999999998 9999999999887653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=357.22 Aligned_cols=264 Identities=22% Similarity=0.379 Sum_probs=214.8
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++.+.||+|+||.||+|+++............|++|.+........ ..+.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~-~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS-ESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGH-HHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHH-HHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45678999999999999999999998754332233345799999866543322 34569999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe-------
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR------- 233 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~------- 233 (394)
+++..++||||+++|+|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999999976532 2577778899999999999999999999999999999998876
Q ss_pred -EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 234 -VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 234 -vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
+||+|||++....... ...++..|+|||++.+.. .++.++|||||||++|||++.|..||........
T Consensus 159 ~~kl~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 159 FIKLSDPGISITVLPKD-----ILQERIPWVPPECIENPK------NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp EEEECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGG------GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred eeeeccCcccccccCcc-----ccCCcCcccCHHHhCCCC------CCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 9999999986543221 234677899999987522 2789999999999999999856677777766665
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
...... ....|...+..+.+++++||+.||+ ||++.|+++.|+++..-
T Consensus 228 ~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 228 LQFYED----RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHT----TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHHhhc----cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 554433 3445566788999999999999998 99999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=379.02 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=211.8
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++.+.||+|+||+||+|+++. ++..||+|+++.... ......+.+|..++..++||||++++++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~-------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQ-------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 4567899999999999999999999873 455899999865331 1122335689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|||||||++|+|.+++...+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999976421 267778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+++.............+||+.|+|||++...........|+.++|||||||++|||++ |+.||.+.+..+.+.++..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHT
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence 999976654444344456899999999998742110111237899999999999999998 9999999998888888765
Q ss_pred CC-CcCCC-CCCCCChHHHHHHHhhhcCCcc-c---cchhhhh
Q psy7505 319 TE-ALRLP-APRAVNSHVDVAARNCLVTSEL-R---VKIGDTG 355 (394)
Q Consensus 319 ~~-~~~~~-~p~~~~~~~~~l~~~cl~~~p~-r---~~~~e~~ 355 (394)
.. ...+| .+..+++++.++|++||. +|. | +++.|+.
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 32 12233 236799999999999999 886 5 4777775
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=375.40 Aligned_cols=251 Identities=19% Similarity=0.275 Sum_probs=211.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++ ..+..+|+|++.... .......+.+|+.+++.++|||||++++++.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~-------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV-------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET-------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 467999999999999999999987 345588999886554 334445577999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT---SELRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~---~~~~vKl~DF 239 (394)
+..|+|||||.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~~-----~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 999999999999999999976533 67778889999999999999999999999999999998 4578999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+++..+..+
T Consensus 158 G~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~-------~~~~~DIwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~ 228 (444)
T 3soa_A 158 GLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDP-------YGKPVDLWACGVILYILLV-GYPPFWDEDQHRLYQQIKAG 228 (444)
T ss_dssp SSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHT
T ss_pred ceeEEecCCCc-eeecccCCcccCCHHHhcCCC-------CCCccccHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC
Confidence 99976543322 223457899999999987654 7899999999999999998 99999999998888888776
Q ss_pred CCcCCCCC--CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPAP--RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~p--~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. .++.+ ..+++.+.+++++||+.||+ ||++.|++.
T Consensus 229 ~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AY-DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CC-CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 42 23322 47899999999999999998 999998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=366.40 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=211.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++. .+..||+|++.... .......+.+|+.++++++|||||++++++.+.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT-------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC-------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4679999999999999999999873 45589999986543 334445577999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~vKl~DF 239 (394)
+..|+|||||.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 999999999999999999976532 5777888999999999999999999999999999999865 45999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++....... ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+
T Consensus 176 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 176 GLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDP-------YSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp TTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred CcceEecCCc--ccccCCCCccccCHHHHccCC-------CCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhC
Confidence 9997654332 223457899999999987654 7899999999999999998 99999999888888888766
Q ss_pred CCcCCCCC--CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPAP--RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~p--~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. .++.+ ..+++.+.+++++||..||+ ||++.|++.
T Consensus 246 ~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 246 AY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CC-CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CC-CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 42 33332 46899999999999999998 999988864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=361.54 Aligned_cols=249 Identities=19% Similarity=0.309 Sum_probs=210.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+++. ++..+|+|.++.... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-------SKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-------CCcEEEEEEEecCcc--cHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 4789999999999999999999873 455889998875442 2334679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCeEEEccCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGS 241 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~--~~~vKl~DFG~ 241 (394)
.+++|||||++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEEeCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 99999999999999999975432 2677788899999999999999999999999999999987 78999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+......... ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+++..+..+..
T Consensus 151 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 220 (321)
T 1tki_A 151 ARQLKPGDNF--RLLFTAPEYYAPEVHQHDV-------VSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp CEECCTTCEE--EEEESCGGGSCHHHHTTCE-------ECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCC
T ss_pred CeECCCCCcc--ccccCChhhcCcHHhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHcCCC
Confidence 9765443322 2346788999999987654 7889999999999999998 9999999999888888876642
Q ss_pred cCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++ ....++.++.+++++||..||+ ||++.|++.
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1247899999999999999998 999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=369.30 Aligned_cols=253 Identities=19% Similarity=0.265 Sum_probs=208.9
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++++.||+|+||.||+|+++. ++..||+|++.... .......+.+|+.+|+.++|||||+++++
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 83 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKND-------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYS 83 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4557899999999999999999999873 45589999886543 11122345689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|+|||||.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 84 FQDEEDMFMVVDLLLGGDLRYHLQQNVH-----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHTTCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEec
Confidence 9999999999999999999999976533 67777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL---SDDQVITR 315 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~---~~~~~~~~ 315 (394)
||++....... .....+||+.|+|||++.... ...|+.++|||||||++|||++ |..||... ...++...
T Consensus 159 FG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~----~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~ 231 (384)
T 4fr4_A 159 FNIAAMLPRET--QITTMAGTKPYMAPEMFSSRK----GAGYSFAVDWWSLGVTAYELLR-GRRPYHIRSSTSSKEIVHT 231 (384)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCS----SCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCTTSCHHHHHHH
T ss_pred cceeeeccCCC--ceeccCCCccccCCeeeccCC----CCCCCccceeechHHHHHHHHh-CCCCCCCCCCccHHHHHHH
Confidence 99997653332 234567899999999986432 1127889999999999999998 99999753 34455555
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc-hhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK-IGDTG 355 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-~~e~~ 355 (394)
+... ....|..++..+.+++++||..+|. |++ +.++.
T Consensus 232 ~~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 232 FETT---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHC---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred Hhhc---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 5443 5667888999999999999999998 887 55554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=351.18 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=217.6
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
+.+..++|++.+.||+|+||.||+|+++ +..||+|+++... .......+.+|+.++++++||||++++++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 75 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ---------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEE
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC---------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEE
Confidence 4566789999999999999999999975 3368999987654 34444557799999999999999999999
Q ss_pred EEeC--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCeE
Q psy7505 159 CLES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 159 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~~~~~v 234 (394)
+.+. +..++||||+++|+|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp ECTTTSSSCEEEEECCTTCBHHHHHHSCSSC---CCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCE
T ss_pred EccCCCCCeEeeecccCCCcHHHHHhhcccC---CCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcce
Confidence 9876 7889999999999999999865321 2577788899999999999999999 9999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++..... ....+|+.|+|||++.+.... .++.++|||||||++|||++ |+.||.+.+..+...
T Consensus 153 ~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~----~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~ 221 (271)
T 3kmu_A 153 RISMADVKFSFQS------PGRMYAPAWVAPEALQKKPED----TNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGM 221 (271)
T ss_dssp EEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGG----SCHHHHHHHHHHHHHHHHHH-CSCTTTTSCHHHHHH
T ss_pred eEEeccceeeecc------cCccCCccccChhhhccCCCC----CCCchhhHHHHHHHHHHHHh-CCCCccccChHHHHH
Confidence 9998887643221 234678899999998765421 14458999999999999998 999999998888766
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+.... .+.+.|..++..+.+++++||..+|+ ||++.|+++.|+++.+
T Consensus 222 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 KVALEG-LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 665432 25677889999999999999999998 9999999999988764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=373.89 Aligned_cols=246 Identities=21% Similarity=0.281 Sum_probs=191.0
Q ss_pred CCCeEEE-ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHh-ccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY-RRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~ 161 (394)
.++|.+. +.||+|+||+||+|+++ .++..||||+++... .+.+|+.++ +..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~------~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECSH------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEEC-------CCCCEEEEEEeCcch------hHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 3567776 68999999999999987 345589999986432 234677776 44589999999999875
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeE
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRV 234 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~v 234 (394)
.+.+|||||||++|+|.+++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccE
Confidence 5678999999999999999976432 12678888999999999999999999999999999999998 7899
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ--- 311 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~--- 311 (394)
||+|||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.....
T Consensus 204 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 273 (400)
T 1nxk_A 204 KLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEK-------YDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISP 273 (400)
T ss_dssp EECCCTTCEECC-------------CTTCCGGGSCCCC-------SSSHHHHHHHHHHHHHHHH-SSCSCCCCTTCSSCC
T ss_pred EEEecccccccCCCC--ccccCCCCCCccCHhhcCCCC-------CCCcccHHHHHHHHHHHHh-CCCCCCCCccccccH
Confidence 999999997543222 223457889999999986654 7899999999999999998 999997754322
Q ss_pred -HHHHHhcCCCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 -VITRVFGTEALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 -~~~~i~~~~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..+. ..++. ...++.++.++|++||..||+ ||++.|++.
T Consensus 274 ~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 274 GMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SHHHHHHHTC-CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCc-ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 333444332 13333 257899999999999999998 999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=377.76 Aligned_cols=251 Identities=19% Similarity=0.313 Sum_probs=206.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+.+++.++||||++++++
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA-------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcC-------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 4556889999999999999999999873 45589999987542 22233345689999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+.+.+.+|||||||++|+|.+++..... +++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+
T Consensus 217 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 217 FQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EEETTEEEEEECCCSSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred EeeCCEEEEEEeeCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999999975432 6777888999999999999998 999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+|+...... .......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..++...+.
T Consensus 292 DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~ 362 (446)
T 4ejn_A 292 DFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELIL 362 (446)
T ss_dssp CCCCCCTTCC------CCSSSCGGGCCHHHHHTSC-------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred cCCCceeccCCC-cccccccCCccccCHhhcCCCC-------CCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Confidence 999997543322 2234568899999999987665 8899999999999999998 999999999888888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.+ .+..|..+++.+.+++.+||+.||. |+ ++.|++
T Consensus 363 ~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell 403 (446)
T 4ejn_A 363 ME---EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM 403 (446)
T ss_dssp HC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred hC---CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHH
Confidence 65 4567788999999999999999998 87 788876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.89 Aligned_cols=266 Identities=25% Similarity=0.414 Sum_probs=204.6
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
.+.+++...+|++.+.||+|+||.||+|++.. .||+|+++... .......+.+|+.++++++||||+++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS----------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC----------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEE
Confidence 34668889999999999999999999998652 48899887554 34444567799999999999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
++++ ..+..++|||||.+|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 86 MGYS-TAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp EEEE-CSSSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred Eeec-cCCccEEEEEecCCCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 9965 45678999999999999999965422 267778889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-H
Q psy7505 236 IGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV-I 313 (394)
Q Consensus 236 l~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~-~ 313 (394)
|+|||++....... ........+|..|+|||++.... ...++.++|||||||++|||++ |+.||.+....+. .
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~ 235 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD----SNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQII 235 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCCHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccC----CCCCCcccchHHHHHHHHHHHH-CCCCccccchHHHHH
Confidence 99999986543211 11122346889999999986321 1127889999999999999998 9999988765444 4
Q ss_pred HHHhcCCCcCC---CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 314 TRVFGTEALRL---PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 314 ~~i~~~~~~~~---~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+..+. ... ..+..+++.+.+++++||..+|. ||++.++++.|+++..
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 236 EMVGRGS-LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHTS-CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHhcccc-cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 4443332 111 12347889999999999999998 9999999999998865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=392.14 Aligned_cols=268 Identities=29% Similarity=0.516 Sum_probs=225.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.++++..++|++.+.||+|+||.||+|.++... .....||+|.++..........+.+|+.++++++|||||++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPE----NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSS----SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCC----CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 356778899999999999999999999986422 2345789999877665555566779999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++. .+..++|||||++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 459 VIT-ENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHHHHTTT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEe-cCceEEEEEcCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence 985 5678999999999999999975432 25677788999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++..............+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+....+++..+.
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~ 606 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCHHHhcCCC-------CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999766544433333446678899999987654 78999999999999999966999999999999888887
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+. +++.|..+++.+.++|++||..||. ||++.|+++.|.++..
T Consensus 607 ~~~--~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 607 NGE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC--CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 776 6778889999999999999999998 9999999999988753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=354.11 Aligned_cols=268 Identities=29% Similarity=0.480 Sum_probs=220.4
Q ss_pred ceecCC--CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 80 FQFPRQ--QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 80 ~~~~~~--~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
+.++.+ .|+..+.||+|+||.||+|++.... .....+|+|.+...........+.+|+.++++++||||+++++
T Consensus 14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 89 (298)
T 3pls_A 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQA----QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEECSS----SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred eEccccceEEccCceeccCCCceEEEEEEecCC----CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 344444 4456699999999999999976322 3344789999887666555566779999999999999999999
Q ss_pred EEEeCCce-EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 158 ACLESDPW-LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 158 ~~~~~~~~-~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
++.+.+.. ++||||+.+|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp EECCSSSCCEEEECCCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCcEEEEecccCCCHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEe
Confidence 99876655 999999999999999976422 2567778899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 237 GDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
+|||+++........ ......+|..|+|||.+.+.. ++.++|||||||++|||++.|.+||...+..++.
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~ 238 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-------FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-------CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCC-------CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH
Confidence 999999754332211 122346678999999987654 7899999999999999998566778887777777
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..+..+. ..+.+..+++.+.+++++||..+|. ||++.++++.|+++...
T Consensus 239 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 239 HFLAQGR--RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCC--CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 7777665 6777889999999999999999998 99999999999887754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=368.09 Aligned_cols=248 Identities=20% Similarity=0.325 Sum_probs=206.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH--HHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--EKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..+|.+.+.||+|+||.||+|++. .++..||+|++....... ....+.+|+.+++.++||||+++++++.+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY-------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 467999999999999999999986 345589999986543111 12346699999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++||||+ +|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred CCEEEEEEECC-CCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence 99999999999 7899999876432 67778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+.....+. .....+||+.|+|||++.+..+ .+.++|||||||++|+|++ |..||.+....++...+..+
T Consensus 155 s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~-- 223 (336)
T 3h4j_B 155 SNIMTDGN--FLKTSCGSPNYAAPEVINGKLY------AGPEVDVWSCGIVLYVMLV-GRLPFDDEFIPNLFKKVNSC-- 223 (336)
T ss_dssp TBTTTTSB--TTCCCTTSTTTSCGGGSCCSGG------GCHHHHHHHHHHHHHHHHH-SSCSSBCSSSTTCBCCCCSS--
T ss_pred ceeccCCc--ccccccCCcCcCCHHHHcCCCC------CCCccchhHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcC--
Confidence 97654332 2234578999999999876542 3689999999999999998 99999887655544443333
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..+++.+.+++++||..||. ||++.|++.
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 4566788999999999999999998 999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=356.59 Aligned_cols=264 Identities=30% Similarity=0.497 Sum_probs=217.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE-eC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL-ES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 162 (394)
..+|++.+.||+|+||.||+|++.... .....+++|.++..........+.+|+.++++++||||+++++++. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC---------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCC----CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 456889999999999999999976321 2334688998887666555566779999999999999999999865 45
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred CceEEEEeCCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccc
Confidence 678999999999999999975432 2566778889999999999999999999999999999999999999999999
Q ss_pred ccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 243 IDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 243 ~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
......... ......+|+.|+|||.+.+.. ++.++|||||||++|||++.|.+||.+....+....+..+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-------FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCC-------CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence 755433221 122346678899999987655 7899999999999999998677888888877777777776
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
. +...|..++..+.+++++||..+|+ ||++.|+++.|+++...
T Consensus 249 ~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 R--RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C--CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 5 5666788999999999999999998 99999999999887754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=365.29 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=204.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+++. ....||+|++...........+.+|+.+++.++|||||++++++.+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECC-------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4789999999999999999999873 455899999865544333345679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..|+|||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 153 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTB-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEEcCCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccc
Confidence 99999999999999999865432 6777888999999999999999999999999999999999999999999986
Q ss_pred cCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCC
Q psy7505 244 DKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEA 321 (394)
Q Consensus 244 ~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~ 321 (394)
...... ........||+.|+|||++.+... ++.++|||||||++|||++ |..||.+.... ......... .
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~-~ 225 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREF------HAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEK-K 225 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHHHHHCSSB------CHHHHHHHHHHHHHHHHHH-SSCSCSSSCTTSHHHHHHHTT-C
T ss_pred eeccCCcccccCCCccCcCccCcHHhccCCC------CCCcccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhcc-c
Confidence 543222 122234578999999999876542 4678999999999999998 99999876543 222333222 2
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+....++..+.+++++||..||. ||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 23444567899999999999999998 999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=356.26 Aligned_cols=274 Identities=31% Similarity=0.517 Sum_probs=216.9
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
..++.+..++|.+.+.||+|+||.||+|++.... .....||+|.++... .......+.+|+.++++++||||+++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQED----GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTT----SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccC----CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 3566788899999999999999999999876321 245589999987553 34444556799999999999999999
Q ss_pred eeEEEeCC-----ceEEEEeeCCCCCHHHHHhhcch-hhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 156 MAACLESD-----PWLLVFESCSRGDLKEFLLSNEA-SREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 156 ~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
++++.+.+ ..++||||+.+|+|.+++..... .....+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 99998654 35999999999999999954321 1112367788899999999999999999999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCceeee-CCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
.++.+||+|||++........... ....+++.|+|||.+.+.. ++.++|||||||++|||++.|..||.+..
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-------YTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSC-------CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC-------ccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 999999999999876543332222 2335678899999987654 78999999999999999976889999988
Q ss_pred HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..++...+..+. +.+.+..+++.+.+++.+||..+|. ||++.+++..|+++..
T Consensus 255 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 255 NHEMYDYLLHGH--RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp GGGHHHHHHTTC--CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCC--CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 888888887775 6677889999999999999999998 9999999999988764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=357.01 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=211.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
...|+..+.||+|+||.||+|+++. .+..||||++........ ..+.+|+.++++++||||+++++++...+
T Consensus 44 ~~~~~~~~~lg~G~~g~V~~a~~~~-------~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (321)
T 2c30_A 44 RLLLDSYVKIGEGSTGIVCLAREKH-------SGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115 (321)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEETTTCCSH-HHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hhhhhccEEeccCCCeEEEEEEECC-------CCcEEEEEEEeccchhHH-HHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 3457788899999999999999862 355899999865543222 33569999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++||||+++|+|.+++.... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~~------l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 9999999999999999986532 5677888999999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+.+..+.......
T Consensus 190 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2c30_A 190 QISKDVP-KRKSLVGTPYWMAPEVISRSL-------YATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPK 260 (321)
T ss_dssp ECCSSSC-CBCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCC
T ss_pred ecccCcc-ccccccCCccccCHhhhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Confidence 5433221 223457899999999987654 7889999999999999998 999999988888888777665445
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+..+++.+.+++.+||+.||+ ||++.|+++
T Consensus 261 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 261 LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 555667899999999999999998 999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=358.63 Aligned_cols=276 Identities=31% Similarity=0.565 Sum_probs=226.3
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
...|.+..++|++.+.||+|+||.||+|++.+... ......||+|+++..........+.+|+.+++++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK--TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCc--cccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34567888999999999999999999999764321 1345689999998766655556677999999999 79999999
Q ss_pred eeEEEeCC-ceEEEEeeCCCCCHHHHHhhcchhh-----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7505 156 MAACLESD-PWLLVFESCSRGDLKEFLLSNEASR-----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223 (394)
Q Consensus 156 ~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~ 223 (394)
++++...+ .+++|||||++|+|.+++....... ...+++..+..++.|++.||.|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 5999999999999999998653210 11156778889999999999999999999999999
Q ss_pred CCEEEcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 224 RNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
+|||++.++.+||+|||+++...... ........+|+.|+|||++.+.. ++.++|||||||++|||++.|..
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-------YTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-------ccchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999987654332 23344456788999999987654 78999999999999999976999
Q ss_pred CCCCCCH-HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 303 PYAELSD-DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 303 Pf~~~~~-~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
||.+... ..+...+..+. +.+.+..+++.+.+++.+||..+|. ||++.|+++.|+.++.
T Consensus 250 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 250 PYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHhccCc--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9988763 34445555554 5667788999999999999999998 9999999999988764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=355.95 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=213.0
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.+..+.|++.+.||+|+||.||+|++..... ..+..||+|.++..........+.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGD---NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSS---SCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccC---ccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4556789999999999999999999653221 3456899999876553333345679999999999999999999998
Q ss_pred eC--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 161 ES--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 161 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
.. +.+++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECc
Confidence 76 678999999999999999965422 267778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---------
Q psy7505 239 TGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL--------- 307 (394)
Q Consensus 239 FG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~--------- 307 (394)
||++........ .......+|..|+|||++.+.. ++.++|||||||++|||++ |..|+...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~ 241 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-------FYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIG 241 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHC
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCC-------CCcchhHHHHHHHHHHHHH-ccCCCcchhhHHhhccC
Confidence 999976544332 2233456788899999987665 6789999999999999998 88875321
Q ss_pred ------CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 308 ------SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 308 ------~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
....+...+..+. +.+.|..+++.+.+++++||..||. ||++.|+++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHHHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1223344454444 6778889999999999999999998 999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=376.71 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=215.7
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+...+|.+.+.||+|+||.||+|+++ .++..||||++...... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHE-------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEET-------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34578999999999999999999987 34558999998654321 1233467999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSSSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEec
Confidence 999999999999999999999976533 677788899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++....... .....+||+.|+|||++.+..+ ++.++|||||||++|||++ |..||.+....++..++..+
T Consensus 161 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 231 (476)
T 2y94_A 161 GLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY------AGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKKICDG 231 (476)
T ss_dssp SSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCB------CSHHHHHHHHHHHHHHHHH-SSCSSCCSSSHHHHHHHHTT
T ss_pred cchhhccccc--cccccCCCcCeEChhhccCCCC------CCCcceehhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC
Confidence 9997654332 2234578999999999876542 4689999999999999998 99999998888888888776
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..+++.+.+++++||..||. ||++.|++.
T Consensus 232 ---~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 ---IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 4566788999999999999999998 999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=367.46 Aligned_cols=264 Identities=18% Similarity=0.234 Sum_probs=208.2
Q ss_pred CCCceecCCCeEEEceeeee--cceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCccee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRG--WFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNIL 153 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv 153 (394)
.+.+.....+|++.+.||+| +||.||+|+++. .+..||+|+++... .......+.+|+.+++.++|||||
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 89 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEcC-------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCC
Confidence 45666678999999999999 999999999873 45589999987654 344455677899999999999999
Q ss_pred ceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 154 RLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 154 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
++++++.+++.+|+|||||++|+|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 90 PYRATFIADNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 166 (389)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred cEeEEEEECCEEEEEEEccCCCCHHHHHhhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 9999999999999999999999999999765221 2677788899999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 234 VKIGDTGSSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
+||+|||.+........ .......||..|+|||++.+... .++.++|||||||++|||++ |+.||.+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~DiwslG~il~el~~-g~~pf~~~ 240 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ-----GYDAKSDIYSVGITACELAN-GHVPFKDM 240 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSS-----CBCTHHHHHHHHHHHHHHHH-SSCTTTTC
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCC-----CCCcHhHHHHHHHHHHHHHH-CCCCCCCC
Confidence 99999998754321111 11123467889999999876321 27899999999999999998 99999887
Q ss_pred CHHHHHHHHhcCCC-------------------------------------------cCCCCCCCCChHHHHHHHhhhcC
Q psy7505 308 SDDQVITRVFGTEA-------------------------------------------LRLPAPRAVNSHVDVAARNCLVT 344 (394)
Q Consensus 308 ~~~~~~~~i~~~~~-------------------------------------------~~~~~p~~~~~~~~~l~~~cl~~ 344 (394)
+..+.+..+..+.. ...+.+..+++.+.+++++||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 65544433322210 01134567889999999999999
Q ss_pred Ccc-ccchhhhhh
Q psy7505 345 SEL-RVKIGDTGS 356 (394)
Q Consensus 345 ~p~-r~~~~e~~~ 356 (394)
||+ ||++.|++.
T Consensus 321 dP~~Rpta~ell~ 333 (389)
T 3gni_B 321 NPDARPSASTLLN 333 (389)
T ss_dssp CTTTSCCHHHHTT
T ss_pred CcccCCCHHHHhc
Confidence 998 999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=352.86 Aligned_cols=262 Identities=16% Similarity=0.174 Sum_probs=207.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|++.. ....||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV-------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC-------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 4789999999999999999999863 34589999987553 33334556799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+++||||+++++|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence 9999999999999999999976432 57777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+...............++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.....+...+.....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 252 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESH-------ATYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIP 252 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-----------CCCHHHHHHHHHHHHHH-SSCSSCSCHHHHHHHHHHSCCC
T ss_pred CccccccccccccccCCCcCccCHHHHcCCC-------CCchHhHHHHHHHHHHHHH-CCCCCCCchHHHHHHHhccCCC
Confidence 8765433323333456888999999987654 7889999999999999998 9999998776655555544432
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-cc-chhhhhhhhhcCCCcc
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RV-KIGDTGSSIDKYPGDY 365 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-~~~e~~~~l~~~~~~~ 365 (394)
.....+..++..+.+++.+||..+|+ || ++.++...|++.+...
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 22344678899999999999999998 88 8999999999888653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=360.12 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=208.4
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..++.+..++|++.+.||+|+||.||+|++. ...||||++........ ...+|+.++++++|||||+++
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~--~~~~E~~~l~~l~hpniv~~~ 84 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL---------NEYVAVKIFPIQDKQSW--QNEYEVYSLPGMKHENILQFI 84 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEET---------TEEEEEEEECGGGHHHH--HHHHHHHTSTTCCCTTBCCEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEEC---------CCEEEEEEeecCchHHH--HHHHHHHHHhcCCCCCchhhc
Confidence 4567788999999999999999999999875 34799999876543322 234699999999999999999
Q ss_pred eEEEeCCc----eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC----------CceecCCC
Q psy7505 157 AACLESDP----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED----------GFIHTDVA 222 (394)
Q Consensus 157 ~~~~~~~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~----------~iiHrDlk 222 (394)
+++..... +++|||||++|+|.+++.... +++..+..++.|++.||.|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlk 158 (322)
T 3soc_A 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158 (322)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCS
T ss_pred ceeccCCCCCceEEEEEecCCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCC
Confidence 99987543 699999999999999997642 56777889999999999999999 99999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
|+|||++.++.+||+|||+++........ ......||+.|+|||++.+.... ...++.++|||||||++|||++ |+
T Consensus 159 p~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~il~el~t-g~ 235 (322)
T 3soc_A 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF--QRDAFLRIDMYAMGLVLWELAS-RC 235 (322)
T ss_dssp GGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC--CHHHHHHHHHHHHHHHHHHHHT-TB
T ss_pred hHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhccccccc--CcCCCccchhHHHHHHHHHHHh-CC
Confidence 99999999999999999999654333221 22335789999999998764211 1125678999999999999998 99
Q ss_pred CCCCCCC----------------HHHHHHHHhcCCCcCCCCCC-----CCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 302 LPYAELS----------------DDQVITRVFGTEALRLPAPR-----AVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 302 ~Pf~~~~----------------~~~~~~~i~~~~~~~~~~p~-----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
.||.+.. ..++...+.... .+...+. .+++.+.+++++||+.||+ ||++.|+++.|+
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcchhccchhhhhccCCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9997532 223333333222 2222222 2234599999999999998 999999999998
Q ss_pred cCCC
Q psy7505 360 KYPG 363 (394)
Q Consensus 360 ~~~~ 363 (394)
++.+
T Consensus 315 ~l~~ 318 (322)
T 3soc_A 315 QMQR 318 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=350.34 Aligned_cols=259 Identities=31% Similarity=0.563 Sum_probs=212.3
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceece
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
....|.+..++|++.+.||+|+||.||+|+++ +..||+|.++.... ...+.+|+.++++++||||+++
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~ 79 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQL 79 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCE
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEc---------CCEEEEEEecchhH---HHHHHHHHHHHHhCCCCCEeeE
Confidence 34567788899999999999999999999875 33789999876542 2345689999999999999999
Q ss_pred eeEEEeC-CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 156 MAACLES-DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 156 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
++++... +.+++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (278)
T 1byg_A 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 156 (278)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcE
Confidence 9997654 579999999999999999976422 225677788999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++....... ....++..|+|||++.+.. ++.++|||||||++|||++.|..||......++..
T Consensus 157 ~l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 225 (278)
T 1byg_A 157 KVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKK-------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225 (278)
T ss_dssp EECCCCC----------------CCTTTSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred EEeeccccccccccc----cCCCccccccCHHHhCCCC-------CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999986543221 2235677899999987654 78999999999999999976999999988888887
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.+..+. +.+.+..+++.+.+++++||..+|. ||++.|+++.|+++.
T Consensus 226 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 226 RVEKGY--KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHTTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCC--CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 776664 6677889999999999999999998 999999999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=346.87 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=204.2
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH---HHHHHHHHHHHHhccCCCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ---AEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
++..++|++.+.||+|+||.||+|++. +..||+|+++..... .....+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI---------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET---------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc---------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 456789999999999999999999875 337899988654322 22244678999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEcC----
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG---FIHTDVAARNCLVTS---- 230 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~---iiHrDlk~~NiLl~~---- 230 (394)
++.+.+..++||||+++|+|.+++.... +++..+..++.|++.||.|||++| |+||||||+|||++.
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp EECCC--CEEEEECCTTEEHHHHHTSSC------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EEecCCceEEEEEcCCCCCHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 9999999999999999999999986432 567778899999999999999999 899999999999986
Q ss_pred ----CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 231 ----ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 231 ----~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
++.+||+|||++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~p~~~ 216 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASM-------FSKGSDVWSYGVLLWELLT-GEVPFRG 216 (271)
T ss_dssp SCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCC-------CSHHHHHHHHHHHHHHHHH-CCCTTTT
T ss_pred ccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCC
Confidence 6789999999986543322 12346788999999987654 7899999999999999998 9999999
Q ss_pred CCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 307 LSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 307 ~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
.........+..+. ...+.+..+++.+.+++++||..+|+ ||++.|+++.|+++
T Consensus 217 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 217 IDGLAVAYGVAMNK-LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCHHHHHHHHHTSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCHHHHHHhhhcCC-CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 88877776665443 36677889999999999999999998 99999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=347.77 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=210.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+..++|++.+.||+|+||.||+|+++. ....||+|++...... .....+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEcc-------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence 3456889999999999999999999873 3457999988654321 123446789999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+..++||||+++|+|.+++..... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 78 FHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECS
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEe
Confidence 9999999999999999999999976432 56777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 153 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 221 (279)
T 3fdn_A 153 FGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRM-------HDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISR 221 (279)
T ss_dssp CCEESCC-----------CCCCTTCCHHHHTTCC-------CCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHH
T ss_pred ccccccCCccc---ccccCCCCCccCHhHhccCC-------CCccchhHhHHHHHHHHHH-CCCCCCCCcHHHHHHHHHh
Confidence 99885443221 23446788999999987654 7889999999999999998 9999999988888777765
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ....|..+++.+.+++++||..+|+ ||++.|+++
T Consensus 222 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 V---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp T---CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred C---CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 5 5667788999999999999999998 999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=359.77 Aligned_cols=267 Identities=30% Similarity=0.461 Sum_probs=217.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACL 160 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 160 (394)
+..++|++.+.||+|+||.||+|+++... ....+++|.++..........+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDG-----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETT-----EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCC-----cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 34588999999999999999999986321 11245888887654444445567999999999 9999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhh-----------hhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASR-----------EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
+.+.+++||||+++|+|.+++....... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999998653110 11367778889999999999999999999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
.++.+||+|||+++.... ........++..|+|||++.+.. ++.++|||||||++|||++.|..||.+...
T Consensus 177 ~~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSV-------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp GGGCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCeEEEcccCcCccccc--cccccCCCCCccccChhhhcccc-------CCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 999999999999864321 11122235677899999986654 788999999999999999769999999998
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.++...+..+. +.+.+..+++.+.+++++||..+|. ||++.|++..|.++...
T Consensus 248 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 248 AELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHHGGGTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHhhcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 88888877664 5677788999999999999999998 99999999999888754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=362.98 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=210.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|.++. .+..||+|++....... ...+.+|+.+|+.++|||||++++++.+.+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA-------TGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC-------CCCEEEEEEecccchhh-HHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 4679999999999999999999873 44578999887654332 334679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCeEEEccCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGS 241 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~--~~~vKl~DFG~ 241 (394)
.+++|||||.+|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 99999999999999999975421 2677788899999999999999999999999999999974 47799999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+......... ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+..+..
T Consensus 198 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 267 (387)
T 1kob_A 198 ATKLNPDEIV--KVTTATAEFAAPEIVDREP-------VGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDW 267 (387)
T ss_dssp CEECCTTSCE--EEECSSGGGCCHHHHTTCC-------BCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCC
T ss_pred ceecCCCcce--eeeccCCCccCchhccCCC-------CCCcccEeeHhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 9765443322 2336889999999987654 7889999999999999998 9999999988888777765531
Q ss_pred -cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........+++.+.+++++||..||+ ||++.|++.
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 12233457899999999999999998 999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=356.93 Aligned_cols=250 Identities=18% Similarity=0.281 Sum_probs=208.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-----HHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-----AEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+.|++.+.||+|+||.||+|+++. ++..||+|+++..... .....+.+|+.++++++||||++++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS-------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT-------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC-------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4679999999999999999999873 4558999988654321 112346699999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----eE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL----RV 234 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~----~v 234 (394)
+.+.+.+++|||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTSSC-----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHhcCC-----cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCE
Confidence 9999999999999999999999976432 67778889999999999999999999999999999999887 89
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+.
T Consensus 158 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 227 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEP-------LGLEADMWSIGVITYILLS-GASPFLGDTKQETLA 227 (326)
T ss_dssp EECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHH
T ss_pred EEEECCCCeECCCCCc--cccccCCcCcCCceeecCCC-------CCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHH
Confidence 9999999976533221 23456889999999986554 7899999999999999998 999999988888877
Q ss_pred HHhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..... .++ .+..++..+.+++++||..||+ ||++.|++.
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 228 NVSAVNY-EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhcCC-CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 7765431 222 1257899999999999999998 999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=363.94 Aligned_cols=254 Identities=19% Similarity=0.282 Sum_probs=205.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH----HHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ----AEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.++|++.+.||+|+||.||+|+++. ++..||+|++...... .....+.+|+.+++.++|||||++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE-------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC-------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4679999999999999999999873 4558999988643211 1123467999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe---EEE
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR---VKI 236 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~---vKl 236 (394)
.+.+.+|+|||||++|+|.+++...... ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 9999999999999999999888654211 112577788899999999999999999999999999999987654 999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+. ..++...+
T Consensus 175 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~-g~~pf~~~-~~~~~~~i 244 (351)
T 3c0i_A 175 GGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREP-------YGKPVDVWGCGVILFILLS-GCLPFYGT-KERLFEGI 244 (351)
T ss_dssp CCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCSS-HHHHHHHH
T ss_pred ecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCC-------CCchHhhHHHHHHHHHHHH-CCCCCCCc-HHHHHHHH
Confidence 99999976543322 233457899999999987654 7899999999999999998 99999875 45556666
Q ss_pred hcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.. ..+ ....++..+.+++++||..||+ ||++.|++.
T Consensus 245 ~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 245 IKGKY-KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHTCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCC-CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 55531 111 1257899999999999999998 999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=351.93 Aligned_cols=255 Identities=20% Similarity=0.272 Sum_probs=205.1
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-------------------------HHHHH
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-------------------------AEKLF 136 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-------------------------~~~~~ 136 (394)
+..++|++.+.||+|+||.||+|+++. .+..||+|++...... .....
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNEN-------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETT-------TTEEEEEEEEECC-------------------------------CH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECC-------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 345789999999999999999999863 4558999988654311 11234
Q ss_pred HHHHHHHhccCCCcceeceeeEEEe--CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC
Q psy7505 137 FLHEATPYRRLRHVNILRLMAACLE--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED 214 (394)
Q Consensus 137 ~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~ 214 (394)
+.+|+.++++++||||+++++++.+ .+.+++||||+++|+|.+++... .+++..+..++.|++.||.|||++
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 6689999999999999999999986 56799999999999998765432 267778889999999999999999
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHH
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~ 294 (394)
||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.... .++.++|||||||++|
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKI----FSGKALDVWAMGVTLY 231 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCC----EESHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCC----CCCchhhhHhHHHHHH
Confidence 999999999999999999999999999876543322 23345789999999998654311 1367899999999999
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 295 EIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 295 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
||++ |..||.+.....+...+.... ..++....+++.+.+++++||..||+ ||++.|++.
T Consensus 232 ~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 232 CFVF-GQCPFMDERIMCLHSKIKSQA-LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH-SSCSSCCSSHHHHHHHHHHCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH-CCCCCCCccHHHHHHHHhccc-CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9998 999999988777776665543 34555668999999999999999998 999998853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=359.29 Aligned_cols=275 Identities=34% Similarity=0.574 Sum_probs=221.7
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++.+.||+|+||.||+|++.+... ......||+|.+...........+.+|+.++++++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPN--DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC----------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCC--CCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4668899999999999999999998653211 13455899999976655555556779999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchh--hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeEE
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEAS--REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRVK 235 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~vK 235 (394)
+.+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||++||+||||||+|||++. +..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999865321 1122567778899999999999999999999999999999984 45699
Q ss_pred EccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
|+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|||++.|..||.+....++..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-------FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCC-------CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 9999988643222221 222346788999999987654 78999999999999999977999999999888888
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcce
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYY 366 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~ 366 (394)
.+..+. +...+..++..+.+++++||..+|. ||++.|+++.|..+..+..
T Consensus 257 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 257 FVTSGG--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHhcCC--CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 887775 5667788999999999999999998 9999999999988876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=349.62 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=204.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|.+.+.||+|+||.||+|+++. ....+++|.+...........+.+|+.++++++||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERS-------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeccCCCeEEEEEEEcc-------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 3679999999999999999999873 455889998876553333345679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEccCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGDTG 240 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~DFG 240 (394)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 999999999999999998654211 1236778888999999999999999999999999999999 445789999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++....... ......+|..|+|||++.. . ++.++|||||||++|||++ |..||.+....++...+....
T Consensus 173 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~-~-------~~~~~Di~slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 241 (285)
T 3is5_A 173 LAELFKSDE--HSTNAAGTALYMAPEVFKR-D-------VTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKATYKE 241 (285)
T ss_dssp CCCC------------CTTGGGCCHHHHTT-C-------CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred cceecCCcc--cCcCcccccCcCChHHhcc-C-------CCcccCeehHHHHHHHHHh-CCCCCCCCCHHHHHhhhccCC
Confidence 996543322 2234568899999998753 2 7889999999999999998 999999998888877665544
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.........+++.+.+++++||+.||+ ||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 322233345789999999999999998 999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=355.48 Aligned_cols=259 Identities=18% Similarity=0.265 Sum_probs=203.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+.++++++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR-------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC-------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 6789999999999999999999863 45589999987653 33444456799999999999999999999986
Q ss_pred CCc----eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 162 SDP----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 162 ~~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
... .|+||||+++|+|.+++...+. +++..++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~ 158 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEe
Confidence 554 4999999999999999975432 5777788999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 238 DTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 238 DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|||++........ .......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+....
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~ 230 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-------VDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQ 230 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCC-------CCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCC-------CCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence 9999875433221 1222346889999999987654 7899999999999999998 9999999988877666
Q ss_pred HhcCCCc-CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhh-hhhhhcCC
Q psy7505 316 VFGTEAL-RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDT-GSSIDKYP 362 (394)
Q Consensus 316 i~~~~~~-~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~-~~~l~~~~ 362 (394)
+...... ....+..++..+.+++.+||+.||+ ||+..+. ...+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 6554311 1112356899999999999999998 8876554 45555543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=353.73 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=212.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|.+.+.||+|+||.||+|++.. ....+++|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD-------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 5789999999999999999999873 34578999886543 33444556799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++||||+.+++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRKA-----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEecCCCCCHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence 9999999999999999999875432 67778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||......+....+..+
T Consensus 188 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-- 256 (335)
T 2owb_A 188 ATKVEYDGE-RKKVLCGTPNYIAPEVLSKKG-------HSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN-- 256 (335)
T ss_dssp CEECCSTTC-CBCCCCSCCSSCCHHHHHTSC-------BCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHT--
T ss_pred ceecccCcc-cccccCCCccccCHHHhccCC-------CCchhhHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHhcC--
Confidence 875432221 223456888999999987654 7889999999999999998 99999998888777777655
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++..+.+++++||..||+ ||++.|++.
T Consensus 257 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 257 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4556778999999999999999998 999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=354.15 Aligned_cols=265 Identities=28% Similarity=0.419 Sum_probs=216.7
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..+.|++++.||+|+||.||+|.++.... ..+..||+|+++..........+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTND---GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC-----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCC---CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 445566999999999999999998764332 34568999999877655556667899999999999999999999987
Q ss_pred C--CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 162 S--DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 162 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
. ..+++||||+++|+|.+++.... +++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 4 57899999999999999997653 566778899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Q psy7505 240 GSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD------- 310 (394)
Q Consensus 240 G~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~------- 310 (394)
|++......... ......+|..|+|||++.+.. ++.++|||||||++|||++ |..||......
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~ 250 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-------FYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGI 250 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCS
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCC-------CCcHHHHHHHHHHHHHHHh-CCCcccccchhhhhhhcc
Confidence 999765443321 223346788899999987654 6789999999999999998 99998753221
Q ss_pred --------HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 311 --------QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 311 --------~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
++...+..+. +.+.+..++..+.+++++||..+|+ ||++.|+++.|+++.+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 251 AQGQMTVLRLTELLERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCHHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHHhccc--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 2233333443 6778889999999999999999998 999999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=358.15 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=194.6
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
....++|++.+.||+|+||.||+|+++. ....||+|+++.... ...+.+|+.++++++||||+++++++.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG-------TQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC-------CCcEEEEEEeccchh---HHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 3446789999999999999999999873 345799999876432 234568999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeEEEc
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIG 237 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~vKl~ 237 (394)
+.+.+++||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEc
Confidence 99999999999999999999976533 567778899999999999999999999999999999976 7899999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ-VITRV 316 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~-~~~~i 316 (394)
|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+ ++..+
T Consensus 194 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~i 263 (349)
T 2w4o_A 194 DFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCA-------YGPEVDMWSVGIITYILLC-GFEPFYDERGDQFMFRRI 263 (349)
T ss_dssp CCC------------------CGGGSCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCTTCCTTCHHHHHHHH
T ss_pred cCccccccCccc--ccccccCCCCccCHHHhcCCC-------CCcccchHHHHHHHHHHHh-CCCCCCCCcccHHHHHHH
Confidence 999987543322 223457889999999987654 7899999999999999998 999998766544 55666
Q ss_pred hcCCCcC-CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALR-LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~-~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.... .+....++..+.+++++||..||+ ||++.|++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6553211 123357899999999999999998 999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=387.58 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=211.0
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+..++|++++.||+|+||+||+|+++. +...||||+++... .......+..|..++..+ +||||+++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG-------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESS-------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECC-------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 4556899999999999999999999873 44579999987543 111223356889999887 8999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++.+.+.+||||||+++|+|.++|...+. +++..+..++.||+.||.|||++|||||||||+||||+.+|.+||+
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEEC
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEe
Confidence 99999999999999999999999976532 6777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+|+....... .....+||+.|||||++.+.. |+.++|||||||++|||++ |..||.+.+..+++..|.
T Consensus 485 DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~-------~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 485 DFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQP-------YGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp CCTTCEECCCTTC-CBCCCCSCSSSCCHHHHTCCC-------BSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred ecceeeccccCCc-ccccccCCCcccCHhhhcCCC-------CCccceEechHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Confidence 9999975332222 234568999999999997665 7899999999999999998 999999999999999998
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
.+ .+..|..++.++.+|+++||..||. |+++
T Consensus 556 ~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 556 EH---NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SS---CCCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred hC---CCCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 76 5677889999999999999999998 8886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=345.94 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=200.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+.++++++||||+++++++.+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECC-------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 579999999999999999999873 45589999886543 2223344569999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++|||||++ +|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EEEEEEECCSE-EHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCC-CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 99999999975 67666654321 26777888999999999999999999999999999999999999999999997
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA-- 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~-- 321 (394)
...... .......+|..|+|||++.+.. .++.++|||||||++|||++.+.++|.+.+..+.+..+.....
T Consensus 150 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 150 AFGIPV-RCYSAEVVTLWYRPPDVLFGAK------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_dssp ECCSCC-SCCCSCCSCGGGCCHHHHTTCS------CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCCcc-ccccCCccccCCcChHHHcCCC------CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 543221 1223457789999999986544 2789999999999999999834445777777666665543110
Q ss_pred ------------------------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 ------------------------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ------------------------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........+++.+.+++++||+.||+ ||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00112235788999999999999998 999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=353.53 Aligned_cols=266 Identities=28% Similarity=0.395 Sum_probs=215.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE-
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL- 160 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 160 (394)
+..++|++.+.||+|+||.||+|+++.... .....||+|++....... ...+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGD---NTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSS---SCSEEEEEEEESSCCHHH-HHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCC---CcceEEEEEEeccCCHHH-HHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 557899999999999999999999753222 345689999987654333 344679999999999999999999987
Q ss_pred -eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 161 -ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 161 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
+.+.+++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 45568999999999999999976422 2677888899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Q psy7505 240 GSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-------- 309 (394)
Q Consensus 240 G~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-------- 309 (394)
|++......... ......+|..|+|||++.+.. ++.++|||||||++|||++ |..||.....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~ 243 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-------FSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGC 243 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-------EEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHCC-
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCC-------CChHHhHHHHHHHHHHHHh-CCCCCccccchhhhhccc
Confidence 998765433221 223346788899999987654 7889999999999999998 9999865332
Q ss_pred -------HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 310 -------DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 310 -------~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
.++...+..+. +.+.+..+++.+.+++++||..+|+ ||++.|+++.|+.+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 244 ERDVPALSRLLELLEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp ---CCHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccccHHHHHHHhhccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 23334444443 6777889999999999999999998 999999999999987643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=347.17 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=207.9
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc---HHHH---HHHHHHHHHhccCCCcceec
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---QAEK---LFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~---~~~~---~~~~~E~~~l~~l~HpnIv~ 154 (394)
.+..++|++.+.||+|+||.||+|+++. ....||+|.+..... .... ..+.+|+.++++++||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 87 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVK-------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETT-------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhhccceehhccccCCceeEEEEEEcC-------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence 3457899999999999999999999873 455899998864331 1111 34679999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCC
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVTSEL 232 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~~~~ 232 (394)
+++++.+. .++||||+++|+|.+++..... .+++..+..++.|++.||.|||++| |+||||||+|||++.++
T Consensus 88 ~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 88 LYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp EEEEETTT--TEEEEECCTTCBHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC
T ss_pred hheeecCC--CeEEEEecCCCCHHHHHhcccC----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC
Confidence 99998654 3799999999999999865432 2677788899999999999999999 99999999999998877
Q ss_pred e-----EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 233 R-----VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 233 ~-----vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
. +||+|||+++..... .....+|+.|+|||++..... .++.++|||||||++|||++ |+.||.+.
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~-----~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 231 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEE-----SYTEKADTYSFAMILYTILT-GEGPFDEY 231 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSC-----EECHHHHHHHHHHHHHHHHH-SSCTTTTC
T ss_pred CCCceeEEeCCCCcccccccc----ccccCCCccccCchhhccCCC-----CcCchhhHHHHHHHHHHHHc-CCCCCccc
Confidence 6 999999998754321 224567889999999854322 27889999999999999998 99999876
Q ss_pred CHHHH--HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 308 SDDQV--ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 308 ~~~~~--~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
...+. ...+... ..+...+..+++.+.+++++||+.||. ||++.|+++.|+++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 232 SYGKIKFINMIREE-GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCHHHHHHHHHHS-CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cccHHHHHHHHhcc-CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 53333 3333322 236677889999999999999999998 99999999998864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=343.45 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=212.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|.+.+.||+|+||.||+|+++. ....+++|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD-------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 5789999999999999999999873 34578999876543 33444556789999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKA-----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence 9999999999999999999865432 56777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+..+
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-- 230 (294)
T 2rku_A 162 ATKVEYDGE-RKKVLCGTPNYIAPEVLSKKG-------HSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN-- 230 (294)
T ss_dssp CEECCSTTC-CBCCCCSCCSSCCHHHHTTSC-------BCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT--
T ss_pred ceecccCcc-ccccccCCCCcCCcchhccCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc--
Confidence 865432221 123356788999999987654 6889999999999999998 99999998888877777665
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++..+.+++++||..+|+ ||++.|++.
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 231 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 4566788999999999999999998 999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=358.55 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=196.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|++.+.||+|+||.||+|+++. ++..||+|++....... ..+.+|+.+++.++|||||++++++.+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKL-------TKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETT-------TCCEEEEEEEESSTTSC--HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC-------CCcEEEEEEEecCcccc--HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 46789999999999999999999873 45589999987544221 2356899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe--EEEccCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--VKIGDTG 240 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~--vKl~DFG 240 (394)
+.+++|||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGR-----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 999999999999999999975432 677788899999999999999999999999999999987765 9999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----DQVITRV 316 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----~~~~~~i 316 (394)
+++...... ......||+.|+|||++.+..+ .+.++|||||||++|||++ |+.||.+... ...+..+
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 234 (361)
T 3uc3_A 164 YSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEY------DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPRDYRKTIQRI 234 (361)
T ss_dssp CC-----------------CTTSCHHHHHCSSC------CHHHHHHHHHHHHHHHHHH-SSCSCC----CCCHHHHHHHH
T ss_pred ccccccccC--CCCCCcCCCCcCChhhhcCCCC------CCCeeeeehhHHHHHHHHh-CCCCCCCCccHHHHHHHHHHH
Confidence 986432221 2234468899999999876652 2345999999999999998 9999987543 4455555
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.... ..++....+++.+.+++++||+.+|+ ||++.|++.
T Consensus 235 ~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 235 LSVK-YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HTTC-CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcCC-CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 5442 35555667899999999999999998 999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.29 Aligned_cols=251 Identities=18% Similarity=0.262 Sum_probs=209.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+..++|++.+.||+|+||.||+|+++. ++..||+|++..... ......+.+|+.+|++++|||||++++++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 567889999999999999999999873 455899999865431 11223456899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+.+|||||||++|+|.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQA---GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEec
Confidence 9999999999999999999999765321 2577788899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DDQVITR 315 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~~~~~~ 315 (394)
|+|+....... ....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.. ..++...
T Consensus 331 Gla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~-------~~~~~DiwSLGvilyeLlt-G~~PF~~~~~~~~~~~i~~~ 400 (576)
T 2acx_A 331 GLAVHVPEGQT--IKGRVGTVGYMAPEVVKNER-------YTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERL 400 (576)
T ss_dssp TTCEECCTTCC--EECCCSCGGGCCHHHHTTCE-------ESSHHHHHHHHHHHHHHHH-SSCSSSCSSSCCCHHHHHHH
T ss_pred ccceecccCcc--ccccCCCccccCHHHHcCCC-------CCccchHHHHHHHHHHHHh-CCCCCcccccchhHHHHHHH
Confidence 99976544332 22457899999999987654 7899999999999999998 999998753 3455555
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
+... ....|..+++.+.+++++||..||. |+ ++.|+.
T Consensus 401 i~~~---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 401 VKEV---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp HHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred hhcc---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 5543 4556788999999999999999998 87 567765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=358.10 Aligned_cols=247 Identities=20% Similarity=0.274 Sum_probs=200.3
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCceEE
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLL 167 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 167 (394)
...+.||+|+||.||+|+++. .+..||+|+++..... ....+.+|+.++++++|||||++++++.+.+.++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~-------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETA-------TGLKLAAKIIKTRGMK-DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp EEEEECC-----CEEEEEETT-------TCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecceEEecCcCEEEEEEEEcC-------CCcEEEEEEEcccccc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 336789999999999999863 4558999998765433 33456799999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE--cCCCeEEEccCCCCccC
Q psy7505 168 VFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV--TSELRVKIGDTGSSIDK 245 (394)
Q Consensus 168 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl--~~~~~vKl~DFG~a~~~ 245 (394)
|||||++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 164 v~E~~~~~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESY----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEECCTTCEEHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 9999999999999875432 26677788899999999999999999999999999999 56789999999999765
Q ss_pred CCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-cCC
Q psy7505 246 YPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA-LRL 324 (394)
Q Consensus 246 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~ 324 (394)
..... .....||+.|+|||++.... ++.++|||||||++|||++ |..||.+.+..+.+..+..... ...
T Consensus 240 ~~~~~--~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 309 (373)
T 2x4f_A 240 KPREK--LKVNFGTPEFLAPEVVNYDF-------VSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAETLNNILACRWDLED 309 (373)
T ss_dssp CTTCB--CCCCCSSCTTCCHHHHTTCB-------CCHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCCCSCS
T ss_pred CCccc--cccccCCCcEeChhhccCCC-------CCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCh
Confidence 43322 23346889999999986554 7889999999999999998 9999999998888888776531 111
Q ss_pred CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.....+++++.+++.+||+.+|. ||++.|++.
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12357899999999999999998 999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=351.15 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
-.++|++++.||+|+||.||+|+++. +..||+|+++.... ......+.+|+.++++++||||+++++++.+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ--------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT--------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC--------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 36889999999999999999998752 44799998875442 2223446699999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++|||||++ +|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcC
Confidence 9999999999974 89888876532 256777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
++....... ......+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+....+.+..+.....
T Consensus 166 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 237 (311)
T 3niz_A 166 ARAFGIPVR-SYTHEVVTLWYRAPDVLMGSK------KYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLPKIFSILG 237 (311)
T ss_dssp CEETTSCCC----CCCCCCTTCCHHHHTTCC------SCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTTTHHHHHHHHHC
T ss_pred ceecCCCcc-cccCCcccCCcCCHHHhcCCC------CCCchHHhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHC
Confidence 975432221 223346788999999986543 27899999999999999998 9999988776655544432110
Q ss_pred cCCC---------------------------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLP---------------------------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~---------------------------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+ ....+++++.+++++||+.||+ ||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 1134678899999999999998 999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=352.97 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=207.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.+.|...+.||+|+||.||+|++. ..+..||||++.... .......+.+|+.++++++|||||++++++.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 125 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEc-------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 466999999999999999999976 245589999986543 23333456799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++..++|||||. |+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CCeEEEEEecCC-CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence 999999999997 689888864321 267777889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+..... .....||+.|+|||++.+.. ...++.++|||||||++|||++ |+.||.+.+..+.+..+..+..
T Consensus 201 a~~~~~-----~~~~~gt~~y~aPE~~~~~~----~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~ 270 (348)
T 1u5q_A 201 ASIMAP-----ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNES 270 (348)
T ss_dssp CBSSSS-----BCCCCSCGGGCCHHHHHTTS----SCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCC
T ss_pred ceecCC-----CCcccCCcceeCHhhhcccc----CCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Confidence 875432 12457889999999986421 1127889999999999999998 9999999888777777666542
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..+++.+.+++++||+.+|+ ||++.+++.
T Consensus 271 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 -PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 2233567899999999999999998 999998864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=355.35 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=191.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++++.||+|+||.||+|.++. ++..||+|.++..........+.+|+.++++++|||||++++++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSS-------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 4678999999999999999998763 455899998875543222234568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchh-hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEAS-REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.+++|||||+ |+|.+++...... ....++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999999998 5999998754211 0112567778889999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
........ ......+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 156 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 156 RAFGIPVN-TFSSEVVTLWYRAPDVLMGSR------TYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp EETTSCCC-CCCCCCSCCTTCCHHHHTTCC------CCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCS
T ss_pred eecCCCcc-cCCCCcccccccCchHhhCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Confidence 75432211 122346788999999986543 27899999999999999998 99999998887776665431000
Q ss_pred -------------------------------CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 -------------------------------RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 -------------------------------~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..++..+.+++++||+.||+ ||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0011235788999999999999998 999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=355.26 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=197.1
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||+|+||.||+|+++. .+..||||+++..........+.+|+.++++++|||||++++++.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKV-------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETT-------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcC-------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 578999999999999999999873 4558999998755544444556799999999999999999999866442
Q ss_pred ---------------------------------------------------------eEEEEeeCCCCCHHHHHhhcchh
Q psy7505 165 ---------------------------------------------------------WLLVFESCSRGDLKEFLLSNEAS 187 (394)
Q Consensus 165 ---------------------------------------------------------~~lv~E~~~~g~L~~~l~~~~~~ 187 (394)
+++|||||++|+|.+++......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 79999999999999999876432
Q ss_pred hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCce-----------eeeCCc
Q psy7505 188 REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDY-----------YVHGEV 256 (394)
Q Consensus 188 ~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~-----------~~~~~~ 256 (394)
. ...+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 159 ~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 159 E--DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp G--GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred c--chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 2 235556788999999999999999999999999999999999999999999876543321 122345
Q ss_pred cCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHH
Q psy7505 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDV 336 (394)
Q Consensus 257 ~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~ 336 (394)
.||+.|+|||++.+.. ++.++|||||||++|||++ |..|+.. ..+....+.... ....+...++.+.+
T Consensus 237 ~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~-~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNN-------YSHKVDIFSLGLILFELLY-SFSTQME--RVRIITDVRNLK--FPLLFTQKYPQEHM 304 (332)
T ss_dssp C-CGGGSCHHHHHCCC-------CCTHHHHHHHHHHHHHHHS-CCCCHHH--HHHHHHHHHTTC--CCHHHHHHCHHHHH
T ss_pred CCCcCccChHHhcCCC-------CcchhhHHHHHHHHHHHHH-cCCChhH--HHHHHHHhhccC--CCcccccCChhHHH
Confidence 7899999999987654 7899999999999999998 8766432 223334443332 11223456778899
Q ss_pred HHHhhhcCCcc-ccchhhhhh
Q psy7505 337 AARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 337 l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++++||+.||+ ||++.|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 99999999998 999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=362.32 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=193.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCC-CcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLR-HVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++++. |||||++++++..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRR-------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETT-------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECC-------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 4789999999999999999999873 45589999886543 3334444568999999997 9999999999985
Q ss_pred CC--ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 162 SD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 162 ~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+ .+|+|||||. |+|.+++.... ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 153 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRANI------LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADF 153 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHHTC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred CCCCEEEEEecccC-cCHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCC
Confidence 44 6899999997 59999997542 566677889999999999999999999999999999999999999999
Q ss_pred CCCccCCCC--------------------ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcC
Q psy7505 240 GSSIDKYPG--------------------DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEF 299 (394)
Q Consensus 240 G~a~~~~~~--------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~ 299 (394)
|+|+..... ........+||+.|+|||++.+.. .++.++|||||||++|||++
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~- 226 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST------KYTKGIDMWSLGCILGEILC- 226 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC------CCCTHHHHHHHHHHHHHHHH-
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC------CCCChhhHHHHHHHHHHHHh-
Confidence 999754221 011123457899999999987532 28899999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCcC--------------------------------------------CCCCCCCChHHH
Q psy7505 300 GKLPYAELSDDQVITRVFGTEALR--------------------------------------------LPAPRAVNSHVD 335 (394)
Q Consensus 300 g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------------------~~~p~~~~~~~~ 335 (394)
|+.||.+.+..+.+..+....... ...+..+++.+.
T Consensus 227 g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 999999998877766664311000 011236788999
Q ss_pred HHHHhhhcCCcc-ccchhhhhh
Q psy7505 336 VAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 336 ~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+++++||+.||+ |+|+.|+++
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhhccCcccCCCHHHHhC
Confidence 999999999998 999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=374.05 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=209.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+..++|.+.+.||+|+||.||+|+++. ++..||+|++...... .....+.+|+.++++++|||||++++++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKA-------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECC-------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 456889999999999999999999873 4558999998654321 1123456899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+.+|+|||||++|+|.+++...... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeec
Confidence 9999999999999999999999765321 122677788899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHH
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL----SDDQVITR 315 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~----~~~~~~~~ 315 (394)
|+++....... .....+||+.|+|||++.+.. |+.++|||||||++|||++ |..||.+. ...++...
T Consensus 334 Gla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~-------~~~~~DiwSlGvilyellt-G~~PF~~~~~~~~~~~~~~~ 404 (543)
T 3c4z_A 334 GLAVELKAGQT-KTKGYAGTPGFMAPELLLGEE-------YDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQR 404 (543)
T ss_dssp TTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCTTCCCCHHHHHHH
T ss_pred ceeeeccCCCc-ccccccCCccccChhhhcCCC-------CChHHhcCcchHHHHHHHh-CCCCCCCCccchhHHHHHHH
Confidence 99976543322 223458899999999997654 7899999999999999998 99999875 34566666
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG 352 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~ 352 (394)
+..+ ....|..++..+.+++++||..||. |+++.
T Consensus 405 i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 405 VLEQ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp HHHC---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred Hhhc---ccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 7655 4566788999999999999999998 88764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=340.47 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=210.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++. .+..||+|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT-------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC-------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 5789999999999999999999873 45589999986554 344445567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe---EEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR---VKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~---vKl~DF 239 (394)
+..++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++. +||+||
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 999999999999999998865432 577778899999999999999999999999999999986654 999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..+
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 153 GLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDP-------YSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp TTCEECCSSC--BCCCSCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred eeeEEcccCc--cccCCCCCcCCcCchhhcCCC-------CCcccchHHHHHHHHHHHH-CCCCCCCCchhHHHHHHHhc
Confidence 9986553322 223457889999999987654 7889999999999999998 99999999888887777655
Q ss_pred CC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. ...+....+++.+.+++++||+.+|+ ||++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 32 12223357899999999999999998 999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=342.74 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=211.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+..++|++.+.||+|+||.||+|++.. ....||+|++...... .....+.+|+.++++++||||+++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQ-------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcC-------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 446789999999999999999999863 3457999988654311 1123467899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+..++||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecc
Confidence 999999999999999999999976432 567778899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||......+....+...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 227 (284)
T 2vgo_A 159 GWSVHAPSLR---RRTMCGTLDYLPPEMIEGKT-------HDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRRIVNV 227 (284)
T ss_dssp TTCEECSSSC---BCCCCSCGGGCCHHHHTTCC-------BCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT
T ss_pred cccccCcccc---cccccCCCCcCCHHHhccCC-------CCcccchhhHHHHHHHHHH-CCCCCCCCCHhHHHHHHhcc
Confidence 9886543221 23456888999999987654 7889999999999999998 99999998888887777765
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++..+.+++++||..+|. ||++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 ---DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 4567788999999999999999998 999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=345.72 Aligned_cols=268 Identities=28% Similarity=0.452 Sum_probs=211.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
..+..++|++.+.||+|+||.||+|++.... .....|++|.++... .......+.+|+.++++++||||+++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS----GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTT----SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCC----CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 3556789999999999999999999875321 223468999887543 2233445679999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
++... ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~-~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 89 VVLTP-PMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp EECSS-SCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEccC-CceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEc
Confidence 99865 4899999999999999997642 126777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 238 DTGSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 238 DFG~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|||++......... ......+|..|+|||++.+.. ++.++|||||||++|||++.|..||.+....+++..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 236 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCC-------CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH
Confidence 99998765433221 122346677899999987654 678999999999999999769999999998888877
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+.... .+++.+..++..+.+++++||..+|+ ||++.++++.|+++...
T Consensus 237 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 237 IDKEG-ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHTSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHccC-CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 76543 36677889999999999999999998 99999999999887753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=353.52 Aligned_cols=260 Identities=17% Similarity=0.288 Sum_probs=203.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCC--cceecee
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRH--VNILRLM 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~H--pnIv~l~ 156 (394)
+.+..++|++.+.||+|+||.||+|.+. ....||+|++.... .......+.+|+.++++++| +||++++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 75 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECT--------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeC--------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEe
Confidence 4566788999999999999999999864 24479999886543 34444556799999999976 9999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++.+++.++|||| +.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 76 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 76 DYEITDQYIYMVME-CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHSCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred eeEeeCCEEEEEEe-CCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEE
Confidence 99999999999999 557899999986533 56777889999999999999999999999999999997 688999
Q ss_pred ccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCc----ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-
Q psy7505 237 GDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSI----QTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD- 310 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~----~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~- 310 (394)
+|||+++........ ......||+.|+|||++.+..... ....++.++|||||||++|||++ |+.||.+....
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~ 227 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 227 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCSHH
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhhhhHH
Confidence 999999765433221 223457899999999986521100 11238899999999999999998 99999875433
Q ss_pred HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+... ......|...+..+.+++++||+.||+ ||++.|++.
T Consensus 228 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 228 SKLHAIIDP-NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHHCT-TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcC-CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 334444432 235667788889999999999999998 999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=355.02 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=205.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.++|++.+.||+|+||.||+|+++ .....||+|++.... .......+.+|+.++++++|||||++++++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN-------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeecceeeecCCeEEEEEEEC-------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 578999999999999999999986 345588999886542 223334567999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchh-----------------------------------hhhhhhHHHHHHHHHHH
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEAS-----------------------------------REALLEQGITIKMAIDV 204 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------------------------------~~~~~~~~~~~~~~~qi 204 (394)
.+.+..++|||||++|+|.+++...... ....+++..+..++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999998521100 01224667788899999
Q ss_pred HHHHHHHHhCCceecCCCCCCEEEcCCC--eEEEccCCCCccCCC---CceeeeCCccCCcccccccccccCCCCcccCC
Q psy7505 205 ATGLSYMIEDGFIHTDVAARNCLVTSEL--RVKIGDTGSSIDKYP---GDYYVHGEVALPVRWCAPESLLCSDTSIQTCT 279 (394)
Q Consensus 205 ~~gl~yLH~~~iiHrDlk~~NiLl~~~~--~vKl~DFG~a~~~~~---~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~ 279 (394)
+.||.|||++||+||||||+|||++.++ .+||+|||++..... ..........+|+.|+|||++.+... .
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~ 252 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE-----S 252 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS-----C
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC-----C
Confidence 9999999999999999999999998776 899999999864322 22222334578899999999865321 2
Q ss_pred CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 280 VTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 280 ~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++.++|||||||++|||++ |+.||.+....+.+..+..+.. .++. ...+++.+.+++++||+.+|. ||++.|++.
T Consensus 253 ~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLM-GAVPFPGVNDADTISQVLNKKL-CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC-CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHHhccc-ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 7899999999999999998 9999999998888777766532 2222 235899999999999999998 999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=363.19 Aligned_cols=282 Identities=11% Similarity=0.118 Sum_probs=208.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHH--H--------HHHHHHHHHhccCCCcce
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE--K--------LFFLHEATPYRRLRHVNI 152 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~--~--------~~~~~E~~~l~~l~HpnI 152 (394)
..++|++.+.||+|+||.||+|.++..... .....||+|++........ . .....|+..++.++||||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESV--GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCC--CTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCcccc--ccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 467899999999999999999998743211 1245899999876542111 1 112356677888999999
Q ss_pred eceeeEEEeC----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7505 153 LRLMAACLES----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228 (394)
Q Consensus 153 v~l~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl 228 (394)
+++++++... ...+|||||| +|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK----RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence 9999999864 4589999999 9999999976422 26788889999999999999999999999999999999
Q ss_pred c--CCCeEEEccCCCCccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC
Q psy7505 229 T--SELRVKIGDTGSSIDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG 300 (394)
Q Consensus 229 ~--~~~~vKl~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g 300 (394)
+ .++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++ |
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~-g 257 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-------PSRRGDLEILGYCMIQWLT-G 257 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-S
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-------CCchhhHHHHHHHHHHHHh-C
Confidence 9 8899999999999654322111 112345899999999987655 7899999999999999998 9
Q ss_pred CCCCCCCC-HHHHHHHHhcCCCcCC-------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcceeeCcc
Q psy7505 301 KLPYAELS-DDQVITRVFGTEALRL-------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYYVHGEV 371 (394)
Q Consensus 301 ~~Pf~~~~-~~~~~~~i~~~~~~~~-------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~~~~~~ 371 (394)
+.||.+.. ...............+ -.+..++.++.++++.||..+|+ ||++.++.+.|.++....... .
T Consensus 258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~--~ 335 (364)
T 3op5_A 258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK--D 335 (364)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC--C
T ss_pred CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC--c
Confidence 99998643 2222211111100000 11357899999999999999998 999999999998887643222 3
Q ss_pred cCCceeccCc
Q psy7505 372 ALPVRWCAPE 381 (394)
Q Consensus 372 ~~~~~~~~~e 381 (394)
..+..|...+
T Consensus 336 ~~~~dw~~~~ 345 (364)
T 3op5_A 336 DGKLDLSVVE 345 (364)
T ss_dssp CCCCCC----
T ss_pred CCccceEecc
Confidence 4555666554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=345.39 Aligned_cols=251 Identities=19% Similarity=0.291 Sum_probs=198.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|++. .+..||+|.+..... ......+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhcccCCCEEEEEEEcC--------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence 57999999999999999999874 244789998865432 112234568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++||||+++ +|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred eEEEEEEecCC-CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 99999999975 99999875422 25677788899999999999999999999999999999999999999999886
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT--EA 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~--~~ 321 (394)
...... .......+|..|+|||++.+.. .++.++|||||||++|||++ |..||.+.+..+.+..+... ..
T Consensus 149 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (288)
T 1ob3_A 149 AFGIPV-RKYTHEIVTLWYRAPDVLMGSK------KYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTP 220 (288)
T ss_dssp HHCC----------CCCTTCCHHHHTTCC------SCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccCccc-cccccccccccccCchheeCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHHCCC
Confidence 543221 1122346788999999986543 27899999999999999998 99999998877766555321 00
Q ss_pred c---------------CC---------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 L---------------RL---------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~---------------~~---------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. .+ .....+++.+.+++++||+.||+ ||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00 01245788999999999999998 999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=347.78 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=204.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+..++|++.+.||+|+||.||+|+++ ...||+|.+.... ....+.+|+.++++++||||+++++++.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~- 71 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR---------AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL- 71 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET---------TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT-
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC---------CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 45688999999999999999999875 2378999886543 2234679999999999999999999886
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEEcCCCe-EEEc
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE---DGFIHTDVAARNCLVTSELR-VKIG 237 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~---~~iiHrDlk~~NiLl~~~~~-vKl~ 237 (394)
+..++||||+++|+|.+++...... ..+.....+.++.|++.||.|||+ +||+||||||+|||++.++. +||+
T Consensus 72 -~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 72 -NPVCLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp -TTTEEEEECCTTCBHHHHHHCSSSE--ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred -CCcEEEEEcCCCCCHHHHHhccCCC--CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 4589999999999999999765321 124566778899999999999999 89999999999999998876 8999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS--DDQVITR 315 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~--~~~~~~~ 315 (394)
|||++...... .....||..|+|||++.+.. ++.++|||||||++|||++ |+.||.... ..++...
T Consensus 149 Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~ 216 (307)
T 2eva_A 149 DFGTACDIQTH----MTNNKGSAAWMAPEVFEGSN-------YSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWA 216 (307)
T ss_dssp CCCC----------------CCTTSSCHHHHTCCC-------CCTHHHHHHHHHHHHHHHH-TCCTTTTTCSSHHHHHHH
T ss_pred ccccccccccc----cccCCCCCceEChhhhCCCC-------CCcHHHHHHHHHHHHHHHH-CCCCchhhCccHHHHHHH
Confidence 99998654321 12346788999999987654 7899999999999999998 999998653 3344455
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
+..+. +.+.+..++..+.+++.+||..+|+ ||++.++++.|..+...+
T Consensus 217 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 217 VHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HhcCC--CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 55554 5666788999999999999999998 999999999998887544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=340.75 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=207.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|.++. ....+++|.+....... ...+.+|+.++++++||||+++++++.+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG-------TRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC-------CCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4679999999999999999999873 34578888886544222 234568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEccCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGDTG 240 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~DFG 240 (394)
..++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 99999999999999999875432 5777888999999999999999999999999999999 778899999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++....... ......+|+.|+|||++.+. ++.++|||||||++|||++ |..||.+....+....+..+.
T Consensus 155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 223 (277)
T 3f3z_A 155 LAARFKPGK--MMRTKVGTPYYVSPQVLEGL--------YGPECDEWSAGVMMYVLLC-GYPPFSAPTDSEVMLKIREGT 223 (277)
T ss_dssp TCEECCTTS--CBCCCCSCTTTCCHHHHTTC--------BCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred cceeccCcc--chhccCCCCCccChHHhccc--------CCchhhehhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCC
Confidence 986554332 22345688899999987532 6789999999999999998 999999999888888887663
Q ss_pred CcCCCCCC----CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPR----AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...|. .+++.+.+++++||+.+|+ ||++.+++.
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 33332 7899999999999999998 999988863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=339.81 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=203.3
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
....|.+.+.||+|+||.||+|.+.. ....|++|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecC-------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 45668999999999999999999873 44578888886544 44455567799999999999999999999875
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCeE
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVT-SELRV 234 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~-~~~~v 234 (394)
...+++||||+++|+|.+++..... ++...+..++.|++.||.|||+++ |+||||||+|||++ .++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHccC-----CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCE
Confidence 3458999999999999999976432 567778899999999999999999 99999999999997 78999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-~~~~ 313 (394)
||+|||++........ ....+|+.|+|||++.+. ++.++|||||||++|+|++ |..||.+... .++.
T Consensus 172 kl~Dfg~~~~~~~~~~---~~~~~t~~y~aPE~~~~~--------~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 239 (290)
T 1t4h_A 172 KIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEEK--------YDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIY 239 (290)
T ss_dssp EECCTTGGGGCCTTSB---EESCSSCCCCCGGGGGTC--------CCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHH
T ss_pred EEeeCCCccccccccc---ccccCCcCcCCHHHHhcc--------CCCcchHHHHHHHHHHHHh-CCCCCCCcCcHHHHH
Confidence 9999999865433221 234678899999987532 7889999999999999998 9999988554 4445
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+. .....+...++.+.+++++||..+|. ||++.|++.
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 240 RRVTSGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHTTTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccC-CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 5554442 23344567788999999999999998 999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=344.53 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=212.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.+.|++.+.||+|+||.||+|++.. ....||+|++...........+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR-------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC-------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 35779999999999999999998762 45589999987654333344567999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++||||+++|+|.+++.... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CeEEEEEEeCCCCcHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccc
Confidence 99999999999999999996532 567778899999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+..+.
T Consensus 167 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~-- 235 (303)
T 3a7i_A 167 GQLTDTQ-IKRNTFVGTPFWMAPEVIKQSA-------YDSKADIWSLGITAIELAR-GEPPHSELHPMKVLFLIPKNN-- 235 (303)
T ss_dssp EECBTTB-CCBCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSC--
T ss_pred eecCccc-cccCccCCCcCccCHHHHhcCC-------CCchhhhHHHHHHHHHHcc-CCCCCCCcCHHHHHHHhhcCC--
Confidence 6543322 1223456888999999987654 7789999999999999998 999999988888777776654
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..++..+.+++++||..+|. ||++.|++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4455678999999999999999998 999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.05 Aligned_cols=258 Identities=17% Similarity=0.246 Sum_probs=206.2
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
.+..++|++.+.||+|+||.||+|++.... ..+..||||+++... .......+.+|+.+++++ +||||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGH----DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSST----TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccC----CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEE
Confidence 345688999999999999999999985211 245689999886532 111112245788999999 799999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++...+.++||||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 126 YAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEeeCceEEEEeecCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999999975432 567778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----CHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL----SDDQV 312 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~----~~~~~ 312 (394)
+|||+++..............||+.|+|||++.+... .++.++|||||||++|||++ |..||... ...++
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~ 274 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS-----GHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEI 274 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC--------CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHH
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCC-----CCCchhhHHHHHHHHHHHHH-CCCCCccCCccchHHHH
Confidence 9999987543333222334578999999999875332 26889999999999999998 99999743 34455
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhhh
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTGS 356 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~~ 356 (394)
...+... ..+.|..++..+.+++++||..||+ || ++.|+++
T Consensus 275 ~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 275 SRRILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHhcc---CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 5555544 4567788999999999999999998 88 7777764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=344.27 Aligned_cols=257 Identities=18% Similarity=0.307 Sum_probs=212.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
.++|++.+.||+|+||.||+|+++. .+..|++|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS-------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECC-------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 4789999999999999999999873 34588999887543 44455567799999999999999999998864
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEcCCCeEE
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG-----FIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-----iiHrDlk~~NiLl~~~~~vK 235 (394)
.+.+++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence 56799999999999999999764321 122677788899999999999999999 99999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||++........ ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....++...
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~ 227 (279)
T 2w5a_A 157 LGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMS-------YNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGK 227 (279)
T ss_dssp ECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC--------CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred EecCchheeeccccc-cccccCCCccccChHHhccCC-------CCchhhHHHHHHHHHHHHH-CCCCCcccCHHHHHHH
Confidence 999998865432211 112236788999999987654 7899999999999999998 9999999988888888
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
+..+. ..+.|..++..+.+++++||..+|+ ||++.|+++.+.
T Consensus 228 i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IREGK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Hhhcc--cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 87775 4466778999999999999999998 999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=347.62 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=209.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH-----HHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA-----EKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|.++...... ....+.+|+.++++++||||++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS-------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC-------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4679999999999999999999873 34589999886543211 13346799999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----eE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL----RV 234 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~----~v 234 (394)
+.+.+.+++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCSC-----EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCE
Confidence 9999999999999999999999976532 57778889999999999999999999999999999999887 79
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+.
T Consensus 159 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~ 228 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEP-------LGLEADMWSIGVITYILLS-GASPFLGDTKQETLA 228 (321)
T ss_dssp EECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHH
T ss_pred EEccCccceecCccc--cccccCCCCCccCcccccCCC-------CCCccccHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence 999999987654332 123446889999999986654 7889999999999999998 999999998888888
Q ss_pred HHhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+.. .++ .+..++..+.+++++||..||+ ||++.|++.
T Consensus 229 ~i~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 229 NITSVSY-DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHTTCC-CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHhccc-ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 7766531 111 1257899999999999999998 999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=350.79 Aligned_cols=267 Identities=16% Similarity=0.233 Sum_probs=207.2
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
...++|.+.+.||+|+||.||+|+++. ++..||+|+++..........+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK-------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC-------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 346889999999999999999999873 4558999998765433333445699999999999999999999987
Q ss_pred CC--ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCeEE
Q psy7505 162 SD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV----TSELRVK 235 (394)
Q Consensus 162 ~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl----~~~~~vK 235 (394)
.+ .+++||||+++|+|.+++...... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEE
Confidence 55 789999999999999999765321 126777888999999999999999999999999999999 7788899
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCC-cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTS-IQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS----DD 310 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~-~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~----~~ 310 (394)
|+|||+++....... .....+|..|+|||++...... .....++.++|||||||++|||++ |..||.... ..
T Consensus 157 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 233 (319)
T 4euu_A 157 LTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPRRNK 233 (319)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTTCGGGCH
T ss_pred EccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCccchhH
Confidence 999999976543332 2245688999999998632100 011237899999999999999998 999997533 34
Q ss_pred HHHHHHhcCCCc------------------CCCC----CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 311 QVITRVFGTEAL------------------RLPA----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 311 ~~~~~i~~~~~~------------------~~~~----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
+++..+..+... .++. +..++..+.+++++||+.||+ |+++.|+++....
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 555555544311 1121 123445788999999999998 9999999876553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=354.81 Aligned_cols=268 Identities=26% Similarity=0.340 Sum_probs=208.6
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..++.+..++|++.+.||+|+||.||+|+++ .+..||+|.+...........+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA--------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCS--------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEec--------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3445566789999999999999999999754 24479999987655333333467999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEcCCCe
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED---GFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~iiHrDlk~~NiLl~~~~~ 233 (394)
+++.+.+..++|||||.+|+|.+++...... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 9999999999999999999999999865322 12267778889999999999999999 9999999999999999999
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----C
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-----S 308 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-----~ 308 (394)
+||+|||++...............||+.|+|||++.+.. ++.++|||||||++|||++ |..||... .
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-------SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 244 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-------ECHHHHHHHHHHHHHHHHH-CCCSBCHHHHTTTS
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCC-------CCccccchhHHHHHHHHHh-CCCccccccccccc
Confidence 999999999765444444445567899999999987654 7889999999999999998 99999521 1
Q ss_pred ---HHHHHHHHhcCCC--------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 309 ---DDQVITRVFGTEA--------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 309 ---~~~~~~~i~~~~~--------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
..+.......... .....+...+..+.+++.+||+.+|. ||++.|+++.|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1111111111110 01111223346799999999999998 99999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=357.02 Aligned_cols=260 Identities=17% Similarity=0.279 Sum_probs=204.6
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCC--Ccceecee
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLR--HVNILRLM 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~--HpnIv~l~ 156 (394)
..+...+|++.+.||+|+||.||+|.+.. ...||||++.... .......+.+|+.+|++++ |||||+++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~ 122 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK--------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT--------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC--------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEE
Confidence 44556779999999999999999998652 4479999886543 3444455779999999996 59999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++...+.+||||| +.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 123 ~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl 195 (390)
T 2zmd_A 123 DYEITDQYIYMVME-CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 195 (390)
T ss_dssp EEEECSSEEEEEEE-CCSEEHHHHHHHCSS-----CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEE
T ss_pred EEEecCCEEEEEEe-cCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEE
Confidence 99999999999999 568899999986542 56667788999999999999999999999999999995 588999
Q ss_pred ccCCCCccCCCCcee-eeCCccCCcccccccccccCCCC----cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HH
Q psy7505 237 GDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTS----IQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DD 310 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~----~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~ 310 (394)
+|||+++........ ......||+.|+|||++.+.... .....++.++|||||||++|||++ |..||.+.. ..
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 274 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHH
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhhHHH
Confidence 999999765433221 23345789999999998652110 011238899999999999999998 999998764 33
Q ss_pred HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+.... ..++.|...+..+.+++++||..||+ ||++.|++.
T Consensus 275 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 275 SKLHAIIDPN-HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHHHCTT-SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCcc-ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 4455555432 35667778889999999999999998 999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=355.81 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=202.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++. ++..||+|+++..... ..+|+.++.++ +||||+++++++.++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA-------TNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 4679999999999999999999873 4558999998765422 23677777777 899999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CeEEEcc
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE----LRVKIGD 238 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~----~~vKl~D 238 (394)
+.+|+|||||.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||+... +.+||+|
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~-----~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKF-----FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 999999999999999999976533 6777888999999999999999999999999999998543 3599999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHH
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE---LSDDQVITR 315 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~---~~~~~~~~~ 315 (394)
||+++....... .....++|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+ ....+++..
T Consensus 164 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~ 234 (342)
T 2qr7_A 164 FGFAKQLRAENG-LLMTPCYTANFVAPEVLERQG-------YDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILAR 234 (342)
T ss_dssp CTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHH-------HHHHHHHHHHHHHHHHHHH-SSCSSCSSTTSCHHHHHHH
T ss_pred CCCcccCcCCCC-ceeccCCCccccCHHHhcCCC-------CCCccCeeeHhHHHHHHhc-CCCCCCCCCcCCHHHHHHH
Confidence 999975433221 223457889999999987654 7789999999999999998 9999986 356677777
Q ss_pred HhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+.. .++ .+..+++.+.+++++||..||+ ||++.|++.
T Consensus 235 i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 235 IGSGKF-SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHCCC-CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HccCCc-ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 766542 222 2357899999999999999998 999988863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=346.95 Aligned_cols=271 Identities=13% Similarity=0.107 Sum_probs=214.9
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAAC 159 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 159 (394)
.+..++|++.+.||+|+||.||+|++. ..+..||+|++...... ..+.+|+.+++.+ +|+||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 345788999999999999999999976 24558999988654321 1245889999999 899999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe-----E
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR-----V 234 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~-----v 234 (394)
.+....++||||+ +|+|.+++...+. .+++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~ 150 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 150 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeE
Confidence 9999999999999 8999999976432 2677788899999999999999999999999999999987765 9
Q ss_pred EEccCCCCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-
Q psy7505 235 KIGDTGSSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL- 307 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~- 307 (394)
||+|||++........ .......||..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~-g~~pf~~~~ 222 (298)
T 1csn_A 151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-------QSRRDDLEALGHVFMYFLR-GSLPWQGLK 222 (298)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTSSCC
T ss_pred EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-------CChHHHHHHHHHHHHHHHc-CCCCcchhh
Confidence 9999999875433221 1223457899999999987654 7899999999999999998 99999874
Q ss_pred --CHHHHHHHHhcCCCcCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcceeeCcccCCcee
Q psy7505 308 --SDDQVITRVFGTEALRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYYVHGEVALPVRW 377 (394)
Q Consensus 308 --~~~~~~~~i~~~~~~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~~~~~~~~~~~~ 377 (394)
...+.+..+..+.. ..+ ....+++.+.+++.+||+.+|+ ||++.++.+.|+++...... ....++.|
T Consensus 223 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~--~~~~~~dw 295 (298)
T 1csn_A 223 AATNKQKYERIGEKKQ-STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT--TEDENFDW 295 (298)
T ss_dssp SCCHHHHHHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC--CSCSCCGG
T ss_pred ccccHHHHHHHHhhcc-CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC--CCCCcccc
Confidence 34444444433211 111 2347899999999999999998 99999999999988754322 23455555
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=363.73 Aligned_cols=256 Identities=11% Similarity=0.078 Sum_probs=193.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHH---HHhccCCCcceec
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEA---TPYRRLRHVNILR 154 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~---~~l~~l~HpnIv~ 154 (394)
+..+.++|++.+.||+|+||.||+|+++. .+..||||++.... .......+.+|+ .++++++|||||+
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~ 140 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQE-------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-C-------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECC-------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHH
Confidence 34456889999999999999999999762 35589999986432 222334567899 5566668999999
Q ss_pred ee-------eEEEeCC-----------------ceEEEEeeCCCCCHHHHHhhcchhhh--hhhhHHHHHHHHHHHHHHH
Q psy7505 155 LM-------AACLESD-----------------PWLLVFESCSRGDLKEFLLSNEASRE--ALLEQGITIKMAIDVATGL 208 (394)
Q Consensus 155 l~-------~~~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~gl 208 (394)
++ +++.+.+ ..||||||| +|+|.+++...+.... ..+++..++.++.||+.||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 219 (377)
T 3byv_A 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 219 (377)
T ss_dssp HHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHH
Confidence 98 6665543 389999999 6899999986532211 2345577788999999999
Q ss_pred HHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCC----CcccCCCCcch
Q psy7505 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDT----SIQTCTVTEKC 284 (394)
Q Consensus 209 ~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~----~~~~~~~~~~~ 284 (394)
.|||++||+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+... ......++.++
T Consensus 220 ~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 220 ASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp HHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred HHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 999999999999999999999999999999999975322 2224456 88999999876500 00001288999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 285 NVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 285 DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
|||||||++|||++ |+.||.+....+....+. ..+..+++.+.++|++||..||+ ||++.|+++
T Consensus 295 DvwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 295 DAWALGLVIYWIWC-ADLPITKDAALGGSEWIF-------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHHH-SSCCC------CCSGGGG-------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred hHHHHHHHHHHHHH-CCCCCcccccccchhhhh-------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999998 999998765444333332 23467899999999999999998 999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=343.73 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=200.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++.+.||+|+||.||+|+++. ++..||+|++.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD-------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 679999999999999999999873 45589999876554 3334455679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++|||||++++|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEEeCCCchHHHHHhhhcC-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 99999999999999998875533 5677788999999999999999999999999999999999999999999987
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC----
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT---- 319 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~---- 319 (394)
....... ......+|..|+|||++.+.. .++.++|||||||++|||++ |..||.+....+....+...
T Consensus 151 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 151 LLTGPSD-YYDDEVATRWYRSPELLVGDT------QYGPPVDVWAIGCVFAELLS-GVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp ECC-------------GGGCCHHHHHTCS------CCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred hccCccc-ccCCCcCCccccChHHHhcCC------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhccc
Confidence 5432221 223446788999999986533 27899999999999999998 99999998876665443221
Q ss_pred --------------CCcCCCCC----------CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 --------------EALRLPAP----------RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 --------------~~~~~~~p----------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....++.+ ..++..+.+++++||..||. ||++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00122222 36788899999999999998 999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=338.58 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=204.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+..++|++.+.||+|+||.||+|+++. .+..|++|.+...... .....+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQL-------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECC-------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 446889999999999999999999862 4558999988654311 1223466899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHGR-----VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeec
Confidence 999999999999999999999976432 567778899999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++........ .....+++.|+|||++.+... .+.++||||||+++|+|++ |..||.+....++...+..+
T Consensus 156 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~------~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 226 (276)
T 2h6d_A 156 GLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLY------AGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRGG 226 (276)
T ss_dssp CGGGCCCC---------------CCTGGGTTSCC------CHHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred ccccccCCCcc--eecccCCccccCHHHHcCCCC------CCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC
Confidence 99876543321 223467889999999876541 3679999999999999998 99999998888888777665
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++..+.+++++||..+|. ||++.|+++
T Consensus 227 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 ---VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 4556788999999999999999998 999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=368.67 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=208.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++ ..+..||+|++.... .......+.+|+.++++++|||||++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET-------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcceEEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 467999999999999999999987 345589999985432 111223466999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT---SELRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~---~~~~vKl~DF 239 (394)
+.+|+|||||.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 999999999999999999875432 67778889999999999999999999999999999995 4567999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++....... ......||+.|+|||++.+. |+.++|||||||++|+|++ |..||.+.+..+++..+..+
T Consensus 169 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 169 GLSTCFQQNT--KMKDRIGTAYYIAPEVLRGT--------YDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp SCTTTBCCC------CCTTGGGGCCGGGGGSC--------CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred CcCeECCCCC--ccCCCcCCCCCCCHHHhCCC--------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Confidence 9997654332 22345789999999998642 7899999999999999998 99999999999988888766
Q ss_pred CC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. ...+....+++.+.+++++||..+|. ||++.+++.
T Consensus 238 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 42 12333457899999999999999998 999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=355.20 Aligned_cols=256 Identities=14% Similarity=0.143 Sum_probs=205.8
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
..++|++.+.||+|+||.||+|++. ..+..||+|++...... ..+.+|+.+++++ +||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNL-------YTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEET-------TTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEEC-------CCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 3678999999999999999999976 34558999988654321 1256899999999 99999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe-----EEE
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR-----VKI 236 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~-----vKl 236 (394)
++..++||||+ +|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDR----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEE
Confidence 99999999999 8999999976421 2678888999999999999999999999999999999998887 999
Q ss_pred ccCCCCccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--
Q psy7505 237 GDTGSSIDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-- 308 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-- 308 (394)
+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~ell~-g~~Pf~~~~~~ 223 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-------QSRRDDLEALGHMFMYFLR-GSLPWQGLKAD 223 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCS
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-------CCchhHHHHHHHHHHHHhc-CCCCccccccc
Confidence 999999754322211 123457899999999987655 7899999999999999998 999998854
Q ss_pred -HHHHHHHHhcCCCcCCCC---CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 309 -DDQVITRVFGTEALRLPA---PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 309 -~~~~~~~i~~~~~~~~~~---p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+.+..+..... ..+. ...++ ++.++++.||..+|. ||++.++...|+++..
T Consensus 224 ~~~~~~~~i~~~~~-~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 224 TLKERYQKIGDTKR-ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp SHHHHHHHHHHHHH-HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHhhhc-cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 3344444433211 1111 12345 999999999999998 9999999988887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=367.55 Aligned_cols=248 Identities=20% Similarity=0.240 Sum_probs=194.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++++.||+|+||.||+|+++. ++..||||++.... .......+.+|+.+|+.++|||||++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV-------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT-------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC-------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 5789999999999999999999873 45589999987543 333444567999999999999999999999754
Q ss_pred C------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 D------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+ .+|||||||.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~~-------l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHTSC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEE
Confidence 3 46999999976 677777543 566777889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|+...... ......||+.|+|||++.+.. |+.++|||||||++|||++ |+.||.+.+..+.+.++
T Consensus 206 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ell~-g~~pF~g~~~~~~~~~i 275 (464)
T 3ttj_A 206 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKV 275 (464)
T ss_dssp CCCCCC-----CC--CC----CCCTTCCHHHHTTCC-------CCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred EEEEeeeecCCCc--ccCCCcccccccCHHHHcCCC-------CCHHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999997653322 223457899999999997764 8899999999999999998 99999998877776665
Q ss_pred hcCCCcC------------------------CCCCCC---------------CChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALR------------------------LPAPRA---------------VNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~------------------------~~~p~~---------------~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....... ...+.. .++.+.+|+++||..||+ |+|+.|+++
T Consensus 276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 4321000 000000 145689999999999998 999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=351.64 Aligned_cols=252 Identities=17% Similarity=0.279 Sum_probs=197.0
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|.+++.||+|+||.||+|+++. ....||+|+++..........+.+|+.++++++||||+++++++.+.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL-------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECC-------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence 579999999999999999999873 4458999998765433332234579999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+++||||+. |+|.+++...+. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred EEEEecccc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 999999997 599999876532 256777888999999999999999999999999999999999999999999865
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCC
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRL 324 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 324 (394)
...... ......+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+........
T Consensus 150 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (324)
T 3mtl_A 150 KSIPTK-TYDNEVVTLWYRPPDILLGST------DYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFIFRILGTPT 221 (324)
T ss_dssp C-------------CGGGCCHHHHTTCC------CCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCCcc-ccccccCcccccChhhhcCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 432221 222346788999999986533 27899999999999999998 9999999887777665543110000
Q ss_pred ---------------------------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 325 ---------------------------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 325 ---------------------------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+++.+.+++++||+.||+ ||++.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11235688999999999999998 999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=367.06 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=206.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH------------HHHHHHHHHHHHhccCCCcc
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ------------AEKLFFLHEATPYRRLRHVN 151 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~------------~~~~~~~~E~~~l~~l~Hpn 151 (394)
.++|.+++.||+|+||.||+|+++. ....||+|+++..... .....+.+|+.++++++|||
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 107 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKN-------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETT-------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred ccceEEEeEecccCCeEEEEEEECC-------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence 5789999999999999999999873 4458999988654311 12344679999999999999
Q ss_pred eeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 152 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
||++++++.+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-----FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 99999999999999999999999999999875432 6777888999999999999999999999999999999887
Q ss_pred C---eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 232 L---RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 232 ~---~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
+ .+||+|||++....... ......||+.|+|||++.+ . ++.++|||||||++|+|++ |..||.+.+
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~-------~~~~~DiwslG~il~~ll~-g~~pf~~~~ 251 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-K-------YNEKCDVWSCGVIMYILLC-GYPPFGGQN 251 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-C-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred CCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-C-------CCchHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence 6 69999999997654332 2234578999999999753 2 7889999999999999998 999999999
Q ss_pred HHHHHHHHhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 309 DDQVITRVFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 309 ~~~~~~~i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+++..+..+.. .++ ....+++.+.+++++||..+|. ||++.|++.
T Consensus 252 ~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 252 DQDIIKKVEKGKY-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCC-CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999888877642 222 1257899999999999999998 999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=348.26 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=179.8
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeCCceEEEE
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPWLLVF 169 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~ 169 (394)
+.||+|+||.||+|+++. .+..||+|++..... ..+.+|+.+++.+. ||||+++++++.+.+..|+||
T Consensus 17 ~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~----~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKK-------SNQAFAVKIISKRME----ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp CCSEEETTEEEEEEEETT-------TCCEEEEEEEEGGGH----HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CccccCCCeEEEEEEECC-------CCCEEEEEEEChhhh----hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 679999999999999873 455899999865432 23458999999996 999999999999999999999
Q ss_pred eeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---eEEEccCCCCccCC
Q psy7505 170 ESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL---RVKIGDTGSSIDKY 246 (394)
Q Consensus 170 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~---~vKl~DFG~a~~~~ 246 (394)
|||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKH-----FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CCCCSCBHHHHHHHCSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EccCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999976533 67778889999999999999999999999999999998765 89999999997543
Q ss_pred CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcC
Q psy7505 247 PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-------DDQVITRVFGT 319 (394)
Q Consensus 247 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-------~~~~~~~i~~~ 319 (394)
.... ......+|..|+|||++.+.. ++.++|||||||++|||++ |..||.+.. ..+++..+..+
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 161 PDNQ-PLKTPCFTLHYAAPELLNQNG-------YDESCDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMKKIKKG 231 (325)
T ss_dssp C-----------------------CC-------CCHHHHHHHHHHHHHHHHH-SSCTTC-------CCCHHHHHHHHTTT
T ss_pred CCCC-cccccCCCcCccCHHHhcCCC-------CCCccchHHHHHHHHHHHh-CCCCCCCCccccccccHHHHHHHHHcC
Confidence 3221 223456789999999987654 7899999999999999998 999998643 35667777665
Q ss_pred CCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 320 EALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 320 ~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.. .++. ...+++++.+++++||..||. ||++.|++
T Consensus 232 ~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 232 DF-SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CC-CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CC-CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 31 1221 136899999999999999998 99999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=341.88 Aligned_cols=250 Identities=19% Similarity=0.300 Sum_probs=186.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH--HHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--EKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|++.. .+..||+|.+....... ....+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH-------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred cccceeeeeecCCCceEEEEEEEcc-------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 4679999999999999999999862 34589999986543211 12346789999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEecCCCCcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence 9999999999999999999976422 257778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||......+.+..+...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-- 227 (278)
T 3cok_A 159 ATQLKMPHE-KHYTLCGTPNYISPEIATRSA-------HGLESDVWSLGCMFYTLLI-GRPPFDTDTVKNTLNKVVLA-- 227 (278)
T ss_dssp CEECC------------------------------------CTHHHHHHHHHHHHHH-SSCSSCCCSCC-----CCSS--
T ss_pred eeeccCCCC-cceeccCCCCcCCcchhcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCChhHHHHHHHHhhc--
Confidence 865432211 122346788999999987654 6789999999999999998 99999887655555544333
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....|..++.++.+++++||..||+ ||++.+++.
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 3456778999999999999999998 999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.40 Aligned_cols=267 Identities=26% Similarity=0.418 Sum_probs=212.9
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
...+..++|++.+.||+|+||.||+|++.... ...+..||+|.+........ ..+.+|+.++++++||||++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ---DNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTS---SSCCEEEEEEEESSCCSHHH-HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEecccc---CCCceEEEEEEeccCCHHHH-HHHHHHHHHHHhCCCCCeeeEEEE
Confidence 33556788999999999999999999864322 13456899999876544333 346699999999999999999999
Q ss_pred EEeCC--ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 159 CLESD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 159 ~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+...+ .+++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence 87643 78999999999999999976532 2567778899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----
Q psy7505 237 GDTGSSIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD----- 309 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~----- 309 (394)
+|||++.......... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.....
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~~~ 258 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-------FSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRM 258 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHH-TTCGGGSHHHHHHHH
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCC-------CCchhhHHHHHHHHHHHHh-cCCCCCCCHHHHHHh
Confidence 9999997654333221 22335677899999987654 6789999999999999998 9888764211
Q ss_pred -----------HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 310 -----------DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 310 -----------~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+...+..+. +++.+..++..+.+++++||..+|+ ||++.|+++.|+++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 259 IGNDKQGQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccchhhhHHHHHHHhhcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12223333343 6677889999999999999999998 9999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=349.60 Aligned_cols=252 Identities=17% Similarity=0.238 Sum_probs=196.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++ ..+..||+|+++.... ......+.+|+.++++++||||+++++++.++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDT-------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred hhhEEEEEEEEecCCeEEEEEEEC-------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 578999999999999999999987 3455899999875542 22334456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-----CCCeEEEc
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT-----SELRVKIG 237 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~-----~~~~vKl~ 237 (394)
+.+++|||||. |+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDKNPD-----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred CEEEEEEecCC-CCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999999997 599999976543 67778889999999999999999999999999999994 45669999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++....... .......+|..|+|||++.+.. .++.++|||||||++|||++ |..||.+....+.+..+.
T Consensus 180 Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 180 DFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSR------HYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp CTTHHHHHC------------CCTTCCHHHHTTCC------CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred cCCCccccCCcc-cccCCCcCCccccCHHHhcCCC------CCCcHHHHHHHHHHHHHHHH-CCCCcCCCCHHHHHHHHH
Confidence 999986543221 1122346788999999987643 27899999999999999998 999999988877766654
Q ss_pred cCCCcCCC---------------------------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLP---------------------------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~---------------------------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........ .+..+++++.+++++||+.||+ ||++.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 32110000 0012678999999999999998 999998864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=367.58 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=203.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++++.||+|+||.||+|+++. ....||+|+++... .......+.+|+.+++.++|||||++++++.+.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV-------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT-------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC-------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4579999999999999999999873 45588999886543 122233467999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~vKl~DF 239 (394)
+.+|+|||||.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+||
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 183 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF 183 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEEC
Confidence 999999999999999998865432 5677788899999999999999999999999999999764 55999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+|....... ......||+.|+|||++.. . ++.++|||||||++|+|++ |..||.+.+..+++..+..+
T Consensus 184 G~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~-------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 184 GLSAVFENQK--KMKERLGTAYYIAPEVLRK-K-------YDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp TTCEECBTTB--CBCCCCSCTTTCCHHHHTT-C-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred CCCeECCCCc--cccccCCCcCeeCHHHHcc-c-------CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Confidence 9987553322 2234578999999999753 2 7889999999999999998 99999999999998888766
Q ss_pred CCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. .++. ...+++.+.+++++||+.+|. ||++.|++.
T Consensus 253 ~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 253 KY-TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CC-CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 42 2222 247899999999999999998 999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=340.69 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=204.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++.+.||+|+||.||+|+++. ....||+|++...........+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRV-------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECC-------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 578999999999999999999873 3458999998755433334456799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|.+++..... ++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTB-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCcHHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 9999999999999998865422 56777889999999999999999999999999999999999999999999865
Q ss_pred CCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCc
Q psy7505 245 KYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QVITRVFGTEAL 322 (394)
Q Consensus 245 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~ 322 (394)
...... .......++..|+|||++.+... ++.++|||||||++|||++ |..||.+.... ..+..+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~ 226 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREF------HAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKK-T 226 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSB------CHHHHHHHHHHHHHHHHHH-SSCCCSCSCTTSHHHHHHHTTC-T
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCC------CCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHhhhcc-c
Confidence 422221 12234578889999999876541 4678999999999999998 99999876543 2233333322 2
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+....++..+.+++++||..||. ||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 3444567899999999999999998 999998864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=349.11 Aligned_cols=255 Identities=18% Similarity=0.227 Sum_probs=203.5
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-----Ccc
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-----HVN 151 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-----Hpn 151 (394)
..+..+-.++|++.+.||+|+||.||+|++.. .+..||+|+++.... ....+..|+.+++.+. |||
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID-------NKKYYAVKVVRNIKK--YTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECSCHH--HHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECC-------CCeEEEEEEeccchh--hhhhhHHHHHHHHHhcccCCCCCC
Confidence 34445567899999999999999999999863 345899999875432 2223457888888886 999
Q ss_pred eeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-
Q psy7505 152 ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS- 230 (394)
Q Consensus 152 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~- 230 (394)
||++++++...+.+++||||+ +|+|.+++...... .++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN---GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCT
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccc
Confidence 999999999999999999999 88999999765321 2567778899999999999999999999999999999975
Q ss_pred ------------------------CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhH
Q psy7505 231 ------------------------ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNV 286 (394)
Q Consensus 231 ------------------------~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~Di 286 (394)
++.+||+|||+|...... .....||+.|+|||++.+.. ++.++||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~Di 242 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG-------WDVSSDM 242 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC-------CCTTHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC-------CCCccch
Confidence 788999999999754322 23457889999999997665 7899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc-----------------------CCCCCC---------------
Q psy7505 287 WSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL-----------------------RLPAPR--------------- 328 (394)
Q Consensus 287 wSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------~~~~p~--------------- 328 (394)
|||||++|||++ |+.||.+....+.+..+...... +...|.
T Consensus 243 wslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 321 (360)
T 3llt_A 243 WSFGCVLAELYT-GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321 (360)
T ss_dssp HHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred HHHHHHHHHHHH-CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence 999999999998 99999988877766555332110 001111
Q ss_pred -----CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 329 -----AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 329 -----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..++.+.+++++||+.||+ ||++.|+++
T Consensus 322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1236778999999999998 999998864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.18 Aligned_cols=258 Identities=21% Similarity=0.377 Sum_probs=196.4
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc--CCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR--LRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~ 160 (394)
-.++|++.+.||+|+||.||+|++. +..||||++....... +.+|.+++.. ++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~----~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ---------GENVAVKIFSSRDEKS----WFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET---------TEEEEEEEECGGGHHH----HHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC---------CEEEEEEEeccccchh----hHHHHHHHHHhhccCcCeeeEEEeec
Confidence 3678999999999999999999874 3479999986543221 2345555444 89999999999976
Q ss_pred eC----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEE
Q psy7505 161 ES----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI--------EDGFIHTDVAARNCLV 228 (394)
Q Consensus 161 ~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH--------~~~iiHrDlk~~NiLl 228 (394)
.. ..+++||||+++|+|.++++... +++..++.++.|++.||.||| +++|+||||||+|||+
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTTCC------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred cccCCCceeEEehhhccCCCHHHHHhhcc------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence 53 45899999999999999996542 567778899999999999999 9999999999999999
Q ss_pred cCCCeEEEccCCCCccCCCCceee---eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC-----
Q psy7505 229 TSELRVKIGDTGSSIDKYPGDYYV---HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG----- 300 (394)
Q Consensus 229 ~~~~~vKl~DFG~a~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g----- 300 (394)
+.++.+||+|||+++......... .....||+.|+|||++.+.... ....++.++|||||||++|||++ |
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DvwslG~il~el~t-g~~~~~ 224 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV-DCFDSYKRVDIWAFGLVLWEVAR-RMVSNG 224 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT-TCHHHHHHHHHHHHHHHHHHHHT-TBCBTT
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC-CcccCCchhhHHHHHHHHHHHHh-hhcCcc
Confidence 999999999999986543322211 2234789999999998765311 00014579999999999999998 8
Q ss_pred -----CCCCCCCC----HHHHHHHHhcCCCcCCCCCC-----CCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 301 -----KLPYAELS----DDQVITRVFGTEALRLPAPR-----AVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 301 -----~~Pf~~~~----~~~~~~~i~~~~~~~~~~p~-----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
..||.+.. ..+.+..+......+...|. .++..+.+++++||+.||+ ||++.|+++.|+++
T Consensus 225 ~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88886532 22333333332222333332 2557899999999999998 99999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=369.01 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=209.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|+++ ..+..||+|++.... .......+.+|+.++++++|||||++++++.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 578999999999999999999987 345589999985432 12223446799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEcc
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGD 238 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~D 238 (394)
.+.+++|||||.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRKR-----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSC-----CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 9999999999999999999976533 6777888999999999999999999999999999999 4578999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||++........ .....||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+.+..+++..+..
T Consensus 173 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 173 FGLSTHFEASKK--MKDKIGTAYYIAPEVLHGT--------YDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEK 241 (484)
T ss_dssp TTHHHHBCCCCS--HHHHTTGGGTCCHHHHHTC--------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred eeeeEEcccccc--cccCCCCccccCceeecCC--------CCCcceeHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHc
Confidence 999865433221 1234688999999998642 7889999999999999998 9999999999998888876
Q ss_pred CCC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 319 TEA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 319 ~~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.. ...+....+++.+.+++++||+.+|. ||++.|++.
T Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 642 12233357899999999999999998 999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=341.51 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=207.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|.+.+.||+|+||.||+|+++. .+..||+|.++...... ...+.+|+.++++++||||+++++++.+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL-------TGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccceeeeeccCCCCceEEEEEECC-------CCCEEEEEEEecccccc-hHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 4679999999999999999999863 44589999987554322 234568999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEccCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGDTG 240 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~DFG 240 (394)
..++||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEEEEcCCCccHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 99999999999999999875432 5677788899999999999999999999999999999 778899999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....++...+..+.
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 223 (304)
T 2jam_A 155 LSKMEQNGI---MSTACGTPGYVAPEVLAQKP-------YSKAVDCWSIGVITYILLC-GYPPFYEETESKLFEKIKEGY 223 (304)
T ss_dssp TTCCCCCBT---THHHHSCCCBCCTTTBSSCS-------CCHHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHCC
T ss_pred cceecCCCc---cccccCCCCccChHHhccCC-------CCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCC
Confidence 986543221 12235788999999987654 7899999999999999998 999999998888888877664
Q ss_pred C-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 A-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ...+.+..++..+.+++.+||..||+ ||++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2 12233467899999999999999998 999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=354.76 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=206.4
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
....++|++.+.||+|+||.||+|+++ .+..||+|.+....... ...+.+|+.+++.++||||+++++++.
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR--------DGAKVALKRRTPESSQG-IEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT--------TCCEEEEEECCSCCSSH-HHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC--------CCCEEEEEEecccChHH-HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 344678999999999999999999864 24479999876654332 234669999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999998654321 1125777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Q psy7505 241 SSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV------- 312 (394)
Q Consensus 241 ~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~------- 312 (394)
+++...... ........||..|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-------LTEKSDVYSFGVVLFEVLC-ARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-------CCTHHHHHHHHHHHHHHHH-CCTTCSCSSSSSCCCHHHHT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCC-------CCcccchHhHHHHHHHHHh-CCCcccccCcHHHHHHHHHh
Confidence 986543221 11223345788999999987654 7899999999999999998 9999976532211
Q ss_pred HHHHhcCCC-------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 313 ITRVFGTEA-------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 313 ~~~i~~~~~-------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
......+.. .....+..++..+.+++.+||+.||+ ||++.|++..|+.++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111110 01112234556789999999999998 999999999988765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.28 Aligned_cols=252 Identities=18% Similarity=0.261 Sum_probs=206.1
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++.+.||+|+||.||+|+++. .+..||+|++...........+.+|+.++++++||||+++++++.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECC-------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 4567899999999999999999999873 455899999887665555566779999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEccC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
+++.+++||||+++|+|.+++...+. +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEEC
Confidence 99999999999999999999976432 56777889999999999999996 9999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT----- 314 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~----- 314 (394)
|++...... ......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||......++..
T Consensus 177 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 245 (360)
T 3eqc_A 177 GVSGQLIDS---MANSFVGTRSYMSPERLQGTH-------YSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQ 245 (360)
T ss_dssp CCCHHHHHH---C----CCCCTTCCHHHHTTCC-------CSHHHHHHHHHHHHHHHHH-TSCCSSCCCHHHHHHHHC--
T ss_pred CCCcccccc---cccCCCCCCCeECHHHHcCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhccc
Confidence 988543211 122346788999999987654 7899999999999999998 999998776544322
Q ss_pred -------------------------------------HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 -------------------------------------RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 -------------------------------------~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+.. ....+..++..+.+++++||..||. ||++.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------------------------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2222221 1111235788999999999999998 999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=353.30 Aligned_cols=262 Identities=16% Similarity=0.157 Sum_probs=199.3
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH--H--------HHHHHHHHHHhccCCCcce
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA--E--------KLFFLHEATPYRRLRHVNI 152 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~--~--------~~~~~~E~~~l~~l~HpnI 152 (394)
..++|++.+.||+|+||.||+|+++... .....||+|......... + ...+.+|+..++.++||||
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKP----EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSC----GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCC----CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 4678999999999999999999987421 245688999886554211 1 1124578889999999999
Q ss_pred eceeeEEEe----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7505 153 LRLMAACLE----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228 (394)
Q Consensus 153 v~l~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl 228 (394)
+++++++.. ....|+||||| +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence 999999987 67899999999 999999997653 26788889999999999999999999999999999999
Q ss_pred cCCC--eEEEccCCCCccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC
Q psy7505 229 TSEL--RVKIGDTGSSIDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG 300 (394)
Q Consensus 229 ~~~~--~vKl~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g 300 (394)
+.++ .+||+|||+++........ ......+|..|+|||++.+.. ++.++|||||||++|||++ |
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~ell~-g 256 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-------LSRRSDVEILGYCMLRWLC-G 256 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-------CCHHHHHHHHHHHHHHHHH-S
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-------CCchhhHHHHHHHHHHHHh-C
Confidence 9887 9999999999654322110 113447889999999987654 7899999999999999998 9
Q ss_pred CCCCCCC--CHHHHHHHHhcCCCcCCC-------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 301 KLPYAEL--SDDQVITRVFGTEALRLP-------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 301 ~~Pf~~~--~~~~~~~~i~~~~~~~~~-------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+.||.+. ...... .........++ .+..+++.+.+++++||..+|+ ||++.++++.|+++..
T Consensus 257 ~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 257 KLPWEQNLKDPVAVQ-TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp SCTTGGGTTCHHHHH-HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CCCccccccccHHHH-HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 9999652 222221 11111100111 1227899999999999999998 9999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=340.31 Aligned_cols=263 Identities=17% Similarity=0.225 Sum_probs=202.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..+|++.+.||+|+||.||+|.+.. .+..||+|+++... .......+.+|+.++++++||||+++++++..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLL-------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETT-------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcC-------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 4679999999999999999999862 34589999887532 34444556799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+..++||||+.+|+|.+++...... ...++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred CCcEEEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 99999999999999999999753211 12257778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL--SDDQVITRVFGT 319 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~--~~~~~~~~i~~~ 319 (394)
+........ ......++..|+|||++.... ++.++|||||||++|||++ |..||.+. ...++...+..+
T Consensus 183 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 253 (310)
T 2wqm_A 183 GRFFSSKTT-AAHSLVGTPYYMSPERIHENG-------YNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQC 253 (310)
T ss_dssp -----------------CCSSCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTC---CCHHHHHHHHHTT
T ss_pred eeeecCCCc-cccccCCCeeEeChHHhCCCC-------CCchhhHHHHHHHHHHHHh-CCCCCcccchhHHHHHHHhhcc
Confidence 865433221 122346788999999987654 7899999999999999998 99999764 344555556554
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.. ....+..++..+.+++.+||..||. ||++.++++.|+++...
T Consensus 254 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 254 DY-PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CS-CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC-CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 32 2222367899999999999999998 99999999999887643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=341.87 Aligned_cols=252 Identities=19% Similarity=0.292 Sum_probs=205.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
...++|++.+.||+|+||.||+|.++. .+..||+|.+...... ..+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE-------TGQIVAIKQVPVESDL---QEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT-------TCCEEEEEEEETTSCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC-------CCCEEEEEecCchHHH---HHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 457889999999999999999999863 3558999988765422 235689999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++||||+++|+|.+++..... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999999964221 267778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+..+..
T Consensus 172 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 242 (314)
T 3com_A 172 AGQLTDTM-AKRNTVIGTPFWMAPEVIQEIG-------YNCVADIWSLGITAIEMAE-GKPPYADIHPMRAIFMIPTNPP 242 (314)
T ss_dssp CEECBTTB-SCBCCCCSCGGGCCHHHHSSSC-------BCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCC
T ss_pred chhhhhhc-cccCccCCCCCccChhhcCCCC-------CCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC
Confidence 86543221 1223446788999999987654 7889999999999999998 9999999887777666666654
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+..++..+.+++++||..+|. ||++.+++.
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 45566778899999999999999998 999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=338.79 Aligned_cols=261 Identities=18% Similarity=0.209 Sum_probs=195.4
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
+++..++|++.+.||+|+||.||+|+++. .+..||+|.++.... ......+.++...++.++||||++++++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP-------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecC-------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 45678999999999999999999999863 455899999876543 3333344455666888999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeEEEc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+.+++..++||||++ |+|.+++...... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 75 LFREGDVWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp EECSSSEEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred eeccCCEEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999997 5998887653111 12367888889999999999999998 99999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-SDDQVITRV 316 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-~~~~~~~~i 316 (394)
|||++....... ......+|..|+|||++.... ....++.++|||||||++|||++ |..||... .....+...
T Consensus 153 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 153 DFGISGYLVDDV--AKDIDAGCKPYMAPERINPEL---NQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp CC-----------------CCCCCCSCHHHHSCCT---TC--CCHHHHHHHHHHHHHHHHH-TSCSSCCCSCHHHHHHHH
T ss_pred ecCCcccccccc--cccccCCCccccChhhcChhh---cCcCCCcHHHHHHHHHHHHHHHH-CCCCccccCchHHHHHHH
Confidence 999986543322 222346888999999974321 11237899999999999999998 99999864 344444444
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..... ....+..+++.+.+++.+||+.+|+ ||++.|+++
T Consensus 227 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCC-CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCC-CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 44432 2223457899999999999999998 999998864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=349.84 Aligned_cols=271 Identities=20% Similarity=0.252 Sum_probs=199.7
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
..+..++|++.+.||+|+||.||+|++. ...||+|++........ ....|+..+..++||||+++++.+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~--~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLD---------ERPVAVKVFSFANRQNF--INEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEET---------TEEEEEEEEEGGGHHHH--HHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEEC---------CeEEEEEEeeccchhhH--HHHHHHHHHHhccCcchhhheecc
Confidence 3566799999999999999999999764 34899999875443221 112445556668999999999866
Q ss_pred Ee-----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCC
Q psy7505 160 LE-----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED---------GFIHTDVAARN 225 (394)
Q Consensus 160 ~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~---------~iiHrDlk~~N 225 (394)
.. ...+++|||||++|+|.+++.... .++.....++.||+.||.|||++ ||+||||||+|
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~N 150 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGG
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccce
Confidence 43 235789999999999999997653 24556778999999999999999 99999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCce-------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDY-------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
||++.++.+||+|||+++....... .......||+.|+|||++.+.........++.++|||||||++|||++
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 9999999999999999975432211 112234689999999998764221111236679999999999999998
Q ss_pred CCCCCC-CCCC----------------HHHHHHHHhcCCCcCCCCCCCC------ChHHHHHHHhhhcCCcc-ccchhhh
Q psy7505 299 FGKLPY-AELS----------------DDQVITRVFGTEALRLPAPRAV------NSHVDVAARNCLVTSEL-RVKIGDT 354 (394)
Q Consensus 299 ~g~~Pf-~~~~----------------~~~~~~~i~~~~~~~~~~p~~~------~~~~~~l~~~cl~~~p~-r~~~~e~ 354 (394)
|..|| .+.. ..+.+.........+...|..+ ++.+.++|++||..||+ ||++.|+
T Consensus 231 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 231 -RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp -TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 75544 3321 1112222222332344444443 34799999999999998 9999999
Q ss_pred hhhhhcCCCcceee
Q psy7505 355 GSSIDKYPGDYYVH 368 (394)
Q Consensus 355 ~~~l~~~~~~~~~~ 368 (394)
++.|++++..+..+
T Consensus 310 l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 310 EERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHHhc
Confidence 99999998776655
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=343.53 Aligned_cols=246 Identities=18% Similarity=0.155 Sum_probs=192.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
.++|++.++||+|+||+||+|+++. .+..||||++.... ..........|+..+.++ +|||||+++++|.+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE-------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC-------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 4679999999999999999999873 45589999876543 222333334555555444 99999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+++||||| +|+|.+++...+. .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 99999999999 6799998876432 267888899999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+....... ......||+.|+|||++.+ . ++.++|||||||++|||++ |..|+.+. +....+..+.
T Consensus 204 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~-------~~~~~DiwslG~il~el~~-g~~~~~~~---~~~~~~~~~~- 268 (311)
T 3p1a_A 204 LVELGTAG--AGEVQEGDPRYMAPELLQG-S-------YGTAADVFSLGLTILEVAC-NMELPHGG---EGWQQLRQGY- 268 (311)
T ss_dssp CEECC--------CCCCCGGGCCGGGGGT-C-------CSTHHHHHHHHHHHHHHHH-TCCCCSSH---HHHHHHTTTC-
T ss_pred eeecccCC--CCcccCCCccccCHhHhcC-C-------CCchhhHHHHHHHHHHHHh-CCCCCCCc---cHHHHHhccC-
Confidence 86553322 2234568999999998864 2 7889999999999999998 76555432 2233343332
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.....+..+++.+.+++++||+.||+ ||++.|+++
T Consensus 269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 12233567899999999999999998 999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=335.49 Aligned_cols=248 Identities=17% Similarity=0.198 Sum_probs=199.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|+++. ....||+|.++... .......+.+|+..+..+ +||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL-------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC-------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 4679999999999999999999873 45589999887543 222333456899988888 99999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----------
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---------- 231 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---------- 231 (394)
.+.+++||||+++|+|.+++...... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 99999999999999999999764221 1226777888999999999999999999999999999999844
Q ss_pred ---------CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 232 ---------LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 232 ---------~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
..+||+|||++....... ...+|..|+|||++.+.. .++.++|||||||++|||++ |..
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~-~~~ 229 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENY------THLPKADIFALALTVVCAAG-AEP 229 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCC------TTHHHHHHHHHHHHHHHHTT-CCC
T ss_pred ccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCC------CCCchhhHHHHHHHHHHHhc-CCC
Confidence 479999999987553322 235788999999987542 16689999999999999997 887
Q ss_pred CCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 303 PYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 303 Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++.... ....+..+. ....|..+++.+.+++++||..||. ||++.|+++
T Consensus 230 ~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 230 LPRNGD---QWHEIRQGR--LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCSSSH---HHHHHHTTC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcchh---HHHHHHcCC--CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 665432 234445554 4456778999999999999999998 999998864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=342.93 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=197.9
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH----HHHHHHHHHHHHhccC---CCcceece
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ----AEKLFFLHEATPYRRL---RHVNILRL 155 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~----~~~~~~~~E~~~l~~l---~HpnIv~l 155 (394)
..++|++.+.||+|+||.||+|+++. .+..||+|++...... .....+.+|+.+++.+ +||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~ 79 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH-------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT-------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred cccceEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence 36789999999999999999999763 4558999988643210 0011233666666655 59999999
Q ss_pred eeEEEeCC-----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 156 MAACLESD-----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 156 ~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
++++.... .+++||||+. |+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPP---GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 99998755 4899999997 5999999865331 2677788899999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
++.+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 225 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQST-------YATPVDMWSVGCIFAEMFR-RKPLFCGNSEA 225 (308)
T ss_dssp TSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSC-------CCSTHHHHHHHHHHHHTTT-SSCSCCCSSHH
T ss_pred CCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCC-------CCchHHHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence 9999999999997553322 223457889999999987665 7889999999999999998 99999999888
Q ss_pred HHHHHHhcCCCcCCC------------------------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEALRLP------------------------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~------------------------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..+......... ....+++.+.+++++||+.||+ ||++.|++.
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 777666432110000 1135788999999999999998 999998864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=344.84 Aligned_cols=258 Identities=20% Similarity=0.317 Sum_probs=206.7
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
..++|++.+.||+|+||.||+|+++. .+..|++|++...... ....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE-------TGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT-------TCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred CccceeecceeccCCCeEEEEEEEcC-------CCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 46889999999999999999999873 3457899988654322 223456899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 999999999999999999865322 2677788899999999999999999999999999999999999999999987
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
...... ........++..|+|||++..... ....++.++|||||||++|||++ |..||...+..+.+..+..+...
T Consensus 165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 165 AKNLKT-LQKRDSFIGTPYWMAPEVVMCETM--KDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSDPP 240 (302)
T ss_dssp HHHHHH-HHC-----CCGGGCCHHHHHHHHT--TSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCC
T ss_pred cccccc-ccccccccCChhhcCCeeeccccC--CCCCCchhhhHHHHHHHHHHHhc-CCCCCccCCHHHHHHHHhccCCc
Confidence 432111 011123467889999999852110 11127889999999999999998 99999999888887777766655
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+..++..+.+++++||..+|+ ||++.+++.
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 5566778999999999999999998 999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=349.24 Aligned_cols=254 Identities=20% Similarity=0.270 Sum_probs=199.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|.++ .++..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 578999999999999999999986 345589999985543 334445567999999999999999999999865
Q ss_pred C------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 D------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+ .+|+||||+ +++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKHEK------LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred CccccCceEEEEEecC-CCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEE
Confidence 3 469999999 789999997532 567778889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..... .....+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+
T Consensus 170 ~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i 238 (367)
T 1cm8_A 170 LDFGLARQADSE----MTGYVVTRWYRAPEVILNWM------RYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEI 238 (367)
T ss_dssp CCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTT------CCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred Eeeecccccccc----cCcCcCCCCcCCHHHHhCCC------CCChhhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 999999764322 23456789999999987632 27899999999999999998 99999998877666555
Q ss_pred hcCCCc----------------------C------CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhcCC
Q psy7505 317 FGTEAL----------------------R------LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDKYP 362 (394)
Q Consensus 317 ~~~~~~----------------------~------~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~~~ 362 (394)
...... . ......+++.+.+++++||..||+ |+++.|++. .+.++.
T Consensus 239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 331100 0 012246788999999999999998 999999874 455443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=335.02 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=204.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-----HHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-----AEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|.++..... .....+.+|+.++++++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG-------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI 76 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC-------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence 3579999999999999999999873 3458899987654311 113346799999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----eE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL----RV 234 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~----~v 234 (394)
+.+.+..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++.++ .+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 77 FENKTDVVLILELVSGGELFDFLAEKES-----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCE
T ss_pred ecCCCeEEEEEeecCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCce
Confidence 9999999999999999999999975422 67778889999999999999999999999999999998877 89
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++........ .....++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+....+.+.
T Consensus 152 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~ 221 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEP-------LGLEADMWSIGVITYILLS-GASPFLGETKQETLT 221 (283)
T ss_dssp EECCCTTCEECC----------CCCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHH
T ss_pred EEEecccceeccCCCc--ccccCCCcCccCcceecCCC-------CCcchhhhhHHHHHHHHHH-CCCCCCCcchHHHHH
Confidence 9999999875433221 22346788999999986654 7889999999999999998 999999988888877
Q ss_pred HHhcCCCcCCC--CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLP--APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~--~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..... ..+ .+..++..+.+++++||..+|. ||++.|++.
T Consensus 222 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 222 NISAVNY-DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTCC-CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhHhccc-CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 7765531 111 2257889999999999999998 999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=343.56 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=192.2
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.|.+..++|++.+.||+|+||.||+|++. .....||+|.+...........+.+|+.++++++||||++++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCA-------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC-----------CEEEEECCC----------------CCCCCCCTTBCCEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEEC-------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence 56777899999999999999999999876 23458999988765433334456799999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchh---hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEAS---REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
+...+..++||||+++|+|.+++...... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 99999999999999999999999752110 112267788889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCce----eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 236 IGDTGSSIDKYPGDY----YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 236 l~DFG~a~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
|+|||++........ .......+|..|+|||++.... .++.++|||||||++|||++ |..||.+....+
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~ 234 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR------GYDFKADIWSFGITAIELAT-GAAPYHKYPPMK 234 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHH------CCCTHHHHHHHHHHHHHHHH-SSCTTTTSCGGG
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc------CCCchhhHHHHHHHHHHHHh-CCCCCccCchhh
Confidence 999998864432211 1122346788999999986422 27889999999999999998 999999887766
Q ss_pred HHHHHhcCCCcCC-------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFGTEALRL-------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~~~~~~~-------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.......+....+ .....++..+.+++++||..||. ||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 6655554432221 22356788999999999999998 999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.11 Aligned_cols=270 Identities=20% Similarity=0.258 Sum_probs=209.0
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+.+..++|++.+.||+|+||.||+|+++. .+..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLH-------DGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAY 94 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETT-------TCCEEEEEEEEESSH-HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecC-------CCcEEEEEEEecCCH-HHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 445778999999999999999999999863 455899998865433 333456799999999999999999999
Q ss_pred EEe----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 159 CLE----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 159 ~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+.. ....++||||+.+|+|.+++...... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE
Confidence 973 34789999999999999999763211 1226778888999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCcee--------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 235 KIGDTGSSIDKYPGDYY--------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
||+|||++......... ......+|..|+|||++..... ..++.++|||||||++|||++ |+.||..
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~Di~slG~il~el~~-g~~p~~~ 248 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH----CVIDERTDVWSLGCVLYAMMF-GEGPYDM 248 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSE----EEECTHHHHHHHHHHHHHHHH-SSCTTHH
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCC----cCCCchhhHHHHHHHHHHHHh-CCCChhh
Confidence 99999987643211000 0012246888999999865431 126789999999999999998 9999954
Q ss_pred CC--HHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 307 LS--DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 307 ~~--~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.. ...+...+... ..++.+..++..+.+++++||..+|. ||++.|+++.|+.+...
T Consensus 249 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 249 VFQKGDSVALAVQNQ--LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHTTSCHHHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hhcccchhhHHhhcc--CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 21 11122233332 35666778999999999999999998 99999999999988754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=350.58 Aligned_cols=271 Identities=19% Similarity=0.295 Sum_probs=212.7
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
..+|++..++|++.+.||+|+||.||+|++++ .+++|+++.... ......+.+|+.++++++||||+++
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~----------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG----------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS----------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC----------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence 34678889999999999999999999998752 478888764321 1111234589999999999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
++++.+.+.+++||||+++|+|.+++...+. .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+|
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTSSCC----CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence 9999999999999999999999999976532 256677889999999999999999999999999999998 67999
Q ss_pred EccCCCCccCCCCce----eeeCCccCCcccccccccccCCCCc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 236 IGDTGSSIDKYPGDY----YVHGEVALPVRWCAPESLLCSDTSI--QTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 236 l~DFG~a~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~--~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
|+|||++........ .......++..|+|||++....... ....++.++|||||||++|||++ |..||.+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~ 248 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQPA 248 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSSCCH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Confidence 999998764321111 1112235788999999987532110 12237899999999999999998 9999999998
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.++...+..+... ...+..++..+.+++.+||..+|+ ||++.++++.|+++...
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 249 EAIIWQMGTGMKP-NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHHTTCCC-CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHHhccCCCC-CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 8888877766422 222347889999999999999998 99999999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.35 Aligned_cols=252 Identities=19% Similarity=0.229 Sum_probs=198.4
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
+...++|++.+.||+|+||.||+|++. .++..||+|++..+... ..+|+.+|+.++|||||++++++.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI-------ESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET-------TTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheee
Confidence 345789999999999999999999987 34558999988654322 237999999999999999999985
Q ss_pred eC--------------------------------------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHH
Q psy7505 161 ES--------------------------------------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202 (394)
Q Consensus 161 ~~--------------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~ 202 (394)
.. ..+++|||||+ |+|.+.+...... ...+++..+..++.
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIY 148 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHH
Confidence 43 23889999998 5888887643111 12367778889999
Q ss_pred HHHHHHHHHHhCCceecCCCCCCEEEc-CCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCC
Q psy7505 203 DVATGLSYMIEDGFIHTDVAARNCLVT-SELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVT 281 (394)
Q Consensus 203 qi~~gl~yLH~~~iiHrDlk~~NiLl~-~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~ 281 (394)
||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....... .....+|..|+|||++.+.. .++
T Consensus 149 qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~------~~~ 220 (383)
T 3eb0_A 149 QLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGAT------EYT 220 (383)
T ss_dssp HHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCS------SCC
T ss_pred HHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCC------CCC
Confidence 999999999999999999999999998 689999999999975533321 22346788899999986543 278
Q ss_pred cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------------cCC----------CCCCCCChHHH
Q psy7505 282 EKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA----------------LRL----------PAPRAVNSHVD 335 (394)
Q Consensus 282 ~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~----------------~~~----------~~p~~~~~~~~ 335 (394)
.++|||||||++|||++ |+.||.+.+..+.+..+..... ..+ ..|..+++.+.
T Consensus 221 ~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELIL-GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299 (383)
T ss_dssp THHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHH
T ss_pred cchhhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHH
Confidence 99999999999999998 9999999887776665543100 011 13456889999
Q ss_pred HHHHhhhcCCcc-ccchhhhh
Q psy7505 336 VAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 336 ~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+++++||..+|+ ||++.|++
T Consensus 300 ~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 300 DLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp HHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHh
Confidence 999999999998 99999886
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=359.66 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=186.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++ .++..||||++.... .......+.+|+.+|++++|||||++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 478999999999999999999987 345589999886543 334445567999999999999999999999543
Q ss_pred -----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 163 -----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 163 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
..+|+||||+ +|+|.+++..... +++..+..++.||+.||.|||++|||||||||+|||++.++.+||+
T Consensus 125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 125 DVEKFDELYVVLEIA-DSDFKKLFRTPVY-----LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp CTTTCCCEEEEECCC-SEEHHHHHHSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred CcccCceEEEEEecc-ccchhhhcccCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeec
Confidence 5689999998 5699999976532 6777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCce--------------------------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHH
Q psy7505 238 DTGSSIDKYPGDY--------------------------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGV 291 (394)
Q Consensus 238 DFG~a~~~~~~~~--------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~ 291 (394)
|||+|+....... ......+||+.|+|||++.... .|+.++|||||||
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE------NYTEAIDVWSIGC 272 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC------CCCTHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC------CCCcHhHHHHHHH
Confidence 9999976432110 1123447799999999875432 2889999999999
Q ss_pred HHHHHHcC----------CCCCCCCCCH--------------------HHHHHHH---hcCCC-----------------
Q psy7505 292 LLWEIFEF----------GKLPYAELSD--------------------DQVITRV---FGTEA----------------- 321 (394)
Q Consensus 292 il~el~t~----------g~~Pf~~~~~--------------------~~~~~~i---~~~~~----------------- 321 (394)
++|||++. |+++|.+.+. .+.+..+ .+...
T Consensus 273 il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 352 (458)
T 3rp9_A 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR 352 (458)
T ss_dssp HHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHT
T ss_pred HHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHH
Confidence 99999962 5666665431 1111111 11100
Q ss_pred ---cC-----CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhcCC
Q psy7505 322 ---LR-----LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDKYP 362 (394)
Q Consensus 322 ---~~-----~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~~~ 362 (394)
.+ ......+++.+.+|+++||..||+ |+++.|+++ .+..+.
T Consensus 353 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 00 011235688999999999999998 999999874 344443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=342.80 Aligned_cols=254 Identities=18% Similarity=0.267 Sum_probs=196.7
Q ss_pred CCCeEEE-ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe
Q psy7505 84 RQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 161 (394)
.+.|++. +.||+|+||.||+|+++ .....||+|++....... ...+.+|+.+++++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-------ITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-------SSCCEEEEEEEECCSSCC-HHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEc-------CCCcEEEEEEEeeCcchh-HHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4678885 67999999999999876 245589999986554322 22356899999885 89999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe---EEEcc
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR---VKIGD 238 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~---vKl~D 238 (394)
++.+++|||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRH-----FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 9999999999999999999976432 567778889999999999999999999999999999988765 99999
Q ss_pred CCCCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----
Q psy7505 239 TGSSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS---- 308 (394)
Q Consensus 239 FG~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~---- 308 (394)
||++........ .......||..|+|||++..... ....++.++|||||||++|||++ |..||.+..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~ 234 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE--EASIYDKRCDLWSLGVILYILLS-GYPPFVGRCGSDC 234 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSH--HHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCCCSCS
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccc--cccCCCcccccHhHHHHHHHHHH-CCCCCcccccccc
Confidence 999865432111 11123458899999999864210 01126789999999999999998 999998754
Q ss_pred -----------HHHHHHHHhcCCCcCCCCC----CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 309 -----------DDQVITRVFGTEALRLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 309 -----------~~~~~~~i~~~~~~~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+...+..+. ...| ..++..+.+++++||..||+ ||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 235 GWDRGEACPACQNMLFESIQEGK---YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CC----CCHHHHHHHHHHHHHCC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccccchhHHHHHHHHHhccC---cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 233455555542 3333 46899999999999999998 999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=350.67 Aligned_cols=243 Identities=20% Similarity=0.334 Sum_probs=201.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-------HHHHHHHHHHHHhccCCCcceecee
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-------AEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|+++..... .....+.+|+.++++++||||++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 95 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKE-------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL 95 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETT-------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECC-------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4679999999999999999999873 4558999988754310 1112345799999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCC-CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEE
Q psy7505 157 AACLESDPWLLVFESCSRG-DLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vK 235 (394)
+++.+.+.+++||||+.+| +|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 170 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK 170 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEE
Confidence 9999999999999999777 99999976543 67778889999999999999999999999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||++........ .....||+.|+|||++.+... ++.++|||||||++|||++ |..||.+...
T Consensus 171 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~el~~-g~~pf~~~~~------ 235 (335)
T 3dls_A 171 LIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPY------RGPELEMWSLGVTLYTLVF-EENPFCELEE------ 235 (335)
T ss_dssp ECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCB------CSHHHHHHHHHHHHHHHHH-SSCSCSSGGG------
T ss_pred EeecccceECCCCCc--eeccCCCccccChhhhcCCCC------CCCcccchhHHHHHHHHHh-CCCchhhHHH------
Confidence 999999976543322 223468899999999876542 4789999999999999998 9999976422
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.... ....|..+++.+.+++++||..+|+ ||++.|++.
T Consensus 236 ~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 236 TVEA---AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp GTTT---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhh---ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 4556778999999999999999998 999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=344.16 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=202.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..++|++.+.||+|+||.||+|+++. .+..||+|++.... .......+.+|+.++++++||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKD-------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETT-------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECC-------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 46889999999999999999999873 45589999875544 34444556799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCcchHHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCC
Confidence 9999999999999999888754432 67778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE- 320 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~- 320 (394)
+........ ......++..|+|||++.+.. .++.++|||||||++|||++ |+.||.+....+.+..+....
T Consensus 171 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 242 (331)
T 4aaa_A 171 ARTLAAPGE-VYDDEVATRWYRAPELLVGDV------KYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLG 242 (331)
T ss_dssp C-------------CCCCCTTCCHHHHTTCT------TCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHC
T ss_pred ceeecCCcc-ccCCCcCCccccCcccccCCC------CcchHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Confidence 865433221 223446788999999986542 27889999999999999998 999999988766655443210
Q ss_pred -----------------CcCCCC----------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 -----------------ALRLPA----------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 -----------------~~~~~~----------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+++. ...+++.+.+++++||..||+ ||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001111 135788999999999999998 999998864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=346.40 Aligned_cols=270 Identities=16% Similarity=0.172 Sum_probs=205.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE-EeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC-LES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~ 162 (394)
.++|++.+.||+|+||.||+|++.. ....||+|+....... ..+.+|+.+++.++|++++..++.+ ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-------AGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEcC-------CCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 4789999999999999999999763 4558999986543321 1246899999999888877777766 566
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~DF 239 (394)
+..++||||+ +|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred CceEEEEEcc-CCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecC
Confidence 7789999999 8999999975322 26777888999999999999999999999999999999 78899999999
Q ss_pred CCCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---
Q psy7505 240 GSSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD--- 310 (394)
Q Consensus 240 G~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~--- 310 (394)
|+++....... .......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.+....
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 224 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-------QSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKR 224 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSSS
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-------CCchhHHHHHHHHHHHHhc-CCCCCcccchhhhh
Confidence 99875433221 1223457889999999987655 7899999999999999998 99999875422
Q ss_pred HHHHHHhcCCCcCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcceeeCcccCCceecc
Q psy7505 311 QVITRVFGTEALRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCA 379 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~ 379 (394)
+.+..+.... ...+ ....+++.+.+++++||+.+|+ ||++.++++.|+++....... ...+..|..
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~--~~~~~dw~~ 294 (296)
T 4hgt_A 225 QKYERISEKK-MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS--YDYVFDWNM 294 (296)
T ss_dssp SHHHHHHHHH-HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC--TTCCCGGGG
T ss_pred hhhhhhhccc-ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC--ccCccchhh
Confidence 2222222221 0111 1257789999999999999998 999999999999887653322 244555544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=349.31 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=192.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI-------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC-------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 4789999999999999999999863 45589999986543 334444567999999999999999999999765
Q ss_pred C------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 163 D------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 163 ~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+ .+|+|||||.+ +|.+++... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDA-NLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred cccccccceEEEEEcCCC-CHHHHHhhc-------cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEE
Confidence 4 68999999974 898888532 566677889999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 169 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i 238 (371)
T 2xrw_A 169 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKV 238 (371)
T ss_dssp CCCCC------------------CTTCCHHHHTTCC-------CCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred EEeeccccccccc--ccCCceecCCccCHHHhcCCC-------CCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999987543221 223457888999999987654 7889999999999999998 99999999888777776
Q ss_pred hcCCCcCC------------------C---------------CCC------CCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRL------------------P---------------APR------AVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~------------------~---------------~p~------~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
........ + .|. ..+..+.+++++||..||+ |||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 65321100 0 000 1146789999999999998 999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=338.03 Aligned_cols=253 Identities=23% Similarity=0.261 Sum_probs=205.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc---HHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---QAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
.++|++.+.||+|+||.||+|.++ .....|++|+++.... ......+.+|+.++++++||||+++++++.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 367889999999999999999976 3455899999875431 123345679999999999999999999984
Q ss_pred --eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 161 --ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 161 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+..++||||+.+| |.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeec
Confidence 456899999999876 8787765422 1267778889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCC-ceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 239 TGSSIDKYPG-DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
||++...... .........++..|+|||++.+... .++.++|||||||++|||++ |..||.+....++...+.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~ 226 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT-----FSGFKVDIWSAGVTLYNITT-GLYPFEGDNIYKLFENIG 226 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC-----EESHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCccc-----CCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHHh
Confidence 9998654321 1122234568899999999865431 14679999999999999998 999999988888888776
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+ ..+.+..+++.+.+++++||..||. ||++.|++.
T Consensus 227 ~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 227 KG---SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HC---CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cC---CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 66 4567788999999999999999998 999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=340.79 Aligned_cols=258 Identities=16% Similarity=0.178 Sum_probs=204.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE-EeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC-LES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~ 162 (394)
.++|++.+.||+|+||.||+|++.. .+..||+|++....... .+.+|+.+++.++|++++..++.+ ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-------AGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEEESCSSCC---HHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC-------CCcEEEEEEecCCcchh---HHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 5789999999999999999999862 45589999876544221 256899999999988877766665 556
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~DF 239 (394)
+..++||||+ +|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CceEEEEEec-CCCHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 7789999999 8999999974322 26778888999999999999999999999999999999 47889999999
Q ss_pred CCCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H
Q psy7505 240 GSSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD---D 310 (394)
Q Consensus 240 G~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~---~ 310 (394)
|++........ .......+|..|+|||++.+.. ++.++|||||||++|||++ |+.||.+... .
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 224 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-------QSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKR 224 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSSS
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCC-------CCcchhhHHHHHHHHHHHh-CCCCCCCcCchhhh
Confidence 99875433221 1123457889999999987655 7899999999999999998 9999987432 2
Q ss_pred HHHHHHhcCCCcCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 311 QVITRVFGTEALRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
+.+..+.... ...+ .+..+++.+.+++++||+.+|. ||++.++.+.|+++....
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 225 QKYERISEKK-MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp SHHHHHHHHH-HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhhhhhcccc-cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 2333332221 0111 2367899999999999999998 999999999999887553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=342.27 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=197.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc--CCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR--LRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|+++ +..||+|++....... +.+|.+++.. ++||||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~----~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR---------GEKVAVKVFFTTEEAS----WFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC---------CceEEEEEEeccccch----hhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 468999999999999999999875 3479999986543221 2244444444 599999999999988
Q ss_pred C----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEc
Q psy7505 162 S----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED--------GFIHTDVAARNCLVT 229 (394)
Q Consensus 162 ~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~--------~iiHrDlk~~NiLl~ 229 (394)
. ..+++|||||++|+|.++++... +++..++.++.|++.||.|||++ ||+||||||+|||++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhccC------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7 67999999999999999996542 56777889999999999999999 999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC------
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG------ 300 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g------ 300 (394)
.++.+||+|||+++........ ......||+.|+|||++.+..... ...++.++|||||||++|||++ |
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DiwslG~il~el~t-g~~~~~~ 254 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN-HFQSYIMADMYSFGLILWEVAR-RCVSGGI 254 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT-CTHHHHHHHHHHHHHHHHHHHT-TBCBTTB
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc-cccCccccchHHHHHHHHHHHh-ccCcccc
Confidence 9999999999998654332221 122457899999999987654210 0001124999999999999998 8
Q ss_pred ----CCCCCCCC----HHHHHHHHhcCCCcCCCCCC-----CCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 301 ----KLPYAELS----DDQVITRVFGTEALRLPAPR-----AVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 301 ----~~Pf~~~~----~~~~~~~i~~~~~~~~~~p~-----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..||.... ..+...........+...|. .+++.+.+++++||+.||. ||++.|+++.|+++.+.
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 77776542 22223333333222344443 5667799999999999998 99999999999987754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=338.76 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=204.8
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
.......++|++.+.||+|+||.||+|++.. .+..||+|++....... ..+.+|+.+++++ +||||++++
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVK-------TGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSSTT--HHHHHHHHHHHHHCCSTTBCCEE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECC-------CCCeEEEEEEecCcccH--HHHHHHHHHHHhccCCCCeeeee
Confidence 3445567899999999999999999999862 34589999886544222 2356899999998 899999999
Q ss_pred eEEEe------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 157 AACLE------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 157 ~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
+++.. .+.+++||||+++|+|.+++..... ..++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 164 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC
Confidence 99987 4678999999999999999976532 22677778899999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
++.+||+|||++....... .......++..|+|||++..... ....++.++|||||||++|||++ |..||.+....
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~ 240 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPM 240 (326)
T ss_dssp TCCEEECCCTTTC--------------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHH-SSCTTTTSCHH
T ss_pred CCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccc--cCcCCCccchHHHHHHHHHHHHh-CCCCCCCCcHH
Confidence 9999999999986543221 12233467889999999864221 12237899999999999999998 99999998887
Q ss_pred HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..+..+.. ....+..++..+.+++++||..+|. ||++.+++.
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 RALFLIPRNPA-PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHSCC-CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhcCcc-ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 77666655432 2223567899999999999999998 999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=359.73 Aligned_cols=272 Identities=16% Similarity=0.225 Sum_probs=211.6
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
...++|.+.+.||+|+||.||+|+++. ++..||+|+++..........+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK-------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC-------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 346789999999999999999999873 4558999998765433333445689999999999999999999987
Q ss_pred CC--ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCeEE
Q psy7505 162 SD--PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV----TSELRVK 235 (394)
Q Consensus 162 ~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl----~~~~~vK 235 (394)
.+ ..++|||||++|+|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEE
Confidence 55 789999999999999999764321 126777888999999999999999999999999999999 7778899
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----CHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSI-QTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL----SDD 310 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~-~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~----~~~ 310 (394)
|+|||+++....... .....||..|+|||++....... ....++.++|||||||++|||++ |+.||... ...
T Consensus 157 L~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~~~~~~~ 233 (396)
T 4eut_A 157 LTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPRRNK 233 (396)
T ss_dssp ECCGGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEECTTCTTTCH
T ss_pred EecCCCceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcccchH
Confidence 999999976543321 22456889999999986421000 00126789999999999999998 99999643 345
Q ss_pred HHHHHHhcCCCc------------------CCCCC----CCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 311 QVITRVFGTEAL------------------RLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 311 ~~~~~i~~~~~~------------------~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
+++..+..+... .++.+ ..++..+.+++++||..||+ |+++.++++.+..++...
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 566666655321 11212 23445788999999999998 999999999988887643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.18 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=197.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++. ++..||||+++... .......+.+|+.+|++++|||||++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN-------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC-------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 5789999999999999999999873 45589999987543 334445567999999999999999999999876
Q ss_pred -----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 163 -----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 163 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+.+|+||||+. |+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTPIF-----LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEc
Confidence 57999999996 599999976532 6777888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCcee---------------------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHH
Q psy7505 238 DTGSSIDKYPGDYY---------------------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296 (394)
Q Consensus 238 DFG~a~~~~~~~~~---------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el 296 (394)
|||+|+........ ......||..|+|||++.... .|+.++|||||||++|||
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~------~~~~~~DiwSlG~il~el 245 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE------NYTKSIDIWSTGCIFAEL 245 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCS------CCCTHHHHHHHHHHHHHH
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC------CCCcccccchHHHHHHHH
Confidence 99999765332111 123457899999999875433 288999999999999999
Q ss_pred Hc----------CCCCCCCCCC-----------------HHHHHHHHh---c--------------------CCCcCCCC
Q psy7505 297 FE----------FGKLPYAELS-----------------DDQVITRVF---G--------------------TEALRLPA 326 (394)
Q Consensus 297 ~t----------~g~~Pf~~~~-----------------~~~~~~~i~---~--------------------~~~~~~~~ 326 (394)
++ .|.++|.+.+ ..+.+..+. + ....+.+.
T Consensus 246 l~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (432)
T 3n9x_A 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325 (432)
T ss_dssp HTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC
T ss_pred HhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCC
Confidence 96 1334444432 011111111 1 00001111
Q ss_pred C-----CCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhcCCC
Q psy7505 327 P-----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDKYPG 363 (394)
Q Consensus 327 p-----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~~~~ 363 (394)
+ ..+++.+.+|+++||..||+ ||++.|+++ .+..+..
T Consensus 326 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp CHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred CHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 1 46899999999999999998 999999874 4555543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=344.24 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=209.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------cHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------SQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
++|++.+.||+|+||.||+|+++. .+..||||++.... .......+.+|+.+++++ +||||++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRA-------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhcccceEEecCCCEEEEEEEECC-------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 579999999999999999999862 34589999886543 112234466899999999 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
+++...+..++||||+++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVA-----LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999975422 677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||++....... ......||+.|+|||++.+.... ....++.++|||||||++|||++ |..||.+....+.+..+
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDE-THPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCT-TSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccc-cCcCCCchhhHHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 9999987654332 22345789999999998654211 11237889999999999999998 99999998888887777
Q ss_pred hcCCCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.. .++. ...++..+.+++++||..||+ ||++.|++.
T Consensus 318 ~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQY-QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCC-CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 66532 2222 257889999999999999998 999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.48 Aligned_cols=264 Identities=13% Similarity=0.147 Sum_probs=203.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccc-cCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceec--------
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEES-TGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILR-------- 154 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~-~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-------- 154 (394)
.++|++.+.||+|+||.||+|+++..... .......||+|.+.... .+.+|+.++++++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------RLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS------THHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc------hHHHHHHHHHHhcccchhhhhhhhccC
Confidence 58999999999999999999998742110 01135589999987542 2568999999999999998
Q ss_pred -------eeeEEEe-CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7505 155 -------LMAACLE-SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNC 226 (394)
Q Consensus 155 -------l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~Ni 226 (394)
+++++.. ++..++||||+ +|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5677765 67889999999 9999999986521 2267888899999999999999999999999999999
Q ss_pred EEcCCC--eEEEccCCCCccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 227 LVTSEL--RVKIGDTGSSIDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 227 Ll~~~~--~vKl~DFG~a~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
|++.++ .+||+|||+++........ ......+|+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-------PSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-------CCchhhHHHHHHHHHHHHh
Confidence 999998 8999999999754322211 112347889999999987654 7899999999999999998
Q ss_pred CCCCCCCCCC--HHHHHHHHh--cCCCcCCCC----CCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 299 FGKLPYAELS--DDQVITRVF--GTEALRLPA----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 299 ~g~~Pf~~~~--~~~~~~~i~--~~~~~~~~~----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
|+.||.+.. ...+..... ......+.. ...++..+.+++++||..+|+ ||++.++++.|+++....
T Consensus 264 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 264 -GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp -SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 999998763 333322221 111111111 125689999999999999998 999999999999887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=345.27 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=198.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH----HHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA----EKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|.++...... ....+.+|+.+++.++||||+++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKN-------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 81 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSS-------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccEEEeEEeecCCEEEEEEEECC-------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 5789999999999999999999763 34589999987543211 122456899999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+.+..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eeCCceEEEEEcCCC-CHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEec
Confidence 999999999999976 89999876432 1556677889999999999999999999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+++...... .......+|+.|+|||++.+.. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 157 g~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 157 GLAKSFGSPN-RAYTHQVVTRWYRAPELLFGAR------MYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp GGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCS------CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred ccceeccCCc-ccCCcccccccccCchHhhCCC------CCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHH
Confidence 9987653322 1223457789999999986543 27889999999999999998 99999999887777666542
Q ss_pred CCcC----CC----------------C-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EALR----LP----------------A-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~~~----~~----------------~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.... .+ . ...++..+.+++++||..||. ||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1000 00 0 145678999999999999998 999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=344.12 Aligned_cols=267 Identities=18% Similarity=0.286 Sum_probs=193.4
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-Ccceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l 155 (394)
...+++...+|++.+.||+|+||.||+|+++. .+..||+|.+....... ...+.+|+.+++++. ||||+++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~~h~~iv~~ 91 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVG-------SGREYALKRLLSNEEEK-NRAIIQEVCFMKKLSGHPNIVQF 91 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETT-------TCCEEEEEEEEESSHHH-HHHHHHHHHHHHHHTTSTTBCCE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECC-------CCcEEEEEEecCCchHH-HHHHHHHHHHHHHhccCCChhhc
Confidence 45667888899999999999999999999863 44589999886554333 334568999999995 9999999
Q ss_pred eeEEEe--------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCC
Q psy7505 156 MAACLE--------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARN 225 (394)
Q Consensus 156 ~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~N 225 (394)
++++.. ...+++||||+. |+|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~N 168 (337)
T 3ll6_A 92 CSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVEN 168 (337)
T ss_dssp EEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGG
T ss_pred cccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCccc
Confidence 999953 345899999996 799999875311 112677888999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEccCCCCccCCCCcee-----------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHH
Q psy7505 226 CLVTSELRVKIGDTGSSIDKYPGDYY-----------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLW 294 (394)
Q Consensus 226 iLl~~~~~vKl~DFG~a~~~~~~~~~-----------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~ 294 (394)
||++.++.+||+|||++......... ......+|+.|+|||++.... ...++.++|||||||++|
T Consensus 169 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~~~Dv~slG~il~ 244 (337)
T 3ll6_A 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS----NFPIGEKQDIWALGCILY 244 (337)
T ss_dssp CEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCT----TSCSSHHHHHHHHHHHHH
T ss_pred EEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc----cCCCChHHhHHHHHHHHH
Confidence 99999999999999998764332211 011345788999999984211 113788999999999999
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 295 EIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 295 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
||++ |..||.+....++.... ...+.+..++..+.+++++||+.+|. ||++.|+++.|..+...
T Consensus 245 el~~-g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 245 LLCF-RQHPFEDGAKLRIVNGK-----YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp HHHH-SSCCC-----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHh-CCCCCcchhHHHhhcCc-----ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9998 99999876554433221 24555677888999999999999998 99999999999888654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=357.33 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=192.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.++|.+.+.||+|+||.||+|.++. +...||+|++.... .......+.+|+.+|++++|||||+++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERK-------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECC-------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 5789999999999999999999873 45589999986542 111222356899999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---e
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL---R 233 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~---~ 233 (394)
+++. .+..++|||||++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++ .
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTSSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcce
Confidence 9985 4568999999999999998865532 67778889999999999999999999999999999997544 5
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QV 312 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~ 312 (394)
+||+|||+++...... ......||+.|+|||++.... ...++.++|||||||++|||++ |..||.+.... .+
T Consensus 281 ~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 281 IKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVG----TAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSL 353 (419)
T ss_dssp EEECCSSTTTSCC-------------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCSSSCCH
T ss_pred EEEeecccceecCCCc--cccccCCCCCccCceeeecCC----CCCCCchhhhHhHHHHHHHHHH-CCCCCCCCcchHHH
Confidence 9999999997653322 233457899999999986421 1127889999999999999998 99999875433 33
Q ss_pred HHHHhcCCCcCC-CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 313 ITRVFGTEALRL-PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 313 ~~~i~~~~~~~~-~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+..+..... .....+++.+.+++++||+.||+ ||++.|++.
T Consensus 354 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 444444431111 11246899999999999999998 999998864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.79 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=203.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
..+|++.+.||+|+||.||+|++. .....||+|++...........+.+|+.++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN-------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEEC-------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 478999999999999999999986 345589999987655555555677999999999999999999999764
Q ss_pred ----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 163 ----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 163 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
..+++||||+. |+|.+++.... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~~~------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEcccC-cCHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEe
Confidence 36899999997 59999997542 56777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||++.......... .....||+.|+|||++.... .++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i 244 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK------GYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHI 244 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC------SCSTHHHHHHHHHHHHHHHH-SSCSSCCSSGGGHHHHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCC------CCCcchhHHHHHHHHHHHHH-CCCCCCCCChHHHHHHH
Confidence 99997543322111 12347899999999876543 27899999999999999998 99999988766655554
Q ss_pred hcCCCc-------------------CCC---------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEAL-------------------RLP---------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~-------------------~~~---------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...... .++ ....++..+.+++++||..||+ ||++.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 321000 000 1146788999999999999998 999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=332.24 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=209.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--------cHHHHHHHHHHHHHhccCC-Ccceec
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--------SQAEKLFFLHEATPYRRLR-HVNILR 154 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~~E~~~l~~l~-HpnIv~ 154 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+.+++++. ||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKP-------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 88 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred hhccceeeeecCCCceEEEEEEEcC-------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 5789999999999999999999873 45589999986442 1223345678999999995 999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+++++..++..++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcE
Confidence 99999999999999999999999999975422 5777888999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++....... ......++..|+|||++.+.... ....++.++|||||||++|||++ |..||.+....+...
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 164 KLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLR 239 (298)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred EEecccchhhcCCCc--ccccccCCccccCHHHhcccccc-ccccCCcccccHhHHHHHHHHHH-CCCCCcCccHHHHHH
Confidence 999999987554332 12345678899999998632110 11127889999999999999998 999999988888777
Q ss_pred HHhcCCCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+.. ..+. ...++..+.+++++||..+|. ||++.|++.
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNY-QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCC-CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCc-ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 7766532 2322 247899999999999999998 999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=335.90 Aligned_cols=258 Identities=18% Similarity=0.271 Sum_probs=201.1
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
+.+..+++.....||+|+||.||+|++.. ....||+|.+....... ...+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~ 88 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLS-------NQVRIAIKEIPERDSRY-SQPLHEEIALHKHLKHKNIVQYLGSF 88 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETT-------TCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECC-------CCeEEEEEEccCCchHH-HHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence 34444455555689999999999999863 34589999887654332 23466999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeEEEcc
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRVKIGD 238 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~vKl~D 238 (394)
...+..++||||+++|+|.+++...... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 89 SENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp EETTEEEEEEECCSEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECC
T ss_pred EeCCcEEEEEEeCCCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEee
Confidence 9999999999999999999999764221 12456677788999999999999999999999999999987 89999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH-H
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV-ITR-V 316 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~-~~~-i 316 (394)
||++....... .......++..|+|||++.+... .++.++|||||||++|||++ |+.||.+...... ... .
T Consensus 167 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 239 (295)
T 2clq_A 167 FGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPR-----GYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQAAMFKVG 239 (295)
T ss_dssp TTTCEESCC------CCCCCCGGGCCHHHHHHGGG-----GCSHHHHHHHHHHHHHHHHH-TSCTTGGGSSHHHHHHHHH
T ss_pred cccccccCCCC-CcccccCCCccccChhhhcCCCC-----CCCcHHHHHHHHHHHHHHHH-CCCCccCCCchhHHHHhhc
Confidence 99987543322 12234568889999999865421 16889999999999999998 9999976543322 222 1
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... .....|..++..+.+++++||..+|+ ||++.|++.
T Consensus 240 ~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 240 MFK--VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHC--CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc--ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222 24556788999999999999999998 999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.26 Aligned_cols=255 Identities=18% Similarity=0.237 Sum_probs=199.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
...+|++.+.||+|+||.||+|+++. .+..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRK-------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETT-------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceeEEEEEecCCCcEEEEEEECC-------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 35789999999999999999999863 45589999875443 11112235689999999999999999999987
Q ss_pred --------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 162 --------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 162 --------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
.+.+++|||||.+ +|.+.+..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 162 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC
Confidence 3468999999975 88888765422 1677788899999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCc---eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 234 VKIGDTGSSIDKYPGD---YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
+||+|||+++...... ........+|+.|+|||++.+.. .++.++|||||||++|||++ |..||.+....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~ 235 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER------DYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQ 235 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC------SCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCC------CCCcHhHHHHHHHHHHHHHh-CCCCCCCCChH
Confidence 9999999986543211 11223456789999999986543 27899999999999999998 99999998877
Q ss_pred HHHHHHhcCCCcCC-CCCCC----------------------------CChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEALRL-PAPRA----------------------------VNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~~~-~~p~~----------------------------~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..+........ ..... .++.+.+++++||+.||+ ||++.|++.
T Consensus 236 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 76655543211000 00000 266799999999999998 999998864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.08 Aligned_cols=249 Identities=20% Similarity=0.230 Sum_probs=195.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
..+|++.+.||+|+||.||+|+++. .+..||||++..... ...+|+.+|++++|||||+++++|....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD-------SGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC-------CCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 4579999999999999999999873 355899998865432 1247999999999999999999986422
Q ss_pred ------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CeEEE
Q psy7505 164 ------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE-LRVKI 236 (394)
Q Consensus 164 ------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~-~~vKl 236 (394)
.+++||||+++ +|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEe
Confidence 36799999975 77777654211 11236777888999999999999999999999999999999965 67899
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++....... .....+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..+
T Consensus 199 ~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~l~~i 269 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGAT------DYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEI 269 (420)
T ss_dssp CCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCS------SCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred ccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCC------CCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 99999976533321 22346788999999986542 27899999999999999998 99999998876655544
Q ss_pred hcC----------------CCcCCC----------CCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 317 FGT----------------EALRLP----------APRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 317 ~~~----------------~~~~~~----------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+. ....++ .+..++.++.+|+++||+.||+ |+++.|++
T Consensus 270 ~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 321 001111 2346788999999999999998 99999886
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.89 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=187.2
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHH-HhccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT-PYRRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l 155 (394)
...|.+..++|++.+.||+|+||.||+|.++. .+..||+|.++..........+..|+. +++.++||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~ 86 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETT-------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcC-------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeee
Confidence 34667888999999999999999999999873 455899999876654433333445555 7888899999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~v 234 (394)
++++.+.+..++||||+.+ +|.+++..........+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEE
T ss_pred eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCE
Confidence 9999999999999999975 888887642111122367777889999999999999999 99999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-~~~~ 313 (394)
||+|||+++...... ......+|..|+|||++.... ....++.++|||||||++|||++ |..||.+... .+.+
T Consensus 166 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~ 239 (327)
T 3aln_A 166 KLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSA---SRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNSVFDQL 239 (327)
T ss_dssp EECCCSSSCC-----------------------------------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-------
T ss_pred EEccCCCceeccccc--ccccCCCCccccCceeecccc---CcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchHHHHH
Confidence 999999987553322 122336788999999984321 11127899999999999999998 9999987543 2333
Q ss_pred HHHhcCCCcCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEALRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+....++. ...++..+.+++++||..||. ||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 3333343222222 246899999999999999998 999998864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=352.20 Aligned_cols=250 Identities=16% Similarity=0.165 Sum_probs=181.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHH---HHhccCCCcceecee-
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEA---TPYRRLRHVNILRLM- 156 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~---~~l~~l~HpnIv~l~- 156 (394)
...+|++.+.||+|+||.||+|+++. .+..||+|+++... .......+.+|+ .+++. +||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVE-------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred CceeeeeeeeccCCCCEEEEEEEECC-------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 44569999999999999999999873 45589999987754 333444566774 55555 799988755
Q ss_pred ------eEEEeCC-----------------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHH------HHHHHHHHHH
Q psy7505 157 ------AACLESD-----------------PWLLVFESCSRGDLKEFLLSNEASREALLEQGIT------IKMAIDVATG 207 (394)
Q Consensus 157 ------~~~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~------~~~~~qi~~g 207 (394)
+++...+ .+|||||||+ |+|.+++...+.. +..... ..++.||+.|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi~~a 206 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQLIRL 206 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHHHHH
Confidence 5554432 3899999998 8999999764221 222223 5677999999
Q ss_pred HHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHH
Q psy7505 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVW 287 (394)
Q Consensus 208 l~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~Diw 287 (394)
|.|||++||+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+.. ..++.++|||
T Consensus 207 L~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~~Diw 277 (371)
T 3q60_A 207 AANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNAST-----ATFTHALNAW 277 (371)
T ss_dssp HHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSE-----EECCHHHHHH
T ss_pred HHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCC-----CCcCccccHH
Confidence 99999999999999999999999999999999999755321 11334558999999996521 1288999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHH--HH----HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 288 SFGVLLWEIFEFGKLPYAELSDDQV--IT----RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 288 SlG~il~el~t~g~~Pf~~~~~~~~--~~----~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
||||++|||++ |+.||.+...... .. .........++.+..+++.+.++|++||..||+ ||++.|++
T Consensus 278 SlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 278 QLGLSIYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHHHH-SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHHHHHHHHHh-CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999999998 9999987643211 00 001122234455568999999999999999998 99998885
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=351.06 Aligned_cols=249 Identities=19% Similarity=0.236 Sum_probs=199.2
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC------CCcceecee
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL------RHVNILRLM 156 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~ 156 (394)
...+|++.+.||+|+||.||+|+++. ....||||+++..... ...+.+|+.+++.+ +|+||++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK-------VHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT-------TTEEEEEEEECSCHHH--HHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC-------CCcEEEEEEECCccch--HHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 45779999999999999999999873 4558999998765322 22344666666655 688999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe--E
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--V 234 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~--v 234 (394)
+++...+.+++||||+. |+|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQ---GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcce
Confidence 99999999999999996 6999999765321 2577788899999999999999999999999999999999987 9
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+|...... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+.
T Consensus 242 kL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~l~ 309 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGAR-------YGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLA 309 (429)
T ss_dssp EECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBC-------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred EEeecccceecCCc----ccccCCCCCccChHHHhCCC-------CCchHHHHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 99999998654322 22457889999999997765 7899999999999999998 999999988777665
Q ss_pred HHhcCCCcC------------------------------------------------CC--------CCCCCChHHHHHH
Q psy7505 315 RVFGTEALR------------------------------------------------LP--------APRAVNSHVDVAA 338 (394)
Q Consensus 315 ~i~~~~~~~------------------------------------------------~~--------~p~~~~~~~~~l~ 338 (394)
.+....... .+ .+...++.+.+++
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 544211000 00 0113467899999
Q ss_pred HhhhcCCcc-ccchhhhhh
Q psy7505 339 RNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 339 ~~cl~~~p~-r~~~~e~~~ 356 (394)
++||+.||+ |||+.|++.
T Consensus 390 ~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCChhhCCCHHHHhC
Confidence 999999998 999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.85 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=203.4
Q ss_pred CCCeEEE-ceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccC-CCcceeceeeEEE
Q psy7505 84 RQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRL-RHVNILRLMAACL 160 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 160 (394)
.+.|.+. +.||+|+||.||+|+++. .+..||+|+++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKS-------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECC-------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 4556666 889999999999999873 455899998875431 11223456899999998 5699999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeEEEc
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIG 237 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~vKl~ 237 (394)
+.+.+++|||||.+|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999998864321 12677788899999999999999999999999999999988 7899999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+.
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDP-------ITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCC-------CCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Confidence 999987553322 123457889999999987654 7889999999999999998 999999988887776665
Q ss_pred cCC-CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTE-ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... ....+.+..++..+.+++++||+.+|+ ||++.|++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 443 223344467899999999999999998 999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.13 Aligned_cols=266 Identities=15% Similarity=0.153 Sum_probs=202.9
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC---Cccee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR---HVNIL 153 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv 153 (394)
..++++..++|.+.+.||+|+||.||+|.++.... ......||+|+++...... +.+|+.+++.++ |+||+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~----~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND--AKNKQKFVLKVQKPANPWE----FYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC---------CCCCEEEEEESSCCHHH----HHHHHHHHHHSCGGGGGGBC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcc--cccCcEEEEEEeCCCChhH----HHHHHHHHHHhhhhhhhhhh
Confidence 35667788999999999999999999996542111 1345689999987654322 346666666665 99999
Q ss_pred ceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---
Q psy7505 154 RLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS--- 230 (394)
Q Consensus 154 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~--- 230 (394)
++++++...+..|||||||++|+|.+++..........+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 99999999999999999999999999997643222334788889999999999999999999999999999999998
Q ss_pred --------CCeEEEccCCCCccCC-CCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 231 --------ELRVKIGDTGSSIDKY-PGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 231 --------~~~vKl~DFG~a~~~~-~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
++.+||+|||+|+... ...........||..|||||++.+.. ++.++|||||||++|||++ |+
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ellt-g~ 282 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-------WNYQIDYFGVAATVYCMLF-GT 282 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-------BSTHHHHHHHHHHHHHHHH-SS
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-------CCccccHHHHHHHHHHHHh-CC
Confidence 8999999999996432 11222344567899999999987665 7899999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-c-cchhhhhhhhhcCCC
Q psy7505 302 LPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-R-VKIGDTGSSIDKYPG 363 (394)
Q Consensus 302 ~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r-~~~~e~~~~l~~~~~ 363 (394)
.||........ . ... .+. ....++.+.+++..|+..+|. | +++.++.+.|.++..
T Consensus 283 ~pf~~~~~~~~--~-~~~---~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 283 YMKVKNEGGEC--K-PEG---LFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp CCCEEEETTEE--E-ECS---CCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred CccccCCCCce--e-ech---hcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 99865432110 0 001 111 113467899999999999997 6 567777777766553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.60 Aligned_cols=252 Identities=17% Similarity=0.245 Sum_probs=187.0
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.|++ .++|++.+.||+|+||.||+|.+. ..+..||||++.... .......+.+|+.+++.++||||+++++
T Consensus 24 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 95 (367)
T 2fst_X 24 IWEV-PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95 (367)
T ss_dssp EEEE-ETTEEEEEECC----CCEEEEEET-------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred ccCC-CCceEEeeEEeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3444 478999999999999999999976 345689999986543 3344445679999999999999999999
Q ss_pred EEEeC------CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 158 ACLES------DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 158 ~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
++... ..+|+||||+ +++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~ 168 (367)
T 2fst_X 96 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168 (367)
T ss_dssp EECSCSSGGGCCCCEEEEECC-CEECC-----CC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred EEecCCccccCCeEEEEeccc-CCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC
Confidence 99754 5689999999 679999886531 5677788999999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
+.+||+|||+++..... .....+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+
T Consensus 169 ~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~ 237 (367)
T 2fst_X 169 CELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWM------HYNQTVDIWSVGCIMAELLT-GRTLFPGTDHID 237 (367)
T ss_dssp CCEEECC-------------------CCCTTCCHHHHTTCC------SCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred CCEEEeecccccccccc----CCCcCcCcCccChHHHcCCc------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 99999999998754321 22346788999999987532 27899999999999999998 999999988776
Q ss_pred HHHHHhcCCC----------------------cCCCC------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFGTEA----------------------LRLPA------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~~~~----------------------~~~~~------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+..... ...+. ...+++.+.+|+++||..||. ||++.|++.
T Consensus 238 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 6655433100 00000 135678899999999999998 999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=347.23 Aligned_cols=256 Identities=17% Similarity=0.189 Sum_probs=196.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
...+|++.+.||+|+||.||+|+++. ...+|+|++...... ..+|+.+|+.++|||||++++++...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~--------~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVE--------SDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETT--------TEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECC--------CCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 35679999999999999999999863 224777776543321 23799999999999999999999765
Q ss_pred Cc------eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCeEE
Q psy7505 163 DP------WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT-SELRVK 235 (394)
Q Consensus 163 ~~------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~-~~~~vK 235 (394)
+. +++|||||++ +|.+.+...... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKL-KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence 43 8899999986 555444322111 12267777889999999999999999999999999999999 789999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||+|+....... .....+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+..
T Consensus 183 L~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~l~~ 253 (394)
T 4e7w_A 183 LIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGAT------NYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVE 253 (394)
T ss_dssp ECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCS------SCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred EeeCCCcccccCCCC--CcccccCcCccCHHHHcCCC------CCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 999999976533321 22446788999999986543 27899999999999999998 9999999887766555
Q ss_pred HhcCCC----------------cCCC----------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhcCC
Q psy7505 316 VFGTEA----------------LRLP----------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDKYP 362 (394)
Q Consensus 316 i~~~~~----------------~~~~----------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~~~ 362 (394)
+..... ..++ .+..+++++.+++++||+.||. ||++.|++. .++.+.
T Consensus 254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 433100 0111 2335888999999999999998 999999874 344444
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=338.27 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=203.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES- 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 162 (394)
.++|++.+.||+|+||.||+|+++ ..+..||||.+...........+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK-------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC-------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 578999999999999999999987 245589999987655554455567999999999999999999998754
Q ss_pred ----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 163 ----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 163 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
...++||||+. |+|.+++.... ++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~D 155 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVISTQM------LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD 155 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred cCccceEEEEEeccC-ccHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEe
Confidence 67899999997 59999987532 56777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCcee---------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 239 TGSSIDKYPGDYY---------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 239 FG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
||++......... ......||..|+|||++.... .++.++|||||||++|||++ |..||.+.+.
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~-g~~pf~~~~~ 228 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA------KYSRAMDVWSCGCILAELFL-RRPIFPGRDY 228 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSCC------CCCHHHHHHHHHHHHHHHHH-SSCSCCCSSH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccCC------CccchhhHHHHHHHHHHHHh-CCCCCCCCCc
Confidence 9998754322111 112346789999999876532 27899999999999999998 9999999886
Q ss_pred HHHHHHHhc--CCCc---------------------CCC------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--h
Q psy7505 310 DQVITRVFG--TEAL---------------------RLP------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--S 357 (394)
Q Consensus 310 ~~~~~~i~~--~~~~---------------------~~~------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~ 357 (394)
.+.+..+.. +... ..+ .+..+++.+.+++++||..||+ ||++.|+++ .
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 665444322 1000 000 1136789999999999999998 999999874 3
Q ss_pred hhcCC
Q psy7505 358 IDKYP 362 (394)
Q Consensus 358 l~~~~ 362 (394)
++...
T Consensus 309 ~~~~~ 313 (353)
T 2b9h_A 309 LQTYH 313 (353)
T ss_dssp GTTTC
T ss_pred ccccC
Confidence 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=330.48 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=206.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|+++. ....|++|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcC-------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 4689999999999999999999863 44589999886543 122233466999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE---LRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~---~~vKl~DF 239 (394)
+.+++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred CeEEEEEEccCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 999999999999999998865432 6777888999999999999999999999999999999764 47999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|++........ .....++..|+|||++.+. ++.++|||||||++|+|++ |..||.+....++...+..+
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--------~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 237 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRGT--------YDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETG 237 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTTC--------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred CcceeecCCCc--cccccCcccccChHHhcCC--------CCCchhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Confidence 99865433221 1233567889999987542 6889999999999999998 99999999888888877665
Q ss_pred CC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 320 EA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 320 ~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.. ...+....++..+.+++++||..+|+ ||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 32 12233357899999999999999998 999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=329.76 Aligned_cols=250 Identities=16% Similarity=0.271 Sum_probs=203.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
..+|++.+.||+|+||.||+|+++. .+..||+|.++.... .+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRI-------DGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETT-------TCCEEEEEEEECCSG-----GGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcC-------CCeEEEEEEeccccH-----HHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 3678999999999999999999862 345899998875542 24589999999999999999999864
Q ss_pred --------------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 162 --------------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 162 --------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
...+++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 3458999999999999999975422 12677788899999999999999999999999999999
Q ss_pred EcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 228 VTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
++.++.+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-~~~~~~~- 223 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-------YGKEVDLYALGLILAELLH-VCDTAFE- 223 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSC-------CCTHHHHHHHHHHHHHHHS-CCSSHHH-
T ss_pred EcCCCCEEECcchhheeccccc--cccccCCcccccChhhhccCC-------CcchhhhHHHHHHHHHHHh-cCCcchh-
Confidence 9999999999999987554332 122346788999999987654 7889999999999999998 8887643
Q ss_pred CHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 308 SDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 308 ~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
.......+..+ ..+..++..+.+++++||..||. ||++.|++..|..+....
T Consensus 224 -~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 224 -TSKFFTDLRDG-----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -HHHHHHHHHTT-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -HHHHHHHhhcc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 22333444333 23567889999999999999998 999999999998887653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=333.77 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=195.4
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l 155 (394)
...+.+..++|++.+.||+|+||.||+|+++. .+..||+|++..... ......+.++..+++.++||||+++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 89 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETT-------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEec-------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeE
Confidence 45667778999999999999999999999873 345899999876543 3333444455667888999999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCeE
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~~~~~v 234 (394)
++++.+.+.+++||||+ ++.+..+..... ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 90 FGTFITNTDVFIAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp EEEEECSSEEEEEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCE
T ss_pred EEEEecCCcEEEEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCE
Confidence 99999999999999999 555655554321 1267778889999999999999995 99999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-SDDQVI 313 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-~~~~~~ 313 (394)
||+|||++....... ......++..|+|||++..... ....++.++|||||||++|||++ |+.||... ...+.+
T Consensus 165 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~ 239 (318)
T 2dyl_A 165 KLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDP--TKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVL 239 (318)
T ss_dssp EECCCTTC----------------CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHH
T ss_pred EEEECCCchhccCCc--cccccCCCccccChhhcccccc--cccCCccccchhhHHHHHHHHHh-CCCCCCCCCccHHHH
Confidence 999999986543322 1223467889999999854211 11237889999999999999998 99999874 456667
Q ss_pred HHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+....++....++..+.+++.+||..||. ||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 240 TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 7777666555555567899999999999999998 999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.94 Aligned_cols=246 Identities=21% Similarity=0.250 Sum_probs=195.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEe
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLE 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 161 (394)
..++|++.+.||+|+||.||+|++.. .+..||+|+++.... ..+.+|+.++++++ ||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT-------NNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECSCCH----HHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCceEEEEEecccCCeEEEEEEECC-------CCcEEEEEEecccch----HHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 35889999999999999999999863 455899999875442 23568999999996 9999999999987
Q ss_pred --CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEcc
Q psy7505 162 --SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGD 238 (394)
Q Consensus 162 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~D 238 (394)
....++||||+.+++|.+++.. ++...+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~D 174 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 174 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEe
Confidence 6678999999999999998743 45666788999999999999999999999999999999776 899999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHh
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-SDDQVITRVF 317 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-~~~~~~~~i~ 317 (394)
||+++....... .....++..|+|||++.+.. .++.++|||||||++|||++ |..||... ...+.+..+.
T Consensus 175 fg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 175 WGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQ------MYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp CTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCC------CCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHHHHH
T ss_pred CCCceEcCCCCc--cccccccccccChhhhcCCC------cCCchhhHHHHHHHHHHHHh-CCCCcccCCchHHHHHHHH
Confidence 999975443322 23446788999999986533 27899999999999999998 99998443 3333222211
Q ss_pred c-------------CCC---------------------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 G-------------TEA---------------------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~-------------~~~---------------------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ... .....+..+++.+.+++++||..||+ ||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 000 00111234789999999999999998 999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=332.61 Aligned_cols=263 Identities=17% Similarity=0.274 Sum_probs=203.2
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCC--Cccee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLR--HVNIL 153 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~--HpnIv 153 (394)
.....+..++|++.+.||+|+||.||+|+++. +..||+|++.... .......+.+|+.++++++ |+||+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK--------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTT--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCC--------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence 34456778899999999999999999998752 4479999886543 3444455679999999996 59999
Q ss_pred ceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 154 RLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 154 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
++++++...+.+++||| +.+|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++ ++.
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~ 164 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM 164 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCe
Confidence 99999999999999999 567899999986532 56677888999999999999999999999999999996 489
Q ss_pred EEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCC----cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy7505 234 VKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTS----IQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~----~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~ 308 (394)
+||+|||++......... ......++..|+|||++.+.... .....++.++|||||||++|||++ |..||.+..
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~ 243 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII 243 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhhHH
Confidence 999999998765332211 12244688999999998652110 011237889999999999999998 999998764
Q ss_pred H-HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 309 D-DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 309 ~-~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ...+..+... ......|..++..+.+++++||..+|+ ||++.|++.
T Consensus 244 ~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 244 NQISKLHAIIDP-NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp SHHHHHHHHHCT-TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhc-ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 3 3334444433 235667778899999999999999998 999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=341.79 Aligned_cols=252 Identities=17% Similarity=0.246 Sum_probs=201.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
..|++ .++|.+.+.||+|+||.||+|+++ ..+..||+|++.... .......+.+|+.+++.++||||++++
T Consensus 36 ~~~~l-~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 107 (371)
T 4exu_A 36 TAWEL-PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107 (371)
T ss_dssp EEEEE-ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ceecc-cccEEEEeEEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhh
Confidence 34455 478999999999999999999987 345589999987643 334445567999999999999999999
Q ss_pred eEEEeCCce------EEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 157 AACLESDPW------LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 157 ~~~~~~~~~------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
+++...+.. ++||||+. |+|.+++... +++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 108 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGME-------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp EEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hheeccCCcccceeEEEEEcccc-ccHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC
Confidence 999876654 99999997 6998887432 567778899999999999999999999999999999999
Q ss_pred CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 231 ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
++.+||+|||+++..... .....+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..
T Consensus 180 ~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~ 248 (371)
T 4exu_A 180 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWM------HYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYL 248 (371)
T ss_dssp TCCEEECSTTCC------------CTTCCCTTSCHHHHSCCS------CCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHH
T ss_pred CCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCC------CCCcHHhHHHHHHHHHHHHh-CCCCCCCCChH
Confidence 999999999998754321 23456789999999987632 27899999999999999998 99999998877
Q ss_pred HHHHHHhcCCCc----------------------CC------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 311 QVITRVFGTEAL----------------------RL------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 311 ~~~~~i~~~~~~----------------------~~------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+..+...... .. ..+..+++.+.+++++||+.||+ ||++.|++.
T Consensus 249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 249 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 766555331100 00 01235789999999999999998 999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=338.98 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=200.3
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
...+.||+|+||.||+|++. ...||+|.+.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVN---------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104 (307)
T ss_dssp TTCCEEEECSSEEEEEEESS---------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccCCccccCCCeEEEEEEEC---------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc
Confidence 34578999999999999864 3378999876432 22334456799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
.++||||+++|+|.+++...... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence 99999999999999999754221 2267778889999999999999999999999999999999999999999999865
Q ss_pred CCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhcC
Q psy7505 245 KYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ----VITRVFGT 319 (394)
Q Consensus 245 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~----~~~~i~~~ 319 (394)
..... ........||..|+|||++.+. ++.++|||||||++|||++ |..||.+....+ +...+...
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 253 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRGE--------ITPKSDIYSFGVVLLEIIT-GLPAVDEHREPQLLLDIKEEIEDE 253 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTTE--------ECTHHHHHHHHHHHHHHHH-CCCSBCTTBSSSBTTHHHHHHHTT
T ss_pred cccccccccccccCCCcCcCChHHhcCC--------CCccchhHHHHHHHHHHHH-CCCCcccCcchHHHHHHHHHhhhh
Confidence 43322 2223345788999999987542 6789999999999999998 999998754322 22222221
Q ss_pred CC--------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 320 EA--------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 320 ~~--------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.. .....+..++..+.+++.+||..+|. ||++.++++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 254 EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 10 01122344567899999999999998 999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=330.61 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=193.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE---
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL--- 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--- 160 (394)
.++|++.+.||+|+||.||+|.++. .+..||+|.+...... ....+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND-------CDKRVAIKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT-------TTEEEEEEEEECCSHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECC-------CCeEEEEEEEecCChH-HHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 6789999999999999999999873 4558999988655433 3344569999999999999999999874
Q ss_pred -----------eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 161 -----------ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 161 -----------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
+.+..++||||+. |+|.+++.... ++...+..++.|++.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP------LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCC------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhcCC------ccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 3467899999997 69999996532 56667788999999999999999999999999999997
Q ss_pred -CCCeEEEccCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy7505 230 -SELRVKIGDTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAE 306 (394)
Q Consensus 230 -~~~~vKl~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~ 306 (394)
.++.+||+|||+++....... .......++..|+|||++.... .++.++|||||||++|||++ |+.||.+
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~il~el~~-g~~pf~~ 227 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN------NYTKAIDMWAAGCIFAEMLT-GKTLFAG 227 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT------CCCHHHHHHHHHHHHHHHHH-SSCSSCC
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcc------cCCchhhhHhHHHHHHHHHh-CCCCCCC
Confidence 567999999999875432211 1112335688899999886532 27899999999999999998 9999999
Q ss_pred CCHHHHHHHHhcCCCc------------------------CC---CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 307 LSDDQVITRVFGTEAL------------------------RL---PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 307 ~~~~~~~~~i~~~~~~------------------------~~---~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
....+.+..+...... .. ..+..++..+.+++++||+.||+ ||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 8877766665433210 00 01246899999999999999998 999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=340.11 Aligned_cols=252 Identities=15% Similarity=0.199 Sum_probs=205.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH----------------HHHHHHHHHHHhc
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA----------------EKLFFLHEATPYR 145 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~----------------~~~~~~~E~~~l~ 145 (394)
+..++|++.+.||+|+||.||+|++. +..||+|.+....... ....+.+|+.+++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKD---------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEET---------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcC---------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 33579999999999999999999872 3489999886543110 0134679999999
Q ss_pred cCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHH------HhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCcee
Q psy7505 146 RLRHVNILRLMAACLESDPWLLVFESCSRGDLKEF------LLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIH 218 (394)
Q Consensus 146 ~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiH 218 (394)
+++||||+++++++.+.+.+++||||+++|+|.++ +.... ...+++..+..++.|++.||.|||+ +||+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence 99999999999999999999999999999999998 54321 1226778888999999999999999 99999
Q ss_pred cCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCc-chhHHHHHHHHHHHH
Q psy7505 219 TDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTE-KCNVWSFGVLLWEIF 297 (394)
Q Consensus 219 rDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~-~~DiwSlG~il~el~ 297 (394)
|||||+|||++.++.+||+|||++...... ......++..|+|||++.+.. .++. ++|||||||++|||+
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNES------SYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCC------CEEHHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCC------CCCcchhhHHHHHHHHHHHH
Confidence 999999999999999999999998754332 234557889999999987652 1445 999999999999999
Q ss_pred cCCCCCCCCCCH-HHHHHHHhcCCCcCCCCC-----------------CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 298 EFGKLPYAELSD-DQVITRVFGTEALRLPAP-----------------RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 298 t~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~p-----------------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+ |..||..... .++...+..+. ..++.. ..++..+.+++++||..+|. ||++.|++.
T Consensus 247 ~-g~~pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 247 Y-NVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H-SSCSSCCSSCSHHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred h-CCCCCCCCCcHHHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 8 9999998776 67777776553 222211 67899999999999999998 999999865
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=325.22 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=191.4
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe---
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE--- 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 161 (394)
++|++.+.||+|+||.||+|++.. .+..||+|.+.... .....+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNAL-------DSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcC-------CCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 578999999999999999999863 34589999886533 333456799999999999999999999865
Q ss_pred ----------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 162 ----------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 162 ----------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
.+..++||||+++|+|.+++..... .++...++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL----NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES 152 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCG----GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhcccc----ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC
Confidence 3568999999999999999976432 25666778899999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCc-------------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 232 LRVKIGDTGSSIDKYPGD-------------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~-------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
+.+||+|||++....... ........++..|+|||++.+.. .++.++|||||||++|||++
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG------HYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS------CCCTHHHHHHHHHHHHHHHS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC------CCcchhhHHHHHHHHHHHHh
Confidence 999999999987543211 11122346788999999986542 27899999999999999996
Q ss_pred CCCCCCCC-CCHHHHHHHHhcCCC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 299 FGKLPYAE-LSDDQVITRVFGTEA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 299 ~g~~Pf~~-~~~~~~~~~i~~~~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
||.. ....++...+..... .....+..++..+.+++++||..||. ||++.|+++
T Consensus 227 ----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 227 ----PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 4543 233444555544321 11223456777899999999999998 999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=337.09 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=202.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc--CCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR--LRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|++. +..||+|.+..... ..+.+|+++++. ++||||+++++++..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECGGGH----HHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc---------CccEEEEEeCchhH----HHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 367999999999999999999874 34799999865432 224477777776 799999999999987
Q ss_pred CC----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEc
Q psy7505 162 SD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI--------EDGFIHTDVAARNCLVT 229 (394)
Q Consensus 162 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH--------~~~iiHrDlk~~NiLl~ 229 (394)
.+ .+++||||+++|+|.+++.... +++..++.++.|++.||.||| +++|+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhccC------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 65 7999999999999999997542 567778899999999999999 89999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCC------
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG------ 300 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g------ 300 (394)
.++.+||+|||++......... ......+|..|+|||++.+.... ....++.++|||||||++|||++ |
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~el~t-g~~~~~~ 259 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIAR-RCSIGGI 259 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT-TCHHHHHHHHHHHHHHHHHHHHT-TBCBTTB
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc-cccccCCcccHHHHHHHHHHHHh-ccCcCCc
Confidence 9999999999998654333221 12345788999999998765311 00013468999999999999998 8
Q ss_pred ----CCCCCCCC-----HHHHHHHHhcCCCcCCCCCC-----CCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 301 ----KLPYAELS-----DDQVITRVFGTEALRLPAPR-----AVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 301 ----~~Pf~~~~-----~~~~~~~i~~~~~~~~~~p~-----~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
..||.+.. ..++...+... ..+...|. .++..+.+++++||..+|+ ||++.|+++.|+++...
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ-KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS-CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccccCccccCcCcccHHHHHHHHHHH-HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 78887642 33444444332 22333343 3446789999999999998 99999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=337.21 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=196.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-------HHHHHHHHHHHHHhccCCCcceecee
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-------QAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.++|.+.+.||+|+||.||+|+++. ....||||++..... ......+.+|+.++++++||||++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 81 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERK-------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 81 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcC-------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence 4679999999999999999999873 455899998865321 11223356899999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe---
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR--- 233 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~--- 233 (394)
+++..+ ..++||||+++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 82 NFFDAE-DYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp EEEESS-SEEEEEECCTTEETHHHHSTTCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCC
T ss_pred eEEcCC-ceEEEEecCCCCcHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCe
Confidence 998765 48999999999999999976532 567778889999999999999999999999999999987654
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD-QV 312 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~-~~ 312 (394)
+||+|||++........ .....+|..|+|||++.... ...++.++|||||||++|||++ |..||.+.... .+
T Consensus 156 ~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 228 (322)
T 2ycf_A 156 IKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVG----TAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSL 228 (322)
T ss_dssp EEECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTT----TTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTCSSCH
T ss_pred EEEccCccceecccccc--cccccCCcCccCchhhccCC----CCCCCchhhHHHHHHHHHHHHh-CCCCCcccchHHHH
Confidence 99999999875533221 12346788999999975321 1127889999999999999998 99999765432 33
Q ss_pred HHHHhcCCCcCC-CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 313 ITRVFGTEALRL-PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 313 ~~~i~~~~~~~~-~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
...+..+..... ..+..++..+.+++++||..||+ ||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 344444421111 11256899999999999999998 999998864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.73 Aligned_cols=251 Identities=17% Similarity=0.242 Sum_probs=199.3
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.|++ .++|.+.+.||+|+||.||+|+++ ..+..||||.+.... .......+.+|+.+++.++||||+++++
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 90 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhh
Confidence 3344 467999999999999999999987 345589999986543 3344455679999999999999999999
Q ss_pred EEEeCCc------eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 158 ACLESDP------WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 158 ~~~~~~~------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
++...+. +++||||+. |+|.+++... +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~ 162 (353)
T 3coi_A 91 VFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLK-------FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED 162 (353)
T ss_dssp EECSCSSGGGCCCCEEEEECCS-EEGGGTTTSC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT
T ss_pred eEecccccccceeEEEEecccc-CCHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC
Confidence 9987654 499999997 5888877432 5677788999999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
+.+||+|||++...... .....+|..|+|||++.+.. .++.++|||||||++|||++ |..||.+.+..+
T Consensus 163 ~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~------~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~ 231 (353)
T 3coi_A 163 CELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWM------HYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLD 231 (353)
T ss_dssp CCEEECSTTCTTC------------CCSBCCSCHHHHSCCS------CCCTTHHHHHHHHHHHHHHH-SSCSSBSSCHHH
T ss_pred CcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcC------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 99999999998754322 22346788999999986532 27889999999999999998 999999988766
Q ss_pred HHHHHhcCCC---------------------------cC-CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFGTEA---------------------------LR-LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~~~~---------------------------~~-~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+..... .. ...+..+++.+.+++++||..||+ ||++.|++.
T Consensus 232 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 6555432100 00 112346789999999999999998 999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.33 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=199.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-HHHHHHHHHHHHhccC---CCcceeceeeE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-AEKLFFLHEATPYRRL---RHVNILRLMAA 158 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-~~~~~~~~E~~~l~~l---~HpnIv~l~~~ 158 (394)
..++|++.+.||+|+||.||+|++.. ..+..||+|+++..... .....+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecC------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 35789999999999999999999842 12447899988643311 1111234666666655 89999999999
Q ss_pred EE-----eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe
Q psy7505 159 CL-----ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR 233 (394)
Q Consensus 159 ~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~ 233 (394)
+. ....+++||||+. |+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 87 4567899999997 6999999765321 2567788899999999999999999999999999999999999
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+
T Consensus 159 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 228 (326)
T 1blx_A 159 IKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSS-------YATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL 228 (326)
T ss_dssp EEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred EEEecCcccccccCCC--CccccccccceeCHHHHhcCC-------CCcchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Confidence 9999999986543221 223456788999999987654 7889999999999999998 99999998887776
Q ss_pred HHHhcCCCc----C--------------------CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 314 TRVFGTEAL----R--------------------LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 314 ~~i~~~~~~----~--------------------~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..+...... . ...+..++..+.+++++||..||+ ||++.|++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 666431100 0 012346888999999999999998 99999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.36 Aligned_cols=256 Identities=19% Similarity=0.285 Sum_probs=181.9
Q ss_pred CCeEE-EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 85 QQLHY-VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 85 ~~~~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
+.|.+ .++||+|+||.||+|+++.. .....||+|++....... .+.+|+.+|++++|||||++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-----KDDKDYALKQIEGTGISM---SACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-----SCCCCEEEEECSSSSCCH---HHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-----CCCeEEEEEEECCCCCCH---HHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 44555 35799999999999997632 234589999987654222 24589999999999999999999965
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchh----hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCe
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEAS----REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV----TSELR 233 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl----~~~~~ 233 (394)
...++|||||+. |+|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 668999999996 5899888654221 11126778889999999999999999999999999999999 67789
Q ss_pred EEEccCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--
Q psy7505 234 VKIGDTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-- 309 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-- 309 (394)
+||+|||+|+....... .......||+.|+|||++.+.. .++.++|||||||++|||++ |..||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~ 243 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR------HYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI 243 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCC------SCCHHHHHHHHHHHHHHHHH-SSCTTCCCC---
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC------cccchhhhHHHHHHHHHHHh-CCCCCCCccccc
Confidence 99999999976532211 1223457899999999987643 27899999999999999998 9999976543
Q ss_pred -------HHHHHHHhcCCCcCCC-----------------------------------CCCCCChHHHHHHHhhhcCCcc
Q psy7505 310 -------DQVITRVFGTEALRLP-----------------------------------APRAVNSHVDVAARNCLVTSEL 347 (394)
Q Consensus 310 -------~~~~~~i~~~~~~~~~-----------------------------------~p~~~~~~~~~l~~~cl~~~p~ 347 (394)
.+.+..+......... .....++.+.+|+++||..||.
T Consensus 244 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~ 323 (405)
T 3rgf_A 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323 (405)
T ss_dssp ---CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence 1333333221100000 0012267889999999999998
Q ss_pred -ccchhhhhh
Q psy7505 348 -RVKIGDTGS 356 (394)
Q Consensus 348 -r~~~~e~~~ 356 (394)
|||+.|++.
T Consensus 324 ~R~ta~e~L~ 333 (405)
T 3rgf_A 324 KRITSEQAMQ 333 (405)
T ss_dssp GSCCHHHHHT
T ss_pred cCCCHHHHhc
Confidence 999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=351.08 Aligned_cols=257 Identities=16% Similarity=0.184 Sum_probs=202.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC-cceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH-VNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||.||+|++.. ....||||++....... .+.+|+.+++.|+| ++|..+..++...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT-------TCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC-------CCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 5789999999999999999999863 35589999876544221 24589999999976 5566666666778
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCeEEEccC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV---TSELRVKIGDT 239 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl---~~~~~vKl~DF 239 (394)
+..+|||||+ +|+|.+++..... .+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+||
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CEEEEEEECC-CCCHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeC
Confidence 8899999999 8999999975322 26788889999999999999999999999999999999 57899999999
Q ss_pred CCCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H
Q psy7505 240 GSSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD---D 310 (394)
Q Consensus 240 G~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~---~ 310 (394)
|+++....... .......||..|+|||++.+.. ++.++|||||||+||||++ |+.||.+... .
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~ 222 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-------QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCC-------CChHHHHHHHHHHHHHHHh-CCCCCccccchhHH
Confidence 99975433221 1122457899999999987665 7899999999999999998 9999987543 3
Q ss_pred HHHHHHhcCCC--cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 311 QVITRVFGTEA--LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 311 ~~~~~i~~~~~--~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+.+..+..... .....+..++.++.+++..||..+|+ ||++.++.+.|+.+..
T Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 223 QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 33333322210 01122357889999999999999998 9999999988887753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.67 Aligned_cols=258 Identities=16% Similarity=0.166 Sum_probs=196.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc----------cHHHHHHHHHHHHHhccCCCcce
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA----------SQAEKLFFLHEATPYRRLRHVNI 152 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~----------~~~~~~~~~~E~~~l~~l~HpnI 152 (394)
..++|.+.+.||+|+||.||+|.+.. +..||||.+.... .......+.+|+.++++++||||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE--------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT--------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hccceEEeEEeccCCCEEEEEEECCC--------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 36889999999999999999998652 4579999885432 12223456799999999999999
Q ss_pred eceeeEEEeC-----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7505 153 LRLMAACLES-----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCL 227 (394)
Q Consensus 153 v~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiL 227 (394)
+++++++... ..+|+||||+. |+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI----VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 9999999643 35899999997 699998875432 2677788899999999999999999999999999999
Q ss_pred EcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy7505 228 VTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL 307 (394)
Q Consensus 228 l~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~ 307 (394)
++.++.+||+|||++....... ......+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~~l~~-g~~pf~~~ 237 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFK------GFTKLVDMWSAGCVMAEMFN-RKALFRGS 237 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCT------TCCTHHHHHHHHHHHHHHHH-SSCSCCCS
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCC------CCCcHhHHHhHHHHHHHHHh-CCCCCCCC
Confidence 9999999999999986433222 223346788999999986532 27899999999999999998 99999998
Q ss_pred CHHHHHHHHhcCCC-----------------------cCC------CCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh-
Q psy7505 308 SDDQVITRVFGTEA-----------------------LRL------PAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS- 356 (394)
Q Consensus 308 ~~~~~~~~i~~~~~-----------------------~~~------~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~- 356 (394)
...+.+..+..... ... ..+..+++.+.+++++||+.||. ||++.|++.
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 87766655532100 000 11245688899999999999998 999999873
Q ss_pred -hhhcCC
Q psy7505 357 -SIDKYP 362 (394)
Q Consensus 357 -~l~~~~ 362 (394)
.++.+.
T Consensus 318 p~f~~~~ 324 (362)
T 3pg1_A 318 PYFESLF 324 (362)
T ss_dssp GGGTTTC
T ss_pred chhhhcc
Confidence 344443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=330.72 Aligned_cols=251 Identities=19% Similarity=0.235 Sum_probs=198.5
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc------eece
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN------ILRL 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l 155 (394)
.-.++|++.+.||+|+||.||+|.+.. ..+..||+|+++.... ....+.+|+.+++.++|+| |+++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHK------AGGRHVAVKIVKNVDR--YCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecC------CCCcEEEEEEEecCCc--hhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 346799999999999999999998742 2345899999875432 2334568888888886665 9999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS----- 230 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~----- 230 (394)
++++.+.+.+++||||+ +|+|.+++...+.. .++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFL---PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCC---CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 99999999999999999 88999999765321 2567778899999999999999999999999999999987
Q ss_pred --------------CCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHH
Q psy7505 231 --------------ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEI 296 (394)
Q Consensus 231 --------------~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el 296 (394)
++.+||+|||++...... .....+|..|+|||++.+.. ++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el 227 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-------WSQPCDVWSIGCILIEY 227 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-------CCTHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-------CCcchhhHHHHHHHHHH
Confidence 667999999998754322 23457889999999987654 78999999999999999
Q ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCc-----------------------------------------CCCCCCCCChHHH
Q psy7505 297 FEFGKLPYAELSDDQVITRVFGTEAL-----------------------------------------RLPAPRAVNSHVD 335 (394)
Q Consensus 297 ~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------~~~~p~~~~~~~~ 335 (394)
++ |..||...+..+....+...... ....+...++.+.
T Consensus 228 ~~-g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 228 YL-GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HH-SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 98 99999988876654433221000 0111223356789
Q ss_pred HHHHhhhcCCcc-ccchhhhhh
Q psy7505 336 VAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 336 ~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+++++||..||. ||++.|++.
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCcCcccccCHHHHhc
Confidence 999999999998 999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=332.93 Aligned_cols=254 Identities=18% Similarity=0.288 Sum_probs=193.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-----HHHHHHHHHHHHhccC----CCcceec
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-----AEKLFFLHEATPYRRL----RHVNILR 154 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l----~HpnIv~ 154 (394)
.++|++.+.||+|+||.||+|+++. .+..||+|++...... .....+.+|+.+++++ +||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLT-------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTT-------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhceEEeeEEEcCCCEEEEEEEEcc-------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 5789999999999999999998763 3458999998654321 1222244788888888 8999999
Q ss_pred eeeEEEeCCceEEEEee-CCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCC
Q psy7505 155 LMAACLESDPWLLVFES-CSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT-SEL 232 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~-~~~ 232 (394)
+++++...+..++|||| +.+|+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC
Confidence 99999999999999999 789999999976432 67778889999999999999999999999999999999 789
Q ss_pred eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
.+||+|||++....... .....++..|+|||++.+... ++.++|||||||++|||++ |+.||... .+
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~------~~~~~Di~slG~il~~l~~-g~~pf~~~--~~- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQY------HALPATVWSLGILLYDMVC-GDIPFERD--QE- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCB------CHHHHHHHHHHHHHHHHHH-SSCSCCSH--HH-
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCC------CCccchHHHHHHHHHHHHH-CCCCCCCh--HH-
Confidence 99999999987654332 224467889999999876542 3568999999999999998 99999753 22
Q ss_pred HHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhcCCCcceee
Q psy7505 313 ITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDKYPGDYYVH 368 (394)
Q Consensus 313 ~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~~~~~~~~~ 368 (394)
+... ....+..++..+.+++++||..+|+ ||++.|++. .++...++.+..
T Consensus 245 ---~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~ 297 (312)
T 2iwi_A 245 ---ILEA---ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297 (312)
T ss_dssp ---HHHT---CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--------
T ss_pred ---Hhhh---ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccccc
Confidence 2222 4556788999999999999999998 999999975 344444444333
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=339.69 Aligned_cols=249 Identities=18% Similarity=0.225 Sum_probs=192.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC--------Ccceec
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR--------HVNILR 154 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~ 154 (394)
-.++|++.+.||+|+||.||+|++.. ....||+|+++... .....+.+|+.+++.++ |+||++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ-------GKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecC-------CCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 35889999999999999999998863 45589999987543 22334568999998885 888999
Q ss_pred eeeEEE----eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEc
Q psy7505 155 LMAACL----ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAARNCLVT 229 (394)
Q Consensus 155 l~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~NiLl~ 229 (394)
+++++. ....++|||||+ +|+|.+++..... ..+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence 999998 456799999999 6677777755421 1267778889999999999999998 999999999999998
Q ss_pred CCC-------------------------------------------------eEEEccCCCCccCCCCceeeeCCccCCc
Q psy7505 230 SEL-------------------------------------------------RVKIGDTGSSIDKYPGDYYVHGEVALPV 260 (394)
Q Consensus 230 ~~~-------------------------------------------------~vKl~DFG~a~~~~~~~~~~~~~~~~t~ 260 (394)
.++ .+||+|||++...... .....+|.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~ 257 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTR 257 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCG
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCC
Confidence 775 7999999998654322 23346889
Q ss_pred ccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHH---hcCCC----------
Q psy7505 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS------DDQVITRV---FGTEA---------- 321 (394)
Q Consensus 261 ~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~------~~~~~~~i---~~~~~---------- 321 (394)
.|+|||++.+.. ++.++|||||||++|||++ |+.||...+ ..+.+..+ .....
T Consensus 258 ~y~aPE~~~~~~-------~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 329 (397)
T 1wak_A 258 QYRSLEVLIGSG-------YNTPADIWSTACMAFELAT-GDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329 (397)
T ss_dssp GGCCHHHHHTSC-------CCTHHHHHHHHHHHHHHHH-SSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG
T ss_pred cccCChhhcCCC-------CCcHHHHHHHHHHHHHHhh-CCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc
Confidence 999999997765 7889999999999999998 999997654 22222222 11100
Q ss_pred --------------------------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 --------------------------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 --------------------------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.....+...+..+.+|+++||+.||+ ||++.|+++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00112233456788999999999998 999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=335.29 Aligned_cols=253 Identities=16% Similarity=0.164 Sum_probs=185.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||.||+|+++. .+..||||.+........ ...+|+..++.++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~--~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKS-------TGMSVAIKKVIQDPRFRN--RELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HTTEEEC----------CEEEEETT-------TCCEEEEEEEECCTTCCC--HHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEecCccccH--HHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 4789999999999999999999873 345899998755432111 2346777788889999999999997644
Q ss_pred c-------eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEcC-CCe
Q psy7505 164 P-------WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI--EDGFIHTDVAARNCLVTS-ELR 233 (394)
Q Consensus 164 ~-------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH--~~~iiHrDlk~~NiLl~~-~~~ 233 (394)
. +++||||+++ +|.+.+..... ....++...+..++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 4 8999999976 66655543211 1122566777889999999999999 999999999999999997 899
Q ss_pred EEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy7505 234 VKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313 (394)
Q Consensus 234 vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~ 313 (394)
+||+|||++....... ......+|..|+|||++.+.. .++.++|||||||++|||++ |+.||.+.+..+.+
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~ 241 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQ------HYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQL 241 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCS------SCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCC------CCCcHHHHHHHHHHHHHHHh-CCCCcCCCChHHHH
Confidence 9999999997654332 123446789999999986543 27899999999999999998 99999998877766
Q ss_pred HHHhcCCCc-----------------------------CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 TRVFGTEAL-----------------------------RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 ~~i~~~~~~-----------------------------~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+...... ....+...++.+.+++++||+.||. ||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 655431100 0111223567899999999999998 999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=330.98 Aligned_cols=247 Identities=19% Similarity=0.272 Sum_probs=171.3
Q ss_pred CCCeEEEc-eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
.++|.+.+ .||+|+||.||+|+++. .+..||+|++....... .+....++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~-----~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR-------TGQKCALKLLYDSPKAR-----QEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEESSHHHH-----HHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC-------CCCEEEEEEecCcHHHH-----HHHHHHHHhcCCCChHHHHHHHhhc
Confidence 56788865 69999999999999873 45589999986543211 122234566799999999999976
Q ss_pred ---CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeEE
Q psy7505 162 ---SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRVK 235 (394)
Q Consensus 162 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~vK 235 (394)
+..+++|||||++|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 4458999999999999999986532 12677888999999999999999999999999999999976 45699
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI-- 313 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~-- 313 (394)
|+|||++....... .....+|+.|+|||++.... ++.++|||||||++|+|++ |..||.+.....+.
T Consensus 172 l~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~ 240 (336)
T 3fhr_A 172 LTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEK-------YDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAISPG 240 (336)
T ss_dssp ECCCTTCEEC-------------------------CH-------HHHHHHHHHHHHHHHHHHH-SSCCC-----------
T ss_pred Eeccccceeccccc---cccCCCCcCccChhhhCCCC-------CCchhhHHHHHHHHHHHHH-CCCCCCCccchhhhhh
Confidence 99999986543221 22346788999999986554 7789999999999999998 99999876554431
Q ss_pred --HHHhcCC-CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 314 --TRVFGTE-ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 314 --~~i~~~~-~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+..+. ....+....++..+.+++++||..+|. ||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222111 112223357899999999999999998 999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=332.33 Aligned_cols=245 Identities=19% Similarity=0.272 Sum_probs=199.0
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-----HHHHHHHHHHHHhccCC--Cccee
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-----AEKLFFLHEATPYRRLR--HVNIL 153 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~--HpnIv 153 (394)
+.-.++|++.+.||+|+||.||+|+++. .+..||+|.++..... .....+.+|+.++++++ |+||+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS-------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT-------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC-------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 3447889999999999999999999863 4558999988654311 01122447888898885 59999
Q ss_pred ceeeEEEeCCceEEEEeeCCC-CCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CC
Q psy7505 154 RLMAACLESDPWLLVFESCSR-GDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT-SE 231 (394)
Q Consensus 154 ~l~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~-~~ 231 (394)
++++++...+..++||||+.+ ++|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 999999999999999999976 899999976432 56777889999999999999999999999999999999 78
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
+.+||+|||++....... .....+|..|+|||++..... ++.++|||||||++|||++ |+.||.... +
T Consensus 187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~------~~~~~Di~slG~il~el~~-g~~pf~~~~--~ 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRY------HGRSAAVWSLGILLYDMVC-GDIPFEHDE--E 254 (320)
T ss_dssp TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCB------CHHHHHHHHHHHHHHHHHH-SSCSCCSHH--H
T ss_pred CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCC------CCccchHHhHHHHHHHHHH-CCCCCCChh--h
Confidence 999999999987654322 224568899999999876542 4678999999999999998 999997532 2
Q ss_pred HHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 312 VITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 312 ~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+ ....+..+++.+.+++++||..+|+ ||++.|++.
T Consensus 255 ----~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----HHHC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hhcc---cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2223 3455678999999999999999998 999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=324.33 Aligned_cols=231 Identities=10% Similarity=0.036 Sum_probs=186.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
..+|++.+.||+|+||.||+|++. ..+..||+|++.... .......+.+|+.++++++||||+++++++.+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT-------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET-------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEec-------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 578999999999999999999986 345589999997654 23444556799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++..|+||||+++|+|.+++.... ....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTSP-------SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTCC-------CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred CCcEEEEEEecCCCCHHHHHhcCC-------ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-
Confidence 999999999999999999996431 223466789999999999999999999999999999999999998654
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHhc
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT---RVFG 318 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~---~i~~ 318 (394)
|++| ++.++|||||||++|||++ |+.||.+.+..+.+. +...
T Consensus 175 --------------------~~~~--------------~~~~~Di~slG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 219 (286)
T 3uqc_A 175 --------------------TMPD--------------ANPQDDIRGIGASLYALLV-NRWPLPEAGVRSGLAPAERDTA 219 (286)
T ss_dssp --------------------CCTT--------------CCHHHHHHHHHHHHHHHHH-SEECSCCCSBCCCSEECCBCTT
T ss_pred --------------------ccCC--------------CCchhHHHHHHHHHHHHHH-CCCCCCcCCcchhhHHHHHHhc
Confidence 3332 5789999999999999998 999998865433211 1111
Q ss_pred CCCcC-CCCCCCCChHHHHHHHhhhcCCccccchhhhhhhhhcCCCc
Q psy7505 319 TEALR-LPAPRAVNSHVDVAARNCLVTSELRVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 319 ~~~~~-~~~p~~~~~~~~~l~~~cl~~~p~r~~~~e~~~~l~~~~~~ 364 (394)
+.... ...+..+++.+.+++.+||+.||++|++.|+++.|+++...
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rs~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAV 266 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCCCHHHHHHHHHHHHC-
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccCCHHHHHHHHHHHhcc
Confidence 21000 01235789999999999999999833999999999887653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=329.11 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=196.3
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc------eecee
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN------ILRLM 156 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~ 156 (394)
-.++|++.+.||+|+||.||+|.++.. ....||+|+++.... ....+.+|+.+++.++|++ ++.++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHAR------GKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT------TTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCC------CceEEEEEEEccccc--chhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 368999999999999999999998631 124799999875432 2334568899998887766 99999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE--------
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV-------- 228 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl-------- 228 (394)
+++...+.++|||||+ +|+|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999 66888887654321 26777888999999999999999999999999999999
Q ss_pred -----------cCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHH
Q psy7505 229 -----------TSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297 (394)
Q Consensus 229 -----------~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~ 297 (394)
+.++.+||+|||+++..... .....+|..|+|||++.+.. ++.++|||||||++|||+
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG-------WAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHH
T ss_pred ccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC-------CCCccchHHHHHHHHHHH
Confidence 56789999999998754322 23457889999999987654 789999999999999999
Q ss_pred cCCCCCCCCCCHHHHHHHHhcCCCc-----------------------------------------CCCCCCCCChHHHH
Q psy7505 298 EFGKLPYAELSDDQVITRVFGTEAL-----------------------------------------RLPAPRAVNSHVDV 336 (394)
Q Consensus 298 t~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------~~~~p~~~~~~~~~ 336 (394)
+ |..||.+....+.+..+...... ........+..+.+
T Consensus 234 ~-g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 234 R-GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp H-SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred h-CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 8 99999988876654443221100 00111122457889
Q ss_pred HHHhhhcCCcc-ccchhhhh
Q psy7505 337 AARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 337 l~~~cl~~~p~-r~~~~e~~ 355 (394)
++++||..||. ||++.|++
T Consensus 313 li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHT
T ss_pred HHHHHhcCChhhCcCHHHHh
Confidence 99999999998 99999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.99 Aligned_cols=211 Identities=23% Similarity=0.267 Sum_probs=171.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-Cc-----ceecee
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HV-----NILRLM 156 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~ 156 (394)
-.++|++.+.||+|+||.||+|+++. .+..||||+++.... ....+.+|+.+++.++ |+ +|++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRV-------EQEWVAIKIIKNKKA--FLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcC-------CCcEEEEEEEeccHH--HHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 35889999999999999999999873 455899999875432 2223446777776663 44 599999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEc--CCC
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI--EDGFIHTDVAARNCLVT--SEL 232 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH--~~~iiHrDlk~~NiLl~--~~~ 232 (394)
+++...+.++|||||+. |+|.+++...... .+++..+..++.|++.||.||| +.||+||||||+|||++ .++
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcC---CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 99999999999999996 5999999765321 2567778899999999999999 57999999999999995 468
Q ss_pred eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy7505 233 RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~ 312 (394)
.+||+|||+|+..... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 266 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMP-------YDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQ 266 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCC-------CCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 8999999999765322 22457888999999997665 7899999999999999998 9999999888777
Q ss_pred HHHHhc
Q psy7505 313 ITRVFG 318 (394)
Q Consensus 313 ~~~i~~ 318 (394)
+..+..
T Consensus 267 ~~~i~~ 272 (382)
T 2vx3_A 267 MNKIVE 272 (382)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 666543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.06 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=193.3
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-----------C
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-----------H 149 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-----------H 149 (394)
.+...+|++.+.||+|+||.||+|+++. ....||+|++..... ....+.+|+.++++++ |
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMV-------NNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecC-------CCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhcccc
Confidence 3456899999999999999999999863 455899999875432 2234568888888876 8
Q ss_pred cceeceeeEEEeCC----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhC-CceecCCCCC
Q psy7505 150 VNILRLMAACLESD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIED-GFIHTDVAAR 224 (394)
Q Consensus 150 pnIv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~iiHrDlk~~ 224 (394)
+||+++++++...+ .+++||||+ +|+|.+++...... .++...+..++.||+.||.|||++ ||+||||||+
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~ 161 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR---GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhcc---CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH
Confidence 99999999998654 789999999 88999999764221 256777889999999999999998 9999999999
Q ss_pred CEEEc------CCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 225 NCLVT------SELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 225 NiLl~------~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
|||++ ..+.+||+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~~ 230 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-------WGCGADIWSTACLIFELIT 230 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-------CCTHHHHHHHHHHHHHHHH
T ss_pred HeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-------CCchHhHHHHHHHHHHHHh
Confidence 99994 3458999999998654322 22346789999999987665 7899999999999999998
Q ss_pred CCCCCCCCCC------HHHHHHHHhc--CCC-------------------------------------cCCCCCCCCChH
Q psy7505 299 FGKLPYAELS------DDQVITRVFG--TEA-------------------------------------LRLPAPRAVNSH 333 (394)
Q Consensus 299 ~g~~Pf~~~~------~~~~~~~i~~--~~~-------------------------------------~~~~~p~~~~~~ 333 (394)
|..||.+.. ..+.+..+.. +.. .....+..++..
T Consensus 231 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 231 -GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp -SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred -CCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence 999998654 2222222211 000 012234455678
Q ss_pred HHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 334 VDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 334 ~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+++++||+.||+ ||++.|++.
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHhccCccccCCHHHHhh
Confidence 99999999999998 999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.27 Aligned_cols=257 Identities=21% Similarity=0.242 Sum_probs=184.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 162 (394)
.+.|...+.||+|+||+||.+... .+..||||.+..... ..+.+|+.+++++ +|||||++++++.++
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~--------~g~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSF--------QGRPVAVKRMLIDFC----DIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEES--------SSSEEEEEEEEGGGH----HHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hheeeccCeEeeCCCeEEEEEEEE--------CCeEEEEEEEcHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 344566788999999999865432 345899998865432 2245899999876 899999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhh--hhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---------
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREA--LLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE--------- 231 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~--------- 231 (394)
+.+|||||||. |+|.+++......... ...+..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 99999999995 6999999865432111 01222346789999999999999999999999999999754
Q ss_pred ----CeEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy7505 232 ----LRVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304 (394)
Q Consensus 232 ----~~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf 304 (394)
+.+||+|||+++........ ......||+.|+|||++.+.........++.++|||||||++|||++.|..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999765433221 12234789999999999763221122348899999999999999997689999
Q ss_pred CCCCHHHHHHHHhcCCCcCCCC-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 305 AELSDDQVITRVFGTEALRLPA-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 305 ~~~~~~~~~~~i~~~~~~~~~~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+....+ ..+..+.. .++. +..++.++.+++++||+.||. ||++.|++.
T Consensus 241 ~~~~~~~--~~i~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTHH--HHHHHTCC-CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhH--HHHhcCCC-CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 8765443 22222221 2221 223457899999999999998 999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=339.60 Aligned_cols=255 Identities=17% Similarity=0.210 Sum_probs=188.2
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 157 (394)
.+.+...+|.+.+.||+|+||.|+..... .+..||||.+...... .+.+|+.+++.+ +|||||++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~--------~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~ 85 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMF--------DNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFC 85 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEES--------SSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEe--------CCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEE
Confidence 45677788999999999999996533222 3458999988654321 134789999998 8999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----CC
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-----EL 232 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-----~~ 232 (394)
++.+.+..|||||||. |+|.+++...... .....++.++.||+.||.|||++||+||||||+|||++. ..
T Consensus 86 ~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFA----HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEETTEEEEEEECCS-EEHHHHHHSSSCC----CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEecCCEEEEEEECCC-CCHHHHHHhcCCC----ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCce
Confidence 9999999999999996 5999999765321 122234578999999999999999999999999999953 23
Q ss_pred eEEEccCCCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy7505 233 RVKIGDTGSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD 310 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~ 310 (394)
.+||+|||+|+....... .......||+.|+|||++..... ..++.++|||||||++|||++.|..||......
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~ 236 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK----ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccc----cCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH
Confidence 688999999876543221 22334578999999999874321 126789999999999999997689999766554
Q ss_pred HHHHHHhcCCCcC-CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 311 QVITRVFGTEALR-LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 311 ~~~~~i~~~~~~~-~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
+... +....... ...+...+..+.+++++||+.||. ||++.|++
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 237 QANI-LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp HHHH-HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHH-HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 4332 22222111 222234456688999999999998 99999887
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=346.12 Aligned_cols=244 Identities=15% Similarity=0.116 Sum_probs=191.8
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+-.++|++.+.||+|+||.||+|+++. ..+..|+||.+...........+.+|+.++++++|||||++++++..
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRN------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGG------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcC------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 345899999999999999999999863 12457999988765555555567799999999999999999999987
Q ss_pred CCc-----eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 162 SDP-----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 162 ~~~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
.+. .||||||+++|+|.+++... +++..++.++.||+.||.|||++|||||||||+|||++.+ .+||
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~~-------l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----CC-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEE
Confidence 666 79999999999999887541 6777888999999999999999999999999999999875 8999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|||++ |..||.+...
T Consensus 223 ~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~--------~~~~sDi~slG~~l~~l~~-g~~~~~~~~~------- 281 (681)
T 2pzi_A 223 IDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG--------PTVATDIYTVGRTLAALTL-DLPTRNGRYV------- 281 (681)
T ss_dssp CCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC--------SCHHHHHHHHHHHHHHHHS-CCCEETTEEC-------
T ss_pred EecccchhcccC-----CccCCCccccCHHHHcCC--------CCCceehhhhHHHHHHHHh-CCCCCccccc-------
Confidence 999998765332 345788999999998643 4789999999999999997 9888875311
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc-hhhhhhhhhcCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK-IGDTGSSIDKYP 362 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-~~e~~~~l~~~~ 362 (394)
.+. ........+++.+.+++.+||..||. ||+ +.++...|..+.
T Consensus 282 -~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 282 -DGL-PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -SSC-CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -ccc-cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 00000113457899999999999998 885 455556555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=308.26 Aligned_cols=226 Identities=19% Similarity=0.269 Sum_probs=176.4
Q ss_pred CCCeEEE-ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHh-ccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPY-RRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~ 161 (394)
.++|.+. +.||+|+||.||+|.++. .+..||+|+++... .+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKR-------TQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECSH------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcC-------CCcEEEEEEecccH------HHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3567776 779999999999999863 45589999986532 234777776 56699999999999987
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeE
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRV 234 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~v 234 (394)
...+++||||+++|+|.+++...... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcE
Confidence 67799999999999999999875321 2677888999999999999999999999999999999998 7889
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++..... . .++.++|||||||++|||++ |..||.+....+...
T Consensus 160 kl~Dfg~a~~~~~-----------------------~-------~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~ 208 (299)
T 3m2w_A 160 KLTDFGFAKETTG-----------------------E-------KYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISP 208 (299)
T ss_dssp EECCCTTCEECTT-----------------------C-------GGGGHHHHHHHHHHHHHHHH-SSCSCCC-------C
T ss_pred EEecccccccccc-----------------------c-------cCCchhhHHHHHHHHHHHHH-CCCCCCCCcchhhhH
Confidence 9999998743211 1 16789999999999999998 999998766544322
Q ss_pred HHhcCC-CcCCCCC----CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTE-ALRLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~-~~~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+.... ......+ ..++..+.+++++||..||. ||++.|++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 211111 0122223 57899999999999999998 999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.45 Aligned_cols=253 Identities=13% Similarity=0.075 Sum_probs=183.4
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH--HHHHHHHHHHHHhccCCC-cceecee--
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ--AEKLFFLHEATPYRRLRH-VNILRLM-- 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~H-pnIv~l~-- 156 (394)
.+..+|...+.||+|+||.||+|++.. ++..||||+++..... .....+.+|+.+++.++| .|+..+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQE-------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CCceeEEEecccccCCCEEEEEEEecC-------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 345668889999999999999999873 4558999998744322 223456799999999977 3221111
Q ss_pred -------------------eEEEe-----CCceEEEEeeCCCCCHHHHHhhcc--hhhhhhhhHHHHHHHHHHHHHHHHH
Q psy7505 157 -------------------AACLE-----SDPWLLVFESCSRGDLKEFLLSNE--ASREALLEQGITIKMAIDVATGLSY 210 (394)
Q Consensus 157 -------------------~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~qi~~gl~y 210 (394)
.++.. ...++++|+++ +|+|.+++.... ......+++..++.++.||+.||.|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 11111 22467788876 679999985321 0112236777888899999999999
Q ss_pred HHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCC--CCc-ccCCCCcchhHH
Q psy7505 211 MIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD--TSI-QTCTVTEKCNVW 287 (394)
Q Consensus 211 LH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~--~~~-~~~~~~~~~Diw 287 (394)
||++||+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.... ... ....++.++|||
T Consensus 227 LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 227 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp HHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred HHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 99999999999999999999999999999998654321 334566 8899999984221 000 112378899999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 288 SFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 288 SlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
||||++|||++ |+.||.+....+....+.. ....+++.+.++|++||..+|+ ||++.+++
T Consensus 302 SlGvil~ellt-g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 302 TLGLAIYWIWC-ADLPNTDDAALGGSEWIFR-------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHHH-SSCCCCTTGGGSCSGGGGS-------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHHH-CCCCCCCcchhhhHHHHHh-------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999998 9999988765443333322 2346789999999999999998 99976654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=342.10 Aligned_cols=261 Identities=22% Similarity=0.297 Sum_probs=197.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
..+|++.+.||+|+||.||+|.++ ..+..||+|+++..........+.+|+.++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~-------~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ-------DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT-------TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 367889999999999999999876 24558999998776555555667799999999999999999998765
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCe---E
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELR---V 234 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~---v 234 (394)
++..++|||||++|+|.+++...... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeE
Confidence 67789999999999999999864321 12566677889999999999999999999999999999997664 9
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||++....... ......+|..|+|||++.+.. ++.++|||||||++|||++ |..||.+......+.
T Consensus 164 KL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~-------~s~ksDIwSLGviLyeLlt-G~~Pf~~~~~~~~~~ 233 (676)
T 3qa8_A 164 KIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKK-------YTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWH 233 (676)
T ss_dssp EECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSC-------CSTTHHHHHHHHHHHHHHS-SCSSCCSSCHHHHSS
T ss_pred EEccccccccccccc--ccccccCCcccCChHHhccCC-------CCchhHHHHHHHHHHHHHH-CCCCCCcccchhhhh
Confidence 999999997654332 223457889999999987654 7889999999999999998 999997643222110
Q ss_pred ---------HH-----hcCC---CcCCCCC----CCCChHHHHHHHhhhcCCcc-ccchhh-----hhhhhhcCCC
Q psy7505 315 ---------RV-----FGTE---ALRLPAP----RAVNSHVDVAARNCLVTSEL-RVKIGD-----TGSSIDKYPG 363 (394)
Q Consensus 315 ---------~i-----~~~~---~~~~~~p----~~~~~~~~~l~~~cl~~~p~-r~~~~e-----~~~~l~~~~~ 363 (394)
.+ ..+. ...++.| ..+++.+.++++.||..||+ ||++.+ .+..++.++.
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 0010 0112222 23567899999999999998 999877 3455555554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=324.76 Aligned_cols=239 Identities=18% Similarity=0.155 Sum_probs=175.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-------HHHHHHHHHHHHHhccCC-------
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-------QAEKLFFLHEATPYRRLR------- 148 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-------~~~~~~~~~E~~~l~~l~------- 148 (394)
..++|++.+.||+|+||+||+|++. +..||||+++.... ......+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~ 88 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIAD---------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEET---------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred ccccchheeeecccCceEEEEEEeC---------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence 3567888899999999999999874 24899999875431 111123457887777775
Q ss_pred --Ccce-----------------eceeeEEEe-------------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHH
Q psy7505 149 --HVNI-----------------LRLMAACLE-------------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196 (394)
Q Consensus 149 --HpnI-----------------v~l~~~~~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 196 (394)
|||| |++++++.+ .+.+|||||||++|+|.+.+.+. .+++..
T Consensus 89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~ 162 (336)
T 2vuw_A 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLAT 162 (336)
T ss_dssp SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHH
T ss_pred ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHH
Confidence 5555 455544443 67899999999999776666432 257778
Q ss_pred HHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCC--------------------eEEEccCCCCccCCCCceeeeCC
Q psy7505 197 TIKMAIDVATGLSYMI-EDGFIHTDVAARNCLVTSEL--------------------RVKIGDTGSSIDKYPGDYYVHGE 255 (394)
Q Consensus 197 ~~~~~~qi~~gl~yLH-~~~iiHrDlk~~NiLl~~~~--------------------~vKl~DFG~a~~~~~~~~~~~~~ 255 (394)
+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 163 ~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~ 236 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------I 236 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------E
T ss_pred HHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------c
Confidence 8899999999999999 99999999999999999887 8999999999754322 3
Q ss_pred ccCCcccccccccccCCCCcccCCCCcchhHHHHHHH-HHHHHcCCCCCCCCCCH-HHHHHHHhcCCCcC----CCCCCC
Q psy7505 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVL-LWEIFEFGKLPYAELSD-DQVITRVFGTEALR----LPAPRA 329 (394)
Q Consensus 256 ~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~i-l~el~t~g~~Pf~~~~~-~~~~~~i~~~~~~~----~~~p~~ 329 (394)
..||+.|||||++.+. .+.++||||||++ .+++++ |..||.+... ..+...+....... .+.+..
T Consensus 237 ~~gt~~y~aPE~~~g~--------~~~~~Diwsl~~~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGD--------GDYQFDIYRLMKKENNNRWG-EYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307 (336)
T ss_dssp EECCCCTTCSGGGCCC--------SSHHHHHHHHHHHHHTTCTT-SCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHH
T ss_pred EEEeecccChhhhcCC--------CccceehhhhhCCCCccccc-ccCCCcchhhhhHHHHhhhhhhccCcccchhhhhh
Confidence 3688899999998654 3679999998777 777886 9999864321 22233333221111 111235
Q ss_pred CChHHHHHHHhhhcCCccccchhhhh
Q psy7505 330 VNSHVDVAARNCLVTSELRVKIGDTG 355 (394)
Q Consensus 330 ~~~~~~~l~~~cl~~~p~r~~~~e~~ 355 (394)
+++++.+++++||+.+ |+.|++
T Consensus 308 ~s~~~~dli~~~L~~d----sa~e~l 329 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHGGGSS----SHHHHH
T ss_pred cCHHHHHHHHHHhccC----CHHHHH
Confidence 7889999999999977 777765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=292.47 Aligned_cols=186 Identities=15% Similarity=0.068 Sum_probs=127.9
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---------cHHHHHHHHHHHHHhccC-CCcceeceeeE
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---------SQAEKLFFLHEATPYRRL-RHVNILRLMAA 158 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---------~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 158 (394)
....++.|++|.+..++.. ..+..+++|.+.... .+.....+.+|+++|+++ .|+||++++++
T Consensus 238 w~~~~~~~~~~~h~~~rr~-------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~ 310 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRY-------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH 310 (569)
T ss_dssp EECC-C--------CCEEE-------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE
T ss_pred hhhccccCCcccccccccc-------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 4455777888877766654 234578888886542 233344578999999999 79999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+++++.+|||||||+||+|.++|...+. ++. ..++.||+.||.|||++|||||||||+|||++.+|.+||+|
T Consensus 311 ~ed~~~~yLVMEyv~G~~L~d~i~~~~~-----l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~D 382 (569)
T 4azs_A 311 GENAQSGWLVMEKLPGRLLSDMLAAGEE-----IDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLID 382 (569)
T ss_dssp EECSSEEEEEEECCCSEEHHHHHHTTCC-----CCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECC
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhCCC-----CCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEee
Confidence 9999999999999999999999987643 333 24789999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
||+|+...... ....+.+||+.|||||++.+. +..++|+||+|+++++|.+
T Consensus 383 FGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g~--------~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 383 FGSIVTTPQDC-SWPTNLVQSFFVFVNELFAEN--------KSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp CTTEESCC----CCSHHHHHHHHHHHHHHC-------------------------CCCCT
T ss_pred cccCeeCCCCC-ccccCceechhhccHHHhCCC--------CCCcccccccccchhhhcc
Confidence 99997654322 223345789999999998654 4678999999999887754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=260.03 Aligned_cols=186 Identities=13% Similarity=0.062 Sum_probs=140.1
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-------cHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-------SQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
.+.||+|+||.||+|.+. ...+++|...... .......+.+|+.++++++||||+++..++...
T Consensus 341 ~~~LG~G~fg~Vy~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL---------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL 411 (540)
T ss_dssp -------CCEEEEEEECS---------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred CCEEeeCCCEEEEEEEEC---------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence 468999999999999654 2356666643221 112234467999999999999999777777778
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..|||||||++|+|.+++.. ...++.|++.||.|||++||+||||||+|||++. .+||+|||+|
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred CccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccC
Confidence 889999999999999999864 2368899999999999999999999999999998 9999999999
Q ss_pred ccCCCCcee------eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q psy7505 243 IDKYPGDYY------VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYA 305 (394)
Q Consensus 243 ~~~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~ 305 (394)
+........ ......||+.|||||++..... .|+..+|+||..+-..+.+. ++-+|.
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-----~Y~~~~d~ws~vl~~l~~v~-~r~rY~ 539 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLE-----GYKSVYDRWEIILELMKDVE-RRARYV 539 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-----HHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHH-----HHHHHHhHHHHHHHHHHHHH-hccccC
Confidence 866442211 1124578999999999876221 16778899999998888875 666664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=208.87 Aligned_cols=145 Identities=16% Similarity=0.070 Sum_probs=113.8
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccH-----------------HHHHHHHHHHHHhccCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQ-----------------AEKLFFLHEATPYRRLR 148 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~-----------------~~~~~~~~E~~~l~~l~ 148 (394)
.|.+.+.||+|+||.||+|++. .+..||+|+++..... .....+.+|+.+|++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~--------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeccCCCceEEEEEeC--------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3456699999999999999973 2448999998643211 12345679999999998
Q ss_pred CcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7505 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLV 228 (394)
Q Consensus 149 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl 228 (394)
| +++++++.. +..|+|||||++|+|.+ +... ....++.|++.||.|||++||+||||||+|||+
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~-----------~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl 226 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE-----------NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 226 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS-----------CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh-----------hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence 5 777776644 66799999999999988 4211 123588999999999999999999999999999
Q ss_pred cCCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccc
Q psy7505 229 TSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269 (394)
Q Consensus 229 ~~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~ 269 (394)
+ ++.+||+|||+|+. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9 99999999998853 22478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=177.77 Aligned_cols=138 Identities=15% Similarity=0.123 Sum_probs=102.7
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccce--EEEEeeccccc-----------------------HHHHHHHHHH
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSK--VFVRILKEDAS-----------------------QAEKLFFLHE 140 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~--vavk~~~~~~~-----------------------~~~~~~~~~E 140 (394)
-|.+.+.||+|+||.||+|.+. ..+.. ||||+.+.... ......+.+|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~-------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 120 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGV-------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKE 120 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEE-------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEc-------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHH
Confidence 3678899999999999999984 12346 99998654321 1122346789
Q ss_pred HHHhccCCCcce--eceeeEEEeCCceEEEEeeCCC-C----CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHH-
Q psy7505 141 ATPYRRLRHVNI--LRLMAACLESDPWLLVFESCSR-G----DLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMI- 212 (394)
Q Consensus 141 ~~~l~~l~HpnI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH- 212 (394)
+.+|++++|++| ..+++. +..+|||||+.+ | +|.+++... ++..+..++.|++.||.|||
T Consensus 121 ~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~--------~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 121 FRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL--------KELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG--------GGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc--------ChHHHHHHHHHHHHHHHHHHH
Confidence 999999988764 333332 357899999942 4 677654321 12235578899999999999
Q ss_pred hCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 213 EDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 213 ~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
++||+||||||+|||++. .++|+|||+|..
T Consensus 189 ~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 189 EAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999999998 899999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.6e-18 Score=162.46 Aligned_cols=137 Identities=12% Similarity=0.083 Sum_probs=94.0
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc----------------H-----HHHHHHHHHHHHh
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS----------------Q-----AEKLFFLHEATPY 144 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~----------------~-----~~~~~~~~E~~~l 144 (394)
-|.+...||+|+||.||+|... .+..||||+++.... . ..+....+|...|
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~--------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE--------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT--------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC--------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 3788999999999999999864 245799998753210 0 0011122455555
Q ss_pred ccCCCcceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 145 ~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
.++.+.++ .....+.. ...+|||||++|++|.++.... ....++.|++.+|.|||++|||||||||.
T Consensus 168 ~rL~~~gv-~vp~p~~~-~~~~LVME~i~G~~L~~l~~~~-----------~~~~l~~qll~~l~~lH~~gIVHrDLKp~ 234 (397)
T 4gyi_A 168 KALYEEGF-PVPEPIAQ-SRHTIVMSLVDALPMRQVSSVP-----------DPASLYADLIALILRLAKHGLIHGDFNEF 234 (397)
T ss_dssp HHHHHTTC-SCCCEEEE-ETTEEEEECCSCEEGGGCCCCS-----------CHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred HHHHhcCC-CCCeeeec-cCceEEEEecCCccHhhhcccH-----------HHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 55543332 22222211 2347999999998886543211 12357789999999999999999999999
Q ss_pred CEEEcCCC----------eEEEccCCCCc
Q psy7505 225 NCLVTSEL----------RVKIGDTGSSI 243 (394)
Q Consensus 225 NiLl~~~~----------~vKl~DFG~a~ 243 (394)
|||++.+| .+.|+||+-+.
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcc
Confidence 99998876 48899999664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=117.62 Aligned_cols=138 Identities=13% Similarity=0.024 Sum_probs=103.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 163 (394)
..|.+...+|.|+.+.||++... ...+++|......... ...+.+|+.+++.+ .|..+.++++++.+.+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~---------~~~~vlK~~~~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE---------NENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS---------SCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred ccceeEeeccCCCCCeEEEEECC---------CCcEEEEeCCcccCCC-HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 35777888898999999988643 2378899876422100 11256888888888 4677889999998888
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh------------------------------
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE------------------------------ 213 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~------------------------------ 213 (394)
..|+||||++|.+|.+.+... .....++.+++.+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecCCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 999999999999988753211 0112466788888899998
Q ss_pred -----------------------------CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 -----------------------------DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 -----------------------------~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..++|+|+++.|||++.++.+.|+||+.+
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 45899999999999987666789999965
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.2e-11 Score=113.30 Aligned_cols=139 Identities=13% Similarity=0.062 Sum_probs=96.3
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeec--ccccHHHHHHHHHHHHHhccCC--CcceeceeeEEEeC---
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK--EDASQAEKLFFLHEATPYRRLR--HVNILRLMAACLES--- 162 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~--~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~--- 162 (394)
++.|+.|.++.||+.... ...+++|... ..........+.+|+.+++.|. +..+.++++++.+.
T Consensus 43 ~~~l~~G~sn~~y~v~~~---------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP---------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp EEECCC-CCSCEEEEECS---------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred EEEcCCcccceEEEEEEC---------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 567899999999988754 1257777765 3221111224568888888886 45678888888765
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-----------------------------
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE----------------------------- 213 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~----------------------------- 213 (394)
+..|+||||++|..|.+.... .++......++.+++..|..||+
T Consensus 114 g~~~~vme~v~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQSLP-------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp SSCEEEEECCCCBCCCCTTCT-------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCeecCCCccc-------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 458999999998777431110 13344455677888888888886
Q ss_pred -----------------------------CCceecCCCCCCEEEcCCC--eEEEccCCCCcc
Q psy7505 214 -----------------------------DGFIHTDVAARNCLVTSEL--RVKIGDTGSSID 244 (394)
Q Consensus 214 -----------------------------~~iiHrDlk~~NiLl~~~~--~vKl~DFG~a~~ 244 (394)
..++|+|+++.|||++.++ .+.|.||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3689999999999998765 369999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=3.9e-11 Score=107.86 Aligned_cols=132 Identities=14% Similarity=0.039 Sum_probs=88.7
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc--eeceeeEEEeCC
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN--ILRLMAACLESD 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~ 163 (394)
.+.+....+.|..+.||++... .+..+++|....... ..+.+|+.+++.+.+.+ +.+++++...++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~--------~g~~~vlK~~~~~~~----~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT--------TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCceEecccCCCCceEEEEecC--------CCCeEEEEeCCcccc----hhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 3444433345667999988643 123688888755411 12457888888875434 556888888777
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG---------------------------- 215 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~---------------------------- 215 (394)
..++||||++|.+|. .... . ...++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~~~--------~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp CEEEEEECCSSEETT--TSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCEEEEEecCCcccC--cCcC--------C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 899999999998884 2110 0 0123445555555565432
Q ss_pred ------------------------------ceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 216 ------------------------------FIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 216 ------------------------------iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
++|+|++|.|||++.++.++|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987766789999976
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1e-09 Score=101.30 Aligned_cols=132 Identities=20% Similarity=0.177 Sum_probs=83.3
Q ss_pred ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcc--eeceeeEEEeCC---c
Q psy7505 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVN--ILRLMAACLESD---P 164 (394)
Q Consensus 91 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~Hpn--Iv~l~~~~~~~~---~ 164 (394)
+.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++......+ .
T Consensus 26 ~~~~~G~~n~v~~v~------------~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~ 90 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------------RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM 90 (304)
T ss_dssp CEEEECSSEEEEEST------------TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred EecCCCCcceEEEEC------------CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence 458999999999643 25778876533 2233456899988877 3322 334444333322 3
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-------------------------------
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE------------------------------- 213 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~------------------------------- 213 (394)
.|+|||+++|.+|.+..... ++......++.+++..+..||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~~~-------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLLNN-------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp SCEEEECCCCEECCHHHHHT-------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEcccCCeECCcccccc-------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 48899999998776432211 2222233344444444444443
Q ss_pred ---------------------------CCceecCCCCCCEEEcC--CCeEEEccCCCCcc
Q psy7505 214 ---------------------------DGFIHTDVAARNCLVTS--ELRVKIGDTGSSID 244 (394)
Q Consensus 214 ---------------------------~~iiHrDlk~~NiLl~~--~~~vKl~DFG~a~~ 244 (394)
..++|+|+++.|||++. .+.+.|+||+.+..
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 24799999999999998 45689999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=3e-06 Score=77.98 Aligned_cols=75 Identities=15% Similarity=0.071 Sum_probs=50.3
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCc---ceeceeeEEE-eCCce
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV---NILRLMAACL-ESDPW 165 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~ 165 (394)
++.++.|....||+. +..+++|+.... .....+.+|+.+|+.|.+. .|.+.+.+.. ..+..
T Consensus 24 v~~l~~G~~n~v~~v------------g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~ 88 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------------NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP 88 (306)
T ss_dssp EEEEEECSSEEEEEE------------TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred eeecCCCcceeEEEE------------CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence 355788999999976 125677774322 2233466899999988642 2455555553 34567
Q ss_pred EEEEeeCCCCCHHH
Q psy7505 166 LLVFESCSRGDLKE 179 (394)
Q Consensus 166 ~lv~E~~~~g~L~~ 179 (394)
++||||++|..|.+
T Consensus 89 ~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 89 FVGYRKVQGQILGE 102 (306)
T ss_dssp EEEEECCCSEECHH
T ss_pred EEEEeccCCeECch
Confidence 89999999987765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=6e-06 Score=74.23 Aligned_cols=80 Identities=11% Similarity=0.020 Sum_probs=53.0
Q ss_pred eeeeecce-EEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeCCceEEEE
Q psy7505 92 EIGRGWFG-KVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESDPWLLVF 169 (394)
Q Consensus 92 ~lG~G~fg-~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~ 169 (394)
.+..|..| .||+..... ....+++|...... ...+.+|...|+.|. +--+-++++++.+.+..++||
T Consensus 31 ~~~~G~S~~~v~rl~~~~-------~~~~~~lk~~~~~~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP-------NAPELFLKHGKGSV----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EEECSSSSCEEEEEECCT-------TCCCEEEEEEETHH----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred EccCCCcCCeEEEEEecC-------CCeEEEEEECCCCC----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 34556555 588765431 12357778754332 223557888887773 333667788888888999999
Q ss_pred eeCCCCCHHHHHh
Q psy7505 170 ESCSRGDLKEFLL 182 (394)
Q Consensus 170 E~~~~g~L~~~l~ 182 (394)
|+++|.++.+...
T Consensus 100 e~l~G~~~~~~~~ 112 (272)
T 4gkh_A 100 TAIPGKTAFQVLE 112 (272)
T ss_dssp ECCCSEEHHHHHH
T ss_pred EeeCCcccccccc
Confidence 9999988776553
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.7e-05 Score=75.64 Aligned_cols=77 Identities=16% Similarity=0.104 Sum_probs=45.7
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc---H---HHHHHHHHHHHHhccCCC--cc-eeceeeEEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS---Q---AEKLFFLHEATPYRRLRH--VN-ILRLMAACL 160 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~---~---~~~~~~~~E~~~l~~l~H--pn-Iv~l~~~~~ 160 (394)
.+.||.|.++.||++.... ....+++|....... . .....+..|..+++.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~-------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-- 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE-------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred EEECCCCceEEEEEEEECC-------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence 4679999999999986542 123688887543211 0 001223467777776632 33 3455543
Q ss_pred eCCceEEEEeeCCCC
Q psy7505 161 ESDPWLLVFESCSRG 175 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g 175 (394)
+.+..++||||+++.
T Consensus 106 d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 DTEMAVTVMEDLSHL 120 (397)
T ss_dssp ETTTTEEEECCCTTS
T ss_pred cCCccEEEEEeCCCc
Confidence 455678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00014 Score=67.43 Aligned_cols=29 Identities=17% Similarity=0.235 Sum_probs=26.5
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
..++|+|+.+.|||++.++.+.|+||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 57999999999999987888999999965
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=1.3e-05 Score=75.08 Aligned_cols=90 Identities=10% Similarity=0.020 Sum_probs=50.8
Q ss_pred eEEEcee-eeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCC-C--cceeceeeEEE
Q psy7505 87 LHYVKEI-GRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLR-H--VNILRLMAACL 160 (394)
Q Consensus 87 ~~~~~~l-G~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~ 160 (394)
....+.| +.|..+.+|+........ .......+++|....... ......+.+|+.+++.|. + -.+.++++++.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~-~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQD-GRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEET-TEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred eEEEEECCCCCccceEEEEEEecccC-CCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 3445678 889999999876430000 000133677777543220 000012346777777663 2 34667777765
Q ss_pred eC---CceEEEEeeCCCCCH
Q psy7505 161 ES---DPWLLVFESCSRGDL 177 (394)
Q Consensus 161 ~~---~~~~lv~E~~~~g~L 177 (394)
+. +..++||||++|..|
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 54 356899999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00092 Score=61.35 Aligned_cols=76 Identities=16% Similarity=0.174 Sum_probs=55.7
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC---CcceeceeeEEEeCCce
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR---HVNILRLMAACLESDPW 165 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~ 165 (394)
-.+.|+.|.+..+|+.... ...+++|+..... ...+..|+..|+.|. ...+.+.+++....+..
T Consensus 40 ~~~~l~gG~~n~~y~v~~~---------~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE---------VQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEEECCSSSSEEEEEESS---------SCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeEEeCCccceeeeEEEEC---------CCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 3567899999999987632 2367788765432 234567888887773 35678888888777889
Q ss_pred EEEEeeCCCCCH
Q psy7505 166 LLVFESCSRGDL 177 (394)
Q Consensus 166 ~lv~E~~~~g~L 177 (394)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00076 Score=64.65 Aligned_cols=32 Identities=22% Similarity=0.286 Sum_probs=27.8
Q ss_pred HhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 212 IEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 212 H~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999998877 99999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.011 Score=50.51 Aligned_cols=141 Identities=12% Similarity=0.024 Sum_probs=88.9
Q ss_pred CHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccCCCCccCCCCceeeeC
Q psy7505 176 DLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHG 254 (394)
Q Consensus 176 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~~~~~ 254 (394)
+|.+.|+..+. .+++..++.++.|.+.+|.-+-. +.-..+=+-+..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 79999875432 38899999999999998876522 2211233446889999999988764 2111
Q ss_pred CccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHH
Q psy7505 255 EVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHV 334 (394)
Q Consensus 255 ~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~ 334 (394)
.....+.+||..... .+.+.=|||||+++|.-+-+|-.+ ..++.+++.+
T Consensus 98 --~~~~~~~~pe~~~~~--------~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~L 146 (229)
T 2yle_A 98 --AGEPPPVAGKLGYSQ--------CMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPL 146 (229)
T ss_dssp -----------CCSSSS--------SCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHH
T ss_pred --ccccCCCChhhcccc--------chHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHH
Confidence 001136788875311 467889999999999999866432 2355677777
Q ss_pred HHHHHhhhcCC-------------------------cc-ccchhhhhhhhhcCCC
Q psy7505 335 DVAARNCLVTS-------------------------EL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 335 ~~l~~~cl~~~-------------------------p~-r~~~~e~~~~l~~~~~ 363 (394)
..|+..|.... +. |+++.+|++.=...+.
T Consensus 147 E~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 147 EQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp HHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred HHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 77777776441 22 6777788766555554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0065 Score=55.63 Aligned_cols=29 Identities=21% Similarity=0.190 Sum_probs=25.2
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.+++|+|+.+.|||++.++.+.|+||+.+
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhc
Confidence 36999999999999988766689999965
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0054 Score=55.32 Aligned_cols=81 Identities=20% Similarity=0.162 Sum_probs=51.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCc---ceeceeeEEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV---NILRLMAACL 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~ 160 (394)
...+.-++.+|.|..+.||+.+..+ +..+++|+....... ....+..|+..|+.|.-- -+.+++++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~D--------G~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-- 82 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELAD--------GTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW-- 82 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETT--------SCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--
T ss_pred CCCeEEEEecCCCCCeEEEEEEECC--------CCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--
Confidence 4556667889999999999988652 347888876543211 112355788877776321 23444443
Q ss_pred eCCceEEEEeeCCCCCH
Q psy7505 161 ESDPWLLVFESCSRGDL 177 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L 177 (394)
+.-++||||+.++..
T Consensus 83 --~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 --DDRTLAMEWVDERPP 97 (288)
T ss_dssp --ETTEEEEECCCCCCC
T ss_pred --cCceEEEEeecccCC
Confidence 234789999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0017 Score=59.02 Aligned_cols=28 Identities=29% Similarity=0.119 Sum_probs=23.9
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++|+|+.+.||| ..++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 556778999999764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0037 Score=60.08 Aligned_cols=80 Identities=11% Similarity=0.063 Sum_probs=46.6
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcc-eeceeeEEEeCCceEEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVN-ILRLMAACLESDPWLLV 168 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv 168 (394)
++.|+.|....||++...+...........+++|+....... ..+.+|..+++.|...+ ..++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcH---HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 456888999999998764211111112346788877432210 12336888777773222 3566666532 389
Q ss_pred EeeCCCCC
Q psy7505 169 FESCSRGD 176 (394)
Q Consensus 169 ~E~~~~g~ 176 (394)
+||++|.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99997633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0024 Score=60.26 Aligned_cols=151 Identities=15% Similarity=0.083 Sum_probs=75.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 163 (394)
+.+++ +.|..|....+|++...............+++|+....... ...+.+|..+++.|. +.-..++++.+.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~--~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG--VDSLVLESVMFAILAERSLGPQLYGVFPE-- 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC--HHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch--HHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence 34443 45777899999998764211111122347788875332111 112347888877762 2223566666543
Q ss_pred ceEEEEeeCCCCCHHH--------------HHhhcchh-----hhhhhhHHHHHHHHHHHH-------------------
Q psy7505 164 PWLLVFESCSRGDLKE--------------FLLSNEAS-----REALLEQGITIKMAIDVA------------------- 205 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~--------------~l~~~~~~-----~~~~~~~~~~~~~~~qi~------------------- 205 (394)
.+||||++|..|.. .|.+-... .....-+..+..+..++.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 39999998754421 11110000 000001122222332221
Q ss_pred HHHHHH----Hh----CCceecCCCCCCEEEcCC----CeEEEccCCCC
Q psy7505 206 TGLSYM----IE----DGFIHTDVAARNCLVTSE----LRVKIGDTGSS 242 (394)
Q Consensus 206 ~gl~yL----H~----~~iiHrDlk~~NiLl~~~----~~vKl~DFG~a 242 (394)
..+..| .. ..++|+|+.+.|||++.+ +.+.|+||..+
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 122333 22 258999999999999876 78999999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0092 Score=54.96 Aligned_cols=31 Identities=32% Similarity=0.274 Sum_probs=26.7
Q ss_pred CCceecCCCCCCEEEcCC----CeEEEccCCCCcc
Q psy7505 214 DGFIHTDVAARNCLVTSE----LRVKIGDTGSSID 244 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~----~~vKl~DFG~a~~ 244 (394)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999997743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.00 E-value=0.029 Score=51.29 Aligned_cols=28 Identities=21% Similarity=0.065 Sum_probs=24.2
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 79999998663
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.63 E-value=0.012 Score=55.00 Aligned_cols=28 Identities=25% Similarity=0.268 Sum_probs=23.5
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++|+|+.+.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998655 8999998663
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.58 E-value=0.069 Score=51.56 Aligned_cols=75 Identities=13% Similarity=0.040 Sum_probs=43.0
Q ss_pred EceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcce-eceeeEEEeCCceEEE
Q psy7505 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNI-LRLMAACLESDPWLLV 168 (394)
Q Consensus 90 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv 168 (394)
++.|+.|-...+|++...+ ....+++|+........ .. ..+|..+++.|...++ .++++.+. + .+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~-------~~~~~vLRi~g~~~~~~-id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-------KQAKYLIRLYGPKTDEI-IN-REREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEEECC--CEEEEEEEETT-------TTEEEEEEEECC-CCSC-SC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEEcCCCeEeEEEEEEECC-------CCceEEEEECCCChhhh-cC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 4568889999999987642 12367777764322110 00 1367777777744334 56777662 2 359
Q ss_pred EeeCCCCCH
Q psy7505 169 FESCSRGDL 177 (394)
Q Consensus 169 ~E~~~~g~L 177 (394)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.73 E-value=0.15 Score=48.23 Aligned_cols=28 Identities=25% Similarity=0.326 Sum_probs=23.7
Q ss_pred ceecCCCCCCEEE------cCCCeEEEccCCCCc
Q psy7505 216 FIHTDVAARNCLV------TSELRVKIGDTGSSI 243 (394)
Q Consensus 216 iiHrDlk~~NiLl------~~~~~vKl~DFG~a~ 243 (394)
++|.|+.+.|||+ +.+..+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 345779999998773
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=92.37 E-value=0.019 Score=55.66 Aligned_cols=63 Identities=11% Similarity=0.068 Sum_probs=17.6
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEE------Eeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV------RILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vav------k~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
+.+.|| ||.||+|.++. ....||| |..+... .......+.+|+.+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~-------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYK-------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC----------------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccc-------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999863 1235677 6655433 22233345689999999999999999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=83.48 E-value=0.81 Score=41.97 Aligned_cols=30 Identities=30% Similarity=0.304 Sum_probs=26.6
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 469999999999999988889999998664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 394 | ||||
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-05 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-05 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 0.002 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-05 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-06 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-04 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-04 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-05 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-04 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-05 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-05 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-05 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-05 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-05 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-04 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 0.004 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 0.004 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-06 |
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 4e-47
Identities = 93/285 (32%), Positives = 134/285 (47%), Gaps = 31/285 (10%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
++PR + YV++IG G FG+V + A GL + V V++LKE+AS + F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP--YEPFTMVAVKMLKEEASADMQADF 63
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
EA + NI++L+ C P L+FE + GDL EFL S L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 198 -------------------IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238
+ +A VA G++Y+ E F+H D+A RNCLV + VKI D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 239 TGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
G S + Y DYY G A+P+RW PE SI T + +VW++GV+LWEIF
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPE-------SIFYNRYTTESDVWAYGVVLWEIF 236
Query: 298 EFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
+G PY ++ ++VI V + L P + R C
Sbjct: 237 SYGLQPYYGMAHEEVIYYV--RDGNILACPENCPLELYNLMRLCW 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.1 bits (103), Expect = 1e-05
Identities = 26/53 (49%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+A RNCLV + VKI D G S + Y DYY G A+P+RW PES+
Sbjct: 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-47
Identities = 90/285 (31%), Positives = 133/285 (46%), Gaps = 30/285 (10%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+++FPR+ L + K +G G FGKV+ A G+ ++ + +V V++LKE A +E+
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG--VSIQVAVKMLKEKADSSEREAL 87
Query: 138 LHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSN------------ 184
+ E +L H NI+ L+ AC S P L+FE C GDL +L S
Sbjct: 88 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147
Query: 185 ------EASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238
E +L + A VA G+ ++ +H D+AARN LVT VKI D
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 207
Query: 239 TGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297
G + D Y V G LPV+W APESL T K +VWS+G+LLWEIF
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESL-------FEGIYTIKSDVWSYGILLWEIF 260
Query: 298 EFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
G PY + D ++ ++ P + + ++C
Sbjct: 261 SLGVNPYPGIPVDANFYKLI-QNGFKMDQPFYATEEIYIIMQSCW 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 2e-05
Identities = 28/62 (45%), Positives = 34/62 (54%), Gaps = 1/62 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQ 391
H D+AARN LVT VKI D G + D Y V G LPV+W APESL +I+
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 392 TC 393
+
Sbjct: 247 SD 248
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-46
Identities = 81/262 (30%), Positives = 132/262 (50%), Gaps = 29/262 (11%)
Query: 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEA 141
++L ++ IG+G FG V+ G+ RG +KV V+ +K DA+ FL EA
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRG---------NKVAVKCIKNDATAQA---FLAEA 51
Query: 142 TPYRRLRHVNILRLMAACLESDPWL-LVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
+ +LRH N+++L+ +E L +V E ++G L ++L S S L +K
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKF 108
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
++DV + Y+ + F+H D+AARN LV+ + K+ D G + + PV
Sbjct: 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV 164
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+W APE+L + + K +VWSFG+LLWEI+ FG++PY + V+ RV +
Sbjct: 165 KWTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--EK 215
Query: 321 ALRLPAPRAVNSHVDVAARNCL 342
++ AP V +NC
Sbjct: 216 GYKMDAPDGCPPAVYEVMKNCW 237
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (86), Expect = 0.002
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 4/52 (7%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+AARN LV+ + K+ D G + + PV+W APE+L
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALR 173
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-46
Identities = 67/266 (25%), Positives = 115/266 (43%), Gaps = 23/266 (8%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL-FF 137
+++ P Q+ + IG G FG V +G + V V++L A ++L F
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAF 51
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
+E R+ RHVNIL M + V + C L L E E
Sbjct: 52 KNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHIIETK----FEMIKL 106
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEV 256
I +A A G+ Y+ IH D+ + N + +L VKIGD G + K + ++
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
+ + W APE + D + + + +V++FG++L+E+ G+LPY+ +++ I +
Sbjct: 167 SGSILWMAPEVIRMQDKN----PYSFQSDVYAFGIVLYELM-TGQLPYSNINNRDQIIFM 221
Query: 317 FGTEALRLPAPRAVNSHVDVAARNCL 342
G P V S+ A + +
Sbjct: 222 VG-RGYLSPDLSKVRSNCPKAMKRLM 246
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (102), Expect = 2e-05
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQ 391
H D+ + N + +L VKIGD G + K + +++ + W APE + D +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 392 T 392
+
Sbjct: 187 S 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-46
Identities = 85/267 (31%), Positives = 123/267 (46%), Gaps = 30/267 (11%)
Query: 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL 135
D SE F V+EIG G FG V G KV ++ ++E A E
Sbjct: 3 DPSELTF-------VQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSEED- 46
Query: 136 FFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQG 195
F+ EA +L H +++L CLE P LVFE G L ++L + + L
Sbjct: 47 -FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT----QRGLFAAE 101
Query: 196 ITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE 255
+ M +DV G++Y+ E IH D+AARNCLV +K+ D G + Y
Sbjct: 102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
PV+W +PE + K +VWSFGVL+WE+F GK+PY S+ +V+
Sbjct: 162 TKFPVKWASPEVF-------SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214
Query: 316 VFGTEALRLPAPRAVNSHVDVAARNCL 342
+ + RL PR ++HV +C
Sbjct: 215 I--STGFRLYKPRLASTHVYQIMNHCW 239
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 9e-06
Identities = 20/60 (33%), Positives = 28/60 (46%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARNCLV +K+ D G + Y PV+W +PE S S ++
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 8e-45
Identities = 94/280 (33%), Positives = 149/280 (53%), Gaps = 17/280 (6%)
Query: 69 LSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED 128
S + + E++ R+++ +E+G+G FG V EG A+G+ + ++V ++ + E
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEA 61
Query: 129 ASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR 188
AS E++ FL+EA+ + +++RL+ + P L++ E +RGDLK +L S +
Sbjct: 62 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 121
Query: 189 E-----ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243
A I+MA ++A G++Y+ + F+H D+AARNC+V + VKIGD G +
Sbjct: 122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181
Query: 244 DKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
D Y DYY G+ LPVRW +PESL + T +VWSFGV+LWEI +
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQ 234
Query: 303 PYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
PY LS++QV+ V E L P + R C
Sbjct: 235 PYQGLSNEQVLRFVM--EGGLLDKPDNCPDMLFELMRMCW 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (90), Expect = 6e-04
Identities = 29/53 (54%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLL 384
H D+AARNC+V + VKIGD G + D Y DYY G+ LPVRW +PESL
Sbjct: 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-44
Identities = 78/269 (28%), Positives = 128/269 (47%), Gaps = 24/269 (8%)
Query: 74 WFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE 133
W++ E++ PR+ L V+ +G G FG+V G G +KV V+ LK+ + +
Sbjct: 3 WWED-EWEVPRETLKLVERLGAGQFGEVWMGYYNG--------HTKVAVKSLKQGSMSPD 53
Query: 134 KLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLE 193
FL EA ++L+H ++RL A +P ++ E G L +FL + + L
Sbjct: 54 A--FLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK---LT 107
Query: 194 QGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH 253
+ MA +A G++++ E +IH D+ A N LV+ L KI D G + +Y
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
P++W APE++ T T K +VWSFG+LL EI G++PY +++ +VI
Sbjct: 168 EGAKFPIKWTAPEAI-------NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 314 TRVFGTEALRLPAPRAVNSHVDVAARNCL 342
+ R+ P + R C
Sbjct: 221 QNL--ERGYRMVRPDNCPEELYQLMRLCW 247
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 3e-04
Identities = 18/60 (30%), Positives = 29/60 (48%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+ A N LV+ L KI D G + +Y P++W APE++ +I++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-43
Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 18/265 (6%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++ R+++ + IG G FG V +G+ S V ++ K S + + FL
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTSDSVREKFL 56
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA R+ H +I++L+ E+ W+ + E C+ G+L+ FL + S L+ I
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYS----LDLASLI 111
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
A ++T L+Y+ F+H D+AARN LV+S VK+GD G S YY + L
Sbjct: 112 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W APES+ T +VW FGV +WEI G P+ + ++ VI R+
Sbjct: 172 PIKWMAPESI-------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-- 222
Query: 319 TEALRLPAPRAVNSHVDVAARNCLV 343
RLP P + C
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWA 247
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 6e-05
Identities = 24/51 (47%), Positives = 31/51 (60%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARN LV+S VK+GD G S YY + LP++W APES+
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-43
Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 23/259 (8%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
+ L ++KE+G G FG V G+ R V ++++KE + ++ F+ EA
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSEDE--FIEEAKV 52
Query: 144 YRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
L H +++L C + P ++ E + G L +L + ++M D
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKD 108
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
V + Y+ F+H D+AARNCLV + VK+ D G S +Y PVRW
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
PE L + K ++W+FGVL+WEI+ GK+PY ++ + + + LR
Sbjct: 169 PPEVL-------MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--AQGLR 219
Query: 324 LPAPRAVNSHVDVAARNCL 342
L P + V +C
Sbjct: 220 LYRPHLASEKVYTIMYSCW 238
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (94), Expect = 2e-04
Identities = 22/51 (43%), Positives = 26/51 (50%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 383
H D+AARNCLV + VK+ D G S +Y PVRW PE L
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-42
Identities = 89/280 (31%), Positives = 129/280 (46%), Gaps = 25/280 (8%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+++FPR +L + K +G G FGKVVE A GL +S V V++LK A E+
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS--DAAMTVAVKMLKPSAHLTEREAL 73
Query: 138 LHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR-------- 188
+ E L H+NI+ L+ AC P L++ E C GDL FL S
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 189 -----EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243
E L+ + + VA G++++ IH D+AARN L+T KI D G +
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 244 DKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302
D Y V G LPV+W AP SI C T + +VWS+G+ LWE+F G
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAP-------ESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 303 PYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
PY + D ++ E R+ +P + + + C
Sbjct: 247 PYPGMPVDSKFYKMI-KEGFRMLSPEHAPAEMYDIMKTCW 285
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 22/278 (7%)
Query: 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
++ PR +L K +G G FG+VV EA GL++ +KV V++LK DA++ +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 138 LHEATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFL-----------LSNE 185
+ E + + +H NI+ L+ AC + P ++ E S+G+L+E+L +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 186 ASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDK 245
+ E L + A VA G+ Y+ IH D+AARN LVT + +KI D G + D
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 246 YPGDYYVHGEV-ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ DYY LPV+W APE+L T + +VWSFGVLLWEIF G PY
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 305 AELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
+ +++ + E R+ P + + + R+C
Sbjct: 239 PGVPVEELFKLL--KEGHRMDKPSNCTNELYMMMRDCW 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-42
Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 23/264 (8%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
++ PR+ L ++G+G FG+V G G T++V ++ LK E FL
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMSPEA--FL 60
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA ++LRH +++L A +P +V E S+G L +FL L + +
Sbjct: 61 QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQ---LV 116
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
MA +A+G++Y+ ++H D+ A N LV L K+ D G + +Y
Sbjct: 117 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W AP + T K +VWSFG+LL E+ G++PY + + +V+ +V
Sbjct: 177 PIKWTAP-------EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-- 227
Query: 319 TEALRLPAPRAVNSHVDVAARNCL 342
R+P P + C
Sbjct: 228 ERGYRMPCPPECPESLHDLMCQCW 251
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (104), Expect = 1e-05
Identities = 18/60 (30%), Positives = 28/60 (46%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+ A N LV L K+ D G + +Y P++W APE+ L +I++
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-42
Identities = 59/261 (22%), Positives = 109/261 (41%), Gaps = 16/261 (6%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P + E+G G FGKV + + + T+ +++ S+ E ++ E
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNK-------ETSVLAAAKVIDTK-SEEELEDYMVEID 61
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
H NI++L+ A + ++ E C+ G + +L E L + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCK 117
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
L+Y+ ++ IH D+ A N L T + +K+ D G S + P W
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP-YW 176
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE ++C + + K +VWS G+ L E+ + P+ EL+ +V+ ++ +E
Sbjct: 177 MAPEVVMCETSKDR--PYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAKSEPP 233
Query: 323 RLPAPRAVNSHVDVAARNCLV 343
L P +S+ + CL
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (100), Expect = 4e-05
Identities = 16/62 (25%), Positives = 25/62 (40%), Gaps = 1/62 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+ A N L T + +K+ D G S + P W APE ++C + +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP-YWMAPEVVMCETSKDRP 191
Query: 393 CT 394
Sbjct: 192 YD 193
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (367), Expect = 2e-41
Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 21/264 (7%)
Query: 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFL 138
+++ R + ++G G +G+V G+ + V V+ LKED + E+ FL
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSL---TVAVKTLKEDTMEVEE--FL 61
Query: 139 HEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITI 198
EA + ++H N+++L+ C P+ ++ E + G+L ++L + + +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLL 118
Query: 199 KMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVAL 258
MA +++ + Y+ + FIH D+AARNCLV VK+ D G S Y H
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P++W APESL + K +VW+FGVLLWEI +G PY + QV +
Sbjct: 179 PIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-- 229
Query: 319 TEALRLPAPRAVNSHVDVAARNCL 342
+ R+ P V R C
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACW 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.8 bits (100), Expect = 4e-05
Identities = 25/61 (40%), Positives = 32/61 (52%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 392
H D+AARNCLV VK+ D G S Y H P++W APESL + SI++
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 393 C 393
Sbjct: 198 D 198
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-41
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 25/274 (9%)
Query: 70 SMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA 129
++ +EF+ +K +G G FG V +G E V ++ L+E
Sbjct: 1 ALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREAT 50
Query: 130 SQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASRE 189
S L EA + + ++ RL+ CL S L+ + G L L +
Sbjct: 51 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL----LDYVREHK 105
Query: 190 ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD 249
+ + + +A G++Y+ + +H D+AARN LV + VKI D G + +
Sbjct: 106 DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165
Query: 250 YYVHGE-VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
H E +P++W A E SI T + +VWS+GV +WE+ FG PY +
Sbjct: 166 KEYHAEGGKVPIKWMALE-------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218
Query: 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
++ + + + RLP P V + C
Sbjct: 219 ASEISSIL--EKGERLPQPPICTIDVYMIMVKCW 250
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 4e-05
Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 1/62 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE-VALPVRWCAPESLLCSDTSIQ 391
H D+AARN LV + VKI D G + + H E +P++W A ES+L + Q
Sbjct: 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193
Query: 392 TC 393
+
Sbjct: 194 SD 195
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 26/294 (8%)
Query: 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATP 143
+H+ + IGRG FG V G V+ L E FL E
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 144 YRRLRHVNILRLMAACLESD-PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+ H N+L L+ CL S+ L+V GDL+ F + I +
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGL 137
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY---VHGEVALP 259
VA G+ ++ F+H D+AARNC++ + VK+ D G + D Y ++ LP
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
V+W A ESL QT T K +VWSFGVLLWE+ G PY +++ + +
Sbjct: 198 VKWMALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 248
Query: 320 EALRLPAPRAVNSHVDVAARNCLVTS-ELRVKIGDTGSSIDK----YPGDYYVH 368
+ RL P + C E+R + S I + G++YVH
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (360), Expect = 3e-40
Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 21/266 (7%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + + IG G FG+V G + G+ V ++ LK ++ ++ FL E
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLK----LPGKREIFVAIKTLKSGYTEKQRRDFLSE 77
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
A+ + H N++ L +S P +++ E G L FL N+ + + M
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI----QLVGM 133
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI----DKYPGDYYVHGEV 256
+A G+ Y+ + ++H D+AARN LV S L K+ D G S D Y
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 257 ALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
+P+RW AP +IQ T +VWS+G+++WE+ +G+ PY ++++ VI +
Sbjct: 194 KIPIRWTAP-------EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246
Query: 317 FGTEALRLPAPRAVNSHVDVAARNCL 342
+ RLP P S + +C
Sbjct: 247 --EQDYRLPPPMDCPSALHQLMLDCW 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-40
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 22/267 (8%)
Query: 79 EFQFPRQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFF 137
+ R L E+G G FG V +G R ++ V +++LK+ +A+
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQI-----DVAIKVLKQGTEKADTEEM 56
Query: 138 LHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
+ EA +L + I+RL+ C +++ +LV E G L +FL+ +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNV 111
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH--GE 255
++ V+ G+ Y+ E F+H D+AARN L+ + KI D G S D Y
Sbjct: 112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
P++W AP I + + +VWS+GV +WE +G+ PY ++ +V+
Sbjct: 172 GKWPLKWYAP-------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 224
Query: 316 VFGTEALRLPAPRAVNSHVDVAARNCL 342
+ + R+ P + +C
Sbjct: 225 I--EQGKRMECPPECPPELYALMSDCW 249
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-39
Identities = 73/255 (28%), Positives = 119/255 (46%), Gaps = 23/255 (9%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL-FFLHEATPYRRLRH 149
KE+G G FG V +G + + V V+ILK +A+ L EA ++L +
Sbjct: 13 KELGSGNFGTVKKGYYQM-----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
I+R++ C E++ W+LV E G L ++L N ++ + I++ V+ G+
Sbjct: 68 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMK 121
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGE--VALPVRWCAPES 267
Y+ E F+H D+AARN L+ ++ KI D G S + Y + PV+W APE
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ + K +VWSFGVL+WE F +G+ PY + +V + + R+ P
Sbjct: 182 I-------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--EKGERMGCP 232
Query: 328 RAVNSHVDVAARNCL 342
+ C
Sbjct: 233 AGCPREMYDLMNLCW 247
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-39
Identities = 89/282 (31%), Positives = 141/282 (50%), Gaps = 24/282 (8%)
Query: 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEK 134
+D+S+++FPR +L K +GRG FG+V+E +A G++++ T V V++LKE A+ +E
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEH 60
Query: 135 LFFLHEATPYRR-LRHVNILRLMAACLESD-PWLLVFESCSRGDLKEFL----------- 181
+ E H+N++ L+ AC + P +++ E C G+L +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 182 LSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241
++ E + L I + VA G+ ++ IH D+AARN L++ + VKI D G
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 242 SIDKYPGDYYVH-GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFG 300
+ D Y YV G+ LP++W AP +I T + +VWSFGVLLWEIF G
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAP-------ETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 301 KLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
PY + D+ R E R+ AP + +C
Sbjct: 234 ASPYPGVKIDEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCW 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-38
Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 18/264 (6%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + K IG G FG+V +G L+ S+G+ V ++ LK ++ +++ FL E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGM---LKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
A + H NI+RL + P +++ E G L +F ++ + M
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF----LREKDGEFSVLQLVGM 115
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVA--L 258
+A G+ Y+ ++H D+AARN LV S L K+ D G S + +
Sbjct: 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P+RW APE +I T +VWSFG+++WE+ +G+ PY ELS+ +V+ +
Sbjct: 176 PIRWTAPE-------AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-- 226
Query: 319 TEALRLPAPRAVNSHVDVAARNCL 342
+ RLP P S + C
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCW 250
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 24/79 (30%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 307 LSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYY 366
S Q++ + G A H D+AARN LV S L K+ D G S
Sbjct: 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 367 VHGEVA--LPVRWCAPESL 383
+ +P+RW APE++
Sbjct: 167 TYTTSGGKIPIRWTAPEAI 185
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 1e-37
Identities = 57/263 (21%), Positives = 96/263 (36%), Gaps = 25/263 (9%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHE 140
P + ++EIG G FG V + V ++ + Q+ + + + E
Sbjct: 13 PEKLFSDLREIGHGSFGAVY----FARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
++LRH N ++ L LV E C + + +E + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAV 120
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
GL+Y+ IH DV A N L++ VK+GD GS+ P + +V
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG-----TP 175
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
W APE +L D K +VWS G+ E+ K P ++ + + E
Sbjct: 176 YWMAPEVILAMDEG----QYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQNE 230
Query: 321 ALRLPAPRAVNSHVDVAARNCLV 343
+ L + + CL
Sbjct: 231 SPALQSGHWSEYFRNFVDS-CLQ 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.6 bits (92), Expect = 4e-04
Identities = 20/55 (36%), Positives = 27/55 (49%), Gaps = 5/55 (9%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSD 387
H DV A N L++ VK+GD GS+ P + +V W APE +L D
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG-----TPYWMAPEVILAMD 187
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 9e-37
Identities = 79/274 (28%), Positives = 113/274 (41%), Gaps = 28/274 (10%)
Query: 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHE 140
+ + IG G FG+V+ + + G ++ +KE AS+ + F E
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVL----KARIKKDGLRM-DAAIKRMKEYASKDDHRDFAGE 60
Query: 141 ATPYRRL-RHVNILRLMAACLESDPWLLVFESCSRGDLKEFL-----------LSNEASR 188
+L H NI+ L+ AC L E G+L +FL + S
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 189 EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248
+ L + A DVA G+ Y+ + FIH D+AARN LV KI D G S +
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS--RGQE 178
Query: 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
Y LPVRW A ESL T +VWS+GVLLWEI G PY ++
Sbjct: 179 VYVKKTMGRLPVRWMAIESL-------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
++ ++ + RL P + V R C
Sbjct: 232 CAELYEKL--PQGYRLEKPLNCDDEVYDLMRQCW 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-36
Identities = 49/261 (18%), Positives = 100/261 (38%), Gaps = 23/261 (8%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEAT 142
P+++ ++IG+G G V ++ +TG+ +V +R + ++ ++E
Sbjct: 18 PKKKYTRFEKIGQGASGTVY----TAMDVATGQ---EVAIRQMNLQQQPKKE-LIINEIL 69
Query: 143 PYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
R ++ NI+ + + L D +V E + G L + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCR 123
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+ L ++ + IH D+ + N L+ + VK+ D G P V P W
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-YW 182
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322
APE + K ++WS G++ E+ G+ PY + + + +
Sbjct: 183 MAPE-------VVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATNGTP 234
Query: 323 RLPAPRAVNSHVDVAARNCLV 343
L P +++ CL
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLD 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-36
Identities = 79/264 (29%), Positives = 118/264 (44%), Gaps = 21/264 (7%)
Query: 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHE 140
+ L ++++G G FG V GE + +G+T V V+ LK D + F+ E
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGE---WDAPSGKTV-SVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 141 ATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
L H N++RL L + V E G L + L ++ G +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRY 116
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGD--YYVHGEVAL 258
A+ VA G+ Y+ FIH D+AARN L+ + VKIGD G D Y + +
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P WCAPESL +T T + + W FGV LWE+F +G+ P+ L+ Q++ ++
Sbjct: 177 PFAWCAPESL-------KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID- 228
Query: 319 TEALRLPAPRAVNSHVDVAARNCL 342
E RLP P + C
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCW 252
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 2e-35
Identities = 50/244 (20%), Positives = 95/244 (38%), Gaps = 25/244 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL-KEDASQAEKLFFLHEATPYRRLR 148
+ IG G +G+ + +S G+ + + L ++AEK + E R L+
Sbjct: 9 LYTIGTGSYGRCQ----KIRRKSDGK---ILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 149 HVNILRLMAACLE--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
H NI+R ++ + +V E C GDL + R+ L E+ +++ +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE-FVLRVMTQLTL 120
Query: 207 GLSYMIEDG-----FIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
L +H D+ N + + VK+GD G + D
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPY 179
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
+ +PE + + EK ++WS G LL+E+ P+ S ++ ++ +
Sbjct: 180 YMSPEQM-------NRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQKELAGKIREGKF 231
Query: 322 LRLP 325
R+P
Sbjct: 232 RRIP 235
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 46/224 (20%), Positives = 83/224 (37%), Gaps = 24/224 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+ E+G G G V + + +G + +++ + A + + E
Sbjct: 11 ISELGAGNGGVVF----KVSHKPSGL---VMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
I+ A + E G L + L + + + I K++I V GL+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLT 118
Query: 210 YMIED-GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ E +H DV N LV S +K+ D G S D + V + +PE L
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGTR-SYMSPERL 175
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV 312
Q + + ++WS G+ L E+ G+ P ++
Sbjct: 176 -------QGTHYSVQSDIWSMGLSLVEMA-VGRYPIPPPDAKEL 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-33
Identities = 51/255 (20%), Positives = 99/255 (38%), Gaps = 20/255 (7%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
V+ +G G +G+V + T V V+I+ + E + L H
Sbjct: 10 VQTLGEGAYGEVQ----LAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
N+++ E + L E CS G+L + + + + + + + G+
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVV 117
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ G H D+ N L+ +KI D G +++ +Y + ++ + + APE L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAPR 328
+ E +VWS G++L + G+LP+ + SD + + L +
Sbjct: 178 KRREFH------AEPVDVWSCGIVLTAML-AGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 329 AVNSHVDVAARNCLV 343
++S LV
Sbjct: 231 KIDSAPLALLHKILV 245
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (84), Expect = 0.004
Identities = 13/53 (24%), Positives = 25/53 (47%), Gaps = 1/53 (1%)
Query: 333 HVDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGEVALPVRWCAPESLL 384
H D+ N L+ +KI D G +++ +Y + ++ + + APE L
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 34/236 (14%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+ IG+G FG+V G+ RG +V V+I + F E LRH
Sbjct: 9 ESIGKGRFGEVWRGKWRG---------EEVAVKIFSSR--EERSWFREAEIYQTVMLRHE 57
Query: 151 NILRLMAACLESDPWL----LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
NIL +AA + + LV + G L ++L + E + IK+A+ A+
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM------IKLALSTAS 111
Query: 207 GLSYMIED--------GFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH---GE 255
GL+++ + H D+ ++N LV I D G ++ +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311
R+ APE +L +++ ++ ++++ G++ WEI D Q
Sbjct: 172 RVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQ 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (83), Expect = 0.004
Identities = 13/54 (24%), Positives = 20/54 (37%), Gaps = 3/54 (5%)
Query: 333 HVDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH---GEVALPVRWCAPESL 383
H D+ ++N LV I D G ++ + R+ APE L
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-31
Identities = 54/256 (21%), Positives = 92/256 (35%), Gaps = 28/256 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL--FFLHEATPYRRL 147
+ +G+G FG V E+ + + +++L + + + E L
Sbjct: 11 GRPLGKGKFGNVY----LAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
RH NILRL ++ L+ E G + L + + ++ T ++A
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 118
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
LSY IH D+ N L+ S +KI D G S+ + + + PE
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPE- 174
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
I+ EK ++WS GVL +E GK P+ + + R+ + P
Sbjct: 175 ------MIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRIS---RVEFTFP 224
Query: 328 RAVNSHVDVAARNCLV 343
V L
Sbjct: 225 DFVTEGARDLISRLLK 240
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (298), Expect = 5e-31
Identities = 51/255 (20%), Positives = 95/255 (37%), Gaps = 27/255 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
++E+G G FG V R +E++TGR + + + +E + +L H
Sbjct: 34 LEELGSGAFGVVH----RCVEKATGR---VFVAKFINTPYPLDKYTV-KNEISIMNQLHH 85
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
++ L A + +L+ E S G+L + + + + + + I GL
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLK 141
Query: 210 YMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
+M E +H D+ N + + VKI D G + P + + APE
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPE- 198
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ V ++W+ GVL + + G P+A D + + V
Sbjct: 199 ------IVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQNVK---RCDWEFD 248
Query: 328 RAVNSHVDVAARNCL 342
S V A++ +
Sbjct: 249 EDAFSSVSPEAKDFI 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-30
Identities = 48/255 (18%), Positives = 93/255 (36%), Gaps = 28/255 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+++GRG FG V R +E S+ +T + +K + E + RH
Sbjct: 10 AEDLGRGEFGIVH----RCVETSSKKT---YMAKFVKVKGTDQV--LVKKEISILNIARH 60
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NIL L + + +++FE S D+ E + ++ L + + V L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQ 116
Query: 210 YMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
++ H D+ N + + +KI + G + PGD + A
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-- 174
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
Q V+ ++WS G L++ + G P+ ++ Q+I + E
Sbjct: 175 -------HQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETNQQIIENIMNAE---YTFD 223
Query: 328 RAVNSHVDVAARNCL 342
+ + A + +
Sbjct: 224 EEAFKEISIEAMDFV 238
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 116 bits (292), Expect = 4e-30
Identities = 50/255 (19%), Positives = 100/255 (39%), Gaps = 27/255 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+E+G G FG V R E +TG + + +++K E LRH
Sbjct: 31 HEELGTGAFGVVH----RVTERATGN---NFAAKFVMTP-HESDKETVRKEIQTMSVLRH 82
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
++ L A + + ++++E S G+L E + A + + ++ V GL
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 210 YMIEDGFIHTDVAARNCLVTSEL--RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
+M E+ ++H D+ N + T++ +K+ D G + + + APE
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPE- 195
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ V ++WS GVL + + G P+ +DD+ + V +
Sbjct: 196 ------VAEGKPVGYYTDMWSVGVLSYILL-SGLSPFGGENDDETLRNVK---SCDWNMD 245
Query: 328 RAVNSHVDVAARNCL 342
+ S + ++ +
Sbjct: 246 DSAFSGISEDGKDFI 260
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 7e-30
Identities = 58/265 (21%), Positives = 99/265 (37%), Gaps = 32/265 (12%)
Query: 87 LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYR 145
L + EIGRG F V +GL+ T +V + +++E+ F EA +
Sbjct: 11 LKFDIEIGRGSFKTVY----KGLDTETTV---EVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 146 RLRHVNILRLMAACLES----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMA 201
L+H NI+R + + +LV E + G LK +L + + +L
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL-----RSWC 118
Query: 202 IDVATGLSYMIEDG--FIHTDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDYYVHGEVAL 258
+ GL ++ IH D+ N +T VKIGD G + + +
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAVIGT 176
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318
P + APE E +V++FG+ + E+ + PY+E + I R
Sbjct: 177 P-EFMAPEMY--------EEKYDESVDVYAFGMCMLEMA-TSEYPYSECQNAAQIYRRVT 226
Query: 319 TEALRLPAPRAVNSHVDVAARNCLV 343
+ + V C+
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIR 251
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 7e-29
Identities = 45/230 (19%), Positives = 85/230 (36%), Gaps = 24/230 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAE---KLFFLHEATPYRR 146
K +G+G FGKV E + T + ++ LK+D + + + +
Sbjct: 7 HKMLGKGSFGKVFLAEFK----KTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 147 LRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
H + + + V E + GDL + S + A ++
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAEIIL 114
Query: 207 GLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266
GL ++ G ++ D+ N L+ + +KI D G + GD + APE
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPE 173
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316
+ + WSFGVLL+E+ G+ P+ ++++ +
Sbjct: 174 -------ILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELFHSI 215
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 7e-29
Identities = 43/268 (16%), Positives = 97/268 (36%), Gaps = 30/268 (11%)
Query: 83 PRQQ----LHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL--F 136
PR++ + K +G G F VV E +T R + ++IL++ E +
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVV----LARELATSR---EYAIKILEKRHIIKENKVPY 54
Query: 137 FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI 196
E RL H ++L + + G+L +++ + ++
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETC 109
Query: 197 TIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG-SSIDKYPGDYYVHGE 255
T ++ + L Y+ G IH D+ N L+ ++ ++I D G + +
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 256 VALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315
++ +PE + + + ++W+ G +++++ G P+ ++ + +
Sbjct: 170 FVGTAQYVSPE-------LLTEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQK 221
Query: 316 VFGTEALRLPAPRAVNSHVDVAARNCLV 343
+ L P LV
Sbjct: 222 II---KLEYDFPEKFFPKARDLVEKLLV 246
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (275), Expect = 2e-28
Identities = 50/261 (19%), Positives = 100/261 (38%), Gaps = 20/261 (7%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRT-----TSKVFVRILKEDASQAEKLFFLHEATPY 144
+ +GRG V R + + T + + Q + L E
Sbjct: 8 KEILGRGVSSVVR----RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 145 RRLR-HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
R++ H NI++L + + LVF+ +G+L ++L + + L + T K+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRA 118
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+ + + + +H D+ N L+ ++ +K+ D G S PG+ V +
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYL 176
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF-GTEAL 322
APE + CS + ++ ++WS GV+++ + G P+ ++ + G
Sbjct: 177 APEIIECS-MNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 323 RLPAPRAVNSHVDVAARNCLV 343
P + V LV
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLV 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (275), Expect = 4e-28
Identities = 41/256 (16%), Positives = 97/256 (37%), Gaps = 28/256 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+G G F +V+ ++ T + V ++ + + A + ++ +E +++H
Sbjct: 14 RDVLGTGAFSEVI----LAEDKRTQK---LVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NI+ L L+ + S G+L + + + + ++ V +
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAVK 121
Query: 210 YMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPE 266
Y+ + G +H D+ N L S + ++ I D G S + PG + AP
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAP- 178
Query: 267 SLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPA 326
+ ++ + WS GV+ + + G P+ + +D ++ ++ E
Sbjct: 179 ------EVLAQKPYSKAVDCWSIGVIAYILL-CGYPPFYDENDAKLFEQILKAE---YEF 228
Query: 327 PRAVNSHVDVAARNCL 342
+ +A++ +
Sbjct: 229 DSPYWDDISDSAKDFI 244
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-25
Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 20/229 (8%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKED-ASQAEKLFFLHEATPYRRLR 148
V++IG G +G V + + TG V ++ ++ D ++ + E + + L
Sbjct: 7 VEKIGEGTYGVVY----KARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI++L+ + LVFE + DLK+F+ ++ + + + + GL
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG---IPLPLIKSYLFQLLQGL 115
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
++ +H D+ +N L+ +E +K+ D G + EV + APE L
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL-WYRAPEIL 174
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
L + ++WS G + E+ + + S+ + R+F
Sbjct: 175 L------GCKYYSTAVDIWSLGCIFAEMV-TRRALFPGDSEIDQLFRIF 216
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 101 bits (253), Expect = 3e-25
Identities = 47/261 (18%), Positives = 94/261 (36%), Gaps = 31/261 (11%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEATPYRRL 147
+ +G G +V + R V V++L+ D ++ + F EA L
Sbjct: 12 GEILGFGGMSEVH----LARDLRLHR---DVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 148 RHVNILRLMAACLESDPWL----LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
H I+ + P +V E L++ + + I++ D
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA-----IEVIAD 119
Query: 204 VATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVH--GEVALPVR 261
L++ ++G IH DV N ++++ VK+ D G + V V +
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321
+ +PE + +V + +V+S G +L+E+ G+ P+ S V + +
Sbjct: 180 YLSPEQA-------RGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSPVSVAYQHVRED- 230
Query: 322 LRLPAPRAVNSHVDVAARNCL 342
P A + + +
Sbjct: 231 --PIPPSARHEGLSADLDAVV 249
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 4e-25
Identities = 49/256 (19%), Positives = 94/256 (36%), Gaps = 29/256 (11%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKL--FFLHEATPYRRL 147
++ +G G FG+V +R GR +++LK++ K E +
Sbjct: 9 LRTLGTGSFGRVHLIRSR----HNGR---YYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
H I+R+ ++ ++ + G+L L ++ + A +V
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-----PVAKFYAAEVCLA 116
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
L Y+ I+ D+ N L+ +KI D G + Y + G + APE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG----TPDYIAPEV 172
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ T + + WSFG+L++E+ G P+ + + + ++ E L P
Sbjct: 173 V-------STKPYNKSIDWWSFGILIYEML-AGYTPFYDSNTMKTYEKILNAE---LRFP 221
Query: 328 RAVNSHVDVAARNCLV 343
N V +
Sbjct: 222 PFFNEDVKDLLSRLIT 237
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 4e-24
Identities = 46/262 (17%), Positives = 101/262 (38%), Gaps = 34/262 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF-----FLHEATPY 144
+E+G G F V + E+STG + + +K+ +++ + E +
Sbjct: 15 GEELGSGQFAVVK----KCREKSTGL---QYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 145 RRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+ ++H N++ L +L+ E + G+L +FL E+ E + +
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-----EATEFLKQI 122
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSE----LRVKIGDTGSSIDKYPGDYYVHGEVALPV 260
G+ Y+ H D+ N ++ R+KI D G + G+ + + +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTP 180
Query: 261 RWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320
+ APE + + + ++WS GV+ + + G P+ + + + V
Sbjct: 181 EFVAPEIVNYE-------PLGLEADMWSIGVITYILL-SGASPFLGDTKQETLANVS--- 229
Query: 321 ALRLPAPRAVNSHVDVAARNCL 342
A+ S+ A++ +
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFI 251
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.8 bits (248), Expect = 5e-24
Identities = 44/256 (17%), Positives = 85/256 (33%), Gaps = 21/256 (8%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTS--KVFVRILKEDASQAEKLFFLHEATPYRRL 147
+ IGRG FG+V + TG+ + + + +K + L +
Sbjct: 9 HRIIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
I+ + A D + + + GDL L + EA + A ++ G
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIILG 119
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
L +M ++ D+ N L+ V+I D G + D + + APE
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEV 176
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
L + +S G +L+++ G P+ + T + + P
Sbjct: 177 LQKG------VAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTKDKHEIDRMTLTMAVELP 229
Query: 328 RAVNSHVDVAARNCLV 343
+ + + L
Sbjct: 230 DSFSPELRSLLEGLLQ 245
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 98.0 bits (243), Expect = 7e-24
Identities = 45/230 (19%), Positives = 88/230 (38%), Gaps = 24/230 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRL 147
+++IG G +G V + + + F +I E + + E + + L
Sbjct: 7 LEKIGEGTYGVVYKAQ---------NNYGETFALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
+H NI++L +LVFE + K E LE + + G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNG 112
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
++Y + +H D+ +N L+ E +KI D G + E+ + AP+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-YRAPDV 171
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
L+ + + ++WS G + E+ G + +S+ + R+F
Sbjct: 172 LM------GSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIF 214
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 9e-24
Identities = 50/268 (18%), Positives = 93/268 (34%), Gaps = 28/268 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+ IG G +G V + +V ++ + Q L E R RH
Sbjct: 13 LSYIGEGAYGMVC----SAYDNVNKV---RVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 150 VNILRLMAACLESD----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVA 205
NI+ + + + DL + L + S + + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC------YFLYQIL 119
Query: 206 TGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVALPVRWC 263
GL Y+ +H D+ N L+ + +KI D G + D E +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323
APE +L S T+ ++WS G +L E+ + + + + L
Sbjct: 180 APEIMLNS------KGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHIL--GILG 230
Query: 324 LPAPRAVNSHVDVAARNCLVTSELRVKI 351
P+ +N +++ ARN L++ + K+
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKV 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 4e-23
Identities = 48/256 (18%), Positives = 98/256 (38%), Gaps = 26/256 (10%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF--FLHEATPYRRL 147
+K +G+G FGKV+ E++TGR ++IL+++ A+ + E+ +
Sbjct: 10 LKLLGKGTFGKVI----LVREKATGR---YYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 148 RHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATG 207
RH + L A D V E + G+L L SRE + + ++ +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSA 117
Query: 208 LSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPES 267
L Y+ ++ D+ N ++ + +KI D G + + P
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL----- 172
Query: 268 LLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALRLPAP 327
+ ++ + W GV+++E+ G+LP+ +++ + E + P
Sbjct: 173 ---APEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELILMEE---IRFP 225
Query: 328 RAVNSHVDVAARNCLV 343
R ++ L
Sbjct: 226 RTLSPEAKSLLAGLLK 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 4e-23
Identities = 43/239 (17%), Positives = 86/239 (35%), Gaps = 29/239 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV-RILKEDASQAEKLFFLHEATPYRRLR 148
+ +IG+G FG+V + R TG+ KV + ++L E+ + + L E + L+
Sbjct: 15 LAKIGQGTFGEVFKARHR----KTGQ---KVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 149 HVNILRLMAACLESDP--------WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKM 200
H N++ L+ C LVF+ C + ++
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRV 122
Query: 201 AIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS--IDKYPGDYYVHGEVAL 258
+ GL Y+ + +H D+ A N L+T + +K+ D G + +
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 259 PVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
W P LL + ++W G ++ E++ ++ + +
Sbjct: 183 VTLWYRPPELLLGERD-----YGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 8e-23
Identities = 45/260 (17%), Positives = 90/260 (34%), Gaps = 33/260 (12%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHV 150
+ +G G GKV+ + + T K +++L+ D +A + LH +R +
Sbjct: 18 QVLGLGINGKVL----QIFNKRTQE---KFALKMLQ-DCPKARREVELH----WRASQCP 65
Query: 151 NILRLMAAC----LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVAT 206
+I+R++ L+V E G+L + + ++ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGE 122
Query: 207 GLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWC 263
+ Y+ H DV N L TS +K+ D G + + + +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYV 180
Query: 264 APESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF-GTEAL 322
APE L + C++WS GV+++ + G P+ + +
Sbjct: 181 APEVL-------GPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 323 RLPAPRAVNSHVDVAARNCL 342
+ P S V + +
Sbjct: 233 QYEFPNPEWSEVSEEVKMLI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.5 bits (234), Expect = 1e-22
Identities = 39/248 (15%), Positives = 79/248 (31%), Gaps = 33/248 (13%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
++IG G FG + G + + G +V +++ + E+ Y+ ++
Sbjct: 12 GRKIGSGSFGDIY----LGTDIAAGE---EVAIKLECVKTKHPQ---LHIESKIYKMMQG 61
Query: 150 VNILRLMAACL-ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
+ + C E D ++V E F + +A + + +
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN-----FCSRKFSLKTVLLLADQMISRI 116
Query: 209 SYMIEDGFIHTDVAARNCLVTSE---LRVKIGDTGSSIDKYPGD------YYVHGEVALP 259
Y+ FIH DV N L+ V I D G + Y + +
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319
R+ + + + + ++ S G +L G LP+ L +
Sbjct: 177 ARYASIN-------THLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKRQKYERI 228
Query: 320 EALRLPAP 327
++ P
Sbjct: 229 SEKKMSTP 236
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 1e-22
Identities = 38/228 (16%), Positives = 73/228 (32%), Gaps = 18/228 (7%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTS-KVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
+G G F V + +++T + + K + +A L E + L H
Sbjct: 4 DFLGEGQFATVY----KARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLS 209
NI+ L+ A LVF+ ++ + + + GL
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI-----KAYMLMTLQGLE 114
Query: 210 YMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLL 269
Y+ + +H D+ N L+ +K+ D G + + +V
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF- 173
Query: 270 CSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
++W+ G +L E+ SD +TR+F
Sbjct: 174 ------GARMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTRIF 214
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-22
Identities = 48/238 (20%), Positives = 84/238 (35%), Gaps = 31/238 (13%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKLFFLHEATPYRRL 147
V EIG G +GKV + + + R+ + + L + E R L
Sbjct: 12 VAEIGEGAYGKVFKARDL-------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 148 ---RHVNILRLMAACLESDP-----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIK 199
H N++RL C S LVFE + E +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKD 120
Query: 200 MAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALP 259
M + GL ++ +H D+ +N LVTS ++K+ D G + + V +
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--RIYSFQMALTSVVVT 178
Query: 260 VRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
+ + AP + + ++WS G + E+F K + SD + ++
Sbjct: 179 LWYRAP-------EVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKIL 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 8e-22
Identities = 49/260 (18%), Positives = 98/260 (37%), Gaps = 22/260 (8%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFV--RILKEDASQAEKL--FFLHEATPYR 145
+K +G G +GKV + +G T K++ + K Q K E
Sbjct: 29 LKVLGTGAYGKVFLVR-----KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 146 RLRHV-NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
+R ++ L A L+ + + G+L L + RE E + I + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVG-EI 138
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCA 264
L ++ + G I+ D+ N L+ S V + D G S + + + + + A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 265 PESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF-GTEALR 323
P+ + D+ + + WS GVL++E+ G P+ + +
Sbjct: 199 PDIVRGGDSGH-----DKAVDWWSLGVLMYELL-TGASPFTVDGEKNSQAEISRRILKSE 252
Query: 324 LPAPRAVNSHVDVAARNCLV 343
P P+ +++ + L+
Sbjct: 253 PPYPQEMSALAKDLIQRLLM 272
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 1e-21
Identities = 44/229 (19%), Positives = 79/229 (34%), Gaps = 20/229 (8%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILK-EDASQAEKLFFLHEATPYRRLR 148
+++IG G +G V + + R T V ++ ++ +D + L E + L+
Sbjct: 7 LEKIGEGTYGTVFKAKNR----ETHE---IVALKRVRLDDDDEGVPSSALREICLLKELK 59
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H NI+RL LVFE C + K F N I + GL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----IVKSFLFQLLKGL 114
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
+ +H D+ +N L+ +K+ + G + EV
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
+ ++WS G + E+ G+ + D + R+F
Sbjct: 175 -------GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 1e-20
Identities = 48/235 (20%), Positives = 80/235 (34%), Gaps = 30/235 (12%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
K IG G FG V + + +G V ++ + +D K F E R+L H
Sbjct: 25 TKVIGNGSFGVVYQAKLC----DSGE---LVAIKKVLQD-----KRFKNRELQIMRKLDH 72
Query: 150 VNILRLMAACLESDPW------LLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAID 203
NI+RL S LV + + + + + + L
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR--VARHYSRAKQTLPVIYVKLYMYQ 130
Query: 204 VATGLSYMIEDGFIHTDV-AARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+ L+Y+ G H D+ L +K+ D GS+ G+ V +
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYY 188
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
APE + T +VWS G +L E+ G+ + S + +
Sbjct: 189 RAPELIF------GATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEII 236
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 2e-20
Identities = 37/223 (16%), Positives = 76/223 (34%), Gaps = 29/223 (13%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF-----FLHEATPY 144
+G G FG V G+ S V ++ +++D E
Sbjct: 9 GPLLGSGGFGSVY----SGIRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 145 RRLR--HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
+++ ++RL+ D ++L+ E ++ + L++ +
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFW 117
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVT-SELRVKIGDTGSSIDKYPGDYYVHGEVALPVR 261
V + + G +H D+ N L+ + +K+ D GS Y +
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRV 174
Query: 262 WCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ PE + VWS G+LL+++ G +P+
Sbjct: 175 YSPPEWIRYHR------YHGRSAAVWSLGILLYDMV-CGDIPF 210
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.7 bits (219), Expect = 3e-20
Identities = 47/274 (17%), Positives = 100/274 (36%), Gaps = 29/274 (10%)
Query: 71 MQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS 130
++ W S+ Q +K +G G FG+V+ + +G ++IL +
Sbjct: 27 LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVM----LVKHKESGN---HYAMKILDKQKV 79
Query: 131 QAEKLF--FLHEATPYRRLRHVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASR 188
K L+E + + +++L + ++ +V E + G++ L R
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RR 134
Query: 189 EALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPG 248
+ A + Y+ I+ D+ N L+ + +++ D G +
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 249 DYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS 308
+ + G APE +L + + W+ GVL++E+ G P+
Sbjct: 195 TWTLCG----TPEALAPEIILSK-------GYNKAVDWWALGVLIYEMA-AGYPPFFADQ 242
Query: 309 DDQVITRVFGTEALRLPAPRAVNSHVDVAARNCL 342
Q+ ++ + + P +S + RN L
Sbjct: 243 PIQIYEKIVSGK---VRFPSHFSSDLKDLLRNLL 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 88.0 bits (217), Expect = 5e-20
Identities = 62/287 (21%), Positives = 105/287 (36%), Gaps = 48/287 (16%)
Query: 44 PLPTL--VPPQHNVKRPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKV 101
P+P+ V N RP Y + ++ W + ++Q V+++GRG + +V
Sbjct: 2 PVPSRARVYTDVNTHRPREYWD--YESHVVE-WGNQDDYQL-------VRKLGRGKYSEV 51
Query: 102 VEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACL 160
+ + KV V+ILK + E LR NI+ L
Sbjct: 52 F----EAINITNNE---KVVVKILKPVKKKK----IKREIKILENLRGGPNIITLADIVK 100
Query: 161 E--SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIH 218
+ S LVFE + D K+ + L + I ++ L Y G +H
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDI-RFYMYEILKALDYCHSMGIMH 152
Query: 219 TDVAARNCLVTSE-LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQT 277
DV N ++ E ++++ D G + +PG Y A + +
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--------RVASRYFKGPELLVDY 204
Query: 278 CTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDD----QVITRVFGTE 320
++WS G +L + F K P+ D+ I +V GTE
Sbjct: 205 QMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLVRIAKVLGTE 250
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 84.5 bits (208), Expect = 5e-19
Identities = 33/255 (12%), Positives = 70/255 (27%), Gaps = 37/255 (14%)
Query: 88 HY--VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYR 145
HY + IG G FG + G + +V ++ + + E Y+
Sbjct: 6 HYKVGRRIGEGSFGVIF----EGTNLLNNQ---QVAIKFEPRRSDAPQ---LRDEYRTYK 55
Query: 146 RLRHVN-ILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDV 204
L I + E +LV + A +
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQM 110
Query: 205 ATGLSYMIEDGFIHTDVAARNCLVTSEL-----RVKIGDTGSS------IDKYPGDYYVH 253
+ + E ++ D+ N L+ + + D G + K Y
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 254 GEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI 313
++ R+ + + L + + + ++ + G + G LP+ L
Sbjct: 171 KNLSGTARYMSINTHLGRE-------QSRRDDLEALGHVFMYFL-RGSLPWQGLKAATNK 222
Query: 314 TRVFGTEALRLPAPR 328
+ + P
Sbjct: 223 QKYERIGEKKQSTPL 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-17
Identities = 44/229 (19%), Positives = 78/229 (34%), Gaps = 20/229 (8%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL-KEDASQAEKLFFLHEATPYRRLR 148
++ +G G +G V ++ TG KV ++ L + S+ E + +R
Sbjct: 23 LQPVGSGAYGAVC----SAVDGRTGA---KVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 149 HVNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGL 208
H N++ L+ + + L E L E I + + GL
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-QFLVYQMLKGL 134
Query: 209 SYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESL 268
Y+ G IH D+ N V + +KI D G + D + G V L
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRAPEVIL 191
Query: 269 LCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
T+ ++WS G ++ E+ GK + + +
Sbjct: 192 -------NWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIM 232
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 7e-16
Identities = 45/267 (16%), Positives = 86/267 (32%), Gaps = 41/267 (15%)
Query: 57 RPPAYSEELVRQLSMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRT 116
RP Y +EL + + ++ P + + +G G +G V + TG
Sbjct: 1 RPTFYRQEL----------NKTIWEVPER-YQNLSPVGSGAYGSVC----AAFDTKTGL- 44
Query: 117 TSKVFVRIL-KEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDPW-----LLVFE 170
+V V+ L + S E + ++H N++ L+ + + +
Sbjct: 45 --RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 171 SCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230
DL + L + + GL Y+ IH D+ N V
Sbjct: 103 HLMGADLNNI------VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156
Query: 231 ELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFG 290
+ +KI D G + D + G VA L + ++WS G
Sbjct: 157 DCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIML-------NWMHYNQTVDIWSVG 206
Query: 291 VLLWEIFEFGKLPYAELSDDQVITRVF 317
++ E+ G+ + + +
Sbjct: 207 CIMAELL-TGRTLFPGTDHIDQLKLIL 232
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (177), Expect = 8e-15
Identities = 44/235 (18%), Positives = 81/235 (34%), Gaps = 32/235 (13%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRIL-KEDASQAEKLFFLHEATPYRRLR 148
+K IG G G V + R V ++ L + +Q E + +
Sbjct: 22 LKPIGSGAQGIVC----AAYDAVLDR---NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 149 HVNILRLMAACL------ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAI 202
H NI+ L+ E LV E + + + R + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS--------YLLY 126
Query: 203 DVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKYPGDYYVHGEVALPVRW 262
+ G+ ++ G IH D+ N +V S+ +KI D G + + G ++ + +
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRYY 184
Query: 263 CAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317
APE I E ++WS G ++ E+ K+ + +V
Sbjct: 185 RAPE-------VILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVI 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.5 bits (166), Expect = 2e-13
Identities = 41/233 (17%), Positives = 78/233 (33%), Gaps = 39/233 (16%)
Query: 90 VKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149
V+++G G F V + V ++I++ D E E +R+
Sbjct: 18 VRKLGWGHFSTVW----LAKDMVNNT---HVAMKIVRGDKVYTEA--AEDEIKLLQRVND 68
Query: 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGI-----------TI 198
+ + + LL + + ++ E E LL
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 199 KMAIDVATGLSYMIED-GFIHTDVAARNCLVTSE------LRVKIGDTGSSIDKYPGDYY 251
+++ + GL YM G IHTD+ N L+ +++KI D G++
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 252 VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPY 304
+ +PE LL + ++WS L++E+ G +
Sbjct: 189 SIQ----TREYRSPEVLLGAP-------WGCGADIWSTACLIFELI-TGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 24/167 (14%), Positives = 50/167 (29%), Gaps = 34/167 (20%)
Query: 91 KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLF---------FLHEA 141
K +G G V + V+ K + +K+ F A
Sbjct: 6 KLMGEGKESAVFNC--------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 142 TPYRRLRHVNILRL----MAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGIT 197
R + +L + + ++ E +L + N
Sbjct: 58 IRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD----------- 106
Query: 198 IKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244
++ + ++ G +H D++ N LV+ E + I D S++
Sbjct: 107 -EVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.52 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.33 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-61 Score=441.67 Aligned_cols=266 Identities=29% Similarity=0.519 Sum_probs=231.7
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
+.|+++.++|++.+.||+|+||+||+|+++. ++..||||+++.+.... +.+.+|+.+|++++|||||+++|
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~--~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGG-------GTEEEEEEECCTTCSCH--HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECC-------CCeEEEEEEECCccchH--HHHHHHHHHHHhCCCCCEecCCc
Confidence 4689999999999999999999999999873 45589999987655332 23679999999999999999999
Q ss_pred EEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 158 ACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 158 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
+|.+++.++||||||++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 99999999999999999999999976432 226778888999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+|+..............+++.|||||++.... |+.++|||||||++|||++.|.+||.+.+..++...+.
T Consensus 158 DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~ 230 (287)
T d1opja_ 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230 (287)
T ss_dssp CCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC-------CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cccceeecCCCCceeeccccccccccChHHHcCCC-------CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh
Confidence 99999876555555555567888999999987765 88999999999999999985566777778888777776
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
.+. +++.|..+++.+.++|++||+.||+ |||+.|++..|+.+..+
T Consensus 231 ~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 231 KDY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred cCC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 665 7788899999999999999999998 99999999999888754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-60 Score=441.90 Aligned_cols=266 Identities=27% Similarity=0.461 Sum_probs=219.8
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++.+.||+|+||+||+|+++... .....||||.+...........+.+|+.+|++++|||||+++|++.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCC----CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 455688999999999999999999987422 2334688998877666555566789999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+++.++||||||++|+|.+++..... .+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eCCEEEEEEEecCCCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcc
Confidence 99999999999999999999876432 26777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCcee----eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 241 SSIDKYPGDYY----VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 241 ~a~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|+........ ......+|+.|||||++.... ++.++|||||||++|||+|+|+.||.+.+..+++..+
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-------FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCC-------CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99765432211 112235788999999987665 8899999999999999998789999999999999999
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+. +++.|..+++.+.++|++||+.||+ ||++.|++..|++++.
T Consensus 247 ~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 EQDY--RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 8776 7888899999999999999999998 9999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-60 Score=435.44 Aligned_cols=262 Identities=30% Similarity=0.511 Sum_probs=227.6
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
.++|+|+.++|++.+.||+|+||.||+|++++ ...||||+++...... ..+.+|+.+|++++|||||+++
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~--~~~~~E~~~l~~l~HpnIv~~~ 74 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNG--------HTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLY 74 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETT--------TEEEEEEEECTTSSCH--HHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECC--------CCEEEEEEEccCcCCH--HHHHHHHHHHHhCCCCCEeEEE
Confidence 56899999999999999999999999999863 3479999987654322 2367999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
|++.+ +.++||||||++|+|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||
T Consensus 75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred eeecc-CCeEEEEEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceee
Confidence 98754 678999999999999998865422 22688888999999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 237 GDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 237 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
+|||+|+..............+|+.|||||++.... ++.++|||||||++|||+|.|.+||...+..+++..+
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i 223 (272)
T d1qpca_ 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-------FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (272)
T ss_dssp CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccccceEEccCCccccccccCCcccccChHHHhCCC-------CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999876655555555667899999999987655 7899999999999999998677888888888998888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
..+. +++.|..+++++.+++++||+.+|+ |||+.|+++.|+.+
T Consensus 224 ~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 224 ERGY--RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcC--CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 8776 7788899999999999999999998 99999999888753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-61 Score=438.60 Aligned_cols=266 Identities=26% Similarity=0.374 Sum_probs=214.8
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
++|+++.++|++.+.||+|+||+||+|++++ .||||+++... .......+.+|+.+|++++|||||+++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 70 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG----------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS----------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC----------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence 4789999999999999999999999998652 58999986543 333445577999999999999999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEE
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKI 236 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl 236 (394)
|++. .+.++||||||++|+|.++|..... .+++..+..++.||+.||.|||+++||||||||+|||++.++.+||
T Consensus 71 ~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 71 GYST-APQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp EEEC-SSSCEEEEECCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEe-ccEEEEEEecCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEE
Confidence 9875 4678999999999999999975432 2677788899999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H
Q psy7505 237 GDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVI-T 314 (394)
Q Consensus 237 ~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~-~ 314 (394)
+|||+|+....... .......||+.|||||++..... ..|+.++|||||||++|||+| |+.||.+.+..+.+ .
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~~~~~~~ 220 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIF 220 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSS----CCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccC----CCCCchhhhhhhHHHHHHHHH-CCCCCCCCChHHHHHH
Confidence 99999976543222 22345678999999999875431 138899999999999999999 99999988765544 4
Q ss_pred HHhcCCCc--CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 315 RVFGTEAL--RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 315 ~i~~~~~~--~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+..+... ....+..+++.+.++|.+||..+|+ |||+.|++..|+.+.+
T Consensus 221 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 44444311 1124568899999999999999998 9999999999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-60 Score=434.59 Aligned_cols=263 Identities=25% Similarity=0.464 Sum_probs=225.6
Q ss_pred ceecCCCeEEEce-eeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 80 FQFPRQQLHYVKE-IGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~-lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
+.+.+++|.+.+. ||+|+||+||+|.++... ....||||+++..........+.+|+.+|++++|||||+++|+
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRK-----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCC-----CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 4567888999884 999999999999886322 2347999999877666666667899999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+ +.+|||||||++|+|.+++..... .+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECC
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeecc
Confidence 865 578999999999999999865432 267788899999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy7505 239 TGSSIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRV 316 (394)
Q Consensus 239 FG~a~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i 316 (394)
||+|+......... .....||+.|||||++.... ++.++|||||||++|||+|.|+.||.+.+..+++..+
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred chhhhcccccccccccccccccCccccChHHHhCCC-------CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99998664433222 23447889999999987665 7899999999999999998799999999988999888
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
..+. +++.|..+++++.++|++||+.+|+ ||++.++.+.|+..
T Consensus 226 ~~~~--~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 226 EQGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCC--CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 8876 7788899999999999999999998 99999999888754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-60 Score=435.24 Aligned_cols=267 Identities=30% Similarity=0.518 Sum_probs=220.9
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
+|+|++++|++.+.||+|+||.||+|++.... .....||||.++..........+.+|+.+|++++|||||+++|+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~----~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPE----NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCC----ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 58999999999999999999999999987422 23457889988776666666667899999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+. .+.+|+|||||++|+|.+++..... .+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEcc
Confidence 96 4679999999999999998865432 267788899999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+|+..............+|+.|+|||++.... |+.++|||||||++|||++.|..||.+.+..+++.++..
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-------~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~ 224 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCC-------CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred chhheeccCCcceeccceecCcccchhhHhccCC-------CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999865544444445567899999999997665 889999999999999999879999999999999999988
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+. +++.|..+++.+.++|.+||+.||+ |||+.|++..|+++++
T Consensus 225 ~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 225 GE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 76 6788899999999999999999998 9999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-60 Score=430.93 Aligned_cols=257 Identities=32% Similarity=0.553 Sum_probs=213.7
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.++|++.+.||+|+||.||+|++++ +..||||+++...... ..+.+|+.++++++|||||+++|+|.++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~--------~~~vAvK~i~~~~~~~--~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN--------KDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT--------TEEEEEEECCSSSSCH--HHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC--------CCEEEEEEECCCcCcH--HHHHHHHHHHHhcCCCCcccccceeccC
Confidence 45789999999999999999999863 3379999987654322 2367999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred CceEEEEEecCCCcHHHHhhcccc----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchh
Confidence 999999999999999999876432 2567778899999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+..............||+.|||||++.+.. |+.++|||||||++|||+|.|.+||...+..+++..+..+.
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-- 219 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSR-------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-- 219 (263)
T ss_dssp ----------------CTTSCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC--
T ss_pred eeccCCCceeecceecCcccCChHHhcCCC-------CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC--
Confidence 866544444444557889999999997665 88999999999999999987788899888989988888776
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+++.|..+++++.++|.+||+.||+ ||++.|+++.|+++.
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 7788899999999999999999998 999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-60 Score=444.85 Aligned_cols=272 Identities=33% Similarity=0.569 Sum_probs=224.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|++++++|++.+.||+|+||+||+|++++..+. .....||+|.+...........+.+|+.+|+++ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT--GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSS--SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcc--cceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 46889999999999999999999999998754322 233478999987665555555677999999998 899999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchh------------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEAS------------------REALLEQGITIKMAIDVATGLSYMIEDGFIH 218 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiH 218 (394)
+++.+.+.++||||||++|+|.++|+..... ....+++..++.++.||+.||.|||+++|||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9999999999999999999999999765321 1123677888999999999999999999999
Q ss_pred cCCCCCCEEEcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHH
Q psy7505 219 TDVAARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIF 297 (394)
Q Consensus 219 rDlk~~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~ 297 (394)
|||||+|||++.++.+||+|||+|+...... ........||+.|||||++.... |+.++|||||||++|||+
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-------YTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHT
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-------CCcceeccchhHHHHHHH
Confidence 9999999999999999999999997654332 23344557899999999987665 889999999999999999
Q ss_pred cCCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhh
Q psy7505 298 EFGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSID 359 (394)
Q Consensus 298 t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~ 359 (394)
|.|..||.+.+..+.+.++..+. .+++.|..+++++.+||++||+.+|+ |||+.||++.|.
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 87899999877655555444332 37888999999999999999999998 999999999885
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=425.67 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=215.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|+++. ++..||+|++..... ......+.+|+.+|++++|||||++++++.+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhHeEEEEEEecCCCcEEEEEEECC-------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 4689999999999999999999873 455899998865431 1223446799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+|||||||++|+|.+++...+. +++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~~~-----l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred CCEEEEEEeecCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccce
Confidence 9999999999999999999976433 67788899999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+...... .....||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++..+.++
T Consensus 153 a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~-------~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~-- 219 (263)
T d2j4za1 153 SVHAPSSR---RTTLCGTLDYLPPEMIEGRM-------HDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-- 219 (263)
T ss_dssp CSCCCCCC---CEETTEEGGGCCHHHHTTCC-------CCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT--
T ss_pred eeecCCCc---ccccCCCCcccCHHHHcCCC-------CCchhhhhhHhHHHHHHhc-CCCCCCCCCHHHHHHHHHcC--
Confidence 97654332 22457899999999997655 7899999999999999998 99999999999998888776
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++.|..+++++.+++++||+.||+ |||+.|+++
T Consensus 220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 4667889999999999999999998 999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=426.91 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=215.4
Q ss_pred CCCeEEE-ceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYV-KEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
++.+.+. ++||+|+||+||+|.++.. .....||||+++... .......+.+|+.+|++++|||||+++|+|.+
T Consensus 5 ~~~~~le~k~iG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 5 RKLLTLEDKELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred hhhCeecCCCcccCCCeEEEEEEEccC-----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 3444544 4699999999999987632 245589999987544 22334457799999999999999999999864
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
+..+||||||++|+|.++++.... +++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+
T Consensus 80 -~~~~lvmE~~~~g~L~~~l~~~~~-----l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 80 -ESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred -CCEEEEEEcCCCCcHHHHHhhccC-----CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhh
Confidence 568999999999999999976543 67788899999999999999999999999999999999999999999999
Q ss_pred CccCCCCceee--eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Q psy7505 242 SIDKYPGDYYV--HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGT 319 (394)
Q Consensus 242 a~~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~ 319 (394)
|+......... .....||+.|||||++.... ++.++|||||||++|||+|.|+.||.+.+..++...+..+
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred hhhccccccccccccccCCCceecCchhhcCCC-------CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 97654433222 23347899999999987665 7899999999999999998799999999999999888887
Q ss_pred CCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcC
Q psy7505 320 EALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKY 361 (394)
Q Consensus 320 ~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~ 361 (394)
. +++.|..+++++.++|.+||+.||+ ||++.+|...|+..
T Consensus 227 ~--~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 227 E--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp C--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C--CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 6 7788899999999999999999998 99999998887653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-59 Score=422.02 Aligned_cols=254 Identities=30% Similarity=0.525 Sum_probs=223.2
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.++||+|+||+||+|++++ ...||||+++...... ..+.+|+.++++++|||||+++|+|.+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~--------~~~vAvK~l~~~~~~~--~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRG--------QYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETT--------TEEEEEEEEESSSSCH--HHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEECC--------CCEEEEEEECcCcCCH--HHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 4678889999999999999999863 3479999987655322 23679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+++|||||++|+|.+++..... .+.+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred ceEEEEEccCCCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhe
Confidence 99999999999999999865432 25677788999999999999999999999999999999999999999999998
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
..............+|+.|+|||++.... ++.++|||||||++|||+|.|+.||.+.+..++..++..+. +
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~--~ 219 (258)
T d1k2pa_ 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL--R 219 (258)
T ss_dssp BCSSSSCCCCCCSCCCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--C
T ss_pred eccCCCceeecccCCCCCcCCcHHhcCCC-------CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC--C
Confidence 66555444444567899999999998765 88999999999999999987899999999999999998876 7
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
++.|..+++++.++|++||+.+|+ |||+.|+++.|..
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 888999999999999999999998 9999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=425.52 Aligned_cols=267 Identities=30% Similarity=0.489 Sum_probs=221.9
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++.+.||+|+||+||+|.++... ......||||.++..........+.+|+.+|++++|||||+++|++.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCC---CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 566788999999999999999999987432 12345799999977666555566789999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+.+++|||||.+|+|.+++..... .+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred cCCceEEEEEecccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccc
Confidence 99999999999999999998876532 26777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 241 SSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 241 ~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
+|+....... .......||+.|||||++.+.. ++.++|||||||++|||++.|.+||.+.+..+++..+..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-------~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 228 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-------FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCC-------CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc
Confidence 9976543322 2223346889999999987665 889999999999999999866777888888888888887
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
+. +++.|..++..+.+++.+||..+|+ ||++.|+++.|+++..
T Consensus 229 ~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TC--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cC--CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 76 7888899999999999999999998 9999999999987764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=427.08 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=206.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++++.||+|+||+||+|+++. ++..||||+++..........+.+|+.+|++++|||||++++++.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV-------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 3679999999999999999999873 455899999876543333445679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|||||||++|+|.++|...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~-----l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTB-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eeEEEEeccCCCcHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 99999999999999999975432 6778888999999999999999999999999999999999999999999997
Q ss_pred cCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 244 DKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 244 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
....... ......+||+.|||||++.+..+ ++.++|||||||++|||++ |+.||..................
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~------~~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~~~~~~~~ 224 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREF------HAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKT 224 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSB------CHHHHHHHHHHHHHHHHHH-SSCSCSSSSTTSHHHHHHHTTCT
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCC------CCCceeeeHhHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Confidence 6533322 22345689999999999976652 4678999999999999998 99999776543332222223222
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.+..+++++.+++++||+.||+ |||+.|++.
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4444568899999999999999998 999998853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-59 Score=428.44 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=216.6
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.++|++.+.||+|+||+||+|+++ .++..||||+++...... ...+.+|+.+|++++|||||++++++.++
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBT-------TTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccccEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 3568999999999999999999987 345589999986544222 23467999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++.+.. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~~------l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHhhccC------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhh
Confidence 99999999999999999886542 677788899999999999999999999999999999999999999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+....... .....+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+.+..+..+..+
T Consensus 164 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~-------~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~ 234 (293)
T d1yhwa1 164 AQITPEQS-KRSTMVGTPYWMAPEVVTRKA-------YGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTP 234 (293)
T ss_dssp EECCSTTC-CBCCCCSCGGGCCHHHHSSSC-------BCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSC
T ss_pred eeeccccc-cccccccCCCccChhhhcCCC-------CCchhceehHhHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 76543332 234567999999999997665 7899999999999999998 99999999888887777766656
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.++.|..+++.+.+++++||+.||+ ||++.|++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6777889999999999999999998 99999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-59 Score=424.59 Aligned_cols=254 Identities=18% Similarity=0.318 Sum_probs=206.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
.++|++++.||+|+||+||+|+++. ++..||+|.++... .+.....+.+|+++|++++|||||++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS-------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred chhCEEeEEEecCCCeEEEEEEECC-------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 4789999999999999999999873 45589999986654 44555667899999999999999999999965
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEcCCCeEE
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG-----FIHTDVAARNCLVTSELRVK 235 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-----iiHrDlk~~NiLl~~~~~vK 235 (394)
++.+|||||||++|+|.+++.+.... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+|
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 46789999999999999999764322 223688889999999999999999876 99999999999999999999
Q ss_pred EccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 236 IGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 236 l~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|+|||+|+...... .......||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..++..+
T Consensus 155 l~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-------~~~~~DIwSlGvilyel~t-g~~Pf~~~~~~~~~~~ 225 (269)
T d2java1 155 LGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMS-------YNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGK 225 (269)
T ss_dssp ECCHHHHHHC------------CCCSCCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred EeeccceeecccCC-CccccCCCCcccCCHHHHcCCC-------CChHHHHHhhCHHHHHHhh-CCCCCCCCCHHHHHHH
Confidence 99999997654332 2234567899999999987654 8899999999999999998 9999999999999988
Q ss_pred HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 316 VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 316 i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+..+. ..+.|..+++++.+++++||+.||+ ||++.|+++
T Consensus 226 i~~~~--~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IREGK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 88775 3456788999999999999999998 999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-58 Score=428.50 Aligned_cols=274 Identities=34% Similarity=0.592 Sum_probs=232.5
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+++|+++|++.+.||+|+||+||+|++++.... .....||||+++..........+.+|+.+|++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPY--EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTT--SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccC--CCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3678999999999999999999999998754332 23448999999877666656667899999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhh-------------------hhhhhHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASR-------------------EALLEQGITIKMAIDVATGLSYMIEDGFIHT 219 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-------------------~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHr 219 (394)
|.+.+..+++|||+++|+|.++|....... ...+++..++.++.|++.||.|||+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999997542110 1125677788999999999999999999999
Q ss_pred CCCCCCEEEcCCCeEEEccCCCCccCCCCce-eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHc
Q psy7505 220 DVAARNCLVTSELRVKIGDTGSSIDKYPGDY-YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFE 298 (394)
Q Consensus 220 Dlk~~NiLl~~~~~vKl~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t 298 (394)
||||+|||++.++.+||+|||+|+....... ...+...+++.|||||.+.+.. |+.++|||||||++|||++
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-------YTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-------CChhhhhccchhhHHHHHc
Confidence 9999999999999999999999975433322 2233457888999999997765 8899999999999999998
Q ss_pred CCCCCCCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 299 FGKLPYAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 299 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+..||.+.+..+++..+..+. +++.|..+++++.++|++||+.+|+ |||+.||+..|+++.+
T Consensus 238 ~~~~p~~~~~~~e~~~~v~~~~--~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 238 YGLQPYYGMAHEEVIYYVRDGN--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTCCTTTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCCCCCCHHHHHHHHHcCC--CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 4468999999999999998876 6778899999999999999999998 9999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-59 Score=426.96 Aligned_cols=250 Identities=16% Similarity=0.321 Sum_probs=213.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|+++. ++..||||+++... .......+.+|+.+|++++|||||++++++.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELA-------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 4679999999999999999999873 45589999986543 12223456799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+|||||||++|+|.+++...+. +++..+..++.|++.||.|||++|||||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEEccCCCCHHHhhhccCC-----CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccc
Confidence 9999999999999999999876533 67788889999999999999999999999999999999999999999999
Q ss_pred CccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 242 SIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 242 a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
|+...... .......+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++.++.++
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-------~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~- 225 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKS-------ACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKL- 225 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCC-------CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTT-
T ss_pred ceecccCCcccccccccCCccccCceeeccCC-------CCcccceehhhHHHHHHhh-CCCCCCCcCHHHHHHHHHcC-
Confidence 97654322 22334567999999999997665 8899999999999999998 99999999999999998877
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..|..+++++.+++++||+.||+ |+|+.|+..
T Consensus 226 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 --EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 4667889999999999999999998 999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-59 Score=429.29 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=219.0
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
+.+.|++++.||+|+||+||+|+++. ++..||+|+++...... ...+.+|+++|++++|||||++++++.++
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 81 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKE-------TSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAFYYE 81 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECSSSGG-GGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECC-------CCeEEEEEEECcCCHHH-HHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 35679999999999999999999873 45589999986544322 23456999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+.+|||||||++|+|.+++.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CeEEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhh
Confidence 999999999999999999865322 2678888999999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+..... ........||+.|||||++..... ....|+.++|||||||++|||++ |+.||.+.+..+++.++..+...
T Consensus 158 ~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~--~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~~~~~~~i~~~~~~ 233 (288)
T d2jfla1 158 AKNTRT-IQRRDSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPP 233 (288)
T ss_dssp EECHHH-HHHHTCCCSCCTTCCHHHHTTCST--TTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHHSCCC
T ss_pred hccCCC-cccccccccccccCCHHHHhhccc--CCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCC
Confidence 653221 112335678999999999865432 22348999999999999999998 99999999998898888888766
Q ss_pred CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 ~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++.|..+++++.++|++||+.||+ |||+.|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7777889999999999999999998 999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-58 Score=421.53 Aligned_cols=266 Identities=28% Similarity=0.496 Sum_probs=222.7
Q ss_pred CCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceec
Q psy7505 75 FDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILR 154 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 154 (394)
...++|+|+.++|++.+.||+|+||+||+|++++ +..||||+++...... +.|.+|+.+|++++|||||+
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~--------~~~vAiK~l~~~~~~~--~~~~~E~~~l~~l~h~nIv~ 76 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQ 76 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETT--------TEEEEEEECCTTSSCH--HHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECC--------CCEEEEEEECcccCCH--HHHHHHHHHHHhcccCCEeE
Confidence 3467899999999999999999999999999863 2379999987655322 34679999999999999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
++|++. .+.+++|||||++|+|..++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 77 ~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~ 152 (285)
T d1fmka3 77 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152 (285)
T ss_dssp EEEEEC-SSSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEe-cCCeEEEEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcE
Confidence 999985 4678999999999999999875422 237888899999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+|+..............+|+.|+|||++..+. ++.++|||||||++|||++.|.+||.+....+++.
T Consensus 153 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~ 225 (285)
T d1fmka3 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225 (285)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred EEcccchhhhccCCCceeeccccccccccChHHHhCCC-------CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999866544444444567899999999997766 78999999999999999986778888888888988
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
.+..+. +++.+..+++++.++|.+||+.||+ ||++.+|++.|+....
T Consensus 226 ~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 226 QVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHhcC--CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 888775 7788999999999999999999998 9999999998887664
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-58 Score=425.27 Aligned_cols=277 Identities=32% Similarity=0.562 Sum_probs=231.6
Q ss_pred CCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceece
Q psy7505 77 SSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRL 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 155 (394)
.+.|+++.++|++.+.||+|+||.||+|++.+..+........||||+++.+........+.+|...+.++ +|||||++
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 35699999999999999999999999999887665555566789999998877666556667888888888 89999999
Q ss_pred eeEEEeCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 156 MAACLESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 156 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
+++|.+++.+++|||||.+|+|.++|...... ....+++..++.++.||+.||.|||+++||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999765321 1123678889999999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||+++........ ......+|+.|+|||.+..+. |+.++|||||||++|||++.|..|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-------y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-------YTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-------CCchhhhHHhHHHHHHhccCCCCC
Confidence 999999999999999999765333221 223457888999999997765 899999999999999999878999
Q ss_pred CCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 304 f~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
|.+.+..++...+..+. +++.|..+++.+.++|.+||+.+|. |||+.|+++.|++++
T Consensus 238 ~~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 238 YPGVPVEELFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp STTCCHHHHHHHHHTTC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC--CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 99999999888887776 7788899999999999999999998 999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=423.95 Aligned_cols=284 Identities=34% Similarity=0.567 Sum_probs=241.4
Q ss_pred cccccCCCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC
Q psy7505 70 SMQNWFDSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH 149 (394)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H 149 (394)
+..+.+.+++|+|+.++|++.+.||+|+||.||+|.+++.... .....||||+++..........+.+|+.++++++|
T Consensus 5 ~~~~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~--~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h 82 (308)
T d1p4oa_ 5 SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82 (308)
T ss_dssp BCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETT--EEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC
T ss_pred CcccCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccC--CCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC
Confidence 4455566778999999999999999999999999998743321 23458999999876666666667899999999999
Q ss_pred cceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhh-----hhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7505 150 VNILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASRE-----ALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAAR 224 (394)
Q Consensus 150 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~ 224 (394)
||||+++|++...+..++|||||++|+|.+++........ ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 83 ~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~ 162 (308)
T d1p4oa_ 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 162 (308)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred CCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence 9999999999999999999999999999999976432111 11356678889999999999999999999999999
Q ss_pred CEEEcCCCeEEEccCCCCccCCCCceee-eCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy7505 225 NCLVTSELRVKIGDTGSSIDKYPGDYYV-HGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP 303 (394)
Q Consensus 225 NiLl~~~~~vKl~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P 303 (394)
|||++.++.+||+|||+|+......... .....+|+.|+|||.+.+.. ++.++|||||||++|||+|.+..|
T Consensus 163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-------~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-------FTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-------CCcccccccHHHHHHHHHhCCCCC
Confidence 9999999999999999997654333322 23346789999999997765 788999999999999999955799
Q ss_pred CCCCCHHHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 304 YAELSDDQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 304 f~~~~~~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
|.+.+..+++..+..+. +++.|..+++.+.++|.+||+.+|+ ||++.++++.|++.++-
T Consensus 236 ~~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 236 YQGLSNEQVLRFVMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCCHHHHHHHHHhCC--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 99999999999998876 7888899999999999999999998 99999999999988753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-58 Score=423.89 Aligned_cols=276 Identities=32% Similarity=0.579 Sum_probs=218.0
Q ss_pred CCCCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceec
Q psy7505 76 DSSEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILR 154 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 154 (394)
+.+.|++++++|++.+.||+|+||+||+|++++.... .....||||+++..........+.+|..++.++ +|+|||.
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSS--SCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcc--cCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 4457889999999999999999999999998754332 234589999998766555555566777777666 7999999
Q ss_pred eeeEEEeC-CceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7505 155 LMAACLES-DPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVA 222 (394)
Q Consensus 155 l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk 222 (394)
+++++... +.+++|||||++|+|.++|+..... ....+++..++.++.||+.||.|||+++|||||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 99998754 4689999999999999999765321 11236778899999999999999999999999999
Q ss_pred CCCEEEcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCC
Q psy7505 223 ARNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGK 301 (394)
Q Consensus 223 ~~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~ 301 (394)
|+|||++.++.+||+|||+|+...... ........||+.|||||++.+.. ++.++|||||||++|||+|.+.
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-------YTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-------CCcccceeehHHHHHHHHhCCC
Confidence 999999999999999999997654332 22334557899999999997765 8899999999999999998567
Q ss_pred CCCCCCCHH-HHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 302 LPYAELSDD-QVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 302 ~Pf~~~~~~-~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.||.+.... .+...+..+. +++.|..+++++.++|.+||+.||+ |||+.|+++.|++++
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 235 SPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 889887644 4445555555 7788889999999999999999998 999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-57 Score=420.11 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=212.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.+.|+.++.||+|+||+||+|+++. ++..||||++.... .......+.+|+.+|++++|||||++++++.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR-------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC-------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence 4569999999999999999999873 45589999986544 33334457799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+|||||||.+|+|..++...+. +++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~~~-----l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CCEEEEEEEecCCCchHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccc
Confidence 9999999999999999877655432 67888899999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|..... .....||+.|||||++.+... ..|+.++|||||||++|||++ |..||.+.+..+.+.++..+..
T Consensus 162 a~~~~~-----~~~~~GT~~Y~APE~~~~~~~----~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~~~~~~~~i~~~~~ 231 (309)
T d1u5ra_ 162 ASIMAP-----ANSFVGTPYWMAPEVILAMDE----GQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNES 231 (309)
T ss_dssp CBSSSS-----BCCCCSCGGGCCHHHHTTTTS----CCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCC
T ss_pred ccccCC-----CCccccCccccCHHHHhccCC----CCcCchhhhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCC
Confidence 976432 234578999999999865321 138899999999999999998 9999999998888888877653
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
+ ...+..+++.+.++|++||+.||+ |||+.|++.
T Consensus 232 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C-CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2 233567899999999999999998 999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-57 Score=409.60 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=203.1
Q ss_pred CeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe---
Q psy7505 86 QLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE--- 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 161 (394)
.|++.++||+|+||+||+|+++. +...||+|.+.... .......+.+|+++|++++|||||++++++.+
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~-------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred EEEeeeEEecCcCcEEEEEEECC-------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 35778899999999999999873 44589999886554 44445567799999999999999999999875
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCeEEEc
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDG--FIHTDVAARNCLVT-SELRVKIG 237 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~--iiHrDlk~~NiLl~-~~~~vKl~ 237 (394)
+..+|||||||++|+|.+++.+... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~~-----~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHhcccc-----ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 3458999999999999999976532 677788899999999999999998 99999999999997 47899999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD-DQVITRV 316 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~-~~~~~~i 316 (394)
|||+|+...... .....||+.|||||++.+ . |+.++|||||||++|||++ |+.||.+... .++...+
T Consensus 158 DFGla~~~~~~~---~~~~~GT~~Y~aPE~~~~-~-------~~~~~DIwSlGvilyel~~-g~~Pf~~~~~~~~~~~~i 225 (270)
T d1t4ha_ 158 DLGLATLKRASF---AKAVIGTPEFMAPEMYEE-K-------YDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRV 225 (270)
T ss_dssp CTTGGGGCCTTS---BEESCSSCCCCCGGGGGT-C-------CCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHH
T ss_pred ecCcceeccCCc---cCCcccCccccCHHHhCC-C-------CCCcCchhhHHHHHHHHHH-CCCCCCCcccHHHHHHHH
Confidence 999997543322 224578999999998853 2 7899999999999999998 9999987654 4555666
Q ss_pred hcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 FGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 ~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+. .....+..+++++.+++++||+.||+ |||+.|+++
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 TSGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCC-CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 5543 23344567899999999999999998 999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-57 Score=421.17 Aligned_cols=251 Identities=19% Similarity=0.307 Sum_probs=200.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.+.|++.+.||+|+||+||+|+++. ++..||||++...........+.+|+.+|++++|||||++++++.+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR-------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT-------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECC-------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5679999999999999999999873 455899999876654444455679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCeEEEccCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT---SELRVKIGDTG 240 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~---~~~~vKl~DFG 240 (394)
.+|||||||+||+|.++|...+. +++..+..++.||+.||.|||++||+||||||+|||+. .++.+||+|||
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred EEEEEEeccCCCcHHHhhhcccC-----CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence 99999999999999999976533 67888899999999999999999999999999999995 46899999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+|+...... .....+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+....++...+..+.
T Consensus 156 ~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~-------~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~ 225 (307)
T d1a06a_ 156 LSKMEDPGS--VLSTACGTPGYVAPEVLAQKP-------YSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAE 225 (307)
T ss_dssp -------------------CTTSCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHTTC
T ss_pred eeEEccCCC--eeeeeeeCccccCcHHHcCCC-------CCcHHHhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHhccC
Confidence 997654332 233467899999999997665 8899999999999999998 999999999988888887765
Q ss_pred C-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 A-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
. ...+.+..+++++.+++++||+.||+ |||+.|++.
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2 22344568999999999999999998 999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-58 Score=425.98 Aligned_cols=265 Identities=25% Similarity=0.407 Sum_probs=219.1
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES 162 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 162 (394)
...+|++++.||+|+||+||+|+++.... ....+||+|.++........+.+.+|+.+|++++|||||+++|+|.+
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 82 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 82 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCC---EEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 35679999999999999999999874322 22347899988765544344557799999999999999999999986
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
+..+++|||+.+|+|.+++..... .+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred CCeeEEEEeccCCccccccccccc----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 567889999999999998876532 2677788899999999999999999999999999999999999999999999
Q ss_pred ccCCCCcee-eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 243 IDKYPGDYY-VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 243 ~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
+........ ......||+.|||||++.++. |+.++|||||||++|||+|.|..||.+.+..++...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~- 230 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRI-------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE- 230 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-
T ss_pred eecccccccccccccccCccccChHHHhcCC-------CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-
Confidence 765443322 223346889999999997765 88999999999999999987899999999888888887776
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
+++.|..+++.+.+++++||..+|. ||++.|++..|.++..+
T Consensus 231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 7888999999999999999999998 99999999988877544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=411.01 Aligned_cols=255 Identities=32% Similarity=0.585 Sum_probs=215.6
Q ss_pred ceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 80 FQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|++..++|++.+.||+|+||.||+|++++ .+||||+++.+... +.+.+|+.++++++|||||+++|+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~vAvK~i~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG---------NKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT---------EEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC---------eEEEEEEECcHHHH---HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 78889999999999999999999999862 37999999765432 3366999999999999999999998
Q ss_pred Ee-CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 160 LE-SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 160 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
.+ .+.++||||||++|+|.++|..... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecc
Confidence 65 4678999999999999999975422 2367888899999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+++..... .....+|..|+|||++.+.. ++.++|||||||++|||+|.|+.||...+..+++..+.+
T Consensus 147 fg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~-------~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~ 215 (262)
T d1byga_ 147 FGLTKEASST----QDTGKLPVKWTAPEALREKK-------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215 (262)
T ss_dssp CCC----------------CCTTTSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred cccceecCCC----CccccccccCCChHHHhCCC-------CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 9999754322 22345678899999987665 889999999999999999878999999999899999887
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
+. +++.|..+++++.+++++||..||+ ||++.|+++.|+++.
T Consensus 216 ~~--~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 216 GY--KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 75 7888899999999999999999998 999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=420.09 Aligned_cols=244 Identities=19% Similarity=0.319 Sum_probs=212.5
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
..++|++++.||+|+||+||+|+++ .++..||+|+++... .......+.+|+.+|++++|||||++++++.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 3578999999999999999999987 345689999987543 1122344669999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTG 240 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG 240 (394)
+.+.+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred cccccccceeccCCCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence 99999999999999999999976543 6777888999999999999999999999999999999999999999999
Q ss_pred CCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Q psy7505 241 SSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTE 320 (394)
Q Consensus 241 ~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~ 320 (394)
+|+....... .....+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++..+..+
T Consensus 151 ~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~-------y~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~i~~~- 220 (337)
T d1o6la_ 151 LCKEGISDGA-TMKTFCGTPEYLAPEVLEDND-------YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME- 220 (337)
T ss_dssp TCBCSCCTTC-CBCCCEECGGGCCGGGGSSSC-------BCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-
T ss_pred cccccccCCc-ccccceeCHHHhhhhhccCCC-------CChhhcccchhhHHHHHHH-CCCCCCCcCHHHHHHHHhcC-
Confidence 9986543222 234568999999999997765 8899999999999999998 99999999999998888776
Q ss_pred CcCCCCCCCCChHHHHHHHhhhcCCcc-ccc
Q psy7505 321 ALRLPAPRAVNSHVDVAARNCLVTSEL-RVK 350 (394)
Q Consensus 321 ~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~ 350 (394)
.++.|..+++++.+||++||+.||. |++
T Consensus 221 --~~~~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred --CCCCCccCCHHHHHHHHhhccCCchhhcc
Confidence 5677889999999999999999998 774
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-57 Score=410.94 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=211.6
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAAC 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 159 (394)
|..++|++.+.||+|+||.||+|+++... .....||||+++... .....+.+.+|+.+|++++|||||+++|+|
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS----GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTT----SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCC----CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45688999999999999999999986422 234478999887643 222334567999999999999999999999
Q ss_pred EeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 160 LESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 160 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
.+ +.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred ee-cchheeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 75 578999999999999998865422 2678888999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCce--eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 240 GSSIDKYPGDY--YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 240 G~a~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|+++....... .......+|..|+|||++.+.. ++.++|||||||++|||+|+|+.||.+.+..+++.++.
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-------EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCC-------CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence 99986543322 2223446788999999998765 78999999999999999987899999999999988886
Q ss_pred cCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhc
Q psy7505 318 GTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDK 360 (394)
Q Consensus 318 ~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~ 360 (394)
... .+++.+..+++.+.+++++||..||+ |||+.|+.+.|.+
T Consensus 229 ~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 229 KEG-ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp TSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCC-CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 553 47788899999999999999999998 9999999988875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-57 Score=421.22 Aligned_cols=251 Identities=18% Similarity=0.281 Sum_probs=204.7
Q ss_pred eecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEE
Q psy7505 81 QFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACL 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 160 (394)
++..++|++++.||+|+||+||+|+++ .++..||+|+++..........+.+|+.+|++++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEET-------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456789999999999999999999987 3456899999876554444455779999999999999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
+.+.+|||||||++|+|.+++.+.+. +++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+||
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~~~-----l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeC
Confidence 99999999999999999999976533 6778888999999999999997 59999999999999999999999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQV------- 312 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~------- 312 (394)
|+|+..... ...+.+||+.|||||++.+.. |+.++||||+||++|||++ |+.||.+.+..+.
T Consensus 150 Gla~~~~~~---~~~~~~GT~~Y~APEvl~~~~-------y~~~~DiWSlGvil~ell~-G~~Pf~~~~~~~~~~~~~~~ 218 (322)
T d1s9ja_ 150 GVSGQLIDS---MANSFVGTRSYMSPERLQGTH-------YSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQ 218 (322)
T ss_dssp CCCHHHHHH---TC---CCSSCCCCHHHHHCSC-------CCTTHHHHHHHHHHHHHHH-SSCCSSCCCTTHHHHHC---
T ss_pred CCccccCCC---ccccccCCccccCchHHcCCC-------CCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHH
Confidence 999754221 123458999999999998765 8899999999999999998 9999976543221
Q ss_pred -----------------------------------HHHHhcCCCcCCCCC-CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 313 -----------------------------------ITRVFGTEALRLPAP-RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 313 -----------------------------------~~~i~~~~~~~~~~p-~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
...+.... ....| ..++.++.+++++||+.||+ |||+.|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L 296 (322)
T d1s9ja_ 219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296 (322)
T ss_dssp ---------------------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hcCCcccCCcccccccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 11111111 11112 24678999999999999998 99999986
Q ss_pred h
Q psy7505 356 S 356 (394)
Q Consensus 356 ~ 356 (394)
.
T Consensus 297 ~ 297 (322)
T d1s9ja_ 297 V 297 (322)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=415.15 Aligned_cols=268 Identities=30% Similarity=0.456 Sum_probs=221.3
Q ss_pred ecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEE
Q psy7505 82 FPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACL 160 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 160 (394)
++.++|++.+.||+|+||+||+|+++... ....||||.++........+.+.+|+.+|+++ +|||||+++|+|.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDG-----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETT-----EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCC-----eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 45688999999999999999999987321 22357788876554444444567999999999 7999999999999
Q ss_pred eCCceEEEEeeCCCCCHHHHHhhcchh-----------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7505 161 ESDPWLLVFESCSRGDLKEFLLSNEAS-----------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT 229 (394)
Q Consensus 161 ~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~ 229 (394)
+++.++||||||++|+|.++|+..... ....+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999999765211 112367788899999999999999999999999999999999
Q ss_pred CCCeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy7505 230 SELRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSD 309 (394)
Q Consensus 230 ~~~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~ 309 (394)
.++.+||+|||+|+.... ........+|..|+|||.+.... |+.++|||||||++|||++.+.+||.+.+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~--~~~~~~~~gt~~y~aPE~l~~~~-------~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSV-------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp GGGCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCE-------ECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCceEEccccccccccc--cccccceecCCcccchHHhccCC-------CCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999865422 11222346788999999997665 889999999999999999855678999999
Q ss_pred HHHHHHHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCcc
Q psy7505 310 DQVITRVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGDY 365 (394)
Q Consensus 310 ~~~~~~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~~ 365 (394)
.++...+..+. +++.|..+++++.++|++||+.||+ ||++.|+++.|+++.++.
T Consensus 233 ~~~~~~i~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 233 AELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHHGGGTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHhcC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 99999888776 7788899999999999999999998 999999999998887543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=415.14 Aligned_cols=274 Identities=33% Similarity=0.549 Sum_probs=231.2
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 156 (394)
..|+++.++|++.+.||+|+||.||+|++++... ......||||+++..........+.+|+.+++++ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK--SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEecccc--CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 3688999999999999999999999999875332 2355689999998777666666678999999999 799999999
Q ss_pred eEEEeCCceEEEEeeCCCCCHHHHHhhcchh-------------hhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7505 157 AACLESDPWLLVFESCSRGDLKEFLLSNEAS-------------REALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAA 223 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~ 223 (394)
|++.+.+.++||||||++|+|.++|+..... ....+++..+..++.||+.||.|||+++||||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 9999999999999999999999999865321 111367788899999999999999999999999999
Q ss_pred CCEEEcCCCeEEEccCCCCccCCCCc-eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 224 RNCLVTSELRVKIGDTGSSIDKYPGD-YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 224 ~NiLl~~~~~vKl~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
+|||++.++.+||+|||+++...... ....+...||+.|+|||++.... ++.++|||||||++|||+|.|.+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-------CCCcccccchHHHHHHHHhCCCC
Confidence 99999999999999999998665433 33344568899999999997665 88999999999999999986788
Q ss_pred CCCCCCHHHHHHH-HhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 303 PYAELSDDQVITR-VFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 303 Pf~~~~~~~~~~~-i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
||.+.+..+.+.+ +..+. ++..|..+++.+.+||.+||+.||+ ||++.+++..|++.+
T Consensus 247 ~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 247 PYPGMPVDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SSTTCCSSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCC--CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 8887776555444 44443 7777889999999999999999998 999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-56 Score=412.63 Aligned_cols=246 Identities=18% Similarity=0.284 Sum_probs=212.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++++.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+|++++|||||++++++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 75 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 75 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee
Confidence 368999999999999999999987 345589999987543 11223456799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+|+|||||.||+|..++..... +.+..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCeeeeEeeecCCcccccccccccc-----ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCcc
Confidence 9999999999999999999876543 45666778999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+..... ....+||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++.++..+
T Consensus 151 a~~~~~~----~~~~~Gt~~Y~APE~l~~~~-------y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~-- 216 (316)
T d1fota_ 151 AKYVPDV----TYTLCGTPDYIAPEVVSTKP-------YNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA-- 216 (316)
T ss_dssp CEECSSC----BCCCCSCTTTCCHHHHTTCC-------BCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHC--
T ss_pred ceEeccc----cccccCcccccCHHHHcCCC-------CCchhhccccchhHHHHHh-CCCCCCCcCHHHHHHHHHcC--
Confidence 9765432 23468999999999987665 7889999999999999998 99999999999999998877
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTGS 356 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~~ 356 (394)
..+.|..+++++.+++++||..||. |+ ++.|++.
T Consensus 217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 4567888999999999999999997 64 6777753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-55 Score=415.79 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=213.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
++|++++.||+|+||+||+|+++ .++..||||+++...... ...+.+|+.+|++++|||||+++++|.+++.
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECCcchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 57999999999999999999987 345589999987654333 3456799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCCeEEEccCCCC
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVT--SELRVKIGDTGSS 242 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~--~~~~vKl~DFG~a 242 (394)
+|||||||++|+|.+++...+. .+++..+..++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEcCCCChHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccc
Confidence 9999999999999998865432 267888899999999999999999999999999999998 5689999999999
Q ss_pred ccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc
Q psy7505 243 IDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 322 (394)
+....... .....+|+.|||||++.+.. |+.++|||||||++|||++ |..||.+.+..+++..+..+...
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~ 246 (352)
T d1koba_ 177 TKLNPDEI--VKVTTATAEFAAPEIVDREP-------VGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDWE 246 (352)
T ss_dssp EECCTTSC--EEEECSSGGGCCHHHHTTCC-------BCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCCC
T ss_pred eecCCCCc--eeeccCcccccCHHHHcCCC-------CCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 77654432 22346789999999987665 8899999999999999998 99999999999998888776421
Q ss_pred -CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 -RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 -~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+.+..+++++.+||++||+.||. |||+.|++.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2223467899999999999999998 999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-55 Score=416.02 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=213.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++++.||+|+||+||+|+++. ++..||||++...... ....+.+|+.+|++++|||||++++++.+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~-------~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA-------TGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3589999999999999999999873 4568999998765433 3455679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCeEEEccCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS--ELRVKIGDTGS 241 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~--~~~vKl~DFG~ 241 (394)
.+|||||||++|+|.++|..... .+++..+..++.||+.||.|||++|||||||||+|||++. ++.+||+|||+
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEEcCCCCCHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 99999999999999999964322 2678888999999999999999999999999999999964 57899999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+....... .....||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++..+..+..
T Consensus 173 a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~-------~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 173 TAHLDPKQS--VKVTTGTAEFAAPEVAEGKP-------VGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp CEECCTTSC--EEEECSCTTTCCHHHHHTCC-------BCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred heecccccc--cceecCcccccCHHHHcCCC-------CChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 976544332 23457899999999997765 7899999999999999998 9999999999998888876642
Q ss_pred -cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 -LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 -~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.....+..+++++.+++++||+.||+ |||+.|++.
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222357899999999999999998 999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=405.42 Aligned_cols=251 Identities=18% Similarity=0.266 Sum_probs=212.4
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-----HHHHHHHHHHHHHhccCCCcceeceeeE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-----QAEKLFFLHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.+.|++.+.||+|+||+||+|+++ .++..||||+++.... ......+.+|+.+|++++|||||+++++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 81 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 467999999999999999999987 3455899998864321 1123446799999999999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----eE
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL----RV 234 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~----~v 234 (394)
+.+.+.+|||||||++|+|.++|...+. +++..+..++.|++.||.|||+++|+||||||+|||++.++ .+
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~~-----l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred EEECCEEEEEEEcCCCccccchhccccc-----cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccce
Confidence 9999999999999999999999976532 67888899999999999999999999999999999998776 59
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+|....... ......+|+.|||||++.+.. ++.++|||||||++|||++ |+.||.+.+..+++.
T Consensus 157 kl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~-------~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~ 226 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEP-------LGLEADMWSIGVITYILLS-GASPFLGDTKQETLA 226 (293)
T ss_dssp EECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred EecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCC-------CCCcccchhhhHHHHHHHc-CCCCCCCCCHHHHHH
Confidence 999999997654332 233457889999999997654 7899999999999999998 999999999999988
Q ss_pred HHhcCCCc-CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEAL-RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~-~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+... ..+.+..++..+.++|++||..||+ ||++.|++.
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 88776421 1122367899999999999999998 999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=407.95 Aligned_cols=247 Identities=21% Similarity=0.329 Sum_probs=210.7
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHHHHHHHHh-ccCCCcceeceeeEEEe
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFFLHEATPY-RRLRHVNILRLMAACLE 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~ 161 (394)
++|++.+.||+|+||+||+|+++ .++..||||+++.... ......+..|..++ +.++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 67999999999999999999987 3456899999875431 11222334666655 46899999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
++.+|||||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCceeEEEeecCCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccch
Confidence 9999999999999999999976543 56778889999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+...... .......||+.|+|||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++.++..+
T Consensus 150 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~-- 218 (320)
T d1xjda_ 150 CKENMLGD-AKTNTFCGTPDYIAPEILLGQK-------YNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-- 218 (320)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC--
T ss_pred hhhccccc-ccccccCCCCCcCCHHHHcCCC-------CCchhhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC--
Confidence 97554332 2234457899999999998765 7899999999999999998 99999999999999888776
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-ccchh-hhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIG-DTG 355 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~-e~~ 355 (394)
.+..|..+++++.+++++||+.||. ||++. |+.
T Consensus 219 -~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 219 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 4677889999999999999999998 99985 664
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-55 Score=412.52 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=212.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++++.||+|+||+||+|+++ .++..||||++.... .......+.+|+.+|+.++|||||++++++.+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~-------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCeEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 478999999999999999999987 345589999986543 11223346799999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCC
Q psy7505 162 SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGS 241 (394)
Q Consensus 162 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~ 241 (394)
.+.+++||||+.+|+|.+++...+. +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~~-----l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ccccccccccccccchhhhHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeecee
Confidence 9999999999999999999976533 67788899999999999999999999999999999999999999999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
|+..... .....||+.|||||++.+.. |+.++|||||||++|||++ |+.||.+.+..+++.++..+
T Consensus 188 a~~~~~~----~~~~~Gt~~Y~APE~~~~~~-------~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~-- 253 (350)
T d1rdqe_ 188 AKRVKGR----TWTLCGTPEALAPEIILSKG-------YNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-- 253 (350)
T ss_dssp CEECSSC----BCCCEECGGGCCHHHHTTCC-------BCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC--
T ss_pred eeecccc----cccccCccccCCHHHHcCCC-------CCccccccchhHHHHHHHh-CCCCCCCcCHHHHHHHHhcC--
Confidence 9765432 23457899999999997765 7899999999999999998 99999999999998888877
Q ss_pred cCCCCCCCCChHHHHHHHhhhcCCcc-cc-----chhhhh
Q psy7505 322 LRLPAPRAVNSHVDVAARNCLVTSEL-RV-----KIGDTG 355 (394)
Q Consensus 322 ~~~~~p~~~~~~~~~l~~~cl~~~p~-r~-----~~~e~~ 355 (394)
.+..|..+++++.+++++||..||. |+ ++.|++
T Consensus 254 -~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell 292 (350)
T d1rdqe_ 254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHH
Confidence 4667789999999999999999997 63 677765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-55 Score=397.21 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=215.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--------cHHHHHHHHHHHHHhccCC-Ccceec
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--------SQAEKLFFLHEATPYRRLR-HVNILR 154 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~~E~~~l~~l~-HpnIv~ 154 (394)
.++|++.+.||+|+||+||+|+++. .+..||||+++... .+.....+.+|+.+|++++ |||||+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~-------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 74 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP-------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 74 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cccCEEceEEecCcCeEEEEEEECC-------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 3789999999999999999999863 45589999986532 1223345679999999996 999999
Q ss_pred eeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 155 LMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 155 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
+++++.+++.+|||||||++|||.++|+.++. +++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~-----l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 75 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred EEeecccCcceEEEEEcCCCchHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCe
Confidence 99999999999999999999999999976533 7888899999999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+|+...... ......||..|+|||.+.+.... ....++.++||||+||++|||++ |+.||.+.+..++..
T Consensus 150 kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~-~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~~~~~~~ 225 (277)
T d1phka_ 150 KLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLR 225 (277)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred EEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccc-cCCCCCchheEcccchhhhhhcc-CCCCCCCCCHHHHHH
Confidence 999999997654432 22345789999999999754321 22237889999999999999998 999999999888888
Q ss_pred HHhcCCC-cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEA-LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~-~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+.. ...+....+++++.+++++||+.+|+ ||++.|+++
T Consensus 226 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 8877642 22333458999999999999999998 999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-55 Score=403.86 Aligned_cols=260 Identities=29% Similarity=0.492 Sum_probs=211.3
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEe-CCceE
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLE-SDPWL 166 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~ 166 (394)
++.++||+|+||+||+|++.... .+...||||.++..........+.+|+++|++++|||||+++|++.+ ++..+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC--------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCC----CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 44678999999999999987422 22336899998765555555667899999999999999999999876 45789
Q ss_pred EEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCccCC
Q psy7505 167 LVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSIDKY 246 (394)
Q Consensus 167 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~~~ 246 (394)
+|||||++|+|.+++...... ..+..++.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~----~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCC----CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEEEEeecCchhhhhcccccc----chHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 999999999999998754322 4566778899999999999999999999999999999999999999999997654
Q ss_pred CCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCcC
Q psy7505 247 PGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEALR 323 (394)
Q Consensus 247 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 323 (394)
..... ......||..|+|||.+.... ++.++|||||||++|||+|.|.+|+.+.+..++...+..+. +
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--~ 252 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQK-------FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--R 252 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCC-------CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--C
T ss_pred ccccccceecccccccccccChHHHhcCC-------CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--C
Confidence 33221 122346789999999987665 88999999999999999985555555666667777787776 7
Q ss_pred CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCCc
Q psy7505 324 LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPGD 364 (394)
Q Consensus 324 ~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~~ 364 (394)
++.|..+++++.++|.+||..||+ ||++.||++.|+++...
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 788899999999999999999998 99999999999988754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-54 Score=397.05 Aligned_cols=259 Identities=19% Similarity=0.272 Sum_probs=209.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc--cHHHHHHHHHHHHHhccCCCcceeceeeEEEe
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA--SQAEKLFFLHEATPYRRLRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+|+.++|||||++++++..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence 467999999999999999999987 345689999987543 34444567799999999999999999999986
Q ss_pred CCc----eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 162 SDP----WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 162 ~~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
.+. +|||||||+||+|.+++...+. +++..+..++.||+.||.|||++|||||||||+|||++.++.++|+
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEEC
T ss_pred ccCCCceEEEEEECCCCCEehhhhcccCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceee
Confidence 543 8999999999999999876533 6778889999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCc--eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy7505 238 DTGSSIDKYPGD--YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITR 315 (394)
Q Consensus 238 DFG~a~~~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~ 315 (394)
|||.+....... ........||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..+++.+
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~ 225 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-------VDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQ 225 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCC-------CCcceecccchHHHHHHHh-CCCCCCCcCHHHHHHH
Confidence 999876443222 12233457899999999987654 8899999999999999998 9999999998888777
Q ss_pred HhcCCCc-CCCCCCCCChHHHHHHHhhhcCCcc-cc-chhhhhhhhhcCC
Q psy7505 316 VFGTEAL-RLPAPRAVNSHVDVAARNCLVTSEL-RV-KIGDTGSSIDKYP 362 (394)
Q Consensus 316 i~~~~~~-~~~~p~~~~~~~~~l~~~cl~~~p~-r~-~~~e~~~~l~~~~ 362 (394)
+..+... .......+++.+.+++++||+.||. || ++.++...|.++.
T Consensus 226 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 6655421 1233467999999999999999998 88 7889988887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-54 Score=410.99 Aligned_cols=246 Identities=17% Similarity=0.167 Sum_probs=199.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc--HHHHHHH---HHHHHHhccCCCcceeceeeE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS--QAEKLFF---LHEATPYRRLRHVNILRLMAA 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~---~~E~~~l~~l~HpnIv~l~~~ 158 (394)
.++|++.+.||+|+||+||+|+++. ++..||||++..... ......+ .+|+.+++.++|||||+++++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~-------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~ 75 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC-------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE
Confidence 4789999999999999999999873 455899999864321 1111112 245788889999999999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.+|||||||++|+|.++|..... +++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|
T Consensus 76 ~~~~~~~~ivmE~~~gg~L~~~l~~~~~-----~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 76 FHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECC
T ss_pred EEECCEEEEEEEecCCCcHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEee
Confidence 9999999999999999999999976533 56777889999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFG 318 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~ 318 (394)
||+|+...... .....||+.|||||++..+. .|+.++|||||||++|||++ |+.||.+.+..+.......
T Consensus 151 FGla~~~~~~~---~~~~~GT~~y~APE~~~~~~------~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~ 220 (364)
T d1omwa3 151 LGLACDFSKKK---PHASVGTHGYMAPEVLQKGV------AYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRM 220 (364)
T ss_dssp CTTCEECSSSC---CCSCCSCGGGCCHHHHSTTC------CCCTHHHHHHHHHHHHHHHH-SSCSSCSSCSSCHHHHHHH
T ss_pred eceeeecCCCc---ccccccccccchhHHhhcCC------CCCcccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence 99997654332 23457999999999986543 27899999999999999998 9999987653322222212
Q ss_pred CCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccch
Q psy7505 319 TEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKI 351 (394)
Q Consensus 319 ~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~ 351 (394)
......+.|..+++++.++|.+||+.||+ |+++
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 22225667889999999999999999998 8883
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=401.58 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=212.5
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++.+.||+|+||+||+|.++. ++..||+|+++....+ ...+.+|+++|+.++|||||++++++.+++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-------~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS-------SKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 4679999999999999999999873 4558999998765533 334679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--CeEEEccCCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE--LRVKIGDTGS 241 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~--~~vKl~DFG~ 241 (394)
.+|||||||+||+|.++|...+. .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence 99999999999999999976532 16788889999999999999999999999999999999854 4899999999
Q ss_pred CccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Q psy7505 242 SIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA 321 (394)
Q Consensus 242 a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 321 (394)
++....... .....+|+.|+|||.+.+.. |+.++|||||||++|||++ |..||.+.+..+++..+.++..
T Consensus 151 ~~~~~~~~~--~~~~~~t~~y~ape~~~~~~-------~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~~i~~~~~ 220 (321)
T d1tkia_ 151 ARQLKPGDN--FRLLFTAPEYYAPEVHQHDV-------VSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp CEECCTTCE--EEEEESCGGGSCHHHHTTCE-------ECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCC
T ss_pred hhccccCCc--ccccccccccccchhccCCC-------CCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 976544332 22346788999999987654 7899999999999999998 9999999999999998887642
Q ss_pred cCCCC--CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRLPA--PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~~~--p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.++. +..+++++.+++++||..||+ ||++.|++.
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2221 247899999999999999998 999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=389.95 Aligned_cols=248 Identities=19% Similarity=0.188 Sum_probs=197.1
Q ss_pred EEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHH----HHHHHHHHHHHhccCCCcceeceeeEEEeCCc
Q psy7505 89 YVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQA----EKLFFLHEATPYRRLRHVNILRLMAACLESDP 164 (394)
Q Consensus 89 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 164 (394)
.++.||+|+||+||+|+++ .++..||||+++...... ....+.+|+.+|++++|||||++++++.+++.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~ 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred cceEeccCcCeEEEEEEEC-------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence 3578999999999999987 345589999986544221 12346799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCcc
Q psy7505 165 WLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSID 244 (394)
Q Consensus 165 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~~ 244 (394)
+|||||||.+|++..++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 75 ~~ivmE~~~~~~~~~~~~~~~~-----l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CEEEEECCSEEHHHHHTTCCSS-----CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eeehhhhhcchHHhhhhhcccC-----CCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccc
Confidence 9999999988777665543322 56667888999999999999999999999999999999999999999999976
Q ss_pred CCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc--
Q psy7505 245 KYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL-- 322 (394)
Q Consensus 245 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 322 (394)
...... .....+||+.|||||++.... .|+.++|||||||++|||++ |..||.+.+..+.+.++.+....
T Consensus 150 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 150 FGSPNR-AYTHQVVTRWYRAPELLFGAR------MYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPT 221 (299)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCS------CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cCCCcc-cccceecChhhccHHHHccCC------CCChhhhhhhcchHHHHHHh-CcCCCCCCCHHHHHHHHHHhcCCCC
Confidence 543322 233457899999999986554 27899999999999999998 99999999988887766532100
Q ss_pred -----------------CCC-C-----CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 323 -----------------RLP-A-----PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 323 -----------------~~~-~-----p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
..+ . ...+++++.+++++||+.||+ |||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 0 135678999999999999998 999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=393.28 Aligned_cols=247 Identities=20% Similarity=0.276 Sum_probs=196.2
Q ss_pred CCCeEEEc-eeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhcc-CCCcceeceeeEEEe
Q psy7505 84 RQQLHYVK-EIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRR-LRHVNILRLMAACLE 161 (394)
Q Consensus 84 ~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~ 161 (394)
.++|.++. .||+|+||+||+|+++. ++..||||+++... .+.+|+.++.+ ++|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~------~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR-------TQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEECSH------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC-------CCCEEEEEEECCcH------HHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 36788875 59999999999999873 45589999986532 24578888655 589999999999976
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeE
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRV 234 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~v 234 (394)
+..+|||||||+||+|.++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~---~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCC---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCE
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCC---CcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccc
Confidence 45689999999999999999764321 2788889999999999999999999999999999999986 4679
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+|+...... ......||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+...
T Consensus 154 Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------y~~~~DiwSlGvily~llt-g~~Pf~~~~~~~~~~ 223 (335)
T d2ozaa1 154 KLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEK-------YDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISP 223 (335)
T ss_dssp EECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGG-------GSHHHHHHHHHHHHHHHTT-SSCSCEETTCC----
T ss_pred cccccceeeeccCCC--ccccccCCcccCCcHHHcCCC-------CCHHHHHHhhchhHHHHhh-CCCCCCCCCHHHHHH
Confidence 999999997654433 233457899999999987655 8899999999999999998 999998766444333
Q ss_pred HHh---cCCCcCCCCC--CCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVF---GTEALRLPAP--RAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~---~~~~~~~~~p--~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+. ......+|.+ ..+++++.+|+++||+.||+ ||++.|++.
T Consensus 224 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 224 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222 1221233333 36899999999999999998 999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=382.93 Aligned_cols=242 Identities=19% Similarity=0.285 Sum_probs=199.0
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-----HHHHHHHHHHHHHhccCC--Ccceecee
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-----QAEKLFFLHEATPYRRLR--HVNILRLM 156 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~~E~~~l~~l~--HpnIv~l~ 156 (394)
.++|++.+.||+|+||+||+|+++. ++..||||+++.... ......+.+|+.+|++++ |||||+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~ 75 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS-------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC-------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEE
Confidence 4679999999999999999999873 456899998864321 011112457999999886 89999999
Q ss_pred eEEEeCCceEEEEeeCCC-CCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCeE
Q psy7505 157 AACLESDPWLLVFESCSR-GDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-ELRV 234 (394)
Q Consensus 157 ~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-~~~v 234 (394)
+++.+++.+++||||+.+ +++.+++..... +++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~-----l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 76 DWFERPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCS-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred EEEeeCCeEEEEEEeccCcchHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeE
Confidence 999999999999999976 588888865432 677888899999999999999999999999999999985 4799
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+|+..... ......||+.|||||++.+..+ ++.++|||||||++|||++ |+.||.+. .
T Consensus 151 kl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~------~~~~~DiwSlGvilyell~-g~~Pf~~~--~---- 214 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRY------HGRSAAVWSLGILLYDMVC-GDIPFEHD--E---- 214 (273)
T ss_dssp EECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCB------CHHHHHHHHHHHHHHHHHH-SSCSCCSH--H----
T ss_pred EECccccceecccc---cccccccCCCcCCHHHHcCCCC------CCcccccccceeeehhHhh-CCCCCCCc--h----
Confidence 99999999754332 2335678999999999976652 5678999999999999998 99999763 2
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
.+..+ ....+..+++++.+++++||+.||+ |||+.|++.
T Consensus 215 ~i~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 EIIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhc---ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 23344 4556788999999999999999998 999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=383.18 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=201.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|++++.||+|+||+||+|+++ .++..||||+++.... +.....+.+|+.+|++++|||||++++++.+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCEeccEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 68999999999999999999987 3455899999865442 222345679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.+|+|||||.+ ++.+++..... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 75 ~~~iv~e~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 75 KLYLVFEFLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp EEEEEEECCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ceeEEEeecCC-chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence 99999999975 55555543321 126888899999999999999999999999999999999999999999999987
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEA-- 321 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~-- 321 (394)
...... .......||+.|+|||++....+ ++.++|||||||++|||++ |+.||.+.+..+.+.++.....
T Consensus 151 ~~~~~~-~~~~~~~gt~~y~apE~~~~~~~------~~~~~DiwSlGvily~m~~-G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 151 AFGVPV-RTYTHEVVTLWYRAPEILLGCKY------YSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp HHCCCS-BCTTCCBCCCTTCCHHHHTTCSS------CCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eccCCc-ccceeecccceeeehhhhccccC------CCccccccccchhhhHHhh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 553322 22334578899999999876552 6789999999999999998 9999999887777666543110
Q ss_pred cCC-------------CC-----------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 322 LRL-------------PA-----------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 322 ~~~-------------~~-----------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... .. ...+++++.+++++||+.||+ |||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 00 125678899999999999998 999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=380.50 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=198.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC-
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD- 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 163 (394)
++|.+.+.||+|+||.||+|+++ +..||||+++..... ......|+..+++++|||||+++|++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~---------g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET---------TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 57889999999999999999975 348999998755432 222335667777899999999999998654
Q ss_pred ---ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEEcCCC
Q psy7505 164 ---PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIE--------DGFIHTDVAARNCLVTSEL 232 (394)
Q Consensus 164 ---~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~--------~~iiHrDlk~~NiLl~~~~ 232 (394)
.+|||||||++|+|.++|++.. +++..++.++.|++.||.|||+ +|||||||||+||||+.++
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~~------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred cceEEEEEEecccCCCHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 5899999999999999997652 5677788999999999999996 5999999999999999999
Q ss_pred eEEEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--
Q psy7505 233 RVKIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAEL-- 307 (394)
Q Consensus 233 ~vKl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~-- 307 (394)
.+||+|||+++........ ......||+.|||||++.+... .....++.++|||||||+||||+| |..||...
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~~~~~ 223 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHED 223 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTBCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhcccccc-ccCCCcCcchhhhhhHHHHHHHhh-CCCCCCcccc
Confidence 9999999999765333221 2234578999999999876432 111226779999999999999998 87766321
Q ss_pred ------------CHHHHHHHHhcCCCcCCCCCCC-----CChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 308 ------------SDDQVITRVFGTEALRLPAPRA-----VNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 308 ------------~~~~~~~~i~~~~~~~~~~p~~-----~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
...+.+.........+++.|.. +...+.++|.+||+.||+ |||+.|+++.|.++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1122233333333334444443 234588999999999998 9999999999987753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-51 Score=374.66 Aligned_cols=250 Identities=18% Similarity=0.257 Sum_probs=200.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|+++++||+|+||+||+|+++. +..||||+++... .+.....+.+|+.+|++++|||||++++++.+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNY--------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT--------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCceeccEEecCCCcEEEEEEeCC--------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 689999999999999999998752 3479999986543 2222344679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..+++|||+.++.+..+....+. +++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTSTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHHHhhcCC-----cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccce
Confidence 99999999988777666654422 6788889999999999999999999999999999999999999999999986
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCc-
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVFGTEAL- 322 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~~~~~~- 322 (394)
....... ......+++.|+|||.+.... .++.++|||||||++|||++ |+.||.+.+..+.+.++......
T Consensus 149 ~~~~~~~-~~~~~~~~~~y~~pE~~~~~~------~~~~~~DiwslGv~l~el~~-G~~pf~~~~~~~~~~~i~~~~~~~ 220 (286)
T d1ob3a_ 149 AFGIPVR-KYTHEIVTLWYRAPDVLMGSK------KYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTP 220 (286)
T ss_dssp HHCC----------CCCTTCCHHHHTTCC------SCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecccCcc-ccceecccchhhhHHHHhCCC------CCCcceeehhcCcHHHHHHH-CCCCCCCCCHHHHHHHHHHhhCCC
Confidence 5433222 223346788899999987554 27899999999999999998 99999998887776665421100
Q ss_pred -------------------------CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 323 -------------------------RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 323 -------------------------~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
....+..+++.+.+++++||+.||+ |||+.|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0112346788999999999999998 99999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=377.67 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=197.7
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-HHHHHHHHHHHHHhccC---CCcceeceeeEE
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-QAEKLFFLHEATPYRRL---RHVNILRLMAAC 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~ 159 (394)
.++|+++++||+|+||+||+|+++.. ....||||+++.... ......+.+|+.+|+.| +|||||+++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 47899999999999999999998521 234689998865431 11111234677766655 899999999998
Q ss_pred Ee-----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 160 LE-----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 160 ~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
.. ...++++||||.+|++......... .+++..+..++.|++.||.|||+++||||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCe
Confidence 64 3468999999988776654443321 26777788899999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 235 KIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
||+|||+++...... ......||+.|||||++.+.. |+.++||||+||++|||++ |+.||.+.+..+.+.
T Consensus 156 kl~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~-------y~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 156 KLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSS-------YATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 225 (305)
T ss_dssp EECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCC-------CCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHH
T ss_pred eecchhhhhhhcccc--cCCCcccChhhcCcchhcCCC-------CChhehhhchHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence 999999987543322 234568899999999987665 8899999999999999998 999999998887776
Q ss_pred HHhcCCC------------------------cCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 315 RVFGTEA------------------------LRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 315 ~i~~~~~------------------------~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
++..... .....+..+++.+.+|+++||+.||+ |||+.|++.
T Consensus 226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 6543100 00112346788999999999999998 999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=384.08 Aligned_cols=255 Identities=18% Similarity=0.252 Sum_probs=205.2
Q ss_pred cCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc---cHHHHHHHHHHHHHhccCCC-cceeceeeE
Q psy7505 83 PRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA---SQAEKLFFLHEATPYRRLRH-VNILRLMAA 158 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~ 158 (394)
..++|++++.||+|+||+||+|+..... .++..||||+++... .......+.+|+.+|++++| |||++++++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGH----DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSST----TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccC----CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 4588999999999999999999875321 345689999886532 11122335689999999966 899999999
Q ss_pred EEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEcc
Q psy7505 159 CLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGD 238 (394)
Q Consensus 159 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~D 238 (394)
+.+.+.++++||||.+|+|.+++...+. +.+.....++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred eccCCceeeeeecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence 9999999999999999999999976643 45566778899999999999999999999999999999999999999
Q ss_pred CCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Q psy7505 239 TGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ----VIT 314 (394)
Q Consensus 239 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~----~~~ 314 (394)
||+|+..............|++.|+|||.+.+.... ++.++|||||||+||||++ |+.||.+.+..+ +..
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~-----~~~ksDIWSlG~iLyellt-G~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG-----HDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC--------CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHH
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcC-----CCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 999976544443334456788999999999765432 7889999999999999998 999998765333 333
Q ss_pred HHhcCCCcCCCCCCCCChHHHHHHHhhhcCCcc-ccc-----hhhhh
Q psy7505 315 RVFGTEALRLPAPRAVNSHVDVAARNCLVTSEL-RVK-----IGDTG 355 (394)
Q Consensus 315 ~i~~~~~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~-----~~e~~ 355 (394)
..... .++.|..+++++.+++++||+.||+ |++ +.|++
T Consensus 247 ~~~~~---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 247 RILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp HHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred hcccC---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 33333 5677889999999999999999998 875 45554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=375.63 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=202.1
Q ss_pred CceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceee
Q psy7505 79 EFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 157 (394)
.|++ .++|++++.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+|++++|||||++++
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~ 84 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 3555 678999999999999999999987 345689999987543 4444455679999999999999999999
Q ss_pred EEEeCC------ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 158 ACLESD------PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 158 ~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
+|...+ .+||||||| +++|..+++... +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~ 157 (346)
T d1cm8a_ 85 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK------LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157 (346)
T ss_dssp EECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred EeccCccccccceEEEEEecc-cccHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc
Confidence 998654 479999999 568888775432 6778889999999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
+.+||+|||+|+..... .....+|+.|+|||++.+... ++.++||||+||++|||++ |+.||.+.+..+
T Consensus 158 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~ 226 (346)
T d1cm8a_ 158 CELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMR------YTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLD 226 (346)
T ss_dssp CCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTC------CCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred cccccccccceeccCCc----cccccccccccCHHHHcCCCC------CCccchhhcchHHHHHHHH-CcCCCCCCChHH
Confidence 99999999999765332 234578899999999876442 6889999999999999998 999999988766
Q ss_pred HHHHHhcCCCc----------------------C------CCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhc
Q psy7505 312 VITRVFGTEAL----------------------R------LPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDK 360 (394)
Q Consensus 312 ~~~~i~~~~~~----------------------~------~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~ 360 (394)
.+..+...... . ......+++.+.+|+++||..||+ |||+.|++. .++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 65443321100 0 012346788999999999999998 999999974 3554
Q ss_pred CC
Q psy7505 361 YP 362 (394)
Q Consensus 361 ~~ 362 (394)
+.
T Consensus 307 ~~ 308 (346)
T d1cm8a_ 307 LH 308 (346)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=372.55 Aligned_cols=253 Identities=19% Similarity=0.230 Sum_probs=197.8
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
.++|++++.||+|+||+||+|+++ .++..||||+++..........+++|+.+|++++|||||++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDN-------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEET-------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCeEEEEEEeeccCeEEEEEEEC-------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 356999999999999999999986 3455899999876555555556679999999999999999999997643
Q ss_pred ----ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccC
Q psy7505 164 ----PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDT 239 (394)
Q Consensus 164 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DF 239 (394)
..++++||+.+|+|.+++.... +++..+..++.|++.||.|||++|||||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~~------l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ccccceEEEEEeecCCchhhhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEccc
Confidence 2345556677999999997542 677888999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCcee--eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 240 GSSIDKYPGDYY--VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 240 G~a~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|+|......... ......||+.|+|||++.... .++.++||||+||++|||++ |+.||.+.+..+......
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~~~DiwSlG~il~eml~-g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK------GYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC------SCSTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCC------CCCchhhhhccCceehHHhh-CCCCCCCCCHHHHHHHHh
Confidence 998654332211 123457889999999986543 27889999999999999998 999999887655543332
Q ss_pred cCC-------------------------CcCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 318 GTE-------------------------ALRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 318 ~~~-------------------------~~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... ....+ ....+++++.+++.+||+.||+ ||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100 00000 1236778899999999999998 999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=373.77 Aligned_cols=254 Identities=19% Similarity=0.213 Sum_probs=197.8
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceeceeeEEEeC--
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRLMAACLES-- 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 162 (394)
-+|+.+++||+|+||+||+|+++ .++..||||+++..... ..+|+.+|++++|||||+++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCcEeeeEEeeCcCeEEEEEEEC-------CCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 36888999999999999999987 34568999998765422 24799999999999999999999643
Q ss_pred ----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEc
Q psy7505 163 ----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIG 237 (394)
Q Consensus 163 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~ 237 (394)
..+|||||||++| +.+.+.... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEe
Confidence 2478999999865 444443211 1112367888899999999999999999999999999999999775 89999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||++........ .....|+..|+|||.+.+.. .|+.++||||+||++|||++ |+.||.+.+..+.+..+.
T Consensus 166 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~------~~~~~~DIwSlG~il~el~~-g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 166 DFGSAKQLVRGEP--NVSYICSRYYRAPELIFGAT------DYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCS------SCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHH
T ss_pred cccchhhccCCcc--cccccccccccChHHhhccc------CCCcceeecccceEEEehhh-CCCCCCCCCHHHHHHHHH
Confidence 9999976544332 23457788999999886543 28899999999999999998 999999888777665553
Q ss_pred cC--C--------------CcCCC----------CCCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhcC
Q psy7505 318 GT--E--------------ALRLP----------APRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDKY 361 (394)
Q Consensus 318 ~~--~--------------~~~~~----------~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~~ 361 (394)
+. . ...++ ....+++++.+|+++||..||+ |||+.|++. .++++
T Consensus 237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 21 0 00111 1235788999999999999998 999999874 34444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=368.51 Aligned_cols=253 Identities=18% Similarity=0.223 Sum_probs=193.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 161 (394)
-++|+++++||+|+||+||+|+++ ..+..||||++.... .+.....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 588999999999999999999987 345689999875443 22223345699999999999999999999865
Q ss_pred -------CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeE
Q psy7505 162 -------SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRV 234 (394)
Q Consensus 162 -------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~v 234 (394)
.+.+|+|||||.++.+..+...... +....+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~-----~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCTTCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred cccccccCceEEEEEeccCCCccchhhhcccc-----cccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcE
Confidence 3468999999987666544433221 5666778899999999999999999999999999999999999
Q ss_pred EEccCCCCccCCCCcee---eeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 235 KIGDTGSSIDKYPGDYY---VHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 235 Kl~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
||+|||+++........ .....+||+.|+|||++.+.. .|+.++|||||||++|||++ |+.||.+.+..+
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~------~~~~k~DiwSlGvil~el~~-g~~pf~~~~~~~ 229 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER------DYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQH 229 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS------SCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCC------CCCcHHHcccCCceeeeHhh-CCCCCCCCCHHH
Confidence 99999999654332221 122347899999999987653 27899999999999999998 999999888776
Q ss_pred HHHHHhcCCCcCCCC-C----------------------------CCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 312 VITRVFGTEALRLPA-P----------------------------RAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 312 ~~~~i~~~~~~~~~~-p----------------------------~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
.+..+........+. . ...++.+.+||.+||+.||+ |+|+.|++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 655543211000000 0 01356778999999999998 99999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=357.32 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=202.6
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 163 (394)
++|+++++||+|+||+||+|+++. .+..||||+++... .......+.+|+.+|++++|||||++++++.+.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECC-------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 579999999999999999999873 45589999986544 3333445679999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
..++|||++.+++|..++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||.|+
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~~~~-----~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ceeEEeeeccccccccccccccc-----cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhh
Confidence 99999999999999888866533 5677788999999999999999999999999999999999999999999997
Q ss_pred cCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCC-CCCCCHHHHHHHHhcCC--
Q psy7505 244 DKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLP-YAELSDDQVITRVFGTE-- 320 (394)
Q Consensus 244 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~P-f~~~~~~~~~~~i~~~~-- 320 (394)
....... ......++..|+|||++..... ++.++|||||||++|||++ |..| |.+.+..+.+.++....
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~------~~~~~DiwSlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 150 AFGIPVR-CYSAEVVTLWYRPPDVLFGAKL------YSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp ECCSCCS-CCCSCCSCGGGCCHHHHTTCSC------CCTHHHHHHHHHHHHHHTT-TSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccCCCc-cceeeccccchhhhhHhccCCC------CCchhhccccchHHHHHhh-CCCCCCCCCCHHHHHHHHHhhcCC
Confidence 6543322 2223456778999999876542 6889999999999999998 7777 55555555555442210
Q ss_pred ------------------------CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 321 ------------------------ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 321 ------------------------~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
......+..+++.+.+|+++||+.||+ |||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122346678999999999999998 999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-49 Score=364.48 Aligned_cols=255 Identities=15% Similarity=0.142 Sum_probs=193.9
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCCcceece-eeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRHVNILRL-MAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l-~~~~~~~~ 163 (394)
++|++.+.||+|+||+||+|+++. ++..||||++....... .+.+|+++++.++|+|+|.+ .+++.+++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~~~---~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA-------AGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEESCTTSC---CHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC-------CCCEEEEEEEchhccCH---HHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 579999999999999999999873 34589999876544221 24589999999987765555 55556778
Q ss_pred ceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCeEEEccCC
Q psy7505 164 PWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS---ELRVKIGDTG 240 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~---~~~vKl~DFG 240 (394)
..++||||| +|+|.+.+..... .+++..+..++.|++.||.|||++|||||||||+|||++. +..+||+|||
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEEEc-CCchhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccC
Confidence 889999999 5577776654322 2677888999999999999999999999999999999864 4579999999
Q ss_pred CCccCCCCce------eeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy7505 241 SSIDKYPGDY------YVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVIT 314 (394)
Q Consensus 241 ~a~~~~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~ 314 (394)
+|+....... .......||+.|||||++.+.. ++.++|||||||++|||++ |+.||.+....+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~~l~el~t-g~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-------QSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQ 223 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-------CCHHHHHHHHHHHHHHHHH-SSCTTCCCC------
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCC-------CCChhhEEecCHHHHHHHh-CCCcccccchHHHHH
Confidence 9976533221 1233457999999999987665 8899999999999999998 999998876554433
Q ss_pred HHhcCCC--cCCC---CCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCC
Q psy7505 315 RVFGTEA--LRLP---APRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYP 362 (394)
Q Consensus 315 ~i~~~~~--~~~~---~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~ 362 (394)
.+..... ...+ .+..+|+++.++|+.||..+|+ ||++.++.+.|+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 224 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 2211110 0111 2357899999999999999998 999988877776653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.9e-49 Score=361.03 Aligned_cols=257 Identities=14% Similarity=0.099 Sum_probs=202.1
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCCC-cceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLRH-VNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~ 162 (394)
.++|++.+.||+|+||+||+|+++. ++..||||++....... .+.+|+.+++.+.| +||+.+++++..+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL-------NNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-------TTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 5789999999999999999999873 45589999875543221 24578888888855 8999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----CCeEEEc
Q psy7505 163 DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS-----ELRVKIG 237 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~-----~~~vKl~ 237 (394)
...++||||| +|+|.+++...+. .++......++.|++.||.|||++|||||||||+|||++. .+.+||+
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CccEEEEEec-CCCHHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEc
Confidence 9999999999 6899999876532 2677778899999999999999999999999999999974 5789999
Q ss_pred cCCCCccCCCCc------eeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---
Q psy7505 238 DTGSSIDKYPGD------YYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS--- 308 (394)
Q Consensus 238 DFG~a~~~~~~~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~--- 308 (394)
|||+|+...... ........||+.|||||++.+.. ++.++|||||||++|||++ |+.||.+..
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-------~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~~~ 220 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-------QSRRDDLEALGHVFMYFLR-GSLPWQGLKAAT 220 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------CCHHHHHHHHHHHHHHHHH-SSCTTSSCCSCC
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-------CChHHHHHHhhHHHHHHHh-CCCcCCCccchh
Confidence 999997643221 11233457999999999987654 8899999999999999998 999998654
Q ss_pred HHHHHHHHhcCCCc--CCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhhhhhcCCC
Q psy7505 309 DDQVITRVFGTEAL--RLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGSSIDKYPG 363 (394)
Q Consensus 309 ~~~~~~~i~~~~~~--~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~~l~~~~~ 363 (394)
..+...++...... ....+..+|+++.+++..||..+|+ ||+...+.+.|+++.+
T Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 221 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 33333333322100 1112357899999999999999997 9988777777766553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=367.10 Aligned_cols=259 Identities=17% Similarity=0.245 Sum_probs=204.0
Q ss_pred CCceecCCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceecee
Q psy7505 78 SEFQFPRQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLM 156 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~ 156 (394)
+.|+++ ++|++++.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+|++++|||||+++
T Consensus 12 ~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~ 83 (348)
T d2gfsa1 12 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83 (348)
T ss_dssp SEEEEE-TTEEEEEECGGGTTSSEEEEEET-------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ccccCC-CCeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 346664 67999999999999999999987 345689999987554 334444567999999999999999999
Q ss_pred eEEEeC-----CceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7505 157 AACLES-----DPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSE 231 (394)
Q Consensus 157 ~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~ 231 (394)
+++... ...+++|||+.+|+|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~------l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~ 157 (348)
T d2gfsa1 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157 (348)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred EEEeeccccccCceEEEEEeecCCchhhhccccc------ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc
Confidence 999643 23466777888999999996542 6778889999999999999999999999999999999999
Q ss_pred CeEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy7505 232 LRVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQ 311 (394)
Q Consensus 232 ~~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~ 311 (394)
|.+|++|||+|..... ......|+..|+|||++.+... ++.++|||||||++|+|++ |+.||.+.+...
T Consensus 158 ~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~------~~~~~DiwSlGv~l~~ll~-g~~pF~~~~~~~ 226 (348)
T d2gfsa1 158 CELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------YNQTVDIWSVGCIMAELLT-GRTLFPGTDHID 226 (348)
T ss_dssp CCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSC------CCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred ccccccccchhcccCc----ccccccccccccCchhhcCCcc------CCcccchhhhhHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999999865422 1234567889999998766542 6889999999999999998 999999988776
Q ss_pred HHHHHhcCCCc----------------------CCCC------CCCCChHHHHHHHhhhcCCcc-ccchhhhhh--hhhc
Q psy7505 312 VITRVFGTEAL----------------------RLPA------PRAVNSHVDVAARNCLVTSEL-RVKIGDTGS--SIDK 360 (394)
Q Consensus 312 ~~~~i~~~~~~----------------------~~~~------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~--~l~~ 360 (394)
....+...... +.+. ...+++.+.+||++||..||. |+|+.|++. .+++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 66555432110 0010 135788999999999999998 999999875 4554
Q ss_pred C
Q psy7505 361 Y 361 (394)
Q Consensus 361 ~ 361 (394)
+
T Consensus 307 ~ 307 (348)
T d2gfsa1 307 Y 307 (348)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=359.52 Aligned_cols=245 Identities=21% Similarity=0.257 Sum_probs=193.3
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEe-
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLE- 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~- 161 (394)
.++|+++++||+|+||+||+|+++ .++..||||+++.... ..+.+|+.+|+++ +||||++++++|..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~----~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSSCH----HHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEECHHHH----HHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 468999999999999999999987 3456899999876542 2356899999999 49999999999974
Q ss_pred -CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-eEEEccC
Q psy7505 162 -SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSEL-RVKIGDT 239 (394)
Q Consensus 162 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~-~vKl~DF 239 (394)
...+++|||||.+|+|..+.+ .+++..+..++.||+.||.|||++|||||||||+|||++.++ .+||+||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred CCCceeEEEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccc
Confidence 456999999999999976542 157777889999999999999999999999999999998654 6999999
Q ss_pred CCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH--
Q psy7505 240 GSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELS-DDQVITRV-- 316 (394)
Q Consensus 240 G~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~-~~~~~~~i-- 316 (394)
|+|+...... ......+|..|+|||.+.+.. .++.++||||+||++|||++ |+.||.... ..+....+
T Consensus 175 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~~l~e~~~-g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 175 GLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQ------MYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp GGCEECCTTC--CCCSCCSCGGGCCHHHHTTCC------CCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHHHHHH
T ss_pred ccceeccCCC--cccccccCccccCcccccCCC------CCCcccchhhhhhhhHHhcc-CCCCCCCCchhHHHHHHHHH
Confidence 9997654332 223457889999999987654 27899999999999999998 999997654 22222111
Q ss_pred -hcC-----------C--------------------CcCCCCCCCCChHHHHHHHhhhcCCcc-ccchhhhhh
Q psy7505 317 -FGT-----------E--------------------ALRLPAPRAVNSHVDVAARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 317 -~~~-----------~--------------------~~~~~~p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~~ 356 (394)
... . ....+....+++++.+||++||..||+ |+|+.|+++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 0 001112235788999999999999998 999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=361.42 Aligned_cols=246 Identities=20% Similarity=0.230 Sum_probs=187.5
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccc-cHHHHHHHHHHHHHhccCCCcceeceeeEEEe--
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDA-SQAEKLFFLHEATPYRRLRHVNILRLMAACLE-- 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 161 (394)
++|+++++||+|+||+||+|+++ .++..||||+++... .......+.+|+.++++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCcCeEEEEEEEC-------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 67999999999999999999987 345689999987654 34444557799999999999999999999964
Q ss_pred ----CCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCeEEEc
Q psy7505 162 ----SDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTSELRVKIG 237 (394)
Q Consensus 162 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~~~~vKl~ 237 (394)
...+|+|||||.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+|||++.++.+|++
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~~~-------~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~ 161 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQME-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTSC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred ccccCceeEEEEeccch-HHHHhhhcC-------CCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeee
Confidence 3578999999966 555555332 5677788999999999999999999999999999999999999999
Q ss_pred cCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q psy7505 238 DTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKLPYAELSDDQVITRVF 317 (394)
Q Consensus 238 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~Pf~~~~~~~~~~~i~ 317 (394)
|||+++...... ......+|..|+|||++.+.. ++.++||||+||++|||++ |+.||.+.+......++.
T Consensus 162 df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~-------~~~~~DiwSlG~~l~ell~-g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 162 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMG-------YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp CCCC-----------------CCTTCCHHHHTTCC-------CCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred chhhhhcccccc--ccccccccccccChhhhcCCC-------CCCCcccccccchHHHHhh-CCCCCCCCCHHHHHHHHH
Confidence 999886543322 223457888999999997654 7899999999999999998 999999887666555443
Q ss_pred cCCCc-------------------CCCC--------------------CCCCChHHHHHHHhhhcCCcc-ccchhhhh
Q psy7505 318 GTEAL-------------------RLPA--------------------PRAVNSHVDVAARNCLVTSEL-RVKIGDTG 355 (394)
Q Consensus 318 ~~~~~-------------------~~~~--------------------p~~~~~~~~~l~~~cl~~~p~-r~~~~e~~ 355 (394)
..... .... +...++++.+|+++||..||+ |||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 21100 0000 012355788999999999998 99999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-40 Score=313.72 Aligned_cols=249 Identities=18% Similarity=0.225 Sum_probs=180.6
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-----------Ccce
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-----------HVNI 152 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnI 152 (394)
..+|+++++||+|+||+||+|+++ .++..||||+++.+... ...+.+|+.+++.++ |+||
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~-------~~g~~vAvKvi~~~~~~--~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCHHH--HHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCcEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeccccc--hHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 356999999999999999999987 34568999999765432 223457888877764 5789
Q ss_pred eceeeEEEe--CCceEEEEeeCCCCCHHH-HHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEE
Q psy7505 153 LRLMAACLE--SDPWLLVFESCSRGDLKE-FLLSNEASREALLEQGITIKMAIDVATGLSYMIE-DGFIHTDVAARNCLV 228 (394)
Q Consensus 153 v~l~~~~~~--~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~iiHrDlk~~NiLl 228 (394)
|++++++.. ....+++|+++..+.... ...... ...+.+..+..++.||+.||.|||+ .||+||||||+|||+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeeccccccccccccccc---ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence 999999865 345677777776654333 332221 1225667788999999999999998 899999999999999
Q ss_pred cCCC------eEEEccCCCCccCCCCceeeeCCccCCcccccccccccCCCCcccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy7505 229 TSEL------RVKIGDTGSSIDKYPGDYYVHGEVALPVRWCAPESLLCSDTSIQTCTVTEKCNVWSFGVLLWEIFEFGKL 302 (394)
Q Consensus 229 ~~~~------~vKl~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~~~~~~~DiwSlG~il~el~t~g~~ 302 (394)
+.++ .+|++|||.|..... ......||+.|+|||++.... ++.++||||+||+++||++ |+.
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~el~~-g~~ 227 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-------WGCGADIWSTACLIFELIT-GDF 227 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-------CCTHHHHHHHHHHHHHHHH-SSC
T ss_pred eccCcccccceeeEeeccccccccc----ccccccccccccChhhccccC-------CCccccccchHHHHHHHHH-CCC
Confidence 8654 499999999865432 223457889999999988665 7899999999999999998 999
Q ss_pred CCCCCCH------HHHHHH---HhcCC--------------------C----------------cCCCCCCCCChHHHHH
Q psy7505 303 PYAELSD------DQVITR---VFGTE--------------------A----------------LRLPAPRAVNSHVDVA 337 (394)
Q Consensus 303 Pf~~~~~------~~~~~~---i~~~~--------------------~----------------~~~~~p~~~~~~~~~l 337 (394)
||..... .+.+.. +++.. . .+...+...++++.+|
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 9975432 111111 11100 0 0111122345688999
Q ss_pred HHhhhcCCcc-ccchhhhhh
Q psy7505 338 ARNCLVTSEL-RVKIGDTGS 356 (394)
Q Consensus 338 ~~~cl~~~p~-r~~~~e~~~ 356 (394)
+.+||..||. |||+.|++.
T Consensus 308 l~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhc
Confidence 9999999998 999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.1e-25 Score=192.72 Aligned_cols=133 Identities=16% Similarity=0.111 Sum_probs=101.2
Q ss_pred EEEceeeeecceEEEEEEEcCcccccCcccceEEEEeeccccc-----------------HHHHHHHHHHHHHhccCCCc
Q psy7505 88 HYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDAS-----------------QAEKLFFLHEATPYRRLRHV 150 (394)
Q Consensus 88 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~-----------------~~~~~~~~~E~~~l~~l~Hp 150 (394)
.+.++||+|+||+||+|++. .+..||||+++.... ........+|...+.++.|.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 74 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred hhCCEeeeCcceEEEEEECC--------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence 46789999999999999875 244899998653211 11122334688899999999
Q ss_pred ceeceeeEEEeCCceEEEEeeCCCCCHHHHHhhcchhhhhhhhHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7505 151 NILRLMAACLESDPWLLVFESCSRGDLKEFLLSNEASREALLEQGITIKMAIDVATGLSYMIEDGFIHTDVAARNCLVTS 230 (394)
Q Consensus 151 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~gl~yLH~~~iiHrDlk~~NiLl~~ 230 (394)
+++..+++. ..+++|||++++.+.++ .......++.|++.||.|||++||+||||||+|||+++
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred CcceEEEec----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence 999887653 23799999988655331 22234468899999999999999999999999999986
Q ss_pred CCeEEEccCCCCccC
Q psy7505 231 ELRVKIGDTGSSIDK 245 (394)
Q Consensus 231 ~~~vKl~DFG~a~~~ 245 (394)
++ ++|+|||+|...
T Consensus 139 ~~-~~liDFG~a~~~ 152 (191)
T d1zara2 139 EG-IWIIDFPQSVEV 152 (191)
T ss_dssp TE-EEECCCTTCEET
T ss_pred CC-EEEEECCCcccC
Confidence 54 899999998654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.6e-06 Score=75.42 Aligned_cols=87 Identities=9% Similarity=-0.011 Sum_probs=53.2
Q ss_pred CCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccC-CCcceeceeeEEEeCC
Q psy7505 85 QQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRL-RHVNILRLMAACLESD 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 163 (394)
+.|.+.+..+.|+.+.||+.... ...+++|......... ...+.+|...++.+ .+--+-+++.+..+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~---------~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGE---------NENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECS---------SCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred hceEEEEcCCCCCCCcEEEEEeC---------CCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34555555554556789977633 2256677665432111 11134666666555 2333567777888888
Q ss_pred ceEEEEeeCCCCCHHHHH
Q psy7505 164 PWLLVFESCSRGDLKEFL 181 (394)
Q Consensus 164 ~~~lv~E~~~~g~L~~~l 181 (394)
..++||++++|.++.+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEEEECCSSEEHHHHT
T ss_pred ceEEEEEecccccccccc
Confidence 899999999988776543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.52 E-value=0.00012 Score=62.64 Aligned_cols=73 Identities=21% Similarity=0.155 Sum_probs=45.0
Q ss_pred eeeecc-eEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC--CcceeceeeEEEeCCceEEEE
Q psy7505 93 IGRGWF-GKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR--HVNILRLMAACLESDPWLLVF 169 (394)
Q Consensus 93 lG~G~f-g~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~ 169 (394)
+..|.. +.||+....+ ...+++|........ .+..|+..++.|. .-.+.+++++..+++..++||
T Consensus 18 ~~~G~s~~~v~r~~~~~--------~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG--------RPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CSCTTSSCEEEEEECTT--------SCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred cCCcccCCeEEEEEeCC--------CCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 444443 6789776542 224667766544321 1335666665552 233566778888888899999
Q ss_pred eeCCCCCH
Q psy7505 170 ESCSRGDL 177 (394)
Q Consensus 170 E~~~~g~L 177 (394)
|+++|-++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00033 Score=64.35 Aligned_cols=28 Identities=18% Similarity=0.256 Sum_probs=24.7
Q ss_pred CceecCCCCCCEEEcCCCeEEEccCCCCc
Q psy7505 215 GFIHTDVAARNCLVTSELRVKIGDTGSSI 243 (394)
Q Consensus 215 ~iiHrDlk~~NiLl~~~~~vKl~DFG~a~ 243 (394)
.++|+|+.+.|||++.++ ++|.||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998765 8999998774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.67 E-value=0.0019 Score=59.05 Aligned_cols=86 Identities=13% Similarity=0.079 Sum_probs=52.9
Q ss_pred CCCeEEEceeeeecceEEEEEEEcCcccccCcccceEEEEeecccccHHHHHHHHHHHHHhccCC-CcceeceeeEEEeC
Q psy7505 84 RQQLHYVKEIGRGWFGKVVEGEARGLEESTGRTTSKVFVRILKEDASQAEKLFFLHEATPYRRLR-HVNILRLMAACLES 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 162 (394)
.+++++ +.|+.|-.-.+|++...............|++++.-....... ..+|..+++.+. +.-..++++++.+
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~id---r~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESH---LVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHH---HHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhH---HHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 345554 5688899999999987643332233445677777653322221 236777777773 3334477777642
Q ss_pred CceEEEEeeCCCCCH
Q psy7505 163 DPWLLVFESCSRGDL 177 (394)
Q Consensus 163 ~~~~lv~E~~~~g~L 177 (394)
.+||||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.33 E-value=0.021 Score=49.78 Aligned_cols=29 Identities=21% Similarity=0.190 Sum_probs=26.0
Q ss_pred CCceecCCCCCCEEEcCCCeEEEccCCCC
Q psy7505 214 DGFIHTDVAARNCLVTSELRVKIGDTGSS 242 (394)
Q Consensus 214 ~~iiHrDlk~~NiLl~~~~~vKl~DFG~a 242 (394)
.|+||+|+.+.|++++.+...-|.||+.+
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred cccccCCcchhhhhcccccceeEeccccc
Confidence 47999999999999998877789999965
|